Citrus Sinensis ID: 003832
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | 2.2.26 [Sep-21-2011] | |||||||
| O81833 | 815 | G-type lectin S-receptor- | yes | no | 0.965 | 0.938 | 0.548 | 0.0 | |
| O81832 | 783 | G-type lectin S-receptor- | no | no | 0.911 | 0.922 | 0.521 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.977 | 0.910 | 0.478 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.967 | 0.908 | 0.474 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.976 | 0.912 | 0.465 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.972 | 0.924 | 0.457 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.978 | 0.908 | 0.466 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.964 | 0.891 | 0.449 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.972 | 0.911 | 0.445 | 0.0 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.976 | 0.910 | 0.444 | 0.0 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 813 bits (2099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/795 (54%), Positives = 553/795 (69%), Gaps = 30/795 (3%)
Query: 21 ITPSQSIRDGETLVSVNGTFELGFFSPGTSAK---RYLGIWYKRVSPRTVAWVANRETPL 77
ITP + ++DG+TL S + F+LGFFS + R+LG+WY + P V WVANR PL
Sbjct: 28 ITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWVANRNNPL 85
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITM-----KNPVVQLMDSGNLVLTDGNYN 131
SG LN++S G + L DG + WSS++S T NP++++ SGNL+ +DG
Sbjct: 86 YGTSGFLNLSSLGDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSDGE-E 144
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVL 191
++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK++ DP+PG+F+L +DT G PQL+L
Sbjct: 145 AVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTRGLPQLIL 204
Query: 192 RKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRLWV 249
RK S YR GSWNGL FTG P + L DYKF + EV Y + VSRL +
Sbjct: 205 RKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHRIVSRLVL 264
Query: 250 NQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR--RCDCLEGFVPK 307
N +G + R I S+Q+ W LA AP D CD YS+CGA A C NS C CL+GF PK
Sbjct: 265 NNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICGAYAVCGINSKNTPSCSCLQGFKPK 323
Query: 308 SPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNA--SMNLKECSELCS 360
S W + GCV E C D F K+ LKLPDTS SW++A M L++C CS
Sbjct: 324 SGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNEMTLEDCKIKCS 383
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+ GQD+YIR+ + ++ VG++
Sbjct: 384 SNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKIEFKGREVVGMV 443
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH--MKEDMELWEFDFASIAKATDNFASY 478
+ SV+ +A+ +V C +K +K+ +ED++L FD +I+ ATD+F+
Sbjct: 444 VGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLPIFDRKTISIATDDFSYV 503
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIA+LQHRNLV+LLGCC
Sbjct: 504 NFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCC 563
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
IQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+KR++I+ G+ARGILYLHQDSR+RIIH
Sbjct: 564 IQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIH 623
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++T++VVGTYGYM PEYA +G FSVKS
Sbjct: 624 RDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKS 683
Query: 659 DVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM-ELAGDTLADSHPPTE 717
DVFSFGVLVLEI++GK N F H DHD NLLGH W +W E R + + L ++ E
Sbjct: 684 DVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPE 743
Query: 718 VLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPSYPQ 777
VLRCIHV LLCVQ +PEDRP M+SVVLM SDS LP P +PGFFT R++P+ S S
Sbjct: 744 VLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSLPHPTQPGFFTNRNVPDISSSLSL-- 801
Query: 778 SSTTNEITITELQGR 792
+ NE++IT LQGR
Sbjct: 802 -RSQNEVSITMLQGR 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function description |
|---|
Score = 786 bits (2030), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/767 (52%), Positives = 535/767 (69%), Gaps = 45/767 (5%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
+ A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR+
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 75 TPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNT-----SITMKNPVVQLMDSGNLVLTD- 127
+PL D SG L V+ G + L + R+ I WSS++ +++NP+VQ++D+GNLV+ +
Sbjct: 81 SPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNS 140
Query: 128 GNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
G+ +WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G P
Sbjct: 141 GDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVP 200
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SR 246
Q L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R
Sbjct: 201 QFFLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTR 259
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
+ +N +G + R W W A +D CD Y++CG+ C N S C CL+GFV
Sbjct: 260 MQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVA 319
Query: 307 KSPN-----NWSEGCVRERELKCRNG-DEFPKYVKLKLPDTSSSWFNASMNLKECSELCS 360
K+P +WSEGCVR +L C G D F K KLKLPDT +SW++ +M+L EC ++C
Sbjct: 320 KTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCL 379
Query: 361 KNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGII 420
+NC+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS ++ ++
Sbjct: 380 RNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQRESS--- 436
Query: 421 IASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNK 480
R +KQ +ED+EL D ++++AT F++ NK
Sbjct: 437 -------------------RVSSRKQ-------EEEDLELPFLDLDTVSEATSGFSAGNK 470
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG+GGFGPVYKGTL GQE+AVKRLS+ S QG+EEFKNE+ LIA+LQHRNLVK+LG C+
Sbjct: 471 LGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVD 530
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+E MLIYEY PNKSLD FIFD+ R LDW KR+ I+ GIARG+LYLH+DSR+RIIHRD
Sbjct: 531 EEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRD 590
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDV 660
LKASNVLLD+DMN KISDFG+AR GGDE + NT +VVGTYGYMSPEY +G FS+KSDV
Sbjct: 591 LKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDV 650
Query: 661 FSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP-TEVL 719
FSFGVLVLEIVSG++N F + +H NLLGHAW + E +A E+ + + +S +EVL
Sbjct: 651 FSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVL 710
Query: 720 RCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSL 766
R IH+GLLCVQ P+DRPNMS VVLMLSS+ LL +P +PGFF ER+L
Sbjct: 711 RVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLDPRQPGFFNERNL 757
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/827 (47%), Positives = 534/827 (64%), Gaps = 53/827 (6%)
Query: 15 SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRE 74
SA + + S +I T+VS FELGFF PG ++ YLGIWYK +S RT WVANR+
Sbjct: 28 SANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRD 87
Query: 75 TPLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS 132
TPL+ G L ++ +V+LD D WS+N T +++P+V +L+D+GN VL D ++
Sbjct: 88 TPLSSSIGTLKISDSNLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNSA 147
Query: 133 ---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+LWQSFD P DTLLP MKLG + KTG +R + SWKS +DP+ G+FS ++T GFP++
Sbjct: 148 PDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPEI 207
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AKGPAVSRLW 248
L YR+G WNG+ F+G P ++ + + F ++ EV Y K SRL
Sbjct: 208 FLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMV-FNFTTSKEEVTYSFRITKSDVYSRLS 266
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ SGL+ R W W +YAP D+CD Y CG C +N+S C+C++GF P++
Sbjct: 267 ISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFKPRN 326
Query: 309 PNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNC 363
P W S+GCVR+ L C GD F + K+KLPDT+++ + + +KEC + C ++C
Sbjct: 327 PQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCLRDC 386
Query: 364 SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGII 420
+CTA+AN+D+ GSGC+ W G+L D++ Y GGQDLY+R+A+ E R+ + K +G
Sbjct: 387 NCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLEDKRNRSAKIIGSS 446
Query: 421 IA-SVLLMAMFIVASLFCIWRKKLKKQGLTKM---------------------------S 452
I SVLL+ FI+ F +W++K K+ L +
Sbjct: 447 IGVSVLLLLSFII---FFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRHISRE 503
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+ +D+EL +F +A AT+NF++ NKLG+GGFG VYKG L++GQE+AVKRLSK S QG
Sbjct: 504 NNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQG 563
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+EFKNEV LIARLQH NLV+LL CC+ A E MLIYEY+ N SLD +FD++R + L+WQ
Sbjct: 564 TDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQ 623
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ GIARG+LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMARIFG DE +
Sbjct: 624 MRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEA 683
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692
NT KVVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+S K+N F + D D NLLG
Sbjct: 684 NTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCV 743
Query: 693 WILWKEKRAMELAGDTLADSHPP---TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749
W WKE + +E+ + DS E+LRCI +GLLCVQ R EDRP MS V+LML S+
Sbjct: 744 WRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSE 803
Query: 750 S-LLPEPNRPGFFTERSLPEAEFSPSYP---QSSTTNEITITELQGR 792
S +P+P PG+ ERSL + + S S +S T N+IT++ L R
Sbjct: 804 STTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/816 (47%), Positives = 525/816 (64%), Gaps = 50/816 (6%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+ PL+ +
Sbjct: 33 TESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSN 92
Query: 82 GLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNSLLWQSFD 139
G L ++ +V+ D DR WS+N T +++PV +L+D+GN +L D N N LLWQSFD
Sbjct: 93 GTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSN-NRLLWQSFD 151
Query: 140 HPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQY 199
P DTLL MKLG + KTG +R L SWK+ +DP+ GEFS ++T FP+ + + Y
Sbjct: 152 FPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESILY 211
Query: 200 RAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLWVNQSGLVLRS 258
R+G WNG+ F+ P + V Y F ++ EV Y K SRL++N +GL+ R
Sbjct: 212 RSGPWNGMRFSSVPGTIQ-VDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQRL 270
Query: 259 IWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNW-----S 313
W W +Y+P D CD Y VCG C +NS C C++GF P + W S
Sbjct: 271 TWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNEQAWDLRDGS 330
Query: 314 EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDV 373
GC+R+ L C D F + ++KLPDT+++ + + LK C E C ++C+CTA+AN+D+
Sbjct: 331 AGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAFANADI 390
Query: 374 ERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIIIA-SVLLMAM 429
GGSGC++W +++DM+ Y GGQDLY+R+A+ E R +K +G I S+LL+
Sbjct: 391 RNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELEDKRIKNEKIIGSSIGVSILLLLS 450
Query: 430 FIVASLFCIWRKKLKK--------------------------QGLTKMSHMKEDMELWEF 463
F++ F W++K K+ +G T E +EL
Sbjct: 451 FVI---FHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEYLELPLL 507
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LI
Sbjct: 508 ELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLI 567
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
A+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR I+ GIAR
Sbjct: 568 AKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIAR 627
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT +VVGTYGY
Sbjct: 628 GLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGY 687
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703
MSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F + + D NLLG W WKE +E
Sbjct: 688 MSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELE 747
Query: 704 LAG----DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL-LPEPNRP 758
+ D+L+ P E+LRCI +GLLCVQ R EDRP MSSV++ML S++ +P+P RP
Sbjct: 748 IVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRP 807
Query: 759 GFFTERSLPEAEFSPSYPQSS--TTNEITITELQGR 792
GF RS EA+ S S + T N+IT++ + R
Sbjct: 808 GFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/825 (46%), Positives = 522/825 (63%), Gaps = 52/825 (6%)
Query: 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRET 75
A+N + T S +I +T++S + FELGFF+P +S++ YLGIWYK + RT WVANR+
Sbjct: 27 ASNFSATESLTISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDN 86
Query: 76 PLTDQSGLLNVTSKGIVLLDGRDRIFWSSN-TSITMKNPVV-QLMDSGNLVLTDGNYNS- 132
PL+ +G L ++ +V+ D DR WS+N T +++PV +L+D GN VL D N
Sbjct: 87 PLSSSNGTLKISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKP 146
Query: 133 --LLWQSFDHPCDTLLPGMKLGRNFKTG-MDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
LWQSFD P DTLL MK+G + K+G +R L SWK+ +DP+ G+FS + T GFP+
Sbjct: 147 SGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEF 206
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA-KGPAVSRLW 248
+ + YR+G W G F+ P +K V D F N +V Y K S L
Sbjct: 207 YIYNKESITYRSGPWLGNRFSSVPGMKP-VDYIDNSFTENNQQVVYSYRVNKTNIYSILS 265
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
++ +GL+ R W W +Y+P D CD Y CG C N+S C+C++GF P +
Sbjct: 266 LSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANTSPICNCIKGFEPMN 325
Query: 309 PN----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+ S GCVR+ +L C D F + K++LPDT+ + + + LKEC E C K C+
Sbjct: 326 EQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCN 385
Query: 365 CTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---ERGRSVTKKQVGIII 421
CTA+AN+D+ GGSGC++W G L D++ Y GGQDLY+R+A+ E R +KK +G I
Sbjct: 386 CTAFANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSI 445
Query: 422 A-SVLLMAMFIVASLFCIWRKKLKK--------------------------QGLTKMSHM 454
S+LL+ FI+ F W++K K+ + T +
Sbjct: 446 GVSILLLLSFII---FHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENK 502
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
+ +EL ++ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +
Sbjct: 503 TDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTD 562
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF NEV LIA+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++ L+WQKR
Sbjct: 563 EFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKR 622
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +E + NT
Sbjct: 623 FDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANT 682
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694
+VVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F + + D NLLG W
Sbjct: 683 RRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWR 742
Query: 695 LWKEKRAMELAG----DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750
WKE + +E+ D L+ P E+LRCI +GLLCVQ R EDRP MSSV++ML S++
Sbjct: 743 HWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSET 802
Query: 751 L-LPEPNRPGFFTERSLPEAEFSPSYPQSS--TTNEITITELQGR 792
+P+P RPGF RS E + S S + T N++T++ + R
Sbjct: 803 TAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/818 (45%), Positives = 510/818 (62%), Gaps = 48/818 (5%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D I QS+RDGE ++S F GFFS G S RY+GIWY ++S +T+ WVANR+ P+
Sbjct: 20 DTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHPIN 79
Query: 79 DQSGLLNVTSKG---IVLLDGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNYNSL 133
D SG++ +++G + D + WS+N S +M P V L D GNLVL D
Sbjct: 80 DTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTGRS 139
Query: 134 LWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK 193
W+SFDHP DT LP M+LG K G+DR L+SWKS DP G+ L ++ GFPQL+L K
Sbjct: 140 FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQLILYK 199
Query: 194 GSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQS 252
G +R GSW G ++G P + + + FV NE+EV + +V +R VN++
Sbjct: 200 GVTPWWRMGSWTGHRWSGVPEMPIGY-IFNNSFVNNEDEVSFTYGVTDASVITRTMVNET 258
Query: 253 GLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR--RCDCLEGFVPKSPN 310
G + R W ++ W + P ++CD Y+ CG N C + SS+ C CL GF PK P
Sbjct: 259 GTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGFEPKFPR 318
Query: 311 NW-----SEGCVRERELK-CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCS 364
+W S GC +++ C D F K ++K+PDTS + + ++ LKEC + C KNCS
Sbjct: 319 HWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQRCLKNCS 378
Query: 365 CTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE------RGRSVTKKQ 416
C AYA++ + +RG GCL W G ++D + Y + GQD YIR+ E R K++
Sbjct: 379 CVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRNGLSGKRR 438
Query: 417 VGIIIASVLLMAMFIVASLFCIWRKKLKK------------------QGLTKMSHMKEDM 458
V +I+ S++ M + LFC+ R++ K + +
Sbjct: 439 VLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFEQDKARNR 498
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL FD +I AT+NF+S NKLG GGFGPVYKG L EIAVKRLS+ SGQGMEEFKN
Sbjct: 499 ELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKN 558
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + + LDW KR+ IV
Sbjct: 559 EVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIV 618
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GIARGILYLHQDSR+RIIHRDLKASN+LLD++M PKISDFGMARIFGG++++ T +VV
Sbjct: 619 RGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVV 678
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
GT+GYM+PEYA EG FS+KSDV+SFGVL+LEI++GKKN F + NL+GH W LW+
Sbjct: 679 GTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGHIWDLWEN 736
Query: 699 KRAMELAGDTLAD--SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL-LPEP 755
A E+ D L D ++ EV++CI +GLLCVQ DR +MSSVV+ML ++ LP P
Sbjct: 737 GEATEII-DNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNP 795
Query: 756 NRPGFFTERSLPEAEFSPSYPQSS-TTNEITITELQGR 792
P F + R + Q+ + N++T +++QGR
Sbjct: 796 KHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 699 bits (1804), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/832 (46%), Positives = 517/832 (62%), Gaps = 57/832 (6%)
Query: 12 LGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVA 71
L S + T S +I +T+VS G FELGFF YLGIWYK++S RT WVA
Sbjct: 28 LSISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVA 86
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVV-QLMDSGNLVLTDGNY 130
NR+TPL++ G+L +++ +V+LD D WS+N + +++ VV +L+D+GN VL
Sbjct: 87 NRDTPLSNPIGILKISNANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 131 NS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFP 187
N LWQSFD P DTLLP MKLGR+ K G++R ++SWKS DP+ G F ++T G P
Sbjct: 147 NESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLP 206
Query: 188 QLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGP-AVSR 246
+ + YR+G W+GL F+G +++ + Y F N EV Y + SR
Sbjct: 207 EFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDII-YNFTENREEVAYTFRVTDHNSYSR 265
Query: 247 LWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVP 306
L +N G + +W Q W + ++ P D CDLY +CG A C ++S C+C++GF P
Sbjct: 266 LTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGFQP 325
Query: 307 KSPNNWSEG-----CVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK 361
SP +W+ G C R+ +L C D F + + +K+P T+++ + + LKEC E C
Sbjct: 326 LSPQDWASGDVTGRCRRKTQLTC-GEDRFFRLMNMKIPATTAAIVDKRIGLKECEEKCKT 384
Query: 362 NCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS----ERGRSVTKKQV 417
+C+CTAYANSD+ GGSGC++W G+ D++ Y GQDL++R+A+ ER K
Sbjct: 385 HCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFGERRTIRGKIIG 444
Query: 418 GIIIASVLLMAMFIVASLFCIWRKKLKKQGLTK--MSHMKEDMEL--------------- 460
II S++L+ FI+ +C W+KK K+ T + + EL
Sbjct: 445 LIIGISLMLVLSFII---YCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRRLL 501
Query: 461 --------WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+F ++ AT+NF+ N LG GGFG VYKG L++GQEIAVKRLS+ S QG
Sbjct: 502 GEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEMSSQG 561
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDW 571
EFKNEV LIARLQH NLV+LL CCI ADE +LIYEY+ N SLD +F+ +++ L+W
Sbjct: 562 TNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSNKLNW 621
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q R I+ GIARG+LYLHQDSR +IIHRDLKASNVLLD +M PKISDFGMARIF DE +
Sbjct: 622 QTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFERDETE 681
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691
NT KVVGTYGYMSPEYA EG+FSVKSDVFSFGVLVLEIVSGK+N F + D+NLLG+
Sbjct: 682 ANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNNLLGY 741
Query: 692 AWILWKEKRAMELAGDTLADS------HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745
W WKE + +E+ + DS P EVLRCI +GLLCVQ R EDRP MSSVVLM
Sbjct: 742 TWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQERAEDRPKMSSVVLM 801
Query: 746 LSSDS-LLPEPNRPGFFTER-SLPEAEFSPSYPQSS---TTNEITITELQGR 792
L S+ +P+P RPG+ R SL A+ S S + S T N+IT++ + R
Sbjct: 802 LGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITVSVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 694 bits (1790), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/826 (44%), Positives = 524/826 (63%), Gaps = 62/826 (7%)
Query: 22 TPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQS 81
T S +I +TLVS FE+GFF T+++ YLG+WYK+VS RT WVANR+ PL++
Sbjct: 39 TESLTISSNKTLVSPGSIFEVGFFR--TNSRWYLGMWYKKVSDRTYVWVANRDNPLSNAI 96
Query: 82 GLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVV-QLMDSGNLVLTDGNYN---SLLWQ 136
G L ++ +VLLD ++ ++W++ T ++PVV +L+ +GN V+ D + N LWQ
Sbjct: 97 GTLKISGNNLVLLDHSNKPVWWTNLTRGNERSPVVAELLANGNFVMRDSSNNDASEYLWQ 156
Query: 137 SFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSV 196
SFD+P DTLLP MKLG N KTG++R L+SW+S +DP+ G FS ++T P+ L + +
Sbjct: 157 SFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSSDDPSSGNFSYKLETQSLPEFYLSRENF 216
Query: 197 LQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLWVNQSGLV 255
+R+G WNG+ F+G P + + Y F+ N EV Y + SRL + G
Sbjct: 217 PMHRSGPWNGIRFSGIPE-DQKLSYMVYNFIENNEEVAYTFRMTNNSFYSRLTLISEGYF 275
Query: 256 LRSIWSSQQDVWFLAYYAPLD-RCDLYSVCGANARCTTNSSRRCDCLEGFVPKSPNNWSE 314
R W +W + +P+D +CD Y +CG A C N+S C+C++GF P++ W +
Sbjct: 276 QRLTWYPSIRIWNRFWSSPVDPQCDTYIMCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQ 335
Query: 315 -----GCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYA 369
GC+R +L C +GD F + K+KLP+T+ + + S+ +KEC + C +C+CTA+A
Sbjct: 336 RVWAGGCIRRTQLSC-SGDGFTRMKKMKLPETTMATVDRSIGVKECKKRCISDCNCTAFA 394
Query: 370 NSDVERGGSGCLLWFGDLMDMKEYNDG---GQDLYIRIASERGRSVTKKQ--VGIIIASV 424
N+D+ GGSGC++W L D++ Y GQDLY+R+A+ + KK+ G II+
Sbjct: 395 NADIRNGGSGCVIWTERLEDIRNYATDAIDGQDLYVRLAAA---DIAKKRNASGKIISLT 451
Query: 425 LLMAMFIVASLFCIWRKKLKKQGLTKMS--------------------------HMKEDM 458
+ +++ ++ +FC+W++K K+ + +S + E++
Sbjct: 452 VGVSVLLLLIMFCLWKRKQKRAKASAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEEL 511
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL + ++ KAT+NF+S NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF N
Sbjct: 512 ELPLIEMETVVKATENFSSCNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMN 571
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EVTLIARLQH NLV++LGCCI+ DE MLIYEY+ N SLD ++F + R + L+W +R I
Sbjct: 572 EVTLIARLQHINLVQVLGCCIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDIT 631
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G+ARG+LYLHQDSR RIIHRDLK SN+LLD +M PKISDFGMARIF DE + NT KVV
Sbjct: 632 NGVARGLLYLHQDSRFRIIHRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVV 691
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
GTYGYMSPEYA G+FS KSDVFSFGV+VLEIVSGKKN F + D++++LL + W WKE
Sbjct: 692 GTYGYMSPEYAMYGIFSEKSDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKE 751
Query: 699 KRAMELAGDTLADS-------HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751
RA+E+ + DS P EVL+CI +GLLCVQ E RP MSSVV M S++
Sbjct: 752 GRALEIVDPVIVDSLSSQPSIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEAT 811
Query: 752 -LPEPNRPGFFTERSLPEAEFSPSYP----QSSTTNEITITELQGR 792
+P+P PG+ RS E + S S+ +S T N+ T + + R
Sbjct: 812 EIPQPKPPGYCVRRSPYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 683 bits (1763), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/831 (44%), Positives = 531/831 (63%), Gaps = 61/831 (7%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+++ I SQS++DG+ + S F GFFS G S RY+GIWY +VS +T+ WVANR+ P
Sbjct: 21 SDNTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHP 80
Query: 77 LTDQSGLLNVTSKGIVLL----DGRDRIFWSSNTSITMKNP--VVQLMDSGNLVLTDGNY 130
+ D SGL+ +++G + + +G + I WS++ ++ P V +L D GNLVL D
Sbjct: 81 INDTSGLIKFSTRGNLCVYASGNGTEPI-WSTDVIDMIQEPALVAKLSDLGNLVLLDPVT 139
Query: 131 NSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190
W+SF+HP +TLLP MK G ++G+DR ++SW+S DP G + I+ GFPQ++
Sbjct: 140 GKSFWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQMM 199
Query: 191 LRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV---YYECDAKGPAVSRL 247
+ KG L +R GSW G ++G P + N + + FV N +EV Y DA +R+
Sbjct: 200 MYKGLTLWWRTGSWTGQRWSGVPEMT-NKFIFNISFVNNPDEVSITYGVLDAS--VTTRM 256
Query: 248 WVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRR--CDCLEGFV 305
+N++G + R W+ + W + AP D+CD+Y+ CG N C + S+ + C CL G+
Sbjct: 257 VLNETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYE 316
Query: 306 PKSPNNW-----SEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELC 359
PK+P +W S+GC R + NG E F K ++K+P+TS+ + ++ LKEC + C
Sbjct: 317 PKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRC 376
Query: 360 SKNCSCTAYANS--DVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRI-ASERGR-----S 411
KNCSC AYA++ + + G GCL W G+++D + Y GQD Y+R+ SE R +
Sbjct: 377 LKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNGNGA 436
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG-----------------------L 448
KK++ +I+ S++ + M ++ S C RK+ ++ L
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
++ EL F+ ++IA AT+NFA NKLG GGFGPVYKG L G EIAVKRLSK
Sbjct: 497 EELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRLSKS 556
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
SGQGMEEFKNEV LI++LQHRNLV++LGCC++ +E ML+YEY+PNKSLD+FIF + +
Sbjct: 557 SGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQRAE 616
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
LDW KR+ I+ GI RGILYLHQDSR+RIIHRDLKASNVLLDN+M PKI+DFG+ARIFGG+
Sbjct: 617 LDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIFGGN 676
Query: 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+I+ +T++VVGTYGYMSPEYA +G FS+KSDV+SFGVL+LEI++GK+N F + NL
Sbjct: 677 QIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAFY--EESLNL 734
Query: 689 LGHAWILWKEKRAMELAGDTLA-DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
+ H W W+ A+E+ + +++ EV++C+H+GLLCVQ DRP+MSSVV ML
Sbjct: 735 VKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDMSSVVFMLG 794
Query: 748 SDSL-LPEPNRPGFFTER-----SLPEAEFSPSYPQSSTTNEITITELQGR 792
+++ LP P P F R + ++ PS SST N++T+T++QGR
Sbjct: 795 HNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/844 (44%), Positives = 504/844 (59%), Gaps = 71/844 (8%)
Query: 9 LFILGASAANDNITPSQSIRDG---ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
F+ +S A + I +S+RDG + LVS TFELGFFSPG+S R+LGIWY + +
Sbjct: 17 FFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNIEDK 76
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSN---TSITMKNPVVQLMDSG 121
V WVANR TP++DQSG+L +++ G +VLLDG++ WSSN ++ N VV + D+G
Sbjct: 77 AVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIHDTG 136
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
N VL++ + + +W+SF+HP DT LP M++ N +TG + SW+S DP+PG +SL +
Sbjct: 137 NFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPGNYSLGV 196
Query: 182 DTHGFPQLVLRKGS-VLQYRAGSWNGLGFTGTPPLKENVPLCD---YKFVINE-----NE 232
D G P++VL +G+ ++R+G WN FTG P N+ L Y F ++
Sbjct: 197 DPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIP----NMSLLTNYLYGFKLSSPPDETGS 252
Query: 233 VYYECDAKGPAVS-RLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCT 291
VY+ P+V R V +G W+ W P CD Y+ CG C
Sbjct: 253 VYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFGICD 312
Query: 292 TNSSRR-CDCLEGFVPKSPNNWSEGCVRERELKCRNG-----DEFPKYVKLKLPDTSSSW 345
S C C+ G+ S NWS GC R LKC DEF +KLPD
Sbjct: 313 MKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNISVGEDEFLTLKSVKLPDFEIPE 372
Query: 346 FNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA 405
N ++ ++C E C +NCSC AY+ GG GC++W DL+D++++ GG L+IR+A
Sbjct: 373 HNL-VDPEDCRERCLRNCSCNAYSLV----GGIGCMIWNQDLVDLQQFEAGGSSLHIRLA 427
Query: 406 SERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------GL 448
K ++ +I+A VL+ + I +WR K KK L
Sbjct: 428 DSEVGENRKTKIAVIVA-VLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADL 486
Query: 449 TKMSHMKEDM----------------ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKG 492
TK EL F +IA AT++F N+LG GGFGPVYKG
Sbjct: 487 TKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKG 546
Query: 493 TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552
L +G+EIAVKRLS SGQG++EFKNE+ LIA+LQHRNLV+LLGCC + +E ML+YEYMP
Sbjct: 547 VLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMP 606
Query: 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
NKSLDFF+FD+ + +DW+ R I+ GIARG+LYLH+DSR+RIIHRDLK SNVLLD +M
Sbjct: 607 NKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEM 666
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
NPKISDFGMARIFGG++ + NT +VVGTYGYMSPEYA EGLFSVKSDV+SFGVL+LEIVS
Sbjct: 667 NPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVS 726
Query: 673 GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHR 732
GK+N +H +L+G+AW L+ R+ EL + + E LRCIHV +LCVQ
Sbjct: 727 GKRNTSLRSSEHG-SLIGYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDS 785
Query: 733 PEDRPNMSSVVLMLSSDS-LLPEPNRPGFF-TERSLPEAEFSPSYPQS--STTNEITITE 788
+RPNM+SV+LML SD+ L P +P F T R+ + F+ Q ++NEIT T
Sbjct: 786 AAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTV 845
Query: 789 LQGR 792
+ GR
Sbjct: 846 VLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | ||||||
| 255575986 | 1597 | ATP binding protein, putative [Ricinus c | 0.996 | 0.494 | 0.612 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.992 | 0.967 | 0.598 | 0.0 | |
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.979 | 0.933 | 0.604 | 0.0 | |
| 224122966 | 783 | predicted protein [Populus trichocarpa] | 0.953 | 0.964 | 0.595 | 0.0 | |
| 255587572 | 822 | S-locus-specific glycoprotein S6 precurs | 0.983 | 0.947 | 0.567 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.993 | 0.962 | 0.562 | 0.0 | |
| 224115102 | 784 | predicted protein [Populus trichocarpa] | 0.952 | 0.961 | 0.584 | 0.0 | |
| 224122810 | 810 | predicted protein [Populus trichocarpa] | 0.988 | 0.966 | 0.558 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.962 | 0.475 | 0.574 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.998 | 0.951 | 0.546 | 0.0 |
| >gi|255575986|ref|XP_002528889.1| ATP binding protein, putative [Ricinus communis] gi|223531688|gb|EEF33513.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1004 bits (2597), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 495/808 (61%), Positives = 610/808 (75%), Gaps = 19/808 (2%)
Query: 1 MLGAYSCLLFILGASAANDN-ITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWY 59
M+ Y LLF+ S + N I PSQS++DGETLVS +G FELGFF+P S RYLGIWY
Sbjct: 1 MVWVYLFLLFLSHTSVSGLNTINPSQSVKDGETLVSADGGFELGFFNPNNSENRYLGIWY 60
Query: 60 KRVSPRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLM 118
K VS V WVANRETPLT+ SG+L+ T +GI +LLDG++ WSS + +NP+VQL+
Sbjct: 61 KEVSAYAVVWVANRETPLTESSGVLSFTKEGILILLDGKNNTIWSSKKAKNSQNPLVQLL 120
Query: 119 DSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPG 175
DSGNLV+ DGN +S LWQSFD PCDT LPGMK+GRNF TG D ++SWKS ++P G
Sbjct: 121 DSGNLVVKDGNDSSSDNFLWQSFDSPCDTFLPGMKIGRNFLTGQDWFITSWKSADNPGKG 180
Query: 176 EFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYY 235
+FSLWID GFPQLVLR G+ YR GSWNGL FTGTP + ++ +F + +N VYY
Sbjct: 181 QFSLWIDPDGFPQLVLRNGTSKYYRLGSWNGLYFTGTPQVPQD--FLKLEFELTKNGVYY 238
Query: 236 ECDAKGPA--VSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTN 293
+ G + ++RL+VN+SG V R + W Y+APLD+CD Y VCGA +C N
Sbjct: 239 GYEVHGYSKLMTRLFVNRSGFVQRFARVDRTVGWRNIYFAPLDQCDKYDVCGAYMKCNIN 298
Query: 294 -SSRRCDCLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNL 352
+S C CLEGFV +SP NWS+GCVR+ L C GD F Y++LKLPDTS SW+N +M+L
Sbjct: 299 DNSPNCVCLEGFVFRSPKNWSDGCVRKTPLHCEKGDVFQTYIRLKLPDTSGSWYNTTMSL 358
Query: 353 KECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSV 412
EC ELCS NCSCTAYANS++ GGSGCLLWFG+L+D++EY +GGQ++YIR++S +
Sbjct: 359 SECKELCSTNCSCTAYANSNISNGGSGCLLWFGELVDIREYTEGGQEIYIRMSSSKPDQT 418
Query: 413 TKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHM--------KEDMELWEFD 464
K +G + + +L+ M +V SL I +K+ + QGLTK SH+ KE+MEL FD
Sbjct: 419 KNKLIGTTVGAAVLIGMLVVGSLVYIRKKEQRMQGLTKGSHINDYENNAGKEEMELPIFD 478
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIA 524
F +I KATDNF++ NKLG+GGFGPVYKG L +GQEIAVKRLSK SGQG+ EF+NEV LI+
Sbjct: 479 FTAIVKATDNFSNNNKLGQGGFGPVYKGILTDGQEIAVKRLSKSSGQGLTEFENEVILIS 538
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+LQHRNLVKLLG CIQ DE MLIYE+MPNKSLDFF+FD+ R FLDW RIHI+ GIARG
Sbjct: 539 KLQHRNLVKLLGYCIQKDEKMLIYEFMPNKSLDFFVFDEMRCKFLDWDLRIHIIDGIARG 598
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+LYLHQDSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGGD+ + NT+KV GTYGYM
Sbjct: 599 LLYLHQDSRLRIIHRDLKASNVLLDKDMNPKISDFGMARIFGGDQTEANTNKVAGTYGYM 658
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
+PEYA +GLFS+KSDVFSFGVLVLEI+SGKKN F HPDH HNLLGHAW L E R+++L
Sbjct: 659 APEYAVDGLFSMKSDVFSFGVLVLEIISGKKNRGFFHPDHSHNLLGHAWKLLLEGRSLDL 718
Query: 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTER 764
D + DS +EVLRCIHVGLLCVQ RPEDRPNMSSVV+ML S++LLP+P +PGFFTER
Sbjct: 719 V-DKMLDSFAASEVLRCIHVGLLCVQQRPEDRPNMSSVVVMLGSENLLPQPKQPGFFTER 777
Query: 765 SLPEAEFSPSYPQSSTTNEITITELQGR 792
++PE + S S +S + NE++ T L+ R
Sbjct: 778 NIPEVDSSSSKLESLSINEMSTTVLEAR 805
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2485), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/807 (59%), Positives = 596/807 (73%), Gaps = 21/807 (2%)
Query: 4 AYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
YS IL S+A D + +QS+RDGETLVS G+FELGFF+P S RYLG+WYK+ S
Sbjct: 9 VYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK-S 67
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
P+TV WVANR P++++ G LNVTS+GI VLL+G + I WSSNTS T++NPV QL+DSGN
Sbjct: 68 PQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSGN 127
Query: 123 LVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
LV+ DGN N + LWQSFD+PCDTLLPGMKLG N TG++ LSSWK +PAPG+F+L
Sbjct: 128 LVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQFTL 187
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDA 239
ID G+PQL+LRK + + YR GSWNG FTG P LK + P+ ++FV N NEVY++ +
Sbjct: 188 GIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPD-PIYTFEFVFNRNEVYFKFEL 246
Query: 240 KGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ +V SRL V SGLV WS Q + W++ A +DRC+ Y++CGANARC +NSS C
Sbjct: 247 QNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPVC 306
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
DCL+GF+ KSP NW+ GC+R L C + D F Y +KLPDTSSSW++ S +L
Sbjct: 307 DCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSLV 366
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSV 412
EC LC +NCSC AYAN D GSGCL WFGDL+D + +GGQD+YIR+A S+ G +
Sbjct: 367 ECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRLAASQSGVTG 426
Query: 413 TKKQ-----VGIIIASVLL-MAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFA 466
KK+ G+I +V+L ++ I+ +FCI R+K +K G + +E+MEL D
Sbjct: 427 EKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFE-DRKEEEMELPMLDLT 485
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+I ATDNF+S KLGEGGFG VYKG L+EGQEIAVKRLSK SGQG+ EFKNEV LIA+L
Sbjct: 486 TIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKL 545
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
QHRNLVKLLGCCI DE MLIYEYMPN+SLD FIFD R FLDW KR HI+ GIARG+L
Sbjct: 546 QHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLL 605
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLHQDSR+RIIHRD+KASN+LLDN++NPKISDFG+AR+FGGD+ + NT +VVGTYGYMSP
Sbjct: 606 YLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRVVGTYGYMSP 665
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH-NLLGHAWILWKEKRAMELA 705
EYA +G FSVKSDVFSFGVLVLEIVSGKKN F HPD++ NLLGHAW+LW +EL
Sbjct: 666 EYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELI 725
Query: 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERS 765
+ ADS P+E LRCIHV LLCVQ RPEDRPNMSSVVLML S++ LP+P +PGFF +
Sbjct: 726 DECFADSCTPSEALRCIHVALLCVQQRPEDRPNMSSVVLMLGSENPLPQPKQPGFFMGSN 785
Query: 766 LPEAEFSPSYPQSSTTNEITITELQGR 792
PE + S + QS + NE+T+T LQ R
Sbjct: 786 PPEKDTSSNKHQSHSANEVTVTLLQAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 944 bits (2440), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/802 (60%), Positives = 584/802 (72%), Gaps = 26/802 (3%)
Query: 8 LLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTV 67
L I A+ D +TP QSIRDG+ LVS +G+FELGFFSPG S RYLGIWY+++S TV
Sbjct: 16 FLLISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRYLGIWYQKISAGTV 75
Query: 68 AWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLT 126
WVANRETPL D SG L VT +GI +LL+ WSSN S T +NPV++L+DSGNLV+
Sbjct: 76 VWVANRETPLNDSSGALIVTDQGILILLNSSKDAIWSSNASRTAQNPVMKLLDSGNLVVK 135
Query: 127 DGNYNS--LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTH 184
D N NS LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS NDPA GEF+ ID
Sbjct: 136 DINDNSENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKSSNDPAQGEFTFRIDPR 195
Query: 185 GFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV 244
G Q++L +G + YR G+WNG +TGTP L+ N+ L Y F+ E+YY+ D +V
Sbjct: 196 GNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNM-LYTYGFISTATEMYYKFDLINSSV 254
Query: 245 -SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEG 303
SR+ +N SG R W ++ + W LD+CD Y++CGA C N C CLEG
Sbjct: 255 ASRIVMNSSGAAQRFTWITRTNSWARFSAVLLDQCDDYALCGAYGSCNVNKQPVCACLEG 314
Query: 304 FVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSEL 358
F+PKSP +WS +GCVR +L C GD F ++ +KLPD SW + S LKEC +L
Sbjct: 315 FIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLPDMIKSWVDTSKGLKECKDL 374
Query: 359 CSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS------ERGRSV 412
C KNCSC AYANSD+ GGSGCLLWF +L+D +E GGQDLYIRIA+ E+ RS
Sbjct: 375 CLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQDLYIRIAASELYNIEKNRSS 434
Query: 413 TKKQVGIIIASVLLMAMFIV-ASLFCIWRKKLKKQGLTKMSHM---------KEDMELWE 462
KKQ+GII+ +++ + +V A + RKKLKKQ K SH+ KEDMEL
Sbjct: 435 DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKTSHLQNYEDEDQRKEDMELPT 494
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
FD ++IA ATDNF+S NKLGEGGFG VYKGTL+EGQE+AVKRLSK SGQG+ EFKNEV L
Sbjct: 495 FDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAVKRLSKNSGQGLTEFKNEVIL 554
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
IA+LQHRNLVKLLGCCI+ DE +LIYEYMPNKSLD+FIFD+ DW+ I+IVGGIA
Sbjct: 555 IAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFDKKTRNSSDWRIWINIVGGIA 614
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+LYLHQDSR+RIIHRDLKA+NVLLDN MNPKISDFG+AR FGGD+ + NT+K+VGTYG
Sbjct: 615 RGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLARTFGGDQTEANTNKIVGTYG 674
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702
YMSPEYA +G FSVKSDVFSFGVLVLEIVSGKKN F+HPDH HNLLGHAW LW E +
Sbjct: 675 YMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHPDHHHNLLGHAWRLWNEGMPL 734
Query: 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFT 762
EL + DS +E++RCIHVGLLCVQ RPEDRPNMSSV++MLSS LP+P +PGFFT
Sbjct: 735 ELINEPEQDSCTLSEIIRCIHVGLLCVQKRPEDRPNMSSVIVMLSSGISLPQPKQPGFFT 794
Query: 763 ERSLPEAEFSPSYPQSSTTNEI 784
ER+LPE E S S +S +TNEI
Sbjct: 795 ERNLPERESSSSNQKSFSTNEI 816
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122966|ref|XP_002330408.1| predicted protein [Populus trichocarpa] gi|222871793|gb|EEF08924.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 472/793 (59%), Positives = 581/793 (73%), Gaps = 38/793 (4%)
Query: 8 LLFILGASAANDNITPSQSIRDGET-LVSVNGTFELGFFSPGTSAKRYLGIWYKR--VSP 64
LLF+ A A DNIT ++SI+DGE+ LVS GTFELGFFSPG S R+LG+WYK +
Sbjct: 21 LLFLSLAFATQDNITSNESIKDGESPLVSAGGTFELGFFSPGNSMNRFLGVWYKNELSTH 80
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
+ V WVANRE PL D+SG LN T +G++LL +G + WSSN + +++PV+QL+DSGNL
Sbjct: 81 KEVIWVANREIPLKDRSGFLNFTQQGVLLLFNGNNERIWSSNKTTNVESPVMQLLDSGNL 140
Query: 124 VLTDGNYNS-LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
V+ DG N+ +LWQSF++PCDT LPGM +G N +TG+DR+L SWKS +DP PG+FS ID
Sbjct: 141 VVIDGKDNNFILWQSFEYPCDTFLPGMMIGGNSQTGVDRNLISWKSADDPGPGQFSFGID 200
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN--EVYYECDAK 240
GFPQLV+R G++ R GSWNG FTGTP L + L Y F++N+ + YE
Sbjct: 201 RQGFPQLVIRNGTLKHCRLGSWNGKRFTGTPDLPRDQFL-KYDFILNKTHADYSYEILRP 259
Query: 241 GPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARC-TTNSSRRCD 299
G ++RL VNQSG V R + Q + W Y AP D CD YSVCGA+ C + S C
Sbjct: 260 GALLTRLIVNQSGFVERFMRPIQNNNWTSIYSAPRDLCDNYSVCGAHMICKMVDQSHNCT 319
Query: 300 CLEGFVPKSPNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
CLEGF PKS +WS GC R L C +G F + LKLPDTS SW++ SM+L EC ++C
Sbjct: 320 CLEGFEPKSHTDWSRGCARRSALNCTHG-IFQNFTGLKLPDTSLSWYDTSMSLVECKDMC 378
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTKKQVGI 419
KNCSCTAYANS++ SGC+LWFG+L+DM+E++ GGQDLYIR+ +T
Sbjct: 379 LKNCSCTAYANSNITGEASGCILWFGELVDMREFSTGGQDLYIRMPPPLKTGLT------ 432
Query: 420 IIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYN 479
F IWRKK +KQ ++EDMEL F A+I KATDNF+S N
Sbjct: 433 ----------------FYIWRKKQRKQ------EIEEDMELPSFHLATIVKATDNFSSNN 470
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+GGFGPVYKGTL++GQEIAVKRLSK S QG+ EFKNEV LIA+LQHRNLVKLLGCCI
Sbjct: 471 KLGQGGFGPVYKGTLIDGQEIAVKRLSKSSRQGLTEFKNEVILIAKLQHRNLVKLLGCCI 530
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q DE MLIYE+MPNKSLD+FIFDQ R FLDWQ+R I+GGIARG+LYLHQDSR+RIIHR
Sbjct: 531 QGDEVMLIYEFMPNKSLDYFIFDQTRNKFLDWQRRNLIIGGIARGLLYLHQDSRLRIIHR 590
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DLKASN+LLD DMNPKISDFGMAR+FG D+I+ +T+KVVGTYGYMSPEYA +G FS+KSD
Sbjct: 591 DLKASNILLDKDMNPKISDFGMARLFGVDQIEADTNKVVGTYGYMSPEYAVDGRFSLKSD 650
Query: 660 VFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVL 719
VFSFGVLVLEI+SGKKN FSHPDH HNLLGHAW LW E+RA+EL + + +EVL
Sbjct: 651 VFSFGVLVLEIISGKKNRGFSHPDHCHNLLGHAWKLWTEERALELLDNMSDRPYSVSEVL 710
Query: 720 RCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPSYPQSS 779
RCIHVGLLCVQ +PE+RPNMSSVVLML S++ LP+P +PGFFTER++P + S +SS
Sbjct: 711 RCIHVGLLCVQQKPEERPNMSSVVLMLGSENSLPDPKQPGFFTERNMPAVDSSSGNHESS 770
Query: 780 TTNEITITELQGR 792
+ N++TI++L R
Sbjct: 771 SINDLTISQLDAR 783
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587572|ref|XP_002534316.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] gi|223525508|gb|EEF28065.1| S-locus-specific glycoprotein S6 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 914 bits (2362), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/825 (56%), Positives = 580/825 (70%), Gaps = 46/825 (5%)
Query: 11 ILGASAAN-DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAW 69
+L SAA + + P QS++DGETL+S +G FELGFFS G S RYLGIWYKR+ +TV W
Sbjct: 1 MLRVSAAQLETLYPGQSMKDGETLISADGNFELGFFSQGDSRSRYLGIWYKRIPVKTVVW 60
Query: 70 VANRETPLTDQSGLLNVTSKGIVLLDGRDR-IFWSSNTSITMKNPVVQLMDSGNLVLTDG 128
V NRE P D G+L V +G+++L + I WSSN+S T KNPV+QL+DSGNL++ DG
Sbjct: 61 VGNREVPSFDNLGVLQVNEQGVIILQNSTKGIIWSSNSSRTAKNPVLQLLDSGNLIVKDG 120
Query: 129 NYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHG 185
N N+ ++WQSFD P +TLLP MKLG N G++R+L+SWKSI+DPA G FS ID G
Sbjct: 121 NGNNPDNIVWQSFDFPYNTLLPSMKLGWNLDKGLNRYLTSWKSIDDPAQGNFSCLIDLRG 180
Query: 186 FPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV- 244
FPQL ++KG +Q R+G WNGL FTG+P L N P+ ++ FV N++E+YY + K +V
Sbjct: 181 FPQLFMKKGDAVQVRSGPWNGLQFTGSPQLNPN-PVFNFSFVSNKHEIYYSYELKNTSVV 239
Query: 245 SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGF 304
SRL V++ G + R W + W L + P D+CD Y +CGA A C NS C CLEGF
Sbjct: 240 SRLIVSEKGALERHNWIDRTQSWTLFFSVPTDQCDTYLLCGAYASCNINSYPVCSCLEGF 299
Query: 305 VPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELC 359
VPKSP ++WS+GCVR EL C GD F K +KLPDTSSSW + SM+LKEC +C
Sbjct: 300 VPKSPTDWSASDWSDGCVRRTELSCHTGDGFRKLKGMKLPDTSSSWVDMSMDLKECEGMC 359
Query: 360 SKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSVTKKQVG 418
+NCSC AYANSD+ GSGCLLWF L+DM+++ +GGQDLYIRIA SE + + +
Sbjct: 360 LRNCSCLAYANSDIR--GSGCLLWFDHLIDMRKFTEGGQDLYIRIAASELAKGKSHGKRV 417
Query: 419 IIIASVLLMAMFIVASLFCIWRKKLKKQ-----------------------GLTKMSHM- 454
II S L++ M + A ++ +K K+ GL K +++
Sbjct: 418 AIIVSCLIIGMGMTALGSLLYTRKRKRNILGQAVPLVLLVSSFAIHFYIISGLAKETYIE 477
Query: 455 -------KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSK 507
KED EL FD +I AT NF++YNKLGEGGFGPVYKGTL++GQEIAVKRLS+
Sbjct: 478 NYGDNGAKEDTELIAFDLITIRNATGNFSNYNKLGEGGFGPVYKGTLLDGQEIAVKRLSE 537
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT 567
SGQG +EFKNEV LIARLQHRNLVKLLGCCI DE MLIYEYMPNKSLD FIFD+ R+
Sbjct: 538 TSGQGGKEFKNEVILIARLQHRNLVKLLGCCIHGDEKMLIYEYMPNKSLDSFIFDKKRSM 597
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
LDW I+GGIARG+LYLHQDSR+RIIHRDLKASN+LLD DMNPKISDFG+AR FG
Sbjct: 598 LLDWHMCFRIIGGIARGLLYLHQDSRLRIIHRDLKASNILLDCDMNPKISDFGLARTFGK 657
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
D+ NT +VVGTYGYMSPEYA +GLFSVKSDVFSFGVLVLEIVSGK+N FSH DH N
Sbjct: 658 DQNAANTKRVVGTYGYMSPEYAVDGLFSVKSDVFSFGVLVLEIVSGKRNRGFSHLDHSLN 717
Query: 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
LLGHAW LW E+RA+EL D + ++VLRCI VGLLCVQ P DRP+MS+VV+ML
Sbjct: 718 LLGHAWRLWMEERALELFDKFSQDEYSVSQVLRCIQVGLLCVQRLPHDRPDMSAVVVMLG 777
Query: 748 SDSLLPEPNRPGFFTERSLPEAEFSPSYPQSSTTNEITITELQGR 792
S+S LP+P +PGF+TER EA+ S S + + NEI+ T ++ R
Sbjct: 778 SESSLPQPKQPGFYTERDPFEADSSTSKERVWSRNEISSTLIEPR 822
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2335), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 455/809 (56%), Positives = 591/809 (73%), Gaps = 22/809 (2%)
Query: 5 YSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSP 64
+S ++ IL S A D+IT +Q I+DGET++S G FELGF GTS +YLGIWYK+V+P
Sbjct: 11 FSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYKKVTP 70
Query: 65 RTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNL 123
RTV WVANRE P+TD SG L VT +G +V+L+G + + WSSN+S + +NP QL+DSGNL
Sbjct: 71 RTVVWVANRELPVTDSSGXLKVTDQGSLVILNGSNGLIWSSNSSRSARNPTAQLLDSGNL 130
Query: 124 VLTDGN---YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
V+ GN ++ LWQSFD+P DTLLPGMK GRN TG+DR+LSSWKS +DP+ G+F+
Sbjct: 131 VIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSKGDFTYG 190
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAK 240
+D G PQL LR GS + +R+G WNG+ F G P L+ N P+ +Y FV NE E+Y+
Sbjct: 191 LDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPN-PVFNYSFVFNEKEMYFTYKLV 249
Query: 241 GPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+V SRL +N +G V R IW + W + A D CD Y++CGA + C + S RC
Sbjct: 250 NSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYSTAYKDDCDSYALCGAYSTCNIHRSPRCG 309
Query: 300 CLEGFVPKSPN-----NWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLKE 354
C++GFVPK P +WS GCVR+ L C+ GD F KY +KLPDT +SWFN SMNLKE
Sbjct: 310 CMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSWFNESMNLKE 369
Query: 355 CSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRSVTK 414
C+ LC +NCSC+AY NSD++ GGSGCLLWFGDL+D+KE+ + GQD YIR+A+ +++K
Sbjct: 370 CASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMAASELDAISK 429
Query: 415 --KQVGIIIASVLLMAMFIVASLFCIW--RKKLKKQGLTKMSH-------MKEDMELWEF 463
K+ +I+++V + M +++ + ++ +K+LK++G T++++ +ED+EL F
Sbjct: 430 VTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGAETNERQEDLELPLF 489
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+I AT NF+ NKLGEGGFGPVYKG L +G+EIAVKRLSK S QG++EFKNEV I
Sbjct: 490 XLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYI 549
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++LQHRNLVKLLGCCI +E MLIYEYMPNKSL+FFIFD ++ LDW KR I+ GIAR
Sbjct: 550 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIAR 609
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+LYLHQDSR+RIIHRDLKA NVLLDN+MNP+ISDFGMAR FGG+E T +VVGTYGY
Sbjct: 610 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETIARTKRVVGTYGY 669
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703
MSPEYA +G++SVKSDVFSFGVL LEI+SGK+N F+HPDHD NLLGHAW L+ E +E
Sbjct: 670 MSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLLGHAWTLYMEGTPLE 729
Query: 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTE 763
L ++ ++ +EVLR ++VGLLCVQ P+DRPNMSSVVLMLSS+ LP+P PGFFTE
Sbjct: 730 LIDASVGYTYNQSEVLRALNVGLLCVQRHPDDRPNMSSVVLMLSSEGALPQPKEPGFFTE 789
Query: 764 RSLPEAEFSPSYPQSSTTNEITITELQGR 792
R++ EA+ + NE TIT L+GR
Sbjct: 790 RNMLEADSLQCKHAVFSGNEHTITILEGR 818
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115102|ref|XP_002316940.1| predicted protein [Populus trichocarpa] gi|222860005|gb|EEE97552.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/797 (58%), Positives = 571/797 (71%), Gaps = 43/797 (5%)
Query: 2 LGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKR 61
L YS LL + S A D I+P Q I DG+T+VS FELGFFSPG+S +RYLGIWYK+
Sbjct: 15 LFVYSFLLSTIRVSNAPDIISPGQFIGDGDTIVSAGQNFELGFFSPGSSTRRYLGIWYKK 74
Query: 62 VSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
S TV WVANRE P+ D SG+L T++G ++LL+G + WSSN + NPV QL++S
Sbjct: 75 FSTGTVVWVANRENPIFDHSGVLYFTNQGTLLLLNGTKDVVWSSNRTTPKNNPVAQLLES 134
Query: 121 GNLVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEF 177
GNLV+ DGN + S LWQSFD+P DT LP MKLGRN TG+D +SSWKS++DPA GE+
Sbjct: 135 GNLVVKDGNDSNPESFLWQSFDYPGDTNLPDMKLGRNLVTGLDWSISSWKSLDDPARGEY 194
Query: 178 SLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYEC 237
SL ID G+ QLV +KG +Q+RAGSWNG+ FTG L+ N P+ Y+FV+N+ EVY+
Sbjct: 195 SLGIDPRGYQQLVYKKGRAIQFRAGSWNGIRFTGATRLRPN-PVYRYEFVLNDKEVYFNF 253
Query: 238 DAKGPAV-SRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSR 296
+ +V SR VN SG+V R W SQ W + D+CD YS CG+NA+C + S
Sbjct: 254 ELLNSSVASRFVVNASGVVERLTWISQMHRWTRYFAVGEDQCDAYSFCGSNAKCNIDKSP 313
Query: 297 RCDCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMN 351
C CL+GF PKS +WS GCVR L C G+ F K+ +KLPDTSSSW+N S++
Sbjct: 314 VCACLDGFEPKSARDWSFQDWSGGCVRRTTLTCNRGEGFVKHTGMKLPDTSSSWYNTSIS 373
Query: 352 LKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASERGRS 411
LKEC ELC K CSC AYAN+DV GGSGCLLWFGDL+DM+E+ + GQDLYIR+A+ S
Sbjct: 374 LKECQELCLKKCSCMAYANTDVRGGGSGCLLWFGDLIDMREFVNTGQDLYIRMAA----S 429
Query: 412 VTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSH-MKEDMELWEFDFASIAK 470
K I+ + SH KE++EL D ++IAK
Sbjct: 430 YLGKMKNIL--------------------------EMDYDSHSRKEELELPIIDLSTIAK 463
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
AT NF+S KLGEGGFG VYKGTL GQ+IAVKRLS SGQG+EEFKNEV LIA+LQHRN
Sbjct: 464 ATGNFSSNKKLGEGGFGLVYKGTLY-GQDIAVKRLSMYSGQGIEEFKNEVLLIAKLQHRN 522
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKLLGCCI+ DE MLIYEYMPNKSLD+FIFDQ+R+ LDW RI I+ GIARG+LYLHQ
Sbjct: 523 LVKLLGCCIEGDERMLIYEYMPNKSLDYFIFDQSRSKLLDWPTRISIIDGIARGLLYLHQ 582
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
DSR+RIIHRDLKASNVLLD DMNPKISDFGMARIFGG++ + NT +VVGTYGYM+PEYA
Sbjct: 583 DSRLRIIHRDLKASNVLLDTDMNPKISDFGMARIFGGNQTEANTKRVVGTYGYMAPEYAV 642
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
EGLFSVKSD+FSFGVLVLEIVSG+KN F +H NL+GHAW LW E+R++EL +TL
Sbjct: 643 EGLFSVKSDIFSFGVLVLEIVSGRKNRGFFSHNHHLNLVGHAWKLWMEERSLELTDNTLG 702
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAE 770
SH +E++R IHVGLLCVQ +P+DRPNMS+ VLML +S LP+P +PGFF ER++P E
Sbjct: 703 ASHALSEIIRYIHVGLLCVQQQPDDRPNMSTAVLMLGGESSLPQPKQPGFFLERNVPRTE 762
Query: 771 FSPSYPQSSTTNEITIT 787
S S +S++TN IT+T
Sbjct: 763 SSSSNYKSTSTNGITMT 779
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122810|ref|XP_002330369.1| predicted protein [Populus trichocarpa] gi|222871754|gb|EEF08885.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 889 bits (2297), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/807 (55%), Positives = 569/807 (70%), Gaps = 24/807 (2%)
Query: 6 SCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPR 65
S + IL S A + I P QS+RDGETLVS +G+FELGFFSP S +YLG+W + SP+
Sbjct: 8 SFFISILTTSTALEIINPGQSLRDGETLVSSSGSFELGFFSPQGSTSKYLGLWLDK-SPQ 66
Query: 66 TVAWVANRETPLTDQSGLLNVTSKGI-VLLDGRDRIFWSSNTSIT--MKNPVVQLMDSGN 122
TV WVANRE L+D G+LN+T++GI +LL+ + I WSSN+S + +NPV QL+DSGN
Sbjct: 67 TVLWVANRENSLSDNMGVLNITTQGILILLNSTNHIVWSSNSSASRNTQNPVAQLLDSGN 126
Query: 123 LVLTDGN-YN--SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSL 179
V+ +GN YN LWQSFDHPCDTLLPGM++G NF T +DR LSSWKS DPA GEF+
Sbjct: 127 FVVREGNDYNPAKFLWQSFDHPCDTLLPGMRIGVNFVTRIDRFLSSWKSPEDPARGEFTF 186
Query: 180 WIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTP-PLKENVPLCDYKFVINENEVYYECD 238
ID G+PQ++L+KG+ +R G W G+ FT P P+ + +FV+N EVY+E
Sbjct: 187 GIDPQGYPQVLLKKGNRTVFRGGPWTGIKFTSNPRPIPNQI--STNEFVLNNQEVYFEYR 244
Query: 239 AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRC 298
+ S+L ++ GL W+ + W + D+C+ Y CG N RC + C
Sbjct: 245 IQSSVSSKLTLSPLGLAQSLTWNDRAQDWVIVENGQYDQCEEYEFCGPNTRCEITRTPIC 304
Query: 299 DCLEGFVPKSP-----NNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASMNLK 353
CL+GF P SP ++WS GC R L C + D F KY KLPDTS+S F+ S++LK
Sbjct: 305 VCLDGFTPMSPVDWNFSDWSGGCHRRTPLNCSDKDGFLKYTANKLPDTSTSSFDKSIDLK 364
Query: 354 ECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERGRSV 412
EC LC KNCSCTAY N D GGSGCL+WFGDL+DM+ GQD+Y+R+A SE G +
Sbjct: 365 ECERLCLKNCSCTAYTNLDFRAGGSGCLIWFGDLIDMRRSTGDGQDVYVRVAASELGANA 424
Query: 413 ------TKKQVGIII-ASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDF 465
TK + GII A+ L M M + +FC R+ L K + KED+EL D
Sbjct: 425 KKRNLSTKLKAGIIASAAALGMGMLLAGMMFCRRRRNLGKNDRLEEVR-KEDIELPIVDL 483
Query: 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
++IA ATDNF+S NKLGEGGFGPVYKG L+EGQEIAVK LSK S QGM+EFKNEV IA+
Sbjct: 484 STIAHATDNFSSSNKLGEGGFGPVYKGILIEGQEIAVKSLSKSSVQGMDEFKNEVKFIAK 543
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
LQHRNLVKLLG CIQ DE+MLIYEYMPNKSLDFFIFDQAR LDW KR++I+GGIARG+
Sbjct: 544 LQHRNLVKLLGYCIQEDENMLIYEYMPNKSLDFFIFDQARRKLLDWTKRMNIIGGIARGL 603
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
LYLHQDSR+R+IHRD+KASN+LLDN++NPKISDFG+AR+F GDE + NTH+V+GTYGYMS
Sbjct: 604 LYLHQDSRLRVIHRDIKASNILLDNELNPKISDFGLARMFRGDETEANTHRVIGTYGYMS 663
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
PEYA+ G FSVK+DVFSFGVL+LEIVSGKKN F HPD + NLLGHAWILW + EL
Sbjct: 664 PEYASNGHFSVKTDVFSFGVLILEIVSGKKNRGFRHPDRNLNLLGHAWILWIKGTPSELI 723
Query: 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERS 765
+ L +EVLRCIHV LLCVQ RPEDRPNM +VV +L +++ LP+P +PGFF ++
Sbjct: 724 DECLGYLSNTSEVLRCIHVALLCVQQRPEDRPNMPTVVQILCNENPLPQPKQPGFFMGKN 783
Query: 766 LPEAEFSPSYPQSSTTNEITITELQGR 792
E E S + ++ ++NE+++T L+ R
Sbjct: 784 PLEQEGSSNQMEACSSNEMSLTLLEAR 810
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2285), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 454/790 (57%), Positives = 568/790 (71%), Gaps = 28/790 (3%)
Query: 2 LGAYSCLLFILGA---SAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIW 58
+GA LL + S A D I +Q +RDGE L S G+FELGFFSP S +RYLGIW
Sbjct: 1 MGALPTLLLVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIW 60
Query: 59 YKRVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRD-RIFWSSNTSITMKNPVVQ 116
YK+VS TV WVANRE PL D SG+L VT +G + +L+G + I WSSN+S + +NP Q
Sbjct: 61 YKKVSTMTVVWVANREIPLNDSSGVLKVTDQGTLAILNGSNTNILWSSNSSRSARNPTAQ 120
Query: 117 LMDSGNLVLTDGNYNS---LLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
L+DSGNLV+ DGN ++ LWQSFD+PC+TLLPGMKLGRN TG+DR+LS+WKS++DP+
Sbjct: 121 LLDSGNLVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPS 180
Query: 174 PGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEV 233
G F+ +D G+PQL+LRKGS + +R+G WNGL F+G P L N P+ Y+FV NE E+
Sbjct: 181 KGNFTYRLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSN-PVYTYEFVFNEKEM 239
Query: 234 YYECD-AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTT 292
Y+ + VSRL +N G R W + W L AP+D CD Y++CG C
Sbjct: 240 YFRYELVNSSVVSRLVLNPDGSKQRVNWIDRTHGWILYSSAPMDSCDSYALCGVYGSCNI 299
Query: 293 NSSRRCDCLEGFVPKSPNNW-----SEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFN 347
N S +C+C+EGFVPK PN+W S GCVR L C+NG+ F K+ +KLPDT +SWFN
Sbjct: 300 NRSPKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFN 359
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIASE 407
SM+LKEC+ +C NCSCTAY N D+ GGSGCLLWFGDL+D++E+N+ GQ+LY+R+A+
Sbjct: 360 RSMDLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAAS 419
Query: 408 R-------GRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLK------KQGLTKMSHM 454
G KK+ +I+ SV + + ++ L ++ K K G
Sbjct: 420 ELGMHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQ 479
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME 514
KED+EL FDFA+++KAT++F+ +NKLGEGGFG VYKGTL E QEIAVKRLSK SGQG+
Sbjct: 480 KEDVELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLN 539
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EFKNEV I++LQHRNLV+LLG CI +E MLIYEYMPNKSLD FIFD+ R+ LDW KR
Sbjct: 540 EFKNEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKR 599
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
I+ GIARG+LYLHQDSR+RIIHRDLKA NVLLD +M PKISDFG+AR FGG+E + NT
Sbjct: 600 FLIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANT 659
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694
+VVGTYGYMSPEYA +GL+S KSDVFSFGVLVLEIVSGK+N FSHPDH NLLGHAW
Sbjct: 660 KRVVGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSLNLLGHAWT 719
Query: 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPE 754
L+ E R+MEL ++ D H ++VLR I+VGLLCVQ P++RP+MSSVVLMLSSDS LP+
Sbjct: 720 LYMEGRSMELIDSSVGDIHNLSQVLRLINVGLLCVQCGPDERPSMSSVVLMLSSDSTLPQ 779
Query: 755 PNRPGFFTER 764
P PGFFT R
Sbjct: 780 PKEPGFFTGR 789
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 882 bits (2278), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/820 (54%), Positives = 575/820 (70%), Gaps = 29/820 (3%)
Query: 1 MLGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYK 60
+L S + F+ S A ++I +QS+ DG+TLVS G FELGFFSPG S RY+GIWYK
Sbjct: 13 ILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYK 72
Query: 61 RVSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMD 119
++S TV WVANR TPL D SG+L G + ++ + WSSN S NPV QL+D
Sbjct: 73 KISSFTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLD 132
Query: 120 SGNLVLTDGNYN---SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGE 176
+GNLV+ N N + LWQSFD+P D+ LPGMK G +F TG++R+L+SWKS +DP+ G+
Sbjct: 133 TGNLVVRAENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGK 192
Query: 177 FSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYE 236
++ +D +G PQ L +GSV Q+R+G WNGL F+G LK N P+ ++FV N+ E+YY+
Sbjct: 193 YTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPN-PIYTFEFVFNQEEIYYK 251
Query: 237 CD-AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSS 295
A +SR+ ++ G++ R W + W L A +D CD +++CGA+ C N+S
Sbjct: 252 YQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNS 311
Query: 296 RRCDCLEGFVPKS-----PNNWSEGCVRERELKCRNGDEFPKYVKLKLPDTSSSWFNASM 350
CDCL+ F PKS +WS+GCVR+ L C NG+ F KY +K+PDT SW+N ++
Sbjct: 312 PACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTI 371
Query: 351 NLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS---- 406
NL+EC E+C KNCSCTAYAN DV GGSGC+LWFGDL+D+++YN+ GQD+YIRIA+
Sbjct: 372 NLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNENGQDIYIRIAASVID 431
Query: 407 ERGRSVTKKQVGIIIASVLLMAMFIVA-SLFCIWRKKLKKQGLTKMSHM----------- 454
+ +S KK+V II+ V L+A ++A LF + +K K+Q LT+ ++
Sbjct: 432 KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPEQDRTKE 491
Query: 455 --KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
ED+EL FD A++ AT+ F+ NKLG+GGFGPVYKG L +GQEIAVKRLSK S QG
Sbjct: 492 SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQEIAVKRLSKRSRQG 551
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ EF+NEV IA+LQHRNLVKLLGCCI+ +E MLIYEYMPNKSLD FIFD+ R LDW
Sbjct: 552 INEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSFIFDKRRNMLLDWT 611
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
KR I+ GIARG+LYLHQDSR+RIIHRDLKASN+LLD +MNPKISDFGMAR FGGDE
Sbjct: 612 KRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDFGMARSFGGDETSA 671
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692
NT ++VGTYGYMSPEYA +GLFSVKSDVFSFGVLVLEIVSG+KN F H +H NLLGHA
Sbjct: 672 NTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGFRHAEHKLNLLGHA 731
Query: 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLL 752
W+L KE R ++L +++ D+ +EVLR I V LLCVQ PEDRP MS VVLMLSSD +L
Sbjct: 732 WMLHKEGRPLDLIDESIVDTCIISEVLRSIEVALLCVQKSPEDRPKMSIVVLMLSSDIVL 791
Query: 753 PEPNRPGFFTERSLPEAEFSPSYPQSSTTNEITITELQGR 792
P+P PGFFTER L S + S+ NE+T T L+ R
Sbjct: 792 PQPKEPGFFTERDLSNDSSSTIKHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 792 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.491 | 0.496 | 0.475 | 4.1e-210 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.925 | 0.899 | 0.531 | 3.7e-206 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.425 | 0.396 | 0.581 | 2.8e-198 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.441 | 0.415 | 0.563 | 6.9e-195 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.434 | 0.406 | 0.561 | 8.2e-190 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.420 | 0.392 | 0.568 | 1.4e-174 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.973 | 0.955 | 0.427 | 3.3e-166 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.421 | 0.402 | 0.519 | 5e-166 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.976 | 0.961 | 0.426 | 5.4e-166 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.940 | 0.926 | 0.440 | 2.3e-165 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1048 (374.0 bits), Expect = 4.1e-210, Sum P(2) = 4.1e-210
Identities = 192/404 (47%), Positives = 277/404 (68%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
A D + +Q+++DG+T+VS G+FE+GFFSPG S RYLGIWYK++S +TV WVANR++P
Sbjct: 23 ATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRDSP 82
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTS-----ITMKNPVVQLMDSGNLVLTD-GN 129
L D SG L V+ G + L + R+ I WSS++S +++NP+VQ++D+GNLV+ + G+
Sbjct: 83 LYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVRNSGD 142
Query: 130 YNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQL 189
+WQS D+P D LPGMK G NF TG++R L+SW++I+DP+ G ++ +D +G PQ
Sbjct: 143 DQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDPNGVPQF 202
Query: 190 VLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAV-SRLW 248
L+K SV+ +R G WNGL FTG P LK N P+ Y++V E EVYY + P+V +R+
Sbjct: 203 FLKKNSVVVFRTGPWNGLRFTGMPNLKPN-PIYRYEYVFTEEEVYYTYKLENPSVLTRMQ 261
Query: 249 VNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
+N +G + R W W A +D CD Y++CG+ C N S C CL+GFV K+
Sbjct: 262 LNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNINESPACRCLKGFVAKT 321
Query: 309 PN-----NWSEGCVRERELKCRNGDE-FPKYVKLKLPDTSSSWFNASMNLKECSELCSKN 362
P +WSEGCVR +L C G++ F K KLKLPDT +SW++ +M+L EC ++C +N
Sbjct: 322 PQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLNECKKVCLRN 381
Query: 363 CSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIAS 406
C+C+AY+ D+ GG GC+LWFGDL+D++EYN+ GQDLY+R+AS
Sbjct: 382 CTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLAS 425
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1994 (707.0 bits), Expect = 3.7e-206, P = 3.7e-206
Identities = 404/760 (53%), Positives = 514/760 (67%)
Query: 53 RYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITM-- 110
R+LG+WY N T L+ + L DG + WSS++S T
Sbjct: 63 RFLGLWYMEPFAVVWVANRNNPLYGTSGFLNLSSLGD-LQLFDGEHKALWSSSSSSTKAS 121
Query: 111 ---KNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK 167
NP++++ SGNL+ +DG ++LWQSFD+P +T+L GMKLG+NFKT M+ LSSWK
Sbjct: 122 KTANNPLLKISCSGNLISSDGE-EAVLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWK 180
Query: 168 SINDPAPGEFSLWIDTHGFPQLVLRKG--SVLQYRAGSWNGLGFTGTPPLKENVPLCDYK 225
++ DP+PG+F+L +DT G PQL+LRK S YR GSWNGL FTG P + L DYK
Sbjct: 181 TLKDPSPGDFTLSLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYK 240
Query: 226 FVINENEVYYECDAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCG 285
F + EV Y + VSRL +N +G + R I S+Q+ W LA AP D CD YS+CG
Sbjct: 241 FTSSAQEVNYSWTPRHRIVSRLVLNNTGKLHRFI-QSKQNQWILANTAPEDECDYYSICG 299
Query: 286 ANARCTTNSSRR--CDCLEGFVPKSPNNWS-----EGCVRERELKCRNGDEFPKYVKLKL 338
A A C NS C CL+GF PKS W+ GCV E C D F K+ LKL
Sbjct: 300 AYAVCGINSKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKL 359
Query: 339 PDTSSSWFNAS--MNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDG 396
PDTS SW++A M L++C CS NCSCTAYAN+D+ GG GCLLWFGDL+DM+EY+
Sbjct: 360 PDTSWSWYDAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSF 419
Query: 397 GQDLYIRIASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQ--GLT-KMSH 453
GQD+YIR+ + ++ VG+++ SV+ +A+ +V +F +RKK+ K+ G +
Sbjct: 420 GQDVYIRMGFAKIEFKGREVVGMVVGSVVAIAVVLVV-VFACFRKKIMKRYRGENFRKGI 478
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM 513
+ED++L FD +I+ ATD+F+ N LG GGFGPVYKG L +GQEIAVKRLS SGQG+
Sbjct: 479 EEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGV 538
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
EEFKNEV LIA+LQHRNLV+LLGCCIQ +E MLIYEYMPNKSLDFFIFD+ R+T LDW+K
Sbjct: 539 EEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKK 598
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
R++I+ G+ARGILYLHQDSR+RIIHRDLKA NVLLDNDMNPKISDFG+A+ FGGD+ +++
Sbjct: 599 RMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESS 658
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693
T++VVGTYGYM PEYA +G FSVKSDVFSFGVLVLEI++GK N F H DHD NLLGH W
Sbjct: 659 TNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHVW 718
Query: 694 ILWKEKRAMELAGDT-LADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXX 752
+W E R +E+ + L ++ EVLRCIHV LLCVQ +PEDRP
Sbjct: 719 KMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVLMFGSDSSL 778
Query: 753 PEPNRPGFFTERSLPEAEFSPSYPQSSTTNEITITELQGR 792
P P +PGFFT R++P+ S S + NE++IT LQGR
Sbjct: 779 PHPTQPGFFTNRNVPDISSSLSL---RSQNEVSITMLQGR 815
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 996 (355.7 bits), Expect = 2.8e-198, Sum P(2) = 2.8e-198
Identities = 200/344 (58%), Positives = 245/344 (71%)
Query: 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE 515
+D+EL +F +A AT+NF++ NKLG+GGFG VYKG L++GQE+AVKRLSK S QG +E
Sbjct: 507 DDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAVKRLSKTSVQGTDE 566
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
FKNEV LIARLQH NLV+LL CC+ A E MLIYEY+ N SLD +FD++R + L+WQ R
Sbjct: 567 FKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFDKSRNSKLNWQMRF 626
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I+ GIARG+LYLHQDSR RIIHRDLKASN+LLD M PKISDFGMARIFG DE + NT
Sbjct: 627 DIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMARIFGRDETEANTR 686
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695
KVVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+S K+N F + D D NLLG W
Sbjct: 687 KVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNSDRDLNLLGCVWRN 746
Query: 696 WKEKRAMELAGDTLADSHPPT---EVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXX 752
WKE + +E+ + DS E+LRCI +GLLCVQ R EDRP
Sbjct: 747 WKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTMSLVILMLGSESTT 806
Query: 753 -PEPNRPGFFTERSLPEAEFSPSYP---QSSTTNEITITELQGR 792
P+P PG+ ERSL + + S S +S T N+IT++ L R
Sbjct: 807 IPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1003 (358.1 bits), Expect = 6.9e-195, Sum P(2) = 6.9e-195
Identities = 201/357 (56%), Positives = 251/357 (70%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAV 502
+ ++G T E +EL + ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAV
Sbjct: 487 VSRRGYTSKEKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAV 546
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562
KRLSK S QG +EF NEV LIA+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FD
Sbjct: 547 KRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFD 606
Query: 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622
Q R++ L+WQKR I+ GIARG+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMA
Sbjct: 607 QTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMA 666
Query: 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
RIFG +E + NT +VVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F +
Sbjct: 667 RIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNS 726
Query: 683 DHDHNLLGHAWILWKEKRAMELAG----DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP- 737
+ D NLLG W WKE +E+ D+L+ P E+LRCI +GLLCVQ R EDRP
Sbjct: 727 NRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPV 786
Query: 738 NXXXXXXXXXXXXXXPEPNRPGFFTERSLPEAEFSPSYPQSS--TTNEITITELQGR 792
P+P RPGF RS EA+ S S + T N+IT++ + R
Sbjct: 787 MSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 991 (353.9 bits), Expect = 8.2e-190, Sum P(2) = 8.2e-190
Identities = 197/351 (56%), Positives = 248/351 (70%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
T + + +EL ++ ++A AT+NF++ NKLG+GGFG VYKG L++G+EIAVKRLSK
Sbjct: 497 TSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKM 556
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
S QG +EF NEV LIA+LQH NLV+LLGCC+ E MLIYEY+ N SLD +FDQ R++
Sbjct: 557 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 616
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
L+WQKR I+ GIARG+LYLHQDSR RIIHRDLKASNVLLD +M PKISDFGMARIFG +
Sbjct: 617 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 676
Query: 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
E + NT +VVGTYGYMSPEYA +G+FS+KSDVFSFGVL+LEI+SGK+N F + + D NL
Sbjct: 677 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 736
Query: 689 LGHAWILWKEKRAMELAG----DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-NXXXXX 743
LG W WKE + +E+ D L+ P E+LRCI +GLLCVQ R EDRP
Sbjct: 737 LGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 796
Query: 744 XXXXXXXXXPEPNRPGFFTERSLPEAEFSPSYPQSS--TTNEITITELQGR 792
P+P RPGF RS E + S S + T N++T++ + R
Sbjct: 797 MLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.4e-174, Sum P(2) = 1.4e-174
Identities = 192/338 (56%), Positives = 240/338 (71%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL F +IA AT++F N+LG GGFGPVYKG L +G+EIAVKRLS SGQG++EFKN
Sbjct: 513 ELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKN 572
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E+ LIA+LQHRNLV+LLGCC + +E ML+YEYMPNKSLDFF+FD+ + +DW+ R I+
Sbjct: 573 EIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSII 632
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GIARG+LYLH+DSR+RIIHRDLK SNVLLD +MNPKISDFGMARIFGG++ + NT +VV
Sbjct: 633 EGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVV 692
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
GTYGYMSPEYA EGLFSVKSDV+SFGVL+LEIVSGK+N +H +L+G+AW L+
Sbjct: 693 GTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYAWYLYTH 751
Query: 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXX-PEPNR 757
R+ EL + + E LRCIHV +LCVQ +RPN P +
Sbjct: 752 GRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQ 811
Query: 758 PGFF-TERSLPEAEFSPSYPQSS--TTNEITITELQGR 792
P F T R+ + F+ Q ++NEIT T + GR
Sbjct: 812 PTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1617 (574.3 bits), Expect = 3.3e-166, P = 3.3e-166
Identities = 349/816 (42%), Positives = 480/816 (58%)
Query: 4 AYSCLL-FILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRV 62
AY L F + +S+A IT + G+TL S NG +ELGFF+ S +Y+GIW+K +
Sbjct: 10 AYLLLSSFFISSSSAG--ITKESPLPIGQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGI 67
Query: 63 SPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSG 121
PR V WVANRE P+TD + L +++ G +LL +G+ + WSS ++ +L D+G
Sbjct: 68 IPRVVVWVANREKPVTDSTANLAISNNGSLLLFNGKHGVAWSSGEALVSNGSRAELSDTG 127
Query: 122 NLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWI 181
NL++ D LWQSFDH DT+LP L N TG + LSSWKS DP+ G+F L I
Sbjct: 128 NLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQI 187
Query: 182 DTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEVYYECDA 239
Q+++ KGS YR+G W FTG P + + P+ + + Y
Sbjct: 188 TPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGSLTYL--N 245
Query: 240 KGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCD 299
+ + R + G S W + D W L + AP CD Y VCG C + +C
Sbjct: 246 RNDRLQRTMLTSKGTQELS-WHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCT 303
Query: 300 CLEGFVPK-----SPNNWSEGCVRERELKCRNGDEFPKYV-------KLKLPDTSSSWFN 347
C +GFVPK NW+ GCVR EL C+ G+ KY ++K PD F
Sbjct: 304 CFKGFVPKLIEEWKRGNWTGGCVRRTELYCQ-GNSTGKYANVFHPVARIKPPDFYE--FA 360
Query: 348 ASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-S 406
+ +N++EC + C NCSC A+A D G GCL+W DLMD ++++GG+ L IR+A S
Sbjct: 361 SFVNVEECQKSCLHNCSCLAFAYID----GIGCLMWNQDLMDAVQFSEGGELLSIRLARS 416
Query: 407 ERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQG--LTKMSHM--KEDMELWE 462
E G + KK + I S+ L+ + + FC WR ++K T S + + D++ +
Sbjct: 417 ELGGNKRKKAITASIVSLSLVVIIAFVA-FCFWRYRVKHNADITTDASQVSWRNDLKPQD 475
Query: 463 ------FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEF 516
FD +I AT+NF+ NKLG+GGFGPVYKG L +G+EIAVKRLS SGQG EEF
Sbjct: 476 VPGLDFFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEF 535
Query: 517 KNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
NE+ LI++LQH+NLV++LGCCI+ +E +LIYE+M N SLD F+FD + +DW KR+
Sbjct: 536 MNEIVLISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLD 595
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I+ GIARGI YLH+DS +++IHRDLK SN+LLD MNPKISDFG+AR++ G E Q NT +
Sbjct: 596 IIQGIARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRR 655
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696
VVGT GYM+PEYA G+FS KSD++SFGVL+LEI+SG+K RFS+ + L+ +AW W
Sbjct: 656 VVGTLGYMAPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGKEEKTLIAYAWESW 715
Query: 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXXPEPN 756
+ ++L +ADS P EV RC+ +GLLCVQH+P DRPN P P
Sbjct: 716 CDTGGIDLLDKDVADSCRPLEVERCVQIGLLCVQHQPADRPNTLELLSMLTTTSDLPPPE 775
Query: 757 RPGFFTERSLPEAEFSPSYPQSSTTNEITITELQGR 792
+P F R + S T NE+T + + GR
Sbjct: 776 QPTFVVHRR----DDKSSSEDLITVNEMTKSVILGR 807
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 909 (325.0 bits), Expect = 5.0e-166, Sum P(2) = 5.0e-166
Identities = 174/335 (51%), Positives = 231/335 (68%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
EL F+F +A AT+NF+ NKLG+GGFG VYKG L EG +IAVKRLS+ SGQG+EEF N
Sbjct: 496 ELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVN 555
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
EV +I++LQHRNLV+LLG CI+ +E ML+YE+MP LD ++FD + LDW+ R +I+
Sbjct: 556 EVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNII 615
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
GI RG++YLH+DSR++IIHRDLKASN+LLD ++NPKISDFG+ARIF G+E + +T +VV
Sbjct: 616 DGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVV 675
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
GTYGYM+PEYA GLFS KSDVFS GV++LEIVSG++N F + + NL +AW LW
Sbjct: 676 GTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNT 735
Query: 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXX-XXXXXXXXXPEPNR 757
+ L + + E+ RC+HVGLLCVQ DRP+ PEP +
Sbjct: 736 GEDIALVDPVIFEECFENEIRRCVHVGLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQ 795
Query: 758 PGFFTERSLPEAEFSPSYPQSSTTNEITITELQGR 792
P F R E E S ++ N +++T++ GR
Sbjct: 796 PAFIPRRGTSEVESSGQSDPRASINNVSLTKITGR 830
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1615 (573.6 bits), Expect = 5.4e-166, P = 5.4e-166
Identities = 346/811 (42%), Positives = 480/811 (59%)
Query: 5 YSCLL-FILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVS 63
++CLL F + + IT + +TL S NG +ELGFFSP S Y+GIW+K +
Sbjct: 9 FACLLLFTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWFKGII 68
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGN 122
PR V WVANRETP TD S L ++S G +LL +G+ + WS + +L D+GN
Sbjct: 69 PRVVVWVANRETPTTDTSANLAISSNGSLLLFNGKHGVVWSIGENFASNGSRAELTDNGN 128
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWID 182
LV+ D LW+SF+H DT+LP L N TG R L+SWK+ DP+PG F I
Sbjct: 129 LVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVFVGQIT 188
Query: 183 THGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN-EVYYECDAKG 241
Q+++ +GS YR G W FTG P L ++ + + N ++ +
Sbjct: 189 PQVPSQVLIMRGSTRYYRTGPWAKTRFTGIP-LMDDTYASPFSLQQDANGSGFFTYFDRS 247
Query: 242 PAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCL 301
+SR+ ++ G + R + W L+Y AP + CD+Y VCG C + +C CL
Sbjct: 248 FKLSRIIISSEGSMKRFRHNGTD--WELSYMAPANSCDIYGVCGPFGLCIVSVPLKCKCL 305
Query: 302 EGFVPKSPN-----NWSEGCVRERELKCRN---GDE---FPKYVKLKLPDTSSSWFNASM 350
+GFVP S NW+ GC R EL C+ G + F +KLPD + +S+
Sbjct: 306 KGFVPHSTEEWKRGNWTGGCARLTELHCQGNSTGKDVNIFHPVTNVKLPDFYE--YESSV 363
Query: 351 NLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA-SERG 409
+ +EC + C NCSC A+A G GCL+W +LMD +++ GG+ L IR+A SE G
Sbjct: 364 DAEECHQSCLHNCSCLAFAYIH----GIGCLIWNQNLMDAVQFSAGGEILSIRLAHSELG 419
Query: 410 RSVTKKQVGIIIASVLLMAMFIV--ASLFCIWRKKLKKQGLTKMSHMKEDMELWE----- 462
+ K II+AS + +++F++ ++ F WR ++K + T + D++ E
Sbjct: 420 GNKRNK---IIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLE 476
Query: 463 -FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT 521
F+ +I AT+NF+ NKLG+GGFG VYKG L +G+EIAVK+LS SGQG EEF NE+
Sbjct: 477 FFEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIV 536
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
LI++LQHRNLV++LGCCI+ +E +LIYE+M NKSLD F+FD + +DW KR IV GI
Sbjct: 537 LISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGI 596
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
ARG+LYLH+DSR+++IHRDLK SN+LLD MNPKISDFG+AR++ G + Q T +VVGT
Sbjct: 597 ARGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTL 656
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
GYMSPEYA G+FS KSD++SFGVL+LEI+ G+K RFS+ + LL +AW W E +
Sbjct: 657 GYMSPEYAWTGVFSEKSDIYSFGVLLLEIIIGEKISRFSYGEEGKTLLAYAWESWGETKG 716
Query: 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXXPEPNRPGFF 761
++L LADS P EV RC+ +GLLCVQH+P DRPN P P +P F
Sbjct: 717 IDLLDQDLADSCRPLEVGRCVQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPTFV 776
Query: 762 TERSLPEAEFSPSYPQSSTTNEITITELQGR 792
E+ S T NE+T + + GR
Sbjct: 777 VHSRDDESSLSKDL---FTVNEMTQSMILGR 804
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1609 (571.5 bits), Expect = 2.3e-165, P = 2.3e-165
Identities = 345/783 (44%), Positives = 463/783 (59%)
Query: 2 LGAYSCLLFILGASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKR 61
L ++ LF L + +++ IT + G+TL S N +ELGFFSP + +Y+GIW+K
Sbjct: 8 LHLFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKD 67
Query: 62 VSPRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
PR V WVANRE P+TD + L ++S G ++LL+G+ WSS + + +L DS
Sbjct: 68 TIPRVVVWVANREKPVTDSTAYLAISSSGSLLLLNGKHGTVWSSGVTFSSSGCRAELSDS 127
Query: 121 GNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLW 180
GNL + D LWQSFDH DTLL L N T R L+SWKS DP+PG+F
Sbjct: 128 GNLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDFLGQ 187
Query: 181 IDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENV--PLCDYKFVINENEV-YYEC 237
I Q + +GS +R+G W FTG P + E+ P ++ V + Y++
Sbjct: 188 ITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQDVNGSGYLTYFQR 247
Query: 238 DAKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRR 297
D K +SR+ + G + ++ W L Y AP CD Y CG C + S
Sbjct: 248 DYK---LSRITLTSEGSI--KMFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPM 302
Query: 298 CDCLEGFVPKSPN-----NWSEGCVRERELKC------RNGDEFPKYVKLKLPDTSSSWF 346
C C GFVPKS NW+ GCVR EL C + D+F + +K PD F
Sbjct: 303 CKCFRGFVPKSVEEWKRGNWTGGCVRHTELDCLGNSTGEDADDFHQIANIKPPDFYE--F 360
Query: 347 NASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGGQDLYIRIA- 405
+S+N +EC + C NCSC A+A G GCL+W DLMD +++ G+ L IR+A
Sbjct: 361 ASSVNAEECHQRCVHNCSCLAFAYIK----GIGCLVWNQDLMDAVQFSATGELLSIRLAR 416
Query: 406 SERGRSVTKKQVGIIIASVLLMAMFIVASL--FCIWRKKLKKQGLTKMSHMKEDMELWE- 462
SE + KK I+AS++ + +F++ F +WR +++ K D++ +
Sbjct: 417 SELDGNKRKKT---IVASIVSLTLFMILGFTAFGVWRCRVEHIAHISKDAWKNDLKPQDV 473
Query: 463 -----FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFK 517
FD +I AT+NF+ NKLG+GGFG VYKG L +G+EIAVKRLS SGQG EEF
Sbjct: 474 PGLDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 533
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
NE+ LI++LQHRNLV++LGCCI+ +E +LIYE+M NKSLD F+FD + +DW KR I
Sbjct: 534 NEIVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDI 593
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ GIARG+LYLH DSR+R+IHRDLK SN+LLD MNPKISDFG+AR++ G E Q NT +V
Sbjct: 594 IQGIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRV 653
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
VGT GYMSPEYA G+FS KSD++SFGVL+LEI+SG+K RFS+ L+ +AW W
Sbjct: 654 VGTLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWS 713
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNXXXXXXXXXXXXXXPEPNR 757
E R ++L LADS P EV RCI +GLLCVQH+P DRPN P P +
Sbjct: 714 EYRGIDLLDQDLADSCHPLEVGRCIQIGLLCVQHQPADRPNTLELLAMLTTTSDLPSPKQ 773
Query: 758 PGF 760
P F
Sbjct: 774 PTF 776
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81833 | SD11_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5484 | 0.9659 | 0.9386 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_134000023 | hypothetical protein (812 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 792 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-55 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-50 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 2e-35 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-33 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-29 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-28 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-27 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 8e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-26 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-26 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-26 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-25 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-25 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-25 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-24 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-24 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-22 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 6e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-20 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-19 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-19 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-18 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-18 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-11 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 8e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-06 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 6e-56
Identities = 97/275 (35%), Positives = 138/275 (50%), Gaps = 30/275 (10%)
Query: 480 KLGEGGFGPVYKGTL-----VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + M++ EYMP L ++ R L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
IHRDL A N L+ ++ KISDFG++R ++ D + K+ +M+PE EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 653 LFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
F+ KSDV+SFGVL+ EI + G++ + L + L K
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP------------ 227
Query: 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+ P E+ + + L C PEDRP S +V +L
Sbjct: 228 -NCPPELYK---LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 1e-55
Identities = 93/274 (33%), Positives = 131/274 (47%), Gaps = 29/274 (10%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ +L H N+VK
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C + + ++ EYM L ++ + L + IARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IHRDL A N L+ ++ KISDFG++R D+ + +M+PE EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESLKEGK 179
Query: 654 FSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
F+ KSDV+SFGVL+ EI + G++ P + + +E G L
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQ------P--------YPGMSNEEVLEYLKNGYRL--P 223
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
PP + L C PEDRP S +V +L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 3e-54
Identities = 91/282 (32%), Positives = 136/282 (48%), Gaps = 35/282 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKG L E+AVK L + S + ++F E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C + + L+ EYM L ++ F + L + + IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSP 646
L + +HRDL A N L+ D+ KISDFG++R ++ D + T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
E +G+F+ KSDV+SFGVL+ EI + G + P + +E
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY----PG----------LSNEEVLEYLRK 222
Query: 706 GDTLAD-SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
G L + P E+ + L C Q PEDRP S +V L
Sbjct: 223 GYRLPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 2e-50
Identities = 70/194 (36%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LGEGGFG VY + G+++A+K + K S +EE E+ ++ +L H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + L + + I+ I G+ YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 599 RDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YAAEGLFSV 656
RDLK N+LLD+D K++DFG++++ D+ T +VGT YM+PE +G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 657 KSDVFSFGVLVLEI 670
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 3e-50
Identities = 91/281 (32%), Positives = 136/281 (48%), Gaps = 42/281 (14%)
Query: 480 KLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVK 533
KLGEG FG VYKGTL ++AVK L +G+ + EEF E +++ +L H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
LLG C Q + ++ EYMP L F+ + L + + + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+HRDL A N L+ ++ KISDFG++R D+ +M+PE +G
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 654 FSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
F+ KSDV+SFGVL+ EI + G++ P + E+ + L D
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQ------P-------------YPGMSNEEVL-ELLEDG 220
Query: 713 HP-------PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+ P E+ + L C + PEDRP S +V L
Sbjct: 221 YRLPRPENCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 69/200 (34%), Positives = 102/200 (51%), Gaps = 14/200 (7%)
Query: 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ RL H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
D L+ EY L ++ +R L + I I RG+ YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YAAEGLF 654
IIHRDLK N+LLD + KI+DFG+A+ ++ VGT YM+PE +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
K DV+S GV++ E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-45
Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
KLGEG FG VY + G+ +A+K + K + E E+ ++ +L+H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
D+ L+ EY L + + R + + R + I + YLH I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEAR-FYLRQILSALEYLHS---KGI 118
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSV 656
+HRDLK N+LLD D + K++DFG+AR E VGT YM+PE +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 657 KSDVFSFGVLVLEIVSGK 674
D++S GV++ E+++GK
Sbjct: 176 AVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 68/230 (29%), Positives = 109/230 (47%), Gaps = 31/230 (13%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG VY + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 536 GCCIQADESML-IY-EYMPNKSLDFFIFDQARATFLDWQKRIHI------VGGIARGILY 587
G +++ L I+ EY+ SL ++ L ++ I G+ Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSL---------SSLLKKFGKLPEPVIRKYTRQILEGLAY 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I+HRD+K +N+L+D+D K++DFG A+ G E T V GT +M+PE
Sbjct: 117 LH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
+ +D++S G V+E+ +GK W L L+K
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPW--------SELGNPMAALYK 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 47/271 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ + +H N+VK G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRM 594
++ DE ++ E+ SL + T + Q + + + +L YLH
Sbjct: 67 LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS---N 117
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IIHRD+KA+N+LL +D K+ DFG++ D NT +VGT +M+PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKARNT--MVGTPYWMAPEVINGKPY 174
Query: 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP 714
K+D++S G+ +E+ GK + P +A+ A + P
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSELPPM----------------KALFKI----ATNGP 214
Query: 715 PTEVLRCIHVG--------LLCVQHRPEDRP 737
P LR C+Q PE RP
Sbjct: 215 PG--LRNPEKWSDEFKDFLKKCLQKNPEKRP 243
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 61/111 (54%), Positives = 69/111 (62%), Gaps = 3/111 (2%)
Query: 64 PRTVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN 122
+TV WVANR PLTD S L + S G +VL DG R+ WSSNTS V L D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 123 LVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173
LVL D + +LWQSFDHP DTLLPG K G N G R L+SWKS DP+
Sbjct: 61 LVLYDNS-GKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 72/228 (31%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVK 533
LGEG FG V+ G L + +AVK L + + + F+ E L+ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKR----------IHIVGGIA 582
G C + D ++++EYM + L+ F+ A FL + I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT-- 640
G++YL + +HRDL N L+ D+ KI DFGM+R D T+ ++V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 641 --YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHD 685
+M PE F+ +SDV+SFGV++ EI + GK+ W + + +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 9e-34
Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 37/288 (12%)
Query: 479 NKLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 533 KLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
K G C + LI EY+P+ SL ++ Q ++ ++ + I +G+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
R IHRDL A N+L++++ KISDFG+A++ D + Y +PE
Sbjct: 128 ---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN-------LLGHAWILWKEKRA 701
FS SDV+SFGV + E+ F++ D + ++G A R
Sbjct: 184 LRTSKFSSASDVWSFGVTLYEL--------FTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
Query: 702 MELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+EL + P P EV + LC + P+DRP+ + ++L++
Sbjct: 236 LELLKEGERLPRPPSCPDEVY---DLMKLCWEAEPQDRPSFADLILIV 280
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 71/199 (35%), Positives = 105/199 (52%), Gaps = 18/199 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ GT ++AVK L G+ M E F E ++ +L+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
C + + ++ EYM SL DF + + L + + + IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYLE---SRNY 124
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGL 653
IHRDL A N+L+ ++ KI+DFG+AR+ DE G + +PE A G
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGR 180
Query: 654 FSVKSDVFSFGVLVLEIVS 672
F++KSDV+SFG+L+ EIV+
Sbjct: 181 FTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 7e-33
Identities = 66/198 (33%), Positives = 103/198 (52%), Gaps = 6/198 (3%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
F KLG G FG V++G +A+K L ++F+ EV + RL+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C + +I E M SL F+ L I + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IHRDL A N+L+ D+ K++DFG+AR+ D ++ K+ Y + +PE A+ G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 655 SVKSDVFSFGVLVLEIVS 672
S KSDV+SFG+L+ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 73/213 (34%), Positives = 109/213 (51%), Gaps = 25/213 (11%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
LGEG FG VYKG L +A+K L + + +EF+ E L++ LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVGG 580
LLG C + + +++EY+ + L F+ D+ + LD +HI
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG 639
IA G+ YL S +HRDL A N L+ + KISDFG++R I+ D + K +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV-QSKSLL 188
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M PE G F+ +SD++SFGV++ EI S
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (321), Expect = 5e-32
Identities = 74/283 (26%), Positives = 121/283 (42%), Gaps = 21/283 (7%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-R 529
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKL L+ EY+ SL+ + R L + + I+ I + YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD----EIQTNTHKVVGTYGYM 644
IIHRD+K N+LLD + K+ DFG+A++ I VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 645 SPEYAAEGLF---SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
+PE S SD++S G+ + E+++G + + I+ +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK--IILELPT- 232
Query: 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744
L+ S+P + + P++R + SS +
Sbjct: 233 -PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 35/211 (16%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+ +G G FG VYKG L G +A+K++S K + ++ E+ L+ L+H N+VK +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG------------IAR 583
G +D +I EY N SL ++ I G + +
Sbjct: 66 GSIETSDSLYIILEYAENGSL---------------RQIIKKFGPFPESLVAVYVYQVLQ 110
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ YLH+ +IHRD+KA+N+L D K++DFG+A + VVGT +
Sbjct: 111 GLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYW 165
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE S SD++S G V+E+++G
Sbjct: 166 MAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/217 (28%), Positives = 108/217 (49%), Gaps = 21/217 (9%)
Query: 464 DFASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
D S + + + K+GEG G VYK T G+E+A+K++ + Q E NE+ +
Sbjct: 10 DIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL------DFFIFDQARATFLDWQKRIH 576
+ +H N+V + DE ++ EYM SL +F ++ + +
Sbjct: 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------- 120
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
+ + +G+ YLH +IHRD+K+ N+LL D + K++DFG A + ++ +
Sbjct: 121 VCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNS 175
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
VVGT +M+PE + K D++S G++ +E+ G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-31
Identities = 56/119 (47%), Positives = 70/119 (58%), Gaps = 4/119 (3%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S + G+TLVS FELGFF ++ Y I YK S RTV WVANR+ P S
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNPSGS-SCT 58
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141
L + S G +V+ DG + WSSNT+ N V+ L+D GNLVL D + N LWQSFD+P
Sbjct: 59 LTLQSDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNF-LWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 43/282 (15%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ +L H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-------TFLDW--QKRIHIVGGI 581
++K + + ++ EY L I Q + LDW Q +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--------L 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ YLH SR +I+HRD+K N+ L ++ K+ DFG++++ T VVGT
Sbjct: 113 CLALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTP 167
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-ILWKEKR 700
Y+SPE ++ KSD++S G ++ E+ + K HP NLL A IL +
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLK------HPFEGENLLELALKILKGQYP 221
Query: 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ S +E LR + LL Q PE+RP+++ +
Sbjct: 222 PIP--------SQYSSE-LRNLVSSLL--QKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 76/210 (36%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 481 LGEGGFGPVYKGTLV-------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLV 532
LG G FG VY+GT +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----LDWQKRIHIVGGIARGILYL 588
KLLG C+ + +I E M L ++ D F L ++ + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 589 HQDSRMRIIHRDLKASNVLL-----DNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYG 642
Q M IHRDL A N L+ D D KI DFG+AR I+ D + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +G F+ +SDV+SFGVL+ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 67/194 (34%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G GQ++AVK L K + F E +++ L+H NLV+LLG +Q
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
+ ++ EYM SL ++ + RA + +++ + G+ YL + +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY--GYMSPEYAAEGLFSVKS 658
L A NVL+ D+ K+SDFG+A+ + Q G + +PE E FS KS
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFSTKS 180
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EI S
Sbjct: 181 DVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 21/206 (10%)
Query: 481 LGEGGFGPVYKGT-LVEGQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARA----TFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + + LI + MP L ++ + L+W +I A+G+ YL +
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
R++HRDL A NVL+ + KI+DFG+A++ DE + + +M+ E
Sbjct: 128 ---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVS-GKK 675
+++ KSDV+S+GV V E+++ G K
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 30/207 (14%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K + +E E +++R+ H +VK
Sbjct: 1 LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILY 587
L Q +E + L+ EY P L + F + RA F I + Y
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEY 108
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH + II+RDLK N+LLD D + K++DFG+A+ + +TNT GT Y++PE
Sbjct: 109 LH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPE 163
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ D +S GVL+ E+++GK
Sbjct: 164 VLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 63/199 (31%), Positives = 106/199 (53%), Gaps = 14/199 (7%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + +A+K L GS +F E +++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G ++ M+I EYM N SLD F+ + + + ++ GIA G+ YL S M
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGG--DEIQTNTHKVVGTYGYMSPEYAAEGL 653
+HRDL A N+L+++++ K+SDFG++R T K+ + +PE A
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYRK 184
Query: 654 FSVKSDVFSFGVLVLEIVS 672
F+ SDV+SFG+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 57/118 (48%), Positives = 74/118 (62%), Gaps = 5/118 (4%)
Query: 24 SQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGL 83
S ++ G+TLVS N FELGFF+ Y I YK S RTV WVANR+ P++D S
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYK-SSSRTVVWVANRDNPVSD-SCT 57
Query: 84 LNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
L + S G +VL DG R+ WSSNT+ N V+ L+D GNLV+ D + + LWQSFD+
Sbjct: 58 LTLQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD-SDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 41/231 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-Q 527
D+F +GEG F V E +E A+K L K + ++ K E ++ RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
H ++KL Q +E++ + EY PN L +I D+ F I
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--------YAAEI 111
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV---- 637
+ YLH IIHRDLK N+LLD DM+ KI+DFG A++ + +
Sbjct: 112 LLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 638 --------------VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT Y+SPE E SD+++ G ++ ++++GK
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 69/213 (32%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D SI KLG G FG V++G +AVK L G+ ++F E
Sbjct: 1 WEIDRTSIQLL-------RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEA 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVG 579
++ +L+H L++L C + ++ E M SL ++ RA L + I +
Sbjct: 53 QIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAA 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+A G+ YL IHRDL A NVL+ + K++DFG+AR+ ++I
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKF 166
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE A FS+KSDV+SFG+L+ EIV+
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 93/282 (32%), Positives = 135/282 (47%), Gaps = 38/282 (13%)
Query: 479 NKLGEGGFGPVYKGTLVE--GQEI--AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + G+E+ AVK L + G +EF E +++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L+G C + + ML+ E P L ++ + D ++ H +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAH---QVAMGMAYLES--- 113
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI--FGGDEIQTNTHKVVGTY--GYMSPEYA 649
+HRDL A NVLL N KISDFGM+R G D + T G + + +PE
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA---GRWPLKWYAPECI 170
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708
G FS KSDV+S+GV + E S G K + + G E AM +G+
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYG--------EMKG------AEVIAMLESGER 216
Query: 709 LADSHPPTEVLRCIH-VGLLCVQHRPEDRPNMSSVVLMLSSD 749
L P E + I+ + L C ++RPEDRP S + D
Sbjct: 217 LPR---PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 9/194 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q + +I EYM N SL DF + L K I + IA G+ ++ R IH
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIK--LTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+N+L+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EIV+
Sbjct: 185 DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI----VGGIARGIL----YLH 589
+ E ++ EYM SL + +K I + IAR IL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----------KKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
IIHRD+K SN+L+++ KI+DFG++++ + + VGT YMSPE
Sbjct: 117 TKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERI 172
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+S +D++S G+ +LE GK
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 84/299 (28%), Positives = 129/299 (43%), Gaps = 56/299 (18%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEG-------QEIAVKRL-SKGSGQGMEEFKNEVTL 522
D+ LG G FG VY+G L G ++AVK L S Q +F E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEG-LYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALI 62
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIV 578
+++ H+N+V+L+G + ++ E M L F+ + R + L + +
Sbjct: 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMAR-IFGGDEIQTNT 634
+A+G YL ++ IHRD+ A N LL KI+DFGMAR I+ +
Sbjct: 123 RDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-------GKKNWRFSHPDHDHN 687
+ + +M PE +G+F+ K+DV+SFGVL+ EI S G+ N
Sbjct: 180 -RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----------- 227
Query: 688 LLGHAWILWKEKRAMEL---AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+ ME G P V R + C QH PEDRPN ++++
Sbjct: 228 -----------QEVMEFVTGGGRLDPPKGCPGPVYR---IMTDCWQHTPEDRPNFATIL 272
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 75/269 (27%), Positives = 130/269 (48%), Gaps = 24/269 (8%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
++G G FG V+ G +E +++A+K + +G+ E+F E ++ +L H LV+L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ L++E+M + L ++ +A+ + + + + G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + K+SDFGM R D+ T++ + SPE + +S KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 660 VFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEV 718
V+SFGVL+ E+ S GK + + + L+K + A V
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA-------------SQSV 230
Query: 719 LRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
+ C + RPEDRP+ S ++ L+
Sbjct: 231 YELMQ---HCWKERPEDRPSFSLLLHQLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 72/194 (37%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ + +I EYM SL DF D+ L K I IA G+ Y+ R IH
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+NVL+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 659 DVFSFGVLVLEIVS 672
DV+SFG+L+ EIV+
Sbjct: 186 DVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 83/281 (29%), Positives = 116/281 (41%), Gaps = 37/281 (13%)
Query: 480 KLGEGGFGPVYKGTLVEGQ----EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKL 534
KLG+G FG V +G +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG----IARGILYLHQ 590
G + M++ E P SL + A FL I + IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFL-----ISTLCDYAVQIANGMRYLES 115
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
R IHRDL A N+LL +D KI DFG+ R D H V + + +PE
Sbjct: 116 K---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPES 171
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
FS SDV+ FGV + E+ + G++ W L + IL K + E
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG---------LSGSQILKKIDKEGERL-- 220
Query: 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
P +V L C H P DRP +++ L
Sbjct: 221 ----ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 14/206 (6%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEG +G VYK GQ +A+K + + ++E E++++ + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ + ++ EY S + D + L ++ I+ +G+ YLH +
Sbjct: 68 FKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS---NKK 120
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSV 656
IHRD+KA N+LL+ + K++DFG++ + NT V+GT +M+PE E ++
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVIQEIGYNN 178
Query: 657 KSDVFSFGVLVLEIVSGKKNWRFSHP 682
K+D++S G+ +E+ GK + HP
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLLGCC 538
K+G+G FG VYKG L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+Q ++ E +P F + + L +K + + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL A N L+ + KISDFGM+R G + + +PE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 659 DVFSFGVLVLEIVSG-----------------KKNWRFSHPDHD----HNLLGHAWILWK 697
DV+S+G+L+ E S + +R P + L+ W
Sbjct: 177 DVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236
Query: 698 EKR 700
E R
Sbjct: 237 ENR 239
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-27
Identities = 36/67 (53%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLW 383
C GD F + +KLPDT+++ + S+ LKEC + C NCSCTAYA +D+ RGGSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADI-RGGSGCLIW 59
Query: 384 FGDLMDM 390
G+L+DM
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 67/208 (32%), Positives = 107/208 (51%), Gaps = 29/208 (13%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG P+ T G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 533 KLLGCCIQA--DESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
K G C A L+ EY+P SL D+ + R LD +K + I +G+ YL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL- 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YM 644
R +HRDL N+L++++ KI DFG+ ++ D+ + V G +
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK----EYYKVREPGESPIFWY 178
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE E FSV SDV+SFGV++ E+ +
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 22/209 (10%)
Query: 481 LGEGGFGPVYKGTLVEG----QEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQARAT---FLDWQKRIHIVGGIARGI 585
+G C +A M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEI-QTNTHKVVGTYGY 643
YL S IHRDL A N +L DM ++DFG+++ I+ GD Q K+ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--PVKW 181
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++ E A+ +++ KSDV++FGV + EI +
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G + +AVK L K +EEF E
Sbjct: 1 WEMERTDITM-------KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE 52
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R ++ +++
Sbjct: 53 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMAT 111
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + + IHRDL A N L+ + K++DFG++R+ GD T T
Sbjct: 112 QISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGA 165
Query: 640 TY--GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
+ + +PE A FS+KSDV++FGVL+ EI + + +P D L + L +
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS---PYPGID---LSQVYELLE 219
Query: 698 EKRAMELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ ME P P +V + C Q P DRP+ + +
Sbjct: 220 KGYRME---------RPEGCPPKVYELMRA---CWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 41/111 (36%), Positives = 60/111 (54%), Gaps = 2/111 (1%)
Query: 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYE-CDAKGPAVSRLWVNQSGLVLR 257
+R+G WNG+ F+G P +++ Y F N EVYY SRL ++ G + R
Sbjct: 1 WRSGPWNGIRFSGIPEMQKL-SYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLER 59
Query: 258 SIWSSQQDVWFLAYYAPLDRCDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308
W W L + AP D+CD+Y CG C N+S +C+C++GFVPK+
Sbjct: 60 FTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 79/264 (29%), Positives = 122/264 (46%), Gaps = 36/264 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
LG G FG V+ G ++A+K + +G+ ++F E ++ +L H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
++ EYM N L ++ + R L + + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGLFSVK 657
L A N L+ D K+SDFG+AR D+ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 658 SDVFSFGVLVLEIVSGKK----NWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713
SDV+SFGVL+ E+ S K + S + G + L++ K A
Sbjct: 182 SDVWSFGVLMWEVFSEGKMPYERFSNSEV-VESVSAG--YRLYRPKLA------------ 226
Query: 714 PPTEVLRCIHVGLLCVQHRPEDRP 737
PTEV ++ C +PEDRP
Sbjct: 227 -PTEVYTIMY---SCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 66/193 (34%), Positives = 105/193 (54%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ GT ++AVK L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ D L + + +A G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+++N+L+ + + KI+DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 1e-25
Identities = 74/218 (33%), Positives = 113/218 (51%), Gaps = 33/218 (15%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLV 532
+LGE FG VYKG L + Q +A+K L K G EEFK+E + +RLQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHIVG 579
LLG + +I+ Y + L F+ D+ + L+ +HIV
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
IA G+ +L S ++H+DL NVL+ + +N KISD G+ R ++ D +K++
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAAD-----YYKLM 183
Query: 639 GT----YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G +MSPE G FS+ SD++S+GV++ E+ S
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 32/209 (15%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG +G VYK G+ +A+K++ ++ + E++L+ L+H N
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + L++EY + L ++ + + K I+ + RG+ Y H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIK--SIMYQLLRGLAYCHS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
RI+HRDLK N+L++ D K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 117 ---HRILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEI-- 169
Query: 651 EGLFSVKS-----DVFSFGVLVLEIVSGK 674
L K D++S G + E+++GK
Sbjct: 170 --LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 70/222 (31%), Positives = 111/222 (50%), Gaps = 22/222 (9%)
Query: 474 NFASYNKLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHI 577
H ++VK G C++ D ++++EYM + L+ F+ R L + +HI
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHK 636
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + H
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
++ +M PE F+ +SDV+S GV++ EI + GK+ W
Sbjct: 183 MLPIR-WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 30/221 (13%)
Query: 480 KLGEGGFGPVYKG---TLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF---------IFDQARATF---LDWQKRIHIVGGI 581
G C + ++++EYM + L+ F I L + + I I
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG-- 639
A G++YL + + +HRDL N L+ + KI DFGM+R D T+ ++V G
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRT 184
Query: 640 --TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+M PE F+ +SD++SFGV++ EI + GK+ W
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 67/203 (33%), Positives = 118/203 (58%), Gaps = 21/203 (10%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V++G L + G++ +A+K L G + + ++F +E +++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + +M+I EYM N +LD ++ D F +Q + ++ GIA G+ YL S M
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQ-LVGMLRGIAAGMKYL---SDMN 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEYA 649
+HRDL A N+L+++++ K+SDFG++R+ D T T T G + +PE
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTAPEAI 182
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS 672
A F+ SDV+SFG+++ E++S
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 39/215 (18%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
++GEG +G VYK G+ +A+K++ ME K E+ L+ +L+H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQKLRHP 58
Query: 530 NLVKLLGCCIQADES--MLIYEYMPNKSLDFF-IFDQARATFLDWQKRIHIVGGIARGIL 586
N+V+L + +++EYM + D + D F + Q + + + G+
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH---DLTGLLDSPEVKFTESQIK-CYMKQLLEGLQ 114
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH I+HRD+K SN+L++ND K++DFG+AR + T++V+ T Y P
Sbjct: 115 YLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPP 170
Query: 647 E-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E Y E D++S G ++ E+ GK
Sbjct: 171 ELLLGATRYGPE------VDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 480 KLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKR-----------IHIVGG 580
G C D ++++EYM + L+ F+ +D Q R +HI
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG 639
IA G++YL + +HRDL N L+ ++ KI DFGM+R ++ D + H ++
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNW 677
+M PE F+ +SDV+SFGV++ EI + GK+ W
Sbjct: 189 IR-WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 63/193 (32%), Positives = 106/193 (54%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT +A+K L G+ E F E ++ +L+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM SL F+ + +L + + + IA G+ Y+ RM +HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+A+N+L+ ++ K++DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+ +
Sbjct: 186 VWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 63/207 (30%), Positives = 109/207 (52%), Gaps = 15/207 (7%)
Query: 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F NK+G+G FG V+K + + A+K+ LSK + + EE +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD---WQKRIHIVGGIARGILY 587
+++ + + ++ EY N L + Q + W+ I I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ ++ KSDV++ GV++ E +GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 34/218 (15%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQG-------MEEFKNEVTLIARLQHRN 530
+G G FG VY G G+ +AVK+ L S ++ E+ L+ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HIVGGIARG 584
+V+ LG + AD + EY+P S+ A L+ + V I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSV---------AALLNNYGAFEETLVRNFVRQILKG 118
Query: 585 ILYLHQDSRMR-IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT--NTHK--VVG 639
+ YLH R IIHRD+K +N+L+DN KISDFG+++ + + T N + + G
Sbjct: 119 LNYLH----NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ +M+PE + ++ K+D++S G LV+E+++GK +
Sbjct: 175 SVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 8e-25
Identities = 83/259 (32%), Positives = 132/259 (50%), Gaps = 24/259 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG G FG V+ T + ++AVK + GS +E F E ++ LQH LVKL +
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKL-HAVV 70
Query: 540 QADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ +I E+M SL DF D+ L K I IA G+ ++ Q + IH
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRN---YIH 125
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKS 658
RDL+A+N+L+ + KI+DFG+AR+ +E T + +PE G F++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 659 DVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEV 718
DV+SFG+L++EIV+ R +P + + ++ RA+E + P E+
Sbjct: 185 DVWSFGILLMEIVT---YGRIPYPG-----MSNPEVI----RALERGYRMPRPENCPEEL 232
Query: 719 LRCIHVGLLCVQHRPEDRP 737
++ + C ++RPE+RP
Sbjct: 233 Y---NIMMRCWKNRPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-24
Identities = 35/81 (43%), Positives = 51/81 (62%), Gaps = 5/81 (6%)
Query: 325 RNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWF 384
+ D F K +KLPD +S+ +++L+EC E C NCSCTAYA ++ G GCLLW
Sbjct: 9 GSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWN 63
Query: 385 GDLMDMKEYNDGGQDLYIRIA 405
G L +++ + GG LY+R+A
Sbjct: 64 GLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 54/293 (18%)
Query: 481 LGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG+G FG VY+G +A+K +++ + EF NE +++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF----DQARATFLD---WQKRIHIVGGIARGIL 586
LLG ++++ E M L ++ + L QK I + IA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT----YG 642
YL + +HRDL A N ++ D+ KI DFGM R D +T+ ++ G
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-------GKKNWRFSHPDHDHNLLGHAWIL 695
+M+PE +G+F+ KSDV+SFGV++ E+ + G N
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------------------- 227
Query: 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
+ ++ D P + + + +C Q+ P+ RP +V L
Sbjct: 228 ---EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 23/208 (11%)
Query: 481 LGEGGFGPVY----KGTLVEGQE--IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
LG G FG V+ KG EG E + VK L K + ++ EF+ E+ + +L H+N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIARGILY 587
LLG C +A+ +I EY L F+ ++ + L ++++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG---YM 644
L S R +HRDL A N L+ + K+S +++ D + +K+ ++
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK----DVYNSEYYKLRNALIPLRWL 185
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE E FS KSDV+SFGVL+ E+ +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 70/210 (33%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKR-----LSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCIQADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-----IARGILYL 588
GC ++ DE++ I+ EYMP S + DQ +A + V I G+ YL
Sbjct: 70 YGC-LRDDETLSIFMEYMPGGS----VKDQLKA----YGALTETVTRKYTRQILEGVEYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H I+HRD+K +N+L D+ N K+ DFG + R+ T V GT +MSPE
Sbjct: 121 H---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ + K+DV+S G V+E+++ K W
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPW 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 74/274 (27%), Positives = 133/274 (48%), Gaps = 42/274 (15%)
Query: 481 LGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LG G F Y+ GTL+ +++ R + + +E + E+ L+ARL H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI--VGGIARGILYLHQD 591
+LG + L E+M S+ + + +++ + I + RG+ YLH++
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHEN 122
Query: 592 SRMRIIHRDLKASNVLLDND-MNPKISDFGMA-----RIFGGDEIQTNTHKVVGTYGYMS 645
+IIHRD+K +N+L+D+ +I+DFG A + G E Q +++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
PE + DV+S G +++E+ + K W + H +++K +A
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW------NAEKHSNHLALIFK------IA 224
Query: 706 GDTLADSHPP--TEVLRCIHVGLLCVQHRPEDRP 737
T A S P + LR V L C++ +PEDRP
Sbjct: 225 SATTAPSIPEHLSPGLR--DVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 65/193 (33%), Positives = 108/193 (55%), Gaps = 7/193 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
KLG+G FG V+ GT ++A+K L G+ E F E ++ +L+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E+M SL F+ + +L + + + IA G+ Y+ RM IHR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL+A+N+L+ +++ KI+DFG+AR+ +E T + +PE A G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ E+V+
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 58/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLG 536
K+GEG +G VYK + G+ +A+K++ E+ L+ L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E+M D + + R L + + +G+ + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--YAAEGLF 654
+HRDLK N+L++ + K++DFG+AR FG + TH VV T Y +PE +G +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKG-Y 176
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
S D++S G + E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 66/211 (31%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K G+ M NE ++ ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHIVGGIARGILY 587
D+ L+ M L + I F +ARA F Q I G+ +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ--------IICGLEH 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LHQ RI++RDLK NVLLD+ N +ISD G+A G GT GYM+PE
Sbjct: 111 LHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPE 164
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D F+ G + E+++G+ +R
Sbjct: 165 VLQGEVYDFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 40/219 (18%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFK-----NEVTLIARLQHRNLV 532
+G+G FG V K +I V K + G+ M E + +EV ++ L+H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKHPNIV 62
Query: 533 KLLG---------------CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+ C D + LI + + +++ + I
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERK------------YIEEEFIWRI 110
Query: 578 VGGIARGILYLH--QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ + + H D ++HRDLK +N+ LD + N K+ DFG+A+I G D T+
Sbjct: 111 LTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY 170
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT YMSPE + KSD++S G L+ E+ +
Sbjct: 171 --VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/202 (33%), Positives = 114/202 (56%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG V EG+ + A+K L++ +G + EF +E ++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP+ L ++ + L+W +I A+G++YL +
Sbjct: 75 LGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
R++HRDL A NVL+ + + KI+DFG+AR+ GDE + N +M+ E
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVS 672
F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 72/279 (25%), Positives = 127/279 (45%), Gaps = 48/279 (17%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLS---------KGSGQGM-EEFKNEVTLIARLQHR 529
+G+G +G VY V G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
N+V+ LG + + EY+P S+ + F++ F Q + G
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLEG 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR----IFGGDEIQTNTHKVVGT 640
+ YLH I+HRDLKA N+L+D D KISDFG+++ I+ D Q + + G+
Sbjct: 121 LAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND--QNMSMQ--GS 173
Query: 641 YGYMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
+M+PE ++ +S K D++S G +VLE+ +G++ W D + + L +
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAAMFKLGNK 227
Query: 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737
+ A + D + P + C P++RP
Sbjct: 228 RSAPPIPPDVSMNLSPVA-----LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 76/207 (36%), Positives = 103/207 (49%), Gaps = 28/207 (13%)
Query: 481 LGEGGFG--------PVYKGTLVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNL 531
LGEG FG P GT G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 532 VKLLGCCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
VK GCC Q + + LI EY+P SL D L+ + + I G+ YLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDE---IQTNTHKVVGTYGYMS 645
IHRDL A NVLLDND KI DFG+A+ + G E ++ + V Y +
Sbjct: 125 SQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY---A 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVS 672
E E FS SDV+SFGV + E+++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 26/215 (12%)
Query: 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
+LG G G V K G+ +AVK + K E+ ++ + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQ 590
G + + EYM SLD I + + + I+G IA +L YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRIPE-----RILGKIAVAVLKGLTYLH- 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +IIHRD+K SN+L+++ K+ DFG++ +T VGT YM+PE
Sbjct: 118 -EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF----VGTSSYMAPERIQ 172
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+SVKSD++S G+ ++E+ +G RF +P +
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATG----RFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 68/227 (29%), Positives = 113/227 (49%), Gaps = 30/227 (13%)
Query: 480 KLGEGGFGPVY-------------KGTLVEGQE--IAVKRL-SKGSGQGMEEFKNEVTLI 523
KLGEG FG V+ +GQ +AVK L + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-QARATF--------LDWQKR 574
+RL++ N+++LLG C+ D +I EYM N L+ F+ + +TF +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTN 633
+++ IA G+ YL + + +HRDL N L+ N KI+DFGM+R ++ GD +
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680
V+ +M+ E G F+ SDV++FGV + E+ + K +S
Sbjct: 189 GRAVLPIR-WMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 7e-23
Identities = 72/216 (33%), Positives = 106/216 (49%), Gaps = 29/216 (13%)
Query: 480 KLGEGGFGPVYKGTLV-----EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLVK 533
+LGE FG +YKG L Q +A+K L + Q EF+ E +L+A L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIF--------------DQARATFLDWQKRIHIVG 579
LLG Q +++EY+ L F+ D + LD +HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--EIQTNTHK 636
IA G+ YL S +H+DL A N+L+ ++ KISD G++R I+ D +Q +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M PE G FS SD++SFGV++ EI S
Sbjct: 189 PI---RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-23
Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 36/276 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG V+KGTL + +AVK + Q ++ +F +E ++ + H N+VKL+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E +P DF F + + L ++ + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + KISDFGM+R ++ K + + +PE G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176
Query: 660 VFSFGVLVLEIVS-------GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
V+S+G+L+ E S G N + + +E
Sbjct: 177 VWSYGILLWETFSLGVCPYPGMTN-------------------QQAREQVEKGYRMSCPQ 217
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
P +V + V C ++PE+RP S + L++
Sbjct: 218 KCPDDVYK---VMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 72/263 (27%), Positives = 109/263 (41%), Gaps = 35/263 (13%)
Query: 482 GEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKL 534
G+G FG V V+ + A+K ++K +N E ++ L H LV L
Sbjct: 9 GKGAFGKVCI---VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
Q +E+M L+ + + L + + + F + Q + I I + YLH
Sbjct: 66 WYS-FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICE-IVLALEYLHS--- 118
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IIHRD+K N+LLD + I+DF +A D T T GT GYM+PE
Sbjct: 119 KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLCRQG 175
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713
+SV D +S GV E + GK+ P H+ I K++ A L +
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKR------PYRGHSRTIRDQIRAKQETADVL--------Y 221
Query: 714 PPTEVLRCIHVGLLCVQHRPEDR 736
P T I ++ P+ R
Sbjct: 222 PATWSTEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 1e-22
Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 31/219 (14%)
Query: 481 LGEGGFGPVYKGT---LVEGQE---IAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVK 533
+G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-------------------LDWQKR 574
LLG C L++EYM L+ F+ ++ L ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTN 633
+ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I+ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + +M PE ++ +SDV+++GV++ EI S
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 47/272 (17%)
Query: 481 LGEGGFGPVYKG-TLVEGQEIAVKRLS-----KGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY+G L +G AVK +S + + +++ + E+ L+++LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 535 LGCCIQADESMLIY-EYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
LG + ++++ I+ E +P SL + F + Q I G+ YL
Sbjct: 68 LGT-EREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ--------ILLGLEYL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +HRD+K +N+L+D + K++DFGMA+ + G+ +M+PE
Sbjct: 119 HDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEV 172
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG- 706
A +G + + +D++S G VLE+ +GK W L G A ++K R+ EL
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPW--------SQLEGVA-AVFKIGRSKELPPI 223
Query: 707 -DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737
D L+D E I L C+Q P RP
Sbjct: 224 PDHLSD-----EAKDFI---LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 3e-22
Identities = 61/217 (28%), Positives = 111/217 (51%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
SI + Y K+G+G G V+ V GQE+A+K+++ E NE+ ++
Sbjct: 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ NVLL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E+V G+ + +P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 3e-22
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 481 LGEGGFGPVYKGTLVEGQ------EIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V K T + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI---------------------FDQARATFLDWQ 572
L G C Q +LI EY SL F+ D L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
I I+RG+ YL + M+++HRDL A NVL+ KISDFG++R ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +M+ E + +++ +SDV+SFGVL+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 9/198 (4%)
Query: 481 LGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ + E +P SL + + + Q I I G+ YLH + +I+HR
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHR 132
Query: 600 DLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSV 656
D+K NVL++ KISDFG ++ G I T GT YM+PE +G +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPRGYGA 190
Query: 657 KSDVFSFGVLVLEIVSGK 674
+D++S G ++E+ +GK
Sbjct: 191 PADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 6e-22
Identities = 69/215 (32%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVG---GIARGILYLHQD 591
G ++ M++ EYM N SLD F+ + T I +VG GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV------IQLVGMLRGIASGMKYL--- 122
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVGTYGYMSPEYAA 650
S M +HRDL A N+L+++++ K+SDFG++R+ D E T + +PE A
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 651 EGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683
F+ SDV+S+G+++ E++S + W S+ D
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 6e-22
Identities = 69/209 (33%), Positives = 110/209 (52%), Gaps = 18/209 (8%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR 529
++ K+GEG +G VYKG GQ +A+K++ S+ G + E++L+ LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
N+V L +Q LI+E++ K LD Q ++D + + I +GIL
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQ----YMDAELVKSYLYQILQGIL 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ H R++HRDLK N+L+DN K++DFG+AR F G ++ TH+VV T Y +P
Sbjct: 116 FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAP 170
Query: 647 E-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E +S D++S G + E+ + K
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 67/236 (28%), Positives = 104/236 (44%), Gaps = 36/236 (15%)
Query: 480 KLGEGGFGPVY-------KGTLVEGQEI----------AVKRLSKG-SGQGMEEFKNEVT 521
KLGEG FG V+ + + AVK L S E+F EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQK 573
+++RL N+ +LLG C +I EYM N L+ F+ + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--EI 630
+++ IA G+ YL + +HRDL N L+ + KI+DFGM+R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH-PDHD 685
Q +M+ E G F+ KSDV++FGV + EI++ + + H D
Sbjct: 189 QGR---APLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 7e-22
Identities = 70/277 (25%), Positives = 119/277 (42%), Gaps = 47/277 (16%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
NK+G G FG VY L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI-VGGIARGILYLHQDSRM 594
G + ++ + EY +L + + + I + + G+ YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTL----EELLEHGRILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEYAAEG 652
I+HRD+K +N+ LD++ K+ DFG A + + GT YM+PE G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 653 LFSVK---SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
+D++S G +VLE+ +GK+ W S D++ ++ H +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMFH-----------------V 219
Query: 710 ADSHPPT---------EVLRCIHVGLLCVQHRPEDRP 737
H P E + C++ P+ RP
Sbjct: 220 GAGHKPPIPDSLQLSPEGKDFLD---RCLESDPKKRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 59/205 (28%), Positives = 101/205 (49%), Gaps = 12/205 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
NF K+G+G F VYK L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGI 585
H N++K L I+ +E ++ E L I F + + + + V + +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ-LCSAL 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
++H RI+HRD+K +NV + K+ D G+ R F T H +VGT YMS
Sbjct: 120 EHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMS 174
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEI 670
PE E ++ KSD++S G L+ E+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 70/216 (32%), Positives = 117/216 (54%), Gaps = 21/216 (9%)
Query: 481 LGEGGFGPVYKGTL-VEGQE---IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G FG V +G L + G+ +A+K L G + + +F +E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG---GIARGILYLHQDS 592
G ++ M+I E+M N +LD F+ Q F I +VG GIA G+ YL S
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL-RQNDGQF----TVIQLVGMLRGIAAGMKYL---S 123
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYG--YMSPEYA 649
M +HRDL A N+L+++++ K+SDFG++R D T T + G + +PE
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683
A F+ SDV+S+G+++ E++S + W S+ D
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 66/273 (24%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 481 LGEGGFGP--VYK----GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG +Y+ +LV +E+ + RLS+ + + NE+ +++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 535 LGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D ++LI EY +L + + + + + + + I + Y+H+
Sbjct: 65 YNHFMD-DNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I+HRD+K N+ L K+ DFG+++I G + T VVGT YMSPE
Sbjct: 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVK 177
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713
++ KSD+++ G ++ E+++ K+ + + N L + + ++ +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYTPVVSVYSS---- 227
Query: 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
E++ +H +Q PE RP V+
Sbjct: 228 ---ELISLVHS---LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 73/232 (31%), Positives = 112/232 (48%), Gaps = 37/232 (15%)
Query: 480 KLGEGGFGPVYKGTLVEGQE------------------IAVKRL-SKGSGQGMEEFKNEV 520
KLGEG FG V+ EG E +AVK L + +F E+
Sbjct: 12 KLGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------FDQARATFLDWQ 572
+++RL+ N+++LL CI +D +I EYM N L+ F+ ++A + +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGD--E 629
I + IA G+ YL S + +HRDL N L+ + KI+DFGM+R ++ GD
Sbjct: 131 TLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYR 187
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681
IQ + V +MS E G F+ SDV++FGV + EI++ K +S
Sbjct: 188 IQG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 13/193 (6%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540
+G+G FG V G G ++AVK + + + F E +++ +L+H NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 541 ADESMLIY-EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ I EYM SL ++ + R + L + + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A NVL+ D K+SDFG+ + E + + +PE E FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181
Query: 660 VFSFGVLVLEIVS 672
V+SFG+L+ EI S
Sbjct: 182 VWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 68/210 (32%), Positives = 111/210 (52%), Gaps = 25/210 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI---AVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG FG V +G L + I AVK +++ + ME+F +E + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 536 GCCIQADES------MLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARG 584
G C+Q ES ++I +M + L F+ D +L Q + + IA G
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP--QYLPTQMLVKFMTDIASG 124
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEI-QTNTHKVVGTYG 642
+ YL S IHRDL A N +L+ +MN ++DFG++ +I+ GD Q K+
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVK 179
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+++ E A+ +++ KSDV+SFGV + EI +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRN 530
+ ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 531 LVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL 586
+VK G + S + EY SLD I+ + + RI ++G IA +L
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKR----GGRIGEKVLGKIAESVL 115
Query: 587 ----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
YLH +IIHRD+K SN+LL K+ DFG++ G+ + + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
YM+PE +S+ SDV+S G+ +LE+ RF P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQN----RFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 3e-21
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 13/211 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG VYKG +E+ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKS-LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ G ++ + +I EY+ S LD T++ I+ I +G+ YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
R IHRD+KA+NVLL + K++DFG+A +I+ NT VGT +M+PE +
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQ 175
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 66/215 (30%), Positives = 106/215 (49%), Gaps = 43/215 (20%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQ---HRNLV 532
++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H N+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 533 KLLGCC--IQADESMLIYEYMPNKSLDFFIFDQARATFLD---------WQKRIHIVGGI 581
+LL C + D + + L F DQ AT+L + ++ +
Sbjct: 65 RLLDVCHGPRTDRELKLT-------LVFEHVDQDLATYLSKCPKPGLPPETIK-DLMRQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
RG+ +LH RI+HRDLK N+L+ +D KI+DFG+ARI+ + T+ VV T
Sbjct: 117 LRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVVTL 170
Query: 642 GYMSPE------YAAEGLFSVKSDVFSFGVLVLEI 670
Y +PE YA V D++S G + E+
Sbjct: 171 WYRAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 84/277 (30%), Positives = 137/277 (49%), Gaps = 40/277 (14%)
Query: 481 LGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+G+G FG VY GTL+ +GQ+I AVK L++ + + +E+F E ++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 536 GCCIQADES-MLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVG---GIARGILYLHQ 590
G C+ ++ S +++ YM + L FI + T D ++G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD------LIGFGLQVAKGMEYLAS 116
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVG-TYGYMSPEY 648
+ +HRDL A N +LD K++DFG+AR I+ + + H +M+ E
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM--ELAG 706
F+ KSDV+SFGVL+ E+++ R + P D + L + +R + E
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRRLLQPEYCP 228
Query: 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
D L + V L C +PE RP S +V
Sbjct: 229 DPLYE------------VMLSCWHPKPEMRPTFSELV 253
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGT---LVEGQ---EIAVKRL-SKGSGQGM 513
WEF +N + LG G FG V + T L + ++AVK L
Sbjct: 30 WEF-------PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER 82
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
E +E+ +++ L H N+V LLG C ++I EY L F+ + R +FL +
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLE 141
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+ +A+G+ +L + IHRDL A NVLL + KI DFG+AR D +
Sbjct: 142 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR----DIMND 194
Query: 633 NTHKVVGT----YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + V G +M+PE +++ +SDV+S+G+L+ EI S
Sbjct: 195 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 6e-21
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLS------KGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G +G VY G +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFI--FDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
+ LG C+ + + E++P S+ + F F + K+I G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDGVAYLH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR---IFGGDEIQTNTHKVV-GTYGYMS 645
+ ++HRD+K +NV+L + K+ DFG AR G +N K + GT +M+
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
PE E + KSD++S G V E+ +GK
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 7e-21
Identities = 61/210 (29%), Positives = 110/210 (52%), Gaps = 11/210 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F ++G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D RA D + ++ I +G+ YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ IHRD+KA+NVLL + K++DFG+A +I+ NT VGT +M+PE +
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 66/226 (29%), Positives = 103/226 (45%), Gaps = 50/226 (22%)
Query: 481 LGEGGFGPVYKGTLV------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRNLV 532
LGEG FG V K V E +AVK L + + + + +E+ ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 533 KLLGCCIQADESMLIYEY----------------MPNKSLDFFIFDQARATFLD-----W 571
LLG C Q ++ EY S D + T D +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q +ARG+ +L + IHRDL A NVL+ D KI+DFG+AR +I
Sbjct: 140 Q--------VARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIH 183
Query: 632 TNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 8e-21
Identities = 69/212 (32%), Positives = 108/212 (50%), Gaps = 28/212 (13%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+ YL Q + IHRDL A N+L+ + KI+DFG++R G E+ K +G
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK--KTMGRLP 186
Query: 643 --YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 187 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 75/295 (25%), Positives = 135/295 (45%), Gaps = 61/295 (20%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQH---R 529
+ +G G +G VY+G V G+ +A+K ++ + + + + EV L+++L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL--- 586
N+ K G ++ +I EY S+ + +A + +K I + I R +L
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIA-EKYISV---IIREVLVAL 114
Query: 587 -YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK---VVGTYG 642
Y+H+ +IHRD+KA+N+L+ N N K+ DFG+A + N+ K VGT
Sbjct: 115 KYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA-----LLNQNSSKRSTFVGTPY 166
Query: 643 YMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
+M+PE EG + K+D++S G+ + E+ +G + P D + RA
Sbjct: 167 WMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAF----------RA 210
Query: 702 MELAGDT----LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLL 752
M L + L D+ + + C+ P++R LS++ LL
Sbjct: 211 MMLIPKSKPPRLEDNGYSKLLREFV---AACLDEEPKER---------LSAEELL 253
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 54/202 (26%), Positives = 105/202 (51%), Gaps = 10/202 (4%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ K+GEG G V T G+++AVK++ Q E NEV ++ QH N+V
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
++ + DE ++ E++ +L D T ++ ++ + + + + +LH
Sbjct: 80 EMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ- 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+IHRD+K+ ++LL +D K+SDFG + + + +VGT +M+PE +
Sbjct: 135 --GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRL 190
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
+ + D++S G++V+E+V G+
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 67/228 (29%), Positives = 107/228 (46%), Gaps = 39/228 (17%)
Query: 480 KLGEGGFGPVYKGTLVEGQE-----------------IAVKRL-SKGSGQGMEEFKNEVT 521
KLGEG FG V+ +V Q+ +AVK L + +F EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ----------------AR 565
+++RL+ N+++LLG C+ D +I EYM N L+ F+
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-I 624
+ + +H+ IA G+ YL S + +HRDL N L+ ++ KI+DFGM+R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ GD + V+ +M+ E G F+ SDV++FGV + EI+
Sbjct: 189 YAGDYYRIQGRAVLPIR-WMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 64/199 (32%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V G ++A+K + +GS +EF E ++ +L H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ EYM N L ++ + + + + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEGLFSV 656
DL A N L+D+ K+SDFG++R DE ++ VG+ + PE FS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKFSS 180
Query: 657 KSDVFSFGVLVLEIVS-GK 674
KSDV++FGVL+ E+ S GK
Sbjct: 181 KSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNL 531
F +G+G FG VYK Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
K G ++ + +I EY S D + LD I+ + G+ YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IHRD+KA+N+LL + + K++DFG++ + NT VGT +M+PE +
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 65/193 (33%), Positives = 102/193 (52%), Gaps = 13/193 (6%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+GEG FG V +G GQ++AVK + + F E ++ +L H+NLV+LLG I
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
+ ++ E M +L F+ + RA + + + +A G+ YL +++HR
Sbjct: 69 LHNGLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N+L+ D K+SDFG+AR+ G + + V T +PE FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV-GSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179
Query: 660 VFSFGVLVLEIVS 672
V+S+GVL+ E+ S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+LG G FG V+ G ++A+K +++G+ E+F E ++ +L H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
Q ++ E+M N L ++ + R L + + + G+ YL ++S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSD 659
DL A N L+ + K+SDFGM R DE T++ + PE +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 660 VFSFGVLVLEIVSGKK 675
V+SFGVL+ E+ + K
Sbjct: 184 VWSFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 58/209 (27%), Positives = 107/209 (51%), Gaps = 10/209 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + K D++S G++ +E+V G+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 17/202 (8%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+G G FG V+ LV ++I V++++K + NE ++ L H N+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
++ M++ EY P +L +I + + LD +H I + ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL-- 121
Query: 595 RIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I+HRDLK N+LLD + M KI DFG+++I ++ + VVGT Y+SPE
Sbjct: 122 -ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKP 177
Query: 654 FSVKSDVFSFGVLVLEIVSGKK 675
++ KSD+++ G ++ E+ S K+
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 61/220 (27%), Positives = 112/220 (50%), Gaps = 21/220 (9%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGSGQ-GMEEFKNEVT 521
IA + D + L EG FG ++ G L++ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 522 LIARLQHRNLVKLLGCCIQ-ADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRI 575
L+ L H+N++ +L CI+ + ++Y YM +L F + + L Q+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDE--IQT 632
H+ IA G+ YLH + +IH+D+ A N ++D ++ KI+D ++R +F D +
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
N ++ V +M+ E +S SDV+SFGVL+ E+++
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-20
Identities = 57/217 (26%), Positives = 110/217 (50%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+K+++ E NE+ ++
Sbjct: 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 73 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+
Sbjct: 129 DFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMA 183
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E+V G+ + +P
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I+ A F + + + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
HQ+ RI++RDLK N+LLD+ + +ISD G+A + G I+ VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ D ++ G L+ E+++G+
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 68/214 (31%), Positives = 111/214 (51%), Gaps = 31/214 (14%)
Query: 480 KLGEGGFGPVY----KGTLVEGQE--IAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY KG + + E +A+K +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFD----------QARATFLDWQKRIHIVGGIA 582
+LLG Q +++I E M L ++ QA + +K I + G IA
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL---KKMIQMAGEIA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT-- 640
G+ YL+ + + +HRDL A N ++ D KI DFGM R D +T+ ++ G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 182
Query: 641 --YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+MSPE +G+F+ SDV+SFGV++ EI +
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 474 NFASYNKLGEGGFGPVYK-GTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRN 530
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 531 LVK-----LLGC--CIQADESMLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIV 578
++ L G CI + EY P L I + + W+ I ++
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
RG+ LH+ +I+HRDLK++N+LL + KI D G++++ + +T +
Sbjct: 114 ----RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT----QI 162
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT YM+PE +S KSD++S G L+ E+ +
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 37/214 (17%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHRNLV 532
KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 533 KLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
LL L++E+M +KS+ + A RG
Sbjct: 66 GLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLM--------TLRG 114
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVVGTYG 642
+ YLH + I+HRDLK +N+L+ +D K++DFG+AR FG ++ TH+VV T
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM---THQVV-TRW 167
Query: 643 YMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE + A + V D++S G + E++
Sbjct: 168 YRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + + + KR+ K G+ M NE ++ ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ +V L D L+ M L F I++ F + ++ + I G+ L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H+++ ++RDLK N+LLD+ + +ISD G+A +I G+ I+ VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
+++ D + G L+ E++ G+ +R
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 1e-19
Identities = 55/217 (25%), Positives = 108/217 (49%), Gaps = 10/217 (4%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY + GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL D T +D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH + ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT +M+
Sbjct: 130 EFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMA 184
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
PE + K D++S G++ +E++ G+ + +P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-19
Identities = 63/206 (30%), Positives = 111/206 (53%), Gaps = 13/206 (6%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
NF K+GEG +G VYK + G+ +A+K RL + E++L+ L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 531 LVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+VKLL I + + L++E++ ++ L F+ D + + + + + +G+ + H
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-Y 648
R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G + E+V+ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 11/210 (5%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
F K+G+G FG V+KG Q++ A+K + + +E+ + E+T++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
K G ++ + +I EY+ S D LD + I+ I +G+ YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ IHRD+KA+NVLL K++DFG+A +I+ N VGT +M+PE +
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ K+D++S G+ +E+ G+ HP
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-19
Identities = 67/215 (31%), Positives = 115/215 (53%), Gaps = 21/215 (9%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEI----AVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + EG+++ A+K L + S + +E +E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFIFDQARAT---FLDWQKRIHI 577
++A + + ++ +LLG C+ + LI + MP L D+ + L+W +I
Sbjct: 62 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
A+G+ YL + R++HRDL A NVL+ + KI+DFG+A++ G DE + +
Sbjct: 119 ----AKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ +SDV+S+GV V E+++
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
K+GEG +G VYK + G+ +A+K++ +E E++L+ L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-DQARATFLDWQKRIHIVGGIARGILYLH 589
+V+LL ++ L++E++ LD + D + T LD + + +GI Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
R++HRDLK N+L+D + K++DFG+AR F G ++T TH+VV T Y +PE
Sbjct: 117 SH---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEIL 171
Query: 650 AEG-LFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G + E+V+ +
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 89/307 (28%), Positives = 134/307 (43%), Gaps = 58/307 (18%)
Query: 481 LGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G + +++ KRL K SG+ M + E+ + ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI--LEKVNSPFIVNL 58
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
L+ M L + I++ L+ ++ IH I GIL+LH M
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHS---M 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
I++RD+K NVLLD+ N ++SD G+A + G +T T + GT GYM+PE E
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQR-AGTNGYMAPEILKEEP 170
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM-ELAGDTLAD- 711
+S D F+ G + E+V+G+ P DH KEK A EL TL D
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRT------PFKDH----------KEKVAKEELKRRTLEDE 214
Query: 712 --------SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTE 763
+ ++ R L + +PEDR L S +P + FF
Sbjct: 215 VKFEHQNFTEESKDICR------LFLAKKPEDR---------LGSREKNDDPRKHEFFKT 259
Query: 764 RSLPEAE 770
+ P E
Sbjct: 260 INFPRLE 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 13/206 (6%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNL 531
NF KLGEG + VYKG G+ +A+K + + +G E++L+ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V+L ++ ML++EYM +K L ++ LD + +GI + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMSPE-Y 648
R++HRDLK N+L++ K++DFG+AR FG I NT ++VV T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVV-TLWYRAPDVL 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++S G ++ E+++G+
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D ++ + I G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
H R RI++RDLK N+LLD+ + +ISD G+A I G+ I+ VGT GYM+PE
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D + G L+ E++ GK +R
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 69/214 (32%), Positives = 100/214 (46%), Gaps = 32/214 (14%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+GGFG V G L +++ KRL K +G E E ++A++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVSL 58
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRIHIVGGIARG 584
Q + L+ M L + I F + RA F Q I G
Sbjct: 59 -AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ--------IISG 109
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LHQ RII+RDLK NVLLDND N +ISD G+A + Q+ T GT G+M
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFM 164
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
+PE + D F+ GV + E+++ + +R
Sbjct: 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 56/176 (31%), Positives = 91/176 (51%), Gaps = 20/176 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 536 ----GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G +L+ EYMP+ L + D+ R K + + +G+ Y+H +
Sbjct: 67 VFPHGSGF-----VLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHAN 118
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
I+HRDLK +N+L+ D KI+DFG+AR+F +E + +H+ V T Y +PE
Sbjct: 119 ---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 70/214 (32%), Positives = 110/214 (51%), Gaps = 26/214 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFK-NEVTLIARLQHR 529
D + K+GEG +G VYK V + IA+K++ + +G+ E++L+ +QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 530 NLVKLLGCCIQADESMLIYEYMP-------NKSLDFFIFDQARATFLDWQKRIHIVGGIA 582
N+V+L L++EY+ + S DF + T+L +Q I
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYL-YQ--------IL 112
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTY 641
RGI Y H R++HRDLK N+L+D N K++DFG+AR F G ++T TH+VV T
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TL 167
Query: 642 GYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE +S D++S G + E+V+ K
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G FG VYK E G A K + S + +E+F E+ +++ +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599
++ ++ E+ +LD I + + Q R + + + +LH ++IHR
Sbjct: 73 YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLH---SHKVIHR 127
Query: 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS---- 655
DLKA N+LL D + K++DFG++ +Q +GT +M+PE A F
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAK-NKSTLQKR-DTFIGTPYWMAPEVVACETFKDNPY 185
Query: 656 -VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
K+D++S G+ ++E+ + P H+ N
Sbjct: 186 DYKADIWSLGITLIELAQMEP------PHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 4e-19
Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 48/292 (16%)
Query: 480 KLGEGGFGPVYKGT---LVEGQ---EIAVKRLSK-GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG+G FG VY+G +++G+ +AVK +++ S + EF NE +++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-----------WQKRIHIVGGI 581
+LLG + ++++ E M + L ++ R+ + Q+ I + I
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYL----RSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT- 640
A G+ YL+ + +HRDL A N ++ +D KI DFGM R D +T+ ++ G
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKG 181
Query: 641 ---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
+M+PE +G+F+ SD++SFGV++ EI S L +
Sbjct: 182 LLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLS 226
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749
++ ++ D P R + +C Q P+ RP +V +L D
Sbjct: 227 NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 7e-19
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 10/202 (4%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKR--LSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+G G VY + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE L+ Y+ SL + LD ++ + +G+ YLH
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNG 122
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGM-ARIF-GGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IHRD+KA N+LL D + KI+DFG+ A + GGD + VGT +M+PE +
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 654 -FSVKSDVFSFGVLVLEIVSGK 674
+ K+D++SFG+ +E+ +G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 9e-19
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K L I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
SPE E ++ KSD++S G L+ E+ +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 9e-19
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 17/211 (8%)
Query: 475 FASYNKLGEGGFGPV------YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH 528
F Y LG+GGFG V G + +++ KR+ K G+ M NE ++ ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R +V L D L+ M L F I++ F D Q+ I + G+ L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE 647
R RI++RDLK N+LLD+ + +ISD G+A +I G+ ++ VGT GYM+PE
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPE 171
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
++ D + G L+ E++ G+ +R
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 1e-18
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + R++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K++DFG A I + + VGT +M+PE
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVIL 194
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F+ ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + + G +G+ YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K+ DFG A I + VGT +M+PE
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 28/212 (13%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI--AVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V + + +G ++ A+K L + S +F E+ ++ +L H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C + EY P +L DF F + A+ L Q+ + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
G+ YL S + IHRDL A NVL+ ++ KI+DFG++R G+E+ K +G
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK--KTMGRLP 181
Query: 643 --YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ KSDV+SFGVL+ EIVS
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 72/279 (25%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 474 NFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHR 529
NF K+G G F VY+ T L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLD---WQKRIHIVGGIARG 584
N++K I+ +E ++ E L I F + + + W+ + + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H SR R++HRD+K +NV + K+ D G+ R F T H +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYM 173
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
SPE E ++ KSD++S G L+ E+ + P G L+ + +E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAA------LQSP-----FYGDKMNLYSLCKKIEQ 222
Query: 705 AG-DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
L H E+ + ++ +C+ PE RP+++ V
Sbjct: 223 CDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 74/270 (27%), Positives = 119/270 (44%), Gaps = 32/270 (11%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGME-EFKNEVTLIARLQHRNLVKLLGC 537
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
C Q ++ E + + DF F + L ++ I +V A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG-----TYGYMSPEYAAEG 652
HRDL A N L+ KISDFGM+R E + + G + +PE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
+S +SDV+SFG+L+ E FS + L + + + A+E
Sbjct: 172 RYSSESDVWSFGILLWEA--------FSLGAVPYANLSNQ----QTREAIEQGVRLPCPE 219
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
P V R + C ++ P RP+ S+V
Sbjct: 220 LCPDAVYRLM---ERCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 14/168 (8%)
Query: 574 RIHIVGGIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I+G IA G+ YL+ + RI+HRD+K SN+L+++ K+ DFG++ G+
Sbjct: 101 PVEILGKIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS----GEL 154
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
I + VGT YMSPE G ++VKSDV+S G+ ++E+ GK + FS D
Sbjct: 155 INSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS-NIDDDGQD 213
Query: 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737
IL ++ ++ L S P ++ + C+ P +RP
Sbjct: 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD---ACLLKDPTERP 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F +++G G FG VY T E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
++ GC ++ + L+ EY + D + L + I G +G+ YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY-- 648
+ +IHRD+KA N+LL K++DFG A + + VGT +M+PE
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVIL 190
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 65/247 (26%), Positives = 119/247 (48%), Gaps = 22/247 (8%)
Query: 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
S+ K+GEG G V T G+++AVK++ Q E NEV ++ H N+V
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ + DE ++ E++ +L D T ++ ++ + + R + YLH
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG- 138
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+IHRD+K+ ++LL +D K+SDFG + + + +VGT +M+PE +
Sbjct: 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLP 194
Query: 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713
+ + D++S G++V+E++ G+ + F+ P L +R + + DSH
Sbjct: 195 YGTEVDIWSLGIMVIEMIDGEPPY-FNEPP-----------LQAMRRIRDNLPPRVKDSH 242
Query: 714 PPTEVLR 720
+ VLR
Sbjct: 243 KVSSVLR 249
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 17/207 (8%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY V+ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 535 LGCCI-QADESMLIY-EYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC +A++++ I+ EYMP S+ DQ +A L I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAA 650
I+HRD+K +N+L D+ N K+ DFG ++ + T V GT +MSPE +
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ K+DV+S G V+E+++ K W
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 81/280 (28%), Positives = 127/280 (45%), Gaps = 38/280 (13%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG + +AVK L + +E E ++ +L + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ F+ T + + +H V + G+ YL + +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQV---SMGMKYLEETN-- 115
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL- 653
+HRDL A NVLL KISDFG+++ G DE N +K + YA E +
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKWYAPECMN 171
Query: 654 ---FSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEK-RAMELAGDT 708
FS KSDV+SFGVL+ E S G+K ++ + G+ E ME
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYK--------GMKGNEVTQMIESGERMECPQRC 223
Query: 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
P E+ + LC + ++RP + V L L +
Sbjct: 224 ------PPEMYDLMK---LCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 480 KLGEGGFGPVY---KGTLVEGQEIAV-KRLSKGSGQGMEEFKN--EVTLIARLQHRNLVK 533
+LG+G FG VY V + + V K + G E + E L+++L H +VK
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGILYLHQD 591
++ D +I EY + LD + T + Q + G+ Y+HQ
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV-CEWFIQLLLGVHYMHQ- 124
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--DEIQTNTHKVVGTYGYMSPEYA 649
RI+HRDLKA N+ L N++ KI DFG++R+ G D T T GT YMSPE
Sbjct: 125 --RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT----GTPYYMSPEAL 177
Query: 650 AEGLFSVKSDVFSFGVLVLEI 670
+ KSD++S G ++ E+
Sbjct: 178 KHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 27/212 (12%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC +E L EYMP S I DQ +A L I +G+ YLH +
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ------TNTHKVVGTYGYMS 645
I+HRD+K +N+L D+ N K+ DFG ++ IQ T V GT +MS
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVTGTPYWMS 177
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
PE + + K+DV+S V+E+++ K W
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 64/198 (32%), Positives = 105/198 (53%), Gaps = 12/198 (6%)
Query: 481 LGEGGFGPVYKGTLV-EGQEI----AVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG V+KG + EG I A+K + SG Q +E + + + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
LG C A L+ + P SL + + LD Q+ ++ IA+G+ YL +
Sbjct: 75 LGICPGA-SLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH--- 128
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
R++HR+L A N+LL +D +I+DFG+A + D+ + + +M+ E G +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 655 SVKSDVFSFGVLVLEIVS 672
+ +SDV+S+GV V E++S
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLV 532
LG+G FG V KGT + AVK L K +E E ++A +H L
Sbjct: 3 LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L C Q + + + EY+ L F I FD+ RA F I G+
Sbjct: 60 QLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY--------AAEIVLGLQ 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH+ II+RDLK NVLLD++ + KI+DFGM + I GG T+T GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTST--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE + + D ++ GVL+ E+++G+
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 75/293 (25%), Positives = 134/293 (45%), Gaps = 37/293 (12%)
Query: 477 SYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
+Y K+GEG G V G+++AVK + Q E NEV ++ QH+N+V++
Sbjct: 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ +E ++ E++ +L I Q R L+ ++ + + + + YLH
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTD-IVSQTR---LNEEQIATVCESVLQALCYLHSQG--- 137
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
+IHRD+K+ ++LL D K+SDFG D + + +VGT +M+PE + +
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYG 195
Query: 656 VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP 715
+ D++S G++V+E+V G+ + P + KR + L ++H
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSP------------VQAMKRLRDSPPPKLKNAHKI 243
Query: 716 TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPE 768
+ VLR +L P++R ++ LL P F + LPE
Sbjct: 244 SPVLRDFLERMLT--REPQERA---------TAQELLDHP----FLLQTGLPE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 28/222 (12%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
T F +GEG +G VYK + ++ ++ EE K E ++ + H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHP 63
Query: 530 NLVKLLGCCIQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------HI 577
N+ G I+ D+ L+ E S + D + KR+ +I
Sbjct: 64 NIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGL-RKKGKRLKEEWIAYI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ RG+ YLH++ ++IHRD+K N+LL + K+ DFG++ + NT
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--F 173
Query: 638 VGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+GT +M+PE + + +SDV+S G+ +E+ GK
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 8e-18
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRN 530
F ++G G FG VY V E+ A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR-------IHIVGGIAR 583
++ GC ++ + L+ EY + D L+ K+ I G +
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDI----------LEVHKKPLQEVEIAAICHGALQ 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ YLH R IHRD+KA N+LL K++DFG A + + + VGT +
Sbjct: 127 GLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYW 177
Query: 644 MSPEY---AAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE EG + K DV+S G+ +E+ K
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 18/214 (8%)
Query: 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCI 539
+G G +G VYKG V+ ++A ++ +G EE K E+ ++ + HRN+ G I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 540 QA------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
+ D+ L+ E+ S+ I + L + +I I RG+ +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA--- 650
++IHRD+K NVLL + K+ DFG++ D + +GT +M+PE A
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 651 --EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + KSD++S G+ +E+ G HP
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
DNF K+GEG G V T+ G+ +AVK++ Q E NEV ++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V++ + DE ++ E++ +L D T ++ ++ + + + + LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+IHRD+K+ ++LL +D K+SDFG A++ E+ +VGT +M+PE +
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQV--SKEVPRRK-SLVGTPYWMAPELIS 189
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ + D++S G++V+E+V G+ + F+ P
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEPPY-FNEP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-----SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 535 LGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQD 591
GC E L E+MP S I DQ ++ L I G+ YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAA 650
I+HRD+K +N+L D+ N K+ DFG ++ + T V GT +MSPE +
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ K+D++S G V+E+++ K W
Sbjct: 183 GEGYGRKADIWSVGCTVVEMLTEKPPW 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 74/290 (25%), Positives = 132/290 (45%), Gaps = 38/290 (13%)
Query: 474 NFASYNKLGEGGFGPVYK-------GTLVEGQEIAVKRLSKGSG-----QGMEEFKNEVT 521
+A LG G FG VYK L+ +EI V + G + + + +EVT
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 522 LI-ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DFFI-FDQARATFLDWQKRI-HI 577
+I +L+H N+V+ ++ D ++ + + L + F + + F ++RI +I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT--EERIWNI 118
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH++ R I+HRDL +N++L D I+DFG+A+ + T+ V
Sbjct: 119 FVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTS---V 173
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
VGT Y PE + K+DV++FG ++ ++ + P + N+L A
Sbjct: 174 VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLA----- 222
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
+ +E + L + +V I C+ E RP++ V M+S
Sbjct: 223 -TKIVEAVYEPLPEGMYSEDVTDVITS---CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V + L Q++AVK L S +EEF E + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 535 LGCCIQADES------MLIYEYMPNKSLDFFIFDQ---ARATFLDWQKRIHIVGGIARGI 585
+G +++ M+I +M + L F+ L Q + + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEI-QTNTHKVVGTYGY 643
YL S IHRDL A N +L+ +M ++DFG+++ I+ GD Q K+ +
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVKW 181
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
++ E A+ +++ SDV++FGV + EI++
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 481 LGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRNLVKLL 535
+GEG FG V K + + + A+KR+ + S +F E+ ++ +L H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 536 GCCIQADESMLIYEYMPNKSL-DF------------FIFDQARATFLDWQKRIHIVGGIA 582
G C L EY P+ +L DF F + A+ L Q+ +H +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
RG+ YL S+ + IHRDL A N+L+ + KI+DFG++R G E+
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+ E +++ SDV+S+GVL+ EIVS
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 75/275 (27%), Positives = 129/275 (46%), Gaps = 54/275 (19%)
Query: 453 HMKEDM---ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG 508
H++ D+ E+WE +LG+G FG VYK E G A K +
Sbjct: 3 HVRRDLDPNEVWEI--------------IGELGDGAFGKVYKAKNKETGALAAAKVIETK 48
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
S + +E++ E+ ++A H +VKLLG + ++ E+ P ++D + + R
Sbjct: 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRG-L 107
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ Q ++ I + + YLH M+IIHRDLKA NVLL D + K++DFG++
Sbjct: 108 TEPQIQV-ICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVS----AK 159
Query: 629 EIQTNTHK--VVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681
++T + +GT +M+PE + + K+D++S G+ ++E+ +
Sbjct: 160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA------QIEP 213
Query: 682 PDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716
P H+ N + +L K +A S PPT
Sbjct: 214 PHHELNPMR---VLLK-----------IAKSEPPT 234
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 79/287 (27%), Positives = 134/287 (46%), Gaps = 37/287 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKL 534
LG G FG VYKG + E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSL-DFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQ 590
LG C+ + L+ + MP L D+ ++ R L+W +I A+G+ YL +
Sbjct: 75 LGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+R++HRDL A NVL+ + + KI+DFG+AR+ DE + + +M+ E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
F+ +SDV+S+GV V E+++ F +D I +E + G+ L
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT------FGAKPYDG-------IPAREIPDLLEKGERL- 230
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNR 757
PP + + + C E RP +V S + +P+R
Sbjct: 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFS--RMARDPSR 274
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 33/236 (13%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYK----GTLVEGQE----IAVKRLS-KGSG 510
WEF D LGEG FG V + G + +AVK L +
Sbjct: 6 KWEF-------PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD 58
Query: 511 QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI--------- 560
+ + + +E+ L+ + +H+N++ LLG C Q +I EY +L F+
Sbjct: 59 KDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPD 118
Query: 561 --FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
FD + L ++ + +ARG+ YL +SR R IHRDL A NVL+ D KI
Sbjct: 119 YTFDITKVPEEQLSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKI 175
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+DFG+AR + T +M+PE + +++ +SDV+SFG+L+ EI +
Sbjct: 176 ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 6e-17
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKLL 535
+LG+G FG VY E E+ A+K++ K EE N EV + +L H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ DE ++EYM +L + D+ F + R I+ I +G+ ++H+
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIHKHGFF- 121
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPE-YA 649
HRDLK N+L+ KI+DFG+AR EI+ T+ V T Y +PE
Sbjct: 122 --HRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD---YVSTRWYRAPEILL 171
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D+++ G ++ E+ + +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 6e-17
Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 481 LGEGGFGPVY------KGTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 534 LLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
G C + + LI E++P+ SL ++ L Q + + I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--G 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVGTYGYMSPEYAA 650
SR + +HRDL A NVL++++ KI DFG+ + D E T + + +PE
Sbjct: 127 SR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 651 EGLFSVKSDVFSFGVLVLEIVS 672
+ F + SDV+SFGV + E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 66/224 (29%), Positives = 107/224 (47%), Gaps = 48/224 (21%)
Query: 474 NFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
F N++GEG +G VY+ G+ +A+K++ M+ ++ E+TL+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 525 RLQHRNLVKLLGCCI--QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR---IHIVG 579
L+H N+V+L + D L+ EY +Q A+ LD V
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 580 GIA----RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ RG+ YLH++ IIHRDLK SN+LL + KI+DFG+AR + G + T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTP 167
Query: 636 KVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
KVV T Y +PE L + D+++ G ++ E+++ K
Sbjct: 168 KVV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 474 NFASYNKLGEGGFGPVY--KGTLVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARLQHR 529
+ K+GEG FG +Y K + + +K L+K + E K EV L+A+++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V + ++ EY L I Q F + Q V I+ G+ ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV-QISLGLKHIH 118
Query: 590 QDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+I+HRD+K+ N+ L N M K+ DFG+AR ++ + VGT Y+SPE
Sbjct: 119 D---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPEI 173
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
++ K+D++S G ++ E+ + K HP +NL
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYELCTLK------HPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 52/202 (25%), Positives = 83/202 (41%), Gaps = 54/202 (26%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIARLQHRN 530
KLGEG FG VYK + G+ +A+K++ M K+ E+ ++ +L+H N
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIKILKKLKHPN 68
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIH------- 576
+V L+ + E D + L+ +
Sbjct: 69 VVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118
Query: 577 -IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ + GI YLH++ I+HRD+KA+N+L+DN KI+DFG+AR + G
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP-PPNPKG 174
Query: 636 K----------VVGTYGYMSPE 647
+V T Y PE
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 64/214 (29%), Positives = 112/214 (52%), Gaps = 26/214 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRL---SKGSGQGMEEFKNEVTLIARLQH 528
D + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ +LQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 529 RNLVKL----LGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIH-IVGGI 581
N+V + +G + D+ ++ EY+ + KSL + + FL Q + ++ +
Sbjct: 64 PNIVTVKEVVVGSNL--DKIYMVMEYVEHDLKSL----METMKQPFL--QSEVKCLMLQL 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
G+ +LH + I+HRDLK SN+LL+N KI DFG+AR + G ++ T VV T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TL 170
Query: 642 GYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE +S D++S G + E+++ K
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 1e-16
Identities = 71/209 (33%), Positives = 102/209 (48%), Gaps = 35/209 (16%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTL-------IARLQHRNLV 532
LG+G FG V L E G+ AVK L K +++ E T+ +AR H L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLAR-NHPFLT 59
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
+L CC Q D + E++ L F I FD+ARA F + I ++
Sbjct: 60 QLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE--------ITSALM 110
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH II+RDLK NVLLD++ + K++DFGM + IF G T GT Y+
Sbjct: 111 FLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE E L+ D ++ GVL+ E++ G
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/200 (26%), Positives = 100/200 (50%), Gaps = 11/200 (5%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
++G G +G VYK + E+ A+K + G E + E++++ +H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
++ D+ ++ EY SL I+ R L + ++ +G+ YLH+ I
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQD-IYQVTRGP-LSELQIAYVCRETLKGLAYLHE---TGKI 123
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE---GLF 654
HRD+K +N+LL D + K++DFG++ + + +GT +M+PE AA G +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS--FIGTPYWMAPEVAAVERKGGY 181
Query: 655 SVKSDVFSFGVLVLEIVSGK 674
K D+++ G+ +E+ +
Sbjct: 182 DGKCDIWALGITAIELAELQ 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 67/216 (31%), Positives = 99/216 (45%), Gaps = 45/216 (20%)
Query: 479 NKLGEGGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRN 530
N++G G G VYK T G+ A+K + G + + E+ ++ + H N
Sbjct: 80 NRIGSGAGGTVYKVIHRPT---GRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPN 133
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLD-------FFIFDQARATFLDWQKRIHIVGGIAR 583
+VK E ++ E+M SL+ F+ D AR I+ GIA
Sbjct: 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----------QILSGIA- 182
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH R I+HRD+K SN+L+++ N KI+DFG++RI N+ VGT Y
Sbjct: 183 ---YLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAY 234
Query: 644 MSPEYAAEGLFSVK-----SDVFSFGVLVLEIVSGK 674
MSPE L D++S GV +LE G+
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 66/235 (28%), Positives = 110/235 (46%), Gaps = 33/235 (14%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLS-KGSGQ 511
WEF + D LGEG FG V + E +AVK L + +
Sbjct: 10 WEF-------SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEK 62
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI---------- 560
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 63 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 122
Query: 561 -FDQARAT--FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+D AR + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR + T +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 480 KLGEGGFGPVYKGTLV--EGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKL 534
+GEG FG VY+G + E ++I AVK + + E+F E ++ + H ++VKL
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G + + ++ E P L ++ Q LD I ++ + YL
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
R +HRD+ A NVL+ + K+ DFG++R + + K +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKAS-KGKLPIKWMAPESINFRRF 185
Query: 655 SVKSDVFSFGVLVLEIVS-GKKNW 677
+ SDV+ FGV + EI+ G K +
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 71/210 (33%), Positives = 102/210 (48%), Gaps = 35/210 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V KGT + A+K L K +E+ E T++ R +H
Sbjct: 3 LGKGSFGKVMLAELKGT---NEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E + + EY+ L F I FD+ARA F + I G
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE--------IICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH+ II+RDLK NVLLD D + KI+DFGM + E + +T GT Y+
Sbjct: 109 LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE ++ D +SFGVL+ E++ G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V KG + ++I A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C +A+ ML+ E L+ F+ + + + ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY--GYMSPEYAAEGL 653
+HRDL A NVLL N KISDFG+++ G D+ + G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174
Query: 654 FSVKSDVFSFGVLVLEIVS-GKKNWR 678
FS +SDV+S+G+ + E S G+K ++
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKPYK 200
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 484 GGFGPVYKGTLVE----GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLLG 536
G +G V+ L + G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 537 CCIQADESM-LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q +++ L+ EY+P SL + D+ A + I + YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI--------YIAEIVLALEYLHS 111
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFG------MARIFGGDEIQTNTHKVVGTYGYM 644
+ IIHRDLK N+L+D++ + K++DFG + R ++ + ++VGT Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE S D +S G ++ E + G
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 26/215 (12%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRLSK-GSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----------FDQAR--ATFLDWQKRIHI 577
++ LLG C Q ++ EY +L ++ FD + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 64/236 (27%), Positives = 108/236 (45%), Gaps = 20/236 (8%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE 519
L + D +++ F +G G +G VYKG V+ ++A ++ + EE K E
Sbjct: 3 LDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE 62
Query: 520 VTLIARL-QHRNLVKLLGCCI------QADESMLIYEYMPNKSL-DFFIFDQARATFLDW 571
+ ++ + HRN+ G I D+ L+ E+ S+ D + A DW
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+I I RG+ +LH ++IHRD+K NVLL + K+ DFG++ +
Sbjct: 123 IA--YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 177
Query: 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
NT +GT +M+PE A + + +SD++S G+ +E+ G HP
Sbjct: 178 RNT--FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 63/227 (27%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 531 LVKLLGCCIQADESM-------LIYEYMP---------NKSLDFFIFDQARATFLDWQKR 574
++ LL I S ++ E M + L D FL +Q
Sbjct: 61 IIGLLD--ILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT----DDHIQYFL-YQ-- 111
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN- 633
I RG+ YLH +IHRDLK SN+L++++ + KI DFG+AR DE +
Sbjct: 112 ------ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162
Query: 634 -THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T VV T Y +PE L S D++S G + E+++ K
Sbjct: 163 LTEYVV-TRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 67/249 (26%), Positives = 118/249 (47%), Gaps = 45/249 (18%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAV-KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ E+ ++D + + R + Q R+ + + YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP-LTEPQIRV-VCKQTLEALNYLHEN---KIIH 126
Query: 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV------VGTYGYMSPEY---- 648
RDLKA N+L D + K++DFG++ NT + +GT +M+PE
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 649 -AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
+ + + K+DV+S G+ ++E+ + P H+ N + +L K
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA------QIEPPHHELNPMR---VLLK---------- 219
Query: 708 TLADSHPPT 716
+A S PPT
Sbjct: 220 -IAKSEPPT 227
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 65/221 (29%), Positives = 102/221 (46%), Gaps = 47/221 (21%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKG----SGQGMEEFKNEVTLIA 524
D+F LG G FG V +KG+ G+ A+K LSK Q +E NE ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQ-VEHVLNEKRILQ 56
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------FDQARATFLDWQKRIHI 577
++H LV L G L+ EY+P + F F + A F Q
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQ----- 109
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + YLH + I++RDLK N+LLD+D KI+DFG A+ ++ T+ +
Sbjct: 110 ---VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTL 158
Query: 638 VGTYGYMSPEYAAEGLFSVK-----SDVFSFGVLVLEIVSG 673
GT Y++PE + K D ++ G+L+ E+++G
Sbjct: 159 CGTPEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 57/199 (28%), Positives = 92/199 (46%), Gaps = 17/199 (8%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFK---NEVTLIARLQHRNLVKLL 535
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 536 GCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
Q DE + L EY+P DF + R ++ + LH +
Sbjct: 68 -YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
IHRDLK N L+D + K++DFG+++ I T + VVG+ YM+PE +
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYANSVVGSPDYMAPEVLRGKGY 175
Query: 655 SVKSDVFSFGVLVLEIVSG 673
D +S G ++ E + G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 42/280 (15%)
Query: 481 LGEGGFGPVYKG--TLVEGQE--IAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG G FG + +G L +E +A+ L G S + F E + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G + + M++ EYM N +LD F+ + L + + ++ G+A G+ YL S M
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYL---SEMG 127
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEYA 649
+H+ L A VL+++D+ KIS F + D+ + + T + +PE
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQ---EDKSEA----IYTTMSGKSPVLWAAPEAI 180
Query: 650 AEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
FS SDV+SFG+++ E++S + W S D +A+E
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------------VIKAVEDGFR 226
Query: 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
A + P + + + L C Q +RP S + +LS
Sbjct: 227 LPAPRNCPNLLHQLM---LDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 481 LGEGGFGPVYKGTLV--------EGQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHRN 530
LGEG FG V + ++AVK L S + + + + +E+ ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIF-------------DQARATFLDWQKRIHI 577
++ LLG C Q +I EY +L ++ Q L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ARG+ YL + + IHRDL A NVL+ D KI+DFG+AR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 17/210 (8%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG GGFG V + + + A+K + K G +E +E ++ H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + + ++ EY + + + R F ++ R + + YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGG--ELWTILRDRGLFDEYTARF-YIACVVLAFEYLHNRG--- 113
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD++ K+ DFG A+ + T GT Y++PE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYD 170
Query: 656 VKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
D +S G+L+ E+++G F D D
Sbjct: 171 FSVDYWSLGILLYELLTG--RPPFGEDDED 198
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 57/205 (27%), Positives = 106/205 (51%), Gaps = 14/205 (6%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLS-KGSGQGMEEFK-NEVTLIARLQHRN 530
+ K+GEG +G V+K E EI A+KR+ +G+ E+ L+ L+H+N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V+L + L++EY ++ L + FD +D + + + +G+ + H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHS 117
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--Y 648
++HRDLK N+L++ + K++DFG+AR F G ++ + +VV T Y P+ +
Sbjct: 118 H---NVLHRDLKPQNLLINKNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLF 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
A+ L+S D++S G + E+ +
Sbjct: 173 GAK-LYSTSIDMWSAGCIFAELANA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 59/203 (29%)
Query: 480 KLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQHRNLV 532
+G G +G VYK G+E A+K+ KG + E+ L+ L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ--------KRIHIVGGIAR- 583
L+ ++ +Y +FD A WQ KR+ I + +
Sbjct: 66 SLVEVFLE-HADKSVY----------LLFDYAEHDL--WQIIKFHRQAKRVSIPPSMVKS 112
Query: 584 -------GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIF------- 625
G+ YLH + ++HRDLK +N+L+ + KI D G+AR+F
Sbjct: 113 LLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 626 -GGDEIQTNTHKVVGTYGYMSPE 647
D VV T Y +PE
Sbjct: 170 ADLD-------PVVVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 74/286 (25%), Positives = 129/286 (45%), Gaps = 53/286 (18%)
Query: 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRL--SKGSGQGMEEFKNEVTLIARLQH 528
+ K+GEG FG K LV +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDWQKRIHIVGGIAR 583
N+V+ + ++ +Y L I Q F LDW +I +
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ 112
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ ++H +I+HRD+K+ N+ L D K+ DFG+AR+ T +GT Y
Sbjct: 113 ALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGTPYY 167
Query: 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703
+SPE ++ KSD+++ G ++ E+ + L HA+ E M+
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT----------------LKHAF----EAGNMK 207
Query: 704 -LAGDTLADSHPPTEV-----LRCIHVGLLCVQHRPEDRPNMSSVV 743
L + S+PP LR + L + P DRP+++S++
Sbjct: 208 NLVLKIIRGSYPPVSSHYSYDLRNLVSQLF--KRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 55/206 (26%), Positives = 101/206 (49%), Gaps = 19/206 (9%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ---HRNLVK 533
++G G +G VYK G +A+K + + + EV L+ RL+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 534 LLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L+ C + + L++E++ ++ L ++ D+ L + ++ RG+ +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H + I+HRDLK N+L+ + K++DFG+ARI+ Q VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ ++ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 18/206 (8%)
Query: 479 NKLGEGGFGPVYKG---TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+++G G FG V G + + VK L + + F EV L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDS 592
LG CI++ +L+ E+ P L ++ QK + + +A G+L+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IH DL N L D++ KI D+G+A + D T V +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 652 ---GLFSVK----SDVFSFGVLVLEI 670
L S+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKG---SGQGMEEFKNE--VTLIA-RLQHRN 530
LG G FG V YK T G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
LV L C D + EY L I F + RA F + G+
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH++ +I++RDLK N+LLD + KI+DFG+ + G +T+T GT +++P
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEFLAP 170
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSG 673
E E ++ D + GVL+ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 35/210 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLV 532
LG+G FG V KGT E+ A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKVMLAERKGT----DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 533 KLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGIL 586
L C Q D + EY+ L + I F + A F IA G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--------AAEIAIGLF 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYM 644
+LH II+RDLK NV+LD + + KI+DFGM + IFGG +T GT Y+
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT----FCGTPDYI 168
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE A + D ++FGVL+ E+++G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 71/223 (31%), Positives = 104/223 (46%), Gaps = 41/223 (18%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR------LQHRN 530
LG+G FG V+ KGT Q A+K L K + + E T++ + +H
Sbjct: 3 LGKGSFGKVFLAELKGT---NQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 531 LVKLLGCCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARG 584
L L C Q E++ + EY+ L F I FD RATF I G
Sbjct: 58 LTHLY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--------AAEIICG 108
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH I++RDLK N+LLD D + KI+DFGM + + +T T GT Y+
Sbjct: 109 LQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT--FCGTPDYI 163
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+PE ++ D +SFGVL+ E++ G+ P H H+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQS------PFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/218 (27%), Positives = 109/218 (50%), Gaps = 25/218 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK----NEVTLIARLQ 527
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 528 HRNLVKLLGCCIQADESM----------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
HRN+V L +++ L++EYM + + + + F + +
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIK-SF 121
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+ + G+ Y H+ + +HRD+K SN+LL+N K++DFG+AR++ +E + T+KV
Sbjct: 122 MKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 638 VGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ T Y PE E + DV+S G ++ E+ + K
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--FKNEVTLIARLQHRNLVKLLG 536
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ L++E++ + LD + LD + + I RGI + H + I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSHN---I 121
Query: 597 IHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYGYMSPEY-AAEGLF 654
IHRD+K N+L+ K+ DFG AR + E+ T+ V T Y +PE + +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPELLVGDTKY 178
Query: 655 SVKSDVFSFGVLVLEIVSG 673
D+++ G LV E+++G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 44/228 (19%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN----- 518
F ++ + T+ + +G G FG V + GQ +A+K++ M+ F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 519 ----EVTLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQK 573
E+ L+ L+H N++ L I E + + E + D +R L+ Q
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRP--LEKQF 109
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ + I RG+ Y+H ++HRDLK SN+L++ + + KI DFG+ARI D T
Sbjct: 110 IQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT- 163
Query: 634 THKVVGTYGYMSPEY--AAEGL-----FSVKSDVFSFGVLVLEIVSGK 674
GY+S Y A E + + V+ D++S G + E++ GK
Sbjct: 164 --------GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKN----EVTLIARLQHRNLVKL 534
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ L++EY+ L+ +A L + + + I Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
IIHRD+K N+L+ K+ DFG AR T V T Y +PE
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSG 673
Y DV++ G ++ E++ G
Sbjct: 179 YGKP------VDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 50/217 (23%), Positives = 97/217 (44%), Gaps = 19/217 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM---EEFKNEVTLIARLQH 528
D+ +G G FG V+ + A+K ++ + + NE ++ + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 529 RNLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
+++L + D+ L + EY+P L F + + F + + I +
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFY-ASEIVCALE 115
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH I++RDLK N+LLD + + K++DFG A+ +++ T + GT Y++P
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYLAP 167
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
E + D ++ G+L+ E++ G + +P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 471 ATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFK--NEVTLIARLQ 527
A ++ + KLGEG + VYKG + + GQ +A+K +S + +G+ F E +L+ L+
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLK 61
Query: 528 HRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+V LL I E++ ++EYM + I Q + R+ + + RG+
Sbjct: 62 HANIV-LLHDIIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLA 117
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI--QTNTHKVVGTYGYM 644
Y+H I+HRDLK N+L+ K++DFG+AR I QT + +VV T Y
Sbjct: 118 YIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVV-TLWYR 170
Query: 645 SPEY---AAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ A + +S D++ G + +E++ G+
Sbjct: 171 PPDVLLGATD--YSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 61/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
+G G FG V K G +AVKR+ S + + ++ ++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 538 CIQADESMLIYEYMPNKSLDFF---IFDQARATFLDWQKRIHIVGGIA----RGILYLHQ 590
+ + + E M + SLD F +++ ++ + I+G IA + + YL +
Sbjct: 72 LFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE-----EILGKIAVATVKALNYLKE 125
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
+ ++IIHRD+K SN+LLD + N K+ DFG++ +T + G YM+PE
Sbjct: 126 E--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT---RDAGCRPYMAPERID 180
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
A +G + V+SDV+S G+ + E+ +GK
Sbjct: 181 PSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
C Q E + + E++ L F I FD RATF + I G+ +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAE--------IVCGLQFLHS 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NV+LD D + KI+DFGM + +FG + T GT Y++PE
Sbjct: 115 KG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTPDYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ D +SFGVL+ E++ G+
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 66/224 (29%), Positives = 105/224 (46%), Gaps = 54/224 (24%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARL-Q 527
KLG+G +G V+K + +A+K++ + F+N E+ + L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 528 HRNLVKLLGCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIH---IVGGI 581
H N+VKLL I+A+ IY EYM L I RA L + +H I+ +
Sbjct: 66 HPNIVKLLNV-IKAENDKDIYLVFEYM-ETDLHAVI----RANIL---EDVHKRYIMYQL 116
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG------GDEIQTNTH 635
+ + Y+H S +IHRDLK SN+LL++D K++DFG+AR + + T+
Sbjct: 117 LKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-- 171
Query: 636 KVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
V T Y +PE L D++S G ++ E++ GK
Sbjct: 172 -YVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 68/229 (29%), Positives = 107/229 (46%), Gaps = 19/229 (8%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ TD + +G+G +G VYK T +G AVK L S EE + E ++
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQS 74
Query: 526 L-QHRNLVKLLGCCIQADESM-----LIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIV 578
L H N+VK G +AD+ + L+ E S+ + LD +I+
Sbjct: 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G G+ +LH + RIIHRD+K +N+LL + K+ DFG++ ++ NT V
Sbjct: 135 YGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 189
Query: 639 GTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
GT +M+PE A + + + DV+S G+ +E+ G HP
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 537 CCIQADESML-IYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
CC Q + + + EY+ L F I FD+ R+ F + +++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY--------AAEVTLALMFLHR 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
+I+RDLK N+LLD + + K++DFGM + I G T GT Y++PE
Sbjct: 115 HG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT----FCGTPDYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
E + D ++ GVL+ E+++G+
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 65/270 (24%), Positives = 121/270 (44%), Gaps = 46/270 (17%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G G VYK + + I AVK + + + ++ +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA----RGILYLHQDSRM 594
+ + E+M SLD + + H++G IA +G+ YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
+I+HRD+K SN+L++ K+ DFG++ + + VGT YM+PE + +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP 714
+ SDV+S G+ +E+ G RF +P N ++ ++L + D P
Sbjct: 171 GIHSDVWSLGISFMELALG----RFPYPQIQKN---QGSLM-----PLQLL-QCIVDEDP 217
Query: 715 P-------TEVLRCIHVGLLCVQHRPEDRP 737
P +E +H C++ +P++RP
Sbjct: 218 PVLPVGQFSEKF--VHFITQCMRKQPKERP 245
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 36/219 (16%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLS-KGSGQGME-EFKNEVTLIARLQ---HRNLV 532
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 533 KLLGCCI-----QADESMLIYEYMPNKSLDFFIFDQARATFLDW--------QKRIHIVG 579
+L C + + L++E++ DQ T+LD + ++
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV----------DQDLTTYLDKVPEPGVPTETIKDMMF 117
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+ Q VV
Sbjct: 118 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 171
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
T Y +PE + ++ D++S G + E+ K +R
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 36/154 (23%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E L+ + H +++++ + + ++ +P+ S D + + R+ L + + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I G+ YLH RIIHRD+K N+ +++ I D G A+ + +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
GT +PE A ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-13
Identities = 79/357 (22%), Positives = 148/357 (41%), Gaps = 61/357 (17%)
Query: 420 IIASVL--LMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFA- 476
I L + + +VA F R + L ++ + ED WE F +K + +
Sbjct: 631 YITCTLGAFLVLALVAFGFVFIRGR-NNLELKRVEN--ED-GTWELQFFD-SKVSKSITI 685
Query: 477 --------SYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ 527
N + G G YKG ++ G + VK ++ + +E+ + +LQ
Sbjct: 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQ 741
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N+VKL+G C + LI+EY+ K+L + + L W++R I GIA+ + +
Sbjct: 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRF 795
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH ++ +L +++D P + + K + Y++PE
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPE 848
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKK-------------NW-RFSHPDHDHNLLGHAW 693
+ KSD++ FG++++E+++GK W R+ + D ++ W
Sbjct: 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM----W 904
Query: 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750
I + GD + + E++ +++ L C P RP + V+ L S S
Sbjct: 905 I------DPSIRGDVSVNQN---EIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + +I+ G I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH ++ II+RD+K N+LLD++ + ++DFG+++ F DE++ + GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 645 SPEYAA--EGLFSVKSDVFSFGVLVLEIVSG 673
+P+ +G D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + +KLGEG + VYKG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L I ++S+ L++EY+ +K L ++ D + + K + + RG+
Sbjct: 62 KHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYM 644
Y H R +++HRDLK N+L++ K++DFG+AR I T T+ V T Y
Sbjct: 118 NYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 645 SPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ +S + D++ G + E+ +G+
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 44/132 (33%), Positives = 75/132 (56%), Gaps = 21/132 (15%)
Query: 549 EYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIA----RGILYLHQDSRMRIIHRDLK 602
E+M SLD + +A RI +I+G I+ RG+ YL + + +I+HRD+K
Sbjct: 79 EHMDGGSLDQ-VLKKAG--------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127
Query: 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFS 662
SN+L+++ K+ DFG++ G I + + VGT YMSPE ++V+SD++S
Sbjct: 128 PSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWS 183
Query: 663 FGVLVLEIVSGK 674
G+ ++E+ G+
Sbjct: 184 LGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKG------TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL 526
+ + KLGEG + V+KG LV +EI RL G + EV+L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 527 QHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+H N+V L + D+S+ L++EY+ +K L ++ D + + I RG+
Sbjct: 62 KHANIVTLHDI-VHTDKSLTLVFEYL-DKDLKQYMDDCG--NIMSMHNVKIFLYQILRGL 117
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYM 644
Y H R +++HRDLK N+L++ K++DFG+AR + T T+ V T Y
Sbjct: 118 AYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 645 SPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
P+ +S + D++ G + E+ SG+
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 474 NFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ G G+ A+K L K + + E + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q D + LI +Y+ L F R F + + R++I I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYI-AEIVLA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LHQ + II+RD+K N+LLD++ + ++DFG+++ F +E + + GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 645 SPEY--AAEGLFSVKSDVFSFGVLVLEIVSG 673
+PE G D +S GVL E+++G
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 51/214 (23%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++F ++G G +G VYK V G+ A+K + G+ + E+ ++ +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA--------- 582
V G ++ D+ + E+ SL Q H+ G ++
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSL---------------QDIYHVTGPLSESQIAYVSR 113
Query: 583 ---RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+G+ YLH +M HRD+K +N+LL ++ + K++DFG++ + + +G
Sbjct: 114 ETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIG 168
Query: 640 TYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEI 670
T +M+PE AA +G ++ D+++ G+ +E+
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 45/214 (21%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KLGEG + VYKG + + GQ +A+K RL G + E +L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TLH 69
Query: 537 CCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVG----GIARGILYL 588
I +++ L++EY+ D ++D H V + RG+ Y
Sbjct: 70 DIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMSP 646
HQ R++HRDLK N+L+ K++DFG+AR + + T ++VV T Y P
Sbjct: 120 HQ---RRVLHRDLKPQNLLISERGELKLADFGLAR---AKSVPSKTYSNEVV-TLWYRPP 172
Query: 647 -------EYAAEGLFSVKSDVFSFGVLVLEIVSG 673
EY S D++ G + E+ +G
Sbjct: 173 DVLLGSTEY------STSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 57/230 (24%), Positives = 105/230 (45%), Gaps = 47/230 (20%)
Query: 479 NKLGEGGFGPVYKG-TLVEGQEIAVKR--LSKGSGQGMEEFKN------------EVTLI 523
LGEG +G V K + G+ +A+K+ + + S ++ + E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGG 580
++H N++ L+ ++ D L+ + M + K +D + + Q + I+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD------RKIRLTESQVKC-ILLQ 127
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN------- 633
I G+ LH+ +HRDL +N+ +++ KI+DFG+AR +G
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 634 ------THKVVGTYGYMSPE--YAAEGL-FSVKSDVFSFGVLVLEIVSGK 674
T KVV T Y +PE AE F+V D++S G + E+++GK
Sbjct: 185 QRREEMTSKVV-TLWYRAPELLMGAEKYHFAV--DMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-12
Identities = 51/191 (26%), Positives = 91/191 (47%), Gaps = 20/191 (10%)
Query: 497 GQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESML-IYEYMP 552
G E+A+K L + + + F+ E L ARL H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 553 NKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--- 608
++L + D A L + ++ + + H I+HRDLK N+++
Sbjct: 63 GRTLREVLAADGA----LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 609 DNDMNPKISDFGMARIFGG----DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSF 663
+ K+ DFG+ + G D T T +V+GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 664 GVLVLEIVSGK 674
G++ LE ++G+
Sbjct: 176 GLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 53/235 (22%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D+ +LG G +G V K V G +AVKR+ T+ ++ Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------------RATVNSQEQKRLL 47
Query: 532 VKL-----LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD------WQKRIHI--- 577
+ L C ++ Y + + D +I + T LD + K + I
Sbjct: 48 MDLDISMRSVDCPY---TVTFYGALFREG-DVWICMEVMDTSLDKFYKKVYDKGLTIPED 103
Query: 578 -VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+G IA I+ YLH S++ +IHRD+K SNVL++ + K+ DFG++ G + +
Sbjct: 104 ILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDS 157
Query: 633 NTHKV-VGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK---KNWR 678
+ G YM+PE +G + VKSDV+S G+ ++E+ +G+ +W+
Sbjct: 158 VAKTIDAGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFPYDSWK 211
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQ 527
NF LG+G FG V E+ A+K L K +E E ++A
Sbjct: 1 DFNFLMV--LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 528 HRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
+ L C Q D + EY+ L + I F + +A F I
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY--------AAEI 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ G+ +LH R II+RDLK NV+LD++ + KI+DFGM + D + T T GT
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT--FCGTP 165
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y++PE A + D +++GVL+ E+++G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++ ++G G +G VYK + G+ AVK + G + E+ ++ +H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA---------- 582
G + ++ + EY SL Q H+ G ++
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSL---------------QDIYHVTGPLSELQIAYVCRE 114
Query: 583 --RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+G+ YLH +M HRD+K +N+LL ++ + K++DFG+A + + +GT
Sbjct: 115 TLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGT 169
Query: 641 YGYMSPEYAA---EGLFSVKSDVFSFGVLVLEI 670
+M+PE AA G ++ D+++ G+ +E+
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 60/207 (28%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
D++ KLGEG + VYKG + V G+ +A+K RL + G + E +L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V LL I E++ L++EY+ + D+ ++ + + RG+ Y+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQ-LLRGLSYI 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYMSPE 647
HQ I+HRDLK N+L+ + K++DFG+AR + ++T+ V T Y P+
Sbjct: 120 HQ---RYILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPD 173
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSG 673
+S D++ G + +E++ G
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 57/229 (24%), Positives = 104/229 (45%), Gaps = 53/229 (23%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
+ + + +GEG +G V T G ++A+K++S Q + E+ ++ R +H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 531 LVKLLGCCIQAD--ESM----LIYEYMP-------------NKSLDFFIFDQARATFLDW 571
++ +L I+ ES ++ E M N + +F++
Sbjct: 65 IIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ--------- 114
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
I RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+ARI +
Sbjct: 115 ---------ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH 162
Query: 632 TNT-HKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T + V T Y +PE + + K D++S G ++ E++S +
Sbjct: 163 TGFLTEYVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 28/206 (13%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534
+GEG FG + LV+ Q+ A+K RL K S +E+ + E L+A+++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYL 588
+AD + ++ EY L I Q T L W ++ + G+ ++
Sbjct: 64 KES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H+ R++HRD+K+ N+ L + K+ DFG AR+ T+ VGT Y+ PE
Sbjct: 117 HEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPPEI 171
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ KSD++S G ++ E+ + K
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLK 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 44/144 (30%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A+ + ++ I + RG+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQ-VLKEAKRIPEEILGKVSI--AVLRGLAYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT YMSPE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+SV+SD++S G+ ++E+ G+
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 37/191 (19%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN--------EVTLIARLQHR 529
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRIHIVGGIAR--- 583
N+V L+ C Y K + +F+ A L + + I +
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN---THK 636
G+ Y+H R +I+HRD+KA+N+L+ D K++DFG+AR F + T++
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 637 VVGTYGYMSPE 647
VV T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 42/214 (19%)
Query: 481 LGEGGFGPVYKGTLV----EGQEIAVKRLS--KGSGQGMEEFKNEVTLIARLQHRNLVK- 533
+G+G +G V +LV +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 534 -------------LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++G C D +Y + + +Q F+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGD----LYHKLKEQKGKLLPENQVVEWFVQ---------- 110
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA + YLH+ I+HRDLK NV L K+ D G+AR+ +T ++GT
Sbjct: 111 IAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
YMSPE + ++ KSDV++ G V E+ + K
Sbjct: 166 PYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 29/285 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM--EEFKNEVTLIARLQHRN 530
D+F ++LG G G V+K + I ++L + + E+ ++
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V G E + E+M SLD + +A + Q + + +G+ YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +I+HRD+K SN+L+++ K+ DFG++ G I + + VGT YMSPE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
+SV+SD++S G+ ++E+ G R+ P D L + + GD
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIG----RYPIPPPDAKELELMF-------GCPVEGDPAE 224
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEP 755
P R G + P+ RP M+ L+ D ++ EP
Sbjct: 225 SETSP----RPRPPGRPLSSYGPDSRPPMAIFELL---DYIVNEP 262
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 33/95 (34%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
I RG+ YLH I+HRD+K N+L++++ KI DFG+AR+ DE + T +VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 641 YGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y Y +PE ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 58/210 (27%), Positives = 90/210 (42%), Gaps = 62/210 (29%)
Query: 494 LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRNLVKLLGCCIQADES 544
V GQ +A+K+LS+ F+N E+ L+ + H+N++ LL
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------- 83
Query: 545 MLIYEYMPNKSLDFF--------------------IFDQARATFLDWQKRIHIVGGIARG 584
+ P KSL+ F D R ++L +Q + G
Sbjct: 84 -----FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQ--------MLCG 130
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
I +LH IIHRDLK SN+++ +D KI DFG+AR G + T VV Y Y
Sbjct: 131 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY--VVTRY-YR 184
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE + D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-11
Identities = 28/81 (34%), Positives = 40/81 (49%), Gaps = 6/81 (7%)
Query: 326 NGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLW- 383
+ D F + KLP S + +L+EC+ C NCSC ++ + G GCLLW
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVISV-ASLEECASKCLNSNCSCRSFTYN---NGTKGCLLWS 57
Query: 384 FGDLMDMKEYNDGGQDLYIRI 404
L D + + GG DLY +I
Sbjct: 58 ESSLGDARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 49/218 (22%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHR--NLV 532
+G G G VYK G +AVK++ + + EE K +V L H +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVL---KSHDCPYIV 77
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD-WQKRI------HIVGGIARGI 585
K G I D FI + +T LD KRI I+G + I
Sbjct: 78 KCYGYFI--------------TDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAI 123
Query: 586 L----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGT 640
+ YL + + +IHRD+K SN+LLD N K+ DFG++ G + + + G
Sbjct: 124 VKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS----GRLVDSKAKTRSAGC 177
Query: 641 YGYMSPEY----AAEGLFSVKSDVFSFGVLVLEIVSGK 674
YM+PE + +++DV+S G+ ++E+ +G+
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 74/279 (26%), Positives = 115/279 (41%), Gaps = 61/279 (21%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN 518
+WE D + + + +G G +G V + G+++A+K+LS+ Q K
Sbjct: 10 VWEVP--------DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKR 60
Query: 519 ---EVTLIARLQHRNLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARA 566
E+ L+ + H N++ LL A L+ M N +
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
FL +Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR
Sbjct: 121 QFLVYQ--------ILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR--- 166
Query: 627 GDEIQTNTHKV--VGTYGYMSPEYAAEGLFSVKS-DVFSFGVLVLEIVSGKKNWRFSHPD 683
T+ V T Y +PE + ++ D++S G ++ E+++GK F D
Sbjct: 167 ----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT--LFPGSD 220
Query: 684 HDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCI 722
H L KR M L G P E+L+ I
Sbjct: 221 HIDQL----------KRIMNLVGT------PDEELLQKI 243
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-------EVTLIARLQHRNL 531
K+GEG +G V+K E GQ +A+K+ + E+ E+ ++ +L+H NL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L+ + + L++EY + L+ + + I+ + + + H+
Sbjct: 63 VNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF-GGDEIQTNTHKVVGTYGYMSPEY-A 649
+ IHRD+K N+L+ K+ DFG ARI G + T+ V T Y +PE
Sbjct: 120 N---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD---YVATRWYRAPELLV 173
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+ + DV++ G + E+++G+ W
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLW 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEF--KNEVTLIARLQHRNL 531
LG+G FG V+ LV GQ A+K L K + + + K E ++A + H +
Sbjct: 4 LGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
VKL + LI +++ + D F F + + ++ +A + +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKFYL-AELALALDHLH-- 115
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
+ II+RDLK N+LLD + + K++DFG+++ E + GT YM+PE
Sbjct: 116 -SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNR 172
Query: 652 GLFSVKSDVFSFGVLVLEIVSG 673
+ +D +SFGVL+ E+++G
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGI 585
L +L C D + EY+ L + I F + A F IA G+
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY--------AAEIAIGL 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH II+RDLK NV+LD++ + KI+DFGM + D + T T GT Y++
Sbjct: 115 FFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT--FCGTPDYIA 169
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE A + D ++FGVL+ E+++G+
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHR 529
+ + +KLGEG + V+KG + + +A+K RL G + EV+L+ L+H
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHA 63
Query: 530 NLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+V L I + + L++EY+ + D + + + + RG+ Y
Sbjct: 64 NIVTLHDI-IHTERCLTLVFEYLDS---DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYC 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH-KVVGTYGYMSPE 647
H + +I+HRDLK N+L++ K++DFG+AR + T T+ V T Y P+
Sbjct: 120 H---KRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPD 173
Query: 648 -YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+S D++ G ++ E+ +G+
Sbjct: 174 VLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 475 FASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQHRNL 531
+ S ++G G +G V G+++A+K+LS+ S + E+TL+ +QH N+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 532 VKLLGCCIQA---DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+ LL A DE Y MP D + L K ++V + G+ Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDL---QKIMGHPLSEDKVQYLVYQMLCGLKYI 133
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H IIHRDLK N+ ++ D KI DFG+AR D T V T Y +PE
Sbjct: 134 HSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTG---YVVTRWYRAPEV 185
Query: 649 AAEGLFSVKS-DVFSFGVLVLEIVSGK 674
+ ++ D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 481 LGEGGFGPVYKGTLVE----GQ----EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
LG+G F ++KG E G+ E+ +K L K E F +++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G C+ DES+++ EY+ SLD ++ + W ++ + +A + +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 593 RMRIIHRDLKASNVLL-----DNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ H ++ A NVLL NP K+SD G++ EI ++ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPWV 171
Query: 645 SPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
PE S+ +D +SFG + EI SG
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 474 NFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGS----GQGMEEFKNEVTLIAR 525
NF LG G +G V+ V G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
++ + L Q + + LI +Y+ + F R F + + R + G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEM--FTHLYQRDNFSEDEVRFY-SGEIILA 117
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH ++ I++RD+K N+LLD++ + ++DFG+++ F +E + T+ GT YM
Sbjct: 118 LEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173
Query: 645 SPEYA-AEGLFSVKSDVFSFGVLVLEIVSG 673
+PE +G D +S G+L+ E+++G
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 49/238 (20%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEE---FKNEVTLIARLQH 528
D+F +G G FG V+ + ++ A+K L K + + E ++A
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 529 RNLVKLLGCCIQADESM-LIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIA 582
+VKL Q +E + L+ EYMP L +F + A F IA
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY-----------IA 108
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-------------------- 622
+L L ++ IHRD+K N+L+D D + K++DFG+
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 623 -----RIFGGDEIQTNT--HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ D Q + VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 480 KLGEGGFGPVYKGTLVEG---QEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGILYLHQDSR 593
G C + +L+ E+ P L ++ +A + + IA G+L+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAAE- 651
IH DL N LL D+ KI D+G++ + D T V +++PE E
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV-PLRWIAPELVDEV 177
Query: 652 --GLFSV----KSDVFSFGVLVLEI 670
L V +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 481 LGEGGFGPVYKGTLVEGQE----IAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V++ V G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+ + LI EY+ L F+ + F++ ++ I+ + +LHQ
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYL-SEISLALEHLHQQG 120
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEYAA 650
II+RDLK N+LLD + K++DFG+ + I G T TH GT YM+PE
Sbjct: 121 ---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILM 173
Query: 651 EGLFSVKSDVFSFGVLVLEIVSG 673
D +S G L+ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 481 LGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
LG+G F +YKG L GQE++V GS F +L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LVKL G C+ DE++++ EY+ LD F+ + L W ++ + +A + YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 591 DSRMRIIHRDLKASNVLL----DNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+++H ++ N+L+ N+ K+SD G+ E + V +
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIPW 170
Query: 644 MSPEYAAEGLFSVKS--DVFSFGVLVLEIVSGKK 675
++PE G S+ D +SFG +LEI S +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 71/255 (27%), Positives = 110/255 (43%), Gaps = 47/255 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQHRNLVKLLGC 537
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 538 CIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
A +E L+ M N + FL +Q + RG+ Y+
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ--------LLRGLKYI 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H IIHRDLK SNV ++ D +I DFG+AR D+ T V T Y +PE
Sbjct: 135 HSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTG---YVATRWYRAPEI 186
Query: 649 AAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
+ ++ D++S G ++ E++ GK F D+ L KR ME+ G
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKA--LFPGNDYIDQL----------KRIMEVVGT 234
Query: 708 TLADSHPPTEVLRCI 722
P EVL+ I
Sbjct: 235 ------PSPEVLKKI 243
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 20/217 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G GGFG VY + G+ A+K L K QG NE +++ + + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIV 60
Query: 537 CCIQA----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
C A D+ I + M L + + F + + R + I G+ ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL--SQHGVFSEKEMRFY-ATEIILGLEHMH--N 115
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
R +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+PE +G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEVLQKG 170
Query: 653 L-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+ +D FS G ++ +++ G +R H +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 65/238 (27%), Positives = 107/238 (44%), Gaps = 30/238 (12%)
Query: 451 MSHMKEDMELWEFDFA-SIAKATDNFASYNKLGEGGFGPVYKG-TLVEGQEIAVKRLSKG 508
MS K D + + S + + +G G G V + + +A+K+LS+
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR- 59
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF--------I 560
F+N+ A+ +R LV L+ C + L+ + P KSL+ F +
Sbjct: 60 ------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 561 FD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
D Q LD ++ +++ + GI +LH IIHRDLK SN+++ +D KI
Sbjct: 111 MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
DFG+AR G + T VV Y Y +PE + D++S G ++ E++ G
Sbjct: 168 LDFGLARTAGTSFMMTP--YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 34/100 (34%), Positives = 57/100 (57%), Gaps = 7/100 (7%)
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +R +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMAPEV 166
Query: 649 AAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+G+ + +D FS G ++ +++ G +R H D +
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-QHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)
Query: 473 DNFASYNKLGEGGFGPVYKG-TLVEGQEIAVK--RLSKGSGQGMEE------FKNEVTLI 523
D + K+GEG +G VYK G+ +A+K RL M+E E++L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 524 ARLQHRN-LVKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQAR--ATFLDWQKR 574
L +V+LL +E L++EY+ + L F+ R L +
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + +G+ + H+ ++HRDLK N+L+D KI+D G+ R F +++
Sbjct: 113 KSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSY 168
Query: 634 THKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
TH++V T Y +PE +S D++S G + E+
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 59/191 (30%), Positives = 92/191 (48%), Gaps = 28/191 (14%)
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
V G +AVK+LS+ F+N+ A+ +R LV LL C + L+ + P K
Sbjct: 44 VLGINVAVKKLSR-------PFQNQTH--AKRAYRELV-LLKCVNHKNIISLLNVFTPQK 93
Query: 555 SLDFF--------IFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602
SL+ F + D Q LD ++ +++ + GI +LH IIHRDLK
Sbjct: 94 SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 150
Query: 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFS 662
SN+++ +D KI DFG+AR + + T V T Y +PE + D++S
Sbjct: 151 PSNIVVKSDCTLKILDFGLARTACTNFMMT---PYVVTRYYRAPEVILGMGYKENVDIWS 207
Query: 663 FGVLVLEIVSG 673
G ++ E+V G
Sbjct: 208 VGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 36/221 (16%)
Query: 479 NKLGEGGFGPVYK------GTLVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHR-- 529
++LG+G +G VYK G + +EI RL ++E K N++ + + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 530 --NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
+V G + EYM SLD + I + +G+ +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
L ++ IIHRD+K +NVL++ + K+ DFG++ +TN +G YM+PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPE 171
Query: 648 Y------AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
++V+SDV+S G+ +LE+ G R+ +P
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALG----RYPYP 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 64/240 (26%), Positives = 102/240 (42%), Gaps = 34/240 (14%)
Query: 442 KLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQ--E 499
K K TK K M+ +F+F LG G FG V T
Sbjct: 11 KKKDSDSTKEPKRKNKMKYEDFNFI------------RTLGTGSFGRVILATYKNEDFPP 58
Query: 500 IAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
+A+KR K + ++ +E ++ + H V L G L+ E++
Sbjct: 59 VAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG-- 116
Query: 557 DFFIFDQARATFLDWQKRI-HIVGGI--ARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613
+FF TFL KR + VG A+ +L + I++RDLK N+LLD D
Sbjct: 117 EFF-------TFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
K++DFG A++ + T T+ + GT Y++PE +D ++ G+ + EI+ G
Sbjct: 170 IKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 484 GGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL---------VK 533
G FG VY G A+K L K M KN+VT + + + + K
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD---MIA-KNQVTNV-KAERAIMMIQGESPYVAK 61
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
L D L+ EY+ I DW K+ + + G+ LHQ
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG- 117
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
IIHRD+K N+L+D + K++DFG++R G E K VGT Y++PE G+
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDYLAPE-TILGV 168
Query: 654 FSVK-SDVFSFGVLVLEIVSGKKNWRFSHPD 683
K SD +S G ++ E + G + PD
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 53/180 (29%), Positives = 90/180 (50%), Gaps = 24/180 (13%)
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE---YMPNKSLDF- 558
KR+ GS + + +NE+ + RL H N++K+ E +L E YM + DF
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI--------EEILRSEANTYMITQKYDFD 248
Query: 559 ---FIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
F++D+A + L Q R I+ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 249 LYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ DFG A F E + + VGT SPE A + +D++S G+++L+++S
Sbjct: 305 KIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 8e-10
Identities = 38/113 (33%), Positives = 63/113 (55%), Gaps = 13/113 (11%)
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
LD + +A+G+ +L + IHRD+ A NVLL + KI DFG+AR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----- 260
Query: 629 EIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676
+I +++ VV +M+PE + +++V+SDV+S+G+L+ EI S K+
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 29/236 (12%)
Query: 465 FASIAKATDNFASYNKLGEGGFGPVYK-GTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLI 523
F S +D + +G+G +G V+K G + AVK L EE + E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 524 ARLQ-HRNLVKLLGC-----CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI-- 575
L H N+VK G D+ L+ E S + D + FL +R+
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGS----VTDLVKG-FLKRGERMEE 123
Query: 576 ----HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+I+ G+ +LH + + IHRD+K +N+LL + K+ DFG++ ++
Sbjct: 124 PIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR 180
Query: 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
NT VGT +M+PE A + + + DV+S G+ +E+ G HP
Sbjct: 181 RNTS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 35/234 (14%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---EVTL 522
+I + + + + + +G G +G V + G +AVK+LS+ Q + K E+ L
Sbjct: 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRL 69
Query: 523 IARLQHRNLVKLLGCCIQA------DESMLIYEYMP---NKSLDFFIFDQARATFLDWQK 573
+ ++H N++ LL A ++ L+ M N + FL +Q
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ- 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR DE+
Sbjct: 129 -------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMT-- 175
Query: 634 THKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
V T Y +PE + ++ D++S G ++ E+++G R P DH
Sbjct: 176 --GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG----RTLFPGTDH 223
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++ +SDV+SFGVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 40/219 (18%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL----- 534
LG G G V+ + + +AVK++ Q ++ E+ +I RL H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 535 ---------LGCCIQADESMLIYEYMPN---KSLDFFIFDQARATFLDWQKRIHIVGGIA 582
+G + + ++ EYM L+ + A +Q +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQ--------LL 124
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHK----- 636
RG+ Y+H + ++HRDLK +NV ++ D+ KI DFG+ARI +HK
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY----SHKGYLSE 177
Query: 637 VVGTYGYMSPEYAAEGLFSVKS-DVFSFGVLVLEIVSGK 674
+ T Y SP K+ D+++ G + E+++GK
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 53/205 (25%), Positives = 99/205 (48%), Gaps = 26/205 (12%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--EVTLIARLQ-HRNLVKL 534
K+GEG F V K + G+ A+K + K + +E+ N E+ + RL H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 535 LGCCIQADESM----LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYL 588
+ D L++E M D +++ + R L ++ + + + + ++
Sbjct: 64 --IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE- 647
H++ I HRD+K N+L+ +D K++DFG R G T + + T Y +PE
Sbjct: 117 HRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYT-EYISTRWYRAPEC 169
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS 672
+G + K D+++ G + EI+S
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 34/92 (36%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + + IHRDL A N+LL + KI DFG+AR D
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 59/233 (25%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY-----LH 589
+ AD + L+++Y + F +A +K + + G+ + +LY +H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGD-EIQTNTHKVVGTYGY 643
++HRDLK +N+L+ + P KI+D G AR+F + + VV T+ Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 644 MSPEYAAEGLFSVKS-DVFSFGVLVLEIVSG-------KKNWRFSHPDHDHNL 688
+PE K+ D+++ G + E+++ +++ + S+P H L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 25/142 (17%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ARG+ +L + +HRDL A NVLL KI DFG+AR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG------------------KKNWRFSHP 682
+M+PE + L++ SDV+S+G+L+ EI S K +R + P
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP 362
Query: 683 DHD----HNLLGHAWILWKEKR 700
DH ++++ W EKR
Sbjct: 363 DHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+F + +G G FG V K T G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMP--------NKSLDFFIFDQARATFLDWQKRIHI 577
+ +L D L+ EY P N+ D FD+ A F
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFY-------- 107
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
+A +L +H +M +HRD+K NVL+D + K++DFG A ++ N+
Sbjct: 108 ---LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVNSKLP 163
Query: 638 VGTYGYMSPEY------AAEGLFSVKSDVFSFGVLVLEIVSGK 674
VGT Y++PE +G + V+ D +S GV+ E++ G+
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 475 FASYNKLGEGGFGPV---YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + +G G G V Y L + +A+K+LS+ F+N+ A+ +R L
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYREL 67
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF--------IFD----QARATFLDWQKRIHIVG 579
V L+ C + L+ + P KSL+ F + D Q LD ++ +++
Sbjct: 68 V-LMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY 126
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ GI +LH IIHRDLK SN+++ +D KI DFG+AR G + T V
Sbjct: 127 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVV 180
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y +PE + D++S G ++ E+V K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIA---VKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQ----ARATFLDWQKRIHIVGGIARGILYLHQD 591
G C++A +L++EY L ++ + + L Q+ + IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR---MACEIAAGVTHMH-- 116
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ +H DL N L +D+ K+ D+G+ + D I+T K V +++PE
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPELVG 174
Query: 651 E---GLFSVK----SDVFSFGVLVLEI 670
E GL + + S+V++ GV + E+
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 34/97 (35%), Positives = 57/97 (58%), Gaps = 13/97 (13%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + IHRDL A N+LL + KI DFG+AR +I+ +++ VV
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKG 274
Query: 641 YG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE +++ +SDV+S+G+L+ EI S
Sbjct: 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRL--SKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 538 CIQADESMLIYEYMPNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L++EY+ L+ ++ R+ K IH + H+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIH----------WCHK 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ I+HRD+K N+L+ ++ K+ DFG AR + N + V T Y SPE
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLL 174
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+ D++S G ++ E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 39/236 (16%)
Query: 467 SIAKATDNFASYNKLGEGGFGPV-YKGTLVEGQEIAVKRLSK--GSGQGMEEFKNEVTLI 523
+I + D + ++G G +G V G ++A+K+L + S + E+ L+
Sbjct: 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 68
Query: 524 ARLQHRNLVKLLGCCIQADESML----IYEYMP------NKSLDFFIFDQARATFLDWQK 573
++H N++ LL D S+ Y MP K + + R FL +Q
Sbjct: 69 KHMKHENVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQ- 126
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ +G+ Y+H IIHRDLK N+ ++ D KI DFG+AR QT+
Sbjct: 127 -------MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTD 169
Query: 634 THKV--VGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
+ V T Y +PE + ++ D++S G ++ E+++GK ++ HDH
Sbjct: 170 SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK----GHDH 221
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 479 NKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNL 531
LG G FG V +KGT G+ A+K L K M++ ++ E +++ L H +
Sbjct: 24 ETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL---YL 588
V ++ + + E++ L F +A D K H A +L YL
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGRFPNDVAKFYH-----AELVLAFEYL 134
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H II+RDLK N+LLDN + K++DFG A+ ++ T + GT Y++PE
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAPEV 186
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
D ++ GVL+ E ++G
Sbjct: 187 IQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G+ AVK L K + +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD+ + ++DFG+ + G E T GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 30/217 (13%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVK 533
LG+G FG V K T G+ A+K L K +E + VT LQ H L
Sbjct: 3 LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE--------IVSALEYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H +++RD+K N++LD D + KI+DFG+ + D T GT Y++PE
Sbjct: 112 HSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 166
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ + D + GV++ E++ G+ F + DH+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + EY+ L +F R L + I+ + Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH+ II+RDLK NVLLD++ + K++D+GM + G T GT Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 166
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF--SHPDHDHNLLGHAWILWKEK-----R 700
+ D ++ GVL+ E+++G+ + S + D N + + + EK R
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 226
Query: 701 AMELAGDTLADS---HPPTEVLRCI-HVGLLCVQHRP 733
++ + ++ S P E L C G +Q P
Sbjct: 227 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 33/219 (15%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF-----IFDQARATFLDWQKRIHIVGGIARGILYL 588
L D + EY L F +F + RA F + I + YL
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE--------IVSALDYL 111
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSP 646
H S +++RDLK N++LD D + KI+DFG+ + I G ++T GT Y++P
Sbjct: 112 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT----FCGTPEYLAP 165
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
E + + D + GV++ E++ G+ F + DH+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 30/233 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQ---EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQK 65
Query: 537 CCI-QADESM-LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGG----IARGILYLH 589
+ +D + L+++Y + F +A +A Q +V I GI YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGD-EIQTNTHKVVGTYGY 643
+ ++HRDLK +N+L+ + P KI+D G AR+F + + VV T+ Y
Sbjct: 126 AN---WVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 644 MSPEYAAEGLFSVKS-DVFSFGVLVLEIVSG-------KKNWRFSHPDHDHNL 688
+PE K+ D+++ G + E+++ +++ + S+P H L
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 476 ASYNKLGE----GGFGPVYK----GTLVEGQEIAVKRLSKGSGQGMEEFK---NEVTLIA 524
+G+ + K TLV AVK+++ S E+ K E+
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLV-----AVKKINLDS-CSKEDLKLLQQEIITSR 54
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI---HIVGGI 581
+LQH N++ + I E ++ M S + + + F + + I+ +
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL----KTHFPEGLPELAIAFILKDV 110
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTH----K 636
+ Y+H IHR +KAS++LL D +S + + + Q H
Sbjct: 111 LNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 637 VVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSG 673
V ++SPE + L ++ KSD++S G+ E+ +G
Sbjct: 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 22/213 (10%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V LV G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG-IARGILYLHQDS 592
L D + EY+ L FF + R D R G I + YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSED---RTRFYGAEIVSALDYLHSG- 114
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+I++RDLK N++LD D + KI+DFG+ + D T GT Y++PE +
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDN 170
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ D + GV++ E++ G+ F + DH+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 481 LGEGGFGPVY----KGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT---LIARLQHRNLVK 533
LG+G FG V K T G+ A+K L K +E + +T ++ +H L
Sbjct: 3 LGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
L D + EY L FF +F + RA F + I + Y
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGAE--------IVSALGY 110
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMS 645
LH +++RDLK N++LD D + KI+DFG+ + I G ++T GT Y++
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT----FCGTPEYLA 163
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
PE + + D + GV++ E++ G R + DH L
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCG----RLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 12/159 (7%)
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
LV L C L+ EY+ L +F R L + I + +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NVLLD D + K++D+GM + + GD T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ D ++ GVL+ E+++G+ + + D N
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 39/158 (24%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIF--DQARATFLDWQKRIH 576
E ++ + H ++++L G + LI +P D + + + D +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI---LA 186
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I + R I YLH++ RIIHRD+KA N+ +++ + + DFG A F D +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDINANKYYG 242
Query: 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT +PE A + D++S G+++ E+ +
Sbjct: 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V +G AVK L K + +E + + L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
A++ + +Y+ L FF + R FL+ + R + +A I YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL-FFHLQRERC-FLEPRARFY-AAEVASAIGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
II+RDLK N+LLD+ + ++DFG+ + G E + T GT Y++PE + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--KVV 638
+ RG+ Y+H + +IHRDLK SN+L++ D +I DFGMAR + + V
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 639 GTYGYMSPEYAAEGLFSV-----KSDVFSFGVLVLEIV 671
T Y +PE L S+ D++S G + E++
Sbjct: 173 ATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVKLLG 536
+G+G FG VY+ + + I A+K LSK +E + E ++ R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 537 C--CIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYL 588
Q D + L+ +YM L + + F + RA F IA +L L
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFY-----------IAELVLAL 109
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE- 647
+ I++RDLK N+LLD + + DFG+++ D TNT GT Y++PE
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLAPEV 167
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSG 673
E ++ D +S GVLV E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 14/170 (8%)
Query: 502 VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYMPNKSLDFFI 560
VK ++ G G E+ ++ + HR ++ L I A + MP D F
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINL----IHAYRWKSTVCMVMPKYKCDLFT 174
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ R+ L ++ I I + + YLH IIHRD+K N+ LD N + DFG
Sbjct: 175 YVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFG 230
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEI 670
A + GT SPE A + K+D++S G+++ E+
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 16/151 (10%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H LV L C + E++ L F + Q + L + I+ + +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNF 111
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR--IFGGDEIQTNTHKVVGTYGYMS 645
LH+ II+RDLK NVLLD + + K++D+GM + I GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYIA 164
Query: 646 PEY--AAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + FSV D ++ GVL+ E+++G+
Sbjct: 165 PEILRGEDYGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-08
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 49/230 (21%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKG-SGQGM--EEFKNEVTLIARLQHRNLVKLL 535
+G+GG G VY V + +A+K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD--WQKR---------------IHIV 578
C D +Y MP +I + L WQK + I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ------- 631
I I Y+H S+ ++HRDLK N+LL I D+G A +E
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 632 ---------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
T K+VGT YM+PE S +D+++ GV++ ++++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 57/244 (23%), Positives = 100/244 (40%), Gaps = 74/244 (30%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 531 LVKLLGCCI-----QADESMLIYEYM---------PNKSL-----DFFIFDQARATFLDW 571
++ + ++ ++YE M +++L +F++
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQ--------- 116
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
+ RG+ Y+H + ++HRDLK SN+LL+ + + KI DFG+AR ++
Sbjct: 117 ---------LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGD 163
Query: 632 TNTHKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684
T VV T Y +PE Y DV+S G + E++ K F D+
Sbjct: 164 FMTEYVV-TRWYRAPELLLNCSEYTT------AIDVWSVGCIFAELLGRKP--LFPGKDY 214
Query: 685 DHNL 688
H L
Sbjct: 215 VHQL 218
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-08
Identities = 29/91 (31%), Positives = 53/91 (58%)
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+L +H +IHRD+K++N+LL ++ K+ DFG ++++ GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+PE +S K+D+FS GVL+ E+++ K+
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243
|
Length = 496 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-08
Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++ AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
AD+ + +Y+ L F Q FL+ + R + IA + YLH +
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFY-AAEIASALGYLHS---LN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN--THKVVGTYGYMSPEYAAEGL 653
I++RDLK N+LLD+ + ++DFG+ + + I+ N T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 654 FSVKSDVFSFGVLVLEIVSG 673
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 51/198 (25%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 481 LGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V ++G+ AVK L K +E K+ + L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
++ + +++ L F + Q +F + + R + IA + YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHL--QRERSFPEPRARFYA-AEIASALGYLHS---IN 116
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
I++RDLK N+LLD+ + ++DFG+ + G T GT Y++PE + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 656 VKSDVFSFGVLVLEIVSG 673
D + G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 17/166 (10%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A G+ +L + +HRDL A NVL+ KI DFG+AR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700
+M+PE L++ SDV+SFG+L+ EI + +P+ N + I KR
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGT---PYPELPMNEQFYNAI----KR 357
Query: 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+A H E+ + C + + E RP+ S +V ++
Sbjct: 358 GYRMAKPA----HASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSGQGM--EEFKNEVTLIARLQ-HRNLVK 533
+LG+G +G V E E +A+K+++ + + + E+ L+ + H+N+
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 534 LLGCCIQADES---MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
L I + + +YE + L I T +Q I+ I G+ Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY---QILCGLKYIHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--KVVGTYGYMSPEY 648
+ ++HRDLK N+L++ D KI DFG+AR F + + + V T Y +PE
Sbjct: 124 AN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEI 180
Query: 649 AAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+ S +S DV+S G ++ E++ K
Sbjct: 181 ----MLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 13/113 (11%)
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
FD +RA F A + L + +I+RDLK N+LLD + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ ++ D+ +TNT GT Y++PE ++ D ++ GVL+ E+++G
Sbjct: 139 LCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 42/229 (18%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIARLQHRNLVKL 534
K+G G FG V+ QE + S +G++E + EV ++ L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 535 LGCCI-QADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YL 588
+ + +A++ + I E+ L I + F ++ H + I R +L Y
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNI-QKCYKMFGKIEE--HAIVDITRQLLHALAYC 134
Query: 589 HQ----DSRMRIIHRDLKASNVLLD-------------NDMN----PKISDFGMARIFGG 627
H + R++HRDLK N+ L N++N KI DFG+++ G
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG- 193
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSV--KSDVFSFGVLVLEIVSGK 674
I++ H VGT Y SPE S KSD+++ G ++ E+ SGK
Sbjct: 194 --IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLG 536
+G G FG V Q++ A+K LSK + F E ++A +V+L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 109
Query: 537 CCIQADESM-LIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
C Q D+ + ++ EYMP L + +D W K A +L L
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE----KWAKFY-----TAEVVLALDAIHS 160
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEY---- 648
M +IHRD+K N+LLD + K++DFG DE VGT Y+SPE
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSG 673
+G + + D +S GV + E++ G
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 63/253 (24%), Positives = 100/253 (39%), Gaps = 70/253 (27%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
D+F S +G G FG V LV+ G A+K+L K Q + + E ++A
Sbjct: 1 DDFESIKVIGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILA 56
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSL-------DFFIFDQARATFLDWQKRIH 576
+ +VKL Q + + LI EY+P + D F ++ R F
Sbjct: 57 EADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR--FY------- 106
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM------------ARI 624
IA IL + ++ IHRD+K N+LLD + K+SDFG+ RI
Sbjct: 107 ----IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 625 FGGDEIQTNT------------------------HKVVGTYGYMSPEYAAEGLFSVKSDV 660
+ VGT Y++PE + ++ + D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 661 FSFGVLVLEIVSG 673
+S GV++ E++ G
Sbjct: 223 WSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 6/95 (6%)
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI-FGGDEIQTNTHKVVGTY 641
R + Y+H + + HRDLK N+L + D KI DFG+AR+ F V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 642 GYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGK 674
Y +PE ++ D++S G + E+++GK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGIL 586
+ N +KL +LI +Y+ + L FD + L + I+ + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
LH + IIH D+K NVL D + + D+G+ +I G + + GT Y S
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG----TPSCYD--GTLDYFS 174
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP---DHDHNL 688
PE + V D ++ GVL E+++GK HP D D L
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK------HPFKEDEDEEL 214
|
Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 34/100 (34%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD-EIQTNTHKVVG 639
IA +L +H ++ +HRD+K NVLLD + + +++DFG D +Q++ VG
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSV--AVG 165
Query: 640 TYGYMSPEY--AAE---GLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE A E G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVG 639
+A +L + ++ +HRD+K NVLLD + + +++DFG R+ +Q+N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNV--AVG 165
Query: 640 TYGYMSPEY--AAE---GLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE A E G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 4/157 (2%)
Query: 517 KNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
++E+ +A H +VK D+ +LI EY L+ I Q L +Q+ +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQE--Y 169
Query: 577 IVGGIARGI-LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
VG + I L L + +++HRDLK++N+ L K+ DFG ++ +
Sbjct: 170 EVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
GT Y++PE +S K+D++S GV++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-06
Identities = 22/81 (27%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 328 DEFPKYVKLKLPDTSSSWFNASMN-LKECSELCSKN---CSCTAYANSDVERGGSGCLLW 383
DEF K L + N EC+ C KN SC A+ R CL +
Sbjct: 2 DEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFV-FAKARK--QCLWF 58
Query: 384 -FGDLMDMKEYNDGGQDLYIR 403
F + +++ G DLY
Sbjct: 59 PFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 9e-06
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 61/250 (24%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F +G G FG V V+ + A+K L K K E ++A +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + IF++ A F + + I
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY--------IAELTCAI 114
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF----------GGDEIQTNT- 634
+H +M IHRD+K N+L+D D + K++DFG+ F GD + ++
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSM 171
Query: 635 ------------------------------HKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664
H +VGT Y++PE ++ D +S G
Sbjct: 172 EPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 231
Query: 665 VLVLEIVSGK 674
V++ E++ G+
Sbjct: 232 VILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 53/216 (24%), Positives = 98/216 (45%), Gaps = 41/216 (18%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-IAVKRLSKGSGQGMEEFKN-EVTLIARLQHRNLVKLLG 536
N +G G FG VY+ ++ E +A+K++ + ++KN E+ ++ L H N++ L
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKD 126
Query: 537 C----CIQADESML----IYEYMPNKSLDFFIF----DQARATFL----DWQKRIHIVGG 580
C + +E + + E++P + + A FL +Q
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ-------- 178
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR-IFGGDEIQTNTHKVV 638
+ R + Y+H I HRDLK N+L+D N K+ DFG A+ + G Q + +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVSYIC 232
Query: 639 GTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSG 673
+ Y +PE ++ D++S G ++ E++ G
Sbjct: 233 SRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 39/180 (21%), Positives = 84/180 (46%), Gaps = 20/180 (11%)
Query: 503 KRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM----LIYEYMPNKSLDF 558
K+ KG ++ +NE+ + R+ N++K+ G I + + LI EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ + L ++ ++ + +G+ L++ ++ +++L + + L+ + KI
Sbjct: 112 VLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKII 165
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS---VKSDVFSFGVLVLEIVSGK 674
G+ +I + + K V Y S + + +FS +K D++S GV++ EI +GK
Sbjct: 166 CHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 14/156 (8%)
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
+E L+ RL H ++ LL + + L+ +P D + + AR L +
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
V +AR +L Y+H + IIHRD+K NVL++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLE 669
+ + GT +PE A ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A +L L M IHRD+K N+LLD + K++DFG + + VGT
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTP 207
Query: 642 GYMSPEY----AAEGLFSVKSDVFSFGVLVLEIVSG 673
Y+SPE +G + + D +S GV + E++ G
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 36/211 (17%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVK 533
+G G FG V +K + Q A+K LSK + F E ++A +V+
Sbjct: 51 IGRGAFGEVQLVRHKSS---KQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 534 LLGCCIQADESML--IYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGIL 586
L D+ L + EYMP L ++ I + W + A +L
Sbjct: 108 L--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWARFY-----TAEVVL 153
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
L M IHRD+K N+LLD + K++DFG + VGT Y+SP
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPDYISP 212
Query: 647 EY----AAEGLFSVKSDVFSFGVLVLEIVSG 673
E +G + + D +S GV + E++ G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 56/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS---GQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + + A+K L K + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V+L D + +Y+P + IF + A F IA
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF----------GGDEIQTNT- 634
+ +M IHRD+K N+L+D D + K++DFG+ F GD ++ ++
Sbjct: 112 CAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSM 171
Query: 635 ----------------------------------HKVVGTYGYMSPEYAAEGLFSVKSDV 660
H +VGT Y++PE ++ D
Sbjct: 172 DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231
Query: 661 FSFGVLVLEIVSGK 674
+S GV++ E++ G+
Sbjct: 232 WSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-05
Identities = 57/243 (23%), Positives = 94/243 (38%), Gaps = 71/243 (29%)
Query: 480 KLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT-------LIARLQH 528
LG+G G V+ LV G+ A+K L K M + +N+V ++A L H
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKE---MIK-RNKVKRVLTEQEILATLDH 60
Query: 529 RNLVKLLGCCIQADE-SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR---- 583
L L Q + L+ +Y P + F Q + K + +AR
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGG--ELFRLLQRQPG-----KCLSEE--VARFYAA 110
Query: 584 ----GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF---------GMARIFGG--- 627
+ YLH + I++RDLK N+LL + +SDF
Sbjct: 111 EVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167
Query: 628 ---------------DEIQTNTHKVVGTYGYMSPEY-AAEG-LFSVKSDVFSFGVLVLEI 670
+E ++ VGT Y++PE + +G +V D ++ G+L+ E+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEM 225
Query: 671 VSG 673
+ G
Sbjct: 226 LYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 8e-05
Identities = 58/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 475 FASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKG---SGQGMEEFKNEVTLIARLQHRN 530
F LG G FG V V+ + A+K L K + + K E ++A +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VKL D + +Y+P + +F + A F IA
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY-----------IAELT 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG------------------- 626
L + +M IHRD+K N+L+D D + K++DFG+ F
Sbjct: 112 LAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 627 --------------GDEIQT------------NTHKVVGTYGYMSPEYAAEGLFSVKSDV 660
GD ++T H +VGT Y++PE ++ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 661 FSFGVLVLEIVSGK 674
+S GV++ E++ G+
Sbjct: 232 WSVGVILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 27/84 (32%), Positives = 45/84 (53%), Gaps = 16/84 (19%)
Query: 546 LIYEYMPN---KSL--DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600
L+ EY+ KSL + FD+ A + +A + YLH+ IIHRD
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVKY--------ISEVALALDYLHRHG---IIHRD 129
Query: 601 LKASNVLLDNDMNPKISDFGMARI 624
LK N+L+ N+ + K++DFG++++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 31/147 (21%), Positives = 59/147 (40%), Gaps = 15/147 (10%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV--KLLGC 537
L G VY + ++ +K S + + + EV ++ L + L K+L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
S L+ E++ ++LD + +++ I +A + LHQ + +
Sbjct: 62 GESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 598 HRDLKASNVLLDNDMNPKISDFGMARI 624
H DL N+L+D+ I D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 1e-04
Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 2/48 (4%)
Query: 747 SSDSLLPEPNRPGFFTERSLPEAEFSPSYP--QSSTTNEITITELQGR 792
S + +P+P +PGF RS E + S S +S T N++T++ + R
Sbjct: 1 SETTEIPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 26/113 (23%)
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT---- 632
I+ G RG+ YLHQ+ IHR++KAS++L IS G+ + G + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 633 -NTHKVVGTYG--------YMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGK 674
KVV + ++SPE + L ++VKSD++S G+ E+ +G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 26/100 (26%), Positives = 55/100 (55%), Gaps = 8/100 (8%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVG 639
+A ++ + ++ +HRD+K N+L+D + + +++DFG ++ +Q++ VG
Sbjct: 108 LAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVG 165
Query: 640 TYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y+SPE +G + + D +S GV + E++ G+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 15/100 (15%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE-----IAVKRL-SKGSGQ 511
E WEF DN LG G FG V + T G+E +AVK L +
Sbjct: 31 EKWEF-------PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTD 83
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEY 550
E +E+ +++ L QH+N+V LLG C ++I EY
Sbjct: 84 EREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 26/165 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN--------EV 520
++F + +G+G FG V LV+ G+ A+K L K E FK E
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++A +V L A LI E++P L + TF + R ++
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYM--- 107
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625
A +L + ++ IHRD+K N+L+D + K+SDFG++ F
Sbjct: 108 -AECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 47/211 (22%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 481 LGEGGFGPVYKGTLV-----------EGQEIAV--KRLSKGSGQGMEEFKNEVTLIARLQ 527
LG G +Y G L +EI V K L F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H+++V L G C++ E++++ E++ LD F+ ++ W + + +A + Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 588 LHQDSRMRIIHRDLKASNVLL-----DNDMNP--KISDFGMARIFGGDEIQTNTHKVVGT 640
L +D + +H ++ N+LL D + P K+SD G+ + + V
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV------LSRQECVER 171
Query: 641 YGYMSPEYAAEG-LFSVKSDVFSFGVLVLEI 670
+++PE + S+ +D +SFG + EI
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-04
Identities = 56/242 (23%), Positives = 94/242 (38%), Gaps = 51/242 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
D+F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + +I A +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM------------------------ 621
L + ++ IHRD+K N+LLD + K+SDFG+
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 622 ----------ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
A + + Q + VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQL-AYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 672 SG 673
G
Sbjct: 231 IG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 41/156 (26%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEE---FKNEVTLIAR 525
++F S +G G FG V LV+ G A+K L K E+ + E ++
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+VK+ LI E++P D + T + + + +I A +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYI----AETV 111
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
L + ++ IHRD+K N+LLD+ + K+SDFG+
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 29/101 (28%), Positives = 51/101 (50%), Gaps = 18/101 (17%)
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----------- 635
YLH I+HRDLK N+L+ + + K++DFG+++I G + TN +
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-GLMSLTTNLYEGHIEKDTREF 171
Query: 636 ---KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+V GT Y++PE + D ++ G+++ E + G
Sbjct: 172 LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 21/114 (18%), Positives = 43/114 (37%), Gaps = 26/114 (22%)
Query: 517 KNEVTLIARLQHRNLVKLLGCC------IQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ E ++A+ + G + D +++ EY+ + L +
Sbjct: 47 RREARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL---------- 90
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
+ R ++ + R + LH + I+H DL SN++L DFG+
Sbjct: 91 EEARPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.82 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.39 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.0 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.98 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.68 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.66 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.44 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.16 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.1 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.04 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.98 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.96 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.88 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.81 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.78 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.68 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.67 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.56 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.48 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.45 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.41 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.41 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.18 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.14 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.0 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.99 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.7 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.56 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.42 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.41 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.24 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 95.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.87 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.16 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.12 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-54 Score=464.06 Aligned_cols=290 Identities=44% Similarity=0.758 Sum_probs=258.0
Q ss_pred cccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeE
Q 003832 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (792)
Q Consensus 459 ~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 538 (792)
....|++.++..||++|...+.||+|+||.||+|.+.+++.||||++.....+...+|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998766543145699999999999999999999999
Q ss_pred EeCC-cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 539 IQAD-ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 539 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
.+.+ +++||||||++|+|.++|+..... .++|.+|++||.++|+||+|||+.+.++|+|||||++|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999876544 88999999999999999999999998899999999999999999999999
Q ss_pred eeccccccCCCCcccccccc-ccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKV-VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||+|+........ .... .||.+|+|||++..+..++|+|||||||+|+||+||+++.+...+.....+..|++..+
T Consensus 220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 99999664331111 1112 79999999999999999999999999999999999999988766566667899999999
Q ss_pred hhhhhhhhcccccc-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 697 KEKRAMELAGDTLA-DSHPP-TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 697 ~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.++.+.+++|+.+. ...+. +++.++.+++.+|++.+|++||+|.||+++|+....
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 99999999999987 55564 788999999999999999999999999999965543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=397.52 Aligned_cols=253 Identities=33% Similarity=0.517 Sum_probs=213.4
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCC-cceEEEeecCC
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYEYMPN 553 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e~~~~ 553 (792)
..+.||+|+||+||+|.+.....||||++..... ...++|.+|+.+|.+++|||||+++|+|.+.. ...||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 3356999999999999996544599999976532 22669999999999999999999999999988 79999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccCCCCccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~~~~~~~ 632 (792)
|+|..+++.. ....+++..+++++.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999775 45679999999999999999999999873 99999999999999997 99999999998765332 2
Q ss_pred cccccccccCcccccccc--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 633 NTHKVVGTYGYMSPEYAA--EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......||+.|||||++. ...|+.|+|||||||+||||+||+.||....+. . .+..++....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-~--------------~~~~v~~~~~R 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-Q--------------VASAVVVGGLR 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-H--------------HHHHHHhcCCC
Confidence 223368999999999999 669999999999999999999999999865441 1 11222333444
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+......+..++.+||+.+|+.||++.+|+.+|+..
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 455555777889999999999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=392.55 Aligned_cols=265 Identities=32% Similarity=0.515 Sum_probs=227.1
Q ss_pred ccccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeee
Q 003832 458 MELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC 537 (792)
Q Consensus 458 ~~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~ 537 (792)
.+.|+++.+++. ..++||+|.||.||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++++
T Consensus 198 ~d~wei~r~~l~-------l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 198 RDPWEIPREELK-------LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred cCCeeecHHHHH-------HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 345666665553 34799999999999999987789999999654 3455789999999999999999999999
Q ss_pred EEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 538 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
|..+...+||||||+.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIs 345 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKIS 345 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEc
Confidence 9999999999999999999999976 34566899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||||+....+.+ .......-++.|.|||.+..+.++.|+|||||||+||||+| |+.||.....
T Consensus 346 DFGLAr~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------------- 410 (468)
T KOG0197|consen 346 DFGLARLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------------- 410 (468)
T ss_pred ccccccccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH--------------
Confidence 9999996554443 33334556889999999999999999999999999999999 8888764432
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
..+.+.++...+-+.|..++..+.+||..||+.+|++|||++.+...|+....
T Consensus 411 --~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 411 --EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 23445566666777888899999999999999999999999999999976543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=366.82 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=208.8
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-ceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-SMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~e~ 550 (792)
+.+..+.||+|..|+|||++++. ++.+|+|++... .+...+++.+|++++++.+||+||+++|.|..... ..|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34445799999999999999875 677899999655 44556789999999999999999999999999995 9999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|++|+|++++... +.+++...-+|+.+|++||.|||+.. .||||||||+||||+..|++||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999999654 45899999999999999999999632 4999999999999999999999999999987554
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||....+.....+ . ....+++.. .
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~-~---------Ll~~Iv~~p-p 299 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF-E---------LLCAIVDEP-P 299 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-H---------HHHHHhcCC-C
Confidence 33457899999999999999999999999999999999999999976522111111 0 011222211 1
Q ss_pred CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPP-TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~-~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...|. ...+++..++..||++||.+||++.|++++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22333 377889999999999999999999998874
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=397.85 Aligned_cols=261 Identities=30% Similarity=0.464 Sum_probs=223.2
Q ss_pred hcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
..+....++||+|+||+||+|+... .+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 3455667899999999999998532 467999999887655 778999999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccc-----------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 545 MLIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
++|+|||..|+|.+||..... ..+|+..+.+.||.|||.||+||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999975321 234889999999999999999999887 999999999999999999
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHH
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~ 692 (792)
|||+||||++.....++........-+++|||||.+..++|+.++|||||||+|||+++ |+-||.....++
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------- 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------- 713 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--------
Confidence 99999999999887776665555566899999999999999999999999999999999 888876443321
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
+.+.+.....-+.|..++.+++.||..||+.+|++||+++||-..|+....
T Consensus 714 --------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 --------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred --------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 222222222356788889999999999999999999999999999976533
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=362.23 Aligned_cols=203 Identities=30% Similarity=0.534 Sum_probs=183.1
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..+|...++||.|+|++||+|+++. +..||||.+.+. ..+..+.+..|+.+|+.++|||||++++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678888999999999999999865 789999999776 5667788899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC------CCceEeeeccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND------MNPKISDFGMA 622 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DFgla 622 (792)
|||.+|+|.++++..+ .+++.....++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999997643 5899999999999999999999998 9999999999999865 45899999999
Q ss_pred cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
+.+.... .....+|++-|||||++..+.|+.|+|+||+|+||||+++|+.||+...+.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~ 220 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPK 220 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHH
Confidence 9987443 234589999999999999999999999999999999999999999855443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.30 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=214.2
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..|+..+.||+|||..||.++. ..|+.||+|++.+. .....+...+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999997 67999999999764 4455678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|+|++++|..++. +++.+++.++..++.||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999985 4567999999999999999999999998 999999999999999999999999999998755
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. +....+||+.|+|||++.....+..+||||+|||||-||.|++||+...-.+. ....+..+.
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket----------y~~Ik~~~Y---- 235 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET----------YNKIKLNEY---- 235 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH----------HHHHHhcCc----
Confidence 32 23458999999999999999999999999999999999999999985432211 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..|.....+..+||..+|+.+|.+|||+++|+..
T Consensus 236 ---~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 ---SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2344566778899999999999999999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=358.64 Aligned_cols=254 Identities=25% Similarity=0.377 Sum_probs=203.5
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch-------hHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-------GMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
..+.|.+.+.||+|+||.|-+|..+ +|+.||||++.+.... ......+|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3466888899999999999999764 5999999999765211 1223569999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeee
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDF 619 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DF 619 (792)
..|||||||++|.|.+.+..+ +.+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998654 45777777889999999999999998 9999999999999766 77999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCC---CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|+|+..+.. ......+||+.|.|||++.++. +..|+|+||+|||||-+++|.+||.....+.. +. +..
T Consensus 324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~----eQI 394 (475)
T KOG0615|consen 324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LK----EQI 394 (475)
T ss_pred chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HH----HHH
Confidence 999987632 2345689999999999997654 34588999999999999999999975443321 11 011
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..++.. .......+..++..+++.+||..||++|||+.|+++.
T Consensus 395 ~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 395 LKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred hcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 111110 0112233556788999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=340.77 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=211.2
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeee-eEEeCCc-ceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG-CCIQADE-SMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g-~~~~~~~-~~lV 547 (792)
.+|.+.++||+|.||.|||+.. .+|..+|.|.++.. +.+..+++..|+.+|++|+|||||++++ .+.+..+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4578889999999999999974 57999999999754 4566778999999999999999999999 5666666 8999
Q ss_pred EeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcC-CCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDS-RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||++..|+|...+.+- ..++.++++.+++++.|++.||..+|.+- +..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999753 34567999999999999999999999842 124999999999999999999999999999998
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... ......+|||.||+||.+.+..|+.|+||||+||++|||..-+.||... ++... .+.+
T Consensus 179 ~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L----------~~KI 240 (375)
T KOG0591|consen 179 SSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSL----------CKKI 240 (375)
T ss_pred cchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHH----------HHHH
Confidence 6543 3345689999999999999999999999999999999999999999754 22211 1111
Q ss_pred cccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 706 GDTLADSHP-PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 706 ~~~~~~~~~-~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
...-....| ...+..+..|+..|+..||+.||+...+++.+.
T Consensus 241 ~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 241 EQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred HcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 222222344 456778889999999999999999655555543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=379.01 Aligned_cols=259 Identities=27% Similarity=0.419 Sum_probs=222.9
Q ss_pred ccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
...+.+.||.|.||.|++|+++- ...||||.|+... ++...+|..|+.||.++.||||++|.|+.......+||.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34667899999999999999864 3469999998774 455678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|||+||+|+.||+.+ .+.+++.+...++.+||.||.||.+.+ +|||||..+||||+.+..+||+||||++.+..+
T Consensus 710 EyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence 999999999999764 356999999999999999999999988 999999999999999999999999999987554
Q ss_pred Ccc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 629 EIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 629 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... ..+....-+++|.|||.+...+++.++|||||||+|||.++ |.+||..... ..+...++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVIkaIe 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVIKAIE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHHHHHH
Confidence 311 11112233689999999999999999999999999999888 9999864432 23445566
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLP 753 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 753 (792)
...+-+.|++++..|.+||++|||+|-.+||.+.||+.+|++...-|
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 67777889999999999999999999999999999999998764443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=345.45 Aligned_cols=243 Identities=23% Similarity=0.352 Sum_probs=203.7
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|++++.||+|+||+||.++.++ ++.+|+|++++. .....+..++|..+|.+++||+||+++..|++.++.||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999998765 788999999875 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+.||.|..+|.++. .+++..+.-++..|+.||.|||+++ ||||||||+|||||++|+++|+||||++...
T Consensus 103 Vld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999996543 4888888899999999999999998 9999999999999999999999999999654
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... ..+...+||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.... .+.+.
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~----------------~~~I~ 238 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM----------------YDKIL 238 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH----------------HHHHh
Confidence 332 233448999999999999999999999999999999999999999975432211 11111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
.......+.....+..+++...++.+|++|-
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1111223333566788899999999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=386.55 Aligned_cols=257 Identities=31% Similarity=0.518 Sum_probs=219.6
Q ss_pred cccccccccCcCCcccEEeeeccC--Cc----EEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE--GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
++.+..+.||+|.||.||.|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667889999999999998654 33 4999999776 5567789999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc----cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 546 LIYEYMPNKSLDFFIFDQA----RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
|++|||++|+|..||.+.. ....|+..+.+.++.|||+|+.||++++ +|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999997652 2446899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
|+.+...++........-+..|||||.+..+.++.|+|||||||+||||+| |..||...+..+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--------------- 913 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--------------- 913 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH---------------
Confidence 997766665554444456789999999999999999999999999999999 8889875443211
Q ss_pred hhh-hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 701 AME-LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 701 ~~~-~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+. ++... +-..|..++..+++||..||+.+|++||++..|++.++.+
T Consensus 914 -~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 914 -LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred -HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 11122 4466778889999999999999999999999999988876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=331.25 Aligned_cols=264 Identities=20% Similarity=0.329 Sum_probs=206.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
+.|+.+.++|+|+||.|||.++++ |+.||||++.... +...+-.++|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999876 8999999986542 2334456899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|++..-|+++-... .-++.....+++.|+++|+.|+|+++ ++||||||+||||+.++.+||+|||+|+.+...
T Consensus 82 ~~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99997776665332 23788899999999999999999998 999999999999999999999999999998632
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHHhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILWKEKR 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~ 700 (792)
....+..+.|.+|+|||.+.+ ..|+..+||||+||++.||++|.+.|......+...++.. ....+....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 123345788999999999876 7899999999999999999999999876655443222221 111111111
Q ss_pred h-hhhcccccc-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 A-MELAGDTLA-----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ~-~~~~~~~~~-----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
. ..+.-+... ...-+....-+++++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111111111 1111233446789999999999999999999875
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=353.01 Aligned_cols=254 Identities=28% Similarity=0.468 Sum_probs=213.7
Q ss_pred ccccccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeee
Q 003832 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535 (792)
Q Consensus 456 ~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~ 535 (792)
...++|++.|++|... +-||.|+.|.||+|++ .++.||||+++.-. ..+|+-|++|+||||+.+.
T Consensus 114 qq~e~WeiPFe~IsEL-------eWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~Fk 178 (904)
T KOG4721|consen 114 QQEELWEIPFEEISEL-------EWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFK 178 (904)
T ss_pred hhhhhccCCHHHhhhh-------hhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEe
Confidence 4557899999887553 6899999999999999 57899999985322 3478899999999999999
Q ss_pred eeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCce
Q 003832 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (792)
Q Consensus 536 g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 615 (792)
|+|.....++||||||..|-|...|... ..+.......+..+||.||.|||.+. |||||||.-||||..+..+|
T Consensus 179 GVCtqsPcyCIiMEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 179 GVCTQSPCYCIIMEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred eeecCCceeEEeeeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEE
Confidence 9999999999999999999999999653 35788889999999999999999987 99999999999999999999
Q ss_pred EeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
|+|||-++..... ...-...||..|||||+++..+.++|+|||||||||||||||..||...+..-.
T Consensus 253 IsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---------- 319 (904)
T KOG4721|consen 253 ISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---------- 319 (904)
T ss_pred eccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----------
Confidence 9999999876433 122347899999999999999999999999999999999999999974332211
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+-.+-...+.-..|..++.-+.-|+++||+..|.+||++++|+.+|+=
T Consensus 320 -----IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 320 -----IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred -----EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 011112233345566777778889999999999999999999999953
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=356.62 Aligned_cols=260 Identities=28% Similarity=0.435 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC-
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD- 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~- 542 (792)
.++|++.++||+|+||.||+|.+ ..++.||||++.... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788889999999999999974 225679999997543 23456789999999999 8999999999987654
Q ss_pred cceEEEeecCCCChhHHHhhccc---------------------------------------------------------
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (792)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999865321
Q ss_pred --CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCc
Q 003832 566 --ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643 (792)
Q Consensus 566 --~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 643 (792)
...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999987 999999999999999999999999999875433222222334567899
Q ss_pred cccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHH
Q 003832 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCI 722 (792)
Q Consensus 644 ~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 722 (792)
+|||++.+..++.++|||||||+||||++ |+.||........ +. .....+ .....+......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~---------~~~~~~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDG---------TRMRAPENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcC---------CCCCCCCCCCHHHH
Confidence 99999999999999999999999999997 9999875332110 00 011111 01112333456788
Q ss_pred HHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 723 HVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 723 ~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+++.+||+.+|++||++.||+++|+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=348.67 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=209.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHH-HHHHHHHHHhcc-cccceeeeeeEEeCC-cceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQ-HRNLVKLLGCCIQAD-ESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~-~~~Ei~~l~~l~-H~niv~l~g~~~~~~-~~~l 546 (792)
..++|..+++||.|.||.||+|+.. .+..||||++++.-....+. =.+|+..|++|+ |||||+|.+++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3468899999999999999999864 48899999997654332222 257999999998 999999999999988 8999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|||||+. +|.+++.++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 9999965 888888665 678999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCccccccccccccCccccccc-cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHhh--
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWKE-- 698 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~-- 698 (792)
.... .+..+.|.+|+|||++ +.+.|+.+.|||++|||++||.+-++.|.+..+.++...+-... ..|.+
T Consensus 162 SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 SKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred cCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 5432 3457889999999987 67889999999999999999999999987655433211111000 00111
Q ss_pred --hhhhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 --KRAMELAGDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 --~~~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.+.-+.... ..-+....++++++.+|++.||++|||++|.+++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111111 1112256788999999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=352.41 Aligned_cols=266 Identities=28% Similarity=0.465 Sum_probs=210.6
Q ss_pred cccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeee
Q 003832 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 459 ~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
+.|++.++++ .....||+|.||+||+|++. ..||||++... ..+..+.|++|+..+++-+|.||+-+.|
T Consensus 385 ~~WeIp~~ev-------~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 385 EEWEIPPEEV-------LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred cccccCHHHh-------hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 4555655554 44579999999999999984 36999999765 4456789999999999999999999999
Q ss_pred eEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 537 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
+|..... .||..+|++.+|..+++... ..++..+.+.|+.||++||.|||.++ |||||||..||||.+++.|||
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEE
Confidence 9998887 99999999999999997654 45889999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
+||||+..-..-..........|...|||||+++. .+|+..+||||||+|+|||+||..||.....+.....++
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG--- 606 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG--- 606 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec---
Confidence 99999875432111112233567889999999963 579999999999999999999999998333322211111
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
+-.-..|.. ........++.+|+..||..++++||.+.+|+.+|+....
T Consensus 607 ------rG~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 607 ------RGYLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ------ccccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 110011111 1223455678888899999999999999999998877643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=351.03 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=213.8
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
..|....+||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||.+++.|...++.++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999964 458899999998776666778899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+.+.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 99999999843 35899999999999999999999998 99999999999999999999999999998865543
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....+||+.|||||+.....|++|+||||||++++||+-|++||-...+-....++. ......-
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa--------------~ng~P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------------TNGTPKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--------------hcCCCCc
Confidence 3445899999999999999999999999999999999999999997544322211110 1112222
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+......+.++..+||+.|+++||++.|++++
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 3455667788999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.81 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=206.5
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~e 549 (792)
.++...+.||+|.||.||++...+ |...|||.+........+.+.+|+.+|.+++|||||+.+|...... ..+++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456667899999999999998765 8899999987764444778999999999999999999999855554 5899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCC-
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG- 627 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~- 627 (792)
|+++|+|.+++...+. .+++..+...+.||++||+|||+++ |+||||||+||||+. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999976543 5999999999999999999999988 999999999999999 79999999999987653
Q ss_pred CCccccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
...........||+.|||||++..+. ...++|||||||++.||+||+.||... .+. ..+ ...+..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~----~~~---------~~~ig~ 237 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE----AEA---------LLLIGR 237 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch----HHH---------HHHHhc
Confidence 11122233578999999999998643 345999999999999999999998742 000 000 011111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.......|...+.+..+++..|++.+|++|||++++++.-
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1122355666777889999999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.15 Aligned_cols=266 Identities=23% Similarity=0.310 Sum_probs=203.4
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (792)
.+.|+.+++||+|.||.||+|+. .+|+.||+|+++.+. +....-..+||.+|++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45678889999999999999985 458999999998764 34445668999999999999999999999887 67899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+|||++ +|.-++.. ..-.++..++..++.||+.||+|+|..+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999988 55555533 2335889999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWKEKR 700 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~ 700 (792)
...... .+..+-|.+|+|||++.+ ..|+.++|+||.||||.||++|++.|....+.++...+-..- ..|...+
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 655443 334567999999999876 479999999999999999999999998765543321110000 0011111
Q ss_pred hhhhccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 AMELAGDTLADSHP-------PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ~~~~~~~~~~~~~~-------~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+...........+. .......++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11000000001111 122345778899999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=312.85 Aligned_cols=281 Identities=24% Similarity=0.362 Sum_probs=212.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|...++||+|.||.||+|+.. .|+.||||+++.... .......+|+..|+.++|+||+.++++|.+.+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46777889999999999999864 589999999976532 223467899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||+. +|+..+.+ +...++..++..++.++++|++|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 78888855 3457899999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH-----HHhhh-hhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-----LWKEK-RAM 702 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~-~~~ 702 (792)
..... .+-|.+|+|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+...-++...+-.+.. .|.+- ...
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 33322 367999999998865 5799999999999999999998877665433222111100000 00000 000
Q ss_pred hh-----ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCccc
Q 003832 703 EL-----AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFT 762 (792)
Q Consensus 703 ~~-----~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~~~ 762 (792)
++ .-.......-+....++++|+..++..||.+|++++|++++= --...|.|..|....
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~-yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP-YFKSLPLPTPPSKLP 297 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch-hhhcCCCCCChhhCc
Confidence 00 001111112334456678999999999999999999998762 223456666665553
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.93 Aligned_cols=260 Identities=30% Similarity=0.437 Sum_probs=210.9
Q ss_pred ccccccccCcCCcccEEeeeccCC----cE-EEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEG----QE-IAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~----~~-vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
+....++||+|+||.||+|++... .. ||||..+.. ......+|.+|+++|++++|||||+++|++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 334448999999999999987542 23 899998752 3566789999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||||+|.||+|+++|.+... .++..+++.++.+.|.||+|||+++ ++||||..+|+|++.++.+||+|||+++.-
T Consensus 238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999999966433 6899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
. ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||......+. ...+
T Consensus 313 ~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v---------------~~kI 375 (474)
T KOG0194|consen 313 S--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV---------------KAKI 375 (474)
T ss_pred c--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH---------------HHHH
Confidence 3 11111212346789999999999999999999999999999999 7888864432200 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEP 755 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p 755 (792)
+....+...+...+..+..++..|++.+|++||+|.+|.+.|+.......+
T Consensus 376 ~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 376 VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 122233344456667788888899999999999999999999877554443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=340.02 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=204.7
Q ss_pred cccccccccCcCCcccEEeeeccC-----------------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 534 (792)
++|...++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999997532 3369999987653 3345679999999999999999999
Q ss_pred eeeEEeCCcceEEEeecCCCChhHHHhhcc----------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEe
Q 003832 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQA----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598 (792)
Q Consensus 535 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 598 (792)
++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985432 1134788899999999999999999987 999
Q ss_pred cCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhC--CCC
Q 003832 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG--KKN 676 (792)
Q Consensus 599 ~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG--~~p 676 (792)
|||||+|||+++++.+||+|||+++.+.............++..|+|||++..+.++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876443322223334568899999999888999999999999999999874 456
Q ss_pred CCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 677 WRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 677 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
|...... ............. ........++..+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQ------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhc------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5432211 1111111111000 0011111233445678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.62 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=205.5
Q ss_pred cccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchh---HHHHHHHHHHHHhcccccceeee
Q 003832 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQHRNLVKLL 535 (792)
Q Consensus 459 ~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~ 535 (792)
.++.++.+++.. .....|++|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|.+++||||++++
T Consensus 11 ~~~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 344455555522 2225799999999999998 78999999997653322 57788999999999999999999
Q ss_pred eeEEe----CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecC
Q 003832 536 GCCIQ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 536 g~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~ 610 (792)
+++.+ ....++||||+++|+|.+++... ..+++...+.++.+++.||.|||+. + ++||||||+||++++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECC
Confidence 99977 34678999999999999999653 3588999999999999999999985 5 789999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l 688 (792)
++.+||+|||+++.+.... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+ +
T Consensus 159 ~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~ 230 (283)
T PHA02988 159 NYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---I 230 (283)
T ss_pred CCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---H
Confidence 9999999999998654321 12467899999999976 689999999999999999999999997432211 1
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. .+.........+...+..+.+++.+||+.+|++|||++||++.|+..
T Consensus 231 ~~------------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 231 YD------------LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred HH------------HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 00 01011111123334566788999999999999999999999999865
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=341.38 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=211.4
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
+...+|...+.||+|+|++|++|+..+ ++++|||++.+. .....+....|-.+|.+| .||.|++|+-.|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 345678888999999999999998654 889999999764 223345567899999999 799999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
|+|+||+++|+|.++|.+. +.+++.....++.+|+.||+|||+.+ ||||||||+|||||.++++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~---Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY---GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHh---CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999999654 45899999999999999999999998 99999999999999999999999999999
Q ss_pred cCCCCcc---------ccc--cccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 625 FGGDEIQ---------TNT--HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 625 ~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
+...... ... ...+||..|.+||++..+..+..+|+|+||||||+|+.|++||....+-..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-------- 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-------- 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH--------
Confidence 8643221 111 347999999999999999999999999999999999999999985433111
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+ .+++. +.-..++..++.+.+|+.+.|..||.+|++.+||.++
T Consensus 296 --F--qkI~~-----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 --F--QKIQA-----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --H--HHHHH-----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 0 11111 1123455556778899999999999999999999886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.87 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=208.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.+.|+..++||.|..++||+|+.. .++.||||++..+ .....+.+++|+..|..++||||++++..|..+...++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 467889999999999999999854 4799999999765 33446889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||.+|++.+++...-..+ +++..+..|.+++++||.|||+++ .||||||+.||||+++|.+||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999997654433 889999999999999999999998 9999999999999999999999999887654322
Q ss_pred -ccccc-cccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 630 -IQTNT-HKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 630 -~~~~~-~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..... +..+||+.|||||++.. ..|+.|+||||||+...||.+|+.||....+-.. +. ...++......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll-----~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LL-----LTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HH-----HHhcCCCCCcc
Confidence 22222 56789999999999644 4699999999999999999999999986554211 00 00011111000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
-..+..+........+.+++..||+.||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111122234467888999999999999999999863
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=349.54 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=204.7
Q ss_pred hcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 543 (792)
.++|+..++||+|+||.||+++. ..+..||||+++... ....+.+.+|+.++..+ +||||++++++|.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688889999999999999963 235689999996543 33456788999999999 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc----------------------------------------------------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (792)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864321
Q ss_pred --------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 566 --------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 566 --------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
...+++..++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999987 999999999999999999999999999876433222
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+. .... ....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~----~~~~---------~~~~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFY----KMIK---------EGYR 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHH----HHHH---------hCcc
Confidence 22222345678999999999999999999999999999998 888886432211 111 1111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+.++.+|+.+||+.+|++||++.||+++|++
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11122234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=349.55 Aligned_cols=260 Identities=28% Similarity=0.443 Sum_probs=205.5
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 543 (792)
.++|++.+.||+|+||.||+++.. ++..||+|+++... ....+.+.+|+++++++ +|+|||+++++|.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888899999999999998742 24579999997543 33456788999999999 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc----------------------------------------------------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (792)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864211
Q ss_pred ---------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 566 ---------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 566 ---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
...+++.++++++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+...........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788889999999999999999987 99999999999999999999999999986543322222222
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP 715 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (792)
..++..|+|||++....++.++|||||||++|||++ |+.||........ + ...+........+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~-------------~~~~~~~~~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F-------------YKMVKRGYQMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H-------------HHHHHcccCccCCC
Confidence 345678999999998999999999999999999997 9999865332211 0 00111111111122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 716 TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 716 ~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..+.++.+++.+||+.+|++||++.+|+++|++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=327.59 Aligned_cols=270 Identities=28% Similarity=0.416 Sum_probs=204.9
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHh--cccccceeeeeeEEeCC----cceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD----ESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~l 546 (792)
+.....+.||+|.||.||||++ +++.||||++.. +..+.|.+|-.+.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 4455567899999999999999 469999999964 455677777776665 58999999999987666 7899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc------CCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
|+||.++|+|.++|. ...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999994 44699999999999999999999975 46789999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCC-CC-----ccCcchhHHHHHHHHHhCCCCCCCCCCCCc---------
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-FS-----VKSDVFSFGVLVLEIVSGKKNWRFSHPDHD--------- 685 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-----~k~DVwS~Gvil~elltG~~p~~~~~~~~~--------- 685 (792)
||..+............+||.+|||||++.+.. +. .+.||||+|.|||||++...-+......+.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999987665555555689999999999996643 22 368999999999999996654432111110
Q ss_pred -cchhHHHHHH-HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003832 686 -HNLLGHAWIL-WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPE 754 (792)
Q Consensus 686 -~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 754 (792)
..-++.-+.. +.++....+.+ ..... ..+..+.+.+..||..||+-|-|+.=|.+++.+...+..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~-~W~~h---~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPD-AWRKH---AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChh-hhhcC---ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0011111111 11111111111 11111 335568899999999999999999999999877655443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=337.19 Aligned_cols=262 Identities=30% Similarity=0.469 Sum_probs=219.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchh-HHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.+...+.++||+|.||.|.......+..||||+++...... ..+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567788999999999999998778999999998875544 48999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|++|+|..++....... +.-...++|+.||+.||+||.+.+ +|||||.++|+|+|.++++||+|||+++-+...++
T Consensus 617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999997653222 566777889999999999999987 99999999999999999999999999998877776
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh--CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc-
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD- 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~- 707 (792)
.....+.+-+++|||||.+.-++++.++|||+||+.|||+++ ...||...+.+. .++ ...++.+.
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vve---------n~~~~~~~~ 760 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVE---------NAGEFFRDQ 760 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHH---------hhhhhcCCC
Confidence 666666778899999999999999999999999999999865 667775333221 111 11222222
Q ss_pred --cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 --TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 --~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......|..++..++++++.||..+-++||+++++...|.+.
T Consensus 761 ~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 223345667788899999999999999999999999998764
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.85 Aligned_cols=257 Identities=31% Similarity=0.507 Sum_probs=209.0
Q ss_pred cccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
++|+..+.||+|+||.||+|.... .+.||+|.+.... ....+.|.+|+..+.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999997643 2579999987543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 546 LIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999965322 145888999999999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ +
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~--- 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V--- 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---
Confidence 999999999987644332222334466889999999988899999999999999999998 999986433211 1
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+........+...+.++.+|+.+||+.+|++||++.||+++|++
T Consensus 236 ----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111222344556788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=339.61 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=205.8
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC----Cc-hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCC
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG----SG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD 542 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~ 542 (792)
...++|...+.||+|.||+|+.|.+. .+..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999765 4799999987653 12 23456778999999999 999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGM 621 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgl 621 (792)
+.++||||+.+|.|.+++.+ .+.+.+.+..+++.|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999966 345788999999999999999999998 9999999999999999 9999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCC-CC-ccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-FS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
+...... .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..... .+. ..
T Consensus 168 s~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~---~l~-------~k- 234 (370)
T KOG0583|consen 168 SAISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP---NLY-------RK- 234 (370)
T ss_pred ccccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH---HHH-------HH-
Confidence 9987311 12334579999999999999877 85 7899999999999999999999852211 110 00
Q ss_pred hhhhhccccccCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 700 RAMELAGDTLADSHPPTE-VLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+.... -.+|... ..++..|+.+|++.+|.+|+++.||++
T Consensus 235 ----i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ----IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ----HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 01111 1223333 677889999999999999999999993
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.83 Aligned_cols=252 Identities=28% Similarity=0.445 Sum_probs=217.8
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
+....++||.|.||.||.|.++. .-.||||.++. +....++|..|+.+|+.++|||+|+|+|+|..+...|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 34667899999999999999876 66899999965 44668899999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|+|.+||.+..+ ..++....+.++.||+.||+||..++ +|||||..+|+||.++..+||+||||++++..+.+..
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999987643 45777788999999999999999988 9999999999999999999999999999987665433
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
. ....-++.|.|||-+....++.|+|||+|||+||||.| |-.||...+. ..+.++++...+-
T Consensus 423 H-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----------------SqVY~LLEkgyRM 485 (1157)
T KOG4278|consen 423 H-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYGLLEKGYRM 485 (1157)
T ss_pred c-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----------------HHHHHHHhccccc
Confidence 2 22345789999999999999999999999999999999 7677754321 2234556666666
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..|..+++.+++||+.||+.+|.+||++.||-+.+|
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 778888899999999999999999999999998876
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.47 Aligned_cols=250 Identities=34% Similarity=0.549 Sum_probs=196.6
Q ss_pred cccccCcCCcccEEeeecc-----CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 477 SYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+.||.|.||.||+|.+. .+..|+||.+.... ....++|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999876 25689999996543 34478999999999999999999999999988889999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++... ....+++..+..|+.||++||.|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999765 2346899999999999999999999987 99999999999999999999999999988743332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
............|+|||.+....++.++||||||+++|||++ |+.||...... .+. ..+ ....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~------------~~~-~~~~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EII------------EKL-KQGQ 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHH------------HHH-HTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccc------------ccc-cccc
Confidence 233334567789999999999899999999999999999999 67887533111 110 111 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
....+...+..+.+++..||+.+|++||+|.+|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1223334566788999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=326.72 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=204.7
Q ss_pred cccccccccCcCCcccEEeeecc----CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.+.+|+..+.+++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999753 35689999997653 23446789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 246889999999999999999999987 99999999999999999999999998765432
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||....... +. ... .
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~---------~ 222 (266)
T cd05064 160 EAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VI----KAV---------E 222 (266)
T ss_pred cchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHH---------H
Confidence 2111 1112345678999999999999999999999999999875 999986432211 10 000 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.......+...+..+.+++..||+.+|++||+++||.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 223 DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111112344456678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=378.61 Aligned_cols=262 Identities=23% Similarity=0.419 Sum_probs=210.7
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
...+...+.||+|+||.||+|+. .+++.||||++...... ...|++.+++++|||||+++++|.+.+..++||||
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 35577778999999999999987 46889999998654322 23468899999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++. .++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++..++. |+.......
T Consensus 765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999984 27899999999999999999997766679999999999999999988876 665543321
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....++..|+|||++.+..++.|+|||||||++|||+||+.||..... ....+..|.............+++.+.
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 1123678999999999999999999999999999999999999854322 223344444443333344445555543
Q ss_pred C--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 711 D--SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 711 ~--~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
. ..+.++..++.+++.+||+.+|++||+|+||+++|++...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 3 3455677789999999999999999999999999987543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.54 Aligned_cols=247 Identities=25% Similarity=0.401 Sum_probs=208.6
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|.+.+.||+|.||.||||+-+. .+.||+|.+.+. ..+..+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888899999999999998764 788999999765 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+.+ +|..+|... +.+++..+..|+.+++.||.|||+.. |+|||+||+|||++..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 999999654 35889999999999999999999987 9999999999999999999999999999876433
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.....+.||+.|||||+..+.+|+..+|+||+|||+||+.+|++||-... +...... -+-|+.
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~--------I~~d~v- 217 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKS--------ILKDPV- 217 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHH--------HhcCCC-
Confidence 23445889999999999999999999999999999999999999985211 1111000 011111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..|......+..++...+++||..|.+..+++.+
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2344667788899999999999999999998874
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=330.10 Aligned_cols=249 Identities=23% Similarity=0.385 Sum_probs=210.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..|...+.||+|.||.||+|.... ++.||+|++..+ .....++..+|+.+|.+++|+||.++++.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346666899999999999998654 788999999766 445578899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|.+|++.+.+.. ...+.+....-|+.++..||.|||.++ .+|||||+.||||..+|.+|++|||++..+.....
T Consensus 93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 999999999843 334578888889999999999999998 99999999999999999999999999998865543
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.. ...+||+.|||||++....|+.|+||||||+..+||.+|.+|+...+|.....++ -+...
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI----------------pk~~P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI----------------PKSAP 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------cCCCC
Confidence 33 5689999999999999889999999999999999999999999877764332222 11111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..........+.+++..||+.+|++||++.++++.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 12222455568899999999999999999999874
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=325.09 Aligned_cols=266 Identities=24% Similarity=0.355 Sum_probs=211.7
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--------------chhHHHHHHHHHHHHhcccccce
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--------------GQGMEEFKNEVTLIARLQHRNLV 532 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------------~~~~~~~~~Ei~~l~~l~H~niv 532 (792)
-.+..++|++.+.||+|.||.|-+|+.. +++.||||++.+.. ....+..++||.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 3455688999999999999999999864 58899999997531 11246789999999999999999
Q ss_pred eeeeeEEeC--CcceEEEeecCCCChhHHHhhcccCcc-CChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 533 KLLGCCIQA--DESMLIYEYMPNKSLDFFIFDQARATF-LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 533 ~l~g~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
+|+.+..+. +..|||+|||..|.+... ...++ ++..++++++.+++.||+|||.++ |+||||||+|+||+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 999998764 578999999999987433 23344 899999999999999999999998 99999999999999
Q ss_pred CCCCceEeeeccccccCCC---CccccccccccccCccccccccCCC----CCccCcchhHHHHHHHHHhCCCCCCCCCC
Q 003832 610 NDMNPKISDFGMARIFGGD---EIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gvil~elltG~~p~~~~~~ 682 (792)
++|++||+|||.+..+... .........+||+.|+|||...++. .+.+.||||+||.||.|+.|+.||-....
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999999876321 1111223478999999999987632 36789999999999999999999963221
Q ss_pred CCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 003832 683 DHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEP 755 (792)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p 755 (792)
+ ....+++...+..+..+++.+++.+|++++|++||+.|-+..+|..+.--....+.|
T Consensus 325 ------~---------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 325 ------L---------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred ------H---------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 1 112234445554444556778899999999999999999999999887555544444
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=308.71 Aligned_cols=237 Identities=26% Similarity=0.358 Sum_probs=202.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..+.||.|+||.|.+++.+. |..+|+|++.+..- +..+...+|..+|+.+.||+++++++.|.+.+..+||
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 3678888999999999999999765 77899999987632 3456778999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|.|..++++.+ .++.+.+..+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+....
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999996543 4889999999999999999999998 99999999999999999999999999997643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
++...+||+.|+|||++....|...+|.|+|||++|||+.|.+||-...+... . ..++..
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i-----Y----------~KI~~~ 256 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI-----Y----------EKILEG 256 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH-----H----------HHHHhC
Confidence 24458999999999999999999999999999999999999999976554211 1 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDR 736 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~R 736 (792)
.+ ..|.....++.+|+...++.|-.+|
T Consensus 257 ~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 KV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 11 3455666778889999999999998
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=342.54 Aligned_cols=260 Identities=27% Similarity=0.390 Sum_probs=206.9
Q ss_pred hcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 543 (792)
.++|.+.++||+|+||.||+|+... +..||||+++.... ...+.+.+|+++++++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999997532 34799999975433 34567899999999996 9999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc----------------------------------------------------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (792)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998865311
Q ss_pred -----------------------------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC
Q 003832 566 -----------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 566 -----------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 610 (792)
...+++.+++.++.|+++||.|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788888999999999999999987 999999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchh
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~ 689 (792)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |+.||........ +.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence 99999999999987643332222233456788999999998999999999999999999997 8899864322111 00
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.... .......+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 351 ----~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 ----NKIK---------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ----HHHh---------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0000 1111122334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.91 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=205.6
Q ss_pred hhcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
.+++|+..++||+|+||.||+|... .+..||+|++.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998753 24679999986543 2345678899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc-------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 234678889999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||....... .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~----~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL----RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HH
Confidence 99999886543332222222355788999999998899999999999999999999 688886432211 10 00
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+.. ....+...+..+.+++.+|++.+|++||++.|++++|++
T Consensus 234 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00110 111223345578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=322.36 Aligned_cols=255 Identities=29% Similarity=0.457 Sum_probs=207.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888899999986533 34578999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998654 2345888999999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||.+....++.++||||||+++|||++ |+.||....... .. ...... ..
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~---------~~ 222 (261)
T cd05072 160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRG---------YR 222 (261)
T ss_pred -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcC---------CC
Confidence 1222346778999999988889999999999999999998 999986432210 11 001100 11
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+.....+..+.+++.+|++.+|++||++++++++|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122344568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.29 Aligned_cols=258 Identities=29% Similarity=0.480 Sum_probs=208.4
Q ss_pred hcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|.+.+.||+|+||.||+|+..+ ++.||+|.+...... ..+.+.+|++++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3567888999999999999998643 478999999765444 567899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc-----------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 545 MLIYEYMPNKSLDFFIFDQA-----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999996532 2345788999999999999999999987 999999999999999999
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHH
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~ 692 (792)
+||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~-- 235 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIE-- 235 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--
Confidence 99999999986543322222233456789999999999999999999999999999998 999986432211 110
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
... .......+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 236 --~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 --CIT---------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred --HHH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000 111112223345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.65 Aligned_cols=252 Identities=27% Similarity=0.447 Sum_probs=203.8
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|+..+.||+|+||.||+++++++..+|+|.+.... ...+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4577888999999999999999888899999986432 335678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886432 35889999999999999999999987 999999999999999999999999998865432221
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+....++.++||||||+++|||++ |+.||...... .... ...+.. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~----~i~~~~---------~~ 220 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVE----MISRGF---------RL 220 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCC---------CC
Confidence 1122345678999999988889999999999999999999 89898643221 1110 011100 01
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+......+.+++.+||+.+|++||+++|++++|+
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 112223456889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=321.98 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=207.9
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778899999986543 34577899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 345899999999999999999999987 999999999999999999999999999876532211
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......+..|+|||++.+..++.++||||||++++||++ |+.||....... +. .. +.....
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~---------~~~~~~ 222 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VL----QQ---------VDQGYR 222 (261)
T ss_pred -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH----HH---------HHcCCC
Confidence 1111233468999999998899999999999999999999 998886432110 00 00 011111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+..+.+++.+|++.+|++||++.++++.|++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 12233445678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=323.98 Aligned_cols=256 Identities=29% Similarity=0.480 Sum_probs=213.3
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
...+|+..++||.|+||.||+|...+++.+++|.+........+++..|+.+++.++||||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45678889999999999999999888999999999877665677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999996543 346899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. .....++..|+|||.+....++.++||||||++++||++ |+.||...... .... .+....
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~-------------~~~~~~ 221 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYD-------------QITAGY 221 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH-------------HHHhCC
Confidence 1 113446778999999988899999999999999999998 89998643311 0110 011111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
....+...+..+.+++.+|++.+|++|||++++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 222334555678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.20 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=213.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+-|+..+.||.|+-|.|-.|++.. |+.+|||++.+.. ......+.+|+.+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 456777899999999999999864 9999999997652 223446788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|-|.+++..+ +.+.+.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|.+-.++
T Consensus 92 Eyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999999654 45889999999999999999999988 999999999999999999999999999874333
Q ss_pred CccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. .....+|.+.|.|||++.+.+| +.++||||.|||||.||||+.||+... ...++ .++.++
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN---ir~LL----lKV~~G-------- 227 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN---IRVLL----LKVQRG-------- 227 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc---HHHHH----HHHHcC--------
Confidence 2 2334689999999999999988 578999999999999999999997221 11221 112222
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCCCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSLLPEP 755 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~~~~p 755 (792)
.-+.|...+.++.+|+.+|+..||++|.|++||+++ |.+-..++.+
T Consensus 228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 124566677788999999999999999999999996 5555444443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=328.05 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=201.9
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
|+..+.||+|+||.||++... +++.||+|.+.+.. ......+.+|+.++.+++|+||+++++++.+.+..++|+||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 58899999986542 22344678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 99999988876432 335889999999999999999999987 99999999999999999999999999987543221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............ . ..... ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------~----~~~~~--~~ 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV-------D----RRVKE--DQ 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH-------H----HHhhc--cc
Confidence 22357899999999999999999999999999999999999999754332110000 0 00001 11
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
...+......+.+|+.+||+.+|++||+ ++++++.
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1233344567889999999999999997 7888774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=321.98 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=206.7
Q ss_pred cccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|+..+.||+|+||.||+|++.. ...||||.++... .....+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998743 3579999987553 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986532 36889999999999999999999987 99999999999999999999999999998752
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+. ..+.
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~-------------~~~~ 222 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVI-------------KAVE 222 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHH-------------HHHH
Confidence 222222222345678999999998999999999999999999998 99998532211 010 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.....+.+...+..+.+++.+|++.+|++||+++||+++|++.
T Consensus 223 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=324.74 Aligned_cols=257 Identities=30% Similarity=0.451 Sum_probs=205.6
Q ss_pred cccccccccCcCCcccEEeeec-----cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|+..++||+|+||.||+|.. ..++.+++|.+.... .+....+.+|+.++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999974 246789999997543 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccc--------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 547 IYEYMPNKSLDFFIFDQAR--------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
||||+++++|.+++..... ...+++.+.+.++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 235788899999999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+. .+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~--- 235 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EV--- 235 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 999999999987644332222333456778999999988889999999999999999998 88888532211 00
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+.+........+......+.+++.+|++.+|++||++.+|.++|..
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 ----------IEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11111111112233345678889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.74 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=207.0
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|+.+..||+|+||.||+++.++ |..+|+|++++. .....+..+.|-.+|....+|.||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 46789999999999999999998765 889999999875 34556778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||++||++..+|.. ...|+...+...+.+++.|+..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~---~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR---KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHh---cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999954 446889999999999999999999998 9999999999999999999999999986432
Q ss_pred C----------------------CCccc-----------------------cccccccccCccccccccCCCCCccCcch
Q 003832 627 G----------------------DEIQT-----------------------NTHKVVGTYGYMSPEYAAEGLFSVKSDVF 661 (792)
Q Consensus 627 ~----------------------~~~~~-----------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVw 661 (792)
. .+... .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00000 00125799999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCCCCcc-chhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC--
Q 003832 662 SFGVLVLEIVSGKKNWRFSHPDHDH-NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-- 738 (792)
Q Consensus 662 S~Gvil~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-- 738 (792)
|+|||+||||.|-+||....+.+.- .++.|. ..+..+.......+..+||.+|+. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr--------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWR--------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh--------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 9999999999999999877665431 222221 011112222333678899999998 9999965
Q ss_pred -HHHHHHH
Q 003832 739 -MSSVVLM 745 (792)
Q Consensus 739 -~~evl~~ 745 (792)
++||-++
T Consensus 438 G~~EIK~H 445 (550)
T KOG0605|consen 438 GAEEIKKH 445 (550)
T ss_pred cHHHHhcC
Confidence 6666654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.61 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=204.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..++||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467899999999999999999876 47789999987653 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 99999999998543 35789999999999999999999853 39999999999999999999999999987653321
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH----------------
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW---------------- 693 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~---------------- 693 (792)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||......+.........
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 233578999999999999999999999999999999999999996432211000000000
Q ss_pred -----------HH---Hhhhhhhh-hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 694 -----------IL---WKEKRAME-LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 694 -----------~~---~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.. ........ +...............++.+++.+||+.+|++||+++||++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 00 00000000 0000000001112445788999999999999999999998763
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=333.35 Aligned_cols=259 Identities=29% Similarity=0.434 Sum_probs=205.0
Q ss_pred cccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccceeeeeeEEeC-Cc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-DE 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~~ 543 (792)
++|++.+.||+|+||.||+|+..+ ++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 578888999999999999996432 46899999875432 3346788899999999 899999999988754 56
Q ss_pred ceEEEeecCCCChhHHHhhccc----------------------------------------------------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (792)
.++++||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999864321
Q ss_pred CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccc
Q 003832 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645 (792)
Q Consensus 566 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 645 (792)
...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136889999999999999999999987 99999999999999999999999999987644332233334566788999
Q ss_pred cccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHH
Q 003832 646 PEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHV 724 (792)
Q Consensus 646 PE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 724 (792)
||++.+..++.++|||||||+|+||++ |+.||......+. +. ... ........+.....++.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~---------~~~~~~~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRL---------KEGTRMRAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHH---------hccCCCCCCccCCHHHHHH
Confidence 999999999999999999999999998 9999865332211 00 000 1111111223345678899
Q ss_pred HHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 725 GLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 725 i~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+.+||+.+|++||++.||+++|+..
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.42 Aligned_cols=246 Identities=22% Similarity=0.386 Sum_probs=208.1
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
-+|++.+.||+|.||+|-+|.. ..|+.||||.++++.. +..-.+++|+++|..|+||||+.++.+|+..+..+|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788999999999999975 5699999999988744 44456789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||..+|.|.+|+.+. ..|++.+...++.||..|+.|+|.+. ++|||||.+|||||.++++||+||||+.++..+
T Consensus 133 EYaS~GeLYDYiSer---~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYISER---GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHHHh---ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999999664 35899999999999999999999987 999999999999999999999999999887654
Q ss_pred CccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .+..+|++.|.+||++.+.+| .+.+|-|||||+||-|+.|..||+..+.. .++.+.....+.++
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------~lvrQIs~GaYrEP 273 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------RLVRQISRGAYREP 273 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------HHHHHhhcccccCC
Confidence 32 345799999999999999888 68899999999999999999999754321 12222222222222
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+....-||+|||-.||++|.|+.||...
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 233456678999999999999999999876
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=326.60 Aligned_cols=258 Identities=28% Similarity=0.462 Sum_probs=209.5
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.+|...+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777889999999999999742 355689999877666666789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 547 IYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999996532 1235889999999999999999999988 999999999999999999
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHH
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~ 692 (792)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~--- 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI--- 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence 99999999986543332222333556789999999999999999999999999999999 999986433211 10
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...... .....+...+..+.+++.+||+.+|++||++++|+++|+.+
T Consensus 236 -~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 236 -ECITQG---------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred -HHHhCC---------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111111 11112223455788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=331.48 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=203.2
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.+|+..+.||+|+||.||+|++.. ++ .||+|+++... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 468888999999999999998643 33 48999987543 34567899999999999999999999999764 5789
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999998653 235788999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... + ....
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~-------------~~~~ 224 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSIL 224 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H-------------HHHH
Confidence 4332222222345678999999999999999999999999999998 999986432110 0 0011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+......+.+++.+||+.+|++||++.+|+..|...
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 225 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111122233445688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=333.94 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=200.9
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 57888999999999999999876 4789999998653 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998653 35788888999999999999999988 999999999999999999999999999866432
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. ....|++.|+|||.+.+..++.++|||||||++|||++|+.||....+. .. .... ....
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~----~~~i--------~~~~ 231 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RI----YEKI--------LAGR 231 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HH----HHHH--------hcCC
Confidence 2 2357899999999999999999999999999999999999998643211 00 0011 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
...+.....++.+++..||+.||++||+ ++|++.+
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122223456789999999999999997 6887754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.48 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=208.4
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888899999999999999742 245689999977666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc----------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
|+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 2235899999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....... .. ..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~----~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VI----EC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HH
Confidence 99999986643332222233456788999999998899999999999999999998 888885433211 10 11
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
...+.. ...+...+..+.+++.+|++.+|.+||++.||++.|+...
T Consensus 235 i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111110 0112223456889999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=330.08 Aligned_cols=245 Identities=20% Similarity=0.273 Sum_probs=201.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998643 35888999999999999999999988 999999999999999999999999999865432
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... +. .. +....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~----~~--------i~~~~ 214 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IY----EK--------ILAGK 214 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HH--------HHhCC
Confidence 123568999999999999899999999999999999999999986432211 00 00 00001
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
...+......+.+++.+||+.||++||+ ++|++++
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122333456789999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=335.78 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=204.0
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||.||+|+..+ ++.||+|++.+.. ....+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999998764 7899999987542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999998543 35889999999999999999999988 99999999999999999999999999986533
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . ...... .......
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~----~~i~~~--~~~~~~~ 220 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---W----ENLKYW--KETLQRP 220 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---H----HHHHhc--cccccCC
Confidence 22346789999999999999999999999999999999999999975433211 0 000000 0001111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...........++.+++.+||+.+|++||+++|++++
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000011335667889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.73 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=206.5
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.+|...++||+|+||.||+|...+ ++.||+|++... ....+++.+|++++++++||||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357778899999999999998754 788999998654 334578899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986532 345889999999999999999999987 999999999999999999999999999876543221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .... +.....
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~---------~~~~~~ 223 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYEL---------LEKGYR 223 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH---------HHCCCC
Confidence 1122334678999999998999999999999999999998 888886432210 0011 111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+...+..+.+++.+|++.+|++||++.|++++|+..
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 222334456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=347.10 Aligned_cols=252 Identities=18% Similarity=0.224 Sum_probs=204.9
Q ss_pred ccccccccCcCCcccEEeeeccC--CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.|...+.||+|+||.||+|.... ++.||+|.+..........+..|+.+++.++|||||++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 48888999999999999997543 5778999876665555667889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 552 PNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 552 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
++|+|.+++... ....++++.++..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653 23456889999999999999999999987 99999999999999999999999999987654322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~------------~~~~~~~-~ 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIM------------QQVLYGK-Y 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH------------HHHHhCC-C
Confidence 22233467999999999999999999999999999999999999998643211 000 0000000 1
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...+......+.+++..||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1122334457889999999999999999999875
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.36 Aligned_cols=258 Identities=29% Similarity=0.465 Sum_probs=205.9
Q ss_pred hhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
..++|.+.+.||+|++|.||+|.+.+ +..|++|.+.... ......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678899999999999999998754 5678999886543 3345678999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc----CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC---CceE
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKI 616 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl 616 (792)
.++||||+++++|.+++..... ...+++..+++++.||+.||.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999865431 235899999999999999999999987 99999999999998765 5899
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |+.||....... +.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~------ 231 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM------ 231 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH------
Confidence 99999987643322222222334568999999998999999999999999999997 999986433211 10
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+........+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111112233444567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.32 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=203.7
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|+..+.||+|+||.||+|+..++..+|+|.+.... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577888999999999999988777789999987543 335679999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 999999986532 25899999999999999999999987 999999999999999999999999998865433211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ...... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~----~~~~~~---------~~~ 220 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TV----EKVSQG---------LRL 220 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHhcC---------CCC
Confidence 1112345678999999988889999999999999999999 999986432210 00 000000 111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 112223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.26 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=198.7
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
++||+|+||.||+|+.. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++|+||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 58899999886543 34456799999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998543 345889999999999999999999987 99999999999999999999999999876543211111111
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP 715 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (792)
...+..|+|||.+.++.++.++||||||+++|||++ |..||....... ....+........+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----------------HHHHHHcCCCCCCcc
Confidence 233567999999999999999999999999999998 888875332210 001111111122333
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 716 TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 716 ~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+..+.+++.+|++.+|++||++.||+++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=335.28 Aligned_cols=244 Identities=25% Similarity=0.392 Sum_probs=206.8
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 544 (792)
...++|...++||+|.||+|+++..+. ++.+|||+++++ .....+..+.|.+++.... ||.|+.++.+|...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 445789999999999999999998865 778999999987 3456788899999998885 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+.||||+.||++..+ .+...+++..+..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999994332 23456899999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
-..... .+...+||+.|||||++.+..|+..+|.|||||+|||||.|+.||...++++... .+
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---------------sI 580 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---------------SI 580 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------HH
Confidence 543222 3456899999999999999999999999999999999999999998765542211 11
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM 739 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~ 739 (792)
+.. ...+|...+.+.+.++.+++..+|++|--+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 123566677788999999999999999876
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.33 Aligned_cols=257 Identities=30% Similarity=0.449 Sum_probs=204.8
Q ss_pred cccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.+|...++||+|+||.||+|...+ ++.||+|+++..... ..+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346677899999999999997633 478999999765433 3467889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 546 LIYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
+++||+.+++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1235788899999999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
.+||+|||+++...............+++.|+|||.+..+.++.++||||||+++|||++ |..||...... ..
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~--- 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DV--- 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HH---
Confidence 999999999887643332222233456789999999988889999999999999999998 77787542211 00
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+.+........+...+..+.+++..|++.+|++||++.+|++.|+.
T Consensus 236 ----------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ----------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111111122334456678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=307.04 Aligned_cols=267 Identities=21% Similarity=0.271 Sum_probs=201.6
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCch-h-HHHHHHHHHHHHhcccccceeeeeeEEeC--Ccce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-G-MEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 545 (792)
..+.|+.++.|++|.||.||+|+.+. ++.||+|+++..... + --.-.+||.+|.+.+|||||.+..+.... +..|
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34678889999999999999998754 788999999765321 1 12357899999999999999999987654 5689
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||||||+. +|..++.... .++...+...+..|+++|++|||... |+|||||++|+|+.+.|.+||+|||+|+.+
T Consensus 154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence 99999987 7878775543 46888999999999999999999987 999999999999999999999999999988
Q ss_pred CCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
+... ...+..+-|.+|+|||++.+. .|+..+||||+|||+.||+++++.|.....-++.+.+-.....-.+.....+
T Consensus 228 gsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 6542 223456789999999998764 6999999999999999999999998765543332111100000000000000
Q ss_pred --------------ccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 --------------AGDTLADSHPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 --------------~~~~~~~~~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....++..++.. ..+.-.+|+...+..||++|.|++|.++.
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 000111111111 33566788889999999999999998764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.48 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=201.6
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|+..+.||+|+||.||+|+... ++ .+++|.+..... ....++..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467778899999999999998643 43 478888764432 34467888999999999999999999875 455789
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
++||+++|+|.+++... ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999653 345899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
............++..|+|||.+.++.++.++||||||+++|||++ |+.||....+... .+++
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~ 224 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----------------PDLL 224 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHH
Confidence 3332222334567789999999998999999999999999999998 9999864332110 0111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
........+......+.+++.+|++.+|++||++.|+++.|....
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 111111112223456778999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.30 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=208.8
Q ss_pred hhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 542 (792)
..++|+..+.||+|+||.||++.... ...+|+|.+.... .+...++.+|+.++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34678888999999999999998643 3679999987643 34456788999999999 7999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhc-------------ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
..+++|||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998643 22356889999999999999999999987 99999999999999
Q ss_pred CCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccch
Q 003832 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNL 688 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l 688 (792)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL--- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence 999999999999987654332222223345678999999988999999999999999999998 8888753322110
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ..+........+......+.+++.+|++.+|++|||+.||++.|+..
T Consensus 244 ----~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ----F---------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----H---------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 0 11111111223334456788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=326.21 Aligned_cols=265 Identities=20% Similarity=0.269 Sum_probs=201.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|++.+.||+|+||.||+++.+. ++.+|+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 368889999999999999999864 7889999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 9999877655422 245889999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHHhhh-h
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILWKEK-R 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~-~ 700 (792)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ........ .
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 122235689999999999988999999999999999999999999975432111000000 00000000 0
Q ss_pred hhhhccccccC------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 AMELAGDTLAD------SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ~~~~~~~~~~~------~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
......+.... .........+.+++.+||+.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 011123456889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=298.21 Aligned_cols=265 Identities=21% Similarity=0.266 Sum_probs=212.7
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----c
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-----S 544 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~ 544 (792)
..++|.+.++||+|||.-||.++. .++..+|+|++.....+..+..++|++.-++++|||+++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 346899999999999999999984 4588899999988877888999999999999999999999999865543 8
Q ss_pred eEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
||+++|...|+|.+.+.... ++..+++.+.+.|+.+|.+||++||+.. ++++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999987654 3448999999999999999999999986 579999999999999999999999999987
Q ss_pred ccCCCCc----cc---cccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 624 IFGGDEI----QT---NTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 624 ~~~~~~~----~~---~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
...-.-. .. .-....-|..|+|||.+. +...++++|||||||+||+|+.|..||+......+ .+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl----- 251 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL----- 251 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE-----
Confidence 6531100 00 011234688999999884 55689999999999999999999999975433211 11
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+.......+.....++.+.+++.+|++.||.+||++.+++..++..
T Consensus 252 -------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0111122222222223677899999999999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.16 Aligned_cols=242 Identities=22% Similarity=0.307 Sum_probs=196.7
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.||+|+||.||+++.. +++.||+|++++. .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 5889999998753 2234456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (792)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 999888543 45889999999999999999999988 9999999999999999999999999987532211 112
Q ss_pred cccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCC
Q 003832 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP 714 (792)
Q Consensus 635 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (792)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. .. ..... ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~--------~~~~~--~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLF----EL--------ILMEE--IRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHH----HH--------HHcCC--CCCC
Confidence 3357999999999999999999999999999999999999998643211 000 00 00000 1223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 715 PTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 715 ~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
......+.+++.+||+.+|++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 34456788999999999999999 79998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.22 Aligned_cols=257 Identities=30% Similarity=0.454 Sum_probs=205.1
Q ss_pred ccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+|.+.+.||+|+||.||+|+... ...+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46677899999999999997532 35789998876533 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc---------------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003832 547 IYEYMPNKSLDFFIFDQA---------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 605 (792)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1235789999999999999999999987 9999999999
Q ss_pred EEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003832 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDH 684 (792)
Q Consensus 606 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~ 684 (792)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222233456778999999988889999999999999999999 999986432211
Q ss_pred ccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 685 DHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 685 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+ + +..........+.....++.+++.+|++.+|++||++.||++.|++.
T Consensus 238 ---~----~---------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 ---L----F---------NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ---H----H---------HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 1 11111111222333456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=347.20 Aligned_cols=262 Identities=22% Similarity=0.297 Sum_probs=209.5
Q ss_pred HHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC
Q 003832 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 465 ~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
.+++....++|.+.++||+|+||+||+++.. +++.||||++... .......+.+|+..+..++|+|++++...+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 3445556789999999999999999999754 5899999998654 334456788999999999999999998877543
Q ss_pred C--------cceEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 542 D--------ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 542 ~--------~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
. ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence 3 2579999999999999986532 3456889999999999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~ 692 (792)
.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.
T Consensus 181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~--- 254 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVM--- 254 (496)
T ss_pred CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH---
Confidence 99999999998765432222334467999999999999999999999999999999999999999643211 000
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .... ......+......+.+++..||+.+|++||++.+++++
T Consensus 255 -~--------~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 -H--------KTLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred -H--------HHhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0000 11112334455678899999999999999999999864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=319.63 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=208.0
Q ss_pred hcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999997643 3689999987553 24456788999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccc-------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 545 MLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999865322 234788999999999999999999987 9999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... +. ...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL----KFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH----HHH
Confidence 9999987654332222233456789999999988899999999999999999998 888886433211 10 000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
........+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 ---------IDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111112233346678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.01 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=203.0
Q ss_pred cccccccCcCCcccEEeeeccC----CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
|.+.+.||+|+||.||+|.+.. +..||+|+++... ....+++..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998643 3679999987542 3345689999999999999999999999876554
Q ss_pred -ceEEEeecCCCChhHHHhhcc---cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 544 -SMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 544 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
.++++||+++++|..++.... ....+++.....++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986532 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
|+++.+.............++..|+|||.+....++.++||||||+++|||++ |..||...... .+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~-------- 226 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD-------- 226 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH--------
Confidence 99987654332222222345678999999988899999999999999999999 88888543211 1110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+. .......+...+..+.+++.+|++.+|++||++.||++.|++.
T Consensus 227 ----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 227 ----YLR-HGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ----HHH-cCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 001 1111123344566789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=327.28 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=214.8
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-ceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-SMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 548 (792)
++|..++++|+|+||.++..+++. ++.+++|++... .....+...+|+.++++++|||||.+.+.+++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578888999999999999998764 778999998654 33445578899999999999999999999999998 89999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
+|++||+|.+.+.++. ...+++++++.++.|++.|+.|||+.. |+|||||+.|||++.+..+||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999997764 567899999999999999999999776 999999999999999999999999999998765
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ....++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+.. .++ .++ ...
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li------------~ki-~~~ 221 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELI------------LKI-NRG 221 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHH------------HHH-hhc
Confidence 42 234589999999999999999999999999999999999999999754322 111 111 112
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.+.....++..++..|++.+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2345667778889999999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.67 Aligned_cols=257 Identities=27% Similarity=0.444 Sum_probs=205.7
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+++...++||+|+||.||++... ++..+++|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999632 356799999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccc------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
++||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 135889999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+. .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~---- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---I---- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---H----
Confidence 9999999976543322222223345788999999998999999999999999999998 8888753222100 0
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+........+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ---------ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ---------HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 0011111112222344568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.37 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=194.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566789999999999999865 58899999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.... ...+..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999985432 3456778899999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..........+. .. +
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~-------~~------~ 288 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM-------CA------I 288 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH-------HH------H
Confidence 1223578999999998743 23456899999999999999999999733221110000 00 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........+.....++.+++.+||+.+|++||++.||+++
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112233445678899999999999999999999985
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.10 Aligned_cols=264 Identities=26% Similarity=0.409 Sum_probs=203.3
Q ss_pred cccccccccCcCCcccEEeeeccC---------------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE---------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~---------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
++|++.++||+|+||.||+++... ...||+|+++... ....+.|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 2358999997653 334567999999999999999999999
Q ss_pred eEEeCCcceEEEeecCCCChhHHHhhccc---------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEE
Q 003832 537 CCIQADESMLIYEYMPNKSLDFFIFDQAR---------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (792)
Q Consensus 537 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 607 (792)
++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854321 124688999999999999999999987 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh--CCCCCCCCCCCCc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPDHD 685 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt--G~~p~~~~~~~~~ 685 (792)
+++++.+||+|||++..+.............++..|+|||.+..+.++.++||||||++++||++ +..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 99999999999999986543322222233455779999999988899999999999999999998 45565432221
Q ss_pred cchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 686 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+....... ...........+...+..+.+++.+|++.+|++||+|.+|++.|.+
T Consensus 240 -~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFF------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhh------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111100000 0001111111222345678999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=320.61 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=208.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 544 (792)
.++|...+.||+|+||.||+|.+.+ ++.|++|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998766 6889999987553 3445678999999999999999999999876 4678
Q ss_pred eEEEeecCCCChhHHHhhcccC-----ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 545 MLIYEYMPNKSLDFFIFDQARA-----TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998654322 56899999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
|+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||....+. .+. .....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHc
Confidence 99987644333222233456778999999988889999999999999999999 99998643221 111 00000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+...+..+.+++.+|++.+|++||++.||+++|+..
T Consensus 235 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 ---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111223345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=315.64 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=203.1
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.+|+..+.||+|+||.||++....+..+|+|.+.... ...+.+.+|++++++++||||+++++++......++|+||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3467788999999999999998777789999986533 234578899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 999999986532 36899999999999999999999988 9999999999999999999999999998654322111
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ... ......
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~---------~~~~~~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESV---------SAGYRL 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHH---------HcCCcC
Confidence 111234568999999998999999999999999999999 788886432211 00 000 011111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+...+..+.+++.+||+.+|++||++.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 223334567889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.98 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=199.4
Q ss_pred ccccccCcCCcccEEeeeccCCc---EEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------Ccc
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQ---EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DES 544 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~---~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~~ 544 (792)
.+.++||+|+||.||+|+..+.. .+|+|.++.. .....+.+..|++++++++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 35578999999999999875532 5899988654 334567889999999999999999999987543 246
Q ss_pred eEEEeecCCCChhHHHhhcc---cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 545 MLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
++++||+++|+|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998875322 2345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+. .....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~~ 231 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIY----DYLRQGN 231 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHcCC
Confidence 987654332222223346778999999999999999999999999999999 78888642211 111 1111110
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 ---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1112233455688999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=320.38 Aligned_cols=266 Identities=29% Similarity=0.393 Sum_probs=203.8
Q ss_pred ccccccCcCCcccEEeeec-----cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cceEE
Q 003832 476 ASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 547 (792)
+..+.||+|+||+||++.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 7788999999999987642 357789999987653 234567899999999999999999999987643 57899
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++.. ..+++.++..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999854 24899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCccc-cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQT-NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
..... ......++..|+|||.+.+..++.++||||||++++||++|+.|+........ ................+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence 22111 11223456779999999888999999999999999999999999864332110 00000000001111122222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.......+...+..+.+++..|++.+|++||++++|+++|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 2222233444566788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.60 Aligned_cols=262 Identities=22% Similarity=0.303 Sum_probs=209.3
Q ss_pred hcccccccccCcCCcccEEeeeccC--CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|+..+.||+|+||.||+|+... +..||+|++.+. .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998644 368999998643 22345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.
T Consensus 109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 99999999999998653 35889999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .. . .+..
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~--~----------~i~~ 242 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IY--Q----------KILE 242 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HH--H----------HHhc
Confidence 22 223578999999999998889999999999999999999999997432210 00 0 0011
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH--hcCC-------CCCCCCCCCCcc
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM--LSSD-------SLLPEPNRPGFF 761 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~--L~~~-------~~~~~p~~p~~~ 761 (792)
.. ...+......+.+++.+|++.+|++|+ +++|+++. +.+. ..++.|..|.+.
T Consensus 243 ~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 243 GI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 11 112333445678899999999999995 89998875 2221 345566666654
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=320.74 Aligned_cols=272 Identities=26% Similarity=0.405 Sum_probs=204.5
Q ss_pred cccccccccCcCCcccEEeeecc-----CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 545 (792)
.+|++.+.||+|+||.||++... +++.||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999742 4788999999876666677899999999999999999999987543 4578
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+|+||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++..+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998543 235899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccc-cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQT-NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
....... ......++..|+|||.+.+..++.++||||||++++||++|..++.........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 111223445699999998889999999999999999999988765422111000000000000000001111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111122334456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=334.29 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~ 543 (792)
.++|.+.++||+|+||.||+|++. .++.||+|+++.... ...+.+..|+.+|.++. ||||+++++++.....
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346777789999999999999853 246899999976532 33457889999999997 9999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc----------------------------------------------------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------------------- 565 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 565 (792)
.++|+||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999965321
Q ss_pred -------------------------------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 566 -------------------------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 566 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...+++...+.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 124677888999999999999999887 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
++++.+||+|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||......+.
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence 9999999999999986543221111222456789999999998889999999999999999998 8888864322110
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ...+........+......+.+++..||+.+|++||+++||++.|+..
T Consensus 351 ----~---------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ----F---------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----H---------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 0 011111111122333456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=324.50 Aligned_cols=265 Identities=21% Similarity=0.314 Sum_probs=198.9
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|...++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 47899999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888887543 235788899999999999999999987 99999999999999999999999999976532221
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHhh----hh
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWKE----KR 700 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~----~~ 700 (792)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.... ..+.. ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223567899999998865 568999999999999999999999997543321110000000 00000 00
Q ss_pred hhhhccccccCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADS----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+..... ..+....++.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000111110000 011223467899999999999999999999853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=318.98 Aligned_cols=265 Identities=28% Similarity=0.447 Sum_probs=206.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-----------------CcEEEEEEccCCC-chhHHHHHHHHHHHHhccccccee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVK 533 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~ 533 (792)
.++|++.++||+|+||.||+++..+ +..||+|++.... ....+++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999987643 2458999987653 345678899999999999999999
Q ss_pred eeeeEEeCCcceEEEeecCCCChhHHHhhcc--------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003832 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQA--------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (792)
Q Consensus 534 l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 605 (792)
+++++......++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986543 1235899999999999999999999987 9999999999
Q ss_pred EEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh--CCCCCCCCCCC
Q 003832 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPD 683 (792)
Q Consensus 606 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt--G~~p~~~~~~~ 683 (792)
|++++++.++|+|||+++...............++..|+|||.+....++.++||||||+++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986644332222334556789999999988889999999999999999998 5666643221
Q ss_pred CccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 684 HDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 684 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.............. ........+...+.++.+++.+|++.+|++||++.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111100000 1111111223344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=313.17 Aligned_cols=246 Identities=29% Similarity=0.433 Sum_probs=197.3
Q ss_pred ccCcCCcccEEeeecc---CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6999999999999643 47889999986543 334568999999999999999999999875 45679999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc-c
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT-N 633 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~-~ 633 (792)
+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++..+....... .
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 999998543 35889999999999999999999987 9999999999999999999999999998765432211 1
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .+ .+.+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~-------------~~~i~~~~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV-------------TQMIESGERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH-------------HHHHHCCCCCC
Confidence 122334678999999988889999999999999999998 99998643221 11 11111111222
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 334455678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.72 Aligned_cols=267 Identities=25% Similarity=0.321 Sum_probs=215.5
Q ss_pred hhcccccccccCcCCcccEEeeeccCC-cEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeE-EeC------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEG-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC-IQA------ 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~-~~~------ 541 (792)
..-++++.+.|.+|||+.||.++...+ ..+|+|++-..++...+..++|+.+|++|+ |+|||.+++.. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999999998776 999999998888888999999999999997 99999999942 221
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
-+.+|.||||.+|.|-+++..+.... |++.++++|+.|+++|+++||... ++|||||||-+||||..+++.||||||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 35689999999999999997665444 999999999999999999999975 7899999999999999999999999999
Q ss_pred ccccCCCCccc-c----cc--ccccccCccccccc---cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH
Q 003832 622 ARIFGGDEIQT-N----TH--KVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 622 a~~~~~~~~~~-~----~~--~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~ 691 (792)
+.......... . .. ...-|+.|+|||.+ .+..+++|+|||+|||+||-|+-...||+....-
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 87532211000 0 00 12358999999976 6788999999999999999999999999854221
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC--CCCCCCCCC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD--SLLPEPNRP 758 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~--~~~~~p~~p 758 (792)
.++......+..+.....+.+||..||+.+|++||++.||+..+-.+ .+.+.+..+
T Consensus 265 -----------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 265 -----------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred -----------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 12223333333457888999999999999999999999999988665 334444433
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.56 Aligned_cols=200 Identities=26% Similarity=0.372 Sum_probs=174.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..++||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999876 47789999887643 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++... +.+++.....++.|++.||.|||+.+ +|+|+||||+|||+++++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999998543 35788999999999999999999753 3999999999999999999999999998765322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 122356899999999999889999999999999999999999998743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.47 Aligned_cols=240 Identities=20% Similarity=0.275 Sum_probs=193.2
Q ss_pred cCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||.||+++..+ ++.||+|++.+. .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999998764 788999998643 234456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 9998653 35889999999999999999999988 9999999999999999999999999988643222 12234
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .... ...... ...+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~---------~~~~~~--~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYR---------KILQEP--LRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHH---------HHHcCC--CCCCCc
Confidence 57899999999999999999999999999999999999999643211 0000 011111 122334
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.+++.+||+.+|++||++.++.+.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHH
Confidence 45668899999999999999865433333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=313.38 Aligned_cols=254 Identities=28% Similarity=0.469 Sum_probs=204.4
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|++.++||+|+||.||+|+..++..||+|+++... ...+.+.+|+.++++++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688899999999999999988777789999997533 23467899999999999999999999874 45689999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999653 2345789999999999999999999987 999999999999999999999999999876433221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||...+..++.++||||||+++|||++ |+.||....... .. . .+.....
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~----~---------~~~~~~~ 221 (262)
T cd05071 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----D---------QVERGYR 221 (262)
T ss_pred -cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH----H---------HHhcCCC
Confidence 1222456778999999988899999999999999999999 888886432210 00 0 0001111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 12234456678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=325.97 Aligned_cols=242 Identities=22% Similarity=0.301 Sum_probs=196.0
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.||+|+||.||+++.. +++.||+|+++.. .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999754 2234556788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (792)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 152 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TM 152 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--cc
Confidence 998888543 35889999999999999999999987 99999999999999999999999999875422211 12
Q ss_pred cccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCC
Q 003832 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP 714 (792)
Q Consensus 635 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (792)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. . ...... ...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~----~--------~~~~~~--~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF----E--------LILMEE--IRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HH----H--------HHhcCC--CCCC
Confidence 23578999999999999999999999999999999999999986432211 00 0 000000 1123
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 715 PTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 715 ~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
......+.+++.+||+.+|++|| ++.++++.
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 33456678999999999999998 88888763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=328.78 Aligned_cols=242 Identities=23% Similarity=0.311 Sum_probs=196.8
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.||+|+||.||+++.. +++.||+|++.+. .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 4889999999754 2334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~ 634 (792)
+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 998888543 35889999999999999999999987 9999999999999999999999999987543221 112
Q ss_pred cccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCC
Q 003832 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP 714 (792)
Q Consensus 635 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 714 (792)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .. .. .... ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~----~~--------~~~~--~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----EL--------ILME--DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HH----HH--------hccC--CccCC
Confidence 33578999999999999999999999999999999999999996432210 00 00 0000 01223
Q ss_pred HHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 715 PTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 715 ~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
.....++.+++.+||+.+|++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 34456688999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=317.58 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=205.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCc----EEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.++|+..++||+|+||.||+|++. +++ .||+|+++... ....+++.+|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 343 48999987543 3445678999999999999999999999975 4578
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998653 345889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||....... +. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~-------------~~ 223 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IP-------------DL 223 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-------------HH
Confidence 53322222222345678999999998899999999999999999998 888886332110 10 01
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLP 753 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 753 (792)
+........+......+.+++.+||+.+|++||++.|+++.|+.....|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1111111222334557889999999999999999999999997765544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.49 Aligned_cols=241 Identities=27% Similarity=0.376 Sum_probs=191.0
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+|+..+ ++.||+|+++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 7789999987532 23344556677777654 899999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 9999888543 35888999999999999999999987 9999999999999999999999999997643222 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+.. .+... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~------------~i~~~--~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD------------SILND--RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH------------HHHcC--CCCC
Confidence 23467899999999999989999999999999999999999999743221 0000 00000 1122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMS-SVVL 744 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~-evl~ 744 (792)
+.....++.+++.+||+.+|++||++. ++++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 333455678899999999999999976 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=295.59 Aligned_cols=250 Identities=26% Similarity=0.376 Sum_probs=210.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+.++|++.+.||+|.||.||.|+.+. +-.||+|++.+. ..+...++++|+++-..|+||||++++++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34688999999999999999998765 567999998764 23445689999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
++||...|.|...|... +.+.++......++.|+|.||.|+|..+ |+||||||+|+|++..+..||+|||-+..-.
T Consensus 100 ilEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999643 3456888999999999999999999987 9999999999999999999999999987543
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.......+||..|.+||...+..++.++|+|++|++.||++.|.+||+....+ +..++....++
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~----------etYkrI~k~~~-- 239 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS----------ETYKRIRKVDL-- 239 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH----------HHHHHHHHccc--
Confidence 22334589999999999999999999999999999999999999999744321 11122222222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..|......+.+++..|+..+|.+|.+..||+..
T Consensus 240 -----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 -----KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2334556678899999999999999999999864
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=319.74 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=205.3
Q ss_pred hhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
..++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+..+++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999997542 4579999986543 2334568899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc-------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999965321 234567788999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+ .. .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~----~- 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL----K- 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----H-
Confidence 99999986543332222223345778999999999999999999999999999999 787875422211 00 0
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+. .....+......+.+++.+|++.+|++||++.|+++.|...
T Consensus 233 -------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 -------FVMDG-GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00111 01112223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.67 Aligned_cols=272 Identities=23% Similarity=0.321 Sum_probs=208.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccC--CCchhHHHHHHHHHHHHhcccccceeeeeeEEe-----CC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-----AD 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-----~~ 542 (792)
....|...+.||+|+||.|..+..+ +|+.||||++.. ......+...+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455666789999999999999865 489999999973 345566788899999999999999999999875 34
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..|+|+|+| ..+|...+..+ ..|+......++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|
T Consensus 100 DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 689999999 56888888543 34888999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HH
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AW 693 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~ 693 (792)
+...........+..+.|.+|.|||++. ...|+...||||.|||+.||++|++.|.+.+..++..++.. ..
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 9876442233345678899999999874 56899999999999999999999999987665443322211 11
Q ss_pred HHHhhhhhhhhcccccc-CC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 694 ILWKEKRAMELAGDTLA-DS-----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
.......+...+..... .. .-+......++|+.+||..||.+|+|++|+++. |+..
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111112222221111 01 111334567899999999999999999999985 4444
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=312.50 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=204.3
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999988888999999875433 3467999999999999999999999875 466899999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05070 84 KGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-
Confidence 999999986532 345789999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... . .+......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~----~---------~~~~~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVL----E---------QVERGYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH----H---------HHHcCCCC
Confidence 1122345678999999988899999999999999999999 88888643211 000 0 01111112
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+..+.+++.+|++.+|++|||+.++++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2333445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.65 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=203.8
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|.+.++||+|+||.||+++.. +++.||||++.+.. ......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999876 58899999987542 244567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 46889999999999999999999987 999999999999999999999999999876433
Q ss_pred C---------------------------ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 629 E---------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 629 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
. .........||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011233578999999999999999999999999999999999999997543
Q ss_pred CCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 003832 682 PDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-MSSVVLM 745 (792)
Q Consensus 682 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-~~evl~~ 745 (792)
.... ... +.... ..............+.+++..|++ +|++||+ ++|+++.
T Consensus 235 ~~~~------~~~------i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNK------IINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHH------HhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2100 000 00000 111111111135667889999997 9999999 9999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.75 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=208.6
Q ss_pred hcccccccccCcCCcccEEeeecc--------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888899999999999999641 24579999987543 34457789999999999 899999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999975421 235788899999999999999999987 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----
Confidence 9999999999999987654332222233456778999999988889999999999999999998 77777533211
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLP 753 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 753 (792)
. ....... ......+...+..+.+++.+||+.+|++||++.||++.|+++..+.
T Consensus 247 --~-~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 --E-LFKLLKE---------GHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred --H-HHHHHHc---------CCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 0 0011111 1111223344567888999999999999999999999998765443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=313.52 Aligned_cols=258 Identities=22% Similarity=0.380 Sum_probs=207.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||.||+|+.. +++.||||.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888899999999999999865 5889999987542 2334457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+++++|.+++.... ....++...+..++.|+++||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2345788999999999999999999987 99999999999999999999999999887643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ..+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~----------~~~~~ 222 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLC----------QKIEQ 222 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHH----------HHHhc
Confidence 321 122356888999999998888999999999999999999999998533221 00000 00111
Q ss_pred c-ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 T-LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~-~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ............+.+++.+||+.+|++||++.+|++.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 223 CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1 11111223456788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=320.16 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=205.9
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 543 (792)
.++|...+.||+|+||.||++... .+..||+|+++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357888999999999999999642 24579999987653 33456789999999999 79999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+.+++|.+++.... ...+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999986532 234899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.+.............++..|+|||.+.+..++.++||||||+++|||++ |+.||........ ....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~------- 256 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKL------- 256 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHH-------
Confidence 6643322112223456788999999999999999999999999999998 9999864322110 0001
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+........+.....++.+++.+|++.+|++||++.||++.|++
T Consensus 257 --~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 257 --IKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --HHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 11111111222334578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.98 Aligned_cols=264 Identities=26% Similarity=0.431 Sum_probs=203.8
Q ss_pred cccccccccCcCCcccEEeeecc-----------------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-----------------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKL 534 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l 534 (792)
++|++.++||+|+||.||++... +...+|+|+++... ....+++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 23468999997653 3445689999999999999999999
Q ss_pred eeeEEeCCcceEEEeecCCCChhHHHhhccc--------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcE
Q 003832 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQAR--------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (792)
Q Consensus 535 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 606 (792)
++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 234778899999999999999999988 99999999999
Q ss_pred EecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh--CCCCCCCCCCCC
Q 003832 607 LLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS--GKKNWRFSHPDH 684 (792)
Q Consensus 607 ll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt--G~~p~~~~~~~~ 684 (792)
++++++.+||+|||++..+.............++..|+|||....+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986643322222222345678999999888889999999999999999998 667775332211
Q ss_pred ccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 685 DHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 685 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+.......... ........+...+..+.+++.+||+.+|++||++.||++.|++
T Consensus 242 ---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111100000000 0011111223344678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.63 Aligned_cols=254 Identities=30% Similarity=0.482 Sum_probs=205.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..++||+|+||.||+|...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++ ..+..++++||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 45788889999999999999998889999999987543 3356889999999999999999999986 456789999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999886543 346889999999999999999999987 999999999999999999999999999876532221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||.+....++.++||||||++++||++ |+.||...... ... .. +.....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~---------~~~~~~ 221 (260)
T cd05067 159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVI----QN---------LERGYR 221 (260)
T ss_pred -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHH----HH---------HHcCCC
Confidence 1122345778999999998899999999999999999999 99998643211 010 00 011111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+.++.+++.+|++.+|++||++++++..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 12223345578899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=320.80 Aligned_cols=257 Identities=28% Similarity=0.410 Sum_probs=203.1
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc--EEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
++|++.+.||+|+||.||+|+..+ +. .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998754 32 4788888743 334456789999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1235889999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||++...... ........+..|+|||.+....++.++|||||||++|||++ |+.||....... +.
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~---- 228 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LY---- 228 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----
Confidence 99999998643211 11111233567999999988899999999999999999998 999986433211 00
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.. +........+......+.+++.+|++.+|.+||++++|++.|+....
T Consensus 229 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EK---------LPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HH---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 11111112233345678899999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=317.94 Aligned_cols=258 Identities=27% Similarity=0.470 Sum_probs=205.3
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|+..+.||+|+||.||++... ++..+|+|++.... ....+++.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 36789999987653 34456799999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc-------------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003832 545 MLIYEYMPNKSLDFFIFDQA-------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 605 (792)
++|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996432 1134788899999999999999999987 9999999999
Q ss_pred EEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003832 606 VLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDH 684 (792)
Q Consensus 606 Ill~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~ 684 (792)
|++++++.+||+|||++..+..............+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999886543322222222345678999999988899999999999999999998 877875322210
Q ss_pred ccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 685 DHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 685 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.. ..... .. ....+...+.++.+++.+|++.+|++||++.||++.|+.
T Consensus 241 ---~~----~~~~~--------~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 ---VI----YYVRD--------GN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ---HH----HHHhc--------CC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 00111 11 111233445678899999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=326.04 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=201.9
Q ss_pred hcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeC-C
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA-D 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~-~ 542 (792)
.++|+..++||+|+||.||+|+. ..++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788899999999999999963 346789999997643 33456788999999999 689999999988755 4
Q ss_pred cceEEEeecCCCChhHHHhhccc---------------------------------------------------------
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQAR--------------------------------------------------------- 565 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 565 (792)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 57899999999999999864310
Q ss_pred -------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccc
Q 003832 566 -------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638 (792)
Q Consensus 566 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~ 638 (792)
...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124688889999999999999999987 9999999999999999999999999998754332222222344
Q ss_pred cccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHH
Q 003832 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTE 717 (792)
Q Consensus 639 gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 717 (792)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+. ....+. .....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~~~---------~~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFC----RRLKEG---------TRMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHH----HHHhcc---------CCCCCCCCC
Confidence 5678999999988899999999999999999997 888886432211 000 001111 111112223
Q ss_pred HHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 718 VLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 718 ~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+.+++..||+.+|++||++.||++.|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 34688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=328.39 Aligned_cols=253 Identities=29% Similarity=0.458 Sum_probs=214.9
Q ss_pred cccccccccCcCCcccEEeeeccC--Cc--EEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE--GQ--EIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~--~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++....++||+|.||.|++|.+.. |+ .||||.++.+... ...+|.+|+.+|.+|+|||+++|+|+..+ ....||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 344556799999999999998864 44 5899999877544 67899999999999999999999999988 788999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+|+++.|+|.+.|++ .....+-......++.|||.||.||..+. +|||||..+|+||-....+||+||||.+-+..
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999987 45667888899999999999999999987 99999999999999999999999999998864
Q ss_pred CC-ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DE-IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.+ .+.......-+..|.|||.+....++.++|||+|||.||||+| |+.||-.-.. ..+.+.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----------------~qIL~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----------------IQILKNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----------------HHHHHhc
Confidence 43 3333333455789999999999999999999999999999999 6777753322 2234556
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
|..-+-..|..++++++++++.||.++|++||++..|.+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 66656677888999999999999999999999999998544
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=313.64 Aligned_cols=257 Identities=28% Similarity=0.475 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeeccC-C---cEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+.+..|++++++++|||++++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3567888999999999999998753 3 379999987653 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999998543 346899999999999999999999987 9999999999999999999999999998664
Q ss_pred CCCcccc-ccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
....... ......+..|+|||.+....++.++||||||+++|||++ |+.||......+ .. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~----~~--------- 222 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VM----KA--------- 222 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH----HH---------
Confidence 3221111 111223567999999988889999999999999999998 999986432210 00 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+......+.+...+..+.+++.+|++.+|++||++.+|++.|+++
T Consensus 223 i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011111122233456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.00 Aligned_cols=261 Identities=26% Similarity=0.408 Sum_probs=206.5
Q ss_pred cccccccccCcCCcccEEeeeccC--------CcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 542 (792)
.+|.+.+.||+|+||.||+++... ...||+|.+.... ....+++.+|++++.++ +||||+++++++.+..
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468888999999999999997421 2368999887543 34467899999999999 7999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
..++++||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986532 1235788999999999999999999987 99999999999999
Q ss_pred CCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccch
Q 003832 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNL 688 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l 688 (792)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||.....+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence 999999999999986643322222222344578999999999999999999999999999998 888875432111
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCC
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLL 752 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~ 752 (792)
...... .......+......+.+++.+|++.+|++||++.|+++.|+.....
T Consensus 245 ---~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 ---LFKLLK---------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ---HHHHHH---------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 000111 1111122333455788999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=322.23 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=205.7
Q ss_pred hcccccccccCcCCcccEEeeeccC--------CcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++|.+.++||+|+||.||+++... ...+|+|.+.... .....++..|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4678999999999999999997522 3569999997643 34456788999999999 799999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...++||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999975421 235889999999999999999999987 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
+.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--- 250 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 250 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence 9999999999999876543221111222334578999999988889999999999999999998 888875322110
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...... .......+......+.+++.+|++.+|++||+|.||++.|+.+
T Consensus 251 ----~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 251 ----LFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred ----HHHHHH---------cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 000111 1111122334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=333.00 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=196.3
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.|+.+++||+|+||+||+|+.. +++.||+|++.+. .....+.+..|+.++.+++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999865 4789999999653 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998653 35788888999999999999999987 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------cccccccccccCccccccccCCCCCccCcchhHH
Q 003832 630 I---------------------------------------------QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664 (792)
Q Consensus 630 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~G 664 (792)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHH--hccCCCCCCCCHHHH
Q 003832 665 VLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLL--CVQHRPEDRPNMSSV 742 (792)
Q Consensus 665 vil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--Cl~~~P~~RPs~~ev 742 (792)
|++|||++|+.||....+.... .. +.. ...............++.+++.+ |+..+|..||++.||
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~------i~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LK------VIN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HH------HHc-cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999754322110 00 000 00001111111233456667766 566777779999999
Q ss_pred HHH
Q 003832 743 VLM 745 (792)
Q Consensus 743 l~~ 745 (792)
+++
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=308.60 Aligned_cols=247 Identities=29% Similarity=0.403 Sum_probs=200.1
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChh
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 557 (792)
+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 37999999999999988889999999876543 33457889999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccccccc
Q 003832 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (792)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (792)
+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCC
Confidence 988543 235789999999999999999999987 99999999999999999999999999876433221 111123
Q ss_pred ccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 638 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
.++..|+|||++.+..++.++||||||+++|||++ |..||....... ..... ........+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~---------~~~~~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQV---------EKGYRMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHH---------HcCCCCCCCCC
Confidence 44678999999998899999999999999999998 998986432210 00001 11111122334
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=320.85 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=193.5
Q ss_pred cccccccccCcCCcccEEeeecc--CCcEEEEEEccCCC--chhHHHHHHHHHHHHhc---ccccceeeeeeEEe-----
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQ----- 540 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~----- 540 (792)
++|++.++||+|+||.||+|+.. +++.||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 36789999986542 22234566777777766 69999999999863
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
....++|+||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999997 58888885432 335889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh---
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK--- 697 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--- 697 (792)
+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. +........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 99865432 122345789999999999888999999999999999999999999975432211 100000000
Q ss_pred hhhhh---hhcccccc--CC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 698 EKRAM---ELAGDTLA--DS-----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 698 ~~~~~---~~~~~~~~--~~-----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..... .+...... .. ..+.....+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00000000 00 01123345778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.37 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|...+.||+|+||.||+++.. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999865 58899999997542 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998653 245889999999999999999999988 999999999999999999999999999876543
Q ss_pred CccccccccccccCcccccccc------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ .......
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~---- 224 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNF---- 224 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcC----
Confidence 222 222357899999999986 45678999999999999999999999964332110 0000000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...............+.+++..|++ +|++||+++++++.
T Consensus 225 ---~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 ---QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ---CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0001111112344567888899998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=323.29 Aligned_cols=245 Identities=26% Similarity=0.404 Sum_probs=194.0
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHH---HhcccccceeeeeeEEeCCcceEE
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLI---ARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
|++.+.||+|+||.||++... +++.||||++++.. ....+.+..|++++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999865 48899999997532 23345566676655 566799999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888743 35899999999999999999999987 99999999999999999999999999875322
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .. ..+...
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~------------~~i~~~ 216 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VF------------DSIVND 216 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HH------------HHHHhC
Confidence 11 12234678999999999999999999999999999999999999997432211 00 001111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
. ...+......+.+++.+||+.+|++|| ++.++++.
T Consensus 217 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 E--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1 112333456678999999999999999 56666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.45 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=200.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|+..++||+|+||.||+++.. +++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999875 4789999998643 22334567889999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++.. ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998853 24778888899999999999999987 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCC----CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEG----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ... .
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~---------~ 257 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTY---------S 257 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHH---------H
Confidence 33211 12335799999999998643 4789999999999999999999999743321 000 0
Q ss_pred hhcccc--ccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003832 703 ELAGDT--LADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~--~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~ 745 (792)
.+.... +...........+.+++..||+.+|++ ||++.|+++.
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 258 KIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 111111 111111134567788999999999988 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=328.57 Aligned_cols=265 Identities=21% Similarity=0.335 Sum_probs=195.9
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----cce
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (792)
+|++.++||+|+||.||+|+.. +++.||||++... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999865 5889999998643 2234457889999999999999999999986543 479
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+. ++|.+++... ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 6888887543 35889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCc-cccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH--------HHHH
Q 003832 626 GGDEI-QTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG--------HAWI 694 (792)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~--------~~~~ 694 (792)
..... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...........+. ....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 111234578999999999865 678999999999999999999999996543211100000 0000
Q ss_pred HHhhhhhhhhc---cccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKEKRAMELA---GDTLADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~~~~~~~---~~~~~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+......... ....... ..+.....+.+++.+||+.+|++||+++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000010 0000000 001123457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=324.01 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=195.4
Q ss_pred cccCcCCcccEEeeec----cCCcEEEEEEccCC----CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTL----VEGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++||+|+||.||+++. ..++.||+|++++. .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999975 24788999998653 223345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... +.+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999988543 35778888899999999999999988 99999999999999999999999999875432221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... . ...+....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~------------~~~~~~~~-- 216 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---T------------IDKILKGK-- 216 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---H------------HHHHHcCC--
Confidence 1233578999999999998889999999999999999999999996433210 0 00111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
...+......+.+++.+||+.+|++|| ++.++++.
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 122334456788999999999999999 78888763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.33 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=194.1
Q ss_pred cccCcCCcccEEeeeccC---CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997643 45799999876543 34457889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc--CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 555 SLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 555 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 234677788899999999999999987 9999999999999999999999999997654333322
Q ss_pred cccccccccCccccccccCC-------CCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 633 NTHKVVGTYGYMSPEYAAEG-------LFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
......++..|+|||++... .++.++||||||+++|||++ |+.||....+.+. .. ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~----~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LT----YTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HH----HHhhcccCCC
Confidence 23345678899999988532 35889999999999999996 9999964332111 00 0000111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+.. .......+.+++..|+ .+|++||+++||++.|+
T Consensus 231 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1123345777888998 58999999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.70 Aligned_cols=247 Identities=27% Similarity=0.375 Sum_probs=197.5
Q ss_pred cCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||+||++... +++.+|+|++.+.. ....+.+..|++++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 58899999986542 22345678899999999999999999999999999999999999999
Q ss_pred hHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccccc
Q 003832 557 DFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635 (792)
Q Consensus 557 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~ 635 (792)
..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875432 3456899999999999999999999987 99999999999999999999999999986543321 123
Q ss_pred ccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCH
Q 003832 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP 715 (792)
Q Consensus 636 ~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 715 (792)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||........... . ........ ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-------~----~~~~~~~~--~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-------L----KQRILNDS--VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH-------H----HHhhcccC--CCCcc
Confidence 35789999999999999999999999999999999999999975432211000 0 00111111 12233
Q ss_pred HHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 716 TEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 716 ~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
..+..+.+++..||+.+|++|| ++++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 4556788999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.07 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=203.1
Q ss_pred cccccccccCcCCcccEEeeeccC-C---cEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..|+..+.||+|+||.||+|+... + ..||||.+... .....++|..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 346778899999999999998754 2 36999998765 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+++++|.+++... .+.+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998653 345889999999999999999999987 99999999999999999999999999876543
Q ss_pred CCcccccc-ccc--cccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 628 DEIQTNTH-KVV--GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 628 ~~~~~~~~-~~~--gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
........ ... .+..|+|||.+....++.++||||||+++|||++ |+.||...... .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~----~i------- 224 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIN----AI------- 224 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHH----HH-------
Confidence 22111111 111 2457999999999999999999999999999886 99998643221 1110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+.+.+..+.+++..||+.+|++||++.+|+++|++.
T Consensus 225 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 --EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111122334456688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.28 Aligned_cols=263 Identities=22% Similarity=0.327 Sum_probs=196.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++..... .....+.+|+.++++++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999876 588999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+. ++|.+++... ...++...+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 5777776442 345788899999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh--------
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR-------- 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------- 700 (792)
.......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..+...........
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchh
Confidence 11223567899999998865 468899999999999999999999997532210 00000000000000
Q ss_pred -hhhhccccccCCCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 -AMELAGDTLADSHPP---------TEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 -~~~~~~~~~~~~~~~---------~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.............+. .....+.+++..||+.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 11245778999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=308.85 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=209.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999886 6899999988642 2334568899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+++++|..++... .....+++.++..++.++++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988653 22445889999999999999999999987 99999999999999999999999999886543
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... .+....
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~----------~~~~~~ 222 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL----------CKKIEK 222 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHH----------Hhhhhc
Confidence 2211 12346788999999998888999999999999999999999998643211 1100 000111
Q ss_pred cccCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 TLADSHPP-TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~~~~~~~~-~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+. .....+.+++.+|++.+|++||++.+|+++|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11112222 4455788999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=316.91 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=202.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
+|+..++||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999864 58899999986532 2233467889999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886532 345899999999999999999999987 9999999999999999999999999988654322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||........ . .. +...+.. .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~---~----~~-----~~~~~~~-~ 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK---R----EE-----VERRVKE-D 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH---H----HH-----HHHHhhh-c
Confidence 1 1234689999999999988999999999999999999999999975332111 0 00 0000111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
....+......+.+++..|++.||++|| ++.+++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1123344556788999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=325.08 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=198.8
Q ss_pred ccccccccCcCCcccEEeeecc----CCcEEEEEEccCC----CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
+|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+..|+.++.++ +||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998753 4789999998643 223345688899999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 35889999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
+...... ......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+. . .+..
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~---~-----~~~~ 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS---R-----RILK 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH---H-----HHhc
Confidence 5432211 12235789999999999765 47899999999999999999999997543222111110 0 0000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
.+ ...+......+.+++.+||+.+|++|| +++++++.
T Consensus 226 -~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 -CD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 11 122333455678899999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.29 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeecc--------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++|.+.++||+|+||.||+++.. ....+|+|.++... .....++..|+.++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888899999999999999742 24578999987543 34456788999999999 699999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...++|+||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ ++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996532 1245889999999999999999999987 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999987643222221222334568999999998899999999999999999999 888885432211
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+. ..... ......+......+.+++.+|++.+|++||++.|+++.|++.
T Consensus 245 ~~----~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 LF----KLLRE---------GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred HH----HHHHc---------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 11 11111 111122334455788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.68 Aligned_cols=250 Identities=34% Similarity=0.526 Sum_probs=205.7
Q ss_pred cccCcCCcccEEeeeccC----CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998754 778999999766433 367899999999999999999999999999999999999999
Q ss_pred CChhHHHhhccc------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 554 KSLDFFIFDQAR------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 554 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
++|.+++..... ...+++.++..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999966421 367899999999999999999999987 99999999999999999999999999988754
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
...........++..|+|||.+....++.++||||+|++++||++ |+.||...... .+. .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~~-------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVL----EYLRK-------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHc--------
Confidence 432222334567889999999988899999999999999999999 68888754221 110 00110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
......+...+.++.+++.+|++.+|++||++.|+++.|+
T Consensus 223 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 -GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233344667889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.48 Aligned_cols=250 Identities=29% Similarity=0.442 Sum_probs=214.6
Q ss_pred ccccccCcCCcccEEeeecc-CC----cEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 476 ASYNKLGEGGFGPVYKGTLV-EG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~-~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
...++||+|+||+||+|.+- +| -+||+|++... ..+...++.+|+.+|.+++||||++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999753 33 46899998665 4556789999999999999999999999998877 889999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||+.|+|.++++. .+..+.-+..+.|..|||+||.|||++. ++||||..+||||..-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999976 3456888999999999999999999887 9999999999999999999999999999988766
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.........-.+.|||-|.+....|+.++|||||||.+|||+| |..|+.....++ +.++++..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~g 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKG 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhcc
Confidence 5544444555789999999999999999999999999999999 999987544332 33444455
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
.+-+.|+....++..++.+||..|++.||+++++...+.
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs 955 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS 955 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence 556778889999999999999999999999999887664
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.88 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=196.3
Q ss_pred ccCcCCcccEEeeecc---CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCC
Q 003832 480 KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 355799999876533 33467999999999999999999999885 457899999999999
Q ss_pred hhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc-cc
Q 003832 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT-NT 634 (792)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~-~~ 634 (792)
|.+++... ...+++..+++++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+....... ..
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998543 346899999999999999999999987 9999999999999999999999999998654332211 11
Q ss_pred cccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 635 ~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
....++..|+|||.+....++.++||||||+++|||++ |+.||....... . ...+........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~---------~~~~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------V---------MSFIEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------H---------HHHHHCCCCCCC
Confidence 11234578999999988889999999999999999996 999986432210 0 111111111223
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+.....++.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 44456778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=308.78 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=203.3
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|...++||+|++|.||++....+..+|+|++.... ...+.+.+|+.++++++|||++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4678888999999999999998777789999986543 33467889999999999999999999875 456899999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999998653 2345789999999999999999999987 999999999999999999999999999876432211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ... ......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~----~~~---------~~~~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VL----EQV---------ERGYRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHH---------HcCCCC
Confidence 1122346778999999988899999999999999999999 888886432210 00 000 001111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233455678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.89 Aligned_cols=260 Identities=17% Similarity=0.200 Sum_probs=195.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+|++.++||+|+||.||++... .++.||+|+... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999865 478999997542 3567899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+. ++|..++... ..+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 165 ~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 96 6787777543 35789999999999999999999987 9999999999999999999999999997543211
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc----chhHHHHHHHh---------
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH----NLLGHAWILWK--------- 697 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~----~l~~~~~~~~~--------- 697 (792)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+-........ ..+........
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 11223357999999999999999999999999999999999999886432211100 00000000000
Q ss_pred -hhhhh----hhcccccc--CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 -EKRAM----ELAGDTLA--DSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 -~~~~~----~~~~~~~~--~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..... ........ ... ....+.++.+|+.+||+.||++|||++|+++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000 000 01234578899999999999999999999863
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.22 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=207.6
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||+++. .+++.+|||.+... .....+++.+|+.+++.++||||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677888999999999999986 46889999987643 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 23456899999999999999999999987 99999999999999999999999999886643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ ... ........
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~---------~~~~~~~~- 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC---------KKIEQCDY- 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh---------hhhhcCCC-
Confidence 321 12234688999999999888999999999999999999999999864322100 000 00111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+......+.+++.+|++.+|++||||.+|++++++.
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 --PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111223456788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.37 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=204.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|++|.||+++.. +++.+++|.+... .....+.+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 4889999998643 344567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998654 2356889999999999999999999987 99999999999999999999999999887643321
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......|+..|+|||++.+..++.++||||||++++||++|+.||...... ... . ... ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~--------~~~-~~~~ 218 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI----L--------KII-RGVF 218 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH----H--------HHH-cCCC
Confidence 122346788999999999999999999999999999999999998643311 000 0 000 0111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12222445678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.15 Aligned_cols=249 Identities=30% Similarity=0.448 Sum_probs=201.4
Q ss_pred cccCcCCcccEEeeeccC--C--cEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+..|+.++++++||||+++++.+.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999998644 2 3689999987765 567789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc-c
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-T 632 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~-~ 632 (792)
++|.+++..... ..+++...+.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976433 56899999999999999999999987 999999999999999999999999999876542211 1
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||++++||++ |+.||......+ ... . .. . .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~-~~-----~---~~~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILK---K-ID-----K---EGERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---H-HH-----h---cCCcC
Confidence 1223457789999999998899999999999999999999 999986332211 100 0 00 0 01111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+...+..+.+++.+|++.+|++||++.||++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 122334567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=329.64 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=199.4
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
...++|+..+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999998764 788999998642 2233456889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999988432 4788889999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCC----CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEG----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
..... .......||+.|+|||++... .++.++|||||||++|||++|+.||...... ...
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~--------- 256 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTY--------- 256 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHH---------
Confidence 43221 122346799999999998653 3789999999999999999999999643221 000
Q ss_pred hhhcccc--ccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003832 702 MELAGDT--LADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~--~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~ 745 (792)
..+++.. +..+........+.+++..|++.++.+ ||++.|++++
T Consensus 257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1111111 111111223556778888899865544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.88 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=198.8
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||+++.. +++.||||++... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999875 4889999999653 2234456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998653 35889999999999999999999988 999999999999999999999999998765321
Q ss_pred Cccc------------------------------------cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh
Q 003832 629 EIQT------------------------------------NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (792)
Q Consensus 629 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt 672 (792)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 003832 673 GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN---MSSVVLM 745 (792)
Q Consensus 673 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs---~~evl~~ 745 (792)
|+.||....+... ..... .. ...+...........+.+++.+|+. +|.+|++ +.|++++
T Consensus 235 G~~Pf~~~~~~~~------~~~i~-~~------~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQET------YRKII-NW------KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHHHH------HHHHH-cC------CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999974332110 00000 00 0001001111234466788888886 8999998 8888774
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=328.84 Aligned_cols=202 Identities=24% Similarity=0.363 Sum_probs=174.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||+||+++.. .++.||+|++++.. ......+..|+.++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999865 47899999997532 233457888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998653 45889999999999999999999988 999999999999999999999999998764321
Q ss_pred Ccc---------------------------------ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCC
Q 003832 629 EIQ---------------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (792)
Q Consensus 629 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~ 675 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCC
Q 003832 676 NWRFS 680 (792)
Q Consensus 676 p~~~~ 680 (792)
||...
T Consensus 235 Pf~~~ 239 (363)
T cd05628 235 PFCSE 239 (363)
T ss_pred CCCCC
Confidence 99743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=305.84 Aligned_cols=248 Identities=30% Similarity=0.435 Sum_probs=201.2
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChh
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 557 (792)
++||+|+||.||++...+++.|++|.+...... ..+.+.+|+.++++++|+||+++++++......++|+||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765433 5678999999999999999999999999999999999999999999
Q ss_pred HHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccccccc
Q 003832 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637 (792)
Q Consensus 558 ~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (792)
+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998553 235788999999999999999999987 999999999999999999999999999865432221111223
Q ss_pred ccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 638 ~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..+..|+|||.+.++.++.++||||||++++||++ |..||........ ...+........+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT----------------RERIESGYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH----------------HHHHhcCCCCCCCcc
Confidence 34667999999988899999999999999999999 7888754332110 000111111122334
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
.+..+.+++.+|++.+|++||++.||++.|.
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.40 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=196.3
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhccc-ccceeeeeeEEeCCcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 548 (792)
+|+..+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999998764 678999998754 23345678889999999976 46888999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999888543 34788999999999999999999987 999999999999999999999999998753221
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..+...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~------------~~i~~~- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF------------QSIMEH- 216 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH------------HHHHcC-
Confidence 1 11233578999999999999999999999999999999999999996432210 10 000111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~ 744 (792)
....+......+.+++.+||+.+|++||+. .++.+
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 112233345567899999999999999986 56554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=321.76 Aligned_cols=249 Identities=21% Similarity=0.329 Sum_probs=196.4
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++.. +++.||+|++++. .....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999875 4789999999754 223445688899999998 699999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... +.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 9998887543 45899999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc--cchhHHHHHHHhhhhhhhhccccccC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD--HNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~-- 222 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQI-- 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCC--
Confidence 2335789999999999999999999999999999999999999974332211 1111111110 111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPN------MSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs------~~evl~~ 745 (792)
..|......+.+++.+||+.+|++||+ ++|+++.
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 123334556889999999999999997 6777753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.15 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=195.3
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++... ++.+|+|++.+. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 788999999754 233455678899888877 799999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 9998887543 35889999999999999999999988 9999999999999999999999999987532211 11
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc--cchhHHHHHHHhhhhhhhhccccccC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD--HNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....||..|+|||++.+..++.++|||||||++|||++|+.||........ .....+..... .... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i--------~~~~--~ 222 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------LEKQ--I 222 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH--------hcCC--C
Confidence 2335789999999999999999999999999999999999999964322111 11111111111 1111 1
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPN------MSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs------~~evl~~ 745 (792)
..|......+.+++.+||+.+|++||+ +.++++.
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 233344566789999999999999998 4676543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.02 Aligned_cols=249 Identities=29% Similarity=0.438 Sum_probs=205.1
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|+..+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 5677889999999999999987 488999999976544 56789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 999999986543 236899999999999999999999988 99999999999999999999999999987632211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
....+..|+|||.+....++.++||||||++++||++ |+.||...... .+. .... .....
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~~~---------~~~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PHVE---------KGYRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHh---------cCCCC
Confidence 2344678999999988899999999999999999997 99888633211 010 0000 11111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+..+.+++.+|++.+|++||+++|++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 2233345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.57 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=203.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-----chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999864 48899999986432 1234578899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988543 35788999999999999999999987 9999999999999999999999999987654
Q ss_pred CCCcccc-ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
....... .....++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. .....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~----------~~~~~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA----------IFKIA 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH----------HHHHh
Confidence 3221111 12356788999999999988999999999999999999999998632211 00 00011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........+......+.+++..||+.+|++||++.|++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122334455678899999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=310.09 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=204.3
Q ss_pred cccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.+|++.+.||+|+||.||+|+... +..+|+|.++... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 567888999999999999998642 3479999987543 33456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999653 245889999999999999999999987 99999999999999999999999999987653
Q ss_pred CCcccc-ccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DEIQTN-THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
...... .....++..|+|||.+.+..++.++||||||++++|+++ |+.||......+ ... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~----~~~~------- 224 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIK----AIEE------- 224 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHH----HHhC-------
Confidence 321111 112233568999999998899999999999999999887 999986433211 110 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+...+..+.+++.+|++.+|++||+|.+|++.|+..
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 --GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122233456678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.91 Aligned_cols=255 Identities=28% Similarity=0.439 Sum_probs=201.0
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc--EEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
++|++.+.||+|+||.||+|.+.+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 577888999999999999998653 43 4688877653 334456788999999999 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
+||+++++|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999996542 1235789999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||++..... ........++..|+|||++.+..++.++||||||++++||+| |..||......+ ..
T Consensus 164 kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~---- 233 (303)
T cd05088 164 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY---- 233 (303)
T ss_pred EeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HH----
Confidence 9999999864211 111111234678999999988889999999999999999998 999986432210 00
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. +........+......+.+++.+|++.+|++||++.+++++|+..
T Consensus 234 ~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 234 EK---------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HH---------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 001111112223345678999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=306.60 Aligned_cols=249 Identities=32% Similarity=0.480 Sum_probs=198.3
Q ss_pred cccCcCCcccEEeeeccC----CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
++||+|+||.||+|+... +..+|+|.+..... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899999976543 34568899999999999999999999875 5568999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc-
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT- 632 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~- 632 (792)
++|.+++.... .+++..+..++.|++.||+|||..+ ++|+||||+||++++++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999996543 5889999999999999999999987 9999999999999999999999999998764332211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. .... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~----~~~~---------~~~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIA----MLES---------GERL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHH----HHHc---------CCcC
Confidence 1112234568999999998899999999999999999998 99998643221 1110 0111 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
..+...+..+.+++.+|++.+|++||++.+|++.|++..
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 223344567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=325.57 Aligned_cols=242 Identities=22% Similarity=0.296 Sum_probs=195.1
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.||+|+||.||+++.. +++.||+|++.+. .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999864 5889999999753 2234567788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
+|..++... ..+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 998888543 358899999999999999999997 56 99999999999999999999999999875432211 1
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.. . .. ..... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~---~----~~--------i~~~~--~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL---F----EL--------ILMEE--IRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH---H----HH--------HhcCC--CCC
Confidence 2235689999999999999999999999999999999999999964322110 0 00 00000 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
+.....++.+++.+||+.+|++|+ ++.++++.
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 233445678999999999999996 89999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=310.86 Aligned_cols=255 Identities=22% Similarity=0.368 Sum_probs=202.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357888999999999999999864 5788999999765555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 9999999988543 35789999999999999999999987 99999999999999999999999999986642211
Q ss_pred cccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
......|+..|+|||.+. ...++.++||||||++++||++|+.||....+....... .. .....+
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~---~~~~~~ 229 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK---SNFQPP 229 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec---CCCCCC
Confidence 122356888999999884 455788999999999999999999998543322110000 00 000001
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.. .........+.+++.+||+.+|++||++++|++.|
T Consensus 230 ~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 01122345788999999999999999999998865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=305.23 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=201.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhccccc-ceeeeeeEEeCC-----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRN-LVKLLGCCIQAD----- 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~----- 542 (792)
...|+.+++||+|.||+||+|+.+ +|+.||+|+++.... .......+|+.++++++|+| ||++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345667788999999999999865 488999999987643 23456789999999999999 999999999887
Q ss_pred -cceEEEeecCCCChhHHHhhcccC-ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 543 -ESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 543 -~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
..++|+||++. +|..++....+. ..++...+..++.||++||+|||+++ |+||||||+||||++.|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 68899999965 788888654422 34666888999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh-
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE- 698 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 698 (792)
+|+.+.-.. ......++|.+|+|||++.+. .|+...||||+|||+.||++++..|......+... ........
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~---~If~~lGtP 240 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF---RIFRLLGTP 240 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH---HHHHHcCCC
Confidence 999764222 113346789999999999776 79999999999999999999999887655422211 11111110
Q ss_pred --hhh---hhhcccc--ccCCC-CH-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 --KRA---MELAGDT--LADSH-PP-------TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 --~~~---~~~~~~~--~~~~~-~~-------~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ..+.+-. ..... +. ....+..+++.+|++.+|++|.|++.++++
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000 0000110 00000 01 111367889999999999999999999886
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.63 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+|+..+.||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999854 5889999999776555667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999999843 34789999999999999999999987 99999999999999999999999999886543221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||....+... +. .. .......
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~----~~--------~~~~~~~ 235 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LI--------ATNGTPE 235 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HH----HH--------hcCCCCC
Confidence 12234688999999999888899999999999999999999999964432110 00 00 0011111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+||+.+|++||++.||++.
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11233445668899999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.33 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=207.3
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|.+.++||+|+||.||+|...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998888899999987543 34577999999999999999999999999989999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999996532 345899999999999999999999987 999999999999999999999999999876532211
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||.+.+..++.++||||||++++||++ |+.||...... .... .. .....
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~----~~---------~~~~~ 222 (261)
T cd05034 160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLE----QV---------ERGYR 222 (261)
T ss_pred -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HH---------HcCCC
Confidence 1112334678999999998899999999999999999999 99998543211 0110 00 01111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 12222335678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=313.62 Aligned_cols=263 Identities=25% Similarity=0.409 Sum_probs=204.2
Q ss_pred cccccccccCcCCcccEEeeec-----cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
+.|++.++||+|+||.||+++. ..+..||+|.++... ....+.+.+|++++++++||||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999874 247789999987553 34456899999999999999999999999875 567
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998543 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCC--------CccchhHHHHHH
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD--------HDHNLLGHAWIL 695 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~--------~~~~l~~~~~~~ 695 (792)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|....... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 234 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR---- 234 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH----
Confidence 6433211 1222355677899999998888999999999999999999987764321100 00000000
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+........+...+..+.+++.+|++.+|++||++++|++.|+++
T Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 -----LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -----HHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011111111222334566799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=309.11 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=190.9
Q ss_pred cccCcCCcccEEeeeccC---CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
++||+|+||.||+|.... ...+++|.+.... ......+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3568899876543 334567889999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc--CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 555 SLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 555 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|.+++..... ....++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999966432 233567888899999999999999987 9999999999999999999999999987543322222
Q ss_pred cccccccccCcccccccc-------CCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 633 NTHKVVGTYGYMSPEYAA-------EGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
......++..|+|||++. ...++.++||||||+++|||++ |..||....+.+ .. ...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~----~~~~~~~~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL----KQVVREQDIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH----HHHhhccCccC
Confidence 223345677899999874 3457889999999999999999 777876432211 00 00001111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+ ..+......+.+++..|+ .+|++||+++||+++|.
T Consensus 231 ~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111 122233455667778888 59999999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.31 Aligned_cols=251 Identities=21% Similarity=0.335 Sum_probs=198.9
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..++||+|+||.||+|+.. +++.||+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35677889999999999999864 5789999998655 334456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997553 3678888899999999999999987 999999999999999999999999999865432
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||............... .....+....
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~ 218 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL--------LQCIVDEDPP 218 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH--------HHHHhccCCC
Confidence 122357899999999999989999999999999999999999998653322211110000 0000111101
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.........++.+++.+|++.+|++||+++|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111234567899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=329.88 Aligned_cols=253 Identities=21% Similarity=0.270 Sum_probs=196.2
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|...++||+|+||.||+++.. +++.||||++.+. .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999764 5889999998653 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 35788889999999999999999988 999999999999999999999999998643211
Q ss_pred Ccc------------c---------------------------------cccccccccCccccccccCCCCCccCcchhH
Q 003832 629 EIQ------------T---------------------------------NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSF 663 (792)
Q Consensus 629 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~ 663 (792)
... . ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0 0012469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC---CCHH
Q 003832 664 GVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR---PNMS 740 (792)
Q Consensus 664 Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~R---Ps~~ 740 (792)
||++|||++|+.||....+.+. . ....... ..+..........++.+++.+|++ +|.+| |++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~---~---~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET---Y---RKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH---H---HHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999964332110 0 0000000 001001111234567788889997 66665 6999
Q ss_pred HHHHH
Q 003832 741 SVVLM 745 (792)
Q Consensus 741 evl~~ 745 (792)
|++++
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.04 Aligned_cols=242 Identities=24% Similarity=0.365 Sum_probs=194.5
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+|+... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999998754 789999998754 233445677889988876 799999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 9999888543 35888999999999999999999988 99999999999999999999999999875432221 1
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~------------~i~~~~--~~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE------------SILHDD--VLY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH------------HHHcCC--CCC
Confidence 233578999999999999999999999999999999999999997443211 110 000110 011
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRP-------NMSSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RP-------s~~evl~~ 745 (792)
+......+.+++..||+.+|++|| +++++++.
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 222345678899999999999999 88888764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=318.05 Aligned_cols=240 Identities=26% Similarity=0.365 Sum_probs=191.0
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++.. +++.||+|++++.. ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999876 47899999997542 23445667788888765 899999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 9999888543 35788999999999999999999987 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~------~~~~----~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESI------RVDT----PHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHH------HhCC----CCC
Confidence 23467899999999999999999999999999999999999999643221 110 000 0001 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMS-SVV 743 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~-evl 743 (792)
+.....++.+++.+||+.+|++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223445678899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=309.92 Aligned_cols=251 Identities=31% Similarity=0.505 Sum_probs=200.0
Q ss_pred cccCcCCcccEEeeeccC-------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2579999886543 24566889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc----cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-----CceEeeecc
Q 003832 551 MPNKSLDFFIFDQA----RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-----NPKISDFGM 621 (792)
Q Consensus 551 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DFgl 621 (792)
+++++|.+++.... ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999996532 2235789999999999999999999887 99999999999999887 899999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
+................++..|+|||.+.++.++.++||||||+++|||++ |+.||...... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~----------- 223 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVL----------- 223 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHH-----------
Confidence 986643332222223345788999999999999999999999999999998 99998633211 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+........+...+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 224 --QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred --HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0011111112233455678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=330.15 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=193.9
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.|+.+++||+|+||.||+|+.. +++.+|+|++.+.. ....+.+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999865 47889999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++.+. ..+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998543 35788888999999999999999988 9999999999999999999999999975432100
Q ss_pred ---------------------------------------------ccccccccccccCccccccccCCCCCccCcchhHH
Q 003832 630 ---------------------------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664 (792)
Q Consensus 630 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~G 664 (792)
.........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHH
Q 003832 665 VLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN---MSS 741 (792)
Q Consensus 665 vil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs---~~e 741 (792)
|+||||++|+.||....+... ..... . ...............++.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~------~~~i~------~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLET------QMKVI------N-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHH------HHHHH------c-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 999999999999975432110 00000 0 0001111111123345566666655 49999997 777
Q ss_pred HHHH
Q 003832 742 VVLM 745 (792)
Q Consensus 742 vl~~ 745 (792)
++++
T Consensus 302 i~~h 305 (382)
T cd05625 302 IKAH 305 (382)
T ss_pred HhcC
Confidence 7753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.58 Aligned_cols=259 Identities=25% Similarity=0.376 Sum_probs=203.9
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++.+++++.....||+|+||.||+|+.. ++..|++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455667777789999999999999865 467899999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~ 625 (792)
|+||+++++|.+++.........++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999965422212278888899999999999999987 999999999999976 679999999998765
Q ss_pred CCCCccccccccccccCccccccccCCC--CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
..... ......++..|+|||++.... ++.++||||||+++|||++|+.||........ .. ...
T Consensus 160 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~-----~~~----- 224 (268)
T cd06624 160 AGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AM-----FKV----- 224 (268)
T ss_pred ccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hH-----hhh-----
Confidence 43221 122345789999999986543 78999999999999999999999864321110 00 000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.........+.....++.+++.+||+.+|++||++.||++.
T Consensus 225 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 225 -GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00011122344455678899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=325.34 Aligned_cols=238 Identities=24% Similarity=0.307 Sum_probs=192.4
Q ss_pred cccCcCCcccEEeeec----cCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 479 NKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
+.||+|+||.||+++. ..++.+|+|++.+.. ......+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 347899999997542 2234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999988543 35889999999999999999999988 99999999999999999999999999886543211
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..+.... ..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~------------~~i~~~~--~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM------------TMILKAK--LG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH------------HHHHcCC--CC
Confidence 1223578999999999998889999999999999999999999996432210 00 0000111 12
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSS 741 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~e 741 (792)
.+......+.+++.+||+.+|++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23334556789999999999999999555
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.30 Aligned_cols=271 Identities=27% Similarity=0.431 Sum_probs=207.0
Q ss_pred cccccccccCcCCcccEEeeecc-----CCcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEe--CCcc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 544 (792)
+.|+..+.||+|+||.||++++. .++.+|||++...... ..+.|.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999854 3678999999765443 56789999999999999999999999987 5578
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999996532 25899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCc-cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...............+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccccccccHHHHHH
Confidence 653221 11122234566799999998889999999999999999999999987543221100 0000000000011111
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+........+...+.++.+++.+|++.+|++||+|.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111112222334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.60 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=195.0
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----ceEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-----SMLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-----~~lV 547 (792)
.|...+++|.|+||.||+|.... ++.||||+.-.+.+ .-..|+++|+++.|||||+++-+|....+ ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46677899999999999998765 68999999865433 22469999999999999999999875432 3579
Q ss_pred EeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecccccc
Q 003832 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIF 625 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgla~~~ 625 (792)
||||+. +|..++.+- ..+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 777777542 12345777778889999999999999987 9999999999999976 99999999999998
Q ss_pred CCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh--
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM-- 702 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-- 702 (792)
..++... ...-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+.+..++..++......-....+.
T Consensus 177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554332 2345789999998866 579999999999999999999999998755443322211111000001110
Q ss_pred -----hhccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 -----ELAGDTLAD-----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 -----~~~~~~~~~-----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+...+.+.. -.......++++++.++++.+|.+|.++.|++.+
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111111 1223445678899999999999999999999875
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=317.77 Aligned_cols=252 Identities=25% Similarity=0.419 Sum_probs=213.7
Q ss_pred ccccccccCcCCcccEEeeeccC---C--cEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE---G--QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~---~--~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.....+.||.|.||.||+|...+ | -.||||..+.+ .....+.|..|..+|++++|||||+++|+|.+ ...+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34556789999999999998543 3 35899999875 44567889999999999999999999999975 567999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||.++-|.|..||..+ ...|+......++.||..||+|||+.. +|||||..+||||...--+||+|||+++.+..
T Consensus 469 mEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999999654 345888889999999999999999987 99999999999999999999999999999877
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
+.+.... ...-++.|||||-+.-..++.++|||.|||.+|||+. |..||......+. ...++
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV----------------I~~iE 606 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV----------------IGHIE 606 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce----------------EEEec
Confidence 6655444 4566889999999999999999999999999999977 9999976443322 12233
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..-+.+.|+.++..++.|+.+||+.+|.+||.+.|+...|+.
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd 648 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD 648 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence 444567888999999999999999999999999999887753
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.58 Aligned_cols=241 Identities=27% Similarity=0.397 Sum_probs=193.4
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++... ++.||+|++.+. .....+.+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998754 789999998753 233456677888888877 699999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 9999888543 35889999999999999999999987 9999999999999999999999999987542221 11
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. .. +.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~----~~--------i~~~~--~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LF----EA--------ILNDE--VVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HH----HH--------HhcCC--CCC
Confidence 233578999999999999999999999999999999999999997433210 00 00 00000 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNM------SSVVL 744 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~------~evl~ 744 (792)
+.....++.+++.+||+.+|++||++ +++++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 22345567899999999999999998 55554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=307.85 Aligned_cols=240 Identities=19% Similarity=0.347 Sum_probs=189.7
Q ss_pred cccCcCCcccEEeeeccC-------------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 479 NKLGEGGFGPVYKGTLVE-------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
+.||+|+||.||+|+... ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358999887655555668899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-------ceEee
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-------PKISD 618 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~D 618 (792)
+||||+++++|+.++... ...+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888543 345889999999999999999999987 999999999999987664 89999
Q ss_pred eccccccCCCCccccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHH-hCCCCCCCCCCCCccchhHHHHHHH
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIV-SGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~ell-tG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
||++...... ....++..|+|||.+. ...++.++||||||+++|||+ +|+.|+......+.. .
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~-- 220 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------R-- 220 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------H--
Confidence 9998754321 2245788999999886 567899999999999999998 577776532211100 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
....... ........+.+|+.+||+.+|++||++.+|++.|+
T Consensus 221 -------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 221 -------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0000000 11112356789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=330.80 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=195.7
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
+|++.++||+|+||.||+++... ++.||||++.+.. ....+.+.+|++++.+++||||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999998654 8899999986532 2334668899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++... ..++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 99999999998543 35788888899999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------ccccccccccccCccccccccCCCCCccCcchhHHHHHH
Q 003832 630 -----------------------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVL 668 (792)
Q Consensus 630 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ 668 (792)
.........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 003832 669 EIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP---NMSSVVLM 745 (792)
Q Consensus 669 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP---s~~evl~~ 745 (792)
||++|+.||....+.+. .... ... ...............+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 236 ell~G~~Pf~~~~~~~~------~~~i-~~~------~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 236 EMLVGQPPFLADTPAET------QLKV-INW------ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred ehhhCCCCCCCCCHHHH------HHHH-hcc------CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999999975432211 0000 000 000001111123345566777765 4999999 88998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=305.92 Aligned_cols=254 Identities=30% Similarity=0.482 Sum_probs=205.0
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..++||+|+||.||++...++..+|+|.+.... ...+.+.+|+.++++++|+||+++.+++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788889999999999999998778889999986542 345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 157 (260)
T cd05073 83 AKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY- 157 (260)
T ss_pred CCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-
Confidence 9999999986542 345788999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......++..|+|||.+....++.++||||||++++|+++ |+.||...... .+. .... ....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~----~~~~---------~~~~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RALE---------RGYR 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHh---------CCCC
Confidence 11222345678999999988889999999999999999999 89898643211 011 0001 1111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+..+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12223345568899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.81 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=196.2
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++... ++.+|+|++++.. ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999998754 7889999997642 23456688999999888 699999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 9998887543 35899999999999999999999988 9999999999999999999999999987532211 11
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||................... .... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~--~~~ 222 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEKP--IRI 222 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhCC--CCC
Confidence 233578999999999999999999999999999999999999997543322211111111111 1111 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNM------SSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~------~evl~~ 745 (792)
+......+.+++.+||+.+|++||++ ++++++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 33344567899999999999999984 566553
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=310.35 Aligned_cols=248 Identities=26% Similarity=0.362 Sum_probs=194.2
Q ss_pred cCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||.||+++.. +++.+|+|++.... ......+..|++++++++||||+++++++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 48999999986431 12234566799999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~ 153 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ 153 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence 98886543 334889999999999999999999987 99999999999999999999999999887643221 123
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..|+..|+|||++.+..++.++|||||||++|||++|+.||......... . ..... ........ ....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~-----~~~~~----~~~~~~~~-~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--E-----ELKRR----TLEDEVKF-EHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--H-----HHHHH----hhcccccc-cccc
Confidence 46899999999999888999999999999999999999998643221110 0 00000 11111100 0112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
...++.+++..||+.+|++||+++|+++.+.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 3456789999999999999999987765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.04 Aligned_cols=249 Identities=29% Similarity=0.449 Sum_probs=195.9
Q ss_pred cccCcCCcccEEeeeccC-Cc--EEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+|+..+ +. .+++|.+... .....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999998754 33 5788988754 334556889999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 554 KSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 554 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 1235789999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
++..... .........+..|+|||++....++.++||||||++++||++ |+.||....... .. ..
T Consensus 158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~---- 223 (270)
T cd05047 158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LY----EK---- 223 (270)
T ss_pred Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HH----HH----
Confidence 9863211 111111234567999999988889999999999999999997 999986432110 00 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+......+.+++.+|++.+|.+||++.|+++.|+..
T Consensus 224 -----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 224 -----LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----HhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 011111112223445688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.20 Aligned_cols=246 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+|...+.||+|+||.||+|+... ++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778899999999999998764 6789999987542 23344567788888877 5899999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|..++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 35889999999999999999999987 999999999999999999999999998754322
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~------------~i~~~~ 217 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQ------------SIMEHN 217 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHH------------HHHhCC
Confidence 11 223467899999999999999999999999999999999999999743321 1110 011111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~ 744 (792)
...+.....++.+++.+|++.+|++|++. .++.+
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 12233445678899999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=305.40 Aligned_cols=248 Identities=26% Similarity=0.402 Sum_probs=199.8
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEE-eCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI-QADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~-~~~~~~lV~e~~ 551 (792)
++|...+.||+|+||.||++.. .+..+|+|.++... ..+.+.+|+.++++++|+|++++++++. +.+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999977 47889999986543 3467899999999999999999999865 446789999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999986543 345889999999999999999999987 9999999999999999999999999987643221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
....++..|+|||++....++.++||||||+++|||++ |+.||...... .+. ... .....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~----~~~---------~~~~~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV----PRV---------EKGYK 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHH---------hcCCC
Confidence 12344678999999998899999999999999999998 99888633211 000 000 00111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
...+...+..+.+++.+|++.+|++||++.++++.|+.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 12233445678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=305.89 Aligned_cols=251 Identities=28% Similarity=0.485 Sum_probs=202.2
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.+|+..+.||+|+||.||++...+++.+|+|.+.... ....+|.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4577788999999999999988778899999986543 234678999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999998543 235789999999999999999999987 9999999999999999999999999988654332111
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .+.. ... .....
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~---------~~~~~ 220 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE----TIN---------AGFRL 220 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH----HHh---------CCCCC
Confidence 112335678999999998899999999999999999998 89988643221 0110 000 00011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
..+...+..+.+++.+||+.+|++||++.||+++|
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11222346788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.56 Aligned_cols=239 Identities=21% Similarity=0.365 Sum_probs=188.5
Q ss_pred ccCcCCcccEEeeeccC-------------------------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceee
Q 003832 480 KLGEGGFGPVYKGTLVE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL 534 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l 534 (792)
+||+|+||.||+|.+.. ...|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876555555678999999999999999999
Q ss_pred eeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC--
Q 003832 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-- 612 (792)
Q Consensus 535 ~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-- 612 (792)
++++.+....++||||+++|+|+.++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999988543 345889999999999999999999987 99999999999998654
Q ss_pred -----CceEeeeccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHH-hCCCCCCCCCCCCc
Q 003832 613 -----NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIV-SGKKNWRFSHPDHD 685 (792)
Q Consensus 613 -----~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~ell-tG~~p~~~~~~~~~ 685 (792)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||....+...
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3799999987643221 12356788999998865 56899999999999999994 78888864332211
Q ss_pred cchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 686 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
.. ... ... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ~~-------~~~---------~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER-------FYE---------KKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH-------HHH---------hcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00 000 000 111112346789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.33 Aligned_cols=242 Identities=27% Similarity=0.367 Sum_probs=195.1
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++... ++.||||++++. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999998764 789999999754 233456677899999888 699999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~ 152 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T 152 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence 9999888543 35889999999999999999999987 99999999999999999999999999875322211 1
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ... . .+.... ...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~----~--------~i~~~~--~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELF----Q--------SILEDE--VRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHH----H--------HHHcCC--CCC
Confidence 22356899999999999999999999999999999999999999643211 000 0 000111 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~~ 745 (792)
+......+.+++.+||+.+|++||++ .++++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 23345568899999999999999999 888764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.97 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=199.2
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeC------
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA------ 541 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~------ 541 (792)
.+.+.|+..+.||+|+||.||+|...+ ++.+|+|++.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456778889999999999999998754 7889999986543 3456788999999998 699999999998763
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 3578999999999999998653 2346889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||....+... . ...
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~------~-~~~ 228 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA------L-FLI 228 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH------H-HHH
Confidence 88653321 1223356889999999985 34688899999999999999999999863322110 0 000
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.. .......+...+..+.+++.+||+.+|.+||++.||++
T Consensus 229 -----~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 -----PR---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----hc---CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 00111111223456789999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.32 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=215.1
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+-|.++++||+|+||.||++.++. |+.+|||++..+ ...+++..|+.+|++.+.|++|+++|.+......++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 347788999999999999999876 899999998654 45788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
.-|+..++++. ++++|.+.++..++...++||+|||... -+|||||..||||+.+|.+||+|||.+..+....
T Consensus 111 GAGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-- 183 (502)
T KOG0574|consen 111 GAGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-- 183 (502)
T ss_pred CCCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence 99999999954 5678999999999999999999999876 7999999999999999999999999998775332
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
...+.+.||+-|||||++..-.|..++||||+|+...||..|++||...++-.....+ -..+...-
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI--------------PT~PPPTF 249 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI--------------PTKPPPTF 249 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec--------------cCCCCCCC
Confidence 2344588999999999999999999999999999999999999999876664332111 11122223
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..|.....++.++++.||-+.|++|-|+-+++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4567788899999999999999999999988774
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=314.46 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=200.9
Q ss_pred hcccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.++|+..+.||+|+||.||+|+... ++ .+|+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567788899999999999998643 43 578998865432 3345788999999999999999999998754 467
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+++||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999998643 235788999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~----~~~-------- 224 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IP----DLL-------- 224 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHH--------
Confidence 53332222223445778999999998899999999999999999998 888885432110 00 011
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+......+.+++..|+..+|++||+++++++.|+..
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 225 -EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111223445788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=316.37 Aligned_cols=237 Identities=23% Similarity=0.316 Sum_probs=187.7
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHH-HHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||+||+|+.. +++.||+|++.+.. ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986532 222334445544 56789999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 9999888543 35888999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... + . ........ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~---~---------~~i~~~~~--~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---M---Y---------DNILNKPL--RL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---H---H---------HHHHcCCC--CC
Confidence 234578999999999999999999999999999999999999986432110 0 0 00111111 12
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMS 740 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~ 740 (792)
++.....+.+++.+|++.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 223356688999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=341.75 Aligned_cols=260 Identities=21% Similarity=0.252 Sum_probs=202.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||.||+|+.. .++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999875 48899999997542 233467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcc--------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 549 EYMPNKSLDFFIFDQA--------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1234567788999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCc----------------cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 003832 621 MARIFGGDEI----------------QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (792)
Q Consensus 621 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~ 684 (792)
+++....... ........||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 011123569999999999999999999999999999999999999996532211
Q ss_pred ccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcCC
Q 003832 685 DHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-NMSSVVLMLSSD 749 (792)
Q Consensus 685 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-s~~evl~~L~~~ 749 (792)
. .. .. ....+.. .......+..+.+++.+|++.+|++|| +++++++.|+..
T Consensus 239 i---~~-------~~---~i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 239 I---SY-------RD---VILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred h---hh-------hh---hccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00 00 0001100 001113345678899999999999995 667777766543
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=318.20 Aligned_cols=241 Identities=26% Similarity=0.380 Sum_probs=191.6
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+|+... ++.||||+++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999998764 7889999987542 23345567788888764 899999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 9999988543 35789999999999999999999987 9999999999999999999999999987532211 11
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... .+. ... ....+ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~-------~~i---~~~~~----~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELF-------QSI---RMDNP----CY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHH-------HHH---HhCCC----CC
Confidence 23357899999999999999999999999999999999999999643221 111 000 00011 12
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMS-SVVL 744 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~-evl~ 744 (792)
+......+.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 223445678899999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=314.30 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=201.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|++.++||+|+||.||++... ++..+|+|.+... .....+++.+|++++.+++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999875 4778899988654 333456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ..+++..+..++.|+++||.|||+.. +++|+||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998643 45788999999999999999999742 39999999999999999999999999987653221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh-------------
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK------------- 697 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------- 697 (792)
.....++..|+|||.+.+..++.++||||||++++||++|+.||....................
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 2235688999999999888899999999999999999999999864322111000000000000
Q ss_pred --------hhhhhhhccccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 --------EKRAMELAGDTLADSHP-PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 --------~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........... ....+ ......+.+++.+||+.+|++||++.||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEP-PPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCC-CccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00011 1134568899999999999999999999886
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=304.66 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=204.7
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
++|+..++||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++||||+++++++.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999865 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998543 346899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||++++||++|+.||....+.... ... .. ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-------~~~-----~~--~~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-------FMI-----PN--KPPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-------hhh-----cc--CCCCCC
Confidence 122345788999999998889999999999999999999999998753322110 000 00 000011
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+......+.+++.+|++.+|++||+++||++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1223344578899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=325.09 Aligned_cols=259 Identities=20% Similarity=0.258 Sum_probs=201.0
Q ss_pred hHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
++....++|+..+.||+|+||.||+++... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 344556899999999999999999998764 788999998642 2233456788999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998853 24778888899999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccCC----CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEG----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
..+..... .......||+.|+|||++... .++.++|||||||++|||++|+.||...... .........
T Consensus 190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~ 262 (371)
T cd05622 190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNH 262 (371)
T ss_pred eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Confidence 87643321 122346799999999998653 3789999999999999999999999743221 111010000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHh
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLML 746 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~L 746 (792)
. ..............+.+++..|++..+.+ ||+++||+++.
T Consensus 263 ~-------~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 K-------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred C-------CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 0 00111112234556778899999854443 78999998863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.85 Aligned_cols=255 Identities=28% Similarity=0.459 Sum_probs=203.6
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|...+.||+|+||.||+|...+ +. .+|+|.+..... ...+++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567788999999999999998643 32 589998876543 445688999999999999999999999987 78899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998653 234899999999999999999999977 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
............++..|+|||.+....++.++||||||++++||++ |+.||......+ +. ..+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~-------------~~~ 224 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IP-------------DLL 224 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HH-------------HHH
Confidence 3322221222334678999999988899999999999999999999 999986433211 00 001
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+......+.+++.+||..+|++||++.++++.|+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 225 EKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11111122233445678899999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=308.60 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=200.8
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
|++.++||+|+||.||+|.... +..+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5677899999999999998764 678899998766666677899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~ 159 (282)
T cd06643 87 GAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 159 (282)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--cc
Confidence 9998887542 346899999999999999999999987 9999999999999999999999999987653221 12
Q ss_pred ccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 634 THKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....++..|+|||++. ...++.++|||||||++|||++|+.||....+... .. . .... ..+.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~-~~~~-----~~~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LL----K-IAKS-----EPPT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HH----H-Hhhc-----CCCC
Confidence 23356889999999883 45678899999999999999999999864322100 00 0 0000 0000
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
...+......+.+++.+||+.+|++||++.++++.-
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 --LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 112223445788999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=307.20 Aligned_cols=256 Identities=28% Similarity=0.424 Sum_probs=204.1
Q ss_pred cccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
++|+..++||+|+||.||+|+.+. .+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 568888999999999999998642 467999998765443 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccC------ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 546 LIYEYMPNKSLDFFIFDQARA------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754422 25899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
|++......... ......++..|+|||.+.+..++.++||||||++++||++ |..||...... .... ...
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~----~~~- 232 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN----RLQ- 232 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH----HHH-
Confidence 998754322211 2223456778999999988889999999999999999999 77787532211 1110 000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
........+...+..+.+++.+|++.+|++||++.|++++|+
T Consensus 233 -------~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 233 -------AGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------cCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 011111122234457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=324.96 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=197.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----cce
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (792)
+|+..++||+|+||.||++... +++.||||++... .....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677899999999999999864 5899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 467776643 345889999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHH
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILW 696 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~ 696 (792)
...... ......++..|+|||.+.+. .++.++|||||||++|||++|+.||....+......+.. .....
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 432211 12234678999999998764 579999999999999999999999975443211100000 00000
Q ss_pred hhhhhhhhccccccC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 KEKRAMELAGDTLAD-------SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.....+....... ........++.+++.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000 0111224567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=305.28 Aligned_cols=250 Identities=28% Similarity=0.409 Sum_probs=192.6
Q ss_pred cccCcCCcccEEeeeccC----CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcceEEEeecC
Q 003832 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESMLIYEYMP 552 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~lV~e~~~ 552 (792)
+.||+|+||.||+|...+ ...+|+|++... .....+.+.+|+.+++.++||||+++++++.. ....++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 357999998643 33456788899999999999999999998764 456789999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc-
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ- 631 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~- 631 (792)
+++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998643 234677888999999999999999987 999999999999999999999999999865432211
Q ss_pred -ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 632 -TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 632 -~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.......++..|+|||.+....++.++||||||+++|||++| ..||...... .+. .. . ....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~---~~-~---------~~~~ 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT---VY-L---------LQGR 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH---HH-H---------hcCC
Confidence 111234567789999999888999999999999999999995 4455422110 010 00 0 0000
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+...+..+.+++..||+.+|++||++.||++.|++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111222345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.77 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=205.5
Q ss_pred ccCcCCcccEEeeeccCCc-EEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChhH
Q 003832 480 KLGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 558 (792)
+||+|.||+||.|+..+.+ .+|||.+.....+..+-+.+|+.+.++++|.|||+++|.+.+....-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987654 699999988777778889999999999999999999999999999999999999999999
Q ss_pred HHhhcccCccC--ChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccccCCCCcccccc
Q 003832 559 FIFDQARATFL--DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTH 635 (792)
Q Consensus 559 ~l~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~ 635 (792)
+|... =+++ .+...-...+||++||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+.. ....+.
T Consensus 662 LLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TE 734 (1226)
T KOG4279|consen 662 LLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTE 734 (1226)
T ss_pred HHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccc
Confidence 99543 3345 67778889999999999999987 99999999999996 568999999999987743 333455
Q ss_pred ccccccCccccccccCC--CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 636 KVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 636 ~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
...||..|||||++..+ .|+.++|||||||.+.||.||++||........ + ..++---....++
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------A--------MFkVGmyKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------A--------MFKVGMYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------h--------hhhhcceecCCCC
Confidence 57899999999999765 588999999999999999999999964332211 1 1111112334577
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
|.+...+...++++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8889999999999999999999999999876
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=303.87 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=202.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+|+..++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999865 4889999998653 3345567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ....++......++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++..+.....
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999999888543 3345788999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... ..... ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~----~~~~~---------~~~~ 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NLI----LKVCQ---------GSYK 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HHH----HHHhc---------CCCC
Confidence 122356889999999999888999999999999999999999998643211 000 00001 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+......+.+++.+||+.+|++||++.+|+..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2233345568899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=332.18 Aligned_cols=261 Identities=19% Similarity=0.285 Sum_probs=192.6
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC--------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-------- 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 541 (792)
..++|+..++||+|+||.||+|+.. .++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3567999999999999999999875 47899999985432 2345799999999999999999887532
Q ss_pred CcceEEEeecCCCChhHHHhh-cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeee
Q 003832 542 DESMLIYEYMPNKSLDFFIFD-QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDF 619 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DF 619 (792)
...++||||+++ +|.+++.. ......+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 56666543 223456889999999999999999999988 99999999999999665 7999999
Q ss_pred ccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
|+++.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +.. .......
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~-i~~~~~~ 289 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVR-IIQVLGT 289 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCC
Confidence 99987643221 123567999999998865 4689999999999999999999999975432211 100 0000000
Q ss_pred hh----------hhh-----hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 KR----------AME-----LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ~~----------~~~-----~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ... .....+....+...+.++.+|+.+||+.+|++|||+.|++++
T Consensus 290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 000 000011111222334578899999999999999999999864
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=308.37 Aligned_cols=240 Identities=25% Similarity=0.422 Sum_probs=191.1
Q ss_pred cccCcCCcccEEeeeccC--------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+.||+|+||.||+|.... ...+++|.+........+.+.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997643 234888888665555667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC--------ceEeeeccc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PKISDFGMA 622 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DFgla 622 (792)
+++|+|..++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 99999999986543 35789999999999999999999987 999999999999988765 589999988
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCC-CCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGK-KNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+....+... .
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~----------- 215 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---L----------- 215 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---H-----------
Confidence 654321 22467889999999976 45799999999999999999995 45432221100 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..... ....+.....++.+++..||+.+|++||++++|++.|+
T Consensus 216 --~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 216 --QFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00000 11223233456889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.33 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=198.8
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
|+..+.||+|+||.||++... .++.+|+|.+.... ....+.+..|+.++++++|+|++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999865 47899999986542 22335677899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 99999999886533 235889999999999999999999987 99999999999999999999999999876532221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||........... . ...... ..
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~---------~~~~~~-~~ 221 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---V---------ERLVKE-VQ 221 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---H---------Hhhhhh-hh
Confidence 1234689999999999999999999999999999999999999975332111000 0 000000 00
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVL 744 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~ 744 (792)
...+......+.+++..||+.+|++||+ ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122233456789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.33 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=200.2
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHH--HHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGME--EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~--~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
|+..+.||+|+||+||+++... ++.+|+|++......... ....|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999998765 568999999876543332 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++. ....+++..+..++.|+++||.+||+.+ ++|+||||+||++++++.++|+|||.+...... .
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--N 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTST--T
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc--c
Confidence 9999999996 3345899999999999999999999987 999999999999999999999999999864211 2
Q ss_pred ccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......++..|+|||++. +..++.++||||+|+++++|++|+.||......... ................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-------EIIEKILKRPLPSSSQ- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-------HHHHHHHHTHHHHHTT-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhh-------hhhhhccccccccccc-
Confidence 2333467899999999998 888999999999999999999999998744111110 0011111111111110
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........+.+++..||+.+|++||++.++++.
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112678899999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.90 Aligned_cols=262 Identities=19% Similarity=0.238 Sum_probs=196.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+|.+.+.||+|+||.||++++.. ++.||||... ...+.+|+++|++++|+|||++++++......++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4579999999999999999998765 7889999643 23467899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+. ++|..++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 6888877543 236899999999999999999999988 99999999999999999999999999987643322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC-CCCccchhHHHHHHHhhhhh--hhh---
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH-PDHDHNLLGHAWILWKEKRA--MEL--- 704 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~--~~~--- 704 (792)
........||..|+|||++.+..++.++|||||||+||||++|..|+-... .................... .++
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222234579999999999999999999999999999999999887653221 11111110001111111000 000
Q ss_pred ---------cc---ccccCC--CC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 ---------AG---DTLADS--HP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ---------~~---~~~~~~--~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ...... .+ ......+.+|+.+||+.||++|||+.||+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000 00 0112357789999999999999999999875
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=315.99 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=198.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|...++||+|+||.||+|+.. .++.||+|+++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 47789999987543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 777777543 335788999999999999999999987 99999999999999999999999999876432221
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHHhhhh-
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILWKEKR- 700 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~- 700 (792)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.. .+.......
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1223467899999998865 5689999999999999999999999975443221111100 000000000
Q ss_pred hhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 AMELAGDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
......+.... .........+.+++.+||+.+|++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 001123456789999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=299.49 Aligned_cols=254 Identities=22% Similarity=0.290 Sum_probs=210.1
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+.|+.++.||.|.-|+||++++++ +..+|+|++.+.. .+.......|-+||+.++||.++.|+..+..+...+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567778899999999999999876 5789999998763 344556778999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC-
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG- 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~- 627 (792)
|||+||+|..+.+++ ..+.++...+..++..|+.||+|||-.| ||.|||||+||||-++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999888665 4567899999999999999999999988 99999999999999999999999999754310
Q ss_pred --------------------------------C-C--------------------ccccccccccccCccccccccCCCC
Q 003832 628 --------------------------------D-E--------------------IQTNTHKVVGTYGYMSPEYAAEGLF 654 (792)
Q Consensus 628 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 654 (792)
. . ...+....+||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0011223679999999999999999
Q ss_pred CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCC
Q 003832 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPE 734 (792)
Q Consensus 655 s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~ 734 (792)
+.++|.|+|||+||||+.|+.||......+. ...++...+.-...+..+..+.+||+..|.+||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999987665433 1222233333233335667889999999999999
Q ss_pred CCCC----HHHHHHH
Q 003832 735 DRPN----MSSVVLM 745 (792)
Q Consensus 735 ~RPs----~~evl~~ 745 (792)
+|-. +.||-++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 8888774
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=315.83 Aligned_cols=237 Identities=22% Similarity=0.307 Sum_probs=187.2
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHH-HHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEV-TLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
++||+|+||.||+++.. +++.||+|++.+.. ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999875 47899999986532 12233455554 467889999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|...+... ..+....+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 9998887542 35778888999999999999999987 9999999999999999999999999987532221 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... .+. . .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~----~--------~i~~~~--~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMY----D--------NILHKP--LQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHH----H--------HHhcCC--CCC
Confidence 23457899999999999999999999999999999999999999643211 000 0 011111 122
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMS 740 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~ 740 (792)
+......+.+++.+||+.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 334456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.39 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=203.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..+.||+|+||.||++... .++.+|+|.+... .....+.+.+|+.++.+++||||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999876 5889999998754 334456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|..++........+++..+..++.|++.||.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999998865433456899999999999999999999742 39999999999999999999999999987653221
Q ss_pred cccccccccccCccccccccCC------CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... ... .....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~---------~~~~~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFA---------QLSAI 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHH---------HHHHH
Confidence 2234578899999998543 35889999999999999999999986432211 000 00011
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ......+.....++.+++.+|++.+|++||++.+++..
T Consensus 223 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 11123344566778899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.38 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=198.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|++|.||+|+.. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999875 58899999986542 23346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
++ ++|.+++........+++..+..++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865444567899999999999999999999987 99999999999999999999999999876542211
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-------HHHhhh---
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-------ILWKEK--- 699 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-------~~~~~~--- 699 (792)
......+++.|+|||.+.+ ..++.++||||||++++||++|+.||........ ...... ..+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhh
Confidence 1122456889999998865 4578999999999999999999999975332110 000000 000000
Q ss_pred -hhhhhccc---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 -RAMELAGD---TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 -~~~~~~~~---~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ ............++.+++.+||+.+|++|||+.+|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 00000011234567799999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=302.07 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=205.0
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHh--cccccceeeeeeEEeCC----cce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD----ESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~----~~~ 545 (792)
.++....+.||+|.||.||+|.+ .|+.||||++.... ++.+.+|.++.+. |+|+||+.+++.-..++ +.+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 45677888999999999999999 58999999996543 4556666666655 59999999999876554 578
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-----cCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-----DSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
||.+|.++|||.+||.+ ..++....++++..+|.||++||- +++|.|.|||||++||||..++.+.|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 99999999999999944 568999999999999999999995 478999999999999999999999999999
Q ss_pred cccccCCC--CccccccccccccCccccccccCCC----C-C-ccCcchhHHHHHHHHHh----C------CCCCCCCCC
Q 003832 621 MARIFGGD--EIQTNTHKVVGTYGYMSPEYAAEGL----F-S-VKSDVFSFGVLVLEIVS----G------KKNWRFSHP 682 (792)
Q Consensus 621 la~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~-s-~k~DVwS~Gvil~ellt----G------~~p~~~~~~ 682 (792)
||...... ......+..+||.+|||||++.+.. + + ..+||||||+|+||+.- | +.||-...+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99876543 3344456679999999999996532 2 2 35999999999999865 2 345544333
Q ss_pred CCccchhHHHHHHHhhhhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003832 683 DHDHNLLGHAWILWKEKRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPE 754 (792)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 754 (792)
.++. +.+. ..-+-..+++... ..+.+..+.++|+.||..+|.-|-|+--|-+.|.+....++
T Consensus 442 ~DPs-~eeM---------rkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 442 SDPS-FEEM---------RKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCCC-HHHH---------hcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 3321 1100 0111222333332 33567789999999999999999999999999987765443
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=304.93 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=201.2
Q ss_pred ccccccccCcCCcccEEeeeccC--CcEEEEEEccCC----------CchhHHHHHHHHHHHHh-cccccceeeeeeEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKG----------SGQGMEEFKNEVTLIAR-LQHRNLVKLLGCCIQ 540 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~ 540 (792)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36778899999999999999765 678999987532 22334567788888875 799999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
.+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999888542 23456889999999999999999999632 3999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... . . .
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~---~-~----- 223 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---L---A-T----- 223 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---H---H-H-----
Confidence 9998754432 2234568899999999998889999999999999999999999986332110 0 0 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..................+.+++.+|++.+|++||++.||..+|+.
T Consensus 224 ---~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 ---KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred ---HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 0111111111111234568899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.62 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=202.8
Q ss_pred cccccccccCcCCcccEEeeeccCC----cEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|...++||+|+||.||+|...+. ..|++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999986442 468999987654 4556789999999999999999999998875 567899
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999653 235899999999999999999999987 99999999999999999999999999987644
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
..... .....++..|+|||.+....++.++||||||++++||++ |+.||......+ .. .....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~----~~~~~-------- 223 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VI----GRIEN-------- 223 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HH----HHHHc--------
Confidence 32211 122344578999999988889999999999999999986 999986443211 00 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+...+..+.+++.+|+..+|++||++.++++.|++.
T Consensus 224 -~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 224 -GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 001122334456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.74 Aligned_cols=261 Identities=25% Similarity=0.405 Sum_probs=209.1
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.+|+..++||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999985 458899999997665555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998843 34889999999999999999999987 99999999999999999999999999886543322
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++|||||||++|||++|+.||....+.... ..... ......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-------~~~~~-------~~~~~~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIAT-------NGTPEL 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHh-------cCCccc
Confidence 122356889999999999888999999999999999999999998654331110 00000 000001
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCCCCCCC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSLLPEPN 756 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~~~~p~ 756 (792)
..+......+.+++.+||+.+|++||++.+|++. +....++..++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~~ 282 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLT 282 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccCC
Confidence 1222344567889999999999999999999874 44444433333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.87 Aligned_cols=248 Identities=25% Similarity=0.402 Sum_probs=203.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35778889999999999999875 47899999987553 34556788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998543 6899999999999999999999987 9999999999999999999999999998765332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||....+... . .... . ...
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~---~----~~~~-----~----~~~ 215 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV---L----FLIP-----K----NNP 215 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH---H----HHhh-----h----cCC
Confidence 122335678899999999988899999999999999999999999964432110 0 0000 0 011
Q ss_pred CCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.. ....+.+++..|++.+|++||+++++++.
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111111 44568889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=323.09 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=198.9
Q ss_pred hcccccccccCcCCcccEEeeecc---CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..+|.+.++||+|+||.||++... .+..||+|.+... ..+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357899999999999999999753 3578999988643 24568999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|++. ++|.+++. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 57777773 2346899999999999999999999988 999999999999999999999999999876543
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh-------
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA------- 701 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------- 701 (792)
..........||+.|+|||++....++.++|||||||++|||++|+.||...........+............
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 3322233467999999999999999999999999999999999999999654433211111000000000000
Q ss_pred ------hhhccccccCCC--C-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 ------MELAGDTLADSH--P-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ------~~~~~~~~~~~~--~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............ + .....++.+++.+||+.+|++||++.|++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 1 0123457789999999999999999999876
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.49 Aligned_cols=251 Identities=24% Similarity=0.409 Sum_probs=205.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|+..+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++++......++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367888999999999999999864 6899999999766555567789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.+ ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999999843 34788999999999999999999987 99999999999999999999999999876543321
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||....+....... .......
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~--------------~~~~~~~ 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPE 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee--------------ccCCCCC
Confidence 122346888999999999888999999999999999999999999654332111000 0000001
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+||+.+|++||++++|++.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223344567889999999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.89 Aligned_cols=251 Identities=23% Similarity=0.369 Sum_probs=204.4
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|+||.||.++.. +++.+++|.+... ......++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998754 4888999987654 344566789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999986542 346889999999999999999999987 99999999999999999999999999987644331
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......++..|+|||.+.+..++.++||||||++++||++|+.||......+ .. . ...... .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~~---~---------~~~~~~-~ 218 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LV---V---------KIVQGN-Y 218 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH---HH---H---------HHHcCC-C
Confidence 2233568999999999988889999999999999999999999986432210 00 0 000011 1
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
...+......+.+++.+|++.+|++||++.|+++.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 112233456688999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.79 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred cccccccCcCCcccEEeeecc----CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 475 FASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
|.+.+.||+|+||.||+|... .++.||||++... .....+++.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456679999999999999753 3678999998754 33456678999999999999999999999875432
Q ss_pred -ceEEEeecCCCChhHHHhhcc---cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 544 -SMLIYEYMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 544 -~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
.++++||+.+|+|..++.... ....+++....+++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 368899999999998875432 2234788899999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||...... .+.. ....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN----YLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH----HHHc
Confidence 99987643332222223445678999999988889999999999999999999 88887633211 1110 0000
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. .....+......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 G---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01112233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=307.63 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.5
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.|++.++||+|+||.||+|+... ++.+++|.+........+.+.+|+.++++++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999998755 7899999998776667788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|..++.+. ...+++..+..++.|++.+|.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 999998887543 235889999999999999999999987 9999999999999999999999999987543221
Q ss_pred ccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.......++..|+|||++. ...++.++|||||||++|||++|+.||....+... . .... ....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~-~~~~-----~~~~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------L-LKIA-----KSEP 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------H-HHHh-----cCCC
Confidence 1122356788999999984 34578899999999999999999999864322100 0 0000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+ ....+.....++.+++.+||+.+|++||+++||++.
T Consensus 233 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 233 P--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred c--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 011123344568899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=307.94 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=201.3
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.|+..+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++......++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999865 47789999987543 344567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999988843 35889999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||++++||++|+.|+....+... . ..+......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~-------------~~~~~~~~~ 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---L-------------FLIPKNSPP 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---H-------------hhhhcCCCC
Confidence 12234678899999999988999999999999999999999999864322111 0 000111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+...+..+.+++.+|++.+|++||+|.||+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2223345668899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=285.27 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=203.5
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--------chhHHHHHHHHHHHHhc-ccccceeeeeeEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--------GQGMEEFKNEVTLIARL-QHRNLVKLLGCCI 539 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~ 539 (792)
....+|...+.||+|..++|-+..++. |+..|+|++.... ....++-..|+.+|+++ -||+|+++.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345678888999999999999887654 7889999985431 12234567899999999 5999999999999
Q ss_pred eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
...-.++|+|.|+.|.|.++|... -.+++++..+|+.|+..|+.|||..+ ||||||||+|||+|++.++||+||
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~---VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSK---VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhh---eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 999999999999999999999653 35889999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCcccccccc------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
|++..+.+... ....+||++|+|||.+. ...|+..+|+|+.|||||-|+.|.+||..... ++..
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlML-- 237 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLML-- 237 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHHH--
Confidence 99998865542 34589999999999884 24588899999999999999999999852111 1100
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+++. ....+.-.+......+|+.+||+.||.+|.|++|++++
T Consensus 238 R~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 00111110 11222233456678899999999999999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.99 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=199.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
-|..++.||.|+||.||.++.. +.+.||||++.... .+..+++..|+..|.+++|||++.+.|+|..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4677789999999999999864 47789999997653 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||-| +-.+++.- ..+++...++..|+.+.+.||+|||+++ .||||||..||||++.|.|||+|||.|.+..+
T Consensus 107 YClG-SAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHhc-cHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 9955 55555532 3567889999999999999999999998 99999999999999999999999999987643
Q ss_pred ccccccccccccCccccccc---cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 630 IQTNTHKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.+..+|||.|||||++ ..+.|+-|+||||||+...||.-.++|+-...- +..+- .+...-.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----------MSALY--HIAQNes 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSALY--HIAQNES 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----------HHHHH--HHHhcCC
Confidence 3347999999999987 468899999999999999999999998642211 00000 0111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+.+ ...+....+.+++..||++-|.+|||.+++++
T Consensus 243 PtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 222 14567888999999999999999999998776
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=301.73 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=190.1
Q ss_pred cccCcCCcccEEeeeccCC---cEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 479 NKLGEGGFGPVYKGTLVEG---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
++||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346777776543 345578999999999999999999999999999999999999999
Q ss_pred ChhHHHhhccc-CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 555 SLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 555 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
+|.+++..... ....++.....++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999975432 334667778899999999999999987 99999999999999999999999999864322222222
Q ss_pred ccccccccCccccccccC-------CCCCccCcchhHHHHHHHHHhC-CCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 634 THKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVSG-KKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..||....+. ... ..........+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~----~~~~~~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVL----NHVIKDQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHhhcccccC
Confidence 234567889999998743 3457899999999999999974 5576432211 111 111111112222
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
++... ......+.+++..|+ .+|++||+++||++.|.
T Consensus 231 ~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 223456777888899 57999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.49 Aligned_cols=261 Identities=24% Similarity=0.352 Sum_probs=204.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|++.++||+|+||+||++... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999865 48889999886543 34467889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... +.+++.....++.+++.||.|||+.. .++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999888542 35889999999999999999999742 39999999999999999999999999987543211
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||................. ......+.....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL----DLLQQIVQEPPP 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH----HHHHHHhhccCC
Confidence 2235789999999999888999999999999999999999999975433211100000000 001111111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.......+..+.+++.+|++.+|++||++.||+++.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 111112455688999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.14 Aligned_cols=255 Identities=20% Similarity=0.240 Sum_probs=196.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||.||+++.. .++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999875 4778999998652 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999653 235788899999999999999999987 999999999999999999999999999876433
Q ss_pred CccccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
... ......|++.|+|||++.+ +.++.++||||||++||||++|+.||......+ ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~-- 226 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEER-- 226 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCc--
Confidence 221 1223578999999999865 568899999999999999999999996432210 00000000000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~ 745 (792)
. . ........+.++.+++.+|++..+++ |+++++++++
T Consensus 227 ~---~-~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 F---Q-FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c---c-CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0 01111123456778888888865544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=315.53 Aligned_cols=241 Identities=26% Similarity=0.386 Sum_probs=193.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 548 (792)
+|+..+.||+|+||.||+++.. +++.||+|++.+. .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 4889999998754 2234456788999998885 577888999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|..++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999888543 35889999999999999999999987 999999999999999999999999998754322
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+....
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~------------~i~~~~ 217 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQ------------SIMEHN 217 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHH------------HHHhCC
Confidence 21 123356899999999999999999999999999999999999999743221 1110 011111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNM 739 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~ 739 (792)
...+......+.+++.+|++.+|++|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233345567899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.41 Aligned_cols=240 Identities=21% Similarity=0.299 Sum_probs=188.6
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHH-HHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++.. +++.+|+|++.+. .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999864 5889999998653 2223345555554 56778999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 999888754 345889999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||....... +. . ....... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~----~--------~~~~~~~--~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY----D--------NILHKPL--VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH----H--------HHHcCCc--cC
Confidence 234578999999999999999999999999999999999999996432210 00 0 0011110 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl 743 (792)
++.....+.+++..|++.+|++||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 223445677899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.66 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=195.5
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..++||+|+||.||+++.+. ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468888999999999999998765 678999998642 2223445888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999653 235888899999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .......... .
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~--~ 226 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE--R 226 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc--c
Confidence 21 1222357999999999986 3568899999999999999999999996432211 0100000000 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCC--CCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRP--EDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P--~~RPs~~evl~~ 745 (792)
. ............+.+++.+|+..++ ..||+++|++++
T Consensus 227 ~----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 F----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0011112234567778888775544 347899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.33 Aligned_cols=254 Identities=23% Similarity=0.392 Sum_probs=205.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 47789999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ...++..++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 999999988553 245889999999999999999999987 9999999999999999999999999988654321
Q ss_pred ccccccccccCccccccccCC---CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.......++..|+|||.+... .++.++||||||+++|||++|+.||....+... .. ... ...+....
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~-----~~~---~~~~~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF-----LIS---KSNFPPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH-----HHH---hccCCCcc
Confidence 112235678899999999776 889999999999999999999999864332111 00 000 00000011
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+||+.+|++||++++|+.+
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 226 --LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11233445678899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.90 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=201.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|...++||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999865 4889999998766555566788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... +.+++.+...++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+....
T Consensus 88 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 88 CGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 9999999988543 35889999999999999999999987 9999999999999999999999999987654321
Q ss_pred cccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||....+.... . . .... ....+
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~-~~~~---~~~~~ 229 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----L-MTKS---NFQPP 229 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----h-hhcc---CCCCC
Confidence 1123357899999999874 456889999999999999999999998543321110 0 0 0000 00000
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... .......+.+++.+|++.+|++||++++|+++
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0000 11223457889999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=322.42 Aligned_cols=253 Identities=22% Similarity=0.293 Sum_probs=195.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||+++.. .++.||+|+++.. .....+.+.+|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999875 4889999998653 2334567888999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998543 35889999999999999999999988 999999999999999999999999998754321
Q ss_pred Cc---------------------------------cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCC
Q 003832 629 EI---------------------------------QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (792)
Q Consensus 629 ~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~ 675 (792)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 000113479999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 003832 676 NWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN---MSSVVLM 745 (792)
Q Consensus 676 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs---~~evl~~ 745 (792)
||....+... . ...... ...+..........++.+++.+++ .+|++|++ +.|++++
T Consensus 235 Pf~~~~~~~~---~----~~i~~~------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQET---Y----RKVMNW------KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHHH---H----HHHHcC------CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9975433211 0 000000 000000001112345667777766 49999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=303.91 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=204.1
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.|+..++||.|+||.||+|... .++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999875 47899999987543 345678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++.. ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998843 34788899999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....+.... ..+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCC
Confidence 122346788999999998888999999999999999999999998643322110 011111122
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+...+..+.+++..||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3344566778899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=300.56 Aligned_cols=238 Identities=24% Similarity=0.445 Sum_probs=190.4
Q ss_pred cccCcCCcccEEeeeccCCc-----------EEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 479 NKLGEGGFGPVYKGTLVEGQ-----------EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~-----------~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999886533 5788887654433 6789999999999999999999999988 788999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-------CceEeeec
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-------NPKISDFG 620 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~DFg 620 (792)
+||+++++|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999865432 5889999999999999999999987 99999999999999888 79999999
Q ss_pred cccccCCCCccccccccccccCccccccccCC--CCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......... ..+.
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~ 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQ 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHh
Confidence 9886543 1224567789999999776 78999999999999999999 56666543321110 0000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
... ..+......+.+++.+||+.+|++||++.||++.|+
T Consensus 221 --------~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --------DQH---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------cCC---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 011111267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=307.21 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=198.6
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
|+..+.||+|+||+||++... +++.+|+|.+.... ......+.+|++++++++|+|++++.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999875 58899999986542 22334578899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999998886542 345899999999999999999999987 9999999999999999999999999987653221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||........... . ...... . .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~-------~-~~~~~~---~--~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE-------V-DRRVLE---T--E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------H-HHhhhc---c--c
Confidence 11235789999999999988999999999999999999999999974322111000 0 000000 0 0
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
...+......+.+++..|++.+|++||+ +.+++..
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1122334456788999999999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.49 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=204.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||.|+||.||++... +++.+|+|.+........+.+..|+.++++++||||+++++.+......++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999875 4789999999776666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999998553 235899999999999999999999988 99999999999999999999999999876532211
Q ss_pred cccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 631 QTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
......++..|+|||.+. ...++.++||||||+++|||++|+.||....... .. ...... .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~----~~~~~~-----~ 224 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VL----LKILKS-----E 224 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HH----HHHhcC-----C
Confidence 122356889999999874 3457889999999999999999999986432210 00 000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+. ...+......+.+++..||+.+|++||++.+|++.
T Consensus 225 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPT--LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCC--cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001 11122344567889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.99 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=200.7
Q ss_pred ccccccccCcCCcccEEeeeccCCcEEEEEEccCCC------chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
+|...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999988789999999986432 12345688999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998543 34788999999999999999999987 99999999999999999999999999886532
Q ss_pred CCc----cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 628 DEI----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 628 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
... ........|+..|+|||.+.+..++.++||||||++++||++|+.||........ ... .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~~~--~~---~~- 223 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----MFY--IG---AH- 223 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----HHH--hh---hc-
Confidence 111 1112235688999999999988899999999999999999999999964321100 000 00 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.......+......+.+++.+||+.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 ---RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111223344566889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.15 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=199.3
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|++.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++.+++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4678889999999999999975 67889999986543 346789999999999999999999998654 5799999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999996543 335789999999999999999999987 999999999999999999999999998764321
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ . .... ......
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~---------~~~~~~ 216 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---V----KECV---------EKGYRM 216 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---H----HHHH---------hCCCCC
Confidence 112334578999999998899999999999999999998 998886432211 0 0001 111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 2223345678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=301.91 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=200.0
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch---------hHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ---------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~---------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
|...+.||+|++|.||+|... +++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556689999999999999864 4789999988654221 235688999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 9999999999999999543 45788899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 625 FGGDEIQ----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 625 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~------------ 220 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---A------------ 220 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---H------------
Confidence 6532111 11123457889999999998899999999999999999999999986432110 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+..... ......+......+.+++.+||+.+|++||++.||++.
T Consensus 221 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 221 IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 000000 11122334455678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.00 Aligned_cols=250 Identities=36% Similarity=0.549 Sum_probs=201.3
Q ss_pred ccccccCcCCcccEEeeeccC-----CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 476 ASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++.+.||.|+||.||+++..+ +..||+|++...... ..+.+..|+..+..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456799999999999998754 378999999765433 56789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++..... ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999865332 12899999999999999999999987 9999999999999999999999999998765442
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
..... ...++..|+|||.+.+..++.++||||+|++++||++ |+.||...... .+. ..... .
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~----~~~~~---------~ 220 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVL----EYLKK---------G 220 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHhc---------C
Confidence 22211 2346789999999988889999999999999999998 77777542111 111 00111 1
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122223456788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.02 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=212.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc---hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 545 (792)
..+.|+..+.||+|.||.||+++.+. |+.+|+|.+.+... ...+.+.+|+.+|+++. |||||.+.+.++.....+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 45678888999999999999999876 89999999977643 24568999999999998 999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC----CCceEeeecc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGM 621 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgl 621 (792)
+|||++.+|.|.+.+... .+++.+...++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999765 2899999999999999999999988 9999999999999643 5799999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....+
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~-- 253 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRG-- 253 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcC--
Confidence 998765 223456899999999999999999999999999999999999999998655432211 01111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+.......-+.....+.+++..|+..+|.+|+++.+++++
T Consensus 254 ----~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 254 ----DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1122223334456778899999999999999999999995
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.28 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=195.0
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999998754 889999998642 2234456889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998542 335888999999999999999999988 999999999999999999999999998765432
Q ss_pred CccccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.. .......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..............
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ 228 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 21 11223468999999999863 45788999999999999999999998643221 11101110000000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccC--CCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQH--RPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~--~P~~RPs~~evl~~ 745 (792)
. ..........+.+++.+|+.. ++..||++.++++.
T Consensus 229 -----~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -----F-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----C-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 011112344566777776644 44458899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.04 Aligned_cols=191 Identities=21% Similarity=0.323 Sum_probs=163.6
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+|++.+.||+|+||.||+|+... ++.||+|+.... ....|+.++++++||||+++++++......++|+|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 4579999999999999999998754 678999986432 235689999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+. ++|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 139 ~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 139 YS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred cC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 95 5787777543 346899999999999999999999987 9999999999999999999999999987533211
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCC
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~ 677 (792)
......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 --AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 122356899999999999999999999999999999999966654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=316.22 Aligned_cols=241 Identities=21% Similarity=0.285 Sum_probs=188.1
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHH-HHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEV-TLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei-~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+++... ++.+|+|++.+.. ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 479999999999998764 6789999986532 12223444444 456788999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ..+.......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 9999988543 34677888889999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~------------~i~~~~--~~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYD------------NILNKP--LQL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHH------------HHHhCC--cCC
Confidence 234579999999999999999999999999999999999999996432210 000 000111 112
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
++.....+.+++.+|++.+|++||++.+.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2234556788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=314.90 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=195.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 542 (792)
..++|+..+.||+|+||.||+++.. .++.||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999865 4889999998654 2334567889999999999999999999986543
Q ss_pred -cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 543 -ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 543 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
..++||||++++ |...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 468999999764 555542 23778888999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh----
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK---- 697 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 697 (792)
++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ .........
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 243 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSA 243 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcH
Confidence 97643221 12335789999999999999999999999999999999999999975432110 000000000
Q ss_pred ------hhhhhhhcccc--cc----------------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 ------EKRAMELAGDT--LA----------------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ------~~~~~~~~~~~--~~----------------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........... .. ..........+.+++.+||+.+|++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 00 00111123567899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=299.55 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=201.0
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-cceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e 549 (792)
+|+..+.||+|++|.||+++... ++.+|+|++... .....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999998654 788999998654 2344567889999999999999999999876544 5789999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++... ....+++.++..++.+++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999998653 2345899999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......+++.|+|||.+.+..++.++||||||++++||++|+.||...... .... ....+ .
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~-~~~~~---------~ 218 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVY-RIIEG---------K 218 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhc---------C
Confidence 1 223356889999999999999999999999999999999999998633211 0000 00000 0
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++.+|++.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112233455678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=300.12 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=206.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..+.||.|+||.||+|... ++..+++|++.... ....+.+.+|++.++.++|+||+++++.+...+..++|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999864 57889999986542 33567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++........+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976444456899999999999999999999987 99999999999999999999999999987654322
Q ss_pred c--ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 Q--TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. .......|+..|+|||.+... .++.++||||||++++||++|+.||....+... +. .... . ..+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~----~~~~-~-----~~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LM----LTLQ-N-----DPP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HH----HHhc-C-----CCC
Confidence 2 122345688999999998776 789999999999999999999999964433211 00 0000 0 001
Q ss_pred cccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSH-PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~-~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...... ....+..+.+++..|++.+|++||++.||++.
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 111111 12345678899999999999999999999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.10 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=192.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhc---ccccceeeeeeEEeC-----C
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA-----D 542 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-----~ 542 (792)
+|++.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 48899999987542 22234556677777665 699999999998653 3
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++|+||+.+ +|..++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999985 7888775432 345889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh---hh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK---EK 699 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~ 699 (792)
....... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ......... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~ 229 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ---LGKIFDLIGLPPED 229 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH---HHHHHHHhCCCChh
Confidence 8764322 12235678999999999988999999999999999999999999864332111 000000000 00
Q ss_pred hhhh---hcccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 700 RAME---LAGDTLA-------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 700 ~~~~---~~~~~~~-------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.... ....... ....+.....+.+++.+||+.||++|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 0011223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=305.75 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=202.7
Q ss_pred HHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEe--
Q 003832 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ-- 540 (792)
Q Consensus 465 ~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~-- 540 (792)
+..+..+.++|++.+.||+|+||.||+++.. .++.+|+|++.... ...+++.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999875 47889999886432 2345788899999999 69999999999853
Q ss_pred ---CCcceEEEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 541 ---ADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 541 ---~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
....++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 35689999999999999987642 23446888999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~ 691 (792)
+|||+++.+..... ......|+..|+|||++. ...++.++|||||||++|||++|+.||....+... +.
T Consensus 166 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~-- 239 (286)
T cd06638 166 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LF-- 239 (286)
T ss_pred ccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hh--
Confidence 99999887643221 122356899999999885 34578999999999999999999999864332110 00
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
... ....+.. ..+......+.+++.+||+.+|++||++.||++.+
T Consensus 240 ---~~~-----~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 ---KIP-----RNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---hcc-----ccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 000 0000000 11112334688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=299.89 Aligned_cols=250 Identities=27% Similarity=0.403 Sum_probs=194.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-----chhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
.+|+..+.||+|+||.||+|... .++.+++|++.... .+..+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36788899999999999999875 48899999986432 23345788999999999999999999998764 557
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998543 34788999999999999999999887 99999999999999999999999999886
Q ss_pred cCCCCc-cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
+..... ........++..|+|||.+.+..++.++||||||+++|||++|+.||....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---------------~~~~ 220 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---------------AIFK 220 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---------------HHHH
Confidence 532111 111223457899999999988889999999999999999999999986332110 0001
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..........+......+..++ .|+..+|++||+++||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1111111222333344455555 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.31 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=197.8
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|...++||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++|+||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999875 47899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
++ ++|..++... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5888887543 335788999999999999999999987 99999999999999999999999999876432221
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHH-hhhh
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILW-KEKR 700 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~-~~~~ 700 (792)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.. .+... ....
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1122456889999998865 4578899999999999999999999975432211000000 00000 0000
Q ss_pred hhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+.... .........+.+++.+|++.+|++|||++||++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000000 0111234467889999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=304.49 Aligned_cols=263 Identities=28% Similarity=0.383 Sum_probs=204.9
Q ss_pred cCHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
+...++..++++|...+.||+|+||.||++... +++.+|+|++.... ...+.+.+|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 444566678899999999999999999999874 57899999986532 2345678899999999 79999999999876
Q ss_pred CC-----cceEEEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 541 AD-----ESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 541 ~~-----~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
.+ ..++|+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 579999999999999988642 23456889999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCC-----CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 689 (792)
||+|||++........ ......|+..|+|||.+... .++.++|||||||++|||++|+.||....+... +
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L- 242 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H-
Confidence 9999999886543221 12234688999999988543 368999999999999999999999864322110 0
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ +. ...+......+.+++.+|++.+|++||++.|+++.
T Consensus 243 ----~~~~~~~~-----~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 ----FKIPRNPP-----PT--LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ----HHHhcCCC-----CC--CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00000100 01 11122344568899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=299.73 Aligned_cols=247 Identities=27% Similarity=0.422 Sum_probs=200.6
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-----chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++......++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566689999999999999876 68899999986543 235567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 999999999998543 35889999999999999999999987 999999999999999999999999998875433
Q ss_pred CccccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. ......++..|+|||.+.... ++.++|+||||+++|||++|+.||....+. .. . .... ..
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~---~~---~---~~~~------~~ 217 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV---AA---V---FKIG------RS 217 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH---HH---H---HHHH------hc
Confidence 2 123356889999999987766 899999999999999999999998643211 00 0 0000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+......+.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 01112233445677889999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.02 Aligned_cols=200 Identities=22% Similarity=0.337 Sum_probs=172.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-c-----ccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-----RNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~g~~~~~~~~~ 545 (792)
-+|++.+.||+|.||.|-++... .++.||||+++... .-..+...|+.+|..|+ | -|+|+++++|...++.+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 37899999999999999999764 48999999996543 44567788999999997 4 38999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC--CceEeeecccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM--NPKISDFGMAR 623 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFgla~ 623 (792)
||+|.++. +|.+++..+.. ..++...+..|+.||+.||.+||+.+ |||+||||+||||.+.. .+||+|||.+.
T Consensus 265 iVfELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eeehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999854 89999976543 44899999999999999999999988 99999999999997544 69999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
.....-. ....+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+..+.
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 7543221 356688999999999999999999999999999999998888765543
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=301.05 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=198.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc----------hhHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG----------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
+|...+.||+|+||.||+|... +++.+|+|.++.... ...+.+..|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666789999999999999764 588999998854211 12346788999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++|+||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 45888999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccCCC--CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
................++..|+|||.+.... ++.++||||||++++|+++|..||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-
Confidence 8654322222223356889999999987654 899999999999999999999998532111 0000000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
................+.+++..|++.+|++||++.||++.
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 ----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00111111122335678889999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=298.69 Aligned_cols=251 Identities=26% Similarity=0.386 Sum_probs=198.4
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-----chhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
++|++.++||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468888999999999999998754 8899999885431 23356788999999999999999999998764 457
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++++||+++++|.+++... ..+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 7999999999999988543 34788889999999999999999987 99999999999999999999999999886
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
+...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~----------~~~~ 220 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----A----------AIFK 220 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----H----------HHHH
Confidence 5432111 1123356889999999998888999999999999999999999998632111 0 0011
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..........+......+.+++..|+. +|++||+++||++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 111111223455556677888888985 89999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.23 Aligned_cols=262 Identities=23% Similarity=0.278 Sum_probs=196.6
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 542 (792)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 4889999999754 2334567888999999999999999999986443
Q ss_pred -cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 543 -ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 543 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999976 5555552 23788889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc-hhH-------HHH
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN-LLG-------HAW 693 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~-l~~-------~~~ 693 (792)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......+... .+. ...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98653321 1233578999999999999999999999999999999999999996433211100 000 000
Q ss_pred HHHhhhhhhhhcccc---------------c---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDT---------------L---ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... ......++.. . ....+......+.+++.+|++.+|++|||+.|+++.
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred Hhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 0 001111234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=309.09 Aligned_cols=197 Identities=25% Similarity=0.418 Sum_probs=160.2
Q ss_pred cccCcCCcccEEeeecc---CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~e~~~~ 553 (792)
++||+|+||.||+|+.. +++.+|+|.+.... ....+.+|+.++++++||||+++++++... ...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 58999999999999864 36789999986542 234578899999999999999999998653 457899999865
Q ss_pred CChhHHHhhcc------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe----cCCCCceEeeecccc
Q 003832 554 KSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (792)
Q Consensus 554 gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgla~ 623 (792)
+|..++.... +...+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 7777664321 2235888899999999999999999988 9999999999999 456789999999998
Q ss_pred ccCCCCc-cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 624 IFGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 624 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
.+..... ........||+.|+|||++.+ ..++.++||||+||+++||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 7643221 112234678999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.74 Aligned_cols=265 Identities=22% Similarity=0.353 Sum_probs=200.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999876 48899999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988887643 234899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH--------HHHhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW--------ILWKEKR 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~~~~ 700 (792)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||......+......... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999999865 568899999999999999999999997543321110000000 0000000
Q ss_pred h-hhhccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 A-MELAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~-~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .....+......+ ......+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 0000000000001 1224568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=326.37 Aligned_cols=267 Identities=19% Similarity=0.224 Sum_probs=193.5
Q ss_pred HhHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhccc------ccceeeeeeE
Q 003832 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH------RNLVKLLGCC 538 (792)
Q Consensus 466 ~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~g~~ 538 (792)
+++...+++|++.++||+|+||+||+|.... ++.||||+++... ....++..|+.++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3445567899999999999999999998754 7889999996432 234456678888777765 4588899988
Q ss_pred EeC-CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCC----
Q 003832 539 IQA-DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM---- 612 (792)
Q Consensus 539 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~---- 612 (792)
... .+.++|||++ +++|.+++.+. ..+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 765 4678899987 66787777543 3588999999999999999999974 6 99999999999998765
Q ss_pred ------------CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 613 ------------NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 613 ------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998764321 123467999999999999999999999999999999999999999754
Q ss_pred CCCCccchhHHHH----HHHhh----hhhhhhccc--cccCCC---------------CHHHHHHHHHHHHHhccCCCCC
Q 003832 681 HPDHDHNLLGHAW----ILWKE----KRAMELAGD--TLADSH---------------PPTEVLRCIHVGLLCVQHRPED 735 (792)
Q Consensus 681 ~~~~~~~l~~~~~----~~~~~----~~~~~~~~~--~~~~~~---------------~~~~~~~l~~li~~Cl~~~P~~ 735 (792)
...+...++.... ..+.. ....++... .+.... .......+++|+.+||+.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 4321111110000 00000 000000000 000000 0011345779999999999999
Q ss_pred CCCHHHHHHH
Q 003832 736 RPNMSSVVLM 745 (792)
Q Consensus 736 RPs~~evl~~ 745 (792)
|||++|++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999973
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.71 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=202.4
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..++||+|+||.+|+++.. +++.+|+|++... .....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999864 5789999998643 234456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+.+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999885432 235788999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......|+..|+|||++.+..++.++||||||++++||++|+.||...... .. . ...... ..
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~---~---------~~~~~~-~~ 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NL---V---------LKIIRG-SY 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HH---H---------HHHhcC-CC
Confidence 122346788999999999889999999999999999999999998642211 00 0 000000 11
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+|++.+|++||++.||++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 12233445678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.14 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=200.0
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.|.....||+|+||.||++... +++.||||.+........+.+.+|+..+++++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 3444568999999999999864 488999999876655666788999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.. ..+++.++..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 103 ~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 103 GGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--
Confidence 9999998743 34789999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......|+..|+|||.+.+..++.++||||||++++||++|+.||....+.. .. .. ...........
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~----~~-----~~~~~~~~~~~- 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AM----RR-----IRDNLPPRVKD- 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH----HH-----HHhcCCCcccc-
Confidence 1223568899999999988899999999999999999999999986432210 00 00 00111111111
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+.+++..|++.+|++||+++||++.
T Consensus 241 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 -SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234467788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=285.08 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=201.0
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++.|++.+.||+|.|+.||+..+. .|+.+|+|++... .....+++.+|+++-+.|+|||||++.+...+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888889999999999998764 4888898887533 345778899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeeeccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARI 624 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgla~~ 624 (792)
+|+|+++.|..-+..+ -..++...-..+.||+.+|.|+|..+ |||||+||+|++|-.. .-+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997666443 34567777789999999999999998 9999999999999543 3589999999998
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
+..... .....||+.|||||+++..+|+..+|||+.|||||-|+.|.+||...+.. .+. .+.....+
T Consensus 163 l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rly-------e~I~~g~y 229 (355)
T KOG0033|consen 163 VNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY-------EQIKAGAY 229 (355)
T ss_pred eCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHH-------HHHhcccc
Confidence 873322 22368999999999999999999999999999999999999999753321 111 11111000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
......-+...++..+|+.+||..||++|.|+.|.+.
T Consensus 230 ---d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 230 ---DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ---CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111122234566788999999999999999999875
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.97 Aligned_cols=240 Identities=21% Similarity=0.270 Sum_probs=185.0
Q ss_pred cCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhc---ccccceeeeeeEEeCCcceEEEeecCC
Q 003832 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
||+|+||.||+|+.. +++.||||++.+.. ......+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 48899999986431 12233455666666665 699999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|..++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~ 152 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--T 152 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--C
Confidence 9999888543 35889999999999999999999988 99999999999999999999999999875432221 1
Q ss_pred ccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 634 THKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
.....||..|+|||.+.+. .++.++|||||||++|||++|+.||....... +. .....+ ...+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~----~~i~~~------~~~~~-- 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MY----RNIAFG------KVRFP-- 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HH----HHHHcC------CCCCC--
Confidence 2345799999999998754 58999999999999999999999986432210 00 000000 00000
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRP----NMSSVVL 744 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RP----s~~evl~ 744 (792)
.......+.+++.+||+.+|++|| ++.|+++
T Consensus 218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112345677899999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=297.86 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=202.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 548 (792)
+|+..+.||.|+||.||++... +++.+|+|++... .....+.+..|++++++++||||+++++++... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999864 5788999998653 234456788999999999999999999988643 4578999
Q ss_pred eecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||+++++|.+++... .....+++..++.++.|++.||.|||..+ ...++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 22456899999999999999999999332 334999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...... .+. +.+
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~-------------~~~ 222 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA-------------SKI 222 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH-------------HHH
Confidence 543321 12346889999999999888999999999999999999999998753311 110 011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........+......+.+++.+|++.+|++||++.+|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111123344556778899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.74 Aligned_cols=265 Identities=23% Similarity=0.366 Sum_probs=199.7
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..++||+|+||.||++...+ ++.+|+|++..... ...+.+.+|++++++++||||+++++++......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 467888999999999999999864 88999999865422 235678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|..+.... ..+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876432 34899999999999999999999987 9999999999999999999999999988764332
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc-chh-------HHHHHHHhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH-NLL-------GHAWILWKEKR 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~-~l~-------~~~~~~~~~~~ 700 (792)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+.. .+. ...........
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1223467899999998865 45788999999999999999999988643321100 000 00000000000
Q ss_pred hh-hhccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AM-ELAGDTLAD-----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~-~~~~~~~~~-----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ....+.... ...+.....+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 00 000000000 0112335678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=306.11 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=202.3
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|++|.||++...+ ++.+|+|.+..... ...+.+..|++++.+++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 368888999999999999998765 88999999976532 24567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999988643 3456899999999999999999999987 999999999999999999999999998765321
Q ss_pred Ccc---------------------------ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 629 EIQ---------------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 629 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 100 01123468899999999998889999999999999999999999986433
Q ss_pred CCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 003832 682 PDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN----MSSVVL 744 (792)
Q Consensus 682 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs----~~evl~ 744 (792)
.... ....................+.+++.+|++.+|++||+ ++|+++
T Consensus 237 ~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 01111111111111124667889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=313.57 Aligned_cols=262 Identities=21% Similarity=0.258 Sum_probs=196.6
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 541 (792)
..++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999865 4788999999754 234456788999999999999999999987643
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
...++||||+++ +|...+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 346999999976 56666532 3778889999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH--------HHH
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG--------HAW 693 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~--------~~~ 693 (792)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...........+. ...
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98653321 1223578999999999999999999999999999999999999997543211100000 000
Q ss_pred HHHhhhhhhhhcccc--------------c----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDT--------------L----ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~--------------~----~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... .......... . ...........+.+++.+|++.||++|||+.|++++
T Consensus 250 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQ-PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred Hhhh-HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 0000000000 0 000111123467899999999999999999999885
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=304.46 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=198.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch-----hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
+|+..+.||+|++|.||+|... +++.||+|++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999865 5889999999765322 345677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+ +++|.+++.... ..+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999985432 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh--------
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE-------- 698 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-------- 698 (792)
... ......++..|+|||.+.+ ..++.++||||||++++||++|..||......+. ..........
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhh
Confidence 321 1122356788999998854 4678999999999999999999877764332110 1000000000
Q ss_pred -hhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 -KRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 -~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............... .......+.+++.+||+.+|++||++.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000111 12235678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=332.87 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=198.5
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
...++|.+.++||+|+||.||+++... ++.+|+|.+... .......|..|+.++.+++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999998755 678899988654 234456789999999999999999999998654 457
Q ss_pred eEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCC----CCEEecCCCCCcEEecC---------
Q 003832 545 MLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSR----MRIIHRDLKASNVLLDN--------- 610 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~----~~ivH~Dlkp~NIll~~--------- 610 (792)
+|||||+++++|..+|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 89999999999999986532 23568999999999999999999998542 34999999999999964
Q ss_pred --------CCCceEeeeccccccCCCCccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 611 --------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 611 --------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
...+||+|||++..+.... ......||+.|+|||++.. ..++.++||||||||||||++|+.||...
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 2348999999998764322 1234578999999999854 45899999999999999999999999643
Q ss_pred CCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 681 HPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 681 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
... .... ...... +.+ ........+.+|+..||+.+|++||++.|+++
T Consensus 247 ~~~-----~qli-~~lk~~-------p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNF-----SQLI-SELKRG-------PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcH-----HHHH-HHHhcC-------CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 1000 000000 000 01123456889999999999999999999984
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.44 Aligned_cols=253 Identities=24% Similarity=0.374 Sum_probs=203.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999876 48899999987653 34556789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++.... ..++......++.|++.||.|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999986532 568889999999999999999999 66 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ....++..|+|||.+.+..++.++||||||++++||++|+.||........ ...... .......
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~---------~~~~~~~- 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELL---------QYIVNEP- 220 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHH---------HHHhcCC-
Confidence 1 125678899999999988999999999999999999999999864432111 111100 0011111
Q ss_pred cCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.. ....+.+++..|+..+|++||++.|++.+
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 1111222 45668899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=302.52 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=202.8
Q ss_pred cCHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
.++.++..+.+.|+..+.||+|+||.||+|+.. .++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 345556667788999999999999999999874 47889999986543 3346788899999999 69999999999863
Q ss_pred ------CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 541 ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 541 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 356799999999999999886532 345788888999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 689 (792)
+|+|||++....... .......|+..|+|||.+. ...++.++||||||+++|||++|+.||....+.....
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-- 236 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-- 236 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh--
Confidence 999999987653221 1123356889999999885 3568889999999999999999999986432211100
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...............+..+.+++.+||+.+|++||++.||++
T Consensus 237 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000011111111234457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.39 Aligned_cols=266 Identities=21% Similarity=0.330 Sum_probs=201.4
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..++||+|+||.||+|...+ ++.||+|+++.. .....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999998764 789999998653 23345788999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|++++.+..+... ...+++.++..++.||+.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9998777666533 234889999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHHhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILWKEKR 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~~~ 700 (792)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+....... ....+....
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 12235678899999999888 889999999999999999999999864322110000000 000000000
Q ss_pred -hh--hhcccc----ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 -AM--ELAGDT----LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 -~~--~~~~~~----~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. +..... .....+......+.+++.+||+.+|++||++++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00 000000 0001122235678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=308.09 Aligned_cols=258 Identities=19% Similarity=0.252 Sum_probs=193.6
Q ss_pred cccccCcC--CcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 477 SYNKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 477 ~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.++||+| +|++||+++.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34689999 78899999865 58899999997542 234456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 234889999999999999999999988 999999999999999999999999875543211100
Q ss_pred -----ccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 632 -----TNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 632 -----~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ... .........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-----~~~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLE-----KLNGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHH-----HhcCCcccc
Confidence 01122356778999999975 4689999999999999999999999964321110 000 000000000
Q ss_pred cc-------------------c-----------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AG-------------------D-----------------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~-------------------~-----------------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+ . .............+.+++.+||+.||++|||++||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0 00001112234578899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.74 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=199.5
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
|+...+||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++|+||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 334458999999999999865 5889999998765555567788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++.. ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..... .
T Consensus 103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 999987733 35789999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....|+..|+|||++.+..++.++||||||++++||++|+.||....+... . ...... ..... ..
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~----~~~~~~-----~~~~~--~~ 239 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---M----KRLRDS-----PPPKL--KN 239 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHhcc-----CCCCc--cc
Confidence 2235688999999999988999999999999999999999999864322110 0 000000 00000 11
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+.+++..|++.+|++||+++||++.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 11234467889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.66 Aligned_cols=253 Identities=27% Similarity=0.470 Sum_probs=202.5
Q ss_pred ccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC------chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 474 NFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+|+..+.||+|++|.||++.. .+++.+|+|++.... ....+.+..|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467778999999999999985 458899999986532 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~ 625 (792)
|+||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++..+
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 35789999999999999999999987 99999999999998776 5999999999876
Q ss_pred CCCCcc--ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 626 GGDEIQ--TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 626 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... .......++..|+|||.+.+..++.++||||+|++++||++|+.||........... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------------~~~ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL------------IFK 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH------------HHH
Confidence 533111 112234678999999999888899999999999999999999999864332111100 001
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..........+.....++.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111122344456677889999999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=314.74 Aligned_cols=261 Identities=23% Similarity=0.316 Sum_probs=194.6
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC-----
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----- 541 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----- 541 (792)
...++|...+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578999999999999999999864 57899999987542 23345678899999999999999999988643
Q ss_pred -CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 542 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
...++++|++ +++|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468899987 778887773 235889999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH--------H
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG--------H 691 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~--------~ 691 (792)
+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+. .
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99865432 223568999999999876 578999999999999999999999996433211000000 0
Q ss_pred HHHHHhhhhhhhhccccccCCCCH--------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 AWILWKEKRAMELAGDTLADSHPP--------TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
................ + ...+. .....+.+++.+|++.+|++|||+.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQS-L-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhc-c-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000000 0 00000 112346789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.03 Aligned_cols=249 Identities=24% Similarity=0.391 Sum_probs=201.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999864 5788999998654 334567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++.... ...+++..+.+++.++++||.|||+.+ ++|+||+|+||++++++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999996532 345889999999999999999999987 99999999999998654 57999999998764332
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
......++..|+|||.+.+..++.++||||||++++||++|+.||....... ... .... ..
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~------------~~~~-~~ 217 (256)
T cd08220 157 ---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVL------------KIMS-GT 217 (256)
T ss_pred ---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHH------------HHHh-cC
Confidence 1223567889999999998889999999999999999999999986433211 110 0000 00
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++.+||+.+|++||+++|+++.
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111222345568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=299.19 Aligned_cols=256 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc----
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE---- 543 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~---- 543 (792)
.++++|+..+.||+|++|.||+|... +++.+++|++..... ..+++.+|+.+++++ +|+||+++++++.....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999875 477899999875543 456799999999999 69999999999977554
Q ss_pred --ceEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 544 --SMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 544 --~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
.++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 799999999999999886532 2456899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
++....... .......|+..|+|||.+.. ..++.++||||||++++||++|+.||........ +. .
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~-----~ 229 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF-----K 229 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH-----H
Confidence 987654322 11223568899999998753 3578899999999999999999999863322100 00 0
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ....+ ....+......+.+++.+||+.+|++|||+.||+++
T Consensus 230 ~~-----~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 230 IP-----RNPPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred hh-----ccCCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 00001 111122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.16 Aligned_cols=252 Identities=26% Similarity=0.372 Sum_probs=207.1
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..+.||+|++|.||+++... ++.+++|++..... ...+.+.+|+..+.+++|+||+++++++......++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999998865 89999999876644 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++... ..+++..++.++.|+++||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999654 468999999999999999999999 77 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..........+. ..+... .
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~------------~~~~~~-~ 219 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM------------QAICDG-P 219 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH------------HHHhcC-C
Confidence 221 2346789999999999889999999999999999999999998654321111110 011111 1
Q ss_pred cCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.. .+..+.+++..|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122223 45678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.10 Aligned_cols=251 Identities=25% Similarity=0.419 Sum_probs=204.9
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|+..+.||+|+||.||++... +++.|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888899999999999999754 5788999998765555567889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999999843 24788999999999999999999987 99999999999999999999999999876543322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......+++.|+|||.+....++.++||||||+++||+++|+.||....+....... .......
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~--------------~~~~~~~ 234 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--------------ATNGTPE 234 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh--------------hcCCCCC
Confidence 122346888999999998888999999999999999999999999754332111000 0011111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++..||+.+|++||++.+++.+
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11222344568889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.18 Aligned_cols=257 Identities=18% Similarity=0.253 Sum_probs=201.7
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 367888999999999999998764 7889999987543 233457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998543 35889999999999999999999987 999999999999999999999999998742110
Q ss_pred C-------------ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 629 E-------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 629 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
. .........++..|+|||.+....++.++|+||||+++|||++|+.||....+. .+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~------ 225 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELF------ 225 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH------
Confidence 0 000111245788999999998889999999999999999999999998643221 011
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..........+. .....+..+.+++.+||+.+|++||++.++.++|+..
T Consensus 226 -~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 226 -GQVISDDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred -HHHHhcccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 000000011111 1112345678999999999999999988888887653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.94 Aligned_cols=250 Identities=26% Similarity=0.472 Sum_probs=200.9
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|...+.||+|+||.||+|... +++.|++|.++.... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 588999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ..+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998643 34788999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccc--ccccccccCccccccccCCC---CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 631 QTN--THKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 631 ~~~--~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
... .....++..|+|||++.... ++.++||||||++++||++|+.||........ . .. . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~--~~---~---~~~-- 221 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---I--MF---H---VGA-- 221 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---H--HH---H---Hhc--
Confidence 111 12356788999999997766 89999999999999999999999964321100 0 00 0 000
Q ss_pred cccccCCCCH--HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 706 GDTLADSHPP--TEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 706 ~~~~~~~~~~--~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.. ....+. .....+.+++.+|++.+|++||++.|++.
T Consensus 222 ~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GH--KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CC--CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11 111122 22556778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.99 Aligned_cols=246 Identities=26% Similarity=0.419 Sum_probs=200.0
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
|+..++||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+..+.+++||||+++++++......++|+||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 666789999999999999864 57899999986442 3445678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999998843 35889999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......++..|+|||.+.+..++.++||||||++++||++|..||....+.. .. ..+.......
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~-------------~~~~~~~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL-------------FLIPKNNPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH-------------HHHhcCCCCC
Confidence 1223467889999999988889999999999999999999999986422110 00 0001111112
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+......+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223345567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=305.51 Aligned_cols=197 Identities=25% Similarity=0.422 Sum_probs=159.7
Q ss_pred cccCcCCcccEEeeeccC---CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe--CCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~lV~e~~~~ 553 (792)
.+||+|+||.||+|+..+ +..||+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 589999999999998653 5689999986543 23467889999999999999999999864 4567899999876
Q ss_pred CChhHHHhhc------ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe----cCCCCceEeeecccc
Q 003832 554 KSLDFFIFDQ------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (792)
Q Consensus 554 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgla~ 623 (792)
+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 666665321 12235788899999999999999999987 9999999999999 566789999999998
Q ss_pred ccCCCCcc-ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 624 IFGGDEIQ-TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 624 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
.+...... .......||..|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433211 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=298.31 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=193.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHH-HHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|++.+.||+|+||.||+++.. +++.||+|++.... .....++..|+.+ ++.++||||+++++++......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 48899999987643 2334455566665 566689999999999999999999999
Q ss_pred ecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 550 YMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 550 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|++ ++|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++..+..
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6887777542 2345689999999999999999999986 5 99999999999999999999999999886542
Q ss_pred CCccccccccccccCccccccccC----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAE----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... .. .. ..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~-~~---------~~ 219 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP----FQ-QL---------KQ 219 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC----HH-HH---------HH
Confidence 21 1122467889999998854 45689999999999999999999998532211 00 00 00
Q ss_pred hccccccCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHP-PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~-~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.... .....+ ...+..+.+++.+||+.+|++||++.||++
T Consensus 220 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 220 VVEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 001111 123456889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=296.47 Aligned_cols=261 Identities=23% Similarity=0.298 Sum_probs=202.2
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 548 (792)
++|+..+.||.|++|.||++... .++.+|+|.+.... ......+.+|++++++++||||+++++++.+.. ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 47889999987543 245567899999999999999999999986543 679999
Q ss_pred eecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+++++|.+++... .....++......++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 23455788999999999999999999987 99999999999999999999999999876532
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ..........+.+.
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMPNPELKDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCCchhhccC
Confidence 21 12345788999999999999999999999999999999999999754321111 11100 00001011111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .........+.+++.+||+.+|++|||+.||++.
T Consensus 232 ~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 P---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred C---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0 1112245678899999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.87 Aligned_cols=247 Identities=23% Similarity=0.411 Sum_probs=199.1
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcc---cccceeeeeeEEeCCcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 548 (792)
.|+..+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999864 5889999998754 3345567889999999997 999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++.. ..+++...+.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999998843 26889999999999999999999987 999999999999999999999999999876543
Q ss_pred CccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.||.......... . ......+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-------~-----~~~~~~~ 220 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-------L-----IPKSKPP 220 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-------c-----cccCCCC
Confidence 31 12234688999999988654 57899999999999999999999996433211100 0 0000001
Q ss_pred cccCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPP-TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~-~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+. .....+.+++.+|++.+|++||++.|++++
T Consensus 221 ----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 ----RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 144568899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=303.16 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=203.6
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 548 (792)
-..|+++++||+||.+.||++...+.+.+|+|++... +.+...-|.+|+..|.+++ |.+||+|++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3468889999999999999999888889999887543 5567788999999999996 999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|+- .-+|..+|.+.. .....| .+..+..|++.|+.++|+++ |||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus 440 E~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 985 458888886543 223345 67788899999999999998 99999999999885 568999999999999888
Q ss_pred CccccccccccccCccccccccCC-----------CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEG-----------LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
.........+||+.||+||.+... ..+.++||||+|||||+|+-|+.||.... . .
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~------- 578 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--Q------- 578 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--H-------
Confidence 777777778999999999998532 25678999999999999999999985211 0 1
Q ss_pred hhhhhhhccccccCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EKRAMELAGDTLADSHPPTE-VLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..++..+.++...-++|..- ..+++++|+.||+.||++||++.|+++.
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12234455553322222211 1128899999999999999999999875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.59 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=206.0
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++.|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|++++++++|+|++++++++......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999886 588999999976544 5678899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999996543 36899999999999999999999987 999999999999999999999999998765432
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||....+... . ...... ..
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~-~~~~~~-------~~ 233 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------L-FLITTK-------GI 233 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHHhc-------CC
Confidence 21 12234578899999999888899999999999999999999999864322110 0 000000 00
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.....+......+.+++.+|++.+|.+||++.+|++.
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0011112244568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.77 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=200.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999865 58899999987653 33456889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+ +++|.+++.... ..+++.++..++.||++||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999986533 56899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh---hh-----
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---RA----- 701 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~----- 701 (792)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.||....... ............ ..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccC
Confidence 112235688999999988654 56899999999999999999987775432211 000000000000 00
Q ss_pred ----hhhccccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 ----MELAGDTL----ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ----~~~~~~~~----~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.....+.. .....++....+.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 000111234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.68 Aligned_cols=268 Identities=20% Similarity=0.290 Sum_probs=197.6
Q ss_pred ccccccccCcCCcccEEeeeccC---CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccce
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESM 545 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~ 545 (792)
+|...++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999998754 7899999997643 34456778899999999999999999999988 7899
Q ss_pred EEEeecCCCChhHHHhhcc-c-CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC----CCCceEeee
Q 003832 546 LIYEYMPNKSLDFFIFDQA-R-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISDF 619 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 619 (792)
+||||+++ +|..++.... . ...++...+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 5655554322 2 236888999999999999999999988 999999999999999 999999999
Q ss_pred ccccccCCCCc-cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh------HH
Q 003832 620 GMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL------GH 691 (792)
Q Consensus 620 gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~------~~ 691 (792)
|++..+..... ........++..|+|||.+.+ ..++.++||||||++++||++|+.||.....+...... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112233567889999998765 45899999999999999999999999765443211000 00
Q ss_pred HHHHHh-----------h-hhhhhhccccccCCCC----H-------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 AWILWK-----------E-KRAMELAGDTLADSHP----P-------TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 ~~~~~~-----------~-~~~~~~~~~~~~~~~~----~-------~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...... + .......+.......+ . ....++.+++.+|++.+|++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 0 0000000000000111 0 223468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=295.99 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=209.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.-|...+.||+|.|..|-+|++. .|..||||++.+.. .....++.+|++.|+.++|||||+|+.+.......|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 44666689999999999999864 69999999998763 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccccCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~~~~~ 628 (792)
+-.+|+|.+|+.+.. .-+.+....+++.||+.|+.|+|+.. +|||||||+||.+- .-|-+||.|||++..+.+.
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999996643 34888899999999999999999987 99999999999875 5688999999999877654
Q ss_pred CccccccccccccCccccccccCCCCC-ccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. ....+|...|-|||++.+..|+ +++||||||||||-|++|+.||+.....+. +..++|.
T Consensus 173 ~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 173 KK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred ch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 32 2346899999999999999885 579999999999999999999975443322 2223333
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. -..|.....++.+||..||..+|++|.+.+||+..
T Consensus 235 K--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 K--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred c--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 2 24577888899999999999999999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=291.15 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=207.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIY 548 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 548 (792)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999876 588999999876542 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999986543 6899999999999999999999987 999999999999999999999999999877544
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
..........++..|+|||.+.....+.++||||||++++||++|+.||..... .... ...+....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~---------~~~~~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMAA---------LYKIGSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHHH---------HHhccccC
Confidence 321112345688999999999888899999999999999999999999875441 0000 01111112
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.....+......+.+++.+|++.+|++||++.|+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 2223444456788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=300.90 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=196.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.+.|...++||+|+||.||+|+.. +++.||+|++.... .+..+++.+|+++++.++||||+++.+++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 355888899999999999999875 58899999986432 23445788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+. |+|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 5666666432 235899999999999999999999987 99999999999999999999999999876432
Q ss_pred CCccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
. ....++..|+|||.+. ...++.++||||||+++|||++|+.||........ .. ..
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~---------~~ 226 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY---------HI 226 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HH---------HH
Confidence 2 2246788999999874 46688999999999999999999999864321100 00 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.........+......+.+++.+||+.+|++||++.+|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 227 AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred hcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 000001111223456788999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=290.13 Aligned_cols=250 Identities=28% Similarity=0.479 Sum_probs=204.3
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999876 588999999977655567889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999986532 46899999999999999999999977 99999999999999999999999999887654321
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
.....++..|+|||.+.+..++.++||||||++++||++|+.||........ . ..... .... ...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~------~~~~-~~~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA---L----FKIAT------NGPP-GLR 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH---H----HHHHh------cCCC-CcC
Confidence 2345688999999999888899999999999999999999999864332110 0 00000 0000 001
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+......+.+++..|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111124568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=297.86 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=200.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 3455579999999999999864 588999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 9999999854 34889999999999999999999987 99999999999999999999999998876543221
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......|+..|+|||.+.+..++.++||||||++++||++|+.||....+.. .. .... ....+.. .
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~-~~~~-----~~~~~~~--~ 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AM-KRIR-----DNLPPKL--K 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HH-HHHH-----hcCCCCC--c
Confidence 1223468899999999988889999999999999999999999986432210 00 0000 0000111 1
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 112234578899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.82 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=195.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..++||+|+||.||+|+.. +|+.+|+|+++... ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999875 48899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++ +|.+++... ...+++..+..++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 777776442 345899999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---h---hhhh
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---K---RAME 703 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~---~~~~ 703 (792)
......++..|+|||.+.+. .++.++|||||||++|||++|+.|+........ ........... . ....
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhh
Confidence 11224578899999988664 478999999999999999999998643221110 00000000000 0 0000
Q ss_pred hcccccc---------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLA---------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~---------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+.... ....+....++.+++.+||+.+|++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0010000 01112234577899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.19 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=200.1
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+|+..++||+|++|.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999975 488999999876533 33467788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||++..+.....
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 88888765544556899999999999999999999987 99999999999999999999999999976533211
Q ss_pred ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHhhhh-hhhh
Q 003832 632 TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWKEKR-AMEL 704 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~-~~~~ 704 (792)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ..+.... ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 1122456889999998865 457899999999999999999999987543321100000000 0000000 0000
Q ss_pred ccccc------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTL------ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~------~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..... .....+.....+.+++.+|++.+|++||++.||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000 000112234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.09 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=195.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 367888899999999999999875 578999999865432 223456789999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+.+ +|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 84 YLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 9985 8988875432 36789999999999999999999987 9999999999999999999999999987543211
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh---hhhhhh--
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK---EKRAME-- 703 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---~~~~~~-- 703 (792)
. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ .......... ......
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhh
Confidence 1 1112346789999998865 4589999999999999999999999864331100 0000000000 000000
Q ss_pred ----hcc--------ccccCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 ----LAG--------DTLADSH-PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ----~~~--------~~~~~~~-~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
... ..+.... .......+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 0011256779999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.02 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=200.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+..+.||+|+||.||++... +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36788899999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ..++...+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 45889999999999999999999987 999999999999999999999999999876433
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||...... . ... .....
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~--------~~~~~- 213 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---Q----IYE--------KILEG- 213 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---H----HHH--------HHhcC-
Confidence 23356889999999998888999999999999999999999998643311 0 000 00111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~ 744 (792)
....+......+.+++.+||+.+|++|| +++|+++
T Consensus 214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1122333456788999999999999999 7777664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.56 Aligned_cols=247 Identities=24% Similarity=0.329 Sum_probs=202.9
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
+|+..+.||.|+||.||++... .++.+|+|.+.+.. ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999876 48899999997542 2456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998543 46889999999999999999999987 9999999999999999999999999988764332
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..........+. ..... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~-~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------AKQET-A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------HHhcc-c
Confidence 122356788999999998888999999999999999999999998754432111000 00010 1
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNM--SSVV 743 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~--~evl 743 (792)
....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122334455788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.61 Aligned_cols=252 Identities=23% Similarity=0.397 Sum_probs=206.4
Q ss_pred cccccccccCcCCcccEEeeeccCCc-EEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQ-EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~-~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.|.++..||.|+||.||+|+.++.. ..|.|++.....+..++|.-|++||+...||+||+|++.|...+.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45677789999999999999987644 45778888778888899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
.||-.+.++..-. ..|+..++..++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 9999999987643 46899999999999999999999998 99999999999999999999999999865322 11
Q ss_pred ccccccccccCccccccc-----cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 632 TNTHKVVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.......||+.|||||+. ...+|+.++||||||+.|.||..+.+|-....+- .... ++...--
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-------RVll-----KiaKSeP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLL-----KIAKSEP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-------HHHH-----HHhhcCC
Confidence 223347899999999976 4678999999999999999999999885432221 0000 0111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+.+ -.|......+.++...||..||+.||++.+++++
T Consensus 253 PTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 253 PTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred Ccc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 121 2355667778899999999999999999999874
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.62 Aligned_cols=265 Identities=23% Similarity=0.326 Sum_probs=198.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 547 (792)
++|+..+.||+|+||.||+|... +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999876 478899999865432 2234567899999999999999999999887 889999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..+..
T Consensus 85 ~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999985 8888875432 36899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh--------HHHHHHHhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------GHAWILWKE 698 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~ 698 (792)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||...........+ ...+..+.+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 11234578899999988654 4689999999999999999999998754321110000 000000000
Q ss_pred ------hhhhhhccccccCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 ------KRAMELAGDTLADSHPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..........+....+.. ....+.+++..||+.+|++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001111112222 35567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.35 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=196.2
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||.|++|.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999875 58899999986542 22345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+. ++|..++.... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 58888875532 346889999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh---------h
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---------R 700 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 700 (792)
......++..|+|||.+.+.. ++.++||||||+++|||+||+.||........ +.... ...... .
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIF-RTLGTPDEVVWPGVTS 230 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH-HHhCCCChhhhhhhhH
Confidence 112235688999999886644 68899999999999999999999864332111 00000 000000 0
Q ss_pred hhhhcc--cccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAG--DTLA----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~--~~~~----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...... +... ....+.....+.+++.+|++.+|++||+++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000 0000 00011223457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.63 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=200.5
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|+||.||++.... ++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46778899999999999998764 788999998654 223456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-ceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-PKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||||+||++++++. +||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999986532 235789999999999999999999987 999999999999998864 6999999998764322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......|++.|+|||.+.+..++.++||||||++++||++|+.||...... .... .......
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~---------~~~~~~~ 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL---------KICQGYF 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH---------HHhcccC
Confidence 1 112246889999999998888999999999999999999999998633211 0110 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...++.....+.+++.+|++.+|++||++.||++.
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11222344568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=298.62 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=197.3
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
|+..+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++|||++++++++.+.+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667789999999999999865 57899999986542 23445788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+.+ +|.+.+... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 107 CLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred CCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 975 776666432 345899999999999999999999987 99999999999999999999999999875432
Q ss_pred cccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.....++..|+|||++. .+.++.++||||||+++|||++|+.||........ . ......
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~------------~~~~~~ 239 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L------------YHIAQN 239 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---H------------HHHHhc
Confidence 12346788999999873 46789999999999999999999999854221100 0 000001
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.............+.+++.+|++.+|++||++.+|++.+--...
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 11111122344568899999999999999999999987644433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.62 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=195.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCc-----
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~----- 543 (792)
++|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999875 588999999865432 23457888999999995 6999999999987766
Q ss_pred ceEEEeecCCCChhHHHhhccc--CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeec
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFG 620 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFg 620 (792)
.++||||+++ +|.+++..... ...+++..++.++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78888765332 356899999999999999999999987 999999999999998 8999999999
Q ss_pred cccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....+... +. .........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~-~~~~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LL-HIFKLLGTP 231 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HH-HHHHHhCCC
Confidence 9886533211 1122356788999998865 4579999999999999999999999865322110 00 000000000
Q ss_pred h------hhhhcc----cccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 R------AMELAG----DTLA----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~------~~~~~~----~~~~----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ...... +... ....+.....+.+++.+||+.+|++||++.|++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000 0000 00011234568899999999999999999998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=290.88 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=196.7
Q ss_pred cCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||.|++|.||+++... ++.+|+|++.+.. ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999998754 8899999986542 23456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 9999543 34888999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..++..|+|||.+....++.++|+||||+++|||++|+.||.....+.. .. .............+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~------------~~~~~~~~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-EI------------YNDILKGNGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-HH------------HHHHhccCCCCCCCcc
Confidence 4678899999999888899999999999999999999999975442110 00 0111111112233333
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPN-----MSSVVL 744 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs-----~~evl~ 744 (792)
....+.+++..||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 4667899999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=295.67 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=195.6
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++++|...++||+|+||.||+|... +++.+|+|++..... .....+.+|+.+++.++|+||+++.+++......++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999864 588999999865432 33346788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+. ++|.+++... ...+.+..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 6776666433 235778888999999999999999987 999999999999999999999999998764322
Q ss_pred CccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh--------
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK-------- 699 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------- 699 (792)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ..+...+......
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhh
Confidence 11 11224568899999998654 57889999999999999999999997433210 0000000000000
Q ss_pred -hhhhhccccccCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 700 -RAMELAGDTLADSHP---------PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 700 -~~~~~~~~~~~~~~~---------~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..............+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 012346778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.82 Aligned_cols=255 Identities=24% Similarity=0.366 Sum_probs=194.8
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..++||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556679999999999999875 47899999987543 344567889999999996 99999999999999999999999
Q ss_pred cCCCChhHHHhh--cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
+.. ++.++... ......+++.....++.+++.||+|||+.. .++||||||+||+++.++.+||+|||++..+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 55443321 112356889999999999999999999752 3999999999999999999999999999765432
Q ss_pred CccccccccccccCccccccccCC---CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.. .....|+..|+|||.+... .++.++||||||+++|||++|+.||..... .... ..+ .....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~----~~~--~~~~~ 227 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ----LTQ--VVKGD 227 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH----Hhh--hcCCC
Confidence 21 1224678899999998766 689999999999999999999999864321 1100 000 00001
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.+....+......+.+++.+|++.+|++||++.||++.
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111112223355678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=323.75 Aligned_cols=259 Identities=29% Similarity=0.427 Sum_probs=211.5
Q ss_pred hcccccccccCcCCcccEEeeeccC--------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++..+.+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|.+.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3444555699999999999997431 34699999976533 4567899999999999 699999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhcc-----c------C--ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQA-----R------A--TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...++|+||++.|+|..++++.+ . . ..+...+.+.++.|||.||+||++.. ++||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997654 0 1 23889999999999999999999987 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccc-cccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNT-HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~ 686 (792)
..+..+||+|||+++........... ....-+..|||||.+....|+.|+|||||||+||||+| |..||.......
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 99999999999999976655444322 11114667999999999999999999999999999999 788886421110
Q ss_pred chhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 687 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.+.+.+.+..+...|..+..+++++|+.||+.+|++||++.|+++.|+.
T Consensus 530 -------------~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 530 -------------ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred -------------HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1122333444445666778889999999999999999999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.50 Aligned_cols=264 Identities=25% Similarity=0.341 Sum_probs=220.9
Q ss_pred HhHHHhhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeE
Q 003832 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (792)
Q Consensus 466 ~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 538 (792)
.++....+++.....+-+|.||.||+|.+.+ .+.|-+|.++.... -....+..|...+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444555678888889999999999996543 45678888866533 3456788999999999999999999999
Q ss_pred EeC-CcceEEEeecCCCChhHHHh-----hcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 539 IQA-DESMLIYEYMPNKSLDFFIF-----DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 539 ~~~-~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
++. ...+.+|.++.-|+|..+|. +......++..+...++.|++.|++|||.++ +||.||..+|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 876 45788999999999999998 4444556888899999999999999999998 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
++||+|=.+++.+.+.++.......-.+..||+||.+....|+..+|||||||+||||+| |+.||...+|.+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 999999999998887777666555667889999999999999999999999999999998 8889876555422
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..++.+..+-..|-.++.++..+|.-||+..|++||+++|++.-|++
T Consensus 508 ----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 508 ----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22333444445677788899999999999999999999999998854
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=289.19 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=204.6
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|++.++||+|+||.||+++.. +++.+++|.+... ......++.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999754 5789999998654 233456788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++.+.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999986532 2356889999999999999999999987 9999999999999999999999999998765431
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.....++..|+|||.+.+..++.++|+||||++++||++|+.||....... + ...+....
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~-------------~~~~~~~~ 217 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L-------------RYKVQRGK 217 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-------------HHHHhcCC
Confidence 222457889999999999999999999999999999999999986433210 0 00011111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.....++.+++.+|++.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 223334566778999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=305.01 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=198.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~ 544 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++... .......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 478999999999999999999864 5889999998643 2334567888999999999999999999876543 47
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+.+ +|..++. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999975 7766663 335889999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCccc-cccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---h
Q 003832 625 FGGDEIQT-NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---K 699 (792)
Q Consensus 625 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~ 699 (792)
........ ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||........ .......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHH
Confidence 54322111 1223568899999998754 5689999999999999999999999964322110 0000000000 0
Q ss_pred hhh--------hhccc-cccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 700 RAM--------ELAGD-TLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 700 ~~~--------~~~~~-~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
... ..... ...... .+....++.+++.+||+.+|++||++.|+++. ++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 000 00000 000000 11224568899999999999999999999997 5544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.28 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=196.1
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
|+..++||.|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999865 58999999987543 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
+ ++|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 68988885433 245899999999999999999999987 99999999999999999999999999976532211
Q ss_pred ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh--------h-hhh
Q 003832 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK--------E-KRA 701 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~--------~-~~~ 701 (792)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ +.. ...... . ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFR-IFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCChHHhhhhhhc
Confidence 11223568899999988654 578999999999999999999999865432111 000 000000 0 000
Q ss_pred hhhccc------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 MELAGD------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.... .......+.....+.+++.+|++.+|++||+++||++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 00001112233568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=291.31 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=197.4
Q ss_pred cCcCCcccEEeeeccC-CcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 89999999865533 4556789999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc------
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI------ 630 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~------ 630 (792)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986532 5899999999999999999999987 99999999999999999999999999876533211
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
........++..|+|||.+.....+.++||||||++++||++|+.||....+.. .. ........
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~------------~~~~~~~~- 218 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IF------------QNILNGKI- 218 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HH------------HHHhcCCc-
Confidence 112234567889999999988889999999999999999999999986433211 00 00010011
Q ss_pred CCCCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 711 DSHPPT--EVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 711 ~~~~~~--~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
..+.. ....+.+++.+|++.+|++||++.+|.+.|+
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111 2567889999999999999999977777775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=306.25 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=191.8
Q ss_pred cccccCcCCcccEEeeeccC-CcEEEEEEccC----CCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc--ceEEEe
Q 003832 477 SYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK----GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE--SMLIYE 549 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~----~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~--~~lV~e 549 (792)
...+||+|+|-+||||.... |.+||=-.++. ..+...+.|..|+.+|+.|+|||||+++.++.+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34689999999999998643 66665322211 244556899999999999999999999999988766 678999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGD 628 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~~ 628 (792)
.|..|+|..|+.+. +.++.+....|+.||++||.|||++. |||+|||||-+||+|+. .|.|||+|+|||..+...
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999999654 34788899999999999999999986 78999999999999974 589999999999987644
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. ...+.|||.|||||.+. ..|.+.+||||||+.|+||+|+..||..= ....+ ....+..+.....+..
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-----~n~AQ-IYKKV~SGiKP~sl~k- 267 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-----TNPAQ-IYKKVTSGIKPAALSK- 267 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-----CCHHH-HHHHHHcCCCHHHhhc-
Confidence 3 23379999999999886 78999999999999999999999998521 11111 1111111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
-.-+++.++|.+|+.. .++|||+.|+++.
T Consensus 268 -------V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 -------VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1123578899999999 9999999999873
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.77 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=193.5
Q ss_pred cCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++||||+++++.+...+..++|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 58899999986532 22345677899999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 999865432 45889999999999999999999987 9999999999999999999999999988654321 1223
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..++..|+|||.+.+..++.++||||||++++||++|+.||...........+ .+. .. ......+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~-----~~-~~~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL-------KRR-----TL-EMAVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH-------Hhc-----cc-cccccCCcc
Confidence 46788999999998888999999999999999999999999654332111000 000 00 011122333
Q ss_pred HHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 003832 717 EVLRCIHVGLLCVQHRPEDRP-----NMSSVVL 744 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RP-----s~~evl~ 744 (792)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 456788999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.70 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=205.8
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|...+.||.|+||.||++... +++.+++|++..... ...+.+.+|++++++++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999875 488999999876532 4566789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999986532 2467899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.......|++.|+|||.+....++.++||||+|+++++|++|+.||...... .+. .. .. ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~----~~--------~~-~~~ 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELA----LK--------IL-KGQ 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHH----HH--------Hh-cCC
Confidence 1223356888999999998888999999999999999999999998643321 000 00 00 111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++.+||+.+|++||++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 122233445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=302.91 Aligned_cols=267 Identities=23% Similarity=0.333 Sum_probs=198.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC--cc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD--ES 544 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~--~~ 544 (792)
..++|+..+.||+|+||.||+|... +++.+|+|++... .......+..|+.++.++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888999999999999999875 4788999988543 233445677899999999 9999999999986543 57
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||++ ++|..++... .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5888887432 6789999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc---ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH--------
Q 003832 625 FGGDEIQ---TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA-------- 692 (792)
Q Consensus 625 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~-------- 692 (792)
+...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 12233568899999998754 56789999999999999999999998654322110000000
Q ss_pred HHHHhhhhhhhhccc---ccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 693 WILWKEKRAMELAGD---TLA---DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.......+.+. ... ....+.....+.+++.+|++.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000011110 000 00111134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.20 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=196.8
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEEEe
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLIYE 549 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV~e 549 (792)
|++.++||+|++|.||+|+..+ ++.+|+|++.... ....+.+.+|++++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667899999999999998764 7899999997653 33456788999999999999999999999988 78999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++ +|..++... ...+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 888887543 246899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---hh---hh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---KR---AM 702 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~~ 702 (792)
. .......++..|+|||.+.+ ..++.++||||||++++||++|+.||........ .......... .. ..
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 1 11223456789999998764 4679999999999999999999999865432111 0000000000 00 00
Q ss_pred hh-----c------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 EL-----A------GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~-----~------~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+ . ...+...........+.+++.+|++.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0 0000000001125578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=280.73 Aligned_cols=205 Identities=26% Similarity=0.406 Sum_probs=169.5
Q ss_pred cccccccccCcCCcccEEeeeccC-----CcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 544 (792)
..|+...+||+|.||.||+|.-.+ .+.+|+|+++.... .......+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 467888999999999999995432 34689999975422 223467789999999999999999999988 6778
Q ss_pred eEEEeecCCCChhHHHhh--cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC----CCceEee
Q 003832 545 MLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISD 618 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~D 618 (792)
+|++||.+. +|..+++. ..+.+.++......|+.||+.|+.|||+.- |+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999988 55555543 234467888999999999999999999987 9999999999999877 8999999
Q ss_pred eccccccCCCCccc-cccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 619 FGMARIFGGDEIQT-NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 619 Fgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
||+++++.+.-... ....++-|.+|+|||.+.+. .|+.+.|||+.|||+.||+|-++.|....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 99999986532221 33457789999999998764 69999999999999999999998886543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.36 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=192.2
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcc-cccceeeeeeEEeC--CcceEEEe
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLIYE 549 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV~e 549 (792)
|+..++||+|+||.||+|... +++.+|+|+++... .........|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456789999999999999864 58899999987642 222234457888898885 99999999999987 88999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|++ ++|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++..+....
T Consensus 81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 4777777543 246899999999999999999999987 999999999999999 999999999998764322
Q ss_pred ccccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH-----------h
Q 003832 630 IQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW-----------K 697 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------~ 697 (792)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||...++.+. +....... .
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHhhc
Confidence 1 12245788999999764 45678999999999999999999999965433211 11000000 0
Q ss_pred hhhhhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EKRAMELAGDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.........+.... ......+..+.+++.+||+.+|++||+++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000000 0012345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.60 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=188.2
Q ss_pred ccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHh---cccccceeeeeeEEeCCcceEEEeecC
Q 003832 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIAR---LQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~---l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.||+|+||.||++... +++.+|+|.+.+.. ......+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 47899999986542 1222334445444433 479999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++... +.+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999888543 35899999999999999999999988 9999999999999999999999999987553221
Q ss_pred cccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....|+..|+|||.+.. ..++.++|||||||+++||++|+.||..........+ .+.. .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~--------~~~~------~~~~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--------DRMT------LTVNV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH--------HHHh------hcCCc
Confidence 123468999999998864 5689999999999999999999999975433211100 0000 01112
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
..+.....++.+++..|++.+|++|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 23344556788999999999999999 69999886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=284.74 Aligned_cols=247 Identities=28% Similarity=0.417 Sum_probs=202.7
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|+..+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 478999999976643 4567899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998543 46899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
. .....++..|+|||.+....++.++||||+|++++||++|+.||...... ... +... ....
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~----~~~~-------~~~~ 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AAL----FRIV-------QDDH 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHH----HHHh-------ccCC
Confidence 1 22356788999999998888999999999999999999999998633210 000 0000 0111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...+......+.+++.+|++.+|++||++.|++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1223334567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=300.59 Aligned_cols=263 Identities=25% Similarity=0.317 Sum_probs=197.2
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 541 (792)
..++|+..+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 5889999998653 233456778899999999999999999998644
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
...++|+||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 346999999965 77777632 2788899999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh--------HHHH
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------GHAW 693 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~--------~~~~ 693 (792)
++....... .....++..|+|||.+.+..++.++|||||||++++|++|+.||...........+ ....
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 987543221 22346788999999999999999999999999999999999998644321100000 0000
Q ss_pred HHHh--------hhh------hhhhccccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWK--------EKR------AMELAGDTL----ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~--------~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... ... ..+...... ....+......+.+++.+||+.+|++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000 000000000 000112345567899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=293.74 Aligned_cols=245 Identities=23% Similarity=0.364 Sum_probs=197.0
Q ss_pred ccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
..+||+|+||.||++... +++.||+|++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 358999999999999874 5889999998765555667799999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 105 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 105 TDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 988743 24789999999999999999999987 99999999999999999999999999876543221 1223
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..|+..|+|||.+.+..++.++||||||+++|||++|+.||........ . .... ........ ....
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~----~~~~-----~~~~~~~~--~~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---M----KMIR-----DNLPPKLK--NLHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H----HHHH-----hhCCcccC--Cccc
Confidence 5678999999999888899999999999999999999999864322100 0 0000 00111110 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.+++.+||+.+|.+||++.+|++.
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 34457788999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=297.57 Aligned_cols=266 Identities=25% Similarity=0.365 Sum_probs=195.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (792)
.++|+..++||+|+||.||+|... +++.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467899999999999999999875 488999999864422 2233567899999999999999999998765 45799
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++ +|.+++... ...+++.++..++.|+++||.|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 787777543 246899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWKEKR 700 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~~~ 700 (792)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....+......+.... ..+....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 3321 1122345788999999865 568999999999999999999999997443221100000000 0000000
Q ss_pred hhhhccc-cccC-CC------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGD-TLAD-SH------PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~-~~~~-~~------~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....... .... .. .......+.+++.+|++.||++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 0000 00 01124557789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=295.89 Aligned_cols=265 Identities=22% Similarity=0.319 Sum_probs=196.6
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCC----
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD---- 542 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~---- 542 (792)
...++|++.+.||+|+||.||+|.... ++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999764 7899999997543 233456788999999999999999999987655
Q ss_pred ------cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 543 ------ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 543 ------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 666665432 345899999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||++..+...... ......++..|+|||.+.+ ..++.++|||||||+++||++|+.||........ .......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~ 233 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRL 233 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHH
Confidence 999999876433211 1122345778999998854 4578999999999999999999999864322110 0000000
Q ss_pred Hhhhh---hhhhc--------cc------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 696 WKEKR---AMELA--------GD------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 696 ~~~~~---~~~~~--------~~------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..... ...+. +. .... .....+..+.+++..||+.+|++||++++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00000 00 0000 011124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=293.04 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=199.1
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
|+..+.||+|++|.||++... +++.+++|++..... .....+..|+.++++++|+||+++++++......++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456679999999999999875 588899999865432 34567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++ +|..++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 76 7877775432 46899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH--------HHHHhh---h
Q 003832 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA--------WILWKE---K 699 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~---~ 699 (792)
.......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+........ +....+ .
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence 112224578899999998776 7899999999999999999999998654321110000000 000000 0
Q ss_pred hhhhhccccc--cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 RAMELAGDTL--ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......... .....+.....+.+++..||+.+|.+||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000000 001122345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.69 Aligned_cols=268 Identities=21% Similarity=0.342 Sum_probs=193.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
.++|+..++||+|+||.||+++.. +++.||||++.... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 467899999999999999999875 48899999986542 2223456789999999999999999999876543
Q ss_pred ---ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 544 ---SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 544 ---~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
.++||||+.+ +|..++... ...+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 777776432 235899999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH---
Q 003832 621 MARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI--- 694 (792)
Q Consensus 621 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~--- 694 (792)
++..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876432211 111234578899999988654 478899999999999999999999865432211100000000
Q ss_pred --HHhhhhhhhhcccc-ccCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 --LWKEKRAMELAGDT-LADSH---------PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 --~~~~~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.........+.. ..... +......+.+++.+||+.+|++||+++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00000000000000 00000 00112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.97 Aligned_cols=268 Identities=21% Similarity=0.271 Sum_probs=186.6
Q ss_pred hhcccccccccCcCCcccEEeeeccC--CcEEEEE------------------EccCCCchhHHHHHHHHHHHHhccccc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVK------------------RLSKGSGQGMEEFKNEVTLIARLQHRN 530 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK------------------~l~~~~~~~~~~~~~Ei~~l~~l~H~n 530 (792)
..++|++.++||+|+||+||++..+. +...++| .+. ........+.+|+.+|++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999986532 1112211 111 12233456889999999999999
Q ss_pred ceeeeeeEEeCCcceEEEeecCCCChhHHHhhccc--CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQAR--ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 531 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
||++++++...+..++|+|++.. +|..++..... ...........++.||+.||.|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999864 66666643221 122335567789999999999999987 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCC-CCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW-RFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~-~~~~~~~~~~ 687 (792)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++ ..........
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876433221 122357899999999999999999999999999999999988643 3222111111
Q ss_pred hhHHHHHHHh--h-------hhhhhhccccccC----CCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 688 LLGHAWILWK--E-------KRAMELAGDTLAD----SHPP-----TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 688 l~~~~~~~~~--~-------~~~~~~~~~~~~~----~~~~-----~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+.... .... . ......++..... ..+. ....++.+++.+||+.||++|||+.|++++
T Consensus 380 ~~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 380 LLKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11000 0000 0 0000111100000 0000 112346677889999999999999999874
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=298.59 Aligned_cols=249 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
-...|.+..+||+|.|++|..|++.. +..||||.+.+. .....+.+.+|+++|..++|||||+++.+.+.....|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 35678899999999999999998754 889999999876 334446689999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+.+|.+.+++.+..+ ........++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 999999999999976554 445788889999999999999998 99999999999999999999999999998763
Q ss_pred CCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. ..+..+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+.....+-. ...+.
T Consensus 208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~ 269 (596)
T KOG0586|consen 208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLR 269 (596)
T ss_pred cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhee
Confidence 32 2345789999999999988776 68999999999999999999999864433211 01111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ..+.....++-+++++++-.+|.+|+++++|.+.
T Consensus 270 gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 GKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eee--cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 2233344567789999999999999999999875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.92 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=202.9
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+.|...+.||+|+||.||-.+.++ |+.+|.|++.+. ..+...-..+|-.+|.+++.+.||.+-..|+..+..+||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 557888999999999999887654 888999988654 3345556788999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
..|.||+|.-+|.+.+. ..+++++++..+.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+...
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999988876654 56899999999999999999999987 999999999999999999999999999987654
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.... ..+||.+|||||++.+..|+...|.||+||+||||+.|+.||....... +...+...+..
T Consensus 341 ~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k~eEvdrr~~~- 404 (591)
T KOG0986|consen 341 KPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------KREEVDRRTLE- 404 (591)
T ss_pred Cccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------hHHHHHHHHhc-
Confidence 4322 2489999999999999999999999999999999999999997433221 11111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPN 738 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs 738 (792)
....++....+++..+....|+.||++|--
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 112455667777888888999999999854
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=301.51 Aligned_cols=269 Identities=22% Similarity=0.322 Sum_probs=199.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
.++|.+.+.||+|+||.||+++.. +++.||||.+... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457889999999999999999865 4889999998653 233455678899999999999999999988654 34
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 6788777532 45889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHH
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWI 694 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~ 694 (792)
...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.............. ...
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764322 11223467889999998864 4689999999999999999999999965432111000000 000
Q ss_pred HHhhhhhhhhcc---cccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 695 LWKEKRAMELAG---DTLA---DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 695 ~~~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
..........+. .... ....+....++.+++.+||+.+|++||+++|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000000000000 0000 00112345668899999999999999999999987 5543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=286.73 Aligned_cols=244 Identities=23% Similarity=0.280 Sum_probs=189.8
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCCc---hhHHHHHHHHHHH-HhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
+.||+|+||.||+|... +++.||+|++++... .....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 488999999875422 2223344555444 445899999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
++|..++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998543 35789999999999999999999987 99999999999999999999999999876432
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....++..|+|||.+.+..++.++||||||+++|||++|..||...... ... ....... . ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~----~--~~~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD---AVF----DNILSRR----I--NWPEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhcc----c--CCCCcc
Confidence 22346788999999998888999999999999999999999998643221 000 0000000 0 001111
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
.......+.+++.+||+.+|++||++.++.+.|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 2234567889999999999999998877776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=284.89 Aligned_cols=251 Identities=26% Similarity=0.377 Sum_probs=199.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-----CchhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
.+|...+.||+|+||.||+|+.. +++.+|+|.+... ..+....+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999865 4889999987532 223456789999999999999999999998764 357
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++++||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998543 34788899999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCc-cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.||...... ..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---------------AAIFK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---------------HHHHH
Confidence 532111 11122356889999999998888999999999999999999999998632111 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..........+......+.+++..|++ +|..||+..+++..
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111122233455566778899999999 57999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=292.15 Aligned_cols=251 Identities=20% Similarity=0.362 Sum_probs=193.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-chhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..+.||+|+||.||+|...+ ++.||||+++... .....++..|+.++.+.. ||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999865 8899999997543 234456677887777775 9999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+.+ +|..++... ...+++..+..++.|+++||.|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 676666442 236899999999999999999999742 39999999999999999999999999987654322
Q ss_pred ccccccccccccCccccccccCCC----CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.. ....++..|+|||.+.... ++.++||||||+++|||++|+.||...... .... ....
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~---------~~~~ 232 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVL---------TKIL 232 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHH---------HHHh
Confidence 11 2235788999999986543 889999999999999999999998642111 0000 0001
Q ss_pred ccc-ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDT-LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~-~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ...+.......++.+++.+||+.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 0001111234568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=327.55 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=207.6
Q ss_pred HHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
+...+-++....+||.|.||.||-+...+ |...|+|-++... ........+|+.++..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34455567777899999999999998655 7788999886543 34456778999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+|.||||++|+|.+.+.+. ...++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g---ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG---RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc---chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 9999999999999999543 23555566677889999999999998 99999999999999999999999999998
Q ss_pred cCCCC--ccccccccccccCccccccccCC---CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 625 FGGDE--IQTNTHKVVGTYGYMSPEYAAEG---LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 625 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~---~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
+.+.. .....+...||+-|||||++.+. .-.-++||||+|||+.||+||++||...+.+ .
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---------------~ 1448 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---------------W 1448 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---------------h
Confidence 76542 22333457899999999999653 3466899999999999999999999744332 1
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
.++--+.-.-....|.....+-.+++..|++.||++|-++.|+++.=
T Consensus 1449 aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 11111222223455666777788999999999999999998887754
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.06 Aligned_cols=267 Identities=19% Similarity=0.318 Sum_probs=198.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC----Ccc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----DES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~ 544 (792)
.++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999865 48899999987542 23456778899999999999999999987643 457
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+. ++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 588888743 234899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCcc--ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HH
Q 003832 625 FGGDEIQ--TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AW 693 (792)
Q Consensus 625 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~ 693 (792)
....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11123578899999998865 4689999999999999999999999965432111000000 00
Q ss_pred HHHhhhhhhhhcccc-ccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDT-LADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+....... ..... .+.....+.+++..|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000001111111100 00111 12235678899999999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=270.65 Aligned_cols=250 Identities=20% Similarity=0.351 Sum_probs=193.6
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-chhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.+.+..||.|..|.|++.+.+. |..+|||.+++.. .+..+.+...+.++.+-+ +|.||+.+|+|......++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 3445789999999999998865 7889999998764 445567777788777765 899999999999999999999998
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
.- .++.++.+- .+++++..+-++...+++||.||.+++ .|+|||+||+|||+|+.|++|++|||++..+-....
T Consensus 174 s~-C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HH-HHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 43 455555432 345777777889999999999999876 699999999999999999999999999987654332
Q ss_pred ccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 632 TNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....|-+.|||||.+. ...|+.++||||||+.|+||.||+.||..-..+-+ .+ .. +..-.-+.
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~l--tk-------vln~ePP~ 314 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VL--TK-------VLNEEPPL 314 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HH--HH-------HHhcCCCC
Confidence 23457889999999985 45789999999999999999999999975332210 00 00 00000011
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+. ........+++++..||++|+.+||...++++.
T Consensus 315 L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 LP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 112256778899999999999999999998874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=299.98 Aligned_cols=271 Identities=23% Similarity=0.305 Sum_probs=197.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|...+.||+|+||.||+|+.. +++.||+|++.+.. ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999864 58999999986542 233456889999999999999999999987553
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++|+||+.. +|..++ ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 45899999964 665554 234789999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HH
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AW 693 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~ 693 (792)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ..
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 764321 123467889999999876 4689999999999999999999999975432110000000 00
Q ss_pred HHHhhhhhhhhccc---cccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCCCCCCC
Q 003832 694 ILWKEKRAMELAGD---TLADSH---PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSLLPEPN 756 (792)
Q Consensus 694 ~~~~~~~~~~~~~~---~~~~~~---~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~~~~p~ 756 (792)
.............. ...... .+.....+.+++.+||+.+|++||+++|+++. +++....++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~ 310 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEET 310 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccC
Confidence 00000000000000 000000 01123457899999999999999999999965 76665444333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=292.09 Aligned_cols=263 Identities=24% Similarity=0.313 Sum_probs=194.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..++||+|++|.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999875 58899999986542 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGD 628 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~~ 628 (792)
|++ ++|.+++.... ...+++.....++.||+.||.|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 47777764432 233578888899999999999999987 999999999999985 567999999999765332
Q ss_pred CccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh-------
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR------- 700 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------- 700 (792)
. .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||....+.+. ............
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGV 231 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhcccc
Confidence 1 11122456889999998865 4578999999999999999999999975332111 000000000000
Q ss_pred --hhhhc--cccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 --AMELA--GDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 --~~~~~--~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..... .+.... ...+.....+.+++.+|++.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 000000 0112234567899999999999999999999873
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-32 Score=288.84 Aligned_cols=260 Identities=17% Similarity=0.190 Sum_probs=183.1
Q ss_pred hcccccccccCcCCcccEEeeeccCC----cEEEEEEccCCCchhH-----------HHHHHHHHHHHhcccccceeeee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQGM-----------EEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
.++|.+.++||+|+||.||+|...++ ..+|+|+......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999987553 4566665433221110 11223334556678999999999
Q ss_pred eEEeCC----cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 537 CCIQAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 537 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
++.... ..++++|++.. ++.+.+... ...++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876554 23667776643 455554322 23567888899999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc
Q 003832 613 NPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~ 687 (792)
.+||+|||+++.+...... .......||+.|+|||.+.+..++.++|||||||+++||++|+.||....... .
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence 9999999999876422111 11223469999999999999999999999999999999999999997542211 1
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
+...... .....+...... ....+..+.+++..|++.+|++||++.++++.|+
T Consensus 242 ~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 242 LIHAAKC----DFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHhHH----HHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1111000 001111111111 1122456888999999999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=292.13 Aligned_cols=261 Identities=20% Similarity=0.220 Sum_probs=192.9
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCC
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
.+.+|.|+++.||++.. +++.||||++... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455566666666655 6899999998765 34556789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc-----
Q 003832 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI----- 630 (792)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~----- 630 (792)
|.+++.... ...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||.+..+.....
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986542 234788899999999999999999987 99999999999999999999999998876532211
Q ss_pred cccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH----HHhhhhhhh-
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI----LWKEKRAME- 703 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~----~~~~~~~~~- 703 (792)
........++..|+|||++.. ..++.++|||||||+++||++|+.||....... .+...... .........
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 111223457788999999865 358899999999999999999999997432211 00000000 000000000
Q ss_pred ----------hccc----cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 ----------LAGD----TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ----------~~~~----~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+. ............++.+++.+||+.+|++||+++|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00111222345678899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=283.51 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=190.2
Q ss_pred HHhhccccccccc--CcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 469 AKATDNFASYNKL--GEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 469 ~~~~~~~~~~~~l--g~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
....++|++.+.+ |+|+||.||+++.+ +++.+|+|.+........ |+.....+ +||||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3445677777776 99999999999865 477899999865321111 22222222 699999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~ 623 (792)
++||||+++++|.+++.... .+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999985532 6899999999999999999999988 99999999999999998 99999999987
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... ...++..|+|||++.+..++.++||||||++++||++|+.||........ .... +...
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~-----~~~~---- 222 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLES-----LLKR---- 222 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHH-----HHHh----
Confidence 654221 24578999999999988999999999999999999999999974332211 1111 0000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-MSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-~~evl~ 744 (792)
... ....+......+.+++.+||+.+|.+||+ ++|+++
T Consensus 223 -~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 223 -QQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -hcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 11122245567889999999999999995 688875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=291.40 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=194.9
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+.|+..+.||+|+||.||+|+.. +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34677789999999999999875 4788999998643 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5777766433 245789999999999999999999987 999999999999999999999999998765322
Q ss_pred CccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
....++..|+|||.+. ...++.++||||||+++|||++|+.||........ . .....
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~----~~~~~------- 228 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L----YHIAQ------- 228 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH---H----HHHhh-------
Confidence 2346788999999874 35688899999999999999999999753221100 0 00000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
..............+.+++.+||+.+|++||++.+|++..
T Consensus 229 -~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 -NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0001111223455678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-32 Score=292.25 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=193.2
Q ss_pred cccCcC--CcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
..||+| +||+||+++.. .++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 89999999875 5899999998654 233457889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc--
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-- 631 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~-- 631 (792)
++|.+++.... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999886542 234788899999999999999999987 999999999999999999999999865443211100
Q ss_pred ---ccccccccccCccccccccCC--CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH---------------
Q 003832 632 ---TNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------------- 691 (792)
Q Consensus 632 ---~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------------- 691 (792)
.......++..|+|||++.+. .++.++||||||++++||++|+.||........ ....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccc
Confidence 001112346679999998763 578999999999999999999999964322100 0000
Q ss_pred -HHHHHh-----------hhh-----hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 -AWILWK-----------EKR-----AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 -~~~~~~-----------~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...... +.. ........+....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000 000 001111112222233456778999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=316.42 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=188.8
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC------
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------ 541 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------ 541 (792)
.-..+|++++.||+||||.||+++.+ ||+.+|||++.... ........+|+..+++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 44567899999999999999999876 79999999997653 34456788999999999999999987332110
Q ss_pred --------------------------------------------------------------------------------
Q 003832 542 -------------------------------------------------------------------------------- 541 (792)
Q Consensus 542 -------------------------------------------------------------------------------- 541 (792)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHH
Q 003832 542 ---------------------------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588 (792)
Q Consensus 542 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL 588 (792)
...||-||||+..+|.+++.++.... .....++++.+|+.||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 01356789998888888885543221 4677889999999999999
Q ss_pred hhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC----------------CCCccccccccccccCccccccccCC
Q 003832 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG----------------GDEIQTNTHKVVGTYGYMSPEYAAEG 652 (792)
Q Consensus 589 H~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 652 (792)
|+.+ ||||||||.||+|+++..+||+|||+|.... ........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 00111123346899999999999654
Q ss_pred ---CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc--CCCCHHHHHHHHHHHHH
Q 003832 653 ---LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA--DSHPPTEVLRCIHVGLL 727 (792)
Q Consensus 653 ---~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~ 727 (792)
.|+.|+|+||+||||+||+. ||.... +.+. .+..+.+..+. ..........-.+++.+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--------ERa~------iL~~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--------ERAS------ILTNLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--------HHHH------HHHhcccCCCCCCcccccccchHHHHHHHH
Confidence 59999999999999999995 443211 1111 11111111111 11233344555689999
Q ss_pred hccCCCCCCCCHHHHHH
Q 003832 728 CVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 728 Cl~~~P~~RPs~~evl~ 744 (792)
++++||.+|||+.|++.
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=288.04 Aligned_cols=263 Identities=24% Similarity=0.326 Sum_probs=195.5
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc-hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
|.+.+.||+|++|.||+|+..+ ++.|+||++..... .......+|+..+++++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 4567899999999999999764 78899999865432 22334567999999999 999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
+++|.+++.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988886543 346899999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH-----HHHHHhhh-hhhhh
Q 003832 632 TNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH-----AWILWKEK-RAMEL 704 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~-----~~~~~~~~-~~~~~ 704 (792)
.....++..|+|||.+. ...++.++||||||++++||++|+.||......+....... ....+.+. .....
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12346788999999874 45679999999999999999999999865432111000000 00000000 00000
Q ss_pred cccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLA-------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~-------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.... ....+.....+.+++.+|++.+|++||+++||+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00011124678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=286.91 Aligned_cols=259 Identities=23% Similarity=0.355 Sum_probs=193.9
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc--hhHHHHHHHHHHHHhc---ccccceeeeeeEEeCCc-----
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARL---QHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~~~----- 543 (792)
|++.+.||+|+||.||+|+... ++.+|+|+++.... .....+.+|+.++.++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999865 88999999974422 2234566788777666 59999999999998876
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+++|||+.+ +|.+++.... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7888875532 235899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh-
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM- 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 702 (792)
.+..... .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+. ..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 229 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ---LDKIFDVIGLPSEEE 229 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH---HHHHHHHcCCCChHh
Confidence 7643321 1224578899999999999999999999999999999999998864332211 00000000000000
Q ss_pred ---------hhcccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 703 ---------ELAGDTLA---DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 703 ---------~~~~~~~~---~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
........ ....+.....+.+++.+||+.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111233467789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=301.39 Aligned_cols=201 Identities=29% Similarity=0.457 Sum_probs=175.0
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC------cceE
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESML 546 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 546 (792)
+...+.||+|+||.||+|+++. |+.||||.++... ....+....|+++|++++|+|||++++.-.+.. ..++
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4455789999999999999654 9999999998753 344567789999999999999999999866544 5789
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec--CCC--CceEeeeccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDM--NPKISDFGMA 622 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kl~DFgla 622 (792)
|||||.+|+|...|.+.....-|+..+.+.+..+++.||.|||+++ |+||||||.||++- ++| ..||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999998888888999999999999999999999988 99999999999994 333 4799999999
Q ss_pred cccCCCCccccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
+.+..+. .....+||..|.+||.+. .+.|+..+|.|||||++||.+||..||....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9886544 344589999999999998 4899999999999999999999999997543
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=288.68 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=199.8
Q ss_pred ccccccccCcCCcccEEeeec----cCCcEEEEEEccCCC----chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 474 NFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
+|+..+.||+|++|.||+++. .+++.+|||.+++.. ....+.+.+|+.++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999874 246789999986532 22345688999999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988543 35889999999999999999999987 99999999999999999999999999887
Q ss_pred cCCCCccccccccccccCccccccccCCC--CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
+...... ......|+..|+|||.+.+.. .+.++||||||++++||++|+.||........ ... ..+.
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-----~~~~--- 223 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSE-----ISRR--- 223 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHH-----HHHH---
Confidence 5433211 122346889999999987655 78899999999999999999999864322111 000 0000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.... ....+......+.+++.+||+.+|++|||+.+|.+.|+-
T Consensus 224 -~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 -ILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -HHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 112233344567889999999999999999999888854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=289.67 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=191.6
Q ss_pred cccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
|...++||+|+||.||+|+.. .++.|++|++.... ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999864 47899999986532 23445788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+. ++|.+++... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5676666432 345889999999999999999999987 99999999999999999999999999864321
Q ss_pred cccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||........ . ... .... .+
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~--~~~--~~~~-----~~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L--YHI--AQND-----SP 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---H--HHH--HhcC-----CC
Confidence 22356888999999984 46688999999999999999999999864322110 0 000 0000 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .........+.+++.+||+.+|++||++.++++.
T Consensus 239 ~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 T---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111233457889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=272.91 Aligned_cols=270 Identities=22% Similarity=0.305 Sum_probs=204.4
Q ss_pred cccCcCCcccEEeee-ccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
+.||+|+++.|--.+ +..|+++|||++.+..........+|++++...+ |+||++|+++|+++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998775 4579999999999988888889999999999996 99999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeeccccccCCC-Cc--
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARIFGGD-EI-- 630 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgla~~~~~~-~~-- 630 (792)
...+.++ +.+++.++.++.++|+.||.|||.++ |.||||||+|||-.+... +||+||.|..-+... ..
T Consensus 164 LshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9998654 45889999999999999999999998 999999999999976554 799999987654311 11
Q ss_pred --cccccccccccCccccccc-----cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 631 --QTNTHKVVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 631 --~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.......+|+..|||||+. ....|+.++|.||||||||-|++|.+||......+-.---+..= ..-+..+.+
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C-r~CQ~~LFe 316 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC-RVCQNKLFE 316 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc-HHHHHHHHH
Confidence 1112236788999999976 23568999999999999999999999998655432210000000 000111112
Q ss_pred hccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH-----HhcCCCCCCCCC
Q 003832 704 LAGDTLADSHPP----TEVLRCIHVGLLCVQHRPEDRPNMSSVVL-----MLSSDSLLPEPN 756 (792)
Q Consensus 704 ~~~~~~~~~~~~----~~~~~l~~li~~Cl~~~P~~RPs~~evl~-----~L~~~~~~~~p~ 756 (792)
.+-+... ++|. ....+..+++...+-.++.+|-++.+++. +.....++|.|+
T Consensus 317 sIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalptp~ 377 (463)
T KOG0607|consen 317 SIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPTPQ 377 (463)
T ss_pred HHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCCCc
Confidence 1111111 2232 23456677888888899999999999887 333446666665
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.1e-32 Score=285.19 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=187.7
Q ss_pred ccCcCCcccEEeeecc-CCcEEEEEEccCCCc---hhHHHHHHHHHH---HHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 480 KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTL---IARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~---l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.||+|+||.||++... .++.||+|.+.+... .....+..|..+ +....||||+++++++...+..++|+||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 478999999865421 222234444443 444579999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|..++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988854 346899999999999999999999987 9999999999999999999999999987653221
Q ss_pred cccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||............ .... ....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----------~~~~----~~~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----------RMTL----TMAV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----------HHhh----ccCC
Confidence 2234689999999998754 6899999999999999999999999754322111000 0000 0111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
..+......+.+++.+|++.+|++|| ++.++++.
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 22333456788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=287.05 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=196.0
Q ss_pred ccccccccCcCCcccEEeeec----cCCcEEEEEEccCCC----chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 474 NFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
+|++.+.||+|+||.||+++. .+|+.||+|++.... ....+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999975 358899999986532 23346788999999999 599999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998653 35788899999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
....... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||........ ......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~--------- 222 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISR--------- 222 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHH---------
Confidence 5432211 1223568899999999865 3478899999999999999999999864322111 110000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
..... ....+......+.+++.+|++.+|++|| ++.+++..
T Consensus 223 ~~~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 223 RILKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred Hhhcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 00000 1122333455678999999999999997 66666553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=288.61 Aligned_cols=249 Identities=29% Similarity=0.408 Sum_probs=203.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 547 (792)
++|...+.||+|+||.||+++.. +++.+|+|++.+. .....+.+..|+.++.+++ ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36788899999999999999875 5889999998653 2234567889999999998 99999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||++++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998653 36899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCcc------------------ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh
Q 003832 628 DEIQ------------------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 628 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 689 (792)
.... .......++..|+|||.+....++.++||||||++++|+++|+.||...... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~ 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTF 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHH
Confidence 3211 1222346788999999998888999999999999999999999998744311 000
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM----SSVVL 744 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~----~evl~ 744 (792)
.... ......+......+.+++..||+.+|++||++ +|+++
T Consensus 232 ------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 ------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0000 11122334446678899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=296.79 Aligned_cols=269 Identities=23% Similarity=0.309 Sum_probs=202.4
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----cce
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESM 545 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~ 545 (792)
+|.+.+.||+|++|.||+++... ++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778899999999999998754 8899999987643 345568899999999999999999999998775 789
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++ +|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~~---~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKSP---QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 788877442 36899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCc-cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHH
Q 003832 626 GGDEI-QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWIL 695 (792)
Q Consensus 626 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~ 695 (792)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||...........+.. .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 0112234678899999999877 889999999999999999999999965432111000000 0000
Q ss_pred Hhhhhhhhhccc-ccc-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 696 WKEKRAMELAGD-TLA-----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~-~~~-----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
.........+.. ... ....+.....+.+++.+||+.+|++||+++++++. +++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000 000 00111235568899999999999999999999985 5443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=291.37 Aligned_cols=264 Identities=22% Similarity=0.342 Sum_probs=197.6
Q ss_pred HHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcc
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADES 544 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~ 544 (792)
...+++|+..+.||.|+||.||++... +++.||+|++.+. .....+.+..|+.++.+++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999855 6889999988653 22345678899999999999999999999876 4578
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+ +++|..++.. ..+++.....++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 4588877742 34778888899999999999999987 99999999999999999999999999875
Q ss_pred cCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh--------HHHHHH
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------GHAWIL 695 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~--------~~~~~~ 695 (792)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+ ......
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 4321 122456889999998765 56899999999999999999999998654321110000 000000
Q ss_pred Hhhhhhhhhcccc-ccCCCCH-----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 696 WKEKRAMELAGDT-LADSHPP-----TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 696 ~~~~~~~~~~~~~-~~~~~~~-----~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......++.... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000111111110 0111111 234678899999999999999999998776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=282.09 Aligned_cols=250 Identities=26% Similarity=0.351 Sum_probs=195.0
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC-----CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999997654 344555555431 122344677899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
+||+++++|.+++... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 23456899999999999999999999987 999999999999975 569999999988764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......|+..|+|||.+....++.++||||||+++++|++|+.||..... .... .....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~---------~~~~~ 219 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV---------LRIVE 219 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH---------HHHHc
Confidence 3321 12235678899999999888899999999999999999999999853211 1000 00001
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+......+.+++.+|++.+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 220 -GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11112334555678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=292.96 Aligned_cols=264 Identities=23% Similarity=0.336 Sum_probs=193.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|++.++||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999865 478999999865422 22346788999999999999999999886544
Q ss_pred --cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 543 --ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 543 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
..++|+||+.. +|...+... ...+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999976 566655432 346899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCcc---------ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH
Q 003832 621 MARIFGGDEIQ---------TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (792)
Q Consensus 621 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~ 690 (792)
++......... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~- 239 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI- 239 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-
Confidence 99865432211 11123456888999998765 45899999999999999999999998643322110000
Q ss_pred HHHHHHhh---------hhhhhhccccccCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 691 HAWILWKE---------KRAMELAGDTLADSHP-------PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 691 ~~~~~~~~---------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...... .......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 --FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred --HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 0000000000000001 112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-33 Score=271.63 Aligned_cols=265 Identities=23% Similarity=0.355 Sum_probs=200.3
Q ss_pred ccccccccCHHhHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccce
Q 003832 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLV 532 (792)
Q Consensus 456 ~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv 532 (792)
.+..++.|+...++ .+..||.|+||+|+|-.++. |+..|||+++.... ...++++.|.+...+- +.||||
T Consensus 54 ~~~~~~~F~~~~Lq-------dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IV 126 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQ-------DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIV 126 (361)
T ss_pred CcccccccccchHH-------HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHH
Confidence 44456667655544 44789999999999998765 89999999987754 5667888888876665 699999
Q ss_pred eeeeeEEeCCcceEEEeecCCCChhHHHhh--cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC
Q 003832 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 533 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 610 (792)
+++|.+..+...++.||+|.- ||+.+-.. ......+++.-.-.|+...+.||.||.+.- .|+|||+||+||||+.
T Consensus 127 kfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr 203 (361)
T KOG1006|consen 127 KFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDR 203 (361)
T ss_pred HHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEec
Confidence 999999999999999999954 55544321 123345788888889999999999998764 6999999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCcccccccc--CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA--EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l 688 (792)
.|.+||+|||++..+...- ..+.-.|-..|||||.+. ...|+.++||||||+.|+|+.||+.||+.....
T Consensus 204 ~G~vKLCDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----- 275 (361)
T KOG1006|consen 204 HGDVKLCDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----- 275 (361)
T ss_pred CCCEeeecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----
Confidence 9999999999998764332 223457889999999984 345999999999999999999999998743321
Q ss_pred hHHHHHHHhhhhhhhhcccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 689 LGHAWILWKEKRAMELAGDTLA--DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+.+-...-.-++... .....+....+.+++..|+.++..+||...++.++
T Consensus 276 -------feql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 276 -------FEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred -------HHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111111111122111 11122345678889999999999999999998764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=295.66 Aligned_cols=267 Identities=21% Similarity=0.285 Sum_probs=197.2
Q ss_pred HhHHHhhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC-
Q 003832 466 ASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA- 541 (792)
Q Consensus 466 ~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~- 541 (792)
.++...+++|...+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566789999999999999999999975 458899999997542 23346788899999999999999999988643
Q ss_pred -----CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 542 -----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 542 -----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEE
Confidence 3357778776 7788877732 34889999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH----
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH---- 691 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~---- 691 (792)
+|||++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+..
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998764321 223467889999998866 5688999999999999999999999864332111000000
Q ss_pred ----HHHHHhhhhhhhh---ccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 ----AWILWKEKRAMEL---AGDTLADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 ----~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............. +....... ........+.+++..|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 00000000 000124467899999999999999999998875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=297.16 Aligned_cols=265 Identities=22% Similarity=0.297 Sum_probs=193.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC----------
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA---------- 541 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~---------- 541 (792)
.+|...+.||.|+||.||+|... .++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67889999999999999999875 4889999998766656667889999999999999999999876544
Q ss_pred ----CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceE
Q 003832 542 ----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKI 616 (792)
Q Consensus 542 ----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl 616 (792)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 34689999997 588777732 35889999999999999999999987 99999999999997 4567899
Q ss_pred eeeccccccCCCCcc-ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH---
Q 003832 617 SDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--- 691 (792)
Q Consensus 617 ~DFgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--- 691 (792)
+|||++..+...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....+.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999865432111 11122457889999998654 5688999999999999999999999964432111000000
Q ss_pred -----HHHHHhhhhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 -----AWILWKEKRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 -----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...................... .+....++.+++.+||+.+|++||+++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000000000000001 11233567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=285.02 Aligned_cols=263 Identities=25% Similarity=0.348 Sum_probs=197.6
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
|+..+.||+|++|.||+|+... ++.+|+|++.... ....+.+..|+.++++++|+|++++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999998765 8899999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
+ ++|.+++.... ..+++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999986532 35899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc-hhH-------HHHHHHhhhhhh
Q 003832 632 TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN-LLG-------HAWILWKEKRAM 702 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~-l~~-------~~~~~~~~~~~~ 702 (792)
......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ... ..+.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223457789999998766 88999999999999999999999986533211100 000 000000000000
Q ss_pred hhccccc----cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAGDTL----ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~~----~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...-+.. .....+.....+.+++..||+.+|++||++++|+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 000011124568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=293.17 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=195.5
Q ss_pred HHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC---
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--- 542 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--- 542 (792)
....++|+..+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999854 5889999998643 2233456889999999999999999999987654
Q ss_pred ---cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 543 ---ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 543 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
..++||||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 6788887742 35889999999999999999999987 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc-chh-------H
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH-NLL-------G 690 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~-~l~-------~ 690 (792)
|++...... .....++..|+|||.+.+ ..++.++||||||+++++|++|+.||......... ... .
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 998865322 123467889999998865 45889999999999999999999998743221000 000 0
Q ss_pred HHHHHHhhhhhhhhccc--ccc----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 691 HAWILWKEKRAMELAGD--TLA----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
................. ... ..........+.+++.+|++.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 000 0011123345789999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.31 Aligned_cols=263 Identities=21% Similarity=0.276 Sum_probs=193.6
Q ss_pred ccccc-ccccCcCCcccEEeeecc-CCcEEEEEEccCCCchh--------------HHHHHHHHHHHHhcccccceeeee
Q 003832 473 DNFAS-YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG--------------MEEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 473 ~~~~~-~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
++|.. .+.||+|+||.||+|... .++.||||+++...... ...+.+|++++.+++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999865 58899999986542211 124778999999999999999999
Q ss_pred eEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 537 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
++...+..++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588888753 335889999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCc------------cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 617 SDFGMARIFGGDEI------------QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 617 ~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
+|||++........ ........++..|+|||.+.+. .++.++||||||++++||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987641110 1111223467889999998764 4789999999999999999999998754321
Q ss_pred CccchhHHHHHHHhhhhh---hhhc-----c---c---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 684 HDHNLLGHAWILWKEKRA---MELA-----G---D---TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 684 ~~~~l~~~~~~~~~~~~~---~~~~-----~---~---~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+ .............. .... . . .............+.+++..|++.+|++||+++|++.+
T Consensus 241 ~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 D---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred H---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 1 11111000000000 0000 0 0 00000011224567899999999999999999999974
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=295.84 Aligned_cols=262 Identities=23% Similarity=0.321 Sum_probs=196.4
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc----
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 543 (792)
..++|+..+.||+|++|.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999875 4789999998653 22344667889999999999999999998876654
Q ss_pred --ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 544 --SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 544 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5689888743 45899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh-H-------HH
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL-G-------HA 692 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~-~-------~~ 692 (792)
+...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...........+ . ..
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 9865432 223467889999998865 46789999999999999999999999643321100000 0 00
Q ss_pred HHHHhhhhhhhhccccc---cCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 693 WILWKEKRAMELAGDTL---ADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.......++.... ... ........+.+++.+|++.+|++|||+.||++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000000 000 001124578899999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=289.24 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=191.3
Q ss_pred ccccccccCcCCcccEEeeeccC---CcEEEEEEccCC--CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeC----Cc
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE---GQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA----DE 543 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 543 (792)
+|+..+.||+|+||.||+++... +..+|+|++... .....+.+.+|+.++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999998653 678999998653 222356788899999999 599999999976533 34
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888886 588888743 345889999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCcc--ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh--------HHH
Q 003832 624 IFGGDEIQ--TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------GHA 692 (792)
Q Consensus 624 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~--------~~~ 692 (792)
.+...... .......|+..|+|||.+.+ ..++.++||||||++++||++|+.||............ ...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 11223578999999998765 46899999999999999999999998653321100000 000
Q ss_pred HHHHhhhhhhhh---cccccc---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 693 WILWKEKRAMEL---AGDTLA---DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 693 ~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............ ...... ....+.....+.+++.+|++.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000000 000000 00011124568899999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=273.92 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=195.1
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCC--Cch-----hHHHHHHHHHHHHhcccccceeeeeeEEe-CC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQ-AD 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~ 542 (792)
.++|-.+++||+|||+.||++.. ...+.||||+-..+ ... ..+...+|..+-+.|.||.||++++++.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35677889999999999999974 45778999985433 211 22346789999999999999999999864 45
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeee
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDF 619 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DF 619 (792)
..+-|.|||++.+|+-+|.. .+.++++++..|+.||+.||.||.+.. +||||-||||.||||.+ -|.+||.||
T Consensus 542 sFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeec
Confidence 67889999999999999954 346899999999999999999999875 78999999999999954 578999999
Q ss_pred ccccccCCCCcc-----ccccccccccCccccccccC----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH
Q 003832 620 GMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAE----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (792)
Q Consensus 620 gla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~ 690 (792)
||++++..+... ..+....||.+|++||.+-- ..++.|+||||.|||+|..+-|++||...... ..++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdIL- 694 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDIL- 694 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHH-
Confidence 999998654332 22345689999999998742 35789999999999999999999999743221 1111
Q ss_pred HHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003832 691 HAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~ev 742 (792)
.+..+....+-. -+.-+....+...+|++||+..-++|....++
T Consensus 695 ------qeNTIlkAtEVq--FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 695 ------QENTILKATEVQ--FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred ------hhhchhcceecc--CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 112221111111 12223345567789999999999999765553
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=270.20 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=196.2
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+.+++||+|.||+|.+.+-+. ++.+|+|++++.. ......-..|-++|+..+||.+..+...|...++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678888999999999999998654 8899999998873 33445567799999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||..+|.|..+|.+ ...+++......-..|+.||.|||+.+ ||.||||.+|.|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999888754 345777888888899999999999987 99999999999999999999999999985322
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. ..+...+||+.|+|||++....|+..+|.|.+||++|||++|+.||-..+.+....++ + ..++
T Consensus 321 ~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI-----l-----~ed~--- 385 (516)
T KOG0690|consen 321 YG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI-----L-----MEDL--- 385 (516)
T ss_pred cc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH-----H-----hhhc---
Confidence 11 2244589999999999999999999999999999999999999999644332211111 0 0011
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
..|.....+...|....|.++|++|.
T Consensus 386 ----kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 386 ----KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 23444455667788889999999995
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=308.90 Aligned_cols=146 Identities=26% Similarity=0.441 Sum_probs=130.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|.+.++||+|+||.||+|... .++.||||+++... ....+.+..|+.++..++||||+++++++......+||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999876 58899999987542 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
|||+.+++|.+++... ..+++..++.++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998543 35788899999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=272.76 Aligned_cols=236 Identities=26% Similarity=0.364 Sum_probs=192.9
Q ss_pred cCcCCcccEEeeeccC-CcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
||+|+||.||++.... ++.+|+|++.+... ...+.+..|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999998754 88999999876532 2456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~ 636 (792)
.+++... ..+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9998543 25889999999999999999999987 9999999999999999999999999998764332 11233
Q ss_pred cccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 637 VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 637 ~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
..++..|+|||.+.+...+.++|+||||+++|||++|+.||...... ... ...... ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~------------~~~~~~--~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIY------------EKILKD--PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH------------HHHhcC--CCCCCCC
Confidence 56788999999998888999999999999999999999998643220 000 001111 1123333
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHH
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSS 741 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~e 741 (792)
....+.+++.+|+..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3567889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=283.27 Aligned_cols=244 Identities=25% Similarity=0.362 Sum_probs=196.7
Q ss_pred ccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
.+.||+|.||+||-|+++ .|+.||||++.+. ..+...++++|+.+|++++||.||.+.-.|+..+..++|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 368999999999999876 4999999999764 4456688999999999999999999999999999999999999776
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeeeccccccCCCCcc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgla~~~~~~~~~ 631 (792)
-|+-+|.. ..+.|+......++.||+.||.|||.++ |+|+||||+||||.+. .++||+|||+|++++....
T Consensus 649 MLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF- 722 (888)
T KOG4236|consen 649 MLEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF- 722 (888)
T ss_pred HHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence 66666643 3456888888889999999999999998 9999999999999644 5799999999999875543
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
...++||+.|+|||+++.+.|...-|+||.|||+|--++|..||.....-.+ -++ -..++-+.
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQ----------NAaFMyPp--- 785 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQ----------NAAFMYPP--- 785 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhh----------ccccccCC---
Confidence 3458999999999999999999999999999999999999999974322111 110 11111111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..-.+.....++||...||..-++|-+..+-+.
T Consensus 786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 112244556788888999999999988877654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=270.94 Aligned_cols=241 Identities=27% Similarity=0.360 Sum_probs=197.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (792)
..+|..+.+||+|+||+|.+|.-+. .+.+|||+++++. ....+--+.|-++|+.. +-|.++++..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3567788899999999999997654 5679999998873 23445556788888877 56899999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+.+|+|-..+.+-+ .+.+..+...|..||-||-+||+++ |+.||||.+||+||.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999977775433 3667788899999999999999998 9999999999999999999999999998532
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
-+. ..+...+||+.|+|||++...+|+..+|.|||||+||||+.|++||+..++++.. ..+++
T Consensus 502 ~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~e 564 (683)
T KOG0696|consen 502 FDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIME 564 (683)
T ss_pred cCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHHH
Confidence 222 2344589999999999999999999999999999999999999999866543221 11222
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
.. -.+|...+.+...+....+.++|.+|.
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 22 246667777888888999999999994
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=267.74 Aligned_cols=219 Identities=19% Similarity=0.156 Sum_probs=176.4
Q ss_pred CCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChhHHHhh
Q 003832 484 GGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (792)
Q Consensus 484 G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 562 (792)
|.+|.||+++.. +++.+|+|+++... .+..|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999875 47899999997643 234455566666799999999999999999999999999999998855
Q ss_pred cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccC
Q 003832 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642 (792)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 642 (792)
. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+..+.... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 3 24889999999999999999999987 9999999999999999999999999876654321 12345678
Q ss_pred ccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHH
Q 003832 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCI 722 (792)
Q Consensus 643 y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 722 (792)
|+|||.+....++.++||||+|++++||++|+.|+........ .......+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHH
Confidence 9999999888899999999999999999999987653211000 0000112233445688
Q ss_pred HHHHHhccCCCCCCCCH
Q 003832 723 HVGLLCVQHRPEDRPNM 739 (792)
Q Consensus 723 ~li~~Cl~~~P~~RPs~ 739 (792)
+++.+|++.+|++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=241.59 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=192.0
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+|...++||+|.||+||+|+..+ ++.||+|+++.+. +..-....+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566799999999999999766 6789999987653 33345788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|.. +|..+... -++.++.+....++.|+++||.++|+++ +.||||||+|.||+.+|+.|++|||+++-++-.-
T Consensus 83 cdq-dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV- 155 (292)
T ss_pred hhH-HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-
Confidence 954 56555522 3456889999999999999999999998 9999999999999999999999999999875322
Q ss_pred cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhh---hhhhc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKR---AMELA 705 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~ 705 (792)
......+-|.+|.+|.++.+. .|+...|+||-|||+.||.. |++.|...+-++....+-+......+.. +..+.
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 122334568999999998765 58999999999999999987 4444543332222111111110011111 12222
Q ss_pred cccccCCCCH---------HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPP---------TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~---------~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
|-.....++. .....-.++....+.-+|..|.++++.++.
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 2222222222 111223456666777789999999887764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=288.23 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=216.2
Q ss_pred cCHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
.+++.+...++.|++.+.||.|.+|.||+++.. +++..|+|++..+. ...++...|.++++.. +|||++.++|++..
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344455566788999999999999999999865 47888999886543 3456778899999888 69999999999875
Q ss_pred -----CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCce
Q 003832 541 -----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPK 615 (792)
Q Consensus 541 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k 615 (792)
++.++||||||.+||..+++.... ...+.|..+..|+..++.|+.+||... ++|||||-.|||++.++.+|
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 457899999999999999997654 677999999999999999999999987 99999999999999999999
Q ss_pred EeeeccccccCCCCccccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH
Q 003832 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (792)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~ 690 (792)
|.|||++..+.... .+.....||+.|||||++.. ..|+.++|+||||++..||--|.+|+...++.....++
T Consensus 164 LvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I- 240 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI- 240 (953)
T ss_pred Eeeeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-
Confidence 99999998875432 33445789999999999843 45788999999999999999999999877664321111
Q ss_pred HHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 691 HAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
-..+......+.....++.++|..||.++-+.||++.+++++
T Consensus 241 -------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 -------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112333334567788899999999999999999999998763
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=301.42 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=207.0
Q ss_pred hHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
++....++|++++.||+|+||.|..++++. ++.+|+|++.+. .......|++|-.+|..-+.+=|+.++..|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 344456889999999999999999999876 778999999873 3445567999999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
+.|+|||||+||+|-.++.+-. .++...+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||.+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999995533 5888888999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCcccccccc----C-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAA----E-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
-.+..+. .......+|||.|++||++. + +.|+..+|.||+||++|||+.|..||-... +++-......
T Consensus 223 lkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~ 295 (1317)
T KOG0612|consen 223 LKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMN 295 (1317)
T ss_pred HhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhc
Confidence 8876444 33445579999999999994 3 679999999999999999999999985322 2222222222
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN---MSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs---~~evl~~ 745 (792)
+.....+. ...+.++...+||...+. +|+.|-. ++|+-.+
T Consensus 296 hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 HKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 21111111 113456677778877664 6778877 8888765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=284.15 Aligned_cols=241 Identities=22% Similarity=0.268 Sum_probs=193.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.++.|+....+|.|+|+.|-+..+. .++..++|++.+.. .+..+|+.++... +||||+++.+.+.+..+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567788888999999999998765 47889999997652 2345677666666 6999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe-cCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DFgla~~~~~ 627 (792)
|.+.++-+.+.+.... ....++..|+.+|+.|+.|||+++ ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877764432 223777789999999999999988 9999999999999 6999999999999998754
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
+ ....+-|..|.|||++....|++++|+||||++||||++|+.||.....+ ..+ ...+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei-------------~~~i-- 526 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI-------------HTRI-- 526 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH-------------HHhh--
Confidence 4 12245688999999999999999999999999999999999999743322 000 0000
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.........+....+|+.+||+.+|.+||+|.++...
T Consensus 527 -~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 -QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111224455667889999999999999999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=263.19 Aligned_cols=236 Identities=28% Similarity=0.398 Sum_probs=193.0
Q ss_pred CcccEEeeeccC-CcEEEEEEccCCCchh-HHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChhHHHhh
Q 003832 485 GFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD 562 (792)
Q Consensus 485 ~fg~Vy~g~~~~-~~~vavK~l~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~ 562 (792)
+||.||+|+... ++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999865 8899999997765444 68899999999999999999999999999999999999999999999865
Q ss_pred cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccC
Q 003832 563 QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642 (792)
Q Consensus 563 ~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~ 642 (792)
.. .+++..++.++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 33 2889999999999999999999987 9999999999999999999999999998765432 2233567889
Q ss_pred ccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH--HHHH
Q 003832 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT--EVLR 720 (792)
Q Consensus 643 y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 720 (792)
|++||.+....++.++||||||++++||++|..||...... ... .+............. ...+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~-------------~~~~~~~~~~~~~~~~~~~~~ 216 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LEL-------------FKKIGKPKPPFPPPEWKISPE 216 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHH-------------HHHHhccCCCCccccccCCHH
Confidence 99999998888999999999999999999999998642111 111 011111111111111 4467
Q ss_pred HHHHHHHhccCCCCCCCCHHHHHH
Q 003832 721 CIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 721 l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+.+++.+|+..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 889999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=256.07 Aligned_cols=260 Identities=20% Similarity=0.253 Sum_probs=197.5
Q ss_pred hhccccc-ccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeC----Cc
Q 003832 471 ATDNFAS-YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA----DE 543 (792)
Q Consensus 471 ~~~~~~~-~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~----~~ 543 (792)
.+++|.+ .++||-|-.|.|-...++. ++.+|+|++.. ....++|+++.-.. .|||||.+++++... ..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 3566654 3579999999999887754 78899999953 24567888887776 599999999998653 45
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeec
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFG 620 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFg 620 (792)
+++|||.|+||.|...+.+++ ...+++.++..|+.||..|+.|||+.+ |.||||||+|+|... +..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 788999999999999886654 456899999999999999999999988 999999999999974 4569999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
+|+..... ......+-|+.|.|||++....|+..+|+||+||++|-|++|-+||-..+.... -.+.
T Consensus 210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgM--------- 275 (400)
T KOG0604|consen 210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGM--------- 275 (400)
T ss_pred cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhH---------
Confidence 99875432 223346779999999999999999999999999999999999999853332100 0000
Q ss_pred hhhhcccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCCCC
Q 003832 701 AMELAGDTLA--DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSLLP 753 (792)
Q Consensus 701 ~~~~~~~~~~--~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~~~ 753 (792)
...+...... .+--...++...++++.+|..+|.+|-|+.|++.. +.+...+|
T Consensus 276 k~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 276 KRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred HhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 0011111110 01112345677889999999999999999999875 44444443
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=287.89 Aligned_cols=260 Identities=19% Similarity=0.198 Sum_probs=168.1
Q ss_pred hhcccccccccCcCCcccEEeeeccC-----CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeee------EE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGC------CI 539 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~------~~ 539 (792)
..++|+..++||+|+||.||+|++.+ +..||+|++...... +....| .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 46789999999999999999998754 588999998643221 111111 1122222222222221 24
Q ss_pred eCCcceEEEeecCCCChhHHHhhcccC-----------------ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCC
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQARA-----------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 602 (792)
.....++|+||+.+++|.+++...... .......+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566789999999999999988643210 01122345579999999999999987 9999999
Q ss_pred CCcEEecC-CCCceEeeeccccccCCCCccccccccccccCccccccccCC----------------------CCCccCc
Q 003832 603 ASNVLLDN-DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG----------------------LFSVKSD 659 (792)
Q Consensus 603 p~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~k~D 659 (792)
|+|||+++ ++.+||+|||+++.+..... .......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 58999999999986543221 122346789999999965321 2445779
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh----hhhhhhccccccCC------CCHHHHHHHHHHHHHhc
Q 003832 660 VFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE----KRAMELAGDTLADS------HPPTEVLRCIHVGLLCV 729 (792)
Q Consensus 660 VwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~------~~~~~~~~l~~li~~Cl 729 (792)
||||||+||||+++..+++.. +.......... ........+..... ..........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~-------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999976653311 10000000000 00001111110000 00001223458999999
Q ss_pred cCCCCCCCCHHHHHHH
Q 003832 730 QHRPEDRPNMSSVVLM 745 (792)
Q Consensus 730 ~~~P~~RPs~~evl~~ 745 (792)
+.||++|||+.|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=281.12 Aligned_cols=266 Identities=18% Similarity=0.225 Sum_probs=181.6
Q ss_pred hhcccccccccCcCCcccEEeeec-----------------cCCcEEEEEEccCCCchhHHHH--------------HHH
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-----------------VEGQEIAVKRLSKGSGQGMEEF--------------KNE 519 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-----------------~~~~~vavK~l~~~~~~~~~~~--------------~~E 519 (792)
..++|++.++||+|+||.||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 2356799999865433323333 347
Q ss_pred HHHHHhcccccc-----eeeeeeEEe--------CCcceEEEeecCCCChhHHHhhccc---------------------
Q 003832 520 VTLIARLQHRNL-----VKLLGCCIQ--------ADESMLIYEYMPNKSLDFFIFDQAR--------------------- 565 (792)
Q Consensus 520 i~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~--------------------- 565 (792)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 677888753 3568999999999999999864211
Q ss_pred CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccc
Q 003832 566 ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645 (792)
Q Consensus 566 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~a 645 (792)
...+++..+..++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++..+..... .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567788899999999999999987 99999999999999999999999999976543221 11112345789999
Q ss_pred cccccCCC----------------------CCccCcchhHHHHHHHHHhCCC-CCCCCCCCCcc-chhHHHHHHHhhhhh
Q 003832 646 PEYAAEGL----------------------FSVKSDVFSFGVLVLEIVSGKK-NWRFSHPDHDH-NLLGHAWILWKEKRA 701 (792)
Q Consensus 646 PE~~~~~~----------------------~s~k~DVwS~Gvil~elltG~~-p~~~~~~~~~~-~l~~~~~~~~~~~~~ 701 (792)
||.+.... ...+.||||+||+++||++|.. |+......... .........|..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--- 455 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--- 455 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh---
Confidence 99875322 1235799999999999999875 55421111000 000000000100
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRP---EDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P---~~RPs~~evl~~ 745 (792)
.......-+..........+++.++|..+| .+|+|++|++++
T Consensus 456 --~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 456 --YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000111111122334567788889998765 789999999864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=263.99 Aligned_cols=264 Identities=18% Similarity=0.231 Sum_probs=198.9
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcc-c-c----cceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-H-R----NLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H-~----niv~l~g~~~~~~~ 543 (792)
.+++|.++.++|+|.||.|-...... +..||||+++. .....+..+-|+++|.++. + | -+|.+.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36889999999999999999987544 68899999954 3445567788999999994 2 3 37888899999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN------------- 610 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------------- 610 (792)
.+||+|.| +-|+.++|..+ ...+.+...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 44888888554 3456788899999999999999999987 999999999999931
Q ss_pred -------CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 611 -------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 611 -------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
...+||+|||.|..-.... ..++.|..|.|||++.+-.++..+||||+||||.|+.||...|...+..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 3358999999998754332 4478899999999999999999999999999999999999998754422
Q ss_pred CccchhHHH--------HHH------Hhhhhhh----------h-hcccc--c--cCCCCHHHHHHHHHHHHHhccCCCC
Q 003832 684 HDHNLLGHA--------WIL------WKEKRAM----------E-LAGDT--L--ADSHPPTEVLRCIHVGLLCVQHRPE 734 (792)
Q Consensus 684 ~~~~l~~~~--------~~~------~~~~~~~----------~-~~~~~--~--~~~~~~~~~~~l~~li~~Cl~~~P~ 734 (792)
+..-+.+.. ... ...+++. . +.+.. + .......+..+|.+|+..||..||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 211000000 000 0000000 0 00000 0 0012234566799999999999999
Q ss_pred CCCCHHHHHHH
Q 003832 735 DRPNMSSVVLM 745 (792)
Q Consensus 735 ~RPs~~evl~~ 745 (792)
+|+|+.|+++.
T Consensus 396 ~RiTl~EAL~H 406 (415)
T KOG0671|consen 396 RRITLREALSH 406 (415)
T ss_pred ccccHHHHhcC
Confidence 99999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=251.65 Aligned_cols=267 Identities=20% Similarity=0.347 Sum_probs=191.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC--------
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-------- 541 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-------- 541 (792)
..|+...+||+|.||.||+|+.++ ++.||+|++--.. ..--....+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 446666799999999999998765 7778988764322 22234567899999999999999999998643
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
...+||+++|+. +|.-+|... ...++..++.+++.++..||.|+|... |+|||+|+.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 237899999987 566666432 345888999999999999999999887 99999999999999999999999999
Q ss_pred ccccCCC--CccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH-------
Q 003832 622 ARIFGGD--EIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH------- 691 (792)
Q Consensus 622 a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~------- 691 (792)
++.+... ......+..+-|..|++||.+.+ ..|+++.|||.-|||+.||.|+.+-+..........++..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9876432 22223344566999999998865 5799999999999999999999987765433222111110
Q ss_pred -HHHHHhhhhhhhhcccc-cc-C--CCCHHH------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 -AWILWKEKRAMELAGDT-LA-D--SHPPTE------VLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 -~~~~~~~~~~~~~~~~~-~~-~--~~~~~~------~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.|.....-...+.++.. +. . ..-.+. -.+.++|+..++..||.+|+.+++++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 01001111111111000 00 0 000111 1256789999999999999999998754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=271.85 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=205.9
Q ss_pred cccccccccCcCCcccEEeeeccCCc-EEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQ-EIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~-~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.+++.+..||-|+||.|-+...+... .+|+|.+++. .....+....|-.+|...+.|.||+++-.|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45566678999999999998875433 3788888654 4455677889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|-|-+|.|...|.++ +.++......++..+++|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.+...
T Consensus 500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999654 35788888899999999999999998 999999999999999999999999999988654
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. .+...+||+.|.|||++.+...+..+|.||||++++||++|.+||...++-...+++-.. ..
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG------id-------- 636 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG------ID-------- 636 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh------hh--------
Confidence 3 345589999999999999999999999999999999999999999877664433222111 01
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
.-..|........+|++.....+|.+|.- +.||-++
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 11334455566778888888999999976 6677664
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=263.81 Aligned_cols=208 Identities=24% Similarity=0.411 Sum_probs=177.7
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.-|..++.||-|+||.|.+++..| ...+|.|.|++.+ +......+.|-.||+....+=||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347788999999999999997655 5578999998753 344556789999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC--
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-- 626 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~-- 626 (792)
||++||++-.+|.+. +.+.+..+..++..+..|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrm---gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHHHh---ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 999999998888654 45778888888899999999999888 9999999999999999999999999987542
Q ss_pred -------CCC-------------------------------ccccccccccccCccccccccCCCCCccCcchhHHHHHH
Q 003832 627 -------GDE-------------------------------IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVL 668 (792)
Q Consensus 627 -------~~~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ 668 (792)
..+ .......++||+.|+|||++....|+.-+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 000 001122468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcc
Q 003832 669 EIVSGKKNWRFSHPDHDH 686 (792)
Q Consensus 669 elltG~~p~~~~~~~~~~ 686 (792)
||+.|+.||....+.+.+
T Consensus 863 em~~g~~pf~~~tp~~tq 880 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQ 880 (1034)
T ss_pred HHhhCCCCccCCCCCcce
Confidence 999999999988776654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=245.66 Aligned_cols=282 Identities=22% Similarity=0.344 Sum_probs=208.7
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (792)
..+|..+++||+|+|.+|..++++. .+.+|+|++++. ..+.+.=...|-.+..+. +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3578888999999999999999865 678899999764 233344455666666666 69999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|.||+++|+|--.+.+ ...++++.+......|..||.|||+.+ |+.||||.+|+|||.+|++||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999998655543 344888888889999999999999998 9999999999999999999999999998632
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCC-ccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH-DHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~ 705 (792)
... ..+...+||+.|+|||++++..|...+|.|++||+++||+.|+.||+...-+. +.+..++.... ++
T Consensus 403 ~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------il 472 (593)
T KOG0695|consen 403 GPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------IL 472 (593)
T ss_pred CCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hh
Confidence 221 12345899999999999999999999999999999999999999998643221 11111111111 11
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHH----------HHhcCCCCCCCCCCCCccccCCCCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN------MSSVV----------LMLSSDSLLPEPNRPGFFTERSLPEA 769 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs------~~evl----------~~L~~~~~~~~p~~p~~~~~~~~~~~ 769 (792)
+..+ .+|.....+...+.+.-+.+||.+|.. ++++- ++||+ .++..|=+|+....+.+..-
T Consensus 473 ekqi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq-k~v~ppf~p~i~~d~~l~~f 549 (593)
T KOG0695|consen 473 EKQI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ-KQVLPPFQPQITDDYGLDNF 549 (593)
T ss_pred hhcc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh-cccCCCCCCccccccCcccc
Confidence 1221 223334445667778889999998842 33332 23433 44455667777666655444
Q ss_pred cCC
Q 003832 770 EFS 772 (792)
Q Consensus 770 ~~~ 772 (792)
.++
T Consensus 550 d~q 552 (593)
T KOG0695|consen 550 DTQ 552 (593)
T ss_pred ccc
Confidence 443
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=232.04 Aligned_cols=207 Identities=26% Similarity=0.388 Sum_probs=170.4
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
++...+.......||+|++|.|-+-++. +|+..|+|+++.. ..+..++...|+.+..+. .+|.+|+++|....+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455566666789999999999998875 5889999999765 445566778888876665 699999999999999999
Q ss_pred eEEEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
++.||.|.- ||+.+-.+- .+...+++.-+-+|+..+.+||.|||++- .++|||+||+|||++.+|++||+|||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999954 676665432 24566888888899999999999999964 69999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCcccccccc----CCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAA----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
.+.+.-. .+...|-..|||||.+. ...|+-|+||||||+.+.||.+++.||+..
T Consensus 198 ~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 198 YLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred eehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 7754321 22246788999999884 347999999999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=274.91 Aligned_cols=246 Identities=26% Similarity=0.381 Sum_probs=186.6
Q ss_pred cccccccCcCCccc-EEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeecC
Q 003832 475 FASYNKLGEGGFGP-VYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 475 ~~~~~~lg~G~fg~-Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
|...+.+|.|..|+ ||+|.. +++.||||++-. +...-..+|+..|+.- +|||||++++.-.+.+..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 44456789999876 699988 789999999843 3334567899999988 59999999999889999999999995
Q ss_pred CCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-----CCCceEeeeccccccC
Q 003832 553 NKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIFG 626 (792)
Q Consensus 553 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgla~~~~ 626 (792)
.+|.+++.... ......-...+.+..|++.||++||+.+ ||||||||+||||+. ..+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 48999986531 1111111445778899999999999977 999999999999975 2579999999999986
Q ss_pred CCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhC-CCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG-KKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.+... .+.....||.+|+|||.+....-+..+||+|+|||+|+.++| .+||...-.. .+.++........
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-------~~NIl~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-------QANILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-------hhhhhcCccceee-
Confidence 54432 234567899999999999988888899999999999999996 8898632211 1111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+ ....++ +..+||.+|++++|..||++.+|+.
T Consensus 735 ----L--~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ----L--EPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----e--ccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 111112 6778999999999999999999985
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=225.22 Aligned_cols=109 Identities=50% Similarity=0.797 Sum_probs=80.6
Q ss_pred CCeeEEeecCCCCCCCC--CceeEEecCceEEe-CCCCceEEee-ccCCCC-CCcEEEEeeccceEEecCCCCceeeecc
Q 003832 64 PRTVAWVANRETPLTDQ--SGLLNVTSKGIVLL-DGRDRIFWSS-NTSITM-KNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (792)
Q Consensus 64 ~~tvvW~ANr~~p~~~~--~~~l~~~~~g~l~l-~~~~~~~Wss-~~~~~~-~~~~a~Lld~GNlVl~~~~~~~~lWqSF 138 (792)
++||||+|||+.|+.+. ...|.++.||+|+| ++.++++|++ ++.... .+..|+|+|+|||||+|.. +.+|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-~~~lW~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-GNVLWQSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-SEEEEEST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-ceEEEeec
Confidence 47999999999999653 47899999999999 8888999999 555333 5789999999999999965 89999999
Q ss_pred CCCCCccCCCCcccceeccCCceeEEeeccCCCCC
Q 003832 139 DHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPA 173 (792)
Q Consensus 139 d~PTDtlLpg~~l~~~~~~g~~~~l~Sw~s~~dps 173 (792)
||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999988888777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=231.38 Aligned_cols=211 Identities=34% Similarity=0.573 Sum_probs=184.0
Q ss_pred cCcCCcccEEeeeccC-CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChhH
Q 003832 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~ 558 (792)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999999765432 45789999999999999999999999999999999999999999999
Q ss_pred HHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCCCCcccccccc
Q 003832 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGDEIQTNTHKV 637 (792)
Q Consensus 559 ~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~~~~~~~~~~~ 637 (792)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 985432 35889999999999999999999987 999999999999999 89999999999987644321 12235
Q ss_pred ccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHH
Q 003832 638 VGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPT 716 (792)
Q Consensus 638 ~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 716 (792)
.+...|++||.+... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999877 889999999999999999
Q ss_pred HHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 717 EVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 717 ~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
..+.+++..|++.+|++||++.++++.|
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=211.88 Aligned_cols=109 Identities=40% Similarity=0.928 Sum_probs=104.0
Q ss_pred eecCCCCCccccCCCCCCCCcccceeeeeecCceEEEEEc-CCCCceeEEEEecCCcEEEEEeecCCccEEEEEeccCcc
Q 003832 199 YRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECD-AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPLDR 277 (792)
Q Consensus 199 ~~~g~w~g~~~~~~p~~~~~~~~~~~~~v~n~~~~~~~~~-~~~~~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~p~d~ 277 (792)
||+|+|||..|+|+|+|.. ...+.+.|+.+++|.+|+|. .+.+.++|++|+.+|+++++.|++..+.|.+.|.+|.|+
T Consensus 1 wrsG~WnG~~f~g~p~~~~-~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~ 79 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSS-NSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQ 79 (110)
T ss_pred CCccccCCeEECCcccccc-cceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccC
Confidence 8999999999999999985 67899999999999999998 688889999999999999999999999999999999999
Q ss_pred CcCCCCCCCCccccCCCCCccCCCCCcccCC
Q 003832 278 CDLYSVCGANARCTTNSSRRCDCLEGFVPKS 308 (792)
Q Consensus 278 C~~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 308 (792)
||+|+.||+||+|+.+..+.|.||+||+|++
T Consensus 80 Cd~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 80 CDVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 9999999999999988899999999999974
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=223.28 Aligned_cols=258 Identities=19% Similarity=0.333 Sum_probs=195.0
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCC--cceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD--ESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~~~l 546 (792)
..++|++.+++|+|.++.||.|.. .+++.++||+++. -..+.+.+|+.+|..+. ||||+++++...+.. ...|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999974 4678999999964 33467889999999997 999999999987754 5689
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgla~~~ 625 (792)
|+||+++.+...+- ..++..++...+.++++||.|+|+.| |.|||+||.|++||.. ..++|+|+|+|.+.
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998876554 24777888899999999999999998 9999999999999965 56999999999987
Q ss_pred CCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh-----
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK----- 699 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----- 699 (792)
.+.... +..+.+..|--||.+-. ..|+..-|+|||||+|.+|+..+.||-..+...+ +++.-+.. +...
T Consensus 184 Hp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakV-LGt~el~~Y 258 (338)
T KOG0668|consen 184 HPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKV-LGTDELYAY 258 (338)
T ss_pred CCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHH-hChHHHHHH
Confidence 655422 23456778899998854 5688999999999999999999999865443222 22211111 1111
Q ss_pred ----------hhhhhccccccCC-------CCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 ----------RAMELAGDTLADS-------HPPT-EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ----------~~~~~~~~~~~~~-------~~~~-~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+...++....+.. .... ...+.++++...|..|-.+|||+.|.+..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 1111111111110 0111 12567889999999999999999998753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-28 Score=237.36 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=193.6
Q ss_pred ccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----cceEE
Q 003832 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESMLI 547 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-----~~~lV 547 (792)
+..+.||.|+||.||..+.. +|+.||+|++... .-...+.+.+|+.+|.-.+|.|++..++...-.. +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34478999999999998764 5899999998543 2234467889999999999999999988865443 46778
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
.|.|. .+|..++.. ...++...+.-+..||++||.|||+.+ |.||||||.|.|++.+..+||+|||+++.-..
T Consensus 136 TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88874 366666643 335777777888999999999999988 99999999999999999999999999998665
Q ss_pred CCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HHHHHhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AWILWKE 698 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~ 698 (792)
++....+. .+-|..|.|||++.+. .|+...||||.|||+.||+..+..|....+.+...++.. ++..--+
T Consensus 209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 55443333 4568899999999775 699999999999999999999988876665544322211 1111122
Q ss_pred hhhhhhccccccC---------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 699 KRAMELAGDTLAD---------SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 699 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
+....++....+. ..+...-.+...+.+.++..+|+.|.+..+.+..+-
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 2222222211111 011122234556777899999999999999888763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=237.09 Aligned_cols=273 Identities=23% Similarity=0.278 Sum_probs=199.7
Q ss_pred cccccccccCcCCcccEEeee-ccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------Cc
Q 003832 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DE 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~-~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 543 (792)
.+|..++.+|.|.- .|-.+. .-.++.||+|++... .....+...+|...+..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777788898888 444443 234889999998654 344566778999999999999999999998643 45
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.|+|||+|.. +|...+.. .++-.....|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7999999954 77777752 3667788899999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc----------------c
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH----------------N 687 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~----------------~ 687 (792)
.-... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+..|.+.+.-+.. .
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 64333 2344578899999999999988999999999999999999999988753321110 0
Q ss_pred hhHHHHHHHhhh------hhhhh-cccccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hc---CCCCCC
Q 003832 688 LLGHAWILWKEK------RAMEL-AGDTLA--DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LS---SDSLLP 753 (792)
Q Consensus 688 l~~~~~~~~~~~------~~~~~-~~~~~~--~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~---~~~~~~ 753 (792)
+...+...+... ...+. .|.... .+.+......+.+++.+||-.+|++|-++++++++ ++ ...+++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ 323 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVE 323 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccccccc
Confidence 111111111000 00000 010000 01122233456789999999999999999999986 55 556677
Q ss_pred CCCCC
Q 003832 754 EPNRP 758 (792)
Q Consensus 754 ~p~~p 758 (792)
+|+.|
T Consensus 324 ap~pe 328 (369)
T KOG0665|consen 324 APPPE 328 (369)
T ss_pred CCCCc
Confidence 77766
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-27 Score=245.86 Aligned_cols=268 Identities=17% Similarity=0.195 Sum_probs=205.2
Q ss_pred HHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcc------cccceeeeeeEEeC
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ------HRNLVKLLGCCIQA 541 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~------H~niv~l~g~~~~~ 541 (792)
+..-..|.+....|+|-|++|-+|.... |+.||||+|+.+. --.+.=+.|+++|++|+ .-|.++++-.|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 3455789999999999999999998654 8899999997643 33345578999999996 34899999999999
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeec
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFG 620 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg 620 (792)
+++|||+|-+ .-+|.++|..-++.--|....+..++.|+.-||..|...+ |+|.||||.||||++. ..+||||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 9999999987 4588999988777777888999999999999999999887 9999999999999876 458999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH-----H
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-----L 695 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~-----~ 695 (792)
.|......+.. ...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+........+...... .
T Consensus 583 SA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 583 SASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99877654432 23446789999999999999999999999999999999999877554332111100000 0
Q ss_pred Hhhh---------------------------hhhhhccc-----------cccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 696 WKEK---------------------------RAMELAGD-----------TLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 696 ~~~~---------------------------~~~~~~~~-----------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
+..+ .++..+.+ .-...-.+.....+.+|...|+..||++|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 0000 00111111 001112234456788899999999999999
Q ss_pred CHHHHHHH
Q 003832 738 NMSSVVLM 745 (792)
Q Consensus 738 s~~evl~~ 745 (792)
|..|++++
T Consensus 739 t~nqAL~H 746 (752)
T KOG0670|consen 739 TVNQALKH 746 (752)
T ss_pred CHHHHhcC
Confidence 99998764
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=204.64 Aligned_cols=114 Identities=46% Similarity=0.765 Sum_probs=101.7
Q ss_pred CCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CCCCceEEe
Q 003832 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWS 103 (792)
Q Consensus 25 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Ws 103 (792)
++|+++++|+|++|.|++|||.+......+.+|||++++ +++||+||++.| ....+.|.++.||+|+| |.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578999999999999999999987664589999999887 899999999998 44567899999999988 889999999
Q ss_pred eccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCC
Q 003832 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (792)
Q Consensus 104 s~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~P 141 (792)
|+++......+|+|+|+|||||++.+ +.+||||||||
T Consensus 80 S~~~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTRVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFDYP 116 (116)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-CCEEEcCCCCC
Confidence 99875345678999999999999987 88999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=228.43 Aligned_cols=199 Identities=32% Similarity=0.473 Sum_probs=172.8
Q ss_pred cccccccCcCCcccEEeeeccC-CcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 475 FASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999876 889999999876554 67789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+++|.+++..... .+++.....++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999999865332 1789999999999999999999987 999999999999999999999999999876543211
Q ss_pred cccccccccCccccccc-cCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 003832 633 NTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gvil~elltG~~p~~~ 679 (792)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12335677899999998 677788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-26 Score=247.55 Aligned_cols=195 Identities=28% Similarity=0.404 Sum_probs=166.0
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc--------hhHHHHHHHHHHHHhcc---cccceeeeeeEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQ 540 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 540 (792)
.+|..++.||+|+||.|+.+.++. ...|+||.+.+... ...-..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999876 55789998876421 11123446999999997 9999999999999
Q ss_pred CCcceEEEeecC-CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 541 ADESMLIYEYMP-NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 541 ~~~~~lV~e~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
.+.+||++|-.. +-+|.+++.. .+.+++.+...|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999774 5577888743 345899999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCC
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNW 677 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~ 677 (792)
|.+........ ...+||..|.|||++.+.+| ...-|||++|++||-++-...||
T Consensus 715 gsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 99987765443 34789999999999998877 56689999999999999888776
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-27 Score=254.20 Aligned_cols=254 Identities=22% Similarity=0.338 Sum_probs=205.2
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|+....+|.|.+|.|||++.. .++..|+|+++........-..+|+.+++..+|||||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3467888899999999999999875 488899999998887788888899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||.+|+|.+.-+- ..++++.++..+++...+||+|||+.+ -+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 9999999887643 456889999999999999999999998 799999999999999999999999998876432
Q ss_pred ccccccccccccCccccccc---cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 630 IQTNTHKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
-.......||+.|||||+. +.+.|.+++|||+.|+...|+---+.|....++-....+ ..+ ...+
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L--------mTk---S~~q 233 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL--------MTK---SGFQ 233 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH--------hhc---cCCC
Confidence 1223347899999999976 567899999999999999999887777543332111000 000 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+. ...-.....+.+.++++.|+.++|++||+++.+++
T Consensus 234 pp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 11123345667888999999999999999987665
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-25 Score=229.70 Aligned_cols=131 Identities=25% Similarity=0.349 Sum_probs=108.1
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcc-----c---ccceeeeeeEEe---
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----H---RNLVKLLGCCIQ--- 540 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~g~~~~--- 540 (792)
.+|.+.++||-|.|++||++.... .+.||+|+.+. .....+....||++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 678999999999999999997654 66899999854 3344566789999999995 3 369999999975
Q ss_pred -CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 541 -ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 541 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
+.+.+||+|++.. +|..+|.... .+-++...+.+|+.||+.||.|||.++ +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4678999999954 5666665433 344888999999999999999999988 69999999999999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=218.53 Aligned_cols=253 Identities=19% Similarity=0.338 Sum_probs=190.2
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeee-EEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC-CIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~-~~~~~~~~lV~ 548 (792)
.+.|.+.+.||+|.||.+-+++++. .+.+++|.+.+.. ....+|.+|...--.| .|.||+.-+++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3578888999999999999999876 5689999987654 3457888888766666 48999987765 56667788899
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec--CCCCceEeeeccccccC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFG 626 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFgla~~~~ 626 (792)
||++.|+|.+-+.. .-+.+.-..+++.|++.||.|+|+++ +||||||.+||||- +..++||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999999887743 33667778899999999999999998 99999999999993 44589999999987643
Q ss_pred CCCccccccccccccCccccccccCC-----CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEG-----LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
.. .....-+..|.|||..... ...+.+|||.||++++.++||+.||......+. .-|.+..|..+..
T Consensus 175 ~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 175 TT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN 246 (378)
T ss_pred ce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC
Confidence 21 1223345689999976432 346789999999999999999999984333222 2234455555554
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHh
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L 746 (792)
+.+.+. .. ...+.+.++.++-+..++++|-.+.++.++.
T Consensus 247 ~~~P~~--F~----~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 247 PALPKK--FN----PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred ccCchh--hc----ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 432221 11 1234567788889999999997777776654
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-24 Score=193.79 Aligned_cols=112 Identities=48% Similarity=0.782 Sum_probs=99.7
Q ss_pred CCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CCCCceEEe
Q 003832 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWS 103 (792)
Q Consensus 25 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Ws 103 (792)
+.|..++.|+|++|.|++|||.+... ..+.+|||+..+ +++||+||++.|+.++ +.|.++.||+|+| +.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEeCCCCEEEEeCCCCEEEE
Confidence 57889999999999999999988765 589999999987 8999999999998664 7899999999998 888999999
Q ss_pred eccCCCCCCcEEEEeeccceEEecCCCCceeeeccCC
Q 003832 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (792)
Q Consensus 104 s~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~ 140 (792)
|+++.+....+|+|+|+|||||++.+ +.+|||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSD-GNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCC-CCEEeCCCCC
Confidence 99874445678999999999999987 7899999997
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=223.14 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=194.6
Q ss_pred HhhcccccccccCcCCcccEEeeeccC----CcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~ 544 (792)
...+.|..+++||+|.|++||++.+.. ...||+|.+.... ......+|+++|..+. +.||+++.+++...+..
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 344668889999999999999997644 5689999987643 3356889999999995 99999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~ 623 (792)
.+|+||++.....++... ++..++...++.+++||.++|..+ ||||||||+|+|.+. .+.-.|.|||+|.
T Consensus 111 ~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 999999999999988843 667888899999999999999998 999999999999985 4678999999998
Q ss_pred ccCCC-------------Cc-----------------------------cccccccccccCccccccccC-CCCCccCcc
Q 003832 624 IFGGD-------------EI-----------------------------QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDV 660 (792)
Q Consensus 624 ~~~~~-------------~~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DV 660 (792)
..... .. ........||++|.|||++.. ...+.++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 22100 00 000112569999999999854 567899999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH-----------------HHhhhh---hhhh------c--ccccc--
Q 003832 661 FSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-----------------LWKEKR---AMEL------A--GDTLA-- 710 (792)
Q Consensus 661 wS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~-----------------~~~~~~---~~~~------~--~~~~~-- 710 (792)
||-|||++-+++++.||-....+-+ .+...+-+ .+.... +.++ + .....
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~-al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDAD-ALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeccceeehhhccccccccCccccc-hHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999854322211 11111000 000000 0000 0 00000
Q ss_pred ------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 ------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+..++++..+|++.||.+|-|++|.+++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00111223468899999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-25 Score=265.79 Aligned_cols=197 Identities=18% Similarity=0.197 Sum_probs=139.1
Q ss_pred hccc-ccceeeeeeE-------EeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCE
Q 003832 525 RLQH-RNLVKLLGCC-------IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596 (792)
Q Consensus 525 ~l~H-~niv~l~g~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 596 (792)
.++| +||++++++| .+....++++|++ +++|.+++... ...+++.+++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888887 3334567788887 55999999543 345899999999999999999999988 9
Q ss_pred EecCCCCCcEEecC-------------------CCCceEeeeccccccCCCCc--------------cccccccccccCc
Q 003832 597 IHRDLKASNVLLDN-------------------DMNPKISDFGMARIFGGDEI--------------QTNTHKVVGTYGY 643 (792)
Q Consensus 597 vH~Dlkp~NIll~~-------------------~~~~kl~DFgla~~~~~~~~--------------~~~~~~~~gt~~y 643 (792)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44566667776654211000 0001124578899
Q ss_pred cccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHH
Q 003832 644 MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIH 723 (792)
Q Consensus 644 ~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 723 (792)
||||++.+..++.++|||||||+||||++|..|+.... ... .... .....+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~----~~~~----~~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RTM----SSLR----HRVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHH----HHHH----HhhcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887754110 000 0000 0011111 1112334567
Q ss_pred HHHHhccCCCCCCCCHHHHHHH
Q 003832 724 VGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 724 li~~Cl~~~P~~RPs~~evl~~ 745 (792)
++.+||+.+|.+||+|.||+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=211.08 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=195.6
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCC
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
..+|.+...|..|+|+++ |..+++|++... ......+|.+|.-.|+.+.||||++++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 457899999999999994 566777777533 33445689999999999999999999999999999999999999999
Q ss_pred hhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe--eeccccccCCCCcccc
Q 003832 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS--DFGMARIFGGDEIQTN 633 (792)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~--DFgla~~~~~~~~~~~ 633 (792)
|...|+... .-.++-.+..+++.++|+|++|||+..+ -|.---|.++.+++|++.+++|+ |--++..-
T Consensus 274 lynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfqe-------- 343 (448)
T KOG0195|consen 274 LYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-------- 343 (448)
T ss_pred HHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeeec--------
Confidence 999997653 3457788999999999999999999873 24444688999999999998885 32221110
Q ss_pred ccccccccCccccccccCCCCC---ccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 634 THKVVGTYGYMSPEYAAEGLFS---VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s---~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
....-.+.||+||.+...+-+ ..+|+|||+++||||.|...||....+-+. -+++..+.++
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec---------------gmkialeglr 407 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC---------------GMKIALEGLR 407 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh---------------hhhhhhcccc
Confidence 011235789999999776543 469999999999999999999976555332 1233445667
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+|+.....+.+|+..|+..||.+||.+..|+-+||.
T Consensus 408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 77888889999999999999999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=204.74 Aligned_cols=166 Identities=17% Similarity=0.163 Sum_probs=124.5
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
|+|.+++... ...+++.+++.++.|+++||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888643 346999999999999999999999875 999999999999999 99988754321
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
..|++.|||||++.+..++.++|||||||++|||++|+.||........ ... ... .. ... ..+. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~---~~~-~~-~~~-~~~~-~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILE---ILL-NG-MPA-DDPR-DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHH---HHH-HH-hcc-CCcc-cccc
Confidence 2588999999999999999999999999999999999999864322111 010 000 00 000 0000 0011
Q ss_pred CHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 714 PPTEVL--RCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 714 ~~~~~~--~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+..... .+.+++.+|++.+|++||++.|+++++..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 222233 58999999999999999999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.7e-22 Score=212.52 Aligned_cols=176 Identities=18% Similarity=0.214 Sum_probs=134.0
Q ss_pred HhhcccccccccCcCCcccEEeeecc--CCcEEEEEEccCC-----CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
...++|...+.||+|+||+||+|++. +++.+|||++... .....+.|.+|+++|++++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 45678999999999999999999875 4777899987533 12235678999999999999999863322 24
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCC-CCCcEEecCCCCceEeeecc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFgl 621 (792)
..+|||||+++++|... . ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~--~--~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA--R--PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHh--C--ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 67999999999999622 1 100 1467889999999999987 999999 99999999999999999999
Q ss_pred ccccCCCCccc------cccccccccCccccccccCCC------CCccCcch
Q 003832 622 ARIFGGDEIQT------NTHKVVGTYGYMSPEYAAEGL------FSVKSDVF 661 (792)
Q Consensus 622 a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~s~k~DVw 661 (792)
++.+....... ......++..|+|||++.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99775432111 112467888999999985432 23346766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=206.19 Aligned_cols=259 Identities=21% Similarity=0.245 Sum_probs=192.6
Q ss_pred ccccccccCcCCcccEEeeeccCC--cEEEEEEccCCCchhHHHHHHHHHHHHhccc----ccceeeeeeE-EeCCcceE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEG--QEIAVKRLSKGSGQGMEEFKNEVTLIARLQH----RNLVKLLGCC-IQADESML 546 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~--~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~g~~-~~~~~~~l 546 (792)
+|.+.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999987553 4788888765533333378889999999873 5888999888 47778899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-----CCceEeeecc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-----MNPKISDFGM 621 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFgl 621 (792)
||+.+ +.+|.++..... .+.++..+.++|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99887 668888775444 567999999999999999999999998 9999999999999865 4589999999
Q ss_pred cc--ccCCCCc----ccc--ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 622 AR--IFGGDEI----QTN--THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 622 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
++ .+..... ... ....+||..|++++.+.+...+.+.|+||++.++.|++.|..||.........
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~------- 246 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK------- 246 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH-------
Confidence 99 3322211 111 22356999999999999999999999999999999999999999654322110
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+......... ..... +..+.++...+-..+..++|....+...|.+.
T Consensus 247 ~~~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHhhhhcccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11111111111111 11222 23344455555558899999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-20 Score=196.09 Aligned_cols=262 Identities=28% Similarity=0.399 Sum_probs=196.8
Q ss_pred cccccccCcCCcccEEeeeccCCcEEEEEEccCCCch---hHHHHHHHHHHHHhcccc-cceeeeeeEEeCCcceEEEee
Q 003832 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ---GMEEFKNEVTLIARLQHR-NLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~g~~~~~~~~~lV~e~ 550 (792)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999886 88899998765332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~~~~ 629 (792)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||++..+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643321135888999999999999999999998 99999999999999998 79999999998665433
Q ss_pred ccc----cccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 630 IQT----NTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 630 ~~~----~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
... ......|+..|+|||.+.. ..+....|+||+|++++++++|..||........ ..............
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA---TSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc---HHHHHHHHHhcCCc
Confidence 221 2355789999999999987 6789999999999999999999999654432100 00000000000000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467788889999999999999987764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.4e-21 Score=220.99 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=187.4
Q ss_pred ccccccCcCCcccEEeeeccC-CcEEEEEEcc----C-CCchh-HHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 476 ASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS----K-GSGQG-MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~----~-~~~~~-~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
...+.+|.|++|.|+...... ....+.|..+ . ..... ...+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 345689999999777765432 3333333322 1 11111 112566777888889999999888887777766679
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++ +|..++... ..+...++..++.|+..|+.|||+.+ |.|||||++|++++.+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 998888543 35788889999999999999999998 999999999999999999999999999877544
Q ss_pred Ccc--ccccccccccCccccccccCCCCCcc-CcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 629 EIQ--TNTHKVVGTYGYMSPEYAAEGLFSVK-SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 629 ~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
... ......+|...|+|||.+....|.+. .||||.|+++..|++|+.||......+...... ....+.-
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~--------~~~~~~~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN--------NYSDQRN 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh--------ccccccc
Confidence 333 34456789999999999999999765 899999999999999999998665544321000 0000000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...-........+.+...++.++|+.+|.+|-||++|++.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0000111223445567789999999999999999999863
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.1e-20 Score=177.99 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=191.7
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhccc-ccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 548 (792)
...+|..+++||.|+||.+|.|.. .+|.+||||.-+..... .++..|..+...++| ..|.++.-+..+.....|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 357899999999999999999974 56999999987654432 467889999999985 67888888889999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgla~~~ 625 (792)
|.+ +-+|+++..-..+ .++.++.+-++-|++.-++|+|.++ ++||||||+|.|..-+ ..+.++|||+++.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 5688887754433 4788899999999999999999998 9999999999999744 45889999999987
Q ss_pred CCCC-----ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 626 GGDE-----IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 626 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
.... .........||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|..||.........+. .+...+.+
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QK----yEkI~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQK----YEKISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHH----HHHHHHhh
Confidence 4322 12233457899999999988888889999999999999999999999986544322211 12222222
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+ +.+....|.+ +.-.+.-|-...-++-|...-+-++
T Consensus 241 ~s~~i-e~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 241 MSTPI-EVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred cCCCH-HHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 22111 1223333333 3344445666666677766555444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=213.99 Aligned_cols=252 Identities=18% Similarity=0.204 Sum_probs=180.1
Q ss_pred ccccccccCcCCcccEEeeeccCCcEEEEEEccCCC-chhHHHHHHHHHH--HHhcccccceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS-GQGMEEFKNEVTL--IARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~-~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++...+.||++.|=+|.++++++|. |+||++-+.. .-..+.|.++++- ...++|||.+++..+-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666789999999999999998887 8999986654 3344555544433 4556899999999887777778899999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC--C
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--D 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~--~ 628 (792)
+.+ +|.+.+. .+..+...+..-|+.|++.||..+|..+ |+|||||.+||||+.-.-+.|+||..-+...- +
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 866 5666663 3556788888899999999999999998 99999999999999999999999987665421 1
Q ss_pred ---CccccccccccccCccccccccCC----------C-CCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 629 ---EIQTNTHKVVGTYGYMSPEYAAEG----------L-FSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 629 ---~~~~~~~~~~gt~~y~aPE~~~~~----------~-~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
+..........-.+|+|||.+-.. . .+++.||||+||++.||++ |++||... ++..+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aYr- 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAYR- 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhHh-
Confidence 111111122334589999987431 2 6789999999999999988 57777521 111110
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
-......+.+-+.+ +...+.++++.|++.||++|-++++.++.-.+.
T Consensus 249 --~~~~~~~e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 --SGNADDPEQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --ccCccCHHHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 00000000000000 011467899999999999999999999985443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-19 Score=180.80 Aligned_cols=172 Identities=15% Similarity=0.171 Sum_probs=134.4
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHH---H------HHHHHHHHHhcccccceeeeeeEEeC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME---E------FKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~---~------~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
..++|...+.||.|+||.||.... +++.+|||.++........ . +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468899999999999999999765 5778999999754322222 2 68999999999999999999886643
Q ss_pred --------CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 542 --------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 542 --------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
...+|||||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 35789999999999977741 221 24568999999999998 99999999999999988
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt 672 (792)
++|+|||.......+... ..+.....|..++|+|+||+.+.-+..
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 999999987654221110 114455567789999999998876553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.4e-19 Score=175.88 Aligned_cols=139 Identities=17% Similarity=0.124 Sum_probs=108.7
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCch--h-------HH-----------------HHHHHHHHHHhcccccc
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--G-------ME-----------------EFKNEVTLIARLQHRNL 531 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--~-------~~-----------------~~~~Ei~~l~~l~H~ni 531 (792)
...||+|+||.||+|...+|+.||||+++..... . .. ....|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999999754211 0 11 22359999999988876
Q ss_pred eeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHH-hhcCCCCEEecCCCCCcEEecC
Q 003832 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 532 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~ 610 (792)
.....+. ....+|||||++++++...... ...++..+...++.|++.+|.|| |+.+ |+||||||+||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 2334899999999877654322 23578899999999999999999 6777 99999999999998
Q ss_pred CCCceEeeecccccc
Q 003832 611 DMNPKISDFGMARIF 625 (792)
Q Consensus 611 ~~~~kl~DFgla~~~ 625 (792)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=173.81 Aligned_cols=200 Identities=21% Similarity=0.304 Sum_probs=168.5
Q ss_pred cccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
-+|.+.++||+|.||.++.|+. -+++.||||.-...+ ..-+++.|.+..+.|. .+.|...+.+-.++-+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 3688899999999999999974 469999999854432 3457888999998885 68999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-----CCceEeeecccccc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-----MNPKISDFGMARIF 625 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DFgla~~~ 625 (792)
+ +-||+++..-.. ..++.++.+.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+..
T Consensus 106 L-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 558877764433 34889999999999999999999998 9999999999999643 35899999999987
Q ss_pred CCCCc-----cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 626 GGDEI-----QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 626 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
..... ........||.+||+=..+.+...+.+.|+=|+|-|+++.|-|..||...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 54322 22334578999999999999999999999999999999999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.6e-19 Score=192.39 Aligned_cols=215 Identities=23% Similarity=0.372 Sum_probs=162.0
Q ss_pred HHhcccccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCC
Q 003832 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (792)
Q Consensus 523 l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 602 (792)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....++|.-...++.+|++||.|||... -..|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999976 3345899999999999999999999864 23999999
Q ss_pred CCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCC-------CCCccCcchhHHHHHHHHHhCCC
Q 003832 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-------LFSVKSDVFSFGVLVLEIVSGKK 675 (792)
Q Consensus 603 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~s~k~DVwS~Gvil~elltG~~ 675 (792)
+.|.++|....+||+|||+.................-...|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876421111111112234689999998653 24778999999999999999999
Q ss_pred CCCCCCCCCcc-chhHHHHHHHhhhhhhhhccccccCCCCH--HHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 676 NWRFSHPDHDH-NLLGHAWILWKEKRAMELAGDTLADSHPP--TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 676 p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
||+........ .++.. +.. .-.+..+..... +...++..++..||..+|++||++++|-..++...
T Consensus 157 ~~~~~~~~~~~~eii~~----~~~-----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILR----VKK-----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHH----HHh-----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99864433221 11111 111 011111221111 33346889999999999999999999999886653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.9e-18 Score=170.59 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=111.9
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCch--------------------------hHHHHHHHHHHHHhcccccc
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--------------------------GMEEFKNEVTLIARLQHRNL 531 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~Ei~~l~~l~H~ni 531 (792)
.+.||+|++|.||+|+..+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998764211 01224678999999999987
Q ss_pred eeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecC
Q 003832 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 532 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~ 610 (792)
.....+... ..+|||||++++++...... ...++..+...++.|++.++.+||+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 35899999998865443222 2346778889999999999999999 77 99999999999999
Q ss_pred CCCceEeeeccccccCC
Q 003832 611 DMNPKISDFGMARIFGG 627 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~ 627 (792)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-18 Score=175.57 Aligned_cols=233 Identities=22% Similarity=0.290 Sum_probs=151.8
Q ss_pred ccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcc----------cccceeeeeeEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ----------HRNLVKLLGCCI 539 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~----------H~niv~l~g~~~ 539 (792)
.+...+.||.|+++.||.+++.+ ++++|||+.... .....+++++|.-.+..+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34556789999999999999876 899999987433 3345677888876666643 222332222221
Q ss_pred -e--------CC--------cceEEEeecCCCChhHHHh---hcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEe
Q 003832 540 -Q--------AD--------ESMLIYEYMPNKSLDFFIF---DQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598 (792)
Q Consensus 540 -~--------~~--------~~~lV~e~~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 598 (792)
. .. ..+++|+-+ .++|.+++. ... ....+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 11 235677776 557766653 221 1234556667788899999999999998 999
Q ss_pred cCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccC--------CCCCccCcchhHHHHHHHH
Q 003832 599 RDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--------GLFSVKSDVFSFGVLVLEI 670 (792)
Q Consensus 599 ~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwS~Gvil~el 670 (792)
+||+|+|++++.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|++|+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--C---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE--G---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee--c---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988765432111 0 234578999997743 2578899999999999999
Q ss_pred HhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC
Q 003832 671 VSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR 736 (792)
Q Consensus 671 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~R 736 (792)
.+|+.||....+...... .-..+. +.++.+..|+..+|+.+|++|
T Consensus 244 WC~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986544322110 112334 667788899999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=189.70 Aligned_cols=250 Identities=26% Similarity=0.310 Sum_probs=189.6
Q ss_pred ccCcCCcccEEeeec----cCCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeecC
Q 003832 480 KLGEGGFGPVYKGTL----VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
.+|+|.||.|+..+. +.+..+|+|.+++... ........|..++..++ ||.+|++...+..+...+++.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998653 3467789988866421 11125567888899997 9999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|.|...+.+. ...+..........++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-....
T Consensus 81 gg~lft~l~~~---~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE---VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccccC---CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 99987776443 23455566667778999999999988 99999999999999999999999999987543222
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
.+||..|||||++. .....+|-||||++++||+||..||.. + ++..+ ......
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~-----------------~~~~I-l~~~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D-----------------TMKRI-LKAELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H-----------------HHHHH-hhhccC
Confidence 28999999999998 567889999999999999999999874 0 00000 011124
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHHHhc------------CCCCCCCCCCCCccccC
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNM--SSVVLMLS------------SDSLLPEPNRPGFFTER 764 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~--~evl~~L~------------~~~~~~~p~~p~~~~~~ 764 (792)
.|.+....+.+++..+...+|.+|--. ..+.++++ .....+.|.+|+.-+++
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~ 271 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITER 271 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchh
Confidence 466666777788888999999999655 34444443 12445666677766654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=161.84 Aligned_cols=185 Identities=18% Similarity=0.119 Sum_probs=137.3
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCch----hHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeec
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----GMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
....|++|+||+||.+.- .+.+++.+.+.....- ....+.+|+++|++++ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997765 6788888877554321 1225789999999995 5889999886 4569999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCC-CCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL-KASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
.+.+|...+.. ....++.|++.+|.++|+.+ |+|||| ||.|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99988654311 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----c-------cccccccccCccccccccCC-CCC-ccCcchhHHHHHHHHHhCCCCCCC
Q 003832 631 Q----T-------NTHKVVGTYGYMSPEYAAEG-LFS-VKSDVFSFGVLVLEIVSGKKNWRF 679 (792)
Q Consensus 631 ~----~-------~~~~~~gt~~y~aPE~~~~~-~~s-~k~DVwS~Gvil~elltG~~p~~~ 679 (792)
. . .......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+.-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 0 01123356777888744221 222 456888999999999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=162.68 Aligned_cols=136 Identities=18% Similarity=0.263 Sum_probs=106.0
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-----ccccceeeeeeEEeCC---c-ceE
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-----QHRNLVKLLGCCIQAD---E-SML 546 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~g~~~~~~---~-~~l 546 (792)
...+.||+|+||.||. +++....+||++........+.+.+|+.++.++ .||||++++|++.+.. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 544333479998765555567899999999999 5799999999998874 2 237
Q ss_pred EEee--cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHH-HHHhhcCCCCEEecCCCCCcEEecC----CCCceEeee
Q 003832 547 IYEY--MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI-LYLHQDSRMRIIHRDLKASNVLLDN----DMNPKISDF 619 (792)
Q Consensus 547 V~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~DF 619 (792)
|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +.+++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5589999999442 24444 35577888777 8999998 999999999999973 347999994
Q ss_pred ccc
Q 003832 620 GMA 622 (792)
Q Consensus 620 gla 622 (792)
+-+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.5e-17 Score=178.52 Aligned_cols=124 Identities=27% Similarity=0.434 Sum_probs=109.7
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++.|+++...+|.++|.++......++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468899999999999999877667778899999999999999999 55 999999999999999999999999998
Q ss_pred cccCCCC----ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh
Q 003832 623 RIFGGDE----IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (792)
Q Consensus 623 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt 672 (792)
....... .........||..||+||.+.+..|+.|+||||||+||+||+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 8765443 2223445789999999999999999999999999999999998
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6.8e-17 Score=188.84 Aligned_cols=198 Identities=23% Similarity=0.269 Sum_probs=160.0
Q ss_pred HHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc---cccceeeeeeEEeCCcce
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESM 545 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~ 545 (792)
+..-+.|.+.+.||+|+||+||+|...+|+.||+|+-+....= +|.-=.+++.+|+ -+-|+++...+.-.+..+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 3445778999999999999999999988999999987654321 1211222333333 345666667777788899
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-------CCCCceEee
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-------NDMNPKISD 618 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-------~~~~~kl~D 618 (792)
||+||.+.|+|.+++. ..+.++|.....++.|+++-++.||..+ |||+||||+|.||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999995 5567999999999999999999999988 99999999999994 334589999
Q ss_pred eccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCC
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~ 675 (792)
||.+..+..-.........++|-.+--+|...+..++..+|-|.++-+++-||.|+.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999987643222234445778999999999999999999999999999999999985
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=5.7e-16 Score=157.00 Aligned_cols=134 Identities=21% Similarity=0.330 Sum_probs=114.1
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCch--------hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999986533211 124578899999999999998888888888889999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999884321 2 78899999999999999988 99999999999999 78999999999874
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.7e-16 Score=176.91 Aligned_cols=137 Identities=20% Similarity=0.332 Sum_probs=112.3
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEE-ccCCC-------chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKR-LSKGS-------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~-l~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
...|...++||+|+||.||+|.+.... +++|+ +.+.. ....+.+.+|++++.+++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 445566789999999999999875443 33333 22211 1123568899999999999999998888888888
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998873 34678999999999999988 9999999999999 67899999999987
Q ss_pred c
Q 003832 624 I 624 (792)
Q Consensus 624 ~ 624 (792)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-16 Score=157.81 Aligned_cols=143 Identities=19% Similarity=0.181 Sum_probs=110.8
Q ss_pred ccccccccCcCCcccEEeee--ccCCcEEEEEEccCCCch------------------------hHHHHHHHHHHHHhcc
Q 003832 474 NFASYNKLGEGGFGPVYKGT--LVEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVTLIARLQ 527 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 527 (792)
.|.+.+.||+|+||.||+|+ ..+|+.||+|+++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47778899999999999998 567999999998753210 1123568999999997
Q ss_pred ccc--ceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCc
Q 003832 528 HRN--LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASN 605 (792)
Q Consensus 528 H~n--iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N 605 (792)
+.. +.++++. ...++||||+++.+|...... ...+...+...++.|++.++.+||+.+ .++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 633 3344432 245899999999888665422 223455667899999999999999876 49999999999
Q ss_pred EEecCCCCceEeeeccccccC
Q 003832 606 VLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 606 Ill~~~~~~kl~DFgla~~~~ 626 (792)
|+++ ++.++|+|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.3e-15 Score=152.80 Aligned_cols=137 Identities=20% Similarity=0.217 Sum_probs=109.1
Q ss_pred ccccccccCcCCcccEEeeeccCCcEEEEEEccCCCch----------------------hHHHHHHHHHHHHhccccc-
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVTLIARLQHRN- 530 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~----------------------~~~~~~~Ei~~l~~l~H~n- 530 (792)
.|...+.||+|+||.||++...+|+.||||+++..... ....+..|+.++.++.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 46777899999999999999888999999987543210 1123677899999998874
Q ss_pred -ceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 531 -LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 531 -iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
+.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++|+||||+||+++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~ 159 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD 159 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence 444443 345689999999999876542 1344678899999999999987 99999999999999
Q ss_pred CCCCceEeeeccccccC
Q 003832 610 NDMNPKISDFGMARIFG 626 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~ 626 (792)
+++.++|+|||++..+.
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=152.89 Aligned_cols=130 Identities=24% Similarity=0.370 Sum_probs=108.0
Q ss_pred ccCcCCcccEEeeeccCCcEEEEEEccCCCc--------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.||+|+||.||+|.+ ++..+++|+...... ...+.+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 678899998643211 11356778999999999988776666677777889999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++++|.+++..... .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999888743210 78999999999999988 99999999999999 89999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.9e-15 Score=155.57 Aligned_cols=197 Identities=20% Similarity=0.277 Sum_probs=135.2
Q ss_pred ccccceeeeeeEEeC---------------------------CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHH
Q 003832 527 QHRNLVKLLGCCIQA---------------------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579 (792)
Q Consensus 527 ~H~niv~l~g~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 579 (792)
+|||||++.++|.+. ...|+||.-.+. +|..++-.+ ..+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence 599999999887542 235778776644 787777433 345666777899
Q ss_pred HHHHHHHHHhhcCCCCEEecCCCCCcEEe--cCCC--CceEeeeccccccCCCC----ccccccccccccCccccccccC
Q 003832 580 GIARGILYLHQDSRMRIIHRDLKASNVLL--DNDM--NPKISDFGMARIFGGDE----IQTNTHKVVGTYGYMSPEYAAE 651 (792)
Q Consensus 580 ~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DFgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~ 651 (792)
|+++|+.|||.++ |.|||+|++|||| |+|+ ...|+|||.+---.... +....-...|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 3444 46889999875432211 1111123467788999999854
Q ss_pred CC------CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHH
Q 003832 652 GL------FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVG 725 (792)
Q Consensus 652 ~~------~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 725 (792)
.+ --.|+|.|+.|-+.||+++...||-....- . ++ .....+..- ...+...+..+.+|+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~---L~-------~r~Yqe~qL----Palp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-L---LD-------TRTYQESQL----PALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-e---ec-------hhhhhhhhC----CCCcccCChHHHHHH
Confidence 32 235899999999999999999998531110 0 00 001111111 233445556688999
Q ss_pred HHhccCCCCCCCCHHHHHHHh
Q 003832 726 LLCVQHRPEDRPNMSSVVLML 746 (792)
Q Consensus 726 ~~Cl~~~P~~RPs~~evl~~L 746 (792)
...++.||.+||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876554444
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.1e-16 Score=125.18 Aligned_cols=66 Identities=52% Similarity=1.111 Sum_probs=58.7
Q ss_pred cCCCCCcceeecccCCCCCcchhccccchhhHhhhcCCCCcccccccccccCCCcceeeeecccccc
Q 003832 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDM 390 (792)
Q Consensus 324 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~C~~~C~C~a~~~~~~~~~~~~C~~~~~~l~~~ 390 (792)
|+.+|+|.++.+|++|++....++.++++++|++.|++||||+||+|.+.. ++++|.+|+|+|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 445689999999999999777776779999999999999999999998655 778999999999885
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-16 Score=177.77 Aligned_cols=216 Identities=19% Similarity=0.254 Sum_probs=145.3
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.+|..++.|..|++|.||..+++. .+.+|+|+ .++.-- +++ ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~li----lRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLI----LRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccchh----hhc---cccccCCccee-------------------
Confidence 578888999999999999999875 56788843 332110 001 22222344433
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC----
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG---- 627 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~---- 627 (792)
|+=...+.. -+.++. +.+.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+.+....
T Consensus 136 --gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 222222211 112221 2378999999988 99999999999999999999999999876311
Q ss_pred ----CC-----ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 628 ----DE-----IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 628 ----~~-----~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
.. .......++||+.|+|||++....|...+|.|++|+|+||.+-|+.||..+.+++-...+..
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis------- 272 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS------- 272 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh-------
Confidence 11 11123347899999999999999999999999999999999999999988776543211100
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
|.....+.......++.+++.+.|+++|..|--....+++
T Consensus 273 -------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev 312 (1205)
T KOG0606|consen 273 -------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEV 312 (1205)
T ss_pred -------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhh
Confidence 0111111123334567788889999999999544444443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=4.8e-14 Score=134.02 Aligned_cols=135 Identities=22% Similarity=0.231 Sum_probs=114.9
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccc--ccceeeeeeEEeCCcceEEEeecCCC
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
+.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++.+++.+....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34689999999999999854 7899999866543 5678999999999986 58999999888888899999999988
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
.+..+ +......++.++++++++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77533 4556678899999999999987545699999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.4e-14 Score=141.00 Aligned_cols=137 Identities=21% Similarity=0.255 Sum_probs=98.8
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCch--hHHH----------------------HHHHHHHHHhccccc--c
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ--GMEE----------------------FKNEVTLIARLQHRN--L 531 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--i 531 (792)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3689999999999999888999999998654221 1111 134666666665433 3
Q ss_pred eeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecC
Q 003832 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 532 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~ 610 (792)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444433 346899999999654322111110 11 5677899999999999998 66 99999999999999
Q ss_pred CCCceEeeeccccccC
Q 003832 611 DMNPKISDFGMARIFG 626 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~ 626 (792)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.2e-15 Score=171.97 Aligned_cols=256 Identities=21% Similarity=0.321 Sum_probs=190.2
Q ss_pred cccccccccCcCCcccEEeeeccC--CcEEEEEEccCCC--chhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV 547 (792)
..|...+.||+|.|+.|-...... ...+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677889999999998887644 3456777665443 223344455777777776 99999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh-hcCCCCEEecCCCCCcEEecCCC-CceEeeecccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~ 625 (792)
.+|..++++.+.+... .....+....-..+.|+..++.|+| ..+ +.|+||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777321 1113455566778899999999999 766 99999999999999999 9999999999988
Q ss_pred CC-CCcccccccccc-ccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 626 GG-DEIQTNTHKVVG-TYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 626 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.. ...........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+............ +.+..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~------~~~~~-- 247 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSS------WKSNK-- 247 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccccee------ecccc--
Confidence 76 444444455678 9999999999874 5578899999999999999999999876554321110 01110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
................++..+++..+|..|.+.+++..
T Consensus 248 ----~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 ----GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ----cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00001112233345667777888899999999888654
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.2e-13 Score=138.92 Aligned_cols=134 Identities=21% Similarity=0.288 Sum_probs=104.1
Q ss_pred cccC-cCCcccEEeeeccCCcEEEEEEccCCC-------------chhHHHHHHHHHHHHhcccccc--eeeeeeEEeCC
Q 003832 479 NKLG-EGGFGPVYKGTLVEGQEIAVKRLSKGS-------------GQGMEEFKNEVTLIARLQHRNL--VKLLGCCIQAD 542 (792)
Q Consensus 479 ~~lg-~G~fg~Vy~g~~~~~~~vavK~l~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~g~~~~~~ 542 (792)
..|| .|+.|+||+... .+..++||++.... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 899999999987 47788998875321 1223467889999999998875 67777654432
Q ss_pred c----ceEEEeecCC-CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 543 E----SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 543 ~----~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
. .++|+|++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+|+||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6888887432 23332 3568999999999998 9999999999999999999999
Q ss_pred eeccccc
Q 003832 618 DFGMARI 624 (792)
Q Consensus 618 DFgla~~ 624 (792)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=145.53 Aligned_cols=140 Identities=22% Similarity=0.286 Sum_probs=101.8
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchhH----------------------------------------HHHHH
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGM----------------------------------------EEFKN 518 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 518 (792)
+.||.|++|.||+|++++|+.||||+.+....... -+|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999865421111 02445
Q ss_pred HHHHHHhcc----cccceeeeeeE-EeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHH-HHHHHhhcC
Q 003832 519 EVTLIARLQ----HRNLVKLLGCC-IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR-GILYLHQDS 592 (792)
Q Consensus 519 Ei~~l~~l~----H~niv~l~g~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~ 592 (792)
|++.+.+++ |.+-+.+-.++ ......+|||||+++++|.++...... .. .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666653 33333333333 234568999999999999887643211 11 24456666666 467888877
Q ss_pred CCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 593 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
++|+|++|.||+++++++++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-13 Score=112.45 Aligned_cols=72 Identities=24% Similarity=0.415 Sum_probs=62.4
Q ss_pred cCCCCCcceeecccCCCCCcchhccccchhhHhhhcCC---CCcccccccccccCCCcceeeeeccc-cccccccCCCcc
Q 003832 324 CRNGDEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK---NCSCTAYANSDVERGGSGCLLWFGDL-MDMKEYNDGGQD 399 (792)
Q Consensus 324 C~~~~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~C~~---~C~C~a~~~~~~~~~~~~C~~~~~~l-~~~~~~~~~~~~ 399 (792)
|....+|.++.+|++|++.. ++++||+++|++ ||||+||+|.+. +.||.+|++++ ++++++..++.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 34457899999999999764 689999999999 999999998753 35899999999 999999888999
Q ss_pred eEEEe
Q 003832 400 LYIRI 404 (792)
Q Consensus 400 lylr~ 404 (792)
+|+|.
T Consensus 76 Ly~r~ 80 (80)
T cd00129 76 LYENK 80 (80)
T ss_pred eEeEC
Confidence 99984
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.1e-13 Score=134.44 Aligned_cols=208 Identities=19% Similarity=0.218 Sum_probs=142.2
Q ss_pred HHHHHHHhcccccceeeeeeEEeC-----CcceEEEeecCCCChhHHHhhccc-CccCChhhHHHHHHHHHHHHHHHhhc
Q 003832 518 NEVTLIARLQHRNLVKLLGCCIQA-----DESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQD 591 (792)
Q Consensus 518 ~Ei~~l~~l~H~niv~l~g~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~ 591 (792)
.-...|-.+-|.|||+++.|+.+. .+..++.|||+.|++..+|.+..+ .+.+......+++-||..||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 334456667799999999997654 346789999999999999987543 45577777789999999999999986
Q ss_pred CCCCEEecCCCCCcEEecCCCCceEeeeccc--cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHH
Q 003832 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMA--RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLE 669 (792)
Q Consensus 592 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla--~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~e 669 (792)
. ++|+|+++.-+.|++..++-+||.--.-. ...-+......+....+.++|.|||.=.....+..+|||+||+..+|
T Consensus 196 ~-PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 D-PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred C-CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 4 78999999999999999999988531111 10001111112223456789999998777777889999999999999
Q ss_pred HHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 670 IVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 670 lltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
|.-+..-......... .+ ......+..+-++.. ..++..|++.+|..||+|++++.+
T Consensus 275 mailEiq~tnseS~~~---~e----e~ia~~i~~len~lq------------r~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE---VE----ENIANVIIGLENGLQ------------RGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHheeccCCCcceee---hh----hhhhhheeeccCccc------------cCcCcccccCCCCCCcchhhhhcC
Confidence 9887653221111100 00 000001111111111 245667999999999999998764
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.2e-11 Score=116.02 Aligned_cols=131 Identities=20% Similarity=0.175 Sum_probs=98.5
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccccee-eeeeEEeCCcceEEEeecCCCCh
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK-LLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~-l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
++.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.++++ ++.+ .....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcc
Confidence 357899999999999874 78899999765432 2335678999999997666554 4433 23456899999999887
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
.... .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 112345678999999999876 23469999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.3e-11 Score=105.09 Aligned_cols=80 Identities=46% Similarity=0.950 Sum_probs=64.5
Q ss_pred ccccCCC---CCcceeecccCCCCCcchhccccchhhHhhhcCCCCcccccccccccCCCcceeeeeccccccccccCCC
Q 003832 321 ELKCRNG---DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG 397 (792)
Q Consensus 321 ~~~C~~~---~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~C~~~C~C~a~~~~~~~~~~~~C~~~~~~l~~~~~~~~~~ 397 (792)
+++|... ++|..+.++++|+..... .++++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+++.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 3456543 689999999999875433 7789999999999999999999874 3578999999999987655556
Q ss_pred cceEEEee
Q 003832 398 QDLYIRIA 405 (792)
Q Consensus 398 ~~lylr~a 405 (792)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 78999864
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=7.1e-11 Score=133.48 Aligned_cols=146 Identities=17% Similarity=0.227 Sum_probs=95.5
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchh------------------------------H----H---
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG------------------------------M----E--- 514 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~------------------------------~----~--- 514 (792)
..|+. +.||.|++|.||+|++++ |+.||||+++....+. . +
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44666 789999999999999988 9999999997552110 0 1
Q ss_pred ---HHHHHHHHHHhcc----cccceeeeeeEEe-CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHH-HH
Q 003832 515 ---EFKNEVTLIARLQ----HRNLVKLLGCCIQ-ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR-GI 585 (792)
Q Consensus 515 ---~~~~Ei~~l~~l~----H~niv~l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~L 585 (792)
+|..|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-.... .+. ..++...+. -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~---~~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDM---KLLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCH---HHHHHHHHHHHH
Confidence 2344555555553 3444444444433 56788999999999997753211111 111 112222211 12
Q ss_pred HHHhhcCCCCEEecCCCCCcEEecCCC----CceEeeeccccccCC
Q 003832 586 LYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFGMARIFGG 627 (792)
Q Consensus 586 ~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFgla~~~~~ 627 (792)
..++..+ ++|+|+||.||+++.++ ++++.|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2333455 99999999999999888 999999999987753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.1e-11 Score=132.87 Aligned_cols=248 Identities=19% Similarity=0.226 Sum_probs=175.8
Q ss_pred ccccccccCc--CCcccEEeeec---cCCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcce
Q 003832 474 NFASYNKLGE--GGFGPVYKGTL---VEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (792)
Q Consensus 474 ~~~~~~~lg~--G~fg~Vy~g~~---~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 545 (792)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455678999 99999999987 3477899998443322 22223345666666664 999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHH----HHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeec
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR----GILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFG 620 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFg 620 (792)
+-.|++. .+|..+.+.. ...++....+.+..+..+ |+.++|... ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9999986 5666666432 334666677777777777 999999987 9999999999999999 899999999
Q ss_pred cccccCCCCccccc---cccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 621 MARIFGGDEIQTNT---HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 621 la~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
+...+......... ....|...|++||.+ .+.++...|+|++|.+..|-.++..+....-. ..|. ...
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~--~~r 339 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWS--QLR 339 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCcc--ccc
Confidence 99988765432222 233678899999977 56678899999999999999998765432210 0110 000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
... +.+ ++......++..++..+++.+|..|++.+.+..
T Consensus 340 ~~~---ip~-----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 340 QGY---IPL-----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccc---Cch-----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000 001 111111233444778899999999998877665
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.9e-10 Score=126.24 Aligned_cols=232 Identities=16% Similarity=0.168 Sum_probs=153.1
Q ss_pred ccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhh
Q 003832 494 LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573 (792)
Q Consensus 494 ~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~ 573 (792)
..++.+|.|...........+..++-++.|+.++||||++++....+....|||.|-+. .|..++.+. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHH
Confidence 34688888888876655555677888999999999999999999999999999999873 455555332 2445
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCC
Q 003832 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653 (792)
Q Consensus 574 ~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 653 (792)
..-.+.||+.||.|||+.+ .++|++|....|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5667889999999999876 599999999999999999999999998765322111 111122334567777553322
Q ss_pred CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCC
Q 003832 654 FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRP 733 (792)
Q Consensus 654 ~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P 733 (792)
-..|.|-||++++|++.|..+- ...-.....+.. ...+....++..... ..+. .++++..|....+
T Consensus 182 --~s~D~~~Lg~li~el~ng~~~~--~~~~~~~~~ipk---~~~~~~~k~~~~~~~------~r~n-~~~~~~~~~~~~g 247 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSLLT--KTDLSNTGKIPK---ALIELYCKKLGATEL------KRPN-KLRFILECRLLGG 247 (690)
T ss_pred --cchhhhhHHHHHHHHhCcccCc--chhhhccCccch---hHHHHHHHHhccccc------cccc-hhhHHHHHHhccc
Confidence 3469999999999999993221 110000000000 000000011111111 1111 4566667777777
Q ss_pred CCCCCHHHHHHHhcCCCC
Q 003832 734 EDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 734 ~~RPs~~evl~~L~~~~~ 751 (792)
-.|=-+-+++..|++..-
T Consensus 248 ff~n~fvd~~~fLeel~l 265 (690)
T KOG1243|consen 248 FFRNDFVDTLLFLEELRL 265 (690)
T ss_pred cccchHHHHHHHHHhccc
Confidence 777777888777776543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.2e-09 Score=109.35 Aligned_cols=142 Identities=19% Similarity=0.276 Sum_probs=109.0
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhccc--ccceeeeeeEEeCC---cceEEEeecC
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH--RNLVKLLGCCIQAD---ESMLIYEYMP 552 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~---~~~lV~e~~~ 552 (792)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999999865432 245678999999999976 34566777766543 5689999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS---------------------------------------- 592 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------------- 592 (792)
+.++...+.. ..++..++..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 23566677777888888888887531
Q ss_pred -------------CCCEEecCCCCCcEEecC--CCCceEeeeccccc
Q 003832 593 -------------RMRIIHRDLKASNVLLDN--DMNPKISDFGMARI 624 (792)
Q Consensus 593 -------------~~~ivH~Dlkp~NIll~~--~~~~kl~DFgla~~ 624 (792)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.3e-10 Score=123.28 Aligned_cols=248 Identities=20% Similarity=0.196 Sum_probs=176.5
Q ss_pred HhhcccccccccCcCCcccEEeeecc--CCcEEEEEEccCCCchhHHH--HHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKGSGQGMEE--FKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
....+|..+..||.|.|+.|++...+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++....+...++.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34567888899999999999987643 47789999887654333332 24566666666 599999998888888888
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgla~ 623 (792)
++=-||++++++...+. -...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..++.|||...
T Consensus 342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 99999999999876662 2234677888999999999999999877 9999999999999886 888999999986
Q ss_pred ccCCCCccccccccccccCcc--ccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYM--SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
.+.-.. ....+.-+++ +|+......+-.+.|++|||.-+.|.+++...-+.... +.
T Consensus 416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~--------- 473 (524)
T KOG0601|consen 416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL--------- 473 (524)
T ss_pred ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce---------
Confidence 432111 0112223344 56666777889999999999999999998753221100 00
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
. +........+. ....+..+...++..++..||.+.+...+.+-
T Consensus 474 -~-i~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 -T-IRSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -e-eecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 0 00010111122 22455566777899999999999887776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=9e-09 Score=101.36 Aligned_cols=137 Identities=13% Similarity=0.099 Sum_probs=98.4
Q ss_pred cccCcCCcccEEeeeccC-------CcEEEEEEccCCC------------c----------hhHHHHH----HHHHHHHh
Q 003832 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGS------------G----------QGMEEFK----NEVTLIAR 525 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~~------------~----------~~~~~~~----~Ei~~l~~ 525 (792)
..||.|--+.||.|.-.+ +..+|||+.+... . ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997543 4789999875310 0 1122333 79999999
Q ss_pred ccc--ccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHH-hhcCCCCEEecCCC
Q 003832 526 LQH--RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL-HQDSRMRIIHRDLK 602 (792)
Q Consensus 526 l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlk 602 (792)
+.. -++.+++++ ...+|||||+.+..+...... ...++..+...+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 963 455566654 567899999987544222111 12244455667789999999999 7776 9999999
Q ss_pred CCcEEecCCCCceEeeeccccccC
Q 003832 603 ASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 603 p~NIll~~~~~~kl~DFgla~~~~ 626 (792)
+.||+++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.2e-09 Score=98.37 Aligned_cols=131 Identities=21% Similarity=0.363 Sum_probs=102.9
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEE-ccCCCc--h-----hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKR-LSKGSG--Q-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~-l~~~~~--~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..+.+|+-..+|.+.+. |..+++|. +.+.-. + ..+...+|+.+|.+++--.|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999774 43455554 433311 1 123467899999999877777777777888999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
.++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888443 3567778888889999998 99999999999998776 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-08 Score=109.32 Aligned_cols=169 Identities=21% Similarity=0.328 Sum_probs=129.6
Q ss_pred cccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe----CCcceEEEeecCC-CChhHH
Q 003832 486 FGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESMLIYEYMPN-KSLDFF 559 (792)
Q Consensus 486 fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~lV~e~~~~-gsL~~~ 559 (792)
-.+.||+.. .+|..+++|+++.+..+.......-+++++++.|+|+|++.+++.. ....++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457788864 4799999999965544444445567889999999999999999873 3457899999985 467666
Q ss_pred Hhhcc------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 560 IFDQA------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 560 l~~~~------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
.+... ....+++..+|.++.|+..||.++|+.| +.-+-|.+.+|+++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 55422 1234677899999999999999999998 88899999999999999999998888766544
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCC
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p 676 (792)
+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 331 1111 12356888999999999999754
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=94.99 Aligned_cols=143 Identities=24% Similarity=0.344 Sum_probs=108.5
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEE-ccCCCc-------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKR-LSKGSG-------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~-l~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
....|-+|+-+.|+++.. .|+..+||. +.+.-+ -.....++|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999988 567666664 433321 12345788999999998767777777788888899999
Q ss_pred eecCC-CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeeccccc
Q 003832 549 EYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARI 624 (792)
Q Consensus 549 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgla~~ 624 (792)
||+++ .++.+++........ .......++..|-+.+.-||..+ |+|+||..+||+|..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 477777765433222 22233678889999999999988 999999999999976554 47999999764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.9e-09 Score=123.20 Aligned_cols=249 Identities=17% Similarity=0.228 Sum_probs=166.0
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..+.+.+.+-+-+|.++.++.+.-.. |...++|..... .....+....+-.++-..+||.+++..--+.......|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 44667777888899999998775432 322333332221 11112222333333333456777766655566778899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
+++|..+++|...|+... ..+..-....+..+.++++|||... +.|+|++|.|++...++..+++||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988886543 3444444556667889999999876 8999999999999999999999998433221
Q ss_pred ---------------------C----CCcc----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCC
Q 003832 627 ---------------------G----DEIQ----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (792)
Q Consensus 627 ---------------------~----~~~~----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~ 677 (792)
. .... .......||+.|.+||.+.+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0000 1123467899999999999999999999999999999999999999
Q ss_pred CCCCCCCccchhHHHHHHHhhhhhhhhccc-cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003832 678 RFSHPDHDHNLLGHAWILWKEKRAMELAGD-TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMS 740 (792)
Q Consensus 678 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~ 740 (792)
....+..... .+... ......+.....+..+++...+..+|.+|-.|.
T Consensus 1036 na~tpq~~f~---------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFE---------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhh---------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 8655542210 00000 001122333444566777778888898887665
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.5e-07 Score=92.32 Aligned_cols=126 Identities=27% Similarity=0.329 Sum_probs=83.3
Q ss_pred cEEeeeccCCcEEEEEEccCCC--------------c------------hhHHHHHHHHHHHHhcccc--cceeeeeeEE
Q 003832 488 PVYKGTLVEGQEIAVKRLSKGS--------------G------------QGMEEFKNEVTLIARLQHR--NLVKLLGCCI 539 (792)
Q Consensus 488 ~Vy~g~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~ 539 (792)
.||.|...+|..+|||+.+... . ......++|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899998889999999875421 0 0123457899999999765 45556544
Q ss_pred eCCcceEEEeecC--CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHH-HhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 540 QADESMLIYEYMP--NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY-LHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 540 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~y-LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
...+|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.||+++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 35689999998 65554443211 1134556677788886665 46766 9999999999999988 9999
Q ss_pred eeeccccccC
Q 003832 617 SDFGMARIFG 626 (792)
Q Consensus 617 ~DFgla~~~~ 626 (792)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.5e-07 Score=96.34 Aligned_cols=133 Identities=20% Similarity=0.170 Sum_probs=96.4
Q ss_pred ccEEeeeccCCcEEEEEEccCCCch-hHH----------HHHHHHHHHHhccccc--ceeeeeeEEe-----CCcceEEE
Q 003832 487 GPVYKGTLVEGQEIAVKRLSKGSGQ-GME----------EFKNEVTLIARLQHRN--LVKLLGCCIQ-----ADESMLIY 548 (792)
Q Consensus 487 g~Vy~g~~~~~~~vavK~l~~~~~~-~~~----------~~~~Ei~~l~~l~H~n--iv~l~g~~~~-----~~~~~lV~ 548 (792)
..|.+..+ +|+.+.||+....... ..+ .+.+|...+.++...+ ..+++++... ....+||+
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34666655 6788999976433211 111 4778999999886433 3344555543 23468999
Q ss_pred eecCCC-ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-------CCCceEeeec
Q 003832 549 EYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------DMNPKISDFG 620 (792)
Q Consensus 549 e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~DFg 620 (792)
|++++. +|.+++.+.. ....+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.++||+
T Consensus 115 e~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 115 EDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred eeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 999986 8988874321 123455677789999999999999998 999999999999975 4678999999
Q ss_pred cccc
Q 003832 621 MARI 624 (792)
Q Consensus 621 la~~ 624 (792)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=9.8e-07 Score=93.09 Aligned_cols=260 Identities=14% Similarity=0.111 Sum_probs=154.7
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeee----EE--eCCc-ceEEE
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC----CI--QADE-SMLIY 548 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~----~~--~~~~-~~lV~ 548 (792)
..+.||+|+-+.+|-.-. -...+.|+.+........+. +..|.+. .||-+-.-+.+ .. .... .-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 346799999999995421 12235677766544333332 2233333 45543321111 11 1111 44566
Q ss_pred eecCCCC-hhHHHh---hcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 549 EYMPNKS-LDFFIF---DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 549 e~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+.+.+.- ...+.. ++......+|.-.++.+..++.+.+-||+.+ .+-+|+.++|+|+.+++.+.|.|=+.-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 6665542 222222 2233456789999999999999999999998 88899999999999999999988554333
Q ss_pred cCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhC-CCCCCCCCCCCccchhHHHHHHHhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSG-KKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
..++. ...-.+|...|.+||.-. +..-+...|-|.+||++++++.| ++||.......+..-.... ....
T Consensus 167 ~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~ 241 (637)
T COG4248 167 NANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAH 241 (637)
T ss_pred ccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhc
Confidence 22211 122357889999999653 34557789999999999999887 9999764322111000000 0001
Q ss_pred hhhhhhcccc--c---cCCCCH-HHHHHHHHHHHHhccC--CCCCCCCHHHHHHHhcCC
Q 003832 699 KRAMELAGDT--L---ADSHPP-TEVLRCIHVGLLCVQH--RPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 699 ~~~~~~~~~~--~---~~~~~~-~~~~~l~~li~~Cl~~--~P~~RPs~~evl~~L~~~ 749 (792)
+......+.. + ..+.|- -.+..+..+..+|+.. ++.-||+++-.+..|.+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 1111111110 0 011122 2234555666778865 367899999888877543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=87.28 Aligned_cols=135 Identities=23% Similarity=0.257 Sum_probs=95.8
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCc----------------------hhHHHHHHHHHHHHhcccc--cc
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG----------------------QGMEEFKNEVTLIARLQHR--NL 531 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~----------------------~~~~~~~~Ei~~l~~l~H~--ni 531 (792)
.+..+||-|--+.||.|...+|.++|||.=+.... ......++|.++|.+|.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 34578999999999999999999999996543210 0123456789999998644 55
Q ss_pred eeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC
Q 003832 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (792)
Q Consensus 532 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 611 (792)
.+.+++ +...+|||+.++-.|...- ++....-.++..|+.-+.-+-..+ |||+|+.+-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 555544 5568999999997664321 122333344444555554444555 9999999999999999
Q ss_pred CCceEeeecccccc
Q 003832 612 MNPKISDFGMARIF 625 (792)
Q Consensus 612 ~~~kl~DFgla~~~ 625 (792)
|.+.++||--+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999877654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.8e-07 Score=99.85 Aligned_cols=141 Identities=17% Similarity=0.266 Sum_probs=94.7
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchh------------------------------HH----------HHHH
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG------------------------------ME----------EFKN 518 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~------------------------------~~----------~~~~ 518 (792)
+.|+.++-|.||+|++++|+.||||+.+.+..+. .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5789999999999999999999999997653211 01 1334
Q ss_pred HHHHHHhcc-----cccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHH-HHHhhcC
Q 003832 519 EVTLIARLQ-----HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI-LYLHQDS 592 (792)
Q Consensus 519 Ei~~l~~l~-----H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~ 592 (792)
|...+.+++ .+++.-..=+..-....+|+|||++|-.+.+....+. ...+.+ .++..++++. ..+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 555555553 2333222222334677899999999999988853322 123322 3333333332 1222234
Q ss_pred CCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 593 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+.|.|.+|.||+++.++++.+.|||+...+..
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.5e-08 Score=107.01 Aligned_cols=150 Identities=17% Similarity=0.220 Sum_probs=101.0
Q ss_pred HHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc-------ccccccccCccccccccC
Q 003832 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN-------THKVVGTYGYMSPEYAAE 651 (792)
Q Consensus 579 ~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 651 (792)
.+++.||.|+|... .+||++|.|++|.++..+..||+.|+.+........... ..-......|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 35669999999865 699999999999999999999999998876543111100 011223568999999999
Q ss_pred CCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhcc
Q 003832 652 GLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQ 730 (792)
Q Consensus 652 ~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~ 730 (792)
...+.++|+||+|+++|-+.. |+.-+......... ......+......+....+.++.+=+.+.+.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-------------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-------------SFSRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchh-------------hhhhcccccccccccccCcHHHHHHHHHHhc
Confidence 888999999999999999995 44444322111110 0111111111122234445556666677899
Q ss_pred CCCCCCCCHHHHH
Q 003832 731 HRPEDRPNMSSVV 743 (792)
Q Consensus 731 ~~P~~RPs~~evl 743 (792)
.++.-||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999776644
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.31 E-value=9.6e-06 Score=80.16 Aligned_cols=139 Identities=17% Similarity=0.145 Sum_probs=103.5
Q ss_pred cCcCCcccEEeeeccCCcEEEEEEccCCC------chhHHHHHHHHHHHHhccc--ccceeeeeeEEeC----CcceEEE
Q 003832 481 LGEGGFGPVYKGTLVEGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQA----DESMLIY 548 (792)
Q Consensus 481 lg~G~fg~Vy~g~~~~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~----~~~~lV~ 548 (792)
-|+||.+-|++..+ +|+.+-+|+-.... +.....|.+|...|.++.. -.+.++..+.... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 46789999999877 45579999875221 3456789999999999963 2344555222222 2368999
Q ss_pred eecCC-CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC--ceEeeeccccc
Q 003832 549 EYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARI 624 (792)
Q Consensus 549 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgla~~ 624 (792)
|-+++ -+|.+++.+.. ..+.+...+..++.++++.+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 58888874432 234567777899999999999999998 999999999999986667 99999987764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=4.4e-06 Score=84.09 Aligned_cols=107 Identities=27% Similarity=0.295 Sum_probs=83.6
Q ss_pred HHHHHHHHHHHHhccc--ccceeeeeeEEeCC----cceEEEeecCCC-ChhHHHhhcccCccCChhhHHHHHHHHHHHH
Q 003832 513 MEEFKNEVTLIARLQH--RNLVKLLGCCIQAD----ESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGI 585 (792)
Q Consensus 513 ~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L 585 (792)
.....+|...+.++.. -...+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3467788888888853 33555666665532 358999999884 78888854222 55667788999999999
Q ss_pred HHHhhcCCCCEEecCCCCCcEEecCCC---CceEeeecccccc
Q 003832 586 LYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIF 625 (792)
Q Consensus 586 ~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgla~~~ 625 (792)
+-||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.4e-05 Score=79.85 Aligned_cols=139 Identities=17% Similarity=0.213 Sum_probs=85.5
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeeeEEeCCcceEEEeecCCCC-
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYEYMPNKS- 555 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e~~~~gs- 555 (792)
.+||+|..+.||+. .+..+++|..+... ......+|.+++..+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999983 35567888876533 3345688999999987443 4667777777777789999999973
Q ss_pred hhHHHh--------------------hcccCccCChhhHH-HHHH----------HHHH-HHHHHhh-cCCCCEEecCCC
Q 003832 556 LDFFIF--------------------DQARATFLDWQKRI-HIVG----------GIAR-GILYLHQ-DSRMRIIHRDLK 602 (792)
Q Consensus 556 L~~~l~--------------------~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~ivH~Dlk 602 (792)
+...+. +............. .+.. .+.. ...+|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 00000001111100 0000 0111 1122221 123457999999
Q ss_pred CCcEEecCCCCceEeeecccc
Q 003832 603 ASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 603 p~NIll~~~~~~kl~DFgla~ 623 (792)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.6e-06 Score=71.01 Aligned_cols=72 Identities=38% Similarity=0.756 Sum_probs=55.2
Q ss_pred CCcceeecccCCCCCcchhccccchhhHhhhcCC-CCcccccccccccCCCcceeeee-ccccccccccCCCcceEEE
Q 003832 328 DEFPKYVKLKLPDTSSSWFNASMNLKECSELCSK-NCSCTAYANSDVERGGSGCLLWF-GDLMDMKEYNDGGQDLYIR 403 (792)
Q Consensus 328 ~~f~~~~~~~~~~~~~~~~~~~~s~~~C~~~C~~-~C~C~a~~~~~~~~~~~~C~~~~-~~l~~~~~~~~~~~~lylr 403 (792)
..|..+.++.+++..... ....++++|++.|++ +|+|.||.|.. ++.+|.+|. +.+.+.+..+..+.++|.+
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 468888999998654332 456799999999999 99999999874 456899999 7777776455555566654
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=72.58 Aligned_cols=84 Identities=23% Similarity=0.407 Sum_probs=59.0
Q ss_pred EEecCceEEe-CCC-CceEEeeccCCC-CCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCce
Q 003832 85 NVTSKGIVLL-DGR-DRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (792)
Q Consensus 85 ~~~~~g~l~l-~~~-~~~~Wss~~~~~-~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~~ 161 (792)
....||++++ +.. +.++|++++... ..+..+.|.++|||||.+.+ +.++|+| +|- +
T Consensus 25 ~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~S-----~t~-~-------------- 83 (114)
T smart00108 25 IMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD-GRVVWSS-----NTT-G-------------- 83 (114)
T ss_pred CCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC-CCEEEEe-----ccc-C--------------
Confidence 3457899998 332 689999997533 23367899999999999877 7789997 111 1
Q ss_pred eEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeec
Q 003832 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRA 201 (792)
Q Consensus 162 ~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~ 201 (792)
..|.+.+.++.+|...++-.++ .+.|.+
T Consensus 84 -----------~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 84 -----------ANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred -----------CCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 1256888999999887654333 466754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=7.8e-07 Score=98.54 Aligned_cols=191 Identities=16% Similarity=0.140 Sum_probs=138.1
Q ss_pred HHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc-ceeeeeeEEeCCcceEE
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLI 547 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV 547 (792)
+..+..+...+.++++++++++|.+-...+....+.+... ....-++++|.+++||| .++.++-+..+....++
T Consensus 238 kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 238 KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 3344555556788999999999988655555556666432 45567899999999999 77777777778888999
Q ss_pred EeecCCC-ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 548 YEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
++++..+ +-..... .....+...+...+...-.+++++||+.. =+|+| ||+..+ +..|..||+....+.
T Consensus 313 ~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~ 382 (829)
T KOG0576|consen 313 MRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLT 382 (829)
T ss_pred hhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccC
Confidence 9999877 2211110 00111233344455566778899999864 48888 777665 678999999988775
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCC
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~ 677 (792)
+.. ..+...+++.++|||......+..+.|+|+.|+--.++--|-+|-
T Consensus 383 ~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 383 RTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 443 234467899999999999999999999999998777777777664
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=1.9e-05 Score=88.76 Aligned_cols=141 Identities=16% Similarity=0.200 Sum_probs=92.0
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchh-------------------------------------HHHHHHHHH
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG-------------------------------------MEEFKNEVT 521 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei~ 521 (792)
+.|+.-+.|.||+|++++|+.||||+-+...... +-+|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999987643211 012445555
Q ss_pred HHHhc----cccc---ceeeeeeEE-eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCC
Q 003832 522 LIARL----QHRN---LVKLLGCCI-QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593 (792)
Q Consensus 522 ~l~~l----~H~n---iv~l~g~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 593 (792)
...+. +|-+ -|++=.++. -...++|+||||+|..+.+...-... .++...+..-+.+...-+-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHHHHhc----
Confidence 55544 3444 122222332 34578999999999988766533221 2444443333333222222222
Q ss_pred CCEEecCCCCCcEEecC----CCCceEeeeccccccC
Q 003832 594 MRIIHRDLKASNVLLDN----DMNPKISDFGMARIFG 626 (792)
Q Consensus 594 ~~ivH~Dlkp~NIll~~----~~~~kl~DFgla~~~~ 626 (792)
+++|+|=+|.||++.. ++++.+-|||+...+.
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 3999999999999983 6789999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.04 E-value=3.2e-05 Score=76.74 Aligned_cols=138 Identities=16% Similarity=0.188 Sum_probs=92.3
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHH---------HHHHHHHHhccc---ccceeeeeeE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEF---------KNEVTLIARLQH---RNLVKLLGCC 538 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~---------~~Ei~~l~~l~H---~niv~l~g~~ 538 (792)
...+|...+.+-......|.+... +|+.+++|..+.......+.| .+++..+.+++. ..+..++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 346777777777777777777666 678999998876543332222 234444444432 2333333333
Q ss_pred E-----eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 539 I-----QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 539 ~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
. .....+|+|||++|..|.++.. ++. .++..+++++.-||+.| ++|+|..|.|+++++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 2 2244578999999988865531 221 34556788899999998 99999999999998655
Q ss_pred ceEeeeccccc
Q 003832 614 PKISDFGMARI 624 (792)
Q Consensus 614 ~kl~DFgla~~ 624 (792)
+++.||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.98 E-value=3.4e-05 Score=69.83 Aligned_cols=81 Identities=21% Similarity=0.359 Sum_probs=58.2
Q ss_pred CceEEe-CC-CCceEEeeccCCC-CCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCceeEEe
Q 003832 89 KGIVLL-DG-RDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSS 165 (792)
Q Consensus 89 ~g~l~l-~~-~~~~~Wss~~~~~-~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~~~l~S 165 (792)
+|++++ +. .+.++|++|+... .....+.|.++|||||.+.+ +.++|+|=-.
T Consensus 30 dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~S~~~------------------------- 83 (116)
T cd00028 30 DYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS-GTVVWSSNTT------------------------- 83 (116)
T ss_pred eEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC-CcEEEEeccc-------------------------
Confidence 888888 33 2689999997542 34567899999999999877 7789986421
Q ss_pred eccCCCCCCcceEEeecCCCCceEEEecCceeeeecC
Q 003832 166 WKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (792)
Q Consensus 166 w~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 202 (792)
.+.+.+.+.++.+|...++-.+ ....|.+.
T Consensus 84 ------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 0136688899999987765443 35567653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.96 E-value=2.8e-05 Score=76.69 Aligned_cols=105 Identities=22% Similarity=0.219 Sum_probs=83.4
Q ss_pred HHHHHHHHhccc-ccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCC
Q 003832 517 KNEVTLIARLQH-RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (792)
Q Consensus 517 ~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 595 (792)
.+|..++..+++ +++.+++|+| ..++|.||...+++...-..-..--..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 45789999987765321000001123689999999999999999999865556
Q ss_pred EEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 596 IIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 596 ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+..+|++++|+-+++++++|+.|.+.+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=76.17 Aligned_cols=140 Identities=14% Similarity=0.162 Sum_probs=85.7
Q ss_pred ccCcCCc-ccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeecCCCChh
Q 003832 480 KLGEGGF-GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLD 557 (792)
Q Consensus 480 ~lg~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL~ 557 (792)
.|..|.. ..||+.... +..+++|+..... ...+..|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555555 788998764 4788888875432 345678999988884 444556777776666789999999998876
Q ss_pred HHHh------------------hccc--CccCC--hhhHHHHHH--------------------HHHHHHHHHhh----c
Q 003832 558 FFIF------------------DQAR--ATFLD--WQKRIHIVG--------------------GIARGILYLHQ----D 591 (792)
Q Consensus 558 ~~l~------------------~~~~--~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----~ 591 (792)
.... +... ..... ......... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 00000 000000000 01111222211 1
Q ss_pred CCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 592 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
..+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23459999999999999998878999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.88 E-value=6.2e-05 Score=77.05 Aligned_cols=144 Identities=20% Similarity=0.214 Sum_probs=85.1
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeeeEEeC---CcceEEEeecC
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQA---DESMLIYEYMP 552 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~---~~~~lV~e~~~ 552 (792)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+.... +.+++.+.... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999866 69999997554 45567888999998886433 45666644332 23688999999
Q ss_pred CCChhH----------------HHh---hc-ccCccCChhh---------HHHH------------HHHHHH-HHHHHhh
Q 003832 553 NKSLDF----------------FIF---DQ-ARATFLDWQK---------RIHI------------VGGIAR-GILYLHQ 590 (792)
Q Consensus 553 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH~ 590 (792)
+..+.. .+. .. .......+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 111 00 0001111110 0000 111222 2333332
Q ss_pred ----cCCCCEEecCCCCCcEEec-CCCCceEeeeccccc
Q 003832 591 ----DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (792)
Q Consensus 591 ----~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~ 624 (792)
.....++|+|+.|.||+++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 566668999988653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00017 Score=72.44 Aligned_cols=153 Identities=16% Similarity=0.210 Sum_probs=97.6
Q ss_pred CHHhHHHhhcccccc---cccCcCCcccEEeeeccCCcEEEEEEccCCCchh-------------------HHH-----H
Q 003832 464 DFASIAKATDNFASY---NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG-------------------MEE-----F 516 (792)
Q Consensus 464 ~~~~i~~~~~~~~~~---~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~-------------------~~~-----~ 516 (792)
+.+.+.....+..+. ..|..|--..||+|...++..+|||+.+...... ..+ .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 344444444444333 3567888889999998889999999986431110 011 2
Q ss_pred HHHHHHHHhcc--cccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCC
Q 003832 517 KNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594 (792)
Q Consensus 517 ~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 594 (792)
.+|...|.++. +-.+.+.+++ .+-.|||||+....+..-. -+.-.+...+...+..++++.+.-|-...
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 34666666663 3334444443 3457999999765221000 01112233356677778888888887633
Q ss_pred CEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 595 ~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
.+||+||+.-|||+. ++.+.|+|++-+....
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 399999999999999 8899999999987654
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.78 E-value=3.3e-05 Score=56.75 Aligned_cols=45 Identities=47% Similarity=0.730 Sum_probs=40.0
Q ss_pred CCCCCCCCCCCCccccCCCCCCcCCCCCC--CCCCcceeEeeeeecC
Q 003832 748 SDSLLPEPNRPGFFTERSLPEAEFSPSYP--QSSTTNEITITELQGR 792 (792)
Q Consensus 748 ~~~~~~~p~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 792 (792)
+...+|.|.+|+++..|...+..+|+... ..+|+|++|+|.+++|
T Consensus 2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 45789999999999999888888776665 8999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.0005 Score=68.17 Aligned_cols=131 Identities=15% Similarity=0.234 Sum_probs=91.3
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCC----------------chhHHHHHHHHHHHHhcc------cccceeee
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------------GQGMEEFKNEVTLIARLQ------HRNLVKLL 535 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv~l~ 535 (792)
...||+|+.-.||. ++++....||+..... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45899999999995 5567778888886654 123456667776666655 78999999
Q ss_pred eeEEeCCcceEEEeecCC------CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 536 GCCIQADESMLIYEYMPN------KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 536 g~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
|+.......-+|+|.+.+ -+|.+++.+. .++. ...+.+ -+-..||-++. |+.+|++|+||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 2577777332 3444 333333 33445666555 99999999999996
Q ss_pred CCC----CceEee-ecc
Q 003832 610 NDM----NPKISD-FGM 621 (792)
Q Consensus 610 ~~~----~~kl~D-Fgl 621 (792)
... .+.|+| ||-
T Consensus 153 ~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGE 169 (199)
T ss_pred ecCCCceEEEEEeCCCC
Confidence 332 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00053 Score=83.65 Aligned_cols=79 Identities=19% Similarity=0.400 Sum_probs=58.2
Q ss_pred ccccCcCCcccEEeeeccCC---cEEEEEEccCCC-chhHHHHHHHHHHHHhcc-cccc--eeeeeeEEeC---CcceEE
Q 003832 478 YNKLGEGGFGPVYKGTLVEG---QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQ-HRNL--VKLLGCCIQA---DESMLI 547 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~---~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 547 (792)
+++|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.+. |+++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46889999999999876553 467788764432 123457889999999995 6664 7778887664 457899
Q ss_pred EeecCCCCh
Q 003832 548 YEYMPNKSL 556 (792)
Q Consensus 548 ~e~~~~gsL 556 (792)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988653
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00026 Score=67.24 Aligned_cols=130 Identities=22% Similarity=0.255 Sum_probs=89.4
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCCC
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
...+.|++|.+|.||++.+. |..+|+|+-+.+++ ...+..|+++|..++-.++-+=+-.+ +..++.|||..+-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~y---g~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFY---GEDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEe---chhhhhhhhhcCcc
Confidence 34468999999999999984 56899998766543 46788999999999876655433222 22345599999988
Q ss_pred hhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCC-CCcEEecCCCCceEeeeccccc
Q 003832 556 LDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK-ASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 556 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kl~DFgla~~ 624 (792)
|.+.-... + .+-...++..---|...+ |-|+.|. |..++|..++.+.|+||.-|..
T Consensus 99 L~~~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 86554211 1 122334555544455545 9999887 5555555666999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00054 Score=70.52 Aligned_cols=73 Identities=15% Similarity=0.288 Sum_probs=45.8
Q ss_pred cccCcCCcc-cEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccc---cceeeeeeEEeCC---cceEEEeec
Q 003832 479 NKLGEGGFG-PVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCIQAD---ESMLIYEYM 551 (792)
Q Consensus 479 ~~lg~G~fg-~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~---~~~lV~e~~ 551 (792)
+.|+.|+.. .||+. +..+++|..+.. .....+..|++++..+... -+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 48875 235777775442 2345788999999888532 2333444333221 348899999
Q ss_pred CCCChh
Q 003832 552 PNKSLD 557 (792)
Q Consensus 552 ~~gsL~ 557 (792)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0011 Score=68.04 Aligned_cols=73 Identities=21% Similarity=0.305 Sum_probs=48.8
Q ss_pred cccCcCCcccEEeeeccC--CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEEeecCCCC
Q 003832 479 NKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~--~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
+.|..|-...+|+....+ ++.+++|+....... .-.-..|+.++..+....+ .++++.+. ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 568888889999988764 678889977543221 1233468888888854334 34443322 248999999877
Q ss_pred h
Q 003832 556 L 556 (792)
Q Consensus 556 L 556 (792)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 6
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00085 Score=70.03 Aligned_cols=139 Identities=17% Similarity=0.135 Sum_probs=79.9
Q ss_pred ccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccce-eeeeeEEeCCcceEEEeecCCCChhH
Q 003832 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMPNKSLDF 558 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~~gsL~~ 558 (792)
.+..|-...+|+... +++.+++|..........-...+|.++++.+....++ +++... ...+|+||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence 466788889998873 5778888876543222112357788888888644333 333332 2479999999876542
Q ss_pred H-----------------Hhhcc-cCccCChhhHH-HHH---------HHHHHHHHHHhhc-----CCCCEEecCCCCCc
Q 003832 559 F-----------------IFDQA-RATFLDWQKRI-HIV---------GGIARGILYLHQD-----SRMRIIHRDLKASN 605 (792)
Q Consensus 559 ~-----------------l~~~~-~~~~l~~~~~~-~i~---------~~ia~~L~yLH~~-----~~~~ivH~Dlkp~N 605 (792)
. ++... ....++....+ ... ..+...+..+... ....++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 01112211111 111 0111112222111 12358999999999
Q ss_pred EEecCCCCceEeeeccccc
Q 003832 606 VLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 606 Ill~~~~~~kl~DFgla~~ 624 (792)
|++++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0017 Score=71.39 Aligned_cols=75 Identities=13% Similarity=0.209 Sum_probs=54.1
Q ss_pred cccCcCCcccEEeeeccCC-cEEEEEEccCC-------CchhHHHHHHHHHHHHhcc-c--ccceeeeeeEEeCCcceEE
Q 003832 479 NKLGEGGFGPVYKGTLVEG-QEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~~~~~lV 547 (792)
+.||.|.+..||++...+| +.++||.-... .+...+.+..|.+.|..+. + .++.+++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998777 58999985321 1224566778888888863 2 345666665 44667999
Q ss_pred EeecCCCC
Q 003832 548 YEYMPNKS 555 (792)
Q Consensus 548 ~e~~~~gs 555 (792)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0015 Score=69.64 Aligned_cols=78 Identities=10% Similarity=0.075 Sum_probs=57.3
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccc---ccceeeeeeEEeC---CcceEEEe
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH---RNLVKLLGCCIQA---DESMLIYE 549 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~g~~~~~---~~~~lV~e 549 (792)
...+.||.|..+.||+....++ .+++|..+.. .....+..|.+.|+.+.- -.+.++++++... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456899999999999876555 4666764321 123578899999998853 3677888887543 56899999
Q ss_pred ecCCCCh
Q 003832 550 YMPNKSL 556 (792)
Q Consensus 550 ~~~~gsL 556 (792)
+++++++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0015 Score=64.25 Aligned_cols=135 Identities=24% Similarity=0.383 Sum_probs=94.8
Q ss_pred ccccccCHHhHHHhhcccccccccCcCCc-ccEEeeeccCCcEEEEEEccC---CCc------------------hhHHH
Q 003832 458 MELWEFDFASIAKATDNFASYNKLGEGGF-GPVYKGTLVEGQEIAVKRLSK---GSG------------------QGMEE 515 (792)
Q Consensus 458 ~~~~~~~~~~i~~~~~~~~~~~~lg~G~f-g~Vy~g~~~~~~~vavK~l~~---~~~------------------~~~~~ 515 (792)
..+..|+. -+.+++.++.||.|.- |.||++++ +|+.+|+|..+. ... .....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 34455554 2277888999999999 99999998 688999999321 100 11235
Q ss_pred HHHHHHHHHhcc---cccc--eeeeeeEEeCC------------------cceEEEeecCCCChhHHHhhcccCccCChh
Q 003832 516 FKNEVTLIARLQ---HRNL--VKLLGCCIQAD------------------ESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572 (792)
Q Consensus 516 ~~~Ei~~l~~l~---H~ni--v~l~g~~~~~~------------------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~ 572 (792)
|..|.+..++|+ +.++ |+.+|+..-.. .+.||.||++... .
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~ 164 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------P 164 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------c
Confidence 788999988885 4466 99999974221 1356777775542 1
Q ss_pred hHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 573 ~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
....-+.++.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 165 ~~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cchhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 12234556778888899888 999999999974 5689999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0028 Score=57.00 Aligned_cols=99 Identities=22% Similarity=0.401 Sum_probs=63.4
Q ss_pred CEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEee-cCCCCCCCCCceeEEecCceEEe-CCCCceEEeeccCC
Q 003832 31 ETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVA-NRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSI 108 (792)
Q Consensus 31 ~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~A-Nr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Wss~~~~ 108 (792)
+.+.+.+|.+.|-|-..|+ |-| |+. ..+++|.. +...... ....+.+.++|+|+| |..+.++|+|...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred cccccccccccceECCCCe-----EEE-EcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence 3455555888888876554 333 332 35779999 4333332 467899999999999 8899999999532
Q ss_pred CCCCcEEEEee--ccceEEecCCCCceeeeccCCCC
Q 003832 109 TMKNPVVQLMD--SGNLVLTDGNYNSLLWQSFDHPC 142 (792)
Q Consensus 109 ~~~~~~a~Lld--~GNlVl~~~~~~~~lWqSFd~PT 142 (792)
...+....++ .||++ .... ..+.|.|=+.|.
T Consensus 82 -ptdt~L~~q~l~~~~~~-~~~~-~~~sw~s~~dps 114 (114)
T PF01453_consen 82 -PTDTLLPGQKLGDGNVT-GKND-SLTSWSSNTDPS 114 (114)
T ss_dssp -SS-EEEEEET--TSEEE-EEST-SSEEEESS----
T ss_pred -CccEEEeccCcccCCCc-cccc-eEEeECCCCCCC
Confidence 3456667777 88988 5433 568898877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0022 Score=68.47 Aligned_cols=144 Identities=21% Similarity=0.221 Sum_probs=87.1
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeee------EEeCCcceEEE
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGC------CIQADESMLIY 548 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~ 548 (792)
..+.|..|....+|+.... +..+++|+... ...+....|++++..+++.. +.+++.. ....+..++|+
T Consensus 18 ~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 3567888888899998764 45788898764 23456677888888885432 4444332 12334568999
Q ss_pred eecCCCChhH----HH----------hhccc--------CccCChhhHH----------HHHHHHHHHHHHHhh----cC
Q 003832 549 EYMPNKSLDF----FI----------FDQAR--------ATFLDWQKRI----------HIVGGIARGILYLHQ----DS 592 (792)
Q Consensus 549 e~~~~gsL~~----~l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~~L~yLH~----~~ 592 (792)
++++|..+.. .. +.... .....|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999877532 11 11000 0111222211 011123344455543 12
Q ss_pred CCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 593 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
...++|+|+.|.||+++++..+.|.||+.+..
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 23599999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0018 Score=77.52 Aligned_cols=199 Identities=17% Similarity=0.154 Sum_probs=134.6
Q ss_pred HHHHHHHHHHHhcccccceeeeeeEEeCCcce----EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh
Q 003832 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESM----LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589 (792)
Q Consensus 514 ~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH 589 (792)
.....|+..+.++.|+|++.++.|..+....- +..|++..-++...+.. -..++....+.+..++..||+|+|
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~---v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS---VGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh---ccccCHHHHHHHHHHHhhhHHHHH
Confidence 34456788888999999999999987664433 34567777777666643 335777888888999999999999
Q ss_pred hcCCCCEEecCCCCC---cEEecCCCCceEe--eeccccccCCCCccccccccccccCccccccccCCCCCc--cCcchh
Q 003832 590 QDSRMRIIHRDLKAS---NVLLDNDMNPKIS--DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSV--KSDVFS 662 (792)
Q Consensus 590 ~~~~~~ivH~Dlkp~---NIll~~~~~~kl~--DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--k~DVwS 662 (792)
+.. ..|.-|..+ +--++.++.+.++ ||+..+.+...... ....-+..+.+||......++. ..|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 885 555544444 5555677777777 88887765432211 1123456788888886665544 479999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 003832 663 FGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742 (792)
Q Consensus 663 ~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~ev 742 (792)
+|..+..+..|..+-..... ...+++.. ....+......|+..++++|+++.++
T Consensus 378 lgll~~~~~~~~~i~~~~~~------------------~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSAV------------------PVSLLDVL--------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHHhhhhhcCcccccccc------------------hhhhhccc--------cchhhhhhhhhhcchhhhhccchhhh
Confidence 99999999998765321100 00111111 11134566678999999999999999
Q ss_pred HHHhc
Q 003832 743 VLMLS 747 (792)
Q Consensus 743 l~~L~ 747 (792)
+.+.-
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 88763
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.007 Score=65.35 Aligned_cols=143 Identities=20% Similarity=0.215 Sum_probs=77.8
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeee------eEEeCCcceEEEe
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLG------CCIQADESMLIYE 549 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g------~~~~~~~~~lV~e 549 (792)
.+.|..|....+|+....+| .+++|+.... ..+....|+.++..|.... +.+.+. +....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 35677888889999876544 6888987521 2234444556665553211 223332 1122455789999
Q ss_pred ecCCCChhH-----H---------Hhhccc--------CccCCh-hhHHH------------HH-HHHHHHHHHHhhc--
Q 003832 550 YMPNKSLDF-----F---------IFDQAR--------ATFLDW-QKRIH------------IV-GGIARGILYLHQD-- 591 (792)
Q Consensus 550 ~~~~gsL~~-----~---------l~~~~~--------~~~l~~-~~~~~------------i~-~~ia~~L~yLH~~-- 591 (792)
|++|..+.. . ++.... ...+.| ..... .. ..+...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 111000 001112 11111 11 1111122233211
Q ss_pred --CCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 592 --SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 592 --~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
-+..++|+|+.+.||+++++...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776668999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0044 Score=66.39 Aligned_cols=141 Identities=24% Similarity=0.330 Sum_probs=83.9
Q ss_pred cccCcCCcccEEeeeccC-------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccce-eeeeeEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVE-------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~ 550 (792)
+.|..|-...+|+....+ ++.+++|+..... ........|.+++..+....+. ++++++. -.+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 466777778999887655 5788999875543 2234557788888888543333 4455443 2368999
Q ss_pred cCCCChhHHH-----------------hhcccC--c----c--CChhhHHH--------------------------HHH
Q 003832 551 MPNKSLDFFI-----------------FDQARA--T----F--LDWQKRIH--------------------------IVG 579 (792)
Q Consensus 551 ~~~gsL~~~l-----------------~~~~~~--~----~--l~~~~~~~--------------------------i~~ 579 (792)
++|..+.... +..... . . .-|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9887764311 110000 0 0 00111101 111
Q ss_pred HHHHHHHHHhh------cCCCCEEecCCCCCcEEecCC----CCceEeeeccccc
Q 003832 580 GIARGILYLHQ------DSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (792)
Q Consensus 580 ~ia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgla~~ 624 (792)
.+..-+..|.. .....++|+|+.+.||+++++ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22222334432 234569999999999999985 8899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.01 Score=62.61 Aligned_cols=75 Identities=20% Similarity=0.301 Sum_probs=49.2
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc---cccceeeeeeEEeCCcceEEEeecC
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
+..+.|+.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. --.+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678999999999987 578889999876 233456888888888884 3457788888887788899999998
Q ss_pred CC
Q 003832 553 NK 554 (792)
Q Consensus 553 ~g 554 (792)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.00042 Score=84.18 Aligned_cols=159 Identities=13% Similarity=-0.027 Sum_probs=111.2
Q ss_pred HHHHHHHHhcccccceeeeeeEE--eCCcceEEEeecCCCChhHHHhhccc-CccCChhhHHHHHHHHHHHHHHHhhc--
Q 003832 517 KNEVTLIARLQHRNLVKLLGCCI--QADESMLIYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQD-- 591 (792)
Q Consensus 517 ~~Ei~~l~~l~H~niv~l~g~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~-- 591 (792)
..|...++...|+++.....-.. +..+.+..++|+..|.+...+.+... ...++..-....-.+...+..-+|..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555566678888776554433 23456889999999999988876432 23333333333223324444444433
Q ss_pred CCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHH
Q 003832 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671 (792)
Q Consensus 592 ~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ell 671 (792)
.....+|++||+-|.+|..+.++|++++|+.+...+.. .......+++-|++|++...-.++.++|+|..|+.+|++-
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 23457999999999999999999999999998433221 1222356788999999998889999999999999999998
Q ss_pred hCCCCC
Q 003832 672 SGKKNW 677 (792)
Q Consensus 672 tG~~p~ 677 (792)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.023 Score=61.92 Aligned_cols=141 Identities=17% Similarity=0.250 Sum_probs=82.0
Q ss_pred cccCcCCcccEEeeeccC-----CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccce-eeeeeEEeCCcceEEEeecC
Q 003832 479 NKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~g~~~~~~~~~lV~e~~~ 552 (792)
+.|-.|-.-.+|+....+ ++.+++|+.........+ -..|..++..+..-++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456667888899886532 367889987655433222 36788888888644443 455555332 5899998
Q ss_pred CCChhHH-------H----------hhcc-c--CccCChhhHHHHHHH-----------------HHHHHHHH----hh-
Q 003832 553 NKSLDFF-------I----------FDQA-R--ATFLDWQKRIHIVGG-----------------IARGILYL----HQ- 590 (792)
Q Consensus 553 ~gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~-----------------ia~~L~yL----H~- 590 (792)
+.+|... + +... . .....|.+..++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 0 1100 0 001112322222211 11112222 21
Q ss_pred cCCCCEEecCCCCCcEEecC-CCCceEeeeccccc
Q 003832 591 DSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARI 624 (792)
Q Consensus 591 ~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~ 624 (792)
.....++|+|+++.||++++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345899999999999986 47899999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.025 Score=59.63 Aligned_cols=31 Identities=26% Similarity=0.567 Sum_probs=25.9
Q ss_pred CCEEecCCCCCcEEecCCCC-ceEeeeccccc
Q 003832 594 MRIIHRDLKASNVLLDNDMN-PKISDFGMARI 624 (792)
Q Consensus 594 ~~ivH~Dlkp~NIll~~~~~-~kl~DFgla~~ 624 (792)
+.++|+|+++.||+++++++ .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.042 Score=58.97 Aligned_cols=143 Identities=22% Similarity=0.268 Sum_probs=82.6
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeeeE------EeCCcceEEEe
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCC------IQADESMLIYE 549 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~------~~~~~~~lV~e 549 (792)
.+.++.|....+|+....++ .+++|+.+... ..++...|++++..|.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 46778888889999876444 67788775432 2344556777777774222 33433321 12345689999
Q ss_pred ecCCCChh----HH----------HhhcccC---------ccCChhhHH------------HHHHHHHHHHHHHhh----
Q 003832 550 YMPNKSLD----FF----------IFDQARA---------TFLDWQKRI------------HIVGGIARGILYLHQ---- 590 (792)
Q Consensus 550 ~~~~gsL~----~~----------l~~~~~~---------~~l~~~~~~------------~i~~~ia~~L~yLH~---- 590 (792)
|++|..+. .. ++..... ..-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99886542 10 1110000 001121111 011123344555542
Q ss_pred cCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 591 ~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.....++|+|+.+.||++++++...|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223569999999999999998877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.032 Score=59.31 Aligned_cols=147 Identities=14% Similarity=0.243 Sum_probs=83.3
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEcc-CCCchhHHHHHHHHHHHHhccc--ccceeeeeeEEeCC--cceEEEeec
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQAD--ESMLIYEYM 551 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~--~~~lV~e~~ 551 (792)
+.+++..|..-.+|..... ++++++++-. ...........+|.++|+.+.- .-+.+.+++|.++. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3344544444455555443 7778888221 1233445566778888888753 23445567776666 669999999
Q ss_pred CCCChhHHHhhcc-----------------------------------cCccCChhhHHHHH--------HHHHHHHHHH
Q 003832 552 PNKSLDFFIFDQA-----------------------------------RATFLDWQKRIHIV--------GGIARGILYL 588 (792)
Q Consensus 552 ~~gsL~~~l~~~~-----------------------------------~~~~l~~~~~~~i~--------~~ia~~L~yL 588 (792)
++..+...+.... .++.-.|....+.+ -....-..+|
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 8843321110000 00001111111100 0112223344
Q ss_pred hhc-----CCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 589 HQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 589 H~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+++ +.+.++|+|+++.||+++++.-+-|.||+++..
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 332 335699999999999999998899999999875
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.0088 Score=62.31 Aligned_cols=147 Identities=16% Similarity=0.213 Sum_probs=98.1
Q ss_pred ccCHHhHHHhhcc---cccccccCcCCcccEEeeeccCCcEEEEEEccCCC---------c---------h----hHHHH
Q 003832 462 EFDFASIAKATDN---FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS---------G---------Q----GMEEF 516 (792)
Q Consensus 462 ~~~~~~i~~~~~~---~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~---------~---------~----~~~~~ 516 (792)
-+++-.|.....+ +...++||-|--+.||.+...+|++.++|.-+... + . ..-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3555555444332 56778999999999999999889999888543210 0 0 01134
Q ss_pred HHHHHHHHhcc-ccc-ceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCC
Q 003832 517 KNEVTLIARLQ-HRN-LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594 (792)
Q Consensus 517 ~~Ei~~l~~l~-H~n-iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 594 (792)
.+|...|+.+. |.. +.+.+++ +..++|||++.+-.|...-+ ..+.. .+...+..-+.-|..+|
T Consensus 158 ~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~---~ly~~lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPP---TLYDDLMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChH---HHHHHHHHHHHHHHHcC--
Confidence 56888888885 333 3334433 45678999998877754321 12222 33344444555666677
Q ss_pred CEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 595 RIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 595 ~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
+||+|..-=||+|++++.++++||--...
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQMVS 251 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechHhhc
Confidence 99999999999999999999999975543
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.0059 Score=50.06 Aligned_cols=49 Identities=14% Similarity=0.358 Sum_probs=33.8
Q ss_pred ecccCCCCCcchhccccchhhHhhhcCCCCcccccccccccCCCcceeeeecc
Q 003832 334 VKLKLPDTSSSWFNASMNLKECSELCSKNCSCTAYANSDVERGGSGCLLWFGD 386 (792)
Q Consensus 334 ~~~~~~~~~~~~~~~~~s~~~C~~~C~~~C~C~a~~~~~~~~~~~~C~~~~~~ 386 (792)
.++.++....... ...+.++|+..|+.+|+|.||.|.. +...|+++.+.
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 3444444333222 3568999999999999999999863 34578877653
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.099 Score=57.51 Aligned_cols=73 Identities=12% Similarity=0.103 Sum_probs=50.2
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCc-------hhHHHHHHHHHHHHhcc---cccceeeeeeEEeCCcceEE
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-------QGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV 547 (792)
.+.||.|....||+... +++.++||+-..... ...+.-..|++.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46899999999999886 456799998642111 13334445566666653 246777887776 557889
Q ss_pred EeecCC
Q 003832 548 YEYMPN 553 (792)
Q Consensus 548 ~e~~~~ 553 (792)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.34 E-value=0.14 Score=55.41 Aligned_cols=74 Identities=16% Similarity=0.198 Sum_probs=48.2
Q ss_pred ccCcCCcccEEeeeccCC-cEEEEEEccCC-------CchhHHHHHHHHHHHHhcc--cccceeeeeeEEeCCcceEEEe
Q 003832 480 KLGEGGFGPVYKGTLVEG-QEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~~~~-~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~e 549 (792)
.||.|....||++...++ +.|+||.-... .+-..+...-|.+.|.... -|..|+-+- +.+.....+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy-~~D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIF-HFDTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEE-EEccccceehHh
Confidence 689999999999998654 58999975311 1233455566777776663 354444332 234556678999
Q ss_pred ecCCC
Q 003832 550 YMPNK 554 (792)
Q Consensus 550 ~~~~g 554 (792)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.16 E-value=0.044 Score=55.21 Aligned_cols=30 Identities=33% Similarity=0.523 Sum_probs=21.7
Q ss_pred CEEecCCCCCcEEe-cCCCCceEeeeccccc
Q 003832 595 RIIHRDLKASNVLL-DNDMNPKISDFGMARI 624 (792)
Q Consensus 595 ~ivH~Dlkp~NIll-~~~~~~kl~DFgla~~ 624 (792)
.++|+||.+.||++ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8999999999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.16 Score=54.26 Aligned_cols=140 Identities=20% Similarity=0.210 Sum_probs=93.3
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCC-----Cch----h-------------HH----HHHHHHHHHHhcccccc
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG-----SGQ----G-------------ME----EFKNEVTLIARLQHRNL 531 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~-----~~~----~-------------~~----~~~~Ei~~l~~l~H~ni 531 (792)
..-|..|--.-||.+...+|..+|||+.+.. .+. + .+ =...|++.|.+|+.-.|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3468889999999999999999999987531 000 0 00 02357777777764332
Q ss_pred eeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC
Q 003832 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611 (792)
Q Consensus 532 v~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~ 611 (792)
.-.--.. -...+|||+|+.......- .-+...++...+..+-++++.-|.-|-+.+ .+||.||.--|+|+ .+
T Consensus 229 P~PePIl--Lk~hVLVM~FlGrdgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hd 300 (520)
T KOG2270|consen 229 PCPEPIL--LKNHVLVMEFLGRDGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HD 300 (520)
T ss_pred CCCCcee--eecceEeeeeccCCCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-EC
Confidence 1110000 1234789999964332111 113334666677888889999999998887 59999999999988 56
Q ss_pred CCceEeeecccccc
Q 003832 612 MNPKISDFGMARIF 625 (792)
Q Consensus 612 ~~~kl~DFgla~~~ 625 (792)
|.+.|+|-+-+...
T Consensus 301 G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 301 GKLYIIDVSQSVEH 314 (520)
T ss_pred CEEEEEEccccccC
Confidence 68899998876644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 792 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-51 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-50 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-39 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-39 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-33 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-24 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-24 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-24 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-24 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-24 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-24 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-24 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-24 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-24 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-24 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-24 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-23 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-23 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-23 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-22 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-22 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-22 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-22 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-21 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-21 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-21 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-20 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-18 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-17 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-17 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 6e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-17 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 9e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-15 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 7e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 421 bits (1085), Expect = e-143
Identities = 101/298 (33%), Positives = 149/298 (50%), Gaps = 17/298 (5%)
Query: 463 FDFASIAKATDNF------ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQG 512
F F + T+NF NK+GEGGFG VYKG + +AVK+L+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
++F E+ ++A+ QH NLV+LLG D+ L+Y YMPN SL + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I G A GI +LH++ IHRD+K++N+LLD KISDFG+AR
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692
T ++VGT YM+PE G + KSD++SFGV++LEI++G LL
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIK 247
Query: 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750
+ E++ +E D + T V V C+ + RP++ V +L +
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-139
Identities = 121/297 (40%), Positives = 173/297 (58%), Gaps = 11/297 (3%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGME-EFKNEVT 521
F + A+DNF++ N LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGG 580
+I+ HRNL++L G C+ E +L+Y YM N S+ + ++ + LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KV 637
ARG+ YLH +IIHRD+KA+N+LLD + + DFG+A++ +TH V
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK----DTHVTTAV 195
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP--DHDHNLLGHAWIL 695
GT G+++PEY + G S K+DVF +GV++LE+++G++ + + D D LL L
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255
Query: 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLL 752
KEK+ L L ++ EV + I V LLC Q P +RP MS VV ML D L
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 366 bits (942), Expect = e-121
Identities = 104/297 (35%), Positives = 161/297 (54%), Gaps = 10/297 (3%)
Query: 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL 522
+ +AT+NF +G G FG VYKG L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-LDWQKRIHIVGGI 581
++ +H +LV L+G C + +E +LIY+YM N +L ++ T + W++R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---KVV 638
ARG+ YLH + IIHRD+K+ N+LLD + PKI+DFG+++ + TH V
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD---QTHLSTVVK 202
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
GT GY+ PEY +G + KSDV+SFGV++ E++ + S P NL A
Sbjct: 203 GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN 262
Query: 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEP 755
+ ++ LAD P + + + C+ EDRP+M V+ L L E
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 290 bits (743), Expect = 8e-92
Identities = 68/319 (21%), Positives = 124/319 (38%), Gaps = 28/319 (8%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ 511
H + ++ + G FG V+K + + +AVK Q
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQ 61
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIYEYMPNKSLDFFIFDQARAT 567
+ + EV + ++H N+++ +G + + LI + SL F+ +A
Sbjct: 62 SWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KAN 116
Query: 568 FLDWQKRIHIVGGIARGILYLHQD-------SRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ W + HI +ARG+ YLH+D + I HRD+K+ NVLL N++ I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-----FSVKSDVFSFGVLVLEIVSGKK 675
+A F + +TH VGT YM+PE + ++ D+++ G+++ E+ S
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236
Query: 676 NWRFSHPDHDHNLLGHAWILWKEKRAMELAGD-----TLADSHPPTEVLRCI-HVGLLCV 729
++ + E+ L D + + C
Sbjct: 237 AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 730 QHRPEDRPNMSSVVLMLSS 748
H E R + V ++
Sbjct: 297 DHDAEARLSAGCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 3e-74
Identities = 66/330 (20%), Positives = 120/330 (36%), Gaps = 41/330 (12%)
Query: 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT 521
E + + DN +G G +G VYKG+L + + +AVK S + Q K +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIY 59
Query: 522 LIARLQHRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIH 576
+ ++H N+ + + + +L+ EY PN SL ++ DW
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCR 115
Query: 577 IVGGIARGILYLHQD------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG--- 627
+ + RG+ YLH + + I HRDL + NVL+ ND ISDFG++ G
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 628 ---DEIQTNTHKVVGTYGYMSPEYAAEGL-------FSVKSDVFSFGVLVLEIVSGKKNW 677
E VGT YM+PE + + D+++ G++ EI +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 678 RFSHPDHDHNLLGHAWILWKEKRAMELAGD--------TLADSHPPTEVLRCIHVGLL-- 727
++ + + ++ ++ + +
Sbjct: 236 FPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 728 CVQHRPEDRPNMSSVVLMLSSDSLLPEPNR 757
C E R ++ ++ E N+
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 1e-66
Identities = 77/305 (25%), Positives = 144/305 (47%), Gaps = 30/305 (9%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGME 514
D + + + + K+G G FG V++ G ++AVK L + + +
Sbjct: 28 DGDDMDIPWCDLNIK-------EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVN 79
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
EF EV ++ RL+H N+V +G Q ++ EY+ SL + LD ++R
Sbjct: 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRR 139
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ + +A+G+ YLH I+HR+LK+ N+L+D K+ DFG++R+ + + +
Sbjct: 140 LSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS 198
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694
GT +M+PE + + KSDV+SFGV++ E+ + ++ P + N
Sbjct: 199 --AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ------PWGNLNPAQVVAA 250
Query: 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS--DSLL 752
+ + + +E+ + +V I C + P RP+ ++++ +L S +
Sbjct: 251 VGFKCKRLEIPRNL------NPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAV 301
Query: 753 PEPNR 757
P PNR
Sbjct: 302 PPPNR 306
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 2e-64
Identities = 73/300 (24%), Positives = 117/300 (39%), Gaps = 41/300 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNE 519
F + + LG+G FG K T G+ + +K L + + F E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
V ++ L+H N++K +G + I EY+ +L I W +R+
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--YPWSQRVSFAK 115
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK--- 636
IA G+ YLH M IIHRDL + N L+ + N ++DFG+AR+ ++ Q +
Sbjct: 116 DIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLK 172
Query: 637 ---------VVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
VVG +M+PE + K DVFSFG+++ EI+ D D+
Sbjct: 173 KPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN------ADPDYL 226
Query: 688 LLGHAWIL-WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+ L + + P + C PE RP+ + L
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNC------PPSFFPIT---VRCCDLDPEKRPSFVKLEHWL 277
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 74/311 (23%), Positives = 124/311 (39%), Gaps = 33/311 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+G G FG V K +++A+K++ S + F E+ ++R+ H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ L+ EY SL + + + ++G+ YLH +IH
Sbjct: 71 LNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 599 RDLKASNVLLDNDMN-PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVK 657
RDLK N+LL KI DFG A +IQT+ G+ +M+PE +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 658 SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTE 717
DVFS+G+++ E+++ +K + + W + R L + P
Sbjct: 184 CDVFSWGIILWEVITRRKPF----DEIGGPAFRIMWAVHNGTR-PPLIKNL------PKP 232
Query: 718 VLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS-DSLLPEPNRPGFFTERSLPEAEFSPSYP 776
+ + C P RP+M +V +++ P + P L P
Sbjct: 233 IESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP-------LQYPCQHSLPP 282
Query: 777 QSSTTNEITIT 787
E +
Sbjct: 283 GEDGRVEPYVD 293
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 2e-61
Identities = 82/301 (27%), Positives = 136/301 (45%), Gaps = 43/301 (14%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQGMEE 515
L E DFA + +G GGFG VY+ G E+AVK Q +E
Sbjct: 1 LLEIDFAELTLE-------EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIEN 52
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
+ E L A L+H N++ L G C++ L+ E+ L+ + + +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILV 108
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMARIFGG 627
+ IARG+ YLH ++ + IIHRDLK+SN+L+ + KI+DFG+AR +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ G Y +M+PE +FS SDV+S+GVL+ E+++G+ P +
Sbjct: 169 TTKMSAA----GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGID 218
Query: 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
L A+ + K A+ + P + + C P RP+ ++++ L+
Sbjct: 219 GLAVAYGVAMNKLALPIPSTC------PEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
Query: 748 S 748
+
Sbjct: 270 T 270
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-60
Identities = 74/312 (23%), Positives = 141/312 (45%), Gaps = 33/312 (10%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAV 502
+KK ++ + WE I ++G G FG VYKG ++AV
Sbjct: 1 MKKGHHHHHHGSRDAADDWEIPDGQITVG-------QRIGSGSFGTVYKGKW--HGDVAV 51
Query: 503 KRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI 560
K L+ + Q ++ FKNEV ++ + +H N++ +G + ++ ++ SL +
Sbjct: 52 KMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHL 110
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
A T + +K I I ARG+ YLH IIHRDLK++N+ L D KI DFG
Sbjct: 111 --HASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 621 MARIFGGDEIQTNTHKVVGTYGYMSPE---YAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
+A ++ G+ +M+PE +S +SDV++FG+++ E+++G+ +
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
Query: 678 RFSHPDHDHNLLGHAWILWK-EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR 736
N+ I+ + ++ + + P + R + C++ + ++R
Sbjct: 226 S--------NINNRDQIIEMVGRGSLSPDLSKVRSNCPK-RMKRLM---AECLKKKRDER 273
Query: 737 PNMSSVVLMLSS 748
P+ ++ +
Sbjct: 274 PSFPRILAEIEE 285
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-60
Identities = 75/305 (24%), Positives = 142/305 (46%), Gaps = 45/305 (14%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG----- 512
L I ++G+GGFG V+KG LV+ +A+K L G +G
Sbjct: 12 RLPTLADNEIEYE-------KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 513 --MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+EF+ EV +++ L H N+VKL G ++ E++P L + D+A +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHP--IK 120
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARIF 625
W ++ ++ IA GI Y+ I+HRDL++ N+ L + + K++DFG+++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 626 GGDEIQTNTHKVVGTYGYMSPE--YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
+ + ++G + +M+PE A E ++ K+D +SF +++ I++G+ + +
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF----DE 230
Query: 684 HDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+ + + ++ +E + D P + I LC P+ RP+ S +V
Sbjct: 231 YSYGKIKFINMIREEGLRPTIPEDC------PPRLRNVIE---LCWSGDPKKRPHFSYIV 281
Query: 744 LMLSS 748
LS
Sbjct: 282 KELSE 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 9e-58
Identities = 75/323 (23%), Positives = 125/323 (38%), Gaps = 47/323 (14%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG 508
K S ++ W+ F + +G+G FG VY G E+A++ +
Sbjct: 16 RKASQTSIFLQEWDIPFEQLEIG-------ELIGKGRFGQVYHGRW--HGEVAIRLIDIE 66
Query: 509 --SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ ++ FK EV + +H N+V +G C+ +I ++L + +
Sbjct: 67 RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAK 124
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
LD K I I +G+ YLH I+H+DLK+ NV DN I+DFG+ I G
Sbjct: 125 IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGLFSISG 180
Query: 627 GDEIQTNTHK---VVGTYGYMSPE---------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ K G +++PE + FS SDVF+ G + E+ + +
Sbjct: 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
Query: 675 KNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPE 734
P W + + L+ E+ + L C E
Sbjct: 241 W------PFKTQPAEAIIWQMGTGMKP------NLSQIGMGKEISDIL---LFCWAFEQE 285
Query: 735 DRPNMSSVVLMLSSDSLLPEPNR 757
+RP + ++ ML LP+ NR
Sbjct: 286 ERPTFTKLMDMLEK---LPKRNR 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 60/280 (21%), Positives = 109/280 (38%), Gaps = 42/280 (15%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
KL E G ++KG +G +I VK L S + +F E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 537 CCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
C LI +MP SL + + +D + + +ARG+ +LH +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV-VDQSQAVKFALDMARGMAFLHTLEPL 133
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE---YAAE 651
I L + +V++D DM +IS + F + + +++PE E
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPE 185
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
+D++SF VL+ E+V+ + + + + ME+ +
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE-------------------VPFADLSNMEIGMKVALE 226
Query: 712 SHPPTEVLRCIHVGL-----LCVQHRPEDRPNMSSVVLML 746
P + I + +C+ P RP +V +L
Sbjct: 227 GLRP-TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 36/296 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G +G V++G+ +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + S LI Y SL +D + T LD + IV IA G+ +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A + +++ + VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD--HNLLGHAWILWK 697
PE + D+++FG+++ E+ + ++++ +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLL-----CVQHRPEDRPNMSSVVLMLSS 748
++ + + + P L C P R + L+
Sbjct: 246 MRKVVCVDQQRP--NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-50
Identities = 67/295 (22%), Positives = 121/295 (41%), Gaps = 34/295 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
++G+G +G V+ G G+++AVK + E + ++H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
I+ S LI +Y N SL +D ++T LD + + + G+ +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A F +E+ + VGT YM
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 646 PEYAAEGLFSV------KSDVFSFGVLVLEIVSGKKNWRFSHPDHD--HNLLGHAWILWK 697
PE E L +D++SFG+++ E+ + H+L+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274
Query: 698 EKRAMELAGD--TLADSHPPTEVLRCIHVGLL--CVQHRPEDRPNMSSVVLMLSS 748
+ + + + + E LR + L+ C H P R V L+
Sbjct: 275 MREIVCIKKLRPSFPNRWSSDECLRQM-GKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-49
Identities = 81/317 (25%), Positives = 133/317 (41%), Gaps = 38/317 (11%)
Query: 449 TKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVK 503
M ED + +F+ + +LG+G FG V G+ +AVK
Sbjct: 24 GAMGSAFEDRDPTQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVK 76
Query: 504 RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIF 561
+L + + + +F+ E+ ++ LQH N+VK G C A LI EY+P SL ++
Sbjct: 77 KLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL- 135
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
Q +D K + I +G+ YL R IHRDL N+L++N+ KI DFG+
Sbjct: 136 -QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGL 191
Query: 622 ARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN 676
++ D+ + V G + +PE E FSV SDV+SFGV++ E+ + +
Sbjct: 192 TKVLPQDK----EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEK 247
Query: 677 WRFSHPDHDHNLLGHAWILWKEKRAMEL--AGDTLADSHP---PTEVLRCIHVGLLCVQH 731
+ + + +EL L P P E+ + C +
Sbjct: 248 SKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPDGCPDEIYMIM---TECWNN 302
Query: 732 RPEDRPNMSSVVLMLSS 748
RP+ + L +
Sbjct: 303 NVNQRPSFRDLALRVDQ 319
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 38/305 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
+F+ + +LG+G FG V G+ +AVK+L + + + +
Sbjct: 5 TQFEERHLKFL-------QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 57
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ LQH N+VK G C A LI EY+P SL ++ Q +D K
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIK 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ I +G+ YL R IHRDL N+L++N+ KI DFG+ ++ D+
Sbjct: 116 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK---- 168
Query: 634 THKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
V G + +PE E FSV SDV+SFGV++ E+ + + + + +
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228
Query: 689 LGHAWILWKEKRAMEL--AGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+EL L P P E+ + C + RP+ +
Sbjct: 229 GNDKQGQMIVFHLIELLKNNGRL--PRPDGCPDEIYMIM---TECWNNNVNQRPSFRDLA 283
Query: 744 LMLSS 748
L +
Sbjct: 284 LRVDQ 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-48
Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNE--VTLIARLQHRNLVKLLG 536
+G+G FG V++G G+E+AVK S + + E + L+H N++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 537 CCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD- 591
+ + + L+ +Y + SL FD + + I + A G+ +LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 592 ----SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMS 645
+ I HRDLK+ N+L+ + I+D G+A D I + VGT YM+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSGKKNW----RFSHPDHDHNLLGHA--- 692
PE ++D+++ G++ EI + P +D +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 279
Query: 693 ---WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLL--CVQHRPEDRPNMSSVVLMLS 747
+ ++ R + + E LR + ++ C R + LS
Sbjct: 280 MRKVVCEQKLR------PNIPNRWQSCEALRVM-AKIMRECWYANGAARLTALRIKKTLS 332
Query: 748 S 748
Sbjct: 333 Q 333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-48
Identities = 81/329 (24%), Positives = 135/329 (41%), Gaps = 39/329 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSGQGMEE 515
F+ + ++LG+G FG V G +AVK+L +
Sbjct: 18 TIFEERHLKYI-------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD 70
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQK 573
F+ E+ ++ L +VK G L+ EY+P+ L F+ Q LD +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASR 128
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ I +G+ YL R +HRDL A N+L++++ + KI+DFG+A++ D+
Sbjct: 129 LLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---- 181
Query: 634 THKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687
+ VV G + +PE ++ +FS +SDV+SFGV++ E+ + K+ S
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 688 LLGHAWILWKEKRAMELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744
+ G L P P EV + LC P+DRP+ S++
Sbjct: 242 GCERDVPALSRLLELLEEGQRL--PAPPACPAEVHELM---KLCWAPSPQDRPSFSALGP 296
Query: 745 MLSSDSLLPEPNRPGFFTERSLPEAEFSP 773
L D L + PE +
Sbjct: 297 QL--DMLWSGSRGCETHAFTAHPEGKHHS 323
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-47
Identities = 79/305 (25%), Positives = 122/305 (40%), Gaps = 40/305 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F + K LGEG FG V G+ +AVK L +G Q
Sbjct: 26 TVFHKRYLKKI-------RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRS 78
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+K E+ ++ L H +++K GCC A + L+ EY+P SL ++ +
Sbjct: 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLA 134
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+ + I G+ YLH IHRDL A NVLLDND KI DFG+A+
Sbjct: 135 QLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--- 188
Query: 633 NTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686
+ V G + +PE E F SDV+SFGV + E+++ + +
Sbjct: 189 -EYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 687 NLLGHAWILWKEKRAMELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+ + + G+ L P P EV + C + RP +++
Sbjct: 248 IGIAQGQMTVLRLTELLERGERL--PRPDKCPAEVYHLM---KNCWETEASFRPTFENLI 302
Query: 744 LMLSS 748
+L +
Sbjct: 303 PILKT 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 73/239 (30%), Positives = 113/239 (47%), Gaps = 40/239 (16%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +++ +LGE FG VYKG L + Q +A+K L G
Sbjct: 2 KLKEISLSAVRFM-------EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGP 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF------------ 559
EEF++E L ARLQH N+V LLG + +I+ Y + L F
Sbjct: 55 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D+ + L+ +H+V IA G+ YL S ++H+DL NVL+ + +N KISD
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISD 171
Query: 619 FGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G+ R E+ + + +M+PE G FS+ SD++S+GV++ E+ S
Sbjct: 172 LGLFR-----EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-46
Identities = 69/319 (21%), Positives = 108/319 (33%), Gaps = 87/319 (27%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG-SGQGMEEFKN 518
W + + ++G G FG V+ G L + +AVK + +F
Sbjct: 109 WVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ 161
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ + H N+V+L+G C Q ++ E + F+ + L + + +V
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMV 219
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
G A G+ YL IHRDL A N L+ KISDFGM+R E +
Sbjct: 220 GDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAAS 271
Query: 639 GTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS-------GKKNWRFSHPDHDH 686
G +PE G +S +SDV+SFG+L+ E S N
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------- 321
Query: 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVG-----------------LLCV 729
+ + G C
Sbjct: 322 -----------------------------QQTREFVEKGGRLPCPELCPDAVFRLMEQCW 352
Query: 730 QHRPEDRPNMSSVVLMLSS 748
+ P RP+ S++ L S
Sbjct: 353 AYEPGQRPSFSTIYQELQS 371
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 70/305 (22%), Positives = 128/305 (41%), Gaps = 38/305 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGSG-QGME 514
F+ + + LGEG FG V G+++AVK L SG +
Sbjct: 16 THFEKRFLKRI-------RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIA 68
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADES--MLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ K E+ ++ L H N+VK G C + + LI E++P+ SL ++ ++ +
Sbjct: 69 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLK 126
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+++ I +G+ YL + +HRDL A NVL++++ KI DFG+ + D+
Sbjct: 127 QQLKYAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--- 180
Query: 633 NTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686
+ V + +PE + F + SDV+SFGV + E+++ +
Sbjct: 181 -EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 687 NLLGHAWILWKEKRAMELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
H + G L P P EV + + C + +P +R + +++
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRL--PCPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLI 294
Query: 744 LMLSS 748
+
Sbjct: 295 EGFEA 299
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-46
Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 39/243 (16%)
Query: 454 MKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSK 507
M + + I +LGEG FG V+ + +AVK L
Sbjct: 3 MHSGIHVQHIKRRDIVLK-------RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD 55
Query: 508 GSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------- 559
+ ++F+ E L+ LQH ++VK G C D ++++EYM + L+ F
Sbjct: 56 PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDA 115
Query: 560 -----IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ L + +HI IA G++YL + +HRDL N L+ ++
Sbjct: 116 MILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLV 172
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLE 669
KI DFGM+R ++ + + VG + +M PE F+ +SDV+SFGV++ E
Sbjct: 173 KIGDFGMSR-----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 227
Query: 670 IVS 672
I +
Sbjct: 228 IFT 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 7e-46
Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D + I +LGEG FG V+ + +AVK L + S
Sbjct: 32 DACVHHIKRRDIVLK-------WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF----------- 559
++F+ E L+ LQH+++V+ G C + ++++EYM + L+ F
Sbjct: 85 SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 560 -IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
+ L + + + +A G++YL + + +HRDL N L+ + KI D
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGD 201
Query: 619 FGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
FGM+R +I + + VG +M PE F+ +SDV+SFGV++ EI +
Sbjct: 202 FGMSR-----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 4e-45
Identities = 61/209 (29%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPE 647
R++HRDL A NVL+ + KI+DFG+A++ G +E + + G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS-GKK 675
+++ +SDV+S+GV V E+++ G K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-45
Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 24/218 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G +AVK L + + + +EEF E
Sbjct: 8 WEMERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 59
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 60 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 118
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH---- 635
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 119 QISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 636 -KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K + +PE A FS+KSDV++FGVL+ EI +
Sbjct: 176 IK------WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 7e-45
Identities = 61/217 (28%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W D + + ++G G FG V+ G + ++A+K + +G+ E+F E
Sbjct: 3 WVIDPSELTFV-------QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L H LV+L G C++ L+ E+M + L ++ + + + + +
Sbjct: 55 EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----- 635
+ G+ YL +IHRDL A N L+ + K+SDFGM R D+ ++T
Sbjct: 113 VCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K + SPE + +S KSDV+SFGVL+ E+ S
Sbjct: 170 K------WASPEVFSFSRYSSKSDVWSFGVLMWEVFS 200
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 9e-45
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV---EGQEI--AVKRLSKGSG-QGME 514
F + K LG G FG V+KG + E +I +K + SG Q +
Sbjct: 8 RIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+ + I L H ++V+LLG C L+ +Y+P SL + + L Q
Sbjct: 61 AVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHV--RQHRGALGPQLL 117
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
++ IA+G+ YL ++HR+L A NVLL + +++DFG+A + D+ Q
Sbjct: 118 LNWGVQIAKGMYYL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 635 HKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M+ E G ++ +SDV+S+GV V E+++
Sbjct: 175 SE-----AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE D + +LG G FG V G ++A+K + +GS +EF E
Sbjct: 19 WEIDPKDLTFL-------KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEA 70
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ L H LV+L G C + +I EYM N L ++ + Q+ + +
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKD 128
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH----- 635
+ + YL + +HRDL A N L+++ K+SDFG++R DE ++
Sbjct: 129 VCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + PE FS KSD+++FGVL+ EI S
Sbjct: 186 R------WSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 21/206 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + +F E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ YL +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYL---A 145
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSP 646
+ +HRDL A N +LD K++DFG+AR D + V G +M+
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-44
Identities = 86/354 (24%), Positives = 137/354 (38%), Gaps = 94/354 (26%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+ WE I + +LG+G FG VY+G +A+K +++ S +
Sbjct: 18 DEWEVAREKITMS-------RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR 70
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------IFDQA 564
EF NE +++ ++V+LLG Q +++I E M L + + +
Sbjct: 71 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
K I + G IA G+ YL + + +HRDL A N ++ D KI DFGM R
Sbjct: 131 VLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR- 186
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679
+I + G G MSPE +G+F+ SDV+SFGV++ EI
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA-------- 234
Query: 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADS----HPPTEVLRCIHVG---------- 725
TLA+ +VLR + G
Sbjct: 235 ----------------------------TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCP 266
Query: 726 -------LLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFT--ERSLPEAE 770
+C Q+ P+ RP+ ++ + + + P F+ E LPE E
Sbjct: 267 DMLFELMRMCWQYNPKMRPSFLEIISSI-KEEMEPGFREVSFYYSEENKLPEPE 319
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
E I +LG G FG V G ++AVK + +GS +EF E
Sbjct: 3 MELKREEITLL-------KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEA 54
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
+ +L H LVK G C + ++ EY+ N L ++ ++ L+ + + +
Sbjct: 55 QTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYD 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+ G+ +L + IHRDL A N L+D D+ K+SDFGM R D+ VGT
Sbjct: 113 VCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGT 165
Query: 641 ---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE +S KSDV++FG+L+ E+ S
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-44
Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 37/300 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNE 519
WE + I +KLG G +G VY+G +AVK L + + + +EEF E
Sbjct: 215 WEMERTDITMK-------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 266
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMAT 325
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + IHR+L A N L+ + K++DFG++R+ GD T
Sbjct: 326 QISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKF 381
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699
+ +PE A FS+KSDV++FGVL+ EI + +
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------------- 427
Query: 700 RAMEL--AGDTLADSHPPTEVLRCIH-VGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN 756
EL + P ++ + C Q P DRP+ + + +++ E +
Sbjct: 428 -VYELLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESS 481
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 32/219 (14%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 16 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 65
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 124
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + + T
Sbjct: 125 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST------- 170
Query: 640 TYG------YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE E FS KSDV+SFG+L+ EI S
Sbjct: 171 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-44
Identities = 62/240 (25%), Positives = 110/240 (45%), Gaps = 34/240 (14%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
++ +E D + LGEG FG V +G L ++AVK +
Sbjct: 20 EELQNKLEDVVIDRNLLILG-------KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL 72
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-----ESMLIYEYMPNKSLDFFI 560
S + +EEF +E + H N+++LLG CI+ + M+I +M L ++
Sbjct: 73 DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 561 ---FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ + Q + + IA G+ YL S +HRDL A N +L +DM ++
Sbjct: 133 LYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVA 189
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+++ +I + + G +++ E A+ +++ KSDV++FGV + EI +
Sbjct: 190 DFGLSK-----KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 7e-44
Identities = 70/214 (32%), Positives = 111/214 (51%), Gaps = 18/214 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ +LG G FG V+ G ++AVK L +GS + F E
Sbjct: 8 WEVPRETLKLV-------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEA 59
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
L+ +LQH+ LV+L Q + +I EYM N SL F+ + L K + +
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQ 117
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ ++ IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E T +
Sbjct: 118 IAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAK 171
Query: 641 YGY--MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE G F++KSDV+SFG+L+ EIV+
Sbjct: 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 8e-44
Identities = 88/359 (24%), Positives = 135/359 (37%), Gaps = 98/359 (27%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 23 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 75
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 76 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS 135
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 136 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 191
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679
+I ++ G M PE EG+F+ K+D +SFGVL+ EI
Sbjct: 192 ----DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF-------- 239
Query: 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADS----HPPTEVLRCIHVG---------- 725
+L EVL + G
Sbjct: 240 ----------------------------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 271
Query: 726 -------LLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPSYPQ 777
C QH+PEDRPN + ++ + + +P+ +LP E+ P +
Sbjct: 272 GPVYRIMTQCWQHQPEDRPNFAIILERI--EYCTQDPD----VINTALPI-EYGPLVEE 323
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-44
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + + +G+G FG V G G ++AVK + + + F E
Sbjct: 188 WALNMKELKLL-------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 237
Query: 521 TLIARLQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ ++ EYM SL ++ + R+ L +
Sbjct: 238 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSL 296
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + E +
Sbjct: 297 DVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 348
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE E FS KSDV+SFG+L+ EI S
Sbjct: 349 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 61/329 (18%), Positives = 119/329 (36%), Gaps = 66/329 (20%)
Query: 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--------VEGQEIAVKRLSKGSGQ 511
+ + LG+G F ++KG + E+ +K L K
Sbjct: 2 FHKIRNEDLIFN-------ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN 54
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDW 571
E F +++++L H++LV G C+ DE++L+ E++ SLD ++ + ++
Sbjct: 55 YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINI 112
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--------KISDFGMAR 623
++ + +A + +L +IH ++ A N+LL + + K+SD G++
Sbjct: 113 LWKLEVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
Query: 624 IFGGDEIQTNTHKVVGTYGY-----MSPEYAAEG-LFSVKSDVFSFGVLVLEIVS-GKKN 676
+ + PE ++ +D +SFG + EI S G K
Sbjct: 170 TVLPKD-----------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
Query: 677 WRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR 736
D K L + E+ I C+ + P+ R
Sbjct: 219 L----SALDSQ----------RKLQFYEDRHQL-PAPKAAELANLI---NNCMDYEPDHR 260
Query: 737 PNMSSVVLMLSSDSLLPEPNRPGFFTERS 765
P+ +++ L +SL P
Sbjct: 261 PSFRAIIRDL--NSLFTPDLVPRGSHHHH 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G+G FG VY G ++ + A+K LS+ + +E F E L+ L H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
L+G + + ++ YM + L FI ++ + I +ARG+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYL---A 141
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-------YMS 645
+ +HRDL A N +LD K++DFG+AR +I + V + + +
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLAR-----DILDREYYSVQQHRHARLPVKWTA 196
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 35/241 (14%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK 507
+KE +E LG+G FG V + L ++AVK L
Sbjct: 9 DELKEKLEDVLIPEQQFTLG-------RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 508 G--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES------MLIYEYMPNKSLDFF 559
+ +EEF E + H ++ KL+G +++ M+I +M + L F
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 560 IFD---QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616
+ L Q + + IA G+ YL S IHRDL A N +L DM +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178
Query: 617 SDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
+DFG++R +I + + G +++ E A+ L++V SDV++FGV + EI+
Sbjct: 179 ADFGLSR-----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
Query: 672 S 672
+
Sbjct: 234 T 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLV 532
LG G FG VYKG + E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+LLG C+ LI + MP L ++ + + Q ++ IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPE 647
R++HRDL A NVL+ + KI+DFG+A++ G +E + + G +M+ E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVS 672
+++ +SDV+S+GV V E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-43
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 18/214 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE S+ KLG G FG V+ T + ++AVK + GS +E F E
Sbjct: 183 WEIPRESLKLE-------KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEA 234
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ LQH LVKL + + +I E+M SL F+ + K I
Sbjct: 235 NVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQ 292
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ ++ + IHRDL+A+N+L+ + KI+DFG+AR+ +E T +
Sbjct: 293 IAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAK 346
Query: 641 YGY--MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +PE G F++KSDV+SFG+L++EIV+
Sbjct: 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-43
Identities = 88/359 (24%), Positives = 134/359 (37%), Gaps = 98/359 (27%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
+L E +I LG G FG VY+G + ++AVK L + S Q
Sbjct: 64 DLKEVPRKNITLI-------RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ 116
Query: 512 GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI----FDQARAT 567
+F E +I++ H+N+V+ +G +Q+ ++ E M L F+ ++ +
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
L +H+ IA G YL IHRD+ A N LL KI DFGMAR
Sbjct: 177 SLAMLDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR- 232
Query: 625 FGGDEIQTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679
+I + G M PE EG+F+ K+D +SFGVL+ EI
Sbjct: 233 ----DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF-------- 280
Query: 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADS----HPPTEVLRCIHVG---------- 725
+L EVL + G
Sbjct: 281 ----------------------------SLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCP 312
Query: 726 -------LLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPSYPQ 777
C QH+PEDRPN + ++ + + +P+ +LP E+ P +
Sbjct: 313 GPVYRIMTQCWQHQPEDRPNFAIILERI--EYCTQDPD----VINTALPI-EYGPLVEE 364
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 4e-43
Identities = 81/367 (22%), Positives = 140/367 (38%), Gaps = 104/367 (28%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE---IAVKRLSKG-SGQGME 514
D+ I + +GEG FG V K + + A+KR+ + S
Sbjct: 18 IYPVLDWNDIKFQ-------DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 70
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFF-------------I 560
+F E+ ++ +L H N++ LLG C L EY P+ +L F
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 561 FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620
+ A+ L Q+ +H +ARG+ YL S+ + IHRDL A N+L+ + KI+DFG
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFG 187
Query: 621 MARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
++R G E+ G +M+ E +++ SDV+S+GVL+ EIV
Sbjct: 188 LSR---GQEVYVKKTM-----GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV---- 235
Query: 676 NWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS----HPPTEVLRCIHVG------ 725
+L + E+ + G
Sbjct: 236 --------------------------------SLGGTPYCGMTCAELYEKLPQGYRLEKP 263
Query: 726 -----------LLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPS 774
C + +P +RP+ + +++ L + +L E + +L E +F+ +
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQILVSL--NRMLEERKT---YVNTTLYE-KFTYA 317
Query: 775 YPQSSTT 781
S
Sbjct: 318 GIDCSAE 324
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-43
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 21/206 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEG----QEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI + + I +A+G+ +L +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMAR-IFGGDEIQTNTHKVVGTYG-----YMSP 646
+ +HRDL A N +LD K++DFG+AR ++ + + T +M+
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK----TGAKLPVKWMAL 265
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVS 672
E F+ KSDV+SFGVL+ E+++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 63/224 (28%), Positives = 112/224 (50%), Gaps = 29/224 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGME 514
E + + + +G G FG VYKG L +A+K L G + +
Sbjct: 39 TEIHPSCVTRQ-------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV 91
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKR 574
+F E ++ + H N+++L G + M+I EYM N +LD F+ + + +
Sbjct: 92 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQL 149
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+ ++ GIA G+ YL + M +HRDL A N+L+++++ K+SDFG++R+ D T T
Sbjct: 150 VGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 635 HKVVGTYG------YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G + +PE + F+ SDV+SFG+++ E+++
Sbjct: 207 TS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 9e-43
Identities = 65/243 (26%), Positives = 104/243 (42%), Gaps = 42/243 (17%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-S 509
D WEF + LG G FG V + + +AVK L +G +
Sbjct: 18 DASKWEFPRDRLKLG-------KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 70
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSL-DF-------- 558
+E+ ++ + H N+V LLG C + M+I E+ +L +
Sbjct: 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 559 ----FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+ FL + I +A+G+ +L + + IHRDL A N+LL
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 187
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLE 669
KI DFG+AR +I + V +M+PE + +++++SDV+SFGVL+ E
Sbjct: 188 KICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWE 242
Query: 670 IVS 672
I S
Sbjct: 243 IFS 245
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 40/229 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
E + + I +G G G V G L +A+K L G + +
Sbjct: 44 REIEASRIHIE-------KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD 96
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E +++ + H N+++L G + +M++ EYM N SLD F+ + + +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLV 154
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ G+ G+ YL S + +HRDL A NVL+D+++ K+SDFG++R+ D
Sbjct: 155 GMLRGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP------ 205
Query: 636 KVVGTYGY------------MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+PE A FS SDV+SFGV++ E+++
Sbjct: 206 -----DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 43/240 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 30 WEFPRDKLTLG-------KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 82
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 83 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 200 DFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-42
Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 33/300 (11%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 177 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 228
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 286
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 287 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 343
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWK 697
+ +PE A G F++KSDV+SFG+L+ E+ + G+ + ++ +
Sbjct: 344 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------------GMVNR 388
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIH-VGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN 756
E G + P E +H + C + PE+RP + L EP
Sbjct: 389 EVLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 29/222 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 10 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 62
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLI 119
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R +
Sbjct: 120 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 636 -----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +M+PE F+ SDV+ FGV + EI+
Sbjct: 177 GKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEILM 212
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 60/227 (26%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 479 NKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNL 531
+GEG FG V++ +AVK L + S +F+ E L+A + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFF---------------------IFDQARATFLD 570
VKLLG C L++EYM L+ F L
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
+++ I +A G+ YL S + +HRDL N L+ +M KI+DFG++R I
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR-----NI 224
Query: 631 QTNTHKVVGTYGY-----MSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + M PE ++ +SDV+++GV++ EI S
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 4e-42
Identities = 81/354 (22%), Positives = 142/354 (40%), Gaps = 80/354 (22%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQE----IAVKRLSKGSG-QGMEE 515
E D +I+ +G G FG V G L + +A+K L G + +
Sbjct: 40 KELDATNISID-------KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E +++ + H N+++L G ++ M++ EYM N SLD F+ + + +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLV 150
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ GIA G+ YL S M +HRDL A N+L+++++ K+SDFG+ R+ D +
Sbjct: 151 GMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP--EAAY 205
Query: 636 KVVGT---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691
G + SPE A F+ SDV+S+G+++ E++S G++ + + +
Sbjct: 206 TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQ---- 257
Query: 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVG-----------------LLCVQHRPE 734
+V++ + G L C Q
Sbjct: 258 -------------------------DVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRN 292
Query: 735 DRPNMSSVVLMLSSDSLLPEPNR----PGFFTERSLPEAEFS-PSYPQSSTTNE 783
+RP +V +L D L+ P S + S TT +
Sbjct: 293 NRPKFEQIVSIL--DKLIRNPGSLKIITSAAARPSNLLLDQSNVDITTFRTTGD 344
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-42
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 480 KLGEGGFGPVYKGTLVEGQE---IAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G ++ +A+K L +G+ EE E ++ +L + +V+L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEG 652
+HRDL A NVLL N KISDFG+++ G D+ + +PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 188
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
FS +SDV+S+GV + E +S
Sbjct: 189 KFSSRSDVWSYGVTMWEALS 208
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-42
Identities = 68/246 (27%), Positives = 107/246 (43%), Gaps = 50/246 (20%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LGEG FG V K T +AVK L + S +
Sbjct: 18 WEFPRKNLVLG-------KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSEL 70
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF-------------- 558
+ +E ++ ++ H +++KL G C Q +LI EY SL F
Sbjct: 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS 130
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
D L I I++G+ YL + M+++HRDL A N+L+
Sbjct: 131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGR 187
Query: 613 NPKISDFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KISDFG++R ++ D + K +M+ E + +++ +SDV+SFGVL
Sbjct: 188 KMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVL 241
Query: 667 VLEIVS 672
+ EIV+
Sbjct: 242 LWEIVT 247
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-42
Identities = 65/240 (27%), Positives = 111/240 (46%), Gaps = 43/240 (17%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WEF + LGEG FG V V E +AVK L + +
Sbjct: 76 WEFPRDKLTLG-------KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK 128
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 129 DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 188
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ ++ + ++ + +ARG+ YL + + IHRDL A NVL+ + KI+
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI +
Sbjct: 246 DFGLAR-----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-41
Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 33/300 (11%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN 518
+ WE S+ KLG+G FG V+ GT +A+K L G+ E F
Sbjct: 260 DAWEIPRESLRLE-------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQ 311
Query: 519 EVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
E ++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMA 369
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
IA G+ Y+ RM +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 370 AQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWK 697
+ +PE A G F++KSDV+SFG+L+ E+ + G+ + ++ +
Sbjct: 427 -PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--------------GMVNR 471
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIH-VGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN 756
E G + P E +H + C + PE+RP + L EP
Sbjct: 472 EVLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 29/222 (13%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+ + LGEG FG VY+G +G++I AVK K + E+
Sbjct: 7 YGIAREDVVLN-------RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 59
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F +E ++ L H ++VKL+G + + + +I E P L ++ + L +
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL--ERNKNSLKVLTLV 116
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I + + YL + +HRD+ N+L+ + K+ DFG++R ++ +
Sbjct: 117 LYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 636 -----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K +MSPE F+ SDV+ F V + EI+S
Sbjct: 174 TRLPIK------WMSPESINFRRFTTASDVWMFAVCMWEILS 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-41
Identities = 58/222 (26%), Positives = 88/222 (39%), Gaps = 25/222 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL--VEGQEI--AVKRLSKG---SGQGM 513
+ KLG+G FG V +G G+ + AVK L + M
Sbjct: 13 CLIGEKDLRLL-------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAM 65
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++F EV + L HRNL++L G + ++ E P SL + +
Sbjct: 66 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL--RKHQGHFLLGT 122
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+A G+ YL R IHRDL A N+LL KI DFG+ R ++
Sbjct: 123 LSRYAVQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 634 THKVVGT---YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ + + +PE FS SD + FGV + E+ +
Sbjct: 180 MQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 66/238 (27%), Positives = 106/238 (44%), Gaps = 39/238 (16%)
Query: 459 ELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQ 511
E WEF ++ LG G FG V + T ++AVK L
Sbjct: 39 EKWEFPRNNLQFG-------KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHAD 91
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-----------DFF 559
E +E+ +++ L QH N+V LLG C ++I EY L +
Sbjct: 92 EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD 151
Query: 560 IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
+ + +H +A+G+ +L + IHRD+ A NVLL N KI DF
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDF 208
Query: 620 GMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
G+AR +I +++ +V +M+PE + +++V+SDV+S+G+L+ EI S
Sbjct: 209 GLAR-----DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-41
Identities = 81/371 (21%), Positives = 131/371 (35%), Gaps = 106/371 (28%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKG-SGQ 511
WE + LGEG FG V + ++AVK L + +
Sbjct: 64 WELPRDRLVLG-------KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 116
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF----------- 558
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++
Sbjct: 117 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 559 -FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ L + + +ARG+ YL + + IHRDL A NVL+ D KI+
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIA 233
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
DFG+AR +I + T G +M+PE + +++ +SDV+SFGVL+ EI
Sbjct: 234 DFGLAR-----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF- 287
Query: 673 GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS----HPPTEVLRCIHVG--- 725
TL S P E+ + + G
Sbjct: 288 -----------------------------------TLGGSPYPGVPVEELFKLLKEGHRM 312
Query: 726 --------------LLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFFTERSLPEAEF 771
C P RP +V L D ++ + E
Sbjct: 313 DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL--DRIVALTS----NQEMGYYHHHH 366
Query: 772 SPSYPQSSTTN 782
Y +T N
Sbjct: 367 HHDYDIPTTEN 377
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 7e-41
Identities = 61/241 (25%), Positives = 97/241 (40%), Gaps = 45/241 (18%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V + T +AVK L
Sbjct: 18 WEFPRNRLSFG-------KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER 70
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL---------------D 557
E +E+ +++ L H N+V LLG C +++I EY L
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 558 FFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
+ LD + + +A+G+ +L + IHRDL A N+LL + KI
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKIC 187
Query: 618 DFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
DFG+AR I + K +M+PE +++ +SDV+S+G+ + E+
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVK------WMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 672 S 672
S
Sbjct: 242 S 242
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 23/204 (11%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKL 534
+LG G FG V KG ++ AVK L +E E ++ +L + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYL---EES 136
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG------YMSPEY 648
+HRDL A NVLL KISDFG+++ DE + +PE
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVS 672
FS KSDV+SFGVL+ E S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 65/246 (26%), Positives = 105/246 (42%), Gaps = 50/246 (20%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGM 513
WEF ++ LG G FG V T ++AVK L +
Sbjct: 40 WEFPRENLEFG-------KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 92
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSL-DF------------- 558
E +E+ ++ +L H N+V LLG C + LI+EY L ++
Sbjct: 93 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152
Query: 559 ------FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
+ ++ L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGK 209
Query: 613 NPKISDFGMAR-IFGGDEIQTNTH-----KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KI DFG+AR I + K +M+PE EG++++KSDV+S+G+L
Sbjct: 210 VVKICDFGLARDIMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGIL 263
Query: 667 VLEIVS 672
+ EI S
Sbjct: 264 LWEIFS 269
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 5e-40
Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 19/217 (8%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV--EGQEI--AVKRLSKG-SGQGMEE 515
+E I +GEG FG V++G + E + A+K S E+
Sbjct: 385 YEIQRERIELG-------RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ Q R LD I
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL--QVRKFSLDLASLI 494
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R +
Sbjct: 495 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+ +M+PE F+ SDV+ FGV + EI+
Sbjct: 552 GKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-39
Identities = 73/341 (21%), Positives = 136/341 (39%), Gaps = 55/341 (16%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-----LDW--QKRIHIVGGIA 582
N+V+ + ++ +Y L I Q F LDW Q I
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ--------IC 135
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
+ ++H +I+HRD+K+ N+ L D ++ DFG+AR+ +GT
Sbjct: 136 LALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPY 190
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702
Y+SPE ++ KSD+++ G ++ E+ + K H ++
Sbjct: 191 YLSPEICENKPYNNKSDIWALGCVLYELCTLK------HAFEAGSM-------------K 231
Query: 703 ELAGDTLADSHPP-----TEVLRCIHVGLLCVQHRPEDRPNMSSV----VLMLSSDSLLP 753
L ++ S PP + LR + L P DRP+++S+ + + L
Sbjct: 232 NLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRN--PRDRPSVNSILEKGFIAKRIEKFLS 289
Query: 754 EPNRPGFFTERSLPEAEFSPSYPQ--SSTTNEITITELQGR 792
F ++ + P + +S N I++ Q
Sbjct: 290 PQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQKI 330
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-39
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 480 KLGEGGFGPVYKGTL-VEGQEI--AVKRLSKGSGQGM-EEFKNEVTLIARLQHRNLVKLL 535
+LG G FG V +G + ++I A+K L +G+ + EE E ++ +L + +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
G C QA+ ML+ E L F+ + + ++ ++ G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT---YGYMSPEYAAEG 652
+HR+L A NVLL N KISDFG+++ G D+ + +PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514
Query: 653 LFSVKSDVFSFGVLVLEIVS 672
FS +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 57/220 (25%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+F +G GGFG V+K ++G+ +KR+ + E+ + EV +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 532 VKLLGCCIQADESM----------------LIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
V GC D + E+ +L+ +I ++ R LD +
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
+ I +G+ Y+H ++I+RDLK SN+ L + KI DFG+ D +T
Sbjct: 126 ELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675
+ GT YMSPE + + + D+++ G+++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-39
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 27/222 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
+F LG GGFG V++ V+ A+KR+ E+ EV +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 531 LVKLLGCCI---------QADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V+ + + + +Y + ++L ++ + + +HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH--- 635
IA + +LH ++HRDLK SN+ D K+ DFG+ DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 636 -------KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEI 670
VGT YMSPE +S K D+FS G+++ E+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-38
Identities = 67/311 (21%), Positives = 119/311 (38%), Gaps = 44/311 (14%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
NF K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGILY 587
N++K I+ +E ++ E L I + + + + + +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+H R++HRD+K +NV + K+ D G+ R F ++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
E ++ KSD++S G L+ E+ + + + + L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----------------YSLCKK 249
Query: 708 TLADSHPP------TEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFF 761
+PP +E LR + +C+ PE RP + R
Sbjct: 250 IEQCDYPPLPSDHYSEELR--QLVNMCINPDPEKRP---------DVTYVYDVAKRMHAC 298
Query: 762 TERSLPEAEFS 772
T SL
Sbjct: 299 TASSLEHHHHH 309
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 72/269 (26%), Positives = 115/269 (42%), Gaps = 39/269 (14%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
LG+G +G VY G L IA+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSRMR 595
+ + E +P S + R+ + + +G + IL YLH +
Sbjct: 90 ENGFIKIFMEQVPGGS----LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQ 142
Query: 596 IIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE---YAAE 651
I+HRD+K NVL++ KISDFG ++ G T T GT YM+PE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPR 200
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
G + +D++S G ++E+ +GK P ++ LG AM G +
Sbjct: 201 G-YGKAADIWSLGCTIIEMATGK------PPFYE---LGEPQ------AAMFKVG--MFK 242
Query: 712 SHPPT-EVL--RCIHVGLLCVQHRPEDRP 737
HP E + L C + P+ R
Sbjct: 243 VHPEIPESMSAEAKAFILKCFEPDPDKRA 271
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 17/211 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
++G G F VYKG E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 537 CCIQADESM----LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+ L+ E M + +L ++ R + + I +G+ +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 593 RMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
IIHRDLK N+ + + KI D G+A + + V+GT +M+PE E
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEMYEE 204
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ DV++FG+ +LE+ + + +
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQN 234
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 10/210 (4%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K +G+ + K L G + + +EV L+ L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H+ D ++HRDLK +NV LD N K+ DFG+ARI D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
SPE ++ KSD++S G L+ E+ +
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 55/243 (22%), Positives = 96/243 (39%), Gaps = 34/243 (13%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+F LG+G FG V K ++ + A+K++ + + +EV L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFI---------FD--QARATFLDWQKRIHIVG 579
+V+ ++ + + KS F +D + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF------------GG 627
I + Y+H IIHRDLK N+ +D N KI DFG+A+
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 628 DEIQTNTHKVVGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
N +GT Y++ E G ++ K D++S G++ E++ FS
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-----FSTGMERV 235
Query: 687 NLL 689
N+L
Sbjct: 236 NIL 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 146
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-35
Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 23/211 (10%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNL--VKL 534
++G GG V++ + Q A+K ++ Q ++ ++NE+ + +LQ + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 535 LGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
I ++ E N L+ ++ + +D +R + + +HQ
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQ---H 174
Query: 595 RIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE------- 647
I+H DLK +N L+ + K+ DFG+A D VG YM PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
++ S KSDV+S G ++ + GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 64/284 (22%), Positives = 114/284 (40%), Gaps = 43/284 (15%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLGEGGF V L +G A+KR+ Q EE + E + H N+++L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 539 IQADESM----LIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++ + L+ + +L + + + FL + + ++ GI RG+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMAR-----IFGGDEIQTNTH--KVVGTYGYMSP 646
HRDLK +N+LL ++ P + D G + G + T T Y +P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 647 EYAAEGLFSV--------KSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698
E LFSV ++DV+S G ++ ++ G+ P G +
Sbjct: 213 E-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE------GPYDMVFQKGDS------ 255
Query: 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
++ S + L + ++ V P RP++ +
Sbjct: 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLL 297
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 25/228 (10%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
I+HR++K N++ D K++DFG AR DE + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYE 188
Query: 648 -----YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR-FSHPDHDHNLL 689
+ + D++S GV +G +R F P + ++
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 47/212 (22%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
LG+G V++G + G A+K + S + E ++ +L H+N+VKL
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 538 CIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+ + E+ P SL + + + A L + + ++ + G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 595 RIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
I+HR++K N++ D K++DFG AR DE + GT Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYE 188
Query: 648 -----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + D++S GV +G
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 59/236 (25%), Positives = 109/236 (46%), Gaps = 12/236 (5%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQ 498
+ ++H + L SY K+GEG G V G+
Sbjct: 14 GTENLYFQSGVVTHEQFKAALRMV--VDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR 71
Query: 499 EIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
++AVK + Q E NEV ++ QH N+V++ + +E ++ E++ +L
Sbjct: 72 QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT- 130
Query: 559 FIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618
D L+ ++ + + + + YLH +IHRD+K+ ++LL D K+SD
Sbjct: 131 ---DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
FG D + + +VGT +M+PE + L++ + D++S G++V+E+V G+
Sbjct: 185 FGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/204 (26%), Positives = 105/204 (51%), Gaps = 10/204 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+G+G G VY V GQE+A+++++ E NE+ ++ ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+V L + DE ++ EY+ SL D T +D + + + + +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVT 189
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+ K D++S G++ +E++ G+
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 28/216 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QH 528
+F ++LG G +G V+K +G+ AVKR + EV ++ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 529 RNLVKLLGCCIQADESMLIY-EYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGI 581
V+L + + + E SL +A+
Sbjct: 117 PCCVRLEQA-WEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD--------T 166
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ +LH ++H D+K +N+ L K+ DFG+ G G
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDP 220
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
YM+PE + +DVFS G+ +LE+ +
Sbjct: 221 RYMAPELLQGS-YGTAADVFSLGLTILEVACNMELP 255
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 479 NKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFK-NEVTLIARLQHRNLVKLLG 536
++G G FG V++ G + AVK++ +E F+ E+ A L +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYG 117
Query: 537 CCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + E + SL + RA ++ +G G+ YLH
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT- 168
Query: 592 SRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHK---VVGTYGYMSPE 647
RI+H D+KA NVLL +D + + DFG A D + + + GT +M+PE
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
K D++S ++L +++G W
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH++
Sbjct: 109 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHRN- 160
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV-GTYGYMSPEYAAE 651
R+IHRDLK N+ L+ D+ KI DFG+A D KV+ GT Y++PE ++
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG---ERKKVLCGTPNYIAPEVLSK 215
Query: 652 GLFSVKSDVFSFGVLVLEIVSGK 674
S + DV+S G ++ ++ GK
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG GG VY + ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ D L+ EY+ +L +I L I+ I GI + H MR
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
I+HRD+K N+L+D++ KI DFG+A+ + T T+ V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATD 190
Query: 656 VKSDVFSFGVLVLEIVSGK 674
+D++S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 66/327 (20%), Positives = 111/327 (33%), Gaps = 52/327 (15%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
L EGGF VY+ + G+E A+KRL + EV + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 538 CIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
E L+ + L F+ L + I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK----------VVGT 640
+ IIHRDLK N+LL N K+ DFG A + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 641 YGYMSPEYAAEGLFSV--------KSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692
Y +PE + + K D+++ G ++ + + HP D L
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDGAKL--- 259
Query: 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLL 752
+ ++ V + +L V PE+R +++ VV L +
Sbjct: 260 --------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQLQEIAAA 309
Query: 753 PEPNRPGFFTERSLPEAEFSPSYPQSS 779
N TE + +
Sbjct: 310 RNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQ 527
+ + +LG GGFG V + + G+++A+K+ + E + E+ ++ +L
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 528 HRNLVKLL------GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
H N+V D +L EY L ++ L ++ I
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + YLH+ RIIHRDLK N++L + KI D G A+ E + V
Sbjct: 131 SSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT Y++PE + ++V D +SFG L E ++G
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+GGF ++ + + + A K + K E E+++ L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D ++ E +SL + + R + + R + + I G YLH
Sbjct: 83 FF--EDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH--- 132
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
R R+IHRDLK N+ L+ D+ KI DFG+A D + + GT Y++PE ++
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKK 190
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
S + DV+S G ++ ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 28/227 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
D+ +LG G +G V K V GQ +AVKR+ + + Q + ++ + R
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
V G + + + E M + SLD F +D + I I+G IA I+
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+LH S++ +IHRD+K SNVL++ K+ DFG++ D++ + G Y
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGCKPY 175
Query: 644 MSPE----YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
M+PE + +SVKSD++S G+ ++E+ RF +
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAIL----RFPYDSWGT 218
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-31
Identities = 61/311 (19%), Positives = 118/311 (37%), Gaps = 56/311 (18%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++D E + K +F + LG G G + + + +++AVKR+ +
Sbjct: 6 SLEQDDGDEETSVVIVGK--ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---EC 60
Query: 513 MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARATFL 569
EV L+ +H N+++ C + D + E +L ++ + +
Sbjct: 61 FSFADREVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624
+ I ++ G+ +LH + I+HRDLK N+L+ + ISDFG+ +
Sbjct: 116 LGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 625 FGGDEIQTNTHK-VVGTYGYMSPEY---AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680
+ V GT G+++PE + + D+FS G + ++S
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS----- 227
Query: 681 HPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTE---------VLRCIHVGLLCVQH 731
HP +++A L G D P + + + I +
Sbjct: 228 HPFGKSL----------QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAM------- 270
Query: 732 RPEDRPNMSSV 742
P+ RP+ V
Sbjct: 271 DPQKRPSAKHV 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 72/333 (21%), Positives = 127/333 (38%), Gaps = 51/333 (15%)
Query: 441 KKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQE 499
KKL++ L + + + L + K D F ++LG G G V+K + G
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQKVGELKDDD-FEKISELGAGNGGVVFKVSHKPSGLV 60
Query: 500 IAVKRLS-KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDF 558
+A K + + + E+ ++ +V G E + E+M SLD
Sbjct: 61 MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD- 119
Query: 559 FIFDQARATFLDWQKRI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDM 612
L RI I+G ++ ++ YL + +I+HRD+K SN+L+++
Sbjct: 120 --------QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRG 169
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
K+ DFG++ G I + + VGT YMSPE +SV+SD++S G+ ++E+
Sbjct: 170 EIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225
Query: 673 GK---------KNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCI- 722
G+ + + + R + G E+L I
Sbjct: 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIV 285
Query: 723 --HVGLL---------------CVQHRPEDRPN 738
L C+ P +R +
Sbjct: 286 NEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 62/202 (30%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G F VY+ + G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 537 CCIQADESM--LIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDS 592
D + L+ E N + + R + H + I G+LYLH
Sbjct: 79 YF--EDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
I+HRDL SN+LL +MN KI+DFG+A + T + GT Y+SPE A
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRS 187
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
++SDV+S G + ++ G+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ F KLGEG +G VYK E GQ +A+K++ ++E E++++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + ++ EY S+ I + R L + I+ +G+ YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
MR IHRD+KA N+LL+ + + K++DFG+A + NT V+GT +M+PE
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
E ++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 536 GCCIQADESMLIY----EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + EY+ +L + + + ++ I ++ + + + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH-- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAA 650
+ IIHRD+K +N+++ K+ DFG+AR T T V+GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
+SDV+S G ++ E+++G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-30
Identities = 54/313 (17%), Positives = 103/313 (32%), Gaps = 54/313 (17%)
Query: 480 KLGEGGFGPVYKG--TLVEGQEIAVKRL-SKGSGQGMEEFKNEVTLIARLQHRNLVKLL- 535
+ GG G +Y V G+ + +K L G + E +A + H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 536 -GCCIQADESMLIY---EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ Y EY+ +SL +++ L + I + I + YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH-- 199
Query: 592 SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
+ +++ DLK N++L + K+ D G + + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEI-VR 250
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
+V +D+++ G + + + D D +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------------------DPVLK 292
Query: 712 SHPPTE--VLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS-DSLLPEPNRPGFFTERSLPE 768
++ + R I P R ++ M + +L E R
Sbjct: 293 TYDSYGRLLRRAID-------PDPRQRF--TTAEEMSAQLTGVLREVVAQDTGVPRPGLS 343
Query: 769 AEFSPSYPQSSTT 781
FSPS
Sbjct: 344 TIFSPSRSTFGVD 356
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGMEEFKNEVTLIARL-QHR 529
++ ++G G +G V K GQ +AVKR+ S + ++ ++ ++ R
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI--HIVGGIARGIL- 586
+V+ G + + + E M + S D F + + I I+G I +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFY----KYVYSVLDDVIPEEILGKITLATVK 136
Query: 587 ---YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+L ++IIHRD+K SN+LLD N K+ DFG++ +T G Y
Sbjct: 137 ALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPY 191
Query: 644 MSPE----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
M+PE A+ + V+SDV+S G+ + E+ +G+
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 54/209 (25%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLLG + ++ E+ P ++D I + + Q ++ + + + +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE--- 647
RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 ---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 648 --YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 59/205 (28%), Positives = 105/205 (51%), Gaps = 11/205 (5%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHR 529
+ F K+G+G FG V+KG + +A+K + + +E+ + E+T++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
+ K G ++ + +I EY+ S D LD + I+ I +G+ YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLH 136
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+ IHRD+KA+NVLL K++DFG+A +I+ NT VGT +M+PE
Sbjct: 137 ---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 191
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + K+D++S G+ +E+ G+
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGE 216
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-30
Identities = 42/225 (18%), Positives = 71/225 (31%), Gaps = 28/225 (12%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
+ ++ LGEG F VY+ T Q+ +K + EF L+ R
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMER 120
Query: 526 LQ---HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF--LDWQKRIHIVGG 580
L+ +K + + S+L+ E +L I + I
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----------KISDFGMARIFGGDE 629
+ I +H IIH D+K N +L N + D G +
Sbjct: 181 MLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T T G+ E + ++ + D F V ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 7e-30
Identities = 35/298 (11%), Positives = 67/298 (22%), Gaps = 51/298 (17%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
L G V+ VE ++ A+K + S +E ARL + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 537 CC--------------------------IQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+L+ F F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 569 -LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ + R L ++H N+ + D + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 628 DEIQTNTHKVVGTYGYMSPEY--AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
T Y E+ A+ F+ + + G+ + + + P
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+W + + + + P V I L R +
Sbjct: 302 -----GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG-RFL--NFDRRRRLLPLEAM 351
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 57/223 (25%), Positives = 98/223 (43%), Gaps = 39/223 (17%)
Query: 480 KLGEGGFGPVYKGTLVE--GQEIAVKRLSK----------------GSGQGMEE-FKNEV 520
L +G F + L E + A+K+ K S + + FKNE+
Sbjct: 38 TLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94
Query: 521 TLIARLQHRNLVKLLGCCIQADESM--LIYEYMPNKSL-----DFFIFDQARATFLDWQK 573
+I +++ + G I + +IYEYM N S+ FF+ D+ F+ Q
Sbjct: 95 QIITDIKNEYCLTCEG--IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I+ + Y+H + I HRD+K SN+L+D + K+SDFG + +I+
Sbjct: 153 IKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG- 209
Query: 634 THKVVGTYGYMSPE-YAAEGLFS-VKSDVFSFGVLVLEIVSGK 674
GTY +M PE ++ E ++ K D++S G+ + +
Sbjct: 210 ---SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 529 RNLVKLLGCCIQADES--MLIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGI 581
N+++L G D + LI EY P ++ + FD+ R + +
Sbjct: 69 PNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE--------L 118
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A + Y H R+IHRD+K N+LL + KI+DFG + + GT
Sbjct: 119 ANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTL 171
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y+ PE + K D++S GVL E + GK
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 53/237 (22%), Positives = 89/237 (37%), Gaps = 36/237 (15%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKR--LSKGSGQGMEEFKNEVTLIARL-Q 527
T F K+G G FG V+K ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 528 HRNLVKLLGCCIQADESMLIY-EYMPNKSLDFFIFDQARA-TFLDWQKRIHIVGGIARGI 585
H ++V+ + D+ MLI EY SL I + R ++ + ++ + RG+
Sbjct: 70 HSHVVRYFSAWAE-DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP-------------------KISDFGMARIFG 626
Y+H M ++H D+K SN+ + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
++ G +++ E E K+D+F+ + V+ + R
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 45/342 (13%), Positives = 92/342 (26%), Gaps = 76/342 (22%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH-------- 528
LG+ + T G+ V +++ K EV + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 529 --------RNLVKLLGCC-----IQADESMLIYEY---MPNKSLDFF-----IFDQARAT 567
+LVK + M + P + + +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 568 -FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681
G + + + L + D ++ G+ + I
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------L 315
Query: 682 PDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSS 741
P+ D LG + +++ + + P V + G L ++ EDR
Sbjct: 316 PNTDDAALGGSEWIFRSCK------------NIPQPVRALLE-GFL--RYPKEDRLLPLQ 360
Query: 742 VVLMLSSDSLLPEPNRPGFFTERSLPEAEFSPSYPQSSTTNE 783
+ P + R+ A T E
Sbjct: 361 AM------------ETPEYEQLRTELSAALPLYQTDGEPTRE 390
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 54/186 (29%), Positives = 95/186 (51%), Gaps = 26/186 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+NF K+GEG +G VYK + G+ +A+K++ ++ E++L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSLDFFIFDQARATFLDWQKRIHIVGGI 581
L H N+VKLL ++ L++E++ K D + T + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+G+ + H R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV T
Sbjct: 113 LQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TL 167
Query: 642 GYMSPE 647
Y +PE
Sbjct: 168 WYRAPE 173
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-29
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 36/229 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNL 531
+ S LG G G V +G+ +AVKR+ + E+ L+ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFFI----FDQARATFLDWQKRIHIVGGIARGIL 586
++ C D + + E N +L + I ++ IA G+
Sbjct: 72 IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDN-------------DMNPKISDFGMARIFGGDE--IQ 631
+LH ++IIHRDLK N+L+ ++ ISDFG+ + + +
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 632 TNTHKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSG 673
TN + GT G+ +PE + + D+FS G + I+S
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 54/188 (28%), Positives = 94/188 (50%), Gaps = 32/188 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK +G+ +A+KR+ ++ E++L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L H N+V L+ L++E+M K LD ++ +Q
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQ------- 127
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ + H + RI+HRDLK N+L+++D K++DFG+AR F G +++ TH+VV
Sbjct: 128 -LLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV- 181
Query: 640 TYGYMSPE 647
T Y +P+
Sbjct: 182 TLWYRAPD 189
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 17/202 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQHRNLVKL- 534
+G GG G VY+ V + +A+K +S + E RLQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 535 -LGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
G + D + + + L + Q L + + IV I + H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAH--- 151
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
HRD+K N+L+ D + DFG+A DE T VGT YM+PE +E
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 653 LFSVKSDVFSFGVLVLEIVSGK 674
+ ++D+++ ++ E ++G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 60/243 (24%), Positives = 101/243 (41%), Gaps = 30/243 (12%)
Query: 444 KKQGLTKMSHMKEDMELWEFDFASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQ 498
++ L ++ ++ I + + KLG G +G V
Sbjct: 10 GRENLYFQGDLQATPGMF------ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 499 EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSL 556
E A+K + K S + EV ++ L H N++KL L+ E L
Sbjct: 64 ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123
Query: 557 DFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---D 611
FD R F + I+ + G+ YLH+ I+HRDLK N+LL++ D
Sbjct: 124 ----FDEIIHRMKFNEVDAA-VIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKD 175
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIV 671
KI DFG++ +F + + +GT Y++PE + K DV+S GV++ ++
Sbjct: 176 ALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILL 231
Query: 672 SGK 674
+G
Sbjct: 232 AGY 234
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 44/189 (23%), Positives = 85/189 (44%), Gaps = 33/189 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ K+GEG +G V+K + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIV 578
L+H+N+V+L + L++E+ K D D +Q
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQ------ 109
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ +G+ + H ++HRDLK N+L++ + K+++FG+AR F G ++ + +VV
Sbjct: 110 --LLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV 163
Query: 639 GTYGYMSPE 647
T Y P+
Sbjct: 164 -TLWYRPPD 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 20/229 (8%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--S 509
H + + + LG+G FG V K QE AVK ++K
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EV L+ +L H N++KL + ++ E L FD R
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKR 117
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + I+ + GI Y+H+ I+HRDLK N+LL++ D + KI DFG++
Sbjct: 118 FSEHDAA-RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
F + +GT Y++PE G + K DV+S GV++ ++SG
Sbjct: 174 FQQNTKM---KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS---KGSGQGMEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S K S + ++ EV + +L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + + + + + + G +G+ Y
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAY 169
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +IHRD+KA N+LL K+ DFG A N+ VGT +M+PE
Sbjct: 170 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGTPYWMAPE 220
Query: 648 YAA---EGLFSVKSDVFSFGVLVLEIVSGK 674
EG + K DV+S G+ +E+ K
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 22/238 (9%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS 509
M+ L E D +++ F +G G +G VYKG V+ GQ A+K + +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVT 60
Query: 510 GQGMEEFKNEVTLIARL-QHRNLVKLLGC------CIQADESMLIYEYMPNKSL-DFFIF 561
G EE K E+ ++ + HRN+ G D+ L+ E+ S+ D +
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LI 118
Query: 562 DQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621
+ L + +I I RG+ +LHQ ++IHRD+K NVLL + K+ DFG+
Sbjct: 119 KNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 622 ARIFGGDEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + NT +GT +M+PE + + KSD++S G+ +E+ G
Sbjct: 176 SAQLDRTVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 53/188 (28%), Positives = 90/188 (47%), Gaps = 32/188 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLIA 524
+ + K+GEG +G VYK G+ A+K++ +E+ E++++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVG 579
L+H N+VKL +L++E++ K LD + A Q
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQ------- 108
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ GI Y H R++HRDLK N+L++ + KI+DFG+AR F G ++ TH++V
Sbjct: 109 -LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV- 162
Query: 640 TYGYMSPE 647
T Y +P+
Sbjct: 163 TLWYRAPD 170
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK---GSGQGMEEFKNE 519
+ +T F+ LG+G FG V GQE AVK +SK E E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHI 577
V L+ +L H N++KL L+ E L FD +R F + I
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RI 131
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNT 634
+ + GI Y+H+ +I+HRDLK N+LL++ D N +I DFG++ F +
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--- 185
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
+GT Y++PE G + K DV+S GV++ ++SG
Sbjct: 186 KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 50/242 (20%), Positives = 90/242 (37%), Gaps = 26/242 (10%)
Query: 451 MSHMK--EDMELWEFDFASIAKATDNFASYNKLGEG--GFGPVYKGTLVE-GQEIAVKR- 504
M+H L+ +S + +G+G V G+ + V+R
Sbjct: 1 MAHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI 60
Query: 505 -LSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
L S + + + E+ + H N+V I +E ++ +M S D
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDL 116
Query: 564 ARATFLDWQKRIHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619
F+D + I I +G+L Y+H M +HR +KAS++L+ D +S
Sbjct: 117 ICTHFMDGMNELAI-AYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGL 172
Query: 620 GMARIFGGDEIQTNT-----HKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVS 672
+ V ++SPE + L + KSD++S G+ E+ +
Sbjct: 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232
Query: 673 GK 674
G
Sbjct: 233 GH 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 49/232 (21%), Positives = 99/232 (42%), Gaps = 33/232 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRL-SKGSGQGME 514
+ + ++ + ++G G G V+K + G IAVK++ G+ + +
Sbjct: 14 TIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 515 EFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQK 573
++ ++ + +V+ G I + + E M + Q
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLK--------KRMQG 119
Query: 574 RI--HIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
I I+G + I+ YL + +IHRD+K SN+LLD K+ DFG++
Sbjct: 120 PIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 628 DEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
D+ + + G YM+PE + + +++DV+S G+ ++E+ +G+
Sbjct: 178 DKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 62/215 (28%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 463 FDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE 515
FD + S+ LG G FG V+K G ++A K + + EE
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQK 573
KNE++++ +L H NL++L ++ +L+ EY+ L FD+ + L
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQ 631
I + I GI ++HQ M I+H DLK N+L N KI DFG+AR + E
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
GT +++PE S +D++S GV+
Sbjct: 246 K---VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 53/192 (27%), Positives = 84/192 (43%), Gaps = 13/192 (6%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGC 537
KLG G FG V+ G E +K ++K Q E + E+ ++ L H N++K+
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 538 CIQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
++ E L + + QAR L ++ + + Y H +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 597 IHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL 653
+H+DLK N+L + KI DFG+A +F DE T GT YM+PE +
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST---NAAGTALYMAPE-VFKRD 201
Query: 654 FSVKSDVFSFGV 665
+ K D++S GV
Sbjct: 202 VTFKCDIWSAGV 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 20/237 (8%)
Query: 440 RKKLKKQGLTKMSHMKEDMELWE-FDFASIAKATDNFASY----NKLGEGGFGPVYKGTL 494
+ + K G + K ++W+ + + + Y +LG G FG V++
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVE 72
Query: 495 VE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553
G+ K ++ KNE++++ +L H L+ L E +LI E++
Sbjct: 73 KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132
Query: 554 KSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L FD+ A + + I+ + G+ ++H+ I+H D+K N++ +
Sbjct: 133 GEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETK 185
Query: 612 MNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
KI DFG+A DEI T + +PE +D+++ GVL
Sbjct: 186 KASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 44/309 (14%), Positives = 88/309 (28%), Gaps = 77/309 (24%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ--------- 527
LG+ + T E G+ V +++ K EV + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 528 ----------------HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFF--IFDQARA- 566
+ ++++ +Y M + F + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 567 TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
L R+ + + R + LH ++H L+ +++LD ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAA-----------EGLFSVKSDVFSFGVLVLEIVSGKK 675
+ G+ PE A L + D ++ G+++ I
Sbjct: 258 ------ARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD- 310
Query: 676 NWRFSHPDHDHNLLG-HAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPE 734
P LG WI + + + P V + G L ++ E
Sbjct: 311 -----LPITKDAALGGSEWIF-RSCKNI------------PQPVRALLE-GFL--RYPKE 349
Query: 735 DRPNMSSVV 743
DR +
Sbjct: 350 DRLLPLQAM 358
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 28/205 (13%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LG+G FG VY + +A+K L K +G+E + E+ + + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 537 CCIQADESM--LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLH 589
D L+ E+ P L + FD+ R+ + +A + Y H
Sbjct: 82 YF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE--------LADALHYCH 131
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++IHRD+K N+L+ KI+DFG + +T + GT Y+ PE
Sbjct: 132 ---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT----MCGTLDYLPPEMI 184
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
K D++ GVL E + G
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 51/245 (20%), Positives = 89/245 (36%), Gaps = 19/245 (7%)
Query: 435 LFCIWRKKLKKQGLTKMSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL 494
+ I R +L + L + M+E L + + I + +N E +
Sbjct: 33 NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR------YFNAWLETPPEKWQEEMD 86
Query: 495 VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554
+ S M+ ++ + +N V L + + +
Sbjct: 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKE 146
Query: 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
+L ++ + + +HI IA + +LH ++HRDLK SN+ D
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVV 203
Query: 615 KISDFGMARIFGGDEIQTNT----------HKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664
K+ DFG+ DE + VGT YMSPE +S K D+FS G
Sbjct: 204 KVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLG 263
Query: 665 VLVLE 669
+++ E
Sbjct: 264 LILFE 268
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 6e-27
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 23/201 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVK-----RLSKGSGQGMEEFKNEVTLIARLQHRNLVK 533
+G+G F V + E GQ+ AVK + + G E+ K E ++ L+H ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDW---QKRIHIVGGIARGILYL 588
LL +++E+M L + RA H + I + Y
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADL----CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 589 HQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
H IIHRD+K VLL +N K+ FG+A G VGT +M+
Sbjct: 147 HD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMA 201
Query: 646 PEYAAEGLFSVKSDVFSFGVL 666
PE + DV+ GV+
Sbjct: 202 PEVVKREPYGKPVDVWGCGVI 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-27
Identities = 53/189 (28%), Positives = 86/189 (45%), Gaps = 30/189 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN--KSL---DFFIFDQARATFLDWQKRIHIV 578
L H N++ LL L++++M + + + + +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM------ 120
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+G+ YLHQ I+HRDLK +N+LLD + K++DFG+A+ F G + TH+VV
Sbjct: 121 --TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV 174
Query: 639 GTYGYMSPE 647
T Y +PE
Sbjct: 175 -TRWYRAPE 182
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 14/213 (6%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLS-KGSGQGMEEFKNEVTLIARLQHRN 530
D++ +G G V +++A+KR++ + M+E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSL-----DFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + DE L+ + + S+ + ++ LD I+ + G+
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM-ARIFGGDEIQTNTHK--VVGTYG 642
YLH + IHRD+KA N+LL D + +I+DFG+ A + G +I N + VGT
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 643 YMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGK 674
+M+PE + + K+D++SFG+ +E+ +G
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 9e-27
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
+DN+ +LG+G F V + G E A K ++ S + ++ + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + L+++ + L F+ AR + + H + I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
Y H I+HR+LK N+LL K++DFG+A E H GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+SPE + +S D+++ GV
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGV 195
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 20/213 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFK 517
+ + + LG+G FG V K QE AVK ++K +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 518 NEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRI 575
EV L+ +L H N++KL + ++ E L FD+ R F +
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA- 124
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQT 632
I+ + GI Y+H+ I+HRDLK N+LL + D + KI DFG++ F +
Sbjct: 125 RIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGV 665
+GT Y++PE G + K DV+S GV
Sbjct: 182 ---DRIGTAYYIAPE-VLRGTYDEKCDVWSAGV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 51/195 (26%), Positives = 89/195 (45%), Gaps = 37/195 (18%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN-----EVTLIA 524
++ F KLG G + VYKG G +A+K + S +G E++L+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLMK 58
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIA-- 582
L+H N+V+L ++ L++E+M D ++D + + G+
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM----------DNDLKKYMDSRTVGNTPRGLELN 108
Query: 583 ----------RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
+G+ + H +I+HRDLK N+L++ K+ DFG+AR F G + T
Sbjct: 109 LVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNT 164
Query: 633 NTHKVVGTYGYMSPE 647
+ +VV T Y +P+
Sbjct: 165 FSSEVV-TLWYRAPD 178
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 469 AKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLI 523
+ Y N +G G +G V A K++ K + ++ FK E+ ++
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGI 581
L H N+++L + L+ E L F++ + F + I+ +
Sbjct: 61 KSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA-RIMKDV 115
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ Y H+ + + HRDLK N L D K+ DFG+A F ++ V
Sbjct: 116 LSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR---TKV 169
Query: 639 GTYGYMSPEYAAEGLFSVKSDVFSFGV 665
GT Y+SP+ EGL+ + D +S GV
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGV 195
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEV 520
+ A+ F+ +LG+G F V + G E A K ++ S + ++ + E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIV 578
+ +LQH N+V+L + L+++ + L F+ AR + + H +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCI 134
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTH 635
I I Y H I+HR+LK N+LL K++DFG+A E H
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WH 188
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGV 665
GT GY+SPE + +S D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 38/202 (18%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G F V+ G+ A+K + K +NE+ ++ +++H N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
L+ + + L FD RI ++ + +
Sbjct: 76 ESTTHYYLVMQLVSGGEL----FD-----------RILERGVYTEKDASLVIQQVLSAVK 120
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH+ I+HRDLK N+L + + I+DFG++++ + T GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST----ACGTPGY 173
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
++PE A+ +S D +S GV
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGV 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 46/201 (22%), Positives = 87/201 (43%), Gaps = 15/201 (7%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYL 588
LV L +E ++IYE+M L F++ + + + + + +G+ ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
H+ +H DLK N++ + K+ DFG+ + + GT + +P
Sbjct: 272 HE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAP 325
Query: 647 EYAAEGLFSVKSDVFSFGVLV 667
E A +D++S GVL
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLS 346
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 56/195 (28%), Positives = 85/195 (43%), Gaps = 41/195 (21%)
Query: 473 DNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
D + KLGEG +G VYK V + +A+KR+ +E + EV+L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIH------I 577
LQHRN+++L LI+EY + ++D +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQT 632
+ + G+ + H R +HRDLK N+LL KI DFG+AR F G I+
Sbjct: 138 LYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQ 193
Query: 633 NTHKVVGTYGYMSPE 647
TH+++ T Y PE
Sbjct: 194 FTHEII-TLWYRPPE 207
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 63/229 (27%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 468 IAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK-------------GS 509
+ K KLG G +G V E A+K + K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARAT 567
+ EE NE++L+ L H N++KL L+ E+ L F+ R
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHK 142
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARI 624
F + +I+ I GI YLH+ I+HRD+K N+LL+N +N KI DFG++
Sbjct: 143 FDE-CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
F D +GT Y++PE + ++ K DV+S GV++ ++ G
Sbjct: 199 FSKDYKL---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 41/192 (21%), Positives = 81/192 (42%), Gaps = 16/192 (8%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
LG G FG V++ + K + G K E++++ +HRN++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+E ++I+E++ + F++ A L+ ++ + V + + +LH I
Sbjct: 71 ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 597 IHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF 654
H D++ N++ + KI +FG AR + + Y +PE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180
Query: 655 SVKSDVFSFGVL 666
S +D++S G L
Sbjct: 181 STATDMWSLGTL 192
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 54/199 (27%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G E A K + K G EE + EV+++ ++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A+ L ++ + I G+ YLH
Sbjct: 79 TLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT- 133
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+I H DLK N++L + P K+ DFG+A N + GT +++PE
Sbjct: 134 --KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPE 188
Query: 648 YAAEGLFSVKSDVFSFGVL 666
+++D++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVI 207
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 45/214 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 646 PE------YAAEGLFSVKSDVFSFGVLVLEIVSG 673
PE + AE DV+S G+++ +++G
Sbjct: 176 PELLKRREFHAE-----PVDVWSCGIVLTAMLAG 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 28/186 (15%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-----EVTLIARL 526
+ + +KLGEG + VYKG +A+K + +G EV+L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPN---KSLD--FFIFDQARATFLDWQKRIHIVGGI 581
+H N+V L L++EY+ + LD I + +Q +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQ--------L 109
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
RG+ Y H R +++HRDLK N+L++ K++DFG+AR +T ++VV T
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TL 164
Query: 642 GYMSPE 647
Y P+
Sbjct: 165 WYRPPD 170
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIA 524
D + +LG G F V K G E A K + K G EE + EV+++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 525 RLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIAR 583
++ H N++ L + +LI E + L FD A+ L ++ + I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQILD 126
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVG 639
G+ YLH +I H DLK N++L + P K+ DFG+A N + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVL 666
T +++PE +++D++S GV+
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 62/206 (30%), Positives = 91/206 (44%), Gaps = 45/206 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
LGEG +G V V + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG-- 72
Query: 539 IQADESM--LIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGI 585
+ + ++ L EY L FD A+ F Q ++ G+
Sbjct: 73 HRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFF--HQ----LMAGVV--- 119
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH + I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++
Sbjct: 120 -YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 646 PE------YAAEGLFSVKSDVFSFGV 665
PE + AE DV+S G+
Sbjct: 176 PELLKRREFHAE-----PVDVWSCGI 196
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 46/223 (20%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL C + L++E++ + L+ F D +Q
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQ------ 132
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
I GI + H IIHRD+K N+L+ K+ DFG AR + +V
Sbjct: 133 --IINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA 186
Query: 639 GTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T Y +PE Y +V DV++ G LV E+ G+
Sbjct: 187 -TRWYRAPELLVGDVKYGK----AV--DVWAIGCLVTEMFMGE 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 47/189 (24%), Positives = 78/189 (41%), Gaps = 33/189 (17%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN--------EVTLI 523
+ + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 524 ARLQHRNLVKLLGCCIQADESMLIYEYMPN---KSLDFF--IFDQARATFLDWQKRIHIV 578
+L+H NLV LL + L++EY + LD + + + WQ
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ------ 110
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ + + H+ IHRD+K N+L+ K+ DFG AR+ +V
Sbjct: 111 --TLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA 164
Query: 639 GTYGYMSPE 647
T Y SPE
Sbjct: 165 -TRWYRSPE 172
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 50/271 (18%), Positives = 89/271 (32%), Gaps = 52/271 (19%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVK-----RLS 506
H E F S+ + + +G+G +G V + A+K ++
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 507 KGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARA 566
+ + + +E K EV L+ +L H N+ +L L+ E L +
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 567 TFLDWQKRI-------------------------------------HIVGGIARGILYLH 589
+ + +I+ I + YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 590 QDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDEIQTNT--HKVVGTYGYMS 645
I HRD+K N L + K+ DFG+++ F GT +++
Sbjct: 186 N---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 646 PE--YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + K D +S GVL+ ++ G
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 53/219 (24%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 451 MSHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGS 509
M+ + +E D + K+G+G FG V+K + + A+K++
Sbjct: 1 MAKQYDSVECPFCDEV------SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--- 51
Query: 510 GQGMEEFKN--------EVTLIARLQHRNLVKLLGCCIQADESM--------LIYEYMPN 553
ME K E+ ++ L+H N+V L+ C L++++ +
Sbjct: 52 ---MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH 108
Query: 554 --KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L F + + ++ + G+ Y+H R +I+HRD+KA+NVL+ D
Sbjct: 109 DLAGL----LSNVLVKFTLSEIK-RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRD 160
Query: 612 MNPKISDFGMARIFG---GDEIQTNTHKVVGTYGYMSPE 647
K++DFG+AR F + T++VV T Y PE
Sbjct: 161 GVLKLADFGLARAFSLAKNSQPNRYTNRVV-TLWYRPPE 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHRN 530
+ + +G G FG V++ LVE E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 531 LVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+V L + L+ EY+P ++ + + L + ++ +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY---QL 150
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVGT 640
R + Y+H + I HRD+K N+LLD K+ DFG A+I + N +
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICSR 205
Query: 641 YGYMSPEYAAEGLF-----SVKSDVFSFGVLVLEIVSGK 674
Y Y +PE +F + D++S G ++ E++ G+
Sbjct: 206 Y-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 56/219 (25%), Positives = 90/219 (41%), Gaps = 34/219 (15%)
Query: 470 KATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EE 515
+T F LG G V + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 516 FKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQ 572
EV ++ ++ H N+++L L+++ M L FD + T + +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKE 125
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
R I+ + I LH+ + I+HRDLK N+LLD+DMN K++DFG + E
Sbjct: 126 TR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-- 179
Query: 633 NTHKVVGTYGYMSPE------YAAEGLFSVKSDVFSFGV 665
+V GT Y++PE + + D++S GV
Sbjct: 180 -LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHRNLV 532
+LG G F V K G+E A K + K G EE + EV ++ ++H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD 591
L + +LI E + L FD A L + + I G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS- 126
Query: 592 SRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
RI H DLK N++L + P K+ DFG+A N + GT +++PE
Sbjct: 127 --KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFVAPE 181
Query: 648 YAAEGLFSVKSDVFSFGVL 666
+++D++S GV+
Sbjct: 182 IVNYEPLGLEADMWSIGVI 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGC 537
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGIL 586
LI EY + FD +AR+ F Q I +
Sbjct: 83 IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKF--RQ--------IVSAVQ 128
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF-GGDEIQTNTHKVVGTYGYMS 645
Y H + RI+HRDLKA N+LLD DMN KI+DFG + F G ++ G Y +
Sbjct: 129 YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA----FCGAPPYAA 181
Query: 646 PE-YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + + + DV+S GV++ +VSG
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNEVTLIARLQH 528
T+ + + +LG+G F V + V GQE A ++ S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGIL 586
N+V+L + LI++ + L F+ AR + + H + I +L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HCIQQILEAVL 124
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ HQ M ++HR+LK N+LL K++DFG+A G+ Q GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGY 179
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+SPE + + D+++ GV
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGV 201
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 466 ASIAKATDNFASY----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK------GSGQGME 514
++ + +N Y +LG G F V K G + A K + K G E
Sbjct: 1 GTVFR-QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 59
Query: 515 EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQK 573
+ + EV+++ +QH N++ L + +LI E + L FD A L ++
Sbjct: 60 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESLTEEE 115
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDE 629
+ I G+ YLH ++I H DLK N++L + P KI DFG+A
Sbjct: 116 ATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
N + GT +++PE +++D++S GV+
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 46/204 (22%), Positives = 87/204 (42%), Gaps = 29/204 (14%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--------MEEFKNEVTLIARL-QHR 529
+G G V + G E AVK + + + E + E ++ ++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILY 587
+++ L+ + L+++ M L FD + + + R I+ + + +
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMRSLLEAVSF 215
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I+HRDLK N+LLD++M ++SDFG + E ++ GT GY++PE
Sbjct: 216 LHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPE 269
Query: 648 ------YAAEGLFSVKSDVFSFGV 665
+ + D+++ GV
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGV 293
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 36/225 (16%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLL 535
LGEG +G V + AVK L K G K E+ L+ RL+H+N+++L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 536 GCCIQADESM--LIYEYMPNKSLDFFIF--------DQARATFLDWQKRIHIVGGIARGI 585
++ ++ EY + QA F Q ++ G+
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF--CQ----LIDGLE--- 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH I+H+D+K N+LL KIS G+A G+ +
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 646 PEYAA-EGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
PE A FS K D++S GV + I +G +P N+
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTG------LYPFEGDNI 218
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 47/220 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE--------FKNEVTL 522
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 523 IARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDW 571
+ +L H ++K+ A++ ++ E M L FD + F
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQ- 122
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGD 628
+ + YLH IIHRDLK NVLL + D KI+DFG ++I G
Sbjct: 123 ---------MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 629 EIQTNTHKVVGTYGYMSPE---YAAEGLFSVKSDVFSFGV 665
+ + GT Y++PE ++ D +S GV
Sbjct: 171 SL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 36/198 (18%)
Query: 470 KATDNFASYNKLGEGGFGPVYKG--TLVEGQEIAVKRLSKGSGQGMEEFKN--------E 519
+A + ++GEG +G V+K G+ +A+KR+ ++ + E
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIRE 61
Query: 520 VTLIARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPN--KSLDFFIFDQARATFL 569
V ++ L+ H N+V+L C + L++E++ + D+ +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY----LDKVPEPGV 117
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ ++ + RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ- 173
Query: 630 IQTNTHKVVGTYGYMSPE 647
T VV T Y +PE
Sbjct: 174 -MALTSVVV-TLWYRAPE 189
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 34/219 (15%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
D F + LG GGFG V+ K T G+ A K+L+K +G + E ++A+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI---------FDQARATFLDWQKRI 575
+ R +V L + + L+ M + + I F + RA F Q
Sbjct: 242 VHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ--- 297
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
I G+ +LHQ II+RDLK NVLLD+D N +ISD G+A + +T
Sbjct: 298 -----IVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG- 348
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT G+M+PE + D F+ GV + E+++ +
Sbjct: 349 -YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 52/203 (25%), Positives = 84/203 (41%), Gaps = 25/203 (12%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538
LGEG V L+ QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 539 IQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMRI 596
+ D L++E M S+ R F + + +V +A + +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 597 IHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNT-----HKVVGTYGYMSPE- 647
HRDLK N+L + KI DF + + + G+ YM+PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 648 ----YAAEGLFSVKSDVFSFGVL 666
++ + D++S GV+
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVI 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-24
Identities = 50/204 (24%), Positives = 86/204 (42%), Gaps = 27/204 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRN 530
LG G G V + +++A++ +SK + E+ ++ +L H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLH 589
++K+ A++ ++ E M L FD+ L + + YLH
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 590 QDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ IIHRDLK NVLL + D KI+DFG ++I G + + GT Y++P
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAP 310
Query: 647 E---YAAEGLFSVKSDVFSFGVLV 667
E ++ D +S GV++
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 45/224 (20%), Positives = 80/224 (35%), Gaps = 60/224 (26%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSK--------GSGQGMEEFKNEVTLIARLQHRNL 531
LG G FG V+ E +E+ VK + K + + E+ +++R++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFI----------FD-----------QARATFLD 570
+K+ + N+ + F A F
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF-- 136
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
Q + + YL IIHRD+K N+++ D K+ DFG A ++
Sbjct: 137 RQ--------LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL 185
Query: 631 QTNTHKVVGTYGYMSPE-YAAEGLFSVKSDVFSFGVLVLEIVSG 673
+ GT Y +PE + +++S GV + +V
Sbjct: 186 ---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/204 (30%), Positives = 91/204 (44%), Gaps = 22/204 (10%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LGEG F V + A+K L K + E +++RL H VKL
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 537 CCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQ 590
Q DE + Y N L +I FD+ F + I + YLH
Sbjct: 98 TF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE--------IVSALEYLHG 148
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VGT Y+SPE
Sbjct: 149 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGK 674
E SD+++ G ++ ++V+G
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGL 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 56/200 (28%), Positives = 88/200 (44%), Gaps = 38/200 (19%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQ-GMEEFKN----EVTLI 523
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 524 ARLQ---HRNLVKLLGCCIQADES-----MLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
RL+ H N+V+L+ C + L++E++ DQ T+LD
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV----------DQDLRTYLDKAPPP 115
Query: 576 HIVGG--------IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627
+ RG+ +LH + I+HRDLK N+L+ + K++DFG+ARI+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSY 172
Query: 628 DEIQTNTHKVVGTYGYMSPE 647
T VV T Y +PE
Sbjct: 173 Q--MALTPVVV-TLWYRAPE 189
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 55/233 (23%), Positives = 89/233 (38%), Gaps = 47/233 (20%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARLQHR--NL 531
LG GGFG VY G + + +A+K + K G EV L+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIVGGIA 582
++LL + D +LI E P D F F + AR+ F WQ +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELARSFF--WQ--------VL 159
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
+ + H ++HRD+K N+L+D N K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD----FDGTR 212
Query: 642 GYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGK---------KNWRFSHPDH 684
Y PE+ + + V+S G+L+ ++V G +
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQR 265
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 2e-23
Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 19/210 (9%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
+ F Y LG+GGFG V + T G+ A K+L K +G NE ++ +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 526 LQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ R +V L + +++ L+ M L F I+ +A F + + + I G
Sbjct: 241 VNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA-AEICCG 298
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ LH R RI++RDLK N+LLD+ + +ISD G+A + VGT GYM
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYM 352
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+PE ++ D ++ G L+ E+++G+
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 468 IAKATDNFASY-----NKLGEGGFGPVYKGTLVE-GQEIAVKRLSK--GSGQGMEEFKNE 519
++ +NF ++ +LG G F V + GQE A K L K E +E
Sbjct: 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHE 78
Query: 520 VTLIARLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD---QARATFLDWQKRI 575
+ ++ + ++ L E +LI EY + F A + I
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVI 134
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFGGDEIQT 632
++ I G+ YLHQ I+H DLK N+LL + + KI DFGM+R G
Sbjct: 135 RLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-- 189
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVL 666
+++GT Y++PE + +D+++ G++
Sbjct: 190 -LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-23
Identities = 53/242 (21%), Positives = 88/242 (36%), Gaps = 63/242 (26%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK------GSGQGMEEFKNEVTLIARL----QHR 529
LG+GGFG V+ G L + ++A+K + + EV L+ ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 530 NLVKLLGCCIQADESM--LIYEYMPNKSLDFFIF---------DQARATFLDWQKRIHIV 578
+++LL + L+ E P + D F + +R F Q
Sbjct: 99 GVIRLLD--WFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFF--GQ------ 147
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKV 637
+ I + H ++HRD+K N+L+D K+ DFG + +
Sbjct: 148 --VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD----F 198
Query: 638 VGTYGYMSPE------YAAEGLFSVKSDVFSFGVLVLEIVSGK---------KNWRFSHP 682
GT Y PE Y A + V+S G+L+ ++V G P
Sbjct: 199 DGTRVYSPPEWISRHQYHAL-----PATVWSLGILLYDMVCGDIPFERDQEILEAELHFP 253
Query: 683 DH 684
H
Sbjct: 254 AH 255
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 8e-23
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 473 DNFASYNKLGEGGFGPVY----KGTLVEGQEIAVKRLSKG---SGQGMEEFKNE---VTL 522
++F+ + +G GGFG VY T G+ A+K L K QG NE ++L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 523 IARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFI-----FDQARATFLDWQKRIH 576
++ +V + + + I + M L + + F +A F +
Sbjct: 246 VSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE---- 300
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I G+ ++H +++RDLK +N+LLD + +ISD G+A F + H
Sbjct: 301 ----IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHA 349
Query: 637 VVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGK 674
VGT+GYM+PE +G+ S D FS G ++ +++ G
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK-------------------------GSGQGME 514
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 515 EF-KNEVTLIARLQHRNLVKLLGCCIQADESML--IYEYMPNKSLDFFIF-------DQA 564
E E+ ++ +L H N+VKL+ +E L ++E + + + DQA
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSEDQA 139
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624
R F D + +GI YLH +IIHRD+K SN+L+ D + KI+DFG++
Sbjct: 140 RFYFQD----------LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 625 FGGDEIQTNTHKVVGTYGYMSPE--YAAEGLFS-VKSDVFSFGV 665
F G + VGT +M+PE +FS DV++ GV
Sbjct: 187 FKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGV 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 54/202 (26%), Positives = 83/202 (41%), Gaps = 39/202 (19%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
+LG G VY+ + A+K L K + + + E+ ++ RL H N++KL
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI------------HIVGGIARGIL 586
E L+ E + L FD RI V I +
Sbjct: 118 ETPTEISLVLELVTGGEL----FD-----------RIVEKGYYSERDAADAVKQILEAVA 162
Query: 587 YLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
YLH+ I+HRDLK N+L D KI+DFG+++I + V GT GY
Sbjct: 163 YLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGY 216
Query: 644 MSPEYAAEGLFSVKSDVFSFGV 665
+PE + + D++S G+
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGI 238
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 47/203 (23%), Positives = 80/203 (39%), Gaps = 22/203 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHR 529
TD + +G G + + E AVK + K + E+ ++ R QH
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KRDPTEEIEILLRYGQHP 76
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILY 587
N++ L ++ E M L D + F + + ++ I + + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEY 131
Query: 588 LHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
LH ++HRDLK SN+L N + +I DFG A+ + T T +
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANF 186
Query: 644 MSPEYAAEGLFSVKSDVFSFGVL 666
++PE + D++S GVL
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVL 209
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 1e-22
Identities = 48/192 (25%), Positives = 84/192 (43%), Gaps = 38/192 (19%)
Query: 480 KLGEGGFGPVYKG---TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ L+H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQK 85
Query: 537 CCIQADES--MLIYEYM-------------PNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ + L+++Y + + L +Q I
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ--------I 137
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTH-- 635
GI YLH ++HRDLK +N+L+ + KI+D G AR+F ++
Sbjct: 138 LDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF-NSPLKPLADLD 193
Query: 636 KVVGTYGYMSPE 647
VV T+ Y +PE
Sbjct: 194 PVVVTFWYRAPE 205
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N+V+L + E L+ +Y+P + + + + + ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---Q 164
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTNTHKVVG 639
+ R + Y+H I HRD+K N+LLD D K+ DFG A+ E N +
Sbjct: 165 LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICS 219
Query: 640 TYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
Y Y +PE Y + DV+S G ++ E++ G+
Sbjct: 220 RY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 20/194 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LGEG F K Q AVK +SK + + E+T + + H N+VKL
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFD--QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ L+ E + L F+ + + F + + +I+ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 596 IIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
++HRDLK N+L ++++ KI DFG AR+ D T T Y +PE +
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQN 184
Query: 653 LFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 185 GYDESCDLWSLGVI 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 72/239 (30%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL-- 76
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + + F + FD +AR F Q
Sbjct: 77 -----------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLF--QQ---- 119
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTH 635
I+ + Y H R ++HRDLK NVLLD MN KI+DFG++ + E +T
Sbjct: 120 ILSAVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT--- 169
Query: 636 KVVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688
+ G SP YAA + S + D++S GV++ ++ G + P D ++
Sbjct: 170 ----SCG--SPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG------TLPFDDEHV 216
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 26/198 (13%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + GQ+ A+K L + + EV + ++V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 538 CIQADESM----LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+I E M L F I ++ F + + I+ I I +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL--FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLHS- 146
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
I HRD+K N+L + D K++DFG A+ + +QT T Y++PE
Sbjct: 147 --HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAPEV 200
Query: 649 AAEGLFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 201 LGPEKYDKSCDMWSLGVI 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 65/224 (29%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEE-FKNEVTLIARLQHRNLVKLLG 536
LGEG FG V T Q++A+K +S+ M + E++ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 537 CCIQADESMLIYEYMPNKSLDFFI--------FD-----------QARATFLDWQKRIHI 577
Y+ + + + FD + R F Q
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFF--QQ----- 116
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QTNTHK 636
I I Y H R +I+HRDLK N+LLD+++N KI+DFG++ I +T
Sbjct: 117 ---IICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT---- 166
Query: 637 VVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGK 674
+ G SP YAA + + + DV+S G+++ ++ G+
Sbjct: 167 ---SCG--SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-21
Identities = 60/224 (26%), Positives = 95/224 (42%), Gaps = 64/224 (28%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSK---GSGQGMEEFKNEVTLIARLQHRNLVKLLG 536
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 537 CCIQADESMLIYEYMPNKSLDFFI---------FD-----------QARATFLDWQKRIH 576
Y+ + S F + FD ++R F Q
Sbjct: 82 -----------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF--QQ---- 124
Query: 577 IVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK 636
I+ G+ Y H R ++HRDLK NVLLD MN KI+DFG++ + E
Sbjct: 125 ILSGVD----YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRT 174
Query: 637 VVGTYGYMSPEYAAEGLFS------VKSDVFSFGVLVLEIVSGK 674
G SP YAA + S + D++S GV++ ++ G
Sbjct: 175 SCG-----SPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-21
Identities = 54/228 (23%), Positives = 90/228 (39%), Gaps = 41/228 (17%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN----EVTLIA 524
K D F G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 525 RLQHRNLVKLLGCCIQADES-------MLIYEYMP---NKSLDFFIFDQARATFLDWQKR 574
L H N+V+L E ++ EY+P ++ + Q + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP-KISDFGMARIFGGDEIQTN 633
+ + R I LH S + HRD+K NVL++ K+ DFG A+ E N
Sbjct: 135 LF---QLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PN 188
Query: 634 THKVVGTYGYMSPE-------YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ Y Y +PE Y + D++S G + E++ G+
Sbjct: 189 VAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 53/206 (25%), Positives = 83/206 (40%), Gaps = 48/206 (23%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHRNLVKLLGCC 538
+G G FG + + +AVK + +G ++E + E+ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 539 IQADESMLIYEYMPNKSLDFFIFD-----------QARATFLDWQKRIHIVGGIARGILY 587
+ +I EY L ++ +AR F Q ++ G++ Y
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFF--QQ----LLSGVS----Y 131
Query: 588 LHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
H M+I HRDLK N LLD KI DFG ++ VGT Y++
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIA 185
Query: 646 PE------YAAEGLFSVKSDVFSFGV 665
PE Y + +DV+S GV
Sbjct: 186 PEVLLRQEYDGK-----IADVWSCGV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-20
Identities = 45/198 (22%), Positives = 78/198 (39%), Gaps = 25/198 (12%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 123
Query: 538 C---IQADESM-LIYEYMPNKSLDFF--IFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ + ++ E + L F I D+ F + + I+ I I YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL--FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLHS- 179
Query: 592 SRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+ I HRD+K N+L + K++DFG A+ T Y++PE
Sbjct: 180 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEV 234
Query: 649 AAEGLFSVKSDVFSFGVL 666
+ D++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 13/97 (13%)
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
+A+G+ +L + + IHRDL A N+LL KI DFG+AR +I + V
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPDYVRKG 253
Query: 641 YG-----YMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
+M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 9e-12
Identities = 38/176 (21%), Positives = 62/176 (35%), Gaps = 26/176 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 13 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 511 QG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQARAT 567
+E+ ++ + H N+V LLG C + M+I E+ +L ++
Sbjct: 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL------- 118
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
KR V +G + + I DLK + + + S F +
Sbjct: 119 ---RSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 54/257 (21%), Positives = 98/257 (38%), Gaps = 44/257 (17%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L + ++ + ++ E + + D+F +G G F V K T
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-- 85
Query: 496 EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
GQ A+K ++K + F+ E ++ R + +L Q + + L+ EY
Sbjct: 86 -GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYY 143
Query: 552 PNKSLDFF-------IFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKAS 604
L A F + I I +H+ + +HRD+K
Sbjct: 144 VGGDL-LTLLSKFGERIPAEMARFY--------LAEIVMAIDSVHR---LGYVHRDIKPD 191
Query: 605 NVLLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE-------YAAEGLFSV 656
N+LLD + +++DFG ++ +++ VGT Y+SPE G +
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQAVGGGPGTGSYGP 249
Query: 657 KSDVFSFGVLVLEIVSG 673
+ D ++ GV E+ G
Sbjct: 250 ECDWWALGVFAYEMFYG 266
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 40/213 (18%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKN---EVTLIARLQHRNLVK 533
+G+G FG V +V+ + A+K ++K E +N E+ ++ L+H LV
Sbjct: 23 IGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q +E M ++ + + L + F + + + +
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLF--------ICELVMALD 129
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YL RIIHRD+K N+LLD + I+DF +A + + Q T + GT YM+P
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET-QITT--MAGTKPYMAP 183
Query: 647 E--YAAEGL---FSVKSDVFSFGVLVLEIVSGK 674
E + +G F+V D +S GV E++ G+
Sbjct: 184 EMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 52/247 (21%), Positives = 101/247 (40%), Gaps = 26/247 (10%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L + ++ E +E + + + + ++F +G G FG V K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNA-- 98
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K L+K E F+ E ++ + + L Q D ++ L+ +Y
Sbjct: 99 -DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYY 156
Query: 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND 611
L + + + R ++ + I +HQ + +HRD+K N+L+D +
Sbjct: 157 VGGDL-LTLLSKFEDRLPEEMARFYL-AEMVIAIDSVHQ---LHYVHRDIKPDNILMDMN 211
Query: 612 MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-----YAAEGLFSVKSDVFSFGVL 666
+ +++DFG D + VGT Y+SPE +G + + D +S GV
Sbjct: 212 GHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVC 270
Query: 667 VLEIVSG 673
+ E++ G
Sbjct: 271 MYEMLYG 277
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 44/217 (20%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR 529
D++ KLG G + V++ + +++ VK L ++ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 530 NLVKLLGCCIQADESM---LIYEYMPNKSLDFFI--FDQARATFLDWQKRIHIVGGIARG 584
N++ L ++ S L++E++ N F ++ I +
Sbjct: 92 NIITLA-DIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE--------ILKA 142
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+ Y H M I+HRD+K NV++D++ ++ D+G+A Q +V Y +
Sbjct: 143 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-F 196
Query: 644 MSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGKK 675
PE L + D++S G ++ ++ K+
Sbjct: 197 KGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-17
Identities = 60/252 (23%), Positives = 103/252 (40%), Gaps = 39/252 (15%)
Query: 443 LKKQGLTKMSHMKEDMELWEFDFASIAKAT---DNFASYNKLGEGGFGPVY----KGTLV 495
L L K ++ + ++ I +++ +G G FG V K T
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST-- 93
Query: 496 EGQEIAVKRLSKGSGQGMEE---FKNEVTLIARLQHRNLVKLLGCCIQADESM-LIYEYM 551
+ A+K LSK + F E ++A +V+L Q D + ++ EYM
Sbjct: 94 -RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 552 PNKSLDFFI-----FDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606
P L + + A F + + + +H M IHRD+K N+
Sbjct: 152 PGGDL-VNLMSNYDVPEKWARFYTAE--------VVLALDAIHS---MGFIHRDVKPDNM 199
Query: 607 LLDNDMNPKISDFGMA-RIFGGDEIQTNTHKVVGTYGYMSPE----YAAEGLFSVKSDVF 661
LLD + K++DFG ++ ++ +T VGT Y+SPE +G + + D +
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKSQGGDGYYGRECDWW 257
Query: 662 SFGVLVLEIVSG 673
S GV + E++ G
Sbjct: 258 SVGVFLYEMLVG 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 31/208 (14%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVK 533
LG+G FG V LV+ G+ A+K L K +E E ++ +H L
Sbjct: 156 LGKGTFGKVI---LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 534 LLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGIL 586
L Q + + + EY L FF +F + RA F I +
Sbjct: 213 LK-YSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFY--------GAEIVSALD 262
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
YLH S +++RDLK N++LD D + KI+DFG+ + D T GT Y++P
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAP 318
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E + + D + GV++ E++ G+
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V + + +A+K+LS+ F+N E+
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +S+ ++ E M +L I D R ++L +
Sbjct: 77 LMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY 134
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 135 Q--------MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T V T Y +PE + D++S G ++ E++ G
Sbjct: 184 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 6e-17
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 46/230 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEE--FKN---------EV 520
+ + G +G V G EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 521 TLIARLQHRNLVKLLGCCI-QADESM----LIYEYMPN------KSLDFFIFDQARATFL 569
L+ H N++ L + + +M L+ E M I Q +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQ-HIQYF 139
Query: 570 DWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629
+ I G+ LH+ ++HRDL N+LL ++ + I DF +AR D
Sbjct: 140 MYH--------ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+T+ V Y +PE + K D++S G ++ E+ + K
Sbjct: 189 NKTHY---VTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 26/205 (12%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + + EY L FF +F + RA F I + YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFY--------GAEIVSALEYLH 122
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+++RD+K N++LD D + KI+DFG+ + D T GT Y++PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVL 177
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + D + GV++ E++ G+
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 28/207 (13%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKL 534
LG+G FG V+ K + + +++ A+K L K + + K E ++ + H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 535 LGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILY 587
Q + + LI +++ L F +F + F + +A + +
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFY--------LAELALALDH 141
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH + II+RDLK N+LLD + + K++DFG+++ E + + GT YM+PE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE 196
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ +D +SFGVL+ E+++G
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 42/201 (20%), Positives = 83/201 (41%), Gaps = 41/201 (20%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
D + + +G G +G V + +E + +A+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104
Query: 522 LIARLQHRNLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLD 570
++ RL H ++VK+L I D ++ E + ++ + + T L
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIK-TLL- 162
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
+ + G+ Y+H S I+HRDLK +N L++ D + K+ DFG+AR E
Sbjct: 163 YN--------LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 631 QTNTHKVVGTYGYMSPEYAAE 651
+ + M+
Sbjct: 212 GNSQLPISPREDDMNLVTFPH 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-16
Identities = 52/254 (20%), Positives = 96/254 (37%), Gaps = 71/254 (27%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN-EVTLIARLQHR 529
+ ++ LG G FG V + +E G+ A+K++ + +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHV 60
Query: 530 NLVKLLGCCIQADESM--------------------------------------LIYEYM 551
N++KL+ + +I EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 552 P---NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608
P +K L FI I+ + R + ++H + I HRD+K N+L+
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIY---QLFRAVGFIHS---LGICHRDIKPQNLLV 174
Query: 609 D-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-------YAAEGLFSVKSDV 660
+ D K+ DFG A+ + + + + Y +PE Y + D+
Sbjct: 175 NSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDL 225
Query: 661 FSFGVLVLEIVSGK 674
+S G + E++ GK
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLV 532
LG+GG+G V+ K T +I A+K L K + K E ++ ++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L+ Q + LI EY+ L F IF + A F + I+ +
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFY--------LAEISMAL 134
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LHQ II+RDLK N++L++ + K++DFG+ + D T+T GT YM+
Sbjct: 135 GHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMA 189
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D +S G L+ ++++G
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 33/208 (15%)
Query: 481 LGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
LG+G FG V +K T Q A+K L K ++ + + L +H L
Sbjct: 25 LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
+ C Q E++ + EY+ L + FD +RATF I G+
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDL-MYHIQSCHKFDLSRATF--------YAAEIILGL 131
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH I++RDLK N+LLD D + KI+DFGM + + +TNT GT Y++
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIA 186
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
PE ++ D +SFGVL+ E++ G
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 27/211 (12%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQH 528
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFI------FDQARATFLDWQKRIHIVGGIA 582
LVKL ++ EY+ + F F + A F I
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 583 RGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYG 642
YLH + +I+RDLK N+L+D +++DFG A+ ++ T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSG 673
++PE ++ D ++ GVL+ E+ +G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V + E ++ AVK L K ++ + +T L H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
CC Q + + + E++ L F FD+ARA F I +++L
Sbjct: 91 -CCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H II+RDLK NVLLD++ + K++DFGM + + + T T GT Y++PE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
E L+ D ++ GVL+ E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-16
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
LG+G FG V E+ AVK L K ++ + + L + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
C Q + + + EY+ L + F + A F IA G+ +L
Sbjct: 88 -SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK NV+LD++ + KI+DFGM + D + T T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
A + D ++FGVL+ E+++G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A+K + K E+ T H LV
Sbjct: 17 IGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 74 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 123
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T GT Y++
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D ++ GVL+ E+++G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + +G G G V V + +A+K+LS+ F+N E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFI---FDQARATFLDW 571
L+ + H+N++ LL +++ L+ E M L I D R ++L +
Sbjct: 114 LMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELMDAN-LCQVIQMELDHERMSYLLY 171
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q + GI +LH S IIHRDLK SN+++ +D KI DFG+AR G +
Sbjct: 172 Q--------MLCGIKHLH--SA-GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
T V T Y +PE + D++S G ++ E+V K
Sbjct: 221 TPY---VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 34/290 (11%), Positives = 76/290 (26%), Gaps = 61/290 (21%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLL 535
G ++ +++A+ + ++E + ++R+ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 536 GCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+++ E++ SL + T I + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAH---RAG 149
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFS 655
+ S V + D G V+ M
Sbjct: 150 VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDANPQ----- 182
Query: 656 VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPP 715
D+ G + ++ + W L + AG + P
Sbjct: 183 --DDIRGIGASLYALLVNR--WPLPEAGVRSGLAPA---------ERDTAGQPI----EP 225
Query: 716 TEVLRCIHVGL-----LCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGF 760
++ R I + VQ R + + LM + ++ G
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 33/217 (15%)
Query: 473 DNFASYNKLGEGGFGPV----YKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVT----LIA 524
+F LG+G FG V KGT + AVK L K ++ + + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 525 RLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHI 577
+ L +L C Q + + + EY+ L + F + A F
Sbjct: 398 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL-MYHIQQVGRFKEPHAVFY-------- 447
Query: 578 VGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKV 637
IA G+ +L II+RDLK NV+LD++ + KI+DFGM + D + T T
Sbjct: 448 AAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--F 502
Query: 638 VGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
GT Y++PE A + D ++FGVL+ E+++G+
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 53/209 (25%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 481 LGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLV 532
+G G + V LV + A++ + K E+ T H LV
Sbjct: 60 IGRGSYAKVL---LVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 533 KLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGI 585
L C Q + + + EY+ L F + A F I+ +
Sbjct: 117 GLH-SCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFY--------SAEISLAL 166
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH+ II+RDLK NVLLD++ + K++D+GM + T+T GT Y++
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 221
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
PE + D ++ GVL+ E+++G+
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEFKNEVT----LIARLQHRNLVKLL 535
+G+G FG V + AVK L K + +E K+ ++ L+ ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 536 GCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYL 588
Q + + + +Y+ L F+ F + RA F IA + YL
Sbjct: 106 -FSFQTADKLYFVLDYINGGEL-FYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H + I++RDLK N+LLD+ + ++DFG+ + T+T GT Y++PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPEV 210
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + D + G ++ E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 41/210 (19%)
Query: 481 LGEGGFGPVYKGTLVEGQEI-AVKRLSKGSGQGMEEF---KNEVTLIARLQHRNLVKLLG 536
LG G FG V+ A+K L K +++ +E +++ + H ++++ G
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 537 CCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLH 589
Q + + +I +Y+ L F F A F + + + YLH
Sbjct: 74 TF-QDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAE--------VCLALEYLH 123
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-- 647
II+RDLK N+LLD + + KI+DFG A+ + T+ + GT Y++PE
Sbjct: 124 S---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVV 175
Query: 648 ----YAAEGLFSVKSDVFSFGVLVLEIVSG 673
Y S+ D +SFG+L+ E+++G
Sbjct: 176 STKPYNK----SI--DWWSFGILIYEMLAG 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 55/228 (24%), Positives = 98/228 (42%), Gaps = 49/228 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 522 LIARLQHRNLVKLLGCCI-QADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ R +H N++ + E M ++ + M K L + +Q
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ- 136
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
I RG+ Y+H S ++HRDLK SN+LL+ + KI DFG+AR+ D T
Sbjct: 137 -------ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186
Query: 634 --THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
T V T Y +PE + + K D++S G ++ E++S +
Sbjct: 187 FLTEYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 36/161 (22%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGC 537
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV 79
Query: 538 C---IQADESM-LIYEYMP---------NKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584
+ + ++ E + ++ F +A I+ I
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEA 129
Query: 585 ILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMA 622
I YLH + I HRD+K N+L + K++DFG A
Sbjct: 130 IQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 53/238 (22%), Positives = 95/238 (39%), Gaps = 60/238 (25%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ LG GG G V+ + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 522 LIARLQHRNLVKLL----------GCCIQADESM----LIYEYMP---NKSLDFFIFDQA 564
+I RL H N+VK+ + + + ++ EYM L+ +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 565 RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMAR 623
A +Q + RG+ Y+H + ++HRDLK +N+ ++ D+ KI DFG+AR
Sbjct: 121 HARLFMYQ--------LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLAR 169
Query: 624 IFGGDEIQTN--THKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
I + +V T Y SP L S + D+++ G + E+++GK
Sbjct: 170 IMDPHYSHKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 481 LGEGGFGPVY---KGTLVEGQEI-AVKRLSKGS----GQGMEEFKNEVTLIARLQHRN-L 531
LG G +G V+ K + + ++ A+K L K + + E + E ++ ++ L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 532 VKLLGCCIQADESM-LIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARG 584
V L Q + + LI +Y+ L F F + VG I
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 585 ILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
+ +LH+ + II+RD+K N+LLD++ + ++DFG+++ F DE + + GT YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYM 227
Query: 645 SPE---YAAEG-LFSVKSDVFSFGVLVLEIVSGK 674
+P+ G +V D +S GVL+ E+++G
Sbjct: 228 APDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 41/194 (21%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
+G G +G VY + +A+K++++ F++ E+T++ RL+
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREITILNRLKSD 85
Query: 530 NLVKLLGCCIQADESM-----LIYEYMPN------KSLDFFIFDQARATFLDWQKRIHIV 578
+++L I D ++ E + K+ F + + + +
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK--TILYN------ 137
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVV 638
+ G ++H IIHRDLK +N LL+ D + K+ DFG+AR ++ + +
Sbjct: 138 --LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 639 GTYGYMSPEYAAEG 652
+
Sbjct: 193 ENEEPGPHNKNLKK 206
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-14
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHR 529
LGEG +G V T G+ +A+K++ F E+ ++ +H
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 530 NLVKLLGCCIQADESM------LIYEYMP---NKSLDFFIFDQARATFLDWQKRIHIVGG 580
N++ + + D +I E M ++ + + + +Q
Sbjct: 70 NIITIFNI-QRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQ-------- 120
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
R + LH + +IHRDLK SN+L++++ + K+ DFG+ARI DE + + G
Sbjct: 121 TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADNSEPTGQ 175
Query: 641 YGYMSPEY-------AAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
M E+ A E + + DV+S G ++ E+ +
Sbjct: 176 QSGMV-EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 48/225 (21%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ S +G G +G V G+++A+K+LS+ F++ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKR 574
L+ +QH N++ LL S+ L+ +M L + F + + +
Sbjct: 76 LLKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQ 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
++V + +G+ Y+H ++HRDLK N+ ++ D KI DFG+AR + T
Sbjct: 130 -YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----T 181
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
VV T Y +PE + S D++S G ++ E+++GK
Sbjct: 182 GYVV-TRWYRAPEV----ILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 47/216 (21%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVTLIARLQHRN 530
+G G +G V G ++A+K+L + F++ E+ L+ ++H N
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMRHEN 85
Query: 531 LVKLLGCCIQADESM-------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LL DE++ L+ +M L + + L + +V + +
Sbjct: 86 VIGLLDV-FTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLK 139
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
G+ Y+H IIHRDLK N+ ++ D KI DFG+AR + T VV T Y
Sbjct: 140 GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVV-TRWY 191
Query: 644 MSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGK 674
+PE + + D++S G ++ E+++GK
Sbjct: 192 RAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 71/276 (25%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ + + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 522 LIARLQHRNLVKLLGCCIQADESM-------LIYEYMP---NKSLDFFIFDQARATFLDW 571
L+ ++H N++ LL S+ L+ M N + FL +
Sbjct: 81 LLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY 139
Query: 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631
Q I RG+ Y+H IIHRDLK SN+ ++ D KI DFG+AR +
Sbjct: 140 Q--------ILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEM 186
Query: 632 TNTHKVVGTYGYMSPEYAAEGLFSVKS-----DVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
T V T Y +PE + + D++S G ++ E+++G+ F DH
Sbjct: 187 TGY---VATRWYRAPEI----MLNWMHYNQTVDIWSVGCIMAELLTGRT--LFPGTDHID 237
Query: 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCI 722
L K + L G P E+L+ I
Sbjct: 238 QL----------KLILRLVG------TPGAELLKKI 257
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.9 bits (170), Expect = 5e-13
Identities = 34/199 (17%), Positives = 56/199 (28%), Gaps = 46/199 (23%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRL--------SKGSGQGMEEFKNEVTL 522
T+ K+GEG FG V++ + +A+K + + + EE E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 523 IARLQ---------HRNLVKLLGCCI----------QADESMLIYEYMPNKSLDFFIFDQ 563
L + L +A + + N DFF DQ
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 564 A----------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607
R I+ + + +R HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 608 LDNDMNPKISDFGMARIFG 626
L K+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 47/200 (23%), Positives = 88/200 (44%), Gaps = 38/200 (19%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKN---------EVT 521
+ KLG+G +G V+K G+ +AVK++ F+N E+
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 522 LIARLQ-HRNLVKLLGCCIQADESM----LIYEYMP---NKSLDFFIFDQARATFLDWQK 573
++ L H N+V LL + ++ L+++YM + + I + ++ +Q
Sbjct: 61 ILTELSGHENIVNLLN--VLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ- 117
Query: 574 RIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633
+ + I YLH S ++HRD+K SN+LL+ + + K++DFG++R F TN
Sbjct: 118 -------LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 634 THKVVGTYGYMSPEYAAEGL 653
+ + + L
Sbjct: 168 NIPLSINENTENFDDDQPIL 187
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 2e-10
Identities = 21/122 (17%), Positives = 43/122 (35%), Gaps = 15/122 (12%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
+ +T + + G++L + + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLD--VEPYHFIMQEDCNL------VLYDH---STSVWASNTGILGK 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
+ + V+ D R W+S++ N V+ L + GN+V+ Y S +W +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTG 106
Query: 139 DH 140
+
Sbjct: 107 TY 108
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 50/230 (21%), Positives = 83/230 (36%), Gaps = 58/230 (25%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
KLG G F V+ +V +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 536 GCCIQADESMLIYEYMPN--KSLDFFIFDQARATFL------------DWQKR------- 574
AD + + K LD F + K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 575 IHIVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNP------KISDFGMARI 624
+ V I++ +L Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-C 186
Query: 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ + + T Y SPE + +D++S L+ E+++G
Sbjct: 187 WYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 2e-10
Identities = 22/120 (18%), Positives = 47/120 (39%), Gaps = 17/120 (14%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
++++ S+ G +L V ++ L + Y W +N T
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASN--TGGL 49
Query: 79 DQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L + + G +V+ D +R+ W + T+ + V+ L N+V+ Y ++W +
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVI----YGPVVWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 1e-09
Identities = 21/125 (16%), Positives = 46/125 (36%), Gaps = 14/125 (11%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
+D + + G +L G + + L ++ W + T
Sbjct: 1 SDRLNSGHQLDTGGSLA--EGGYLFIIQNDC-----NLVLYDNN----RAVWASG--TNG 47
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
+L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 48 KASGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWAT 106
Query: 138 FDHPC 142
+
Sbjct: 107 HTNVG 111
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-09
Identities = 21/121 (17%), Positives = 39/121 (32%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + Q++ +L G + L + + Y+ W +N T
Sbjct: 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCNL------VKYQN---GRQIWASN--TDR 48
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
L + S G +V+ D + W S + L G V+ Y +LW
Sbjct: 49 RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVI----YGPVLWS 104
Query: 137 S 137
Sbjct: 105 L 105
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.2 bits (134), Expect = 1e-08
Identities = 40/262 (15%), Positives = 72/262 (27%), Gaps = 35/262 (13%)
Query: 14 ASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSA--KRYLGIWYKRVSPRTVAWVA 71
+ Q++ G+ L+S N F+L G +W + +
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIP 69
Query: 72 NRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSI-----TMKNPVVQLMDSGNLVLT 126
R ++ L G L D R W ++ S + L D GN+V
Sbjct: 70 LR----NKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV-L 124
Query: 127 DGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGF 186
+ + + L + + G L G
Sbjct: 125 VDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGA---------GASKLVFQGDGN 175
Query: 187 PQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVI--NENEVYYECDAKGPAV 244
G+ +WN T V D V+ N V + G A
Sbjct: 176 LVAYGPNGAA------TWN--AGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHAS 227
Query: 245 SRLWVNQSG-LVL---RSIWSS 262
+ L + +G + + + +W+
Sbjct: 228 AVLRLQANGSIAILDEKPVWAR 249
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 3e-08
Identities = 26/121 (21%), Positives = 45/121 (37%), Gaps = 18/121 (14%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L NG + + Y W N T
Sbjct: 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCNL------VLYDV---DKPIWATN--TGG 47
Query: 78 TDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136
D+ L++ S G +V+ R+ W+SNT N V L N+V+ Y + W
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVI----YGTARWA 103
Query: 137 S 137
+
Sbjct: 104 T 104
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 49/222 (22%), Positives = 82/222 (36%), Gaps = 50/222 (22%)
Query: 478 YNKLGEGGFGPVYKGT-LVEGQEIAVK---RLSKGSGQGMEEFKNEVTLIARLQHR---- 529
+ +G+G FG V K VE + +A+K Q EV L+ +
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEM 114
Query: 530 --NLVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIV 578
+V L C+ E S +Y+ + N + + R
Sbjct: 115 KYYIVHLKRHFMFRNHLCL-VFEMLSYNLYDLLRNTNFRGVSLNLTR----------KFA 163
Query: 579 GGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHK 636
+ +L+L + IIH DLK N+LL N KI DFG + +
Sbjct: 164 QQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---------CQLGQ 213
Query: 637 VVGTY----GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
+ Y Y SPE + + D++S G +++E+ +G+
Sbjct: 214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 42/178 (23%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
K+G G FG +Y GT + G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRII 597
+ D ++++ E + SL+ +F+ F + + + + I Y+H + I
Sbjct: 74 GAEGDYNVMVMELL-GPSLE-DLFNFCSRKF-SLKTVLLLADQMISRIEYIHSKN---FI 127
Query: 598 HRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH-------KVVGTYGYMS 645
HRD+K N L+ I DFG+A+ + + +T+ H + GT Y S
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLTGTARYAS 183
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 40/187 (21%), Positives = 68/187 (36%), Gaps = 38/187 (20%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG + G L + +A+K S + + ++
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-YKQLGSGDGIPQVYYFG 74
Query: 539 IQADESMLIYEYMPNKSL-DFFIFDQARATFLDWQKR---IHIVGGIARGIL----YLHQ 590
+ ++ E + SL D F D R + V IA ++ Y+H
Sbjct: 75 PCGKYNAMVLELL-GPSLEDLF----------DLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH-------KVV 638
+ +I+RD+K N L+ N I DF +A+ + + +T H +
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYREHKSLT 178
Query: 639 GTYGYMS 645
GT YMS
Sbjct: 179 GTARYMS 185
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 47/396 (11%), Positives = 113/396 (28%), Gaps = 101/396 (25%)
Query: 25 QSIRDGETLVSVNGTFELGFFSPGTS-----AKRYLGIWYKRVSPRTVAW--VANRETPL 77
+R + ++ ++G LG G + + + + W + N +P
Sbjct: 145 LELRPAKNVL-IDGV--LGS---GKTWVALDVCLSYKV--QCKMDFKIFWLNLKNCNSPE 196
Query: 78 TD----QSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGN--LVLTDGNYN 131
T Q L + D I ++ +++ N LVL N
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL-LNVQN 255
Query: 132 SLLWQSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWK----SINDPAPG----E----FSL 179
+ W +F+ C LL R K D LS+ S++ + E
Sbjct: 256 AKAWNAFNLSCKILL----TTRF-KQVTDF-LSAATTTHISLDHHSMTLTPDEVKSLLLK 309
Query: 180 WIDT----------HGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLC------- 222
++D P+ + ++ +W+ L +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 223 DYKFVINENEVYYEC-----DAKGPA--VSRLWVNQSGLVLRSIWSS-------QQDVWF 268
+Y+ +++ A P +S +W + + + + ++
Sbjct: 370 EYR------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKE 423
Query: 269 LAYYAP---LD-RCDLYSVCGANARCTTN-SSRRCDCLEGFVPKSPNNWS--------EG 315
P L+ + L + + + + + + +P + + +
Sbjct: 424 STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKN 483
Query: 316 CVRERELKCRNGDEFPK------YVKLKLPDTSSSW 345
+ F +++ K+ S++W
Sbjct: 484 IEHPERM-----TLFRMVFLDFRFLEQKIRHDSTAW 514
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.3 bits (101), Expect = 4e-04
Identities = 52/413 (12%), Positives = 121/413 (29%), Gaps = 93/413 (22%)
Query: 306 PKSPNNWSEGCVRERELKCRNGDEFPKY--------VKLKLPDTSSSWFNASMNLKECSE 357
+ P+ + + +R+ + F KY +KL+ A + L+
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR---------QALLELRPAKN 152
Query: 358 L-------CSKNC-SCTAYANSDVERGGSGCLLWFGDLMDMKEYNDGG------QDLYIR 403
+ K + + V+ + W +++K N Q L +
Sbjct: 153 VLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW----LNLKNCNSPETVLEMLQKLLYQ 208
Query: 404 IASERGRSVTKKQVGIIIASVLLMAMFIVASLFCIWRKKLKKQGLTKMSHMKEDMELWE- 462
I +++ L I A L + + K + L + +++ + + W
Sbjct: 209 IDPN------WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQ-NAKAWNA 261
Query: 463 FDF----------ASIAKATDNFASYNKLGE---GGFGPVYKGTLVEGQEIAVKRLSKGS 509
F+ + + + + T E + + L K
Sbjct: 262 FNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL------TPDEVKSL----LLKYL 311
Query: 510 GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY--EYMPNK-------SLDFFI 560
++ EV + ++ I+ + +K SL+
Sbjct: 312 DCRPQDLPREVLTTNPR----RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367
Query: 561 FDQARATFLD---WQKRIHIVGGIARGILYLHQDSR--MRIIHRDLKASNVLLDNDMNP- 614
+ R F + HI + +++ M ++++ K S L++
Sbjct: 368 PAEYRKMFDRLSVFPPSAHIPTILL-SLIWFDVIKSDVMVVVNKLHKYS--LVEKQPKES 424
Query: 615 KISDFGMA-RIFGGDEIQTNTHK-VVGTYGYMSPEYAAEGLFSVKSD--VFSF 663
IS + + E + H+ +V Y + ++ L D +S
Sbjct: 425 TISIPSIYLELKVKLENEYALHRSIVDHYNIPK-TFDSDDLIPPYLDQYFYSH 476
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 39/182 (21%), Positives = 75/182 (41%), Gaps = 30/182 (16%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV-KLLGC 537
K+G G FG +Y GT + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
++ D ++L+ + + SL+ +F+ + V +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLE-DLFNFCSRKL-----SLKTVLMLADQMINRVEFVHS--- 121
Query: 594 MRIIHRDLKASNVLLDNDMNPK---ISDFGMARIFGGDEIQTNTH-------KVVGTYGY 643
+HRD+K N L+ I DFG+A+ + + T+ H + GT Y
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY--RDTSTHQHIPYRENKNLTGTARY 179
Query: 644 MS 645
S
Sbjct: 180 AS 181
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 30/203 (14%), Positives = 62/203 (30%), Gaps = 50/203 (24%)
Query: 479 NKLGEGGFGPVYKGT---------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR 529
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 530 NLVKLLGC---CI---------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHI 577
KL I Q L+ + +SL + +
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVL-----SERS 160
Query: 578 VGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIFGGDEIQ 631
V +A +L +LH++ +H ++ A N+ +D + ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY----CP 213
Query: 632 TNTHK---------VVGTYGYMS 645
+ H G ++S
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFIS 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 38/200 (19%), Positives = 69/200 (34%), Gaps = 46/200 (23%)
Query: 480 KLGEGGFGPVYKGTLVEGQEI------AVKRLSKGSGQGMEEFK-----NEVTLIARLQH 528
+G+GGFG +Y + + + VK +G E K + I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 529 RNLVKLLG-----CCIQADESMLIYEYMP----NKSLDFFIFDQARATFLDWQKR---IH 576
+K LG D++ Y +M L + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQ---------KIYEANAKRFSRK 152
Query: 577 IVGGIARGIL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIF----G 626
V ++ IL Y+H+ +H D+KASN+LL+ ++ D+G+A +
Sbjct: 153 TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209
Query: 627 GDEIQTNTHKV-VGTYGYMS 645
+ + GT + S
Sbjct: 210 HKAYAADPKRCHDGTIEFTS 229
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 39/184 (21%), Positives = 76/184 (41%), Gaps = 32/184 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGC 537
++GEG FG +++GT L+ Q++A+K + S ++E L + +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 74
Query: 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL----YLHQDSR 593
+ ++L+ + + SL+ + D F + V A+ +L +H
Sbjct: 75 GQEGLHNVLVIDLLG-PSLE-DLLDLCGRKF-----SVKTVAMAAKQMLARVQSIH---E 124
Query: 594 MRIIHRDLKASNVLLDNDMNPK-----ISDFGMARIFGGDEIQTNTH-------KVVGTY 641
+++RD+K N L+ + + DFGM + + + T H + GT
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY--RDPVTKQHIPYREKKNLSGTA 182
Query: 642 GYMS 645
YMS
Sbjct: 183 RYMS 186
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 4e-07
Identities = 24/133 (18%), Positives = 42/133 (31%), Gaps = 26/133 (19%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + Q++ L NG F+L + Y G W ++ R+
Sbjct: 2 GTNYLLSGQTLDTEGHLK--NGDFDLVMQDDC-NLVLYNGNW------QSNTANNGRDCK 52
Query: 77 LTDQS-GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
LT G L V+ +G W S N + G LV+ + ++
Sbjct: 53 LTLTDYGEL-------VIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVV----FGPSVF 101
Query: 136 QSFDHPCDTLLPG 148
+ D + G
Sbjct: 102 KI-----DPWVRG 109
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 52/219 (23%)
Query: 481 LGEGGFGPVYKGT-LVEGQEIAVKRL---SKGSGQGMEEFKNEVTLIARLQHR------N 530
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 531 LVKLLGC-------CIQADE--SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++ +L C+ E SM +YE + F R I
Sbjct: 161 VIHMLENFTFRNHICM-TFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSI 209
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVG 639
+ + LH + RIIH DLK N+LL K+ DFG + H+ V
Sbjct: 210 LQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---------CYEHQRVY 257
Query: 640 TY----GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
TY Y +PE + + D++S G ++ E+++G
Sbjct: 258 TYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 21/122 (17%), Positives = 41/122 (33%), Gaps = 19/122 (15%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
N+ + Q + L + +L + W +N T
Sbjct: 5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNLV----------LYGGKYGWQSN--TH 50
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
+ L + KG +++ D + WSS +S V+ L D G V+ Y ++
Sbjct: 51 GNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI----YGPAIF 106
Query: 136 QS 137
++
Sbjct: 107 ET 108
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-06
Identities = 14/73 (19%), Positives = 25/73 (34%), Gaps = 7/73 (9%)
Query: 66 TVAWVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLV 124
W N T + G +V++ + W S + + V+ L N+V
Sbjct: 49 NPIWATN--TGGLGNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 125 LTDGNYNSLLWQS 137
+ Y LW +
Sbjct: 107 I----YGDALWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 14/77 (18%), Positives = 26/77 (33%), Gaps = 1/77 (1%)
Query: 61 RVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDS 120
P+ + + E + + ++L + W++NT L
Sbjct: 11 DNHPQILHATESLEILFGTHVYRFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPD 70
Query: 121 GNLVLTDGNYNSLLWQS 137
G LV+ N +WQS
Sbjct: 71 GVLVVITNE-NVTVWQS 86
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 5e-06
Identities = 22/122 (18%), Positives = 41/122 (33%), Gaps = 16/122 (13%)
Query: 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETP 76
+ + SQ + D L + + L + K S + W + T
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESG--TS 53
Query: 77 LTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135
Q + + G + + D R + SNT + V+ L +G V+ Y +W
Sbjct: 54 GRGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV----YGPAVW 109
Query: 136 QS 137
+
Sbjct: 110 ST 111
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 33/192 (17%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIA---VKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLL 535
K+G GGFG +Y + ++ A VK + +G +E+ R+ ++ +K
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP----LFSELKFYQRVAKKDCIKKW 99
Query: 536 GCCIQADES---MLIY---EYMPNKSLDFFIFD---QARATFLDWQKR--IHIVGGIARG 584
Q D + +S F + + V +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 585 IL----YLHQDSRMRIIHRDLKASNVLLDNDMNPKI--SDFGMARIF----GGDEIQTNT 634
+L Y+H++ +H D+KA+N+LL ++ +D+G++ + + Q N
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216
Query: 635 HKV-VGTYGYMS 645
K GT + S
Sbjct: 217 RKGHNGTIEFTS 228
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 50/268 (18%), Positives = 86/268 (32%), Gaps = 94/268 (35%)
Query: 480 KLGEGGFGPVYKG-TLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLG G F V+ + + +A+K + K + E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 539 IQADESMLIYEYMPNKSLDFF------------IFDQARATFLDWQKR-------IHIVG 579
+D + E + + LD F +F+ L W + + V
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 580 GIARGIL----YLHQDSRMRIIHRDLKASNVLL--------------------------- 608
I + +L YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 609 ----------------------DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSP 646
+ KI+D G A + T + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW--VHKHFTE---DIQTRQYRSL 262
Query: 647 EYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
E ++ +D++S + E+ +G
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 14/70 (20%), Positives = 24/70 (34%), Gaps = 5/70 (7%)
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
V + T + G + +L ++ W+S S + V L NL +
Sbjct: 170 RVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAI-- 227
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 228 --YGGALWTT 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.83 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.82 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.81 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.79 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.72 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.64 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.62 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.62 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.57 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.53 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.5 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.15 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.15 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.12 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.92 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.9 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.88 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.82 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.72 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.05 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.01 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.66 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.5 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.96 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.85 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.76 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.69 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.64 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.45 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.24 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.35 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-53 Score=448.16 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=216.7
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 367899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc----------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 547 IYEYMPNKSLDFFIFDQA----------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
|||||++|+|.++|.... ....++|.+++.|+.||++||.|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 2356999999999999999999999987 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
+|||+++...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .+. ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~----~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVI----EC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HH
Confidence 99999997755444334444679999999999999999999999999999999999 89999743321 111 11
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
... ......|...+.++.+|+.+||+.+|++||||+||++.|++.
T Consensus 243 i~~---------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQ---------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHc---------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 112234455667789999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=448.21 Aligned_cols=259 Identities=29% Similarity=0.453 Sum_probs=215.4
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.+++..++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999863 46789999997553 345678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 546 LIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
||||||++|+|.++|..... ...++|.++++|+.|||+||+|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975321 346899999999999999999999987 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
++||+|||+++.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||...... .+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~-- 257 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVV-- 257 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHH--
Confidence 999999999987754443344455789999999999999999999999999999999999 89999743321 111
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
..+......+.|...+..+.+|+.+||+.+|++||||+||+++|+...
T Consensus 258 -----------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 258 -----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -----------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 111112223445566778999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=453.65 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=210.1
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|...++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999864 378899999988777778899999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhccc------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 547 IYEYMPNKSLDFFIFDQAR------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
|||||++|+|.+++..... ..+++|.+++.|+.||++||.|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 346999999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||+++.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... .++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~---- 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAI---- 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHH----
Confidence 9999999997755444444445789999999999999999999999999999999999 89999643221 111
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
..+.+ ......|...+.++.+|+.+||+.||++||||+||+++|+.+..
T Consensus 271 ~~i~~---------g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQ---------GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHH---------TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHc---------CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111 11223445566778999999999999999999999999987643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=436.21 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=203.5
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
+++...++||+|+||+||+|+++. .||||+++.. ..+..+.|.+|+.+|++++|||||+++|++.+ +..+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 456778899999999999998753 6999998654 34556789999999999999999999998864 568999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|++|+|.++|... ...++|.+++.|+.||++||+|||+++ |+||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 9999999999653 346999999999999999999999987 99999999999999999999999999987654333
Q ss_pred cccccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
........||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ .......+ ...+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~----~~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRG----YASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTT----CCCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC----CCCC
Confidence 333445789999999999853 4699999999999999999999999974332110 11111111 1111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ....+...+..+.+|+.+||+.+|++||||.||+++|+.+
T Consensus 258 ~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 D-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp C-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred C-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1223445567788999999999999999999999999765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=436.69 Aligned_cols=269 Identities=28% Similarity=0.407 Sum_probs=220.0
Q ss_pred cCHHhHHHhhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhccc-ccceee
Q 003832 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQH-RNLVKL 534 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H-~niv~l 534 (792)
++..+.+...++|++.++||+|+||+||+|++.. ++.||||++..... ...++|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4444445556889999999999999999998643 36899999976543 445689999999999965 999999
Q ss_pred eeeEEeC-CcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecC
Q 003832 535 LGCCIQA-DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600 (792)
Q Consensus 535 ~g~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 600 (792)
+|+|.+. +..+||||||++|+|.++|..... ...++|.+++.++.|||+||.|||+++ |+|||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 568999999999999999975432 345899999999999999999999988 99999
Q ss_pred CCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCC
Q 003832 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (792)
Q Consensus 601 lkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~ 679 (792)
|||+||||++++.+||+|||+|+.+..+..........||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765544444555789999999999999999999999999999999998 9999975
Q ss_pred CCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 680 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...... ....+. ...+...|...+.++.+++.+||+.||++||||+||+++|+..
T Consensus 291 ~~~~~~------~~~~i~---------~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 291 VKIDEE------FCRRLK---------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCCSHH------HHHHHH---------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCHHHH------HHHHHH---------cCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 433211 111111 1122234445566788999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=429.75 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=203.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+++++||+|+||+||+|+.. +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999865 5899999999754 33456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
||++|+|.+++... +...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999654 3445788999999999999999999998 9999999999999999999999999998764221
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. .......
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~----~~i~~~~--------- 241 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLV----LKIISGS--------- 241 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTC---------
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHHcCC---------
Confidence 1223467999999999999999999999999999999999999999743221 111 0011110
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 112233455678899999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=427.66 Aligned_cols=250 Identities=22% Similarity=0.345 Sum_probs=209.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999875 58999999997665555677899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.+ ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 99999999854 34899999999999999999999998 99999999999999999999999999997754322
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ... .... ....+ ..
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~-----~~~~~--~~ 290 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMIR-----DNLPP--RL 290 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHH-----HSSCC--CC
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHHH-----cCCCC--CC
Confidence 233478999999999999999999999999999999999999999643221 111 1111 10111 11
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+.....++.+|+.+||+.||++|||++|++++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2233455678899999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=420.38 Aligned_cols=252 Identities=22% Similarity=0.264 Sum_probs=205.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.+.|+..++||+|+||.||+|++. +|+.||||+++.... ..+|+.++++++|||||++++++.+.+..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 457888899999999999999875 489999999976432 24699999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccCCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFGGDE 629 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~~~~ 629 (792)
|++|+|.+++.+. +.+++.++..++.||+.||.|||+++ |+||||||+||||+.++ ++||+|||+|+.+....
T Consensus 132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 9999999999653 35899999999999999999999988 99999999999999987 69999999999875432
Q ss_pred cc---ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 630 IQ---TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 630 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. ......+||+.|||||++.+..|+.++|||||||+||||++|+.||........ ... ... .
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~---i~~-~------- 271 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK---IAS-E------- 271 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH---HHH-S-------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH---HHc-C-------
Confidence 21 122346899999999999999999999999999999999999999976544322 110 000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+......++..+..+.+++.+||+.||++|||+.|+++.|..
T Consensus 272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 111112344556678899999999999999999999988754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=420.96 Aligned_cols=267 Identities=21% Similarity=0.245 Sum_probs=200.7
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC----cceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 548 (792)
++|.+.++||+|+||+||+|++ +|+.||||++..... ....+..|+..+.+++|||||+++++|.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4677888999999999999998 689999999965322 1223345666677899999999999998765 468999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-----CCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
|||++|+|.+++.. ..++|..+++++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999954 3489999999999999999999986 23459999999999999999999999999998
Q ss_pred ccCCCCcc--ccccccccccCccccccccCC------CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc--h--hHH
Q 003832 624 IFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN--L--LGH 691 (792)
Q Consensus 624 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~--l--~~~ 691 (792)
........ .......||+.|||||++.+. .++.++|||||||+||||+||+.|+.......... . ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76543222 223346899999999998654 47889999999999999999998875432211100 0 000
Q ss_pred HHHHHhhhhhhhhccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 692 AWILWKEKRAMELAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..... ...+.+..++...| .+.+..+.+|+.+||+.||++||||.||+++|+++
T Consensus 237 ~~~~~----~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEM----RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHH----HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHH----HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000 01112222222222 34567889999999999999999999999999764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=418.46 Aligned_cols=248 Identities=25% Similarity=0.341 Sum_probs=209.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||+||+++.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57999999999999999999875 5899999999753 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++.+. +.+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999653 35899999999999999999999998 999999999999999999999999999987654
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||...+.. .+. ...... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i~~~--------~ 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIF----AKIIKL--------E 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHT--------C
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcC--------C
Confidence 4444455678999999999999999999999999999999999999999743211 111 001111 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl 743 (792)
...|.....++.+|+.+||+.||++|||++|++
T Consensus 251 --~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred --CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122334456788999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=410.79 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=196.6
Q ss_pred ccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC----CcceEEE
Q 003832 476 ASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----DESMLIY 548 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~lV~ 548 (792)
+..++||+|+||+||+|++.. ++.||+|++... .....+.|.+|+++|++++|||||++++++.+. ...+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 556789999999999998754 889999998653 334567899999999999999999999998762 4579999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~ 627 (792)
|||++|+|.+++.+. ..+++..+..++.||+.||.|||+++ ++|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 999999999999653 45899999999999999999999875 35999999999999985 79999999999986433
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||...... ..+ ........ .+
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~----~~~i~~~~-----~~ 248 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQI----YRRVTSGV-----KP 248 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHH----HHHHTTTC-----CC
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHH----HHHHHcCC-----CC
Confidence 2 2234689999999998865 6999999999999999999999999643221 000 01111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 249 ---~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 249 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01112223467899999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=429.04 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=210.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.+.|+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356999999999999999999875 4899999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
|++|+|.+++.. ..+++.++..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 999999999854 34899999999999999999999998 99999999999999999999999999997754322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||....+. ... ... .....+.
T Consensus 303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~----~~i-----~~~~~~~-- 366 (423)
T 4fie_A 303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAM----KMI-----RDNLPPR-- 366 (423)
T ss_dssp --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHH-----HHSCCCC--
T ss_pred --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHH----HHH-----HcCCCCC--
Confidence 234478999999999999999999999999999999999999999643221 111 111 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+.....++.+|+.+||+.||++|||+.|++++
T Consensus 367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11223345678899999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=401.55 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=191.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999865 58999999997542 334567999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+ +|+|.+++.+. +.+++.++..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67898888653 45999999999999999999999998 999999999999999999999999999876433
Q ss_pred CccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. ......||+.|||||++.+..+ +.++||||+||++|||++|+.||...... .+. ......
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~----~~i~~~-------- 227 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLF----KNISNG-------- 227 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHT--------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcC--------
Confidence 2 2234689999999999988876 57999999999999999999999643211 111 011111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ...+...+.++.+|+.+||+.||++|||++|++++
T Consensus 228 ~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 228 V--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred C--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 12233345678899999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=409.09 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=197.3
Q ss_pred cccccccccCcCCcccEEeeecc----CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|++.++||+|+||+||+|+.. .++.||||++++.. ......+.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 36789999997642 2234468899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|||||++|+|.+++.+. +.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999653 35899999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .......||+.|||||++.+..|+.++||||+||+||||+||+.||...... .+. .... .
T Consensus 178 ~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~----~~i~--------~ 240 (304)
T 3ubd_A 178 DHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETM----TMIL--------K 240 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH--------H
T ss_pred CCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHH----HHHH--------c
Confidence 322 1233468999999999999999999999999999999999999999743221 111 0000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~ 744 (792)
. ....|...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 241 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 112334455678899999999999999984 67765
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=402.03 Aligned_cols=248 Identities=23% Similarity=0.380 Sum_probs=190.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-------
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------- 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------- 543 (792)
++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 56899999999999999999865 589999999976543 345679999999999999999999999976553
Q ss_pred -----ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEee
Q 003832 544 -----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 544 -----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
.++|||||++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999977655555677788999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCcc----------ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch
Q 003832 619 FGMARIFGGDEIQ----------TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (792)
Q Consensus 619 Fgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l 688 (792)
||+|+.+...... ......+||+.|||||++.+..|+.++|||||||+||||++ ||.... ..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HH
Confidence 9999987543211 11223579999999999999999999999999999999996 664110 00
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHP---PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
. .. ..... ....| ......+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~----~~-----~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 V----RT-----LTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----HH-----HHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HH-----HHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00 00000 11122 223345678999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=391.34 Aligned_cols=288 Identities=35% Similarity=0.588 Sum_probs=246.3
Q ss_pred cCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC
Q 003832 463 FDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD 542 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~ 542 (792)
+.+.++..++++|+..+.||+|+||.||+|++.+++.||||++........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445566889999999999999999999998889999999998777677889999999999999999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999986543 2335899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
++...............||+.|+|||.+.+..++.++||||||+++|||++|+.||....+........+..........
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98754333222334456899999999999899999999999999999999999999876666555555555444445555
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCC
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLP 753 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~ 753 (792)
...+++......+...+..+.+++.+||+.+|++|||+.||++.|+....+.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 5666777777778889999999999999999999999999999998764443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=395.03 Aligned_cols=263 Identities=21% Similarity=0.330 Sum_probs=200.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC------Cc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------DE 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~~ 543 (792)
++|++.++||+|+||+||+|++. +|+.||||++++.. ....+.+.+|+++|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 67999999999999999999875 58999999997643 34456788999999999999999999997643 56
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.|||||||+ |+|.+++.. .+.+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 799999996 678888854 346999999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC--ccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh--
Q 003832 624 IFGGDE--IQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE-- 698 (792)
Q Consensus 624 ~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-- 698 (792)
.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+ ......
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPS 283 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCC
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCC
Confidence 764322 12223457899999999998765 5799999999999999999999999754322111000 000000
Q ss_pred ---------hhhhhhcccc-ccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 ---------KRAMELAGDT-LADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ---------~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+... .....+ +....++.+|+.+||+.||++|||++|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 000111 1123567899999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=381.83 Aligned_cols=289 Identities=41% Similarity=0.684 Sum_probs=242.0
Q ss_pred ccccCHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeE
Q 003832 460 LWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (792)
Q Consensus 460 ~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 538 (792)
...+++.++....++|+..+.||+|+||.||+|+..+++.||||++..... .....+.+|+.++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976532 2334789999999999999999999999
Q ss_pred EeCCcceEEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 539 IQADESMLIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 539 ~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
......++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+...++|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999997643 34458999999999999999999999833339999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--CCCccchhHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH--PDHDHNLLGHAWIL 695 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~--~~~~~~l~~~~~~~ 695 (792)
|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .........+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999876533322 2334569999999999988899999999999999999999999996321 12222333443334
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..........+.......+...+..+.+++.+||+.+|++|||+.||+++|++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 444555666666777778889999999999999999999999999999999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.94 Aligned_cols=233 Identities=20% Similarity=0.230 Sum_probs=180.4
Q ss_pred hhccccCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCC----CceeEEec
Q 003832 13 GASAANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQ----SGLLNVTS 88 (792)
Q Consensus 13 ~~~~~~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~----~~~l~~~~ 88 (792)
+++++.|+|++||+|+++++|+|++|+|+||||+++ ++|| |+ +.+ |||+|||++|++++ ++.|+++.
T Consensus 9 ~~~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~ 79 (276)
T 3m7h_A 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAF 79 (276)
T ss_dssp CCCTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEE
T ss_pred eccccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeC
Confidence 467889999999999999999999999999999543 5777 77 777 99999999999885 78999999
Q ss_pred CceEEe---CCCCceEEeeccCCC-----CCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCc
Q 003832 89 KGIVLL---DGRDRIFWSSNTSIT-----MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (792)
Q Consensus 89 ~g~l~l---~~~~~~~Wss~~~~~-----~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~ 160 (792)
||+|+| |++|.+||+|+++.. ..+.+|+|+|+|||||+| +.+|||| |||||+|||||+|.++++|+.
T Consensus 80 ~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~~ 154 (276)
T 3m7h_A 80 YVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGSE 154 (276)
T ss_dssp EESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSEE
T ss_pred CCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCcc
Confidence 998866 678999999997642 245789999999999998 6799999 999999999999999998865
Q ss_pred eeEEeeccCCCCCCcceEEeecCCCCceEEEec-CceeeeecCCCCCccccCCCCCCCCcccceeeeeecCc-eEEEEEc
Q 003832 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK-GSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINEN-EVYYECD 238 (792)
Q Consensus 161 ~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~-~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~v~n~~-~~~~~~~ 238 (792)
| ++.+||++|.|+++++++|.. ++++ +...||++|.|++.... ..++. .-.+.+..+++ ...+++.
T Consensus 155 --L---~S~~dps~G~fsl~l~~dGnl--vLy~~~~~~yW~Sgt~~~~~~~--l~l~~---dGnLvl~d~~~~~vWsS~t 222 (276)
T 3m7h_A 155 --L---VQGVVYGAGASKLVFQGDGNL--VAYGPNGAATWNAGTQGKGAVR--AVFQG---DGNLVVYGAGNAVLWHSHT 222 (276)
T ss_dssp --E---CTTCEEEETTEEEEECTTSCE--EEECTTSSEEEECCCTTTTCCE--EEECT---TSCEEEECTTSCEEEECSC
T ss_pred --c---ccCCCCCCceEEEeecCCceE--EEEeCCCeEEEECCCCCCccEE--EEEcC---CCeEEEEeCCCcEEEEecC
Confidence 6 678999999999999999954 4444 56899999999753211 11111 11222333322 2222332
Q ss_pred CCCCceeEEEEecCCcEEEEEeecCCccEEEEEeccC
Q 003832 239 AKGPAVSRLWVNQSGLVLRSIWSSQQDVWFLAYYAPL 275 (792)
Q Consensus 239 ~~~~~~~r~~l~~~G~l~~~~w~~~~~~W~~~~~~p~ 275 (792)
. .....|++|+.+|++++|.| ...|..+|..|.
T Consensus 223 ~-~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 G-GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp T-TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred C-CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 2 23358999999999999998 345665555554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=383.32 Aligned_cols=200 Identities=25% Similarity=0.363 Sum_probs=171.1
Q ss_pred HhhcccccccccCcCCcccEEeeecc----CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
...+.|++.++||+|+||+||+|+.+ .++.||||++.... ....+.+|+++|.++ +|||||++++++.+.++.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45678999999999999999999753 36789999986543 345688999999998 699999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgla~ 623 (792)
+|||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999882 3889999999999999999999998 9999999999999877 799999999998
Q ss_pred ccCCCCcc--------------------------ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCC
Q 003832 624 IFGGDEIQ--------------------------TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKN 676 (792)
Q Consensus 624 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p 676 (792)
........ ......+||+.|||||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432111 112235799999999999775 589999999999999999999999
Q ss_pred CCCC
Q 003832 677 WRFS 680 (792)
Q Consensus 677 ~~~~ 680 (792)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=404.45 Aligned_cols=253 Identities=22% Similarity=0.298 Sum_probs=209.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||.||+++.+ +|+.||+|++........+.+.+|+.+|++++|||||++++++.+....+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999875 4899999999877666677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC--CCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFgla~~~~~~ 628 (792)
|++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999998543 346899999999999999999999998 9999999999999854 89999999999987544
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ....+||+.|||||++.+..|+.++||||+||+||||++|+.||......+ .. ...... +..
T Consensus 311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---~~----~~i~~~------~~~ 374 (573)
T 3uto_A 311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TL----RNVKSC------DWN 374 (573)
T ss_dssp SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHTT------CCC
T ss_pred Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHhC------CCC
Confidence 32 234689999999999999999999999999999999999999997433211 00 000000 001
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...........++.+|+.+||+.||++|||+.|++++
T Consensus 375 ~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 375 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111112334567899999999999999999999984
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=398.08 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=201.6
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHH---HHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEF---KNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|++.++||+|+||.||+++... |+.||||++.+.. ......+ +.++.++..++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 4689999999999999999998764 8999999996431 1222233 3446677778999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
|||||||++|+|..+|.+. +.+++..+..++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999654 45899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
+.... ....+||+.|||||++.. ..|+.++||||+||+||||++|+.||..........+.. .
T Consensus 342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~------------~ 405 (689)
T 3v5w_A 342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------M 405 (689)
T ss_dssp CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH------------H
T ss_pred cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------------h
Confidence 65432 234689999999999964 579999999999999999999999997543322111100 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
.... ....|.....++.+|+.+||+.||++|++ ++||+++
T Consensus 406 i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 406 TLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp HHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred hcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 0000 11234445667889999999999999998 6887763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=361.33 Aligned_cols=284 Identities=35% Similarity=0.550 Sum_probs=234.1
Q ss_pred cccccCHHhHHHhhcccccc------cccCcCCcccEEeeeccCCcEEEEEEccCC----CchhHHHHHHHHHHHHhccc
Q 003832 459 ELWEFDFASIAKATDNFASY------NKLGEGGFGPVYKGTLVEGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQH 528 (792)
Q Consensus 459 ~~~~~~~~~i~~~~~~~~~~------~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H 528 (792)
....|.+.++..++++|... ++||+|+||.||+|+. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45679999999999999877 8899999999999987 6889999998653 23446789999999999999
Q ss_pred ccceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 529 ~niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976555667999999999999999999999988 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l 688 (792)
+.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ +
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--L 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--T
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--H
Confidence 9999999999999987654333333344679999999998865 589999999999999999999999976543322 1
Q ss_pred hHHHHHHH-hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 689 LGHAWILW-KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 689 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
........ ........++... ...+......+.+++..||+.+|++||++.||+++|++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11111111 1122333444433 3456778889999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=369.59 Aligned_cols=266 Identities=26% Similarity=0.436 Sum_probs=208.2
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
...++|++.++||+|+||.||+|+. .++.||||++.... ....+++.+|+.++++++||||+++++++.+....++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 3457899999999999999999987 68899999987653 34456899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 999999999999976544456999999999999999999999875 3499999999999999999999999999986543
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ......
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~------------~~~~~~ 254 (309)
T 3p86_A 192 TF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VV------------AAVGFK 254 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HH------------HHHHHS
T ss_pred cc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH------------HHHHhc
Confidence 22 12234678999999999999999999999999999999999999996432210 00 000001
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPE 754 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 754 (792)
......+......+.+++.+||+.+|++|||+.||++.|+....-..
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 255 CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 11223344455678899999999999999999999999988744333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=371.90 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=214.5
Q ss_pred hcccccccccCcCCcccEEeeecc--------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468899999999999999999752 35679999997653 34567899999999999 899999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976432 235889999999999999999999998 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999987655443333444567889999999999999999999999999999999 999987533211
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+. ..+........+......+.+++.+||+.+|++||++.||++.|+.+
T Consensus 314 ~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LF-------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH-------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH-------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111112233445566788999999999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=361.78 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=213.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|...++||+|+||.||+++.. +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 367888999999999999999875 4889999999777777788999999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 9999999999653 345899999999999999999999998 99999999999999999999999999987643322
Q ss_pred cc------------cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 631 QT------------NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 631 ~~------------~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|..|+....+........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------- 235 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------- 235 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC--------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh--------
Confidence 11 1114579999999999999999999999999999999999999987544332211110
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.....+.. .+...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 236 --~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 236 --VRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp --HHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00111111 1222334578899999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.26 Aligned_cols=269 Identities=24% Similarity=0.314 Sum_probs=209.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc----ceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----SMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----~~lV 547 (792)
.++|+..++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999874 7999999996543 334456679999999999999999999988654 5999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc----------CCCCEEecCCCCCcEEecCCCCceEe
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD----------SRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
|||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999543 489999999999999999999987 6 9999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~ 692 (792)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999988765443333444679999999999976 35677899999999999999999999765443222211110
Q ss_pred HHHHhhhhhhh-hccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 693 WILWKEKRAME-LAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 693 ~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........... .......... ....+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00000000011 1111111111 224566799999999999999999999999999764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=370.12 Aligned_cols=271 Identities=27% Similarity=0.400 Sum_probs=218.5
Q ss_pred cccCHHhHHHhhcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccce
Q 003832 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLV 532 (792)
Q Consensus 461 ~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv 532 (792)
..++....+...++|++.++||+|+||.||+|++ .+++.||||+++... ....+.+.+|++++.++ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 3455566666788999999999999999999963 346789999997653 34456799999999999 799999
Q ss_pred eeeeeEEeCCc-ceEEEeecCCCChhHHHhhccc----------------------------------------------
Q 003832 533 KLLGCCIQADE-SMLIYEYMPNKSLDFFIFDQAR---------------------------------------------- 565 (792)
Q Consensus 533 ~l~g~~~~~~~-~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------- 565 (792)
++++++.+.+. .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999988655 8999999999999999976432
Q ss_pred -----------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 566 -----------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 566 -----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 122889999999999999999999998 999999999999999999999999999876544
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
..........||+.|+|||++.+..++.++||||||+++|||++ |+.||........ ..... ..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~---------~~ 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRL---------KE 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHH---------HH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHH---------Hc
Confidence 43334445678999999999999999999999999999999998 9999975443211 00111 11
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+......+.+++..||+.+|++||+++||+++|++.
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111223334456788999999999999999999999999754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=357.44 Aligned_cols=251 Identities=22% Similarity=0.411 Sum_probs=209.3
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|+..++||+|+||.||+|+. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999985 45889999999766556677899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999998543 4889999999999999999999998 99999999999999999999999999987654332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+... .... .. .....
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~~-~~-------~~~~~ 235 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLI-AT-------NGTPE 235 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHH-HH-------HCSCC
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-Hh-------CCCCC
Confidence 22346799999999999999999999999999999999999999964322100 0000 00 01111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 12234455678899999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=364.40 Aligned_cols=263 Identities=27% Similarity=0.423 Sum_probs=212.0
Q ss_pred hcccccccccCcCCcccEEeeecc----CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467889999999999999999874 3556999999765 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999999543 345899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
..... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .+ ...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~-------------~~~ 266 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR---DV-------------ISS 266 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HH-------------HHH
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH---HH-------------HHH
Confidence 43211 12223456788999999998999999999999999999999 99998643221 00 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEP 755 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p 755 (792)
+........+...+..+.+++..||+.+|++||++.||+++|+.....++.
T Consensus 267 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred HHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111122233445566788999999999999999999999999887544433
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=373.49 Aligned_cols=258 Identities=26% Similarity=0.383 Sum_probs=211.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++|...++||+|+||.||+|++. +++.||||+++... ....++|.+|+.++++++||||+++++++...+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3467889999999999999999986 68899999997653 234457889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999999653 335889999999999999999999998 999999999999999999999999999875433
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
..........+++.|+|||.+....++.++||||||+++|||++ |+.||....... ..+.+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----------------~~~~~~~ 330 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TREFVEK 330 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----------------HHHHHHT
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHc
Confidence 22222222346788999999998899999999999999999998 999986432210 0111111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+...+..+.+++.+||+.+|++|||+++|++.|+.+
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 122233444556788999999999999999999999999754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=355.92 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=214.3
Q ss_pred ccCHHhHHHhhcc----------cccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc
Q 003832 462 EFDFASIAKATDN----------FASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530 (792)
Q Consensus 462 ~~~~~~i~~~~~~----------~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n 530 (792)
.++++++..+++. |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4666777666653 677789999999999999876 68999999998776667788999999999999999
Q ss_pred ceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC
Q 003832 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 531 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 610 (792)
|+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 99999999999999999999999999999843 35899999999999999999999987 999999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG 690 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~ 690 (792)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~---~~-- 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV---QA-- 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HH--
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH--
Confidence 99999999999987654321 223467999999999999999999999999999999999999999643221 00
Q ss_pred HHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 691 HAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... +.....+.. ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 250 --~~~-----~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 --MKR-----LRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHH-----HHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHH-----HhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 111111111 1122334568899999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=369.61 Aligned_cols=272 Identities=26% Similarity=0.408 Sum_probs=219.3
Q ss_pred hhcccccccccCcCCcccEEeeecc--------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
..++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999752 24579999997653 34557899999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEE
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 607 (792)
.+..++||||+++|+|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999976432 245899999999999999999999988 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~ 686 (792)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||++++||++ |+.||......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~--- 300 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--- 300 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999999987755443333444677899999999999999999999999999999999 99998643211
Q ss_pred chhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCcc
Q 003832 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFF 761 (792)
Q Consensus 687 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~p~~p~~~ 761 (792)
. . ...+........+......+.+++.+||+.+|++||+++||++.|+............+.
T Consensus 301 ~----~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 301 E----L---------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp H----H---------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred H----H---------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 0 0 111111112223344556788999999999999999999999999887555444444443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.67 Aligned_cols=256 Identities=26% Similarity=0.457 Sum_probs=204.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.++|+..++||+|+||.||+|++.. ++ +||+|.++.. .....+++.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 3678999999999999999998643 33 4688888654 3355678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999999653 345899999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH----------------HHH
Confidence 65443333444567889999999999999999999999999999999 9999975432211 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+......+.+++.+||+.+|++||++.||+++|+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111222233445566788999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=347.45 Aligned_cols=257 Identities=26% Similarity=0.400 Sum_probs=212.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..+.||+|+||.||+++..++..||+|++..... ..+++.+|+.++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467899999999999999999998888999999976543 3467999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 999999999654 345899999999999999999999988 999999999999999999999999999876544322
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
. .....+|+.|+|||.+.+..++.++||||||++++||++ |+.||....... . ..... ....
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~----~~~~~---------~~~~ 223 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---V----VLKVS---------QGHR 223 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H----HHHHH---------TTCC
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH---H----HHHHH---------cCCC
Confidence 2 223456788999999998899999999999999999999 999986432210 0 00000 1111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
...+......+.+++..||+.+|++|||+.||++.|+...+
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 12222334568899999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.38 Aligned_cols=257 Identities=27% Similarity=0.462 Sum_probs=200.1
Q ss_pred hcccccccccCcCCcccEEeeecc----CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|++.+.||+|+||.||+|++. .+..||||+++.. .....+.|.+|+.++++++||||+++++++.+....++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999875 4678999999765 33456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999643 346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccc-cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQT-NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . ....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~-------------~~~~ 262 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---D-------------VIKA 262 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---H-------------HHHH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---H-------------HHHH
Confidence 432111 1222345778999999999999999999999999999998 99998643211 0 1111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+...+..+.+++.+||+.+|++||++.||+++|+..
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 112222233445567789999999999999999999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=349.58 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=211.5
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..+.||+|+||.||+|+..+++.||+|++.... ...+++.+|+.++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 35788999999999999999999889999999997654 33467999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 161 (269)
T ss_dssp TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-
Confidence 999999999543 346899999999999999999999998 99999999999999999999999999987643321
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......+++.|+|||.+.+..++.++||||||++++||++ |+.||...... ... .. +.....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~---~~~----~~---------~~~~~~ 225 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV----ED---------ISTGFR 225 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HH---------HHTTCC
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH---HHH----HH---------HhcCcc
Confidence 22233567788999999998999999999999999999999 99998643221 000 00 011111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+......+.+++..||+.+|++||+++|++++|++.
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 222333456688999999999999999999999999764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=359.88 Aligned_cols=273 Identities=26% Similarity=0.387 Sum_probs=209.3
Q ss_pred hcccccccccCcCCcccEEeeec-----cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
.++|++.++||+|+||.||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999973 35889999999877777778899999999999999999999998654 568
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999654 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.........................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 222334577889999999999999999999999999999999998753211000000000000000001112
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+........+...+..+.+++..||+.+|++|||+.||++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2222223334555667789999999999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=362.77 Aligned_cols=264 Identities=26% Similarity=0.423 Sum_probs=214.9
Q ss_pred HHhhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
....++|+..+.||+|+||.||+|+... ++.||||+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3456889999999999999999998743 4789999997653 34457899999999999999999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhccc---------------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecC
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRD 600 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 600 (792)
+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976321 256899999999999999999999998 99999
Q ss_pred CCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCC
Q 003832 601 LKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRF 679 (792)
Q Consensus 601 lkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~ 679 (792)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654333233334678899999999998899999999999999999999 9999864
Q ss_pred CCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 680 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.... .+ ....... .....+...+..+.+++.+||+.+|++||++.||+++|++...
T Consensus 280 ~~~~---~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHE---EV----IYYVRDG---------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHH---HH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChH---HH----HHHHhCC---------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 3211 00 0111111 1112333445678899999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=366.18 Aligned_cols=259 Identities=30% Similarity=0.455 Sum_probs=210.3
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|+..++||+|+||.||+|+.. .++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999843 3668999999754 344556789999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcc----cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC---CceEe
Q 003832 545 MLIYEYMPNKSLDFFIFDQA----RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKIS 617 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 617 (792)
++||||+++|+|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997643 2245899999999999999999999998 99999999999999555 59999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||+++.+.............||+.|+|||.+.+..++.++|||||||++|||++ |+.||...... .+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---~~-------- 295 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EV-------- 295 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH--------
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH--------
Confidence 9999986533222223334567899999999999999999999999999999998 99998643221 01
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+........+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 296 -----~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 296 -----LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111111223334456788999999999999999999999999765
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=355.00 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=214.9
Q ss_pred hhcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
..++|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 357899999999999999999975 235789999997653 3456789999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc---------------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCC
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR---------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 602 (792)
.++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999976432 234889999999999999999999988 9999999
Q ss_pred CCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCC
Q 003832 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSH 681 (792)
Q Consensus 603 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~ 681 (792)
|+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987755443333444567889999999999899999999999999999999 999987543
Q ss_pred CCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 682 PDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 682 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
... +. ..+........+...+..+.+++.+||+.+|++||++.||++.|++.
T Consensus 258 ~~~---~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PER---LF-------------NLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGG---HH-------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH---HH-------------HHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 321 11 11111112223344556788999999999999999999999999754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=375.22 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=213.5
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
...++|+..++||+|+||.||+|++.+++.||||+++... ...+.|.+|+.+|++++|||||++++++. .+..++|||
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 4457889999999999999999999888999999997644 45688999999999999999999999986 667899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999996432 235788999999999999999999988 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. .......++..|+|||.+....++.++||||||++||||++ |+.||...... .+. .. +...
T Consensus 339 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~---~~~----~~---------i~~~ 401 (454)
T 1qcf_A 339 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVI----RA---------LERG 401 (454)
T ss_dssp H-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HH---------HHHT
T ss_pred e-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH---HHH----HH---------HHcC
Confidence 1 11223456789999999998999999999999999999999 99999643221 000 01 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.....+...+..+.+++.+||+.+|++|||+++|+++|+....
T Consensus 402 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1222344456678899999999999999999999999988643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=351.67 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=206.1
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|++.+.||+|+||.||+|+. .++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788889999999999999987 4789999999643 34578999999999999999999999887 45899999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-ceEeeeccccccCCCCcc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-PKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DFgla~~~~~~~~~ 631 (792)
+++|.+++........+++..++.++.|+++||.|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999976655556889999999999999999999943234999999999999998887 799999999765322
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .. .+ .... ....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~--~~-~~~~---------~~~~ 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RI--MW-AVHN---------GTRP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HH--HH-HHHT---------TCCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HH--HH-HHhc---------CCCC
Confidence 1234689999999999999999999999999999999999999974332110 00 00 0000 1111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC-CCCCCCCCCCccc
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD-SLLPEPNRPGFFT 762 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~-~~~~~p~~p~~~~ 762 (792)
..+...+..+.+++.+||+.+|++|||++||+++|+.. ..++.+..|..+.
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~ 275 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYP 275 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCCCCE
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCccccc
Confidence 22233445688999999999999999999999999876 3455555554443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=357.91 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=207.2
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|+..+.||+|+||.||+|++ .+++.||||++... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999987 46899999998654 334567789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 9999999999998654 34889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCCCCC-ccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFS-VKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. ......||+.|+|||++.+..+. .++|||||||++|||++|+.||...... .+. .... .
T Consensus 167 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~----~~i~--------~ 228 (328)
T 3fe3_A 167 GG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK---ELR----ERVL--------R 228 (328)
T ss_dssp SC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH--------H
T ss_pred CC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHH--------h
Confidence 32 23346799999999999888765 7999999999999999999999743221 000 0000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ...|......+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 229 GK--YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 12233345668899999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=376.35 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=215.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|+..++||+|+||.||+|++.. ++.||||+++... ...++|.+|+.+|++++||||++++++|.+....++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4678889999999999999999865 8899999997643 3467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 99999999996543 345899999999999999999999988 99999999999999999999999999997654332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......++..|+|||.+....++.++|||||||+||||++ |+.||....... + .+.+....
T Consensus 374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~-------------~~~~~~~~ 436 (495)
T 1opk_A 374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V-------------YELLEKDY 436 (495)
T ss_dssp E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H-------------HHHHHTTC
T ss_pred e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHHHcCC
Confidence 2 2233456789999999998999999999999999999999 999987543221 1 11111222
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
....+...+..+.+|+.+||+.+|++||++.||++.|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 22344455677889999999999999999999999998763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=358.90 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=212.6
Q ss_pred HhhcccccccccCcCCcccEEeeec------cCCcEEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
...++|+..+.||+|+||.||+|+. ..++.||||++... .....+.+.+|+.++.++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 23568999999754 334457899999999999 899999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhcccC--------------------ccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCC
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARA--------------------TFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDL 601 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl 601 (792)
+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999764321 34899999999999999999999988 999999
Q ss_pred CCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCC
Q 003832 602 KASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFS 680 (792)
Q Consensus 602 kp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~ 680 (792)
||+|||++.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654433333344567889999999999999999999999999999998 99999754
Q ss_pred CCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 681 HPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 681 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
..... + ...+........+......+.+++.+||+.+|++||++.||+++|+...
T Consensus 279 ~~~~~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 279 PVDAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp CCSHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcHHH--H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 33211 0 0111111122233344567889999999999999999999999998753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=359.10 Aligned_cols=261 Identities=25% Similarity=0.410 Sum_probs=196.8
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCc----EEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQ----EIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~----~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
...++|+..+.||+|+||.||+|+..... .||||+++.. .....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 34578999999999999999999876532 7999999765 34556789999999999999999999999988766
Q ss_pred c------eEEEeecCCCChhHHHhhccc---CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 544 S------MLIYEYMPNKSLDFFIFDQAR---ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 544 ~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
. ++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 999999999999999965432 225899999999999999999999998 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~---- 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---Y---- 249 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H----
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---H----
Confidence 9999999987654433333334567889999999999999999999999999999999 8999875432211 1
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..+........+...+..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 250 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 ---------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp ---------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00011111223344556788999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=346.03 Aligned_cols=253 Identities=31% Similarity=0.489 Sum_probs=199.2
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCc----hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG----QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~----~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..++||+|+||.||+|+. .++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 46788999999999999999997 488999999876432 3357889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC--------CCCceEeee
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--------DMNPKISDF 619 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~DF 619 (792)
|||+++++|.+++. ...+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999999983 346899999999999999999999987666999999999999986 778999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
|++....... .....|++.|+|||.+.+..++.++||||||++++||++|+.||....... .
T Consensus 161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~----------- 222 (271)
T 3dtc_A 161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V----------- 222 (271)
T ss_dssp CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H-----------
T ss_pred Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H-----------
Confidence 9998654322 123578999999999999999999999999999999999999996432110 0
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.............+...+..+.+++.+||+.+|++|||+.|++++|+.
T Consensus 223 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 223 -AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 011111222223344455678899999999999999999999999975
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.39 Aligned_cols=254 Identities=25% Similarity=0.337 Sum_probs=204.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999875 58899999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999988843 345899999999999999999999988 9999999999999999999999999998764333
Q ss_pred ccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||......... . ..+.. ..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~--------~~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKE--------KK 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHT--------TC
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhc--------cc
Confidence 3333345689999999999987765 78999999999999999999999754332110 0 00111 11
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............+.+|+.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111122344567889999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=352.93 Aligned_cols=261 Identities=25% Similarity=0.408 Sum_probs=214.0
Q ss_pred hhcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 542 (792)
..++|+..+.||+|+||.||+|+. ..++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346889999999999999999974 3467899999976543 4457899999999999 8999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhccc---------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEE
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQAR---------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 607 (792)
..++||||+++|+|.+++..... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 225899999999999999999999988 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~ 686 (792)
++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999987765443333344567889999999999999999999999999999999 9999875432211
Q ss_pred chhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 687 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. .. .+........+...+..+.+++.+||+.+|++||++.||+++|++.
T Consensus 257 -~----~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 -F----YK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp -H----HH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -H----HH---------HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 0 01 1111111222334456788999999999999999999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=373.57 Aligned_cols=264 Identities=18% Similarity=0.222 Sum_probs=209.7
Q ss_pred CHHhHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEE
Q 003832 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (792)
Q Consensus 464 ~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 539 (792)
.+.++....++|+..++||+|+||+||+|++.. ++.||+|++.+.. ....+.+.+|+.++.+++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445556677899999999999999999999765 7889999996531 122334889999999999999999999999
Q ss_pred eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
+.+..+||||||++|+|.+++... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 999999999999999999999652 345899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
|+++........ ......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ . ...
T Consensus 220 Gla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~---~~~ 292 (437)
T 4aw2_A 220 GSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---T---YGK 292 (437)
T ss_dssp TTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---H---HHH
T ss_pred hhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---H---HHh
Confidence 999876543322 223468999999999986 5678999999999999999999999997432211 1 101
Q ss_pred HHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003832 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~ 745 (792)
..... ..+.-+ .........+.+|+.+||+.+|++ ||+++||++.
T Consensus 293 i~~~~--~~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 293 IMNHK--ERFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHTHH--HHCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hhhcc--ccccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11000 001111 111224456788999999888888 9999999985
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=372.10 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=207.7
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..++|+..++||+|+||.||+|++.++..||||+++... ...++|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 456788999999999999999999888899999997644 345789999999999999999999999876 678999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++... ....+++.+++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999643 2345899999999999999999999988 99999999999999999999999999987653322
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...+....
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~-------------~~~i~~~~ 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV-------------LDQVERGY 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH-------------HHHHHTTC
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH---HH-------------HHHHHcCC
Confidence 1 2223457889999999999999999999999999999999 99998643221 00 01111112
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
....+...+..+.+++.+||+.+|++|||+++|++.|+....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 223344556778899999999999999999999999988643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=347.60 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=208.7
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..++|+..++||+|+||.||++++.++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3468999999999999999999998888999999976543 347799999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999999653 345899999999999999999999988 99999999999999999999999999987643321
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...+....
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~-------------~~~~~~~~ 238 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T-------------AEHIAQGL 238 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H-------------HHHHHTTC
T ss_pred -ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---H-------------HHHHhccc
Confidence 12223456788999999998899999999999999999998 999986433210 0 00011111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+......+.+++.+||+.+|++||+++|+++.|++.
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1222333346788999999999999999999999999753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=349.10 Aligned_cols=271 Identities=20% Similarity=0.265 Sum_probs=215.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 547 (792)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3678999999999999999998764 8899999997543 344677889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe----cCCCCceEeeecccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgla~ 623 (792)
|||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999977655556999999999999999999999998 9999999999999 788889999999998
Q ss_pred ccCCCCccccccccccccCcccccccc--------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAA--------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||............ ....
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~ 239 (319)
T 4euu_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKI 239 (319)
T ss_dssp ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH--HHHH
T ss_pred ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH--HHHH
Confidence 7654332 22357899999999886 578899999999999999999999999754332221111 1111
Q ss_pred Hhhhhh---hh---hc--------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 696 WKEKRA---ME---LA--------GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 696 ~~~~~~---~~---~~--------~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
...... .. .. .-......+......+.+++.+||+.||++|||++|+++..++..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 110000 00 00 001122445677888999999999999999999999999987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=358.41 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=205.2
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|+..++||+|+||.||+|++.. ++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 578889999999999999998643 43 38888875442 344467788999999999999999999986 567899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999653 346899999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~-------------~~~ 230 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---P-------------DLL 230 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---H-------------HHH
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---H-------------HHH
Confidence 5544444445678889999999999999999999999999999999 9999975433211 0 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
........+......+.+++.+||+.+|++||++.||++.|+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 231 EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111222233445778999999999999999999999997753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.19 Aligned_cols=263 Identities=24% Similarity=0.343 Sum_probs=207.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|++.+.||+|+||.||+++.. .++.||+|++... .....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999864 5889999998554 234456889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+..
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999654 35899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...... .... +
T Consensus 164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~-~~~~-----~ 230 (294)
T 4eqm_A 164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHI-QDSV-----P 230 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHH-SSCC-----C
T ss_pred ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh-hccC-----C
Confidence 321 22234579999999999999999999999999999999999999996432210 000000 0000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcCCCCCC
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRP-NMSSVVLMLSSDSLLP 753 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-s~~evl~~L~~~~~~~ 753 (792)
......+...+..+.+++.+|++.+|++|| +++++.+.|+....-.
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 000111223445688999999999999998 9999999998764433
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=358.20 Aligned_cols=263 Identities=28% Similarity=0.429 Sum_probs=213.0
Q ss_pred HHhhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
+...++|...+.||+|+||.||+|.... ...||+|++.... ....+.+.+|+.++.++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456789999999999999999998643 3479999997653 34567799999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhccc-----------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQAR-----------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 9999999999999999999975421 345789999999999999999999987 99999999999999
Q ss_pred CCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccch
Q 003832 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNL 688 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l 688 (792)
.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ +
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~ 276 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F 276 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence 999999999999987654333333334567889999999999999999999999999999999 9999875432211 0
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. .+........+...+..+.+++..||+.+|++||++.||++.|++.
T Consensus 277 ----~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 ----YK---------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HH---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HH---------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 01 1111111122333456788999999999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=353.66 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=202.2
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
..++|+..+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3468999999999999999999976 68999999997543 3456789999999999999999999999876543
Q ss_pred ----------------------------------------------------ceEEEeecCCCChhHHHhhcccCccCCh
Q 003832 544 ----------------------------------------------------SMLIYEYMPNKSLDFFIFDQARATFLDW 571 (792)
Q Consensus 544 ----------------------------------------------------~~lV~e~~~~gsL~~~l~~~~~~~~l~~ 571 (792)
.++||||+++++|.+++.........++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 7899999999999999987666666778
Q ss_pred hhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc----------cccccccccc
Q 003832 572 QKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ----------TNTHKVVGTY 641 (792)
Q Consensus 572 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~----------~~~~~~~gt~ 641 (792)
..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 889999999999999999988 999999999999999999999999999887543211 1223357999
Q ss_pred CccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHH
Q 003832 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRC 721 (792)
Q Consensus 642 ~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 721 (792)
.|+|||.+.+..++.++||||||+++|||++|..|+.. .. ... ..... .............+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----------~~-~~~-----~~~~~-~~~~~~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----------RV-RII-----TDVRN-LKFPLLFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----------HH-HHH-----HHHHT-TCCCHHHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----------HH-HHH-----HHhhc-cCCCcccccCChhH
Confidence 99999999999999999999999999999998765310 00 000 00000 00111122334567
Q ss_pred HHHHHHhccCCCCCCCCHHHHHHH
Q 003832 722 IHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 722 ~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+++.+||+.+|++||+++|+++.
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 899999999999999999999874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.40 Aligned_cols=258 Identities=24% Similarity=0.347 Sum_probs=202.1
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHh--cccccceeeeeeEEeC----Ccc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQA----DES 544 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~----~~~ 544 (792)
..++|+..++||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 357899999999999999999988 6899999998643 34556667777766 7899999999997654 347
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh--------hcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
++||||+++|+|.+++. ...+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 89999999999999993 345899999999999999999999 665 999999999999999999999
Q ss_pred eeeccccccCCCCcc--ccccccccccCccccccccCC------CCCccCcchhHHHHHHHHHhC----------CCCCC
Q 003832 617 SDFGMARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSG----------KKNWR 678 (792)
Q Consensus 617 ~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gvil~elltG----------~~p~~ 678 (792)
+|||+++........ .......||+.|+|||.+.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999876443222 112335799999999999776 456799999999999999999 77775
Q ss_pred CCCCCCccchhHHHHHHHhhhhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 679 FSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 679 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+..... .... .. .......... +...+..+.+++.+||+.+|++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~-~~~~-~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPSF-EDMR-KV--------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCCH-HHHH-HH--------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcch-hhhh-HH--------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 443332211 1000 00 0011111111 234677899999999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=366.62 Aligned_cols=251 Identities=26% Similarity=0.383 Sum_probs=208.4
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-cceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD-ESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~-~~~lV~e 549 (792)
..++|+..++||+|+||.||+|+.. ++.||||+++... ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3567899999999999999999884 7899999997653 4578999999999999999999999988765 6899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999999997643 334789999999999999999999998 999999999999999999999999999854321
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+. . ..+...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~-------------~~i~~~ 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V-------------PRVEKG 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H-------------HHHHTT
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H-------------HHHHcC
Confidence 112356889999999999999999999999999999998 9999975443211 1 011111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.....+...+..+.+++..||+.+|++|||+.||++.|+..
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12233445567788999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.30 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=206.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..+.||+|+||.||+++.. +++.||+|++++. .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 468999999999999999999875 4889999999654 233456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 9999999999988653 35889999999999999999999998 99999999999999999999999999986432
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ... ...
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i--------~~~ 220 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF----ELI--------LME 220 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHH--------HHC
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHH----HHH--------HcC
Confidence 22 1233467999999999999999999999999999999999999999643211 110 000 001
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
. ...+......+.+++.+||+.+|++|| +++||+++
T Consensus 221 ~--~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1 122334456788999999999999999 89999874
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=352.01 Aligned_cols=261 Identities=28% Similarity=0.427 Sum_probs=212.9
Q ss_pred hhcccccccccCcCCcccEEeeecc--------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ 540 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~ 540 (792)
..++|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 3578999999999999999999763 46789999997653 34567899999999999 89999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEE
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 607 (792)
.+..++||||+++++|.+++..... ...+++.+++.++.||+.||.|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 9999999999999999999975432 234899999999999999999999988 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCcc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDH 686 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~ 686 (792)
++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 99999999999999987765443333444567889999999988899999999999999999999 99998643211
Q ss_pred chhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 687 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
.+ ...... ......+......+.+++.+||+.+|++||++.||++.|+.+.
T Consensus 267 ~~----~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 267 EL----FKLLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp HH----HHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HHHHhc---------CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 011111 1112233344567889999999999999999999999998763
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=354.55 Aligned_cols=266 Identities=26% Similarity=0.415 Sum_probs=215.5
Q ss_pred hHHHhhcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEE
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 539 (792)
+.+...++|+..+.||+|+||.||+|+.. .++.||||++.... ......+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 44456688999999999999999999764 36789999997653 344567899999999999999999999999
Q ss_pred eCCcceEEEeecCCCChhHHHhhccc-------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQAR-------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
+.+..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCC
Confidence 99999999999999999999865321 245789999999999999999999998 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHH
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~ 691 (792)
.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~--- 249 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QV--- 249 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HH---
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH---HH---
Confidence 999999999987644333333334567889999999999999999999999999999999 88888643211 00
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
....... .....+...+..+.+++.+||+.+|++||++.|+++.|++...
T Consensus 250 -~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 -LRFVMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0011111 1112233445678899999999999999999999999987633
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.31 Aligned_cols=264 Identities=23% Similarity=0.333 Sum_probs=203.0
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++|+..++||+|+||.||+|+..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 457899999999999999999999889999999997543 233567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99985 777777543 345899999999999999999999988 999999999999999999999999999876432
Q ss_pred CccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh---hhh-
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR---AME- 703 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~- 703 (792)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+... .......... ...
T Consensus 173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQV 247 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGG
T ss_pred cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhh
Confidence 21 2233578999999999876 568999999999999999999999997654432211 1100000000 000
Q ss_pred -----hccc--cccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 -----LAGD--TLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 -----~~~~--~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... ...... .+....++.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 000000 11223567899999999999999999999873
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.62 Aligned_cols=270 Identities=28% Similarity=0.414 Sum_probs=216.8
Q ss_pred ccCHHhHHHhhcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-cccccee
Q 003832 462 EFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVK 533 (792)
Q Consensus 462 ~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~ 533 (792)
.++........++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 345555556678999999999999999999974 3467899999976543 3456789999999999 7999999
Q ss_pred eeeeEEeCC-cceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEec
Q 003832 534 LLGCCIQAD-ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (792)
Q Consensus 534 l~g~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 599 (792)
+++++...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999998765 48999999999999999976432 223789999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCC
Q 003832 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWR 678 (792)
Q Consensus 600 Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~ 678 (792)
||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654433333444677899999999999999999999999999999998 999987
Q ss_pred CCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 679 FSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 679 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....... + ....... .....+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 253 ~~~~~~~--~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 253 GVKIDEE--F----CRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp TCCCSHH--H----HHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhHH--H----HHHhccC---------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 5433211 1 0111111 11122333455688999999999999999999999999764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=340.89 Aligned_cols=255 Identities=28% Similarity=0.510 Sum_probs=205.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchh-------HHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQG-------MEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~-------~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
.++|+..+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 467899999999999999999874 58899999986543221 267899999999999999999999986544
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-----ceEee
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISD 618 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~D 618 (792)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ .+|+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 7999999999998888653 346899999999999999999999875 34999999999999988776 99999
Q ss_pred eccccccCCCCccccccccccccCccccccc--cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYA--AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||......... ..
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~------- 239 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FI------- 239 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HH-------
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HH-------
Confidence 999985432 12336789999999998 4556789999999999999999999999754332110 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
............+...+..+.+++..||+.+|++||+++||++.|+++
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 -----NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011112222234445566788999999999999999999999999763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=346.70 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=195.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--------------------------hhHHHHHHHHHHHH
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------------------------QGMEEFKNEVTLIA 524 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------------------------~~~~~~~~Ei~~l~ 524 (792)
.++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999864 588999999865421 12356889999999
Q ss_pred hcccccceeeeeeEEe--CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCC
Q 003832 525 RLQHRNLVKLLGCCIQ--ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLK 602 (792)
Q Consensus 525 ~l~H~niv~l~g~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk 602 (792)
+++||||+++++++.+ ....++||||+++++|.+++ ....+++.++..++.|++.||.|||+.+ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 56789999999999998765 3346899999999999999999999998 9999999
Q ss_pred CCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCC---CCccCcchhHHHHHHHHHhCCCCCCC
Q 003832 603 ASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRF 679 (792)
Q Consensus 603 p~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gvil~elltG~~p~~~ 679 (792)
|+|||++.++.+||+|||++..+..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999987654322 123457999999999997654 47889999999999999999999964
Q ss_pred CCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 680 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
... .... .... ...............+.+++.+||+.+|++||++.||++
T Consensus 243 ~~~------~~~~-~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERI------MCLH-SKIK--------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSH------HHHH-HHHH--------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccH------HHHH-HHHh--------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 221 1000 0000 011111112234456889999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.81 Aligned_cols=274 Identities=25% Similarity=0.370 Sum_probs=215.6
Q ss_pred hcccccccccCcCCcccEEeeec-----cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe--CCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~ 544 (792)
.++|+..++||+|+||.||++++ ..++.||||++........+.+.+|++++++++||||+++++++.. ....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999983 3588999999988777777889999999999999999999999874 4568
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 89999999999999996532 35899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCc-cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEI-QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... ........||..|+|||.+.+..++.++||||||+++|||++|+.||.......... ...............
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHHH
Confidence 654322 222334568889999999999999999999999999999999999975321100000 000000000011122
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.+........+...+..+.+++.+||+.+|++|||++||+++|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222333334455566778999999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=340.54 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=210.8
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|+..+.||+|+||.||+++..+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999988889999999976543 3478999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 159 (267)
T ss_dssp TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-
T ss_pred CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-
Confidence 999999999653 345889999999999999999999998 99999999999999999999999999987643221
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .... ....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~----~~i~---------~~~~ 223 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS---EVV----EDIS---------TGFR 223 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHH---------TTCC
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH---HHH----HHHh---------cCCc
Confidence 12223567889999999998899999999999999999999 89998643211 000 0000 1111
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+......+.+++.+||+.+|++||+++|++++|++.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 122333456788999999999999999999999999764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=353.11 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=200.7
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhccc--ccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~l 546 (792)
..++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++......++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34679999999999999999999888999999998654 33455789999999999986 999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+.
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5788999999653 45889999999999999999999998 99999999999997 5789999999998775
Q ss_pred CCCccccccccccccCccccccccC-----------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~------ 227 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I------ 227 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----H------
Confidence 4433333345679999999999864 67899999999999999999999999632211 1
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+++......+......+.+++..||+.+|++|||+.|+++.
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 228 ---SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp ---HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 01122223333333344444578899999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.79 Aligned_cols=260 Identities=17% Similarity=0.198 Sum_probs=207.8
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999986 4688999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-----ceEeeeccccc
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFgla~~ 624 (792)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999999653 346899999999999999999999998 999999999999998887 99999999987
Q ss_pred cCCCCccc-----cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 625 FGGDEIQT-----NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 625 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
+....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.............. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK----IGDT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH----HHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH----HHhh
Confidence 64332211 12346899999999999999999999999999999999999999986543322111111 1111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
... ...+.+... .+ .+.+++..|++.+|++||++++|++.|++.
T Consensus 236 ~~~-~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRA-TPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHH-SCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hcc-CCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 000001111 12 788999999999999999999999998643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=342.16 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=197.5
Q ss_pred hhcccccccccCcCCcccEEeeeccC----CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
..++|++.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccE
Confidence 34689999999999999999998643 457999998764 334567899999999999999999999998 456789
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999999653 345899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
...... ......+++.|+|||.+....++.++||||||+++|||++ |+.||......+ ... ...
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~----~i~------- 231 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIE------- 231 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHH-------
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH----HHH-------
Confidence 543221 1223456789999999998899999999999999999997 999987543221 110 000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.......+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 232 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 232 --NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111223344556788999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.31 Aligned_cols=249 Identities=22% Similarity=0.290 Sum_probs=205.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch------hHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ------GMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
..+.|++.+.||+|+||.||+++.. +|+.||+|++.+.... ..+.+.+|+.++.+++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467999999999999999999875 4889999999765321 35789999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC----CceEeee
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDF 619 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF 619 (792)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999954 346899999999999999999999988 99999999999998877 7999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
|++..+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ....
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~----~~i~-- 231 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANIT-- 231 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHH--
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHH--
Confidence 9998765432 123467999999999999999999999999999999999999999643211 010 0000
Q ss_pred hhhhhccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 RAMELAGDTLADSHPP----TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ...+. .....+.+++..||+.||++|||+.|++++
T Consensus 232 ------~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 232 ------AVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp ------TTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ------hcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01111 224567899999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.91 Aligned_cols=257 Identities=28% Similarity=0.442 Sum_probs=214.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|+..++||+|+||.||+|+... ++.||+|++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 45789999999999999999998765 7889999997543 456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999996543 356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........ .+.+...
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~~~~~~~ 228 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKD 228 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------HHHHHTT
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhcc
Confidence 2 22233567889999999998999999999999999999999 9999865432211 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.....+...+..+.+++..|++.+|++||++.||++.|+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 22233444556788999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.40 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=204.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.+.|+..+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 467899999999999999999875 488999999875432 2467899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC----CceEeeec
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg 620 (792)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999854 345899999999999999999999988 99999999999999887 89999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... .....
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~~~~~- 232 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLA----NVSAV- 232 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHH----HHHHT-
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHH----HHHhc-
Confidence 998764332 123457999999999999999999999999999999999999999643211 0000 00000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...............+.+++.+||+.+|++|||+.|+++.
T Consensus 233 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 233 -----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp -----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000001223567899999999999999999999984
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=356.15 Aligned_cols=255 Identities=22% Similarity=0.325 Sum_probs=203.4
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (792)
.++|+..++||+|+||.||+++... ++.||+|++++.. ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999998764 7889999997542 23345688899999887 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998633
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc--chhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH--NLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 704 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .+
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~--------~i 274 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VI 274 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH--------HH
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH--------HH
Confidence 221 1234468999999999999999999999999999999999999999754322111 00110000 01
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM------SSVVL 744 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~------~evl~ 744 (792)
... ....|.....++.+|+..||+.||++||++ +||++
T Consensus 275 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 LEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred hcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111 112344455678899999999999999995 56665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=374.81 Aligned_cols=258 Identities=27% Similarity=0.464 Sum_probs=212.4
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|+++|++++||||+++++++.+ +..+|||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456788999999999999999999888899999997654 345789999999999999999999999876 678999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++... ....+++.+++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999643 2245889999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.......++..|+|||.+....++.++|||||||+||||++ |+.||...... .+ . ..+....
T Consensus 419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~---~~----~---------~~i~~~~ 481 (535)
T 2h8h_A 419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----L---------DQVERGY 481 (535)
T ss_dssp -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH---HH----H---------HHHHTTC
T ss_pred -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH----H---------HHHHcCC
Confidence 12223456789999999999999999999999999999999 99998643211 00 0 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
....+......+.+|+.+||+.+|++||++++|+++|+....
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 223344556678899999999999999999999999988643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=341.55 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=196.5
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++|+..++||+|+||.||+|+.. ..||+|+++.. .....+.+.+|+.++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3567999999999999999999864 35999998654 334567899999999999999999999965 556789999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999998543 346899999999999999999999988 999999999999999999999999999866533
Q ss_pred CccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..........||+.|+|||.+. +..++.++||||||+++|||++|+.||....... . ..........
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~----~~~~~~~~~~---- 243 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--Q----IIEMVGRGSL---- 243 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--H----HHHHHHHTSC----
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--H----HHHHhccccc----
Confidence 3233334467899999999986 6678999999999999999999999996433211 1 1111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
.+. ........+..+.+++..||+.+|++||++.||+++|++..
T Consensus 244 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred Ccc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111 11122344567889999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.82 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=206.5
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~lV 547 (792)
.++|+..++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 36788899999999999999998 48899999997653 34556899999999999999999999999887 778999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.++|.|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999996532 336899999999999999999999864 3599999999999999999999999998764322
Q ss_pred CCccccccccccccCccccccccCCCCCc---cCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSV---KSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||....... . ....
T Consensus 166 -------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~---------~~~~ 223 (271)
T 3kmu_A 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------I---------GMKV 223 (271)
T ss_dssp -------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------H---------HHHH
T ss_pred -------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------H---------HHHH
Confidence 2356899999999998765544 7999999999999999999996432110 0 0111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.........+...+..+.+++..||+.+|++|||++||++.|+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 111222233444566788999999999999999999999999765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=347.35 Aligned_cols=252 Identities=18% Similarity=0.252 Sum_probs=205.1
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.+.||+|+||.||+++... ++.+|+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 4789999999999999999998754 7889999986543 4456789999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC--CCCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgla~~~~~~ 628 (792)
+++++|.+++... ...+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++..+...
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999998542 345899999999999999999999998 999999999999987 789999999999877543
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... ....... .....
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~----~i~~~~~--~~~~~ 225 (321)
T 1tki_A 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIE----NIMNAEY--TFDEE 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH----HHHHTCC--CCCHH
T ss_pred Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHH----HHHcCCC--CCChh
Confidence 22 23357899999999999888999999999999999999999999643221 1110 0000000 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0 01234568899999999999999999999984
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.57 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=209.4
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
..++|+..+.||+|+||.||+|+..+++.||+|++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 88 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence 346899999999999999999998888899999997643 34578999999999999999999999986 4568999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 89 MENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999985432 235899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......++..|+|||.+.+..++.++||||||++++||++ |+.||...... ... ... ....
T Consensus 165 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~----~~~---------~~~~ 227 (279)
T 1qpc_A 165 T-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVI----QNL---------ERGY 227 (279)
T ss_dssp E-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHH----HHH---------HTTC
T ss_pred c-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH---HHH----HHH---------hccc
Confidence 2 2233567889999999998899999999999999999999 89998643211 010 001 1111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+...+..+.+++..|++.+|++||++.+|+++|++.
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1122334456788999999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=352.64 Aligned_cols=250 Identities=21% Similarity=0.363 Sum_probs=205.6
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|++.+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+....++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3679999999999999999998754 789999998653 223456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+.+|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++..+..
T Consensus 94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 9999999999998643 45899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+... .
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------~ 232 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------F 232 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH------------H
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH------------H
Confidence 32 2334689999999999864 4589999999999999999999999975443322111110 0
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-MSSVVL 744 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-~~evl~ 744 (792)
. ......+......+.+|+.+||+.+|++||+ +++|.+
T Consensus 233 ~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 E--TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H--HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred h--hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 0111234445567889999999999999998 777765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.81 Aligned_cols=261 Identities=16% Similarity=0.218 Sum_probs=209.4
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999985 468999999986543 234688899999999 79999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC-----ceEeeeccccc
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN-----PKISDFGMARI 624 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DFgla~~ 624 (792)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999653 335899999999999999999999987 999999999999987776 99999999987
Q ss_pred cCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 625 FGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 625 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||................ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----EK 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----HH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH----hh
Confidence 6543221 12334679999999999999999999999999999999999999998654332221111110 00
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. ....+.... ..+..+.+++..||+.+|++||++++|++.|++.
T Consensus 237 ~~-~~~~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 237 KQ-STPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HH-HSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cc-CccHHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 00 000011111 2345688999999999999999999999999865
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.24 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=199.9
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcc--cccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999888999999998654 3445678999999999996 599999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
| +.+++|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 6788999998654 35888999999999999999999987 99999999999995 589999999999877544
Q ss_pred CccccccccccccCccccccccC-----------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... ..
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~------- 275 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----IS------- 275 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HH-------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HH-------
Confidence 33333345679999999999865 46899999999999999999999999643211 00
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+++.......+......+.+|+.+||+.+|++||++.||++.
T Consensus 276 --~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 276 --KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1112222222222333334568899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=346.38 Aligned_cols=266 Identities=25% Similarity=0.423 Sum_probs=201.7
Q ss_pred HHhHHHhhcccccccccCcCCcccEEeeeccC----CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeE
Q 003832 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538 (792)
Q Consensus 465 ~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~ 538 (792)
+.++....++|...+.||+|+||.||+|+... ++.||+|++... .....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 33444556789999999999999999997643 458999998754 334557899999999999999999999999
Q ss_pred EeCCc-----ceEEEeecCCCChhHHHhhc---ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC
Q 003832 539 IQADE-----SMLIYEYMPNKSLDFFIFDQ---ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 539 ~~~~~-----~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 610 (792)
.+... .++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence 87654 49999999999999998543 23456899999999999999999999987 999999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchh
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~ 689 (792)
++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 259 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MY 259 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HH
Confidence 99999999999987654433333334567889999999999999999999999999999999 888886443221 11
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ... .......+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus 260 ~----~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 D----YLL---------HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H----HHH---------TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHH---------cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 1111222334456788999999999999999999999999764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=347.02 Aligned_cols=246 Identities=21% Similarity=0.256 Sum_probs=193.9
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..++||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +||||+++++++.+....++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 368999999999999999999876 68999999986542 23344555666666665 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||++.....
T Consensus 136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 66888888654 346899999999999999999999987 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .+........ .+
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~----~~ 271 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC----CH
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC----Cc
Confidence 32 2233568999999999875 78999999999999999999977653210 0111111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+......+.+++.+||+.+|++|||++|++++
T Consensus 272 ----~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 272 ----EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 1111234568899999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=359.95 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=205.1
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
...++|+..++||+|+||.||++... +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 34678999999999999999999764 58899999987653 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec---CCCCceEeeecccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMAR 623 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgla~ 623 (792)
||||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++.
T Consensus 88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 99999999999988654 35899999999999999999999998 99999999999998 46789999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+. .....+..
T Consensus 162 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~~~-- 230 (444)
T 3soa_A 162 EVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLY----QQIKAGAY-- 230 (444)
T ss_dssp CCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHTCC--
T ss_pred EecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHH----HHHHhCCC--
Confidence 7654322 223467999999999999999999999999999999999999999643211 111 01111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.............+.+++..||+.||++|||+.|+++.
T Consensus 231 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 231 ----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 00011112334568899999999999999999999984
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.00 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=202.9
Q ss_pred hcccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.++|+..++||+|+||.||+|++.. ++ +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3679999999999999999998643 43 4688887544 3456678999999999999999999999998754 78
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+|+||+.+|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999999654 345899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSI 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHH
Confidence 54433333334567889999999999999999999999999999999 9999975433211 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
+........+......+.+++.+||+.+|++||++.||++.|+....
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11122223344455678899999999999999999999999987643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=362.69 Aligned_cols=259 Identities=20% Similarity=0.233 Sum_probs=207.3
Q ss_pred HhHHHhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeC
Q 003832 466 ASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 466 ~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
.++....++|+..++||+|+||.||+++... ++.||+|++.+.. ....+.+.+|+.+++.++|||||++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 3455567899999999999999999998764 7899999986521 12234588999999999999999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecc
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGM 621 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgl 621 (792)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999998542 4889999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCC----CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL----FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
++.+..... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .......
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 287 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 287 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHT
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHh
Confidence 987654332 2233468999999999997655 8899999999999999999999997432211 0100000
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPED--RPNMSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~--RPs~~evl~~ 745 (792)
... . +..+........+.+|+.+||+.+|++ ||+++||+++
T Consensus 288 ~~~--~-----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 288 HKN--S-----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHH--H-----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ccc--c-----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 000 0 011111233456889999999999988 9999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.55 Aligned_cols=247 Identities=22% Similarity=0.341 Sum_probs=203.9
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|.+.+.||+|+||.||+|++ .+++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999986 458899999986431 22345789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+ +|+|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 68888888654 35899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........... +.
T Consensus 161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i~ 221 (336)
T 3h4j_B 161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------VN 221 (336)
T ss_dssp SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------CC
T ss_pred Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------HH
Confidence 321 234579999999999988776 7899999999999999999999975433221100 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .....+......+.+++.+||+.||++|||++||++.
T Consensus 222 ~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 S-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp S-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred c-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0 0112233445678899999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=354.21 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=207.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||.||+|+.. +++.||+|++..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999875 5889999999876666667899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC--CCCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgla~~~~~~ 628 (792)
+++|+|.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||++..+...
T Consensus 130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 9999999988543 345899999999999999999999988 999999999999974 577999999999876543
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ...... ...
T Consensus 205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~----~~i~~~------~~~ 268 (387)
T 1kob_A 205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETL----QNVKRC------DWE 268 (387)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHHC------CCC
T ss_pred cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhC------CCC
Confidence 32 22347899999999999999999999999999999999999999743211 011 000000 001
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111222345568899999999999999999999985
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=355.53 Aligned_cols=249 Identities=27% Similarity=0.387 Sum_probs=200.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (792)
..++|+..++||+|+||.||+++.. +++.||||++++. .....+.+..|..++.++ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3578999999999999999999875 4889999999754 223456788999999998 6999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 999999999999998654 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. . .+.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~----~--------~i~ 237 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLF----E--------AIL 237 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----H--------HHH
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHH----H--------HHH
Confidence 3222 1233468999999999999989999999999999999999999999743221 111 0 011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM------SSVVL 744 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~------~evl~ 744 (792)
... ...+......+.+++..||+.+|++||++ +||++
T Consensus 238 ~~~--~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 NDE--VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred cCC--CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 12233345668899999999999999998 77776
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=353.27 Aligned_cols=267 Identities=16% Similarity=0.208 Sum_probs=205.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC------CcEEEEEEccCCCchhH-----------HHHHHHHHHHHhccccccee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKGSGQGM-----------EEFKNEVTLIARLQHRNLVK 533 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~ 533 (792)
..++|++.++||+|+||.||+|++.. ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998755 47899999876542211 12344666777888999999
Q ss_pred eeeeEEeC----CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 534 LLGCCIQA----DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 534 l~g~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4479999999 99999999653 346999999999999999999999997 99999999999999
Q ss_pred --CCCCceEeeeccccccCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCC
Q 003832 610 --NDMNPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682 (792)
Q Consensus 610 --~~~~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~ 682 (792)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 8899999999999876432211 111235599999999999999999999999999999999999999974332
Q ss_pred CCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 683 DHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. ...... ..........+++..+.. ...+.++.+++..||+.+|++||++.+|+++|+..
T Consensus 267 ~~--~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 267 DP--KYVRDS-KIRYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp CH--HHHHHH-HHHHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CH--HHHHHH-HHHhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 21 111111 111112233333333321 12245678899999999999999999999998765
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=338.63 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=208.4
Q ss_pred ccccccc-ccCcCCcccEEeeecc---CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|.+.+ .||+|+||.||+|+.. .++.||||+++... ....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5566666 8999999999999753 47789999997653 34567899999999999999999999999 56678999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999854 3346899999999999999999999998 99999999999999999999999999987754
Q ss_pred CCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +. ..+
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~-------------~~i 226 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM-------------AFI 226 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH-------------HHH
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HH-------------HHH
Confidence 3322 22233456899999999988889999999999999999999 999996543211 10 011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+...+..+.+++..||+.+|++||++.||++.|++.
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 227 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11112233445566788999999999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.49 Aligned_cols=254 Identities=23% Similarity=0.316 Sum_probs=203.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-----CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
.+.|++.+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 467999999999999999999865 5899999998532 1224678999999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeecc
Q 003832 546 LIYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGM 621 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgl 621 (792)
+||||+++++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999988886543 3345899999999999999999999998 999999999999987655 99999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+. ........
T Consensus 180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~----~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLF----EGIIKGKY 249 (351)
T ss_dssp CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHH----HHHHHTCC
T ss_pred eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHH----HHHHcCCC
Confidence 987654322 1234579999999999999999999999999999999999999996421 0010 00000000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...+... ......+.+++.+||+.||++||++.|+++
T Consensus 250 --~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 --KMNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 122456889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.46 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=195.7
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|+..++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 3568999999999999999999876 58899999997543 234678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC--ceEeeeccccccCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGMARIFGG 627 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgla~~~~~ 627 (792)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 99999999998653 35899999999999999999999988 999999999999987765 99999999975322
Q ss_pred CCccccccccccccCccccccccCCCCCcc-CcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVK-SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||......... ... ......
T Consensus 171 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~---------~~~~~~ 236 (361)
T 3uc3_A 171 HS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKT---------IQRILS 236 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHH---------HHHHHT
T ss_pred cC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHH---------HHHHhc
Confidence 21 2233579999999999988887665 89999999999999999999754432221 100 011111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..............+.+|+.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111111111234568899999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=351.64 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=205.2
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|+..+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999875 4889999999654 334557789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC---CceEeeeccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARI 624 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgla~~ 624 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 107 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999988543 45899999999999999999999998 99999999999998654 599999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ........
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~----~~i~~~~~--- 247 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----AQIKAGAY--- 247 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC---
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhCCC---
Confidence 65332 123467999999999999999999999999999999999999998643211 111 00111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.............+.+++.+||+.+|++||++.|+++.
T Consensus 248 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 248 ---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp ---CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ---CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112334568899999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=352.29 Aligned_cols=267 Identities=28% Similarity=0.384 Sum_probs=209.6
Q ss_pred cccccccCcCCcccEEeeecc-----CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC--CcceE
Q 003832 475 FASYNKLGEGGFGPVYKGTLV-----EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DESML 546 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~-----~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~~l 546 (792)
|+..++||+|+||.||++... +++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999877532 47899999997653 34567799999999999999999999999884 56789
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999543 3899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..... .......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ................+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43221 223345688899999999998999999999999999999999999863211000 0000000001111222333
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 33333444555667899999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.45 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..+.||+|+||.||+++.. +++.||+|++++.. ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 367999999999999999999875 58899999996542 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 9999999999999653 35889999999999999999999988 99999999999999999999999999987543
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. . ..+...
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~---~---------~~i~~~ 218 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KT---Y---------EKILNA 218 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HH---H---------HHHHHC
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HH---H---------HHHHhC
Confidence 2 23467999999999999999999999999999999999999999643211 00 0 001111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
. ...+.....++.+++.+||+.+|++|| +++||+++
T Consensus 219 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 122334456788999999999999999 89999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=349.09 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=202.1
Q ss_pred cccccccccCcCCcccEEeeeccC-----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|...+.||+|+||.||+|+... +..||||+++... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567788999999999999998653 2369999997653 3445678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999653 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ ...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~-------------~~~ 262 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EV-------------MKA 262 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH-------------HHH
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HH-------------HHH
Confidence 43211 11222456789999999999999999999999999999999 99998643211 00 011
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+...+..+.+++.+||+.+|++||++.||+++|+..
T Consensus 263 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 263 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111111223344556788999999999999999999999999765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=346.58 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=204.7
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (792)
.++|+..+.||+|+||.||+++... ++.||+|++.+. .....+.+.+|+.++.++ +||||+++++++.+....++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 3678999999999999999998764 889999999754 234456788999999988 89999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 99999999999998653 35899999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc--chhHHHHHHHhhhhhhhh
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH--NLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~--~l~~~~~~~~~~~~~~~~ 704 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .+
T Consensus 162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~i 231 (345)
T 3a8x_A 162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------VI 231 (345)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH--------HH
T ss_pred CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH--------HH
Confidence 221 1233468999999999999999999999999999999999999999753221110 00000000 01
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM------SSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~------~evl~~ 745 (792)
.... ...+......+.+++.+||+.+|++||++ .||+++
T Consensus 232 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 232 LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred HcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 1111 12334455678899999999999999995 666653
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.75 Aligned_cols=271 Identities=23% Similarity=0.335 Sum_probs=201.0
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc---
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES--- 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~--- 544 (792)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+.++.+++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46899999999999999999986 468899999997653 33456789999999999999999999999877655
Q ss_pred -eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 545 -MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 545 -~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
++||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999999653 35899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 624 IFGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 624 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~- 237 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPI- 237 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCC-
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCC-
Confidence 76543211 22334578999999999999999999999999999999999999996432210 01111110000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH-HhcCCCCCCCCCCCCcc
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL-MLSSDSLLPEPNRPGFF 761 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~-~L~~~~~~~~p~~p~~~ 761 (792)
.+. ......+.++.+++.+||+.+|++||++.++++ .|........|..|...
T Consensus 238 ---~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~~ 291 (311)
T 3ork_A 238 ---PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291 (311)
T ss_dssp ---CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCCC
T ss_pred ---Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCccc
Confidence 000 001123456889999999999999997666554 44443333333334433
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=340.54 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=200.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999875 48899999997543 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|++++ |.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQD-LKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEE-HHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCC-HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864 4444433 2345899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh------hh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR------AM 702 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 702 (792)
.......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+...... ............... ..
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhc
Confidence 1223457899999999997765 899999999999999999999886432211 111111101000000 00
Q ss_pred hhcc---------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAG---------DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~---------~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+ ........+.....+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000011122345678899999999999999999999873
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.08 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=200.1
Q ss_pred hcccccc-cccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.+.|.+. +.||+|+||.||+++.. +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 68999999999999864 5889999999877666678899999999985 7999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgla~~~ 625 (792)
||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 999999999999654 35889999999999999999999998 999999999999998776 999999999865
Q ss_pred CCCCc-----cccccccccccCccccccccC-----CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 626 GGDEI-----QTNTHKVVGTYGYMSPEYAAE-----GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 626 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
..... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||......+...........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 111223468999999999865 56899999999999999999999999765433211000000000
Q ss_pred HhhhhhhhhccccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 696 WKEKRAMELAGDTLADSHPP----TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........+.... ...+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000000010111 11121 134568899999999999999999999984
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=341.71 Aligned_cols=263 Identities=25% Similarity=0.413 Sum_probs=208.9
Q ss_pred cccccccccCcCCcccEEeeec-----cCCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeC--Ccc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA--DES 544 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~--~~~ 544 (792)
+.|+..++||+|+||.||++++ .+++.||+|++... .....+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999983 35889999999754 334567899999999999999999999999877 668
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999999553 245899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC--------CCCccchhHHHHHH
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH--------PDHDHNLLGHAWIL 695 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~--------~~~~~~l~~~~~~~ 695 (792)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+.... +.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM-------- 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGG--------
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCccccc--------
Confidence 7543321 22334678889999999999999999999999999999999998854211 000000
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+........+...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 248 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 248 -TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp -HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 00111112222223334455567789999999999999999999999999753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=344.08 Aligned_cols=252 Identities=22% Similarity=0.392 Sum_probs=204.3
Q ss_pred hcccccccccCcCCcccEEeeeccC-C-------cEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-------QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~-------~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
.++|...+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678899999999999999998654 3 4799999977666777889999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC--------ce
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--------PK 615 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 615 (792)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999999653 334899999999999999999999998 999999999999998887 99
Q ss_pred EeeeccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
|+|||++...... ....|++.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .. ...
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~-~~~ 229 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QR-KLQ 229 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HH-HHH
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HH-HHH
Confidence 9999998754321 22457889999999987 77999999999999999999965554321111 00 000
Q ss_pred HHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
... . ....+......+.+++.+||+.+|++|||+.|+++.|++...
T Consensus 230 ~~~--------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 230 FYE--------D---RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHH--------T---TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred Hhh--------c---cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 000 0 011112223457889999999999999999999999987654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=343.25 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=207.2
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe----CCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~~l 546 (792)
.++|+..+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46899999999999999999986 4689999999977666777889999999999999999999999973 346789
Q ss_pred EEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
|+||+++++|.+++... .....+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998653 23456899999999999999999999998 999999999999999999999999998765
Q ss_pred CCCCcc-------ccccccccccCccccccccCCC---CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 626 GGDEIQ-------TNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 626 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
...... .......||+.|+|||.+.... ++.++||||||+++|||++|+.||........ .+
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~------- 256 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SV------- 256 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CH-------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hh-------
Confidence 321100 0012245799999999987543 78999999999999999999999853211110 00
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
............+......+.+++.+||+.+|++||++.||++.|+....
T Consensus 257 ------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 257 ------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp ------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred ------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 00001111112223345678899999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.35 Aligned_cols=262 Identities=22% Similarity=0.312 Sum_probs=199.9
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+..++||+|+||.||+|+...++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57889999999999999999987799999999965432 2346788999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++ +|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 986 888888543 345889999999999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh------hhh
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR------AME 703 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~~ 703 (792)
......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ............. ..+
T Consensus 156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhc
Confidence 1223578999999999865 468999999999999999999999997432211 1110000000000 000
Q ss_pred --hcccccc-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 --LAGDTLA-------DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 --~~~~~~~-------~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..++... ..........+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00112234567899999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=345.67 Aligned_cols=259 Identities=30% Similarity=0.450 Sum_probs=205.8
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|+..+.||+|+||.||+|+.. +++.||||++... ......++.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 468999999999999999999842 3678999999754 344566899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhccc----CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEe
Q 003832 545 MLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKIS 617 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~ 617 (792)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976432 245889999999999999999999988 999999999999984 4569999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||++................|++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~- 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVL----EF- 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHH----HH-
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHH----HH-
Confidence 9999986644333333334567899999999998999999999999999999998 99998643211 000 00
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+........+......+.+++.+||+.+|++||++.||++.|+..
T Consensus 258 --------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 258 --------VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp --------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 111111122334456788999999999999999999999999765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=349.32 Aligned_cols=267 Identities=16% Similarity=0.193 Sum_probs=199.8
Q ss_pred hcccccccccCcCCcccEEeeecc----CCcEEEEEEccCCCchh-----------HHHHHHHHHHHHhcccccceeeee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQG-----------MEEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
.++|.+.++||+|+||.||+|+.. .+..+|||++....... .+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999875 46789999987654321 124667889999999999999999
Q ss_pred eEEe----CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 537 CCIQ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 537 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
++.. ....++||||+ +++|.+++.... .+++.+++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67789999999 999999985433 6899999999999999999999987 99999999999999887
Q ss_pred --CceEeeeccccccCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003832 613 --NPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (792)
Q Consensus 613 --~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~ 685 (792)
.+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432111 112345799999999999999999999999999999999999999963222111
Q ss_pred cchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 686 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.......... ......+.... .....+..+.+++..||+.+|++||++++|++.|+....
T Consensus 269 --~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 --AVQTAKTNLL-DELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp --HHHHHHHHHH-HTTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred --HHHHHHHhhc-ccccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0100000000 00111110000 011234568899999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=340.78 Aligned_cols=256 Identities=28% Similarity=0.402 Sum_probs=205.0
Q ss_pred hhccccccc-ccCcCCcccEEeeecc---CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 471 ATDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 471 ~~~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
..++|.+.+ .||+|+||.||+|... .++.||||+++... ....+++.+|+.++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788777 9999999999999542 36789999997653 33467899999999999999999999999 66778
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999653 35889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .+ .
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~-------------~ 230 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV-------------T 230 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH-------------H
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH-------------H
Confidence 6543322 12223456789999999988889999999999999999999 99998643221 00 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..+........+...+..+.+++..||+.+|++||++.||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 231 AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111112233444566788999999999999999999999999753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=350.94 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=204.5
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~ 544 (792)
...++|...+.||+|+||.||+|+.+ +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45678999999999999999999975 48899999997542 23456788899999887 899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998653 35889999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ....
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i~------- 231 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF----HSIR------- 231 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH-------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHH-------
Confidence 43222 1234468999999999999999999999999999999999999999643221 111 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMS-SVVL 744 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~-evl~ 744 (792)
.. ....+......+.+++.+||+.+|++||++. ||++
T Consensus 232 -~~--~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 232 -MD--NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp -HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -hC--CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 00 0122333456788999999999999999998 7654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=372.44 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=203.4
Q ss_pred ccccccc-ccCcCCcccEEeeecc---CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
+++...+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444444 7999999999999764 35679999997653 3456889999999999999999999999976 568999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 9999999999999543 456899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||......+ + ...+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~-------------~~~i 552 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V-------------MAFI 552 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H-------------HHHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H-------------HHHH
Confidence 3211 11222346789999999999999999999999999999998 999997543221 1 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+...+..+.+|+..||+.+|++||++.+|++.|+..
T Consensus 553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11122234455667889999999999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=348.10 Aligned_cols=261 Identities=19% Similarity=0.213 Sum_probs=202.2
Q ss_pred hHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-----CchhHHHHHHHHHHHHhcccccceeeeeeEEe
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-----SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 540 (792)
++....++|+..++||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45567789999999999999999999874 4788999998643 33456789999999999999999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhcc-------------------------------------cCccCChhhHHHHHHHHHH
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQA-------------------------------------RATFLDWQKRIHIVGGIAR 583 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~ 583 (792)
.+..++||||+++|+|.+++.... ....+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999984210 1122456778889999999
Q ss_pred HHHHHhhcCCCCEEecCCCCCcEEecCCC--CceEeeeccccccCCCC--ccccccccccccCccccccccC--CCCCcc
Q 003832 584 GILYLHQDSRMRIIHRDLKASNVLLDNDM--NPKISDFGMARIFGGDE--IQTNTHKVVGTYGYMSPEYAAE--GLFSVK 657 (792)
Q Consensus 584 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DFgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~s~k 657 (792)
||.|||+.+ |+||||||+|||++.++ .+||+|||++..+.... .........||+.|+|||.+.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999998 99999999999998776 89999999998753221 1112334679999999999865 678999
Q ss_pred CcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC--CCCHHHHHHHHHHHHHhccCCCCC
Q 003832 658 SDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD--SHPPTEVLRCIHVGLLCVQHRPED 735 (792)
Q Consensus 658 ~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~Cl~~~P~~ 735 (792)
+||||||+++|||++|+.||......+ ... .+....... .........+.+++.+||+.+|++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TIS---------QVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHH---------HHHhcccccCCcccccCCHHHHHHHHHHcCCChhH
Confidence 999999999999999999996432210 000 111111110 111123457889999999999999
Q ss_pred CCCHHHHHHH
Q 003832 736 RPNMSSVVLM 745 (792)
Q Consensus 736 RPs~~evl~~ 745 (792)
||++.|+++.
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999884
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.32 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=206.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 468999999999999999999875 5889999998644 23445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..+....
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988843 345899999999999999999999988 9999999999999999999999999998764333
Q ss_pred ccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.........|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. ..+... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-----~~~~~~--------~ 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EY-----SDWKEK--------K 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HH-----HHHHTT--------C
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HH-----HHhhhc--------c
Confidence 2223344678999999999987665 7899999999999999999999975433211 00 011110 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
............+.+++..||+.+|++|||++||++.
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011122334567899999999999999999998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.53 Aligned_cols=275 Identities=18% Similarity=0.243 Sum_probs=207.5
Q ss_pred hhcccccccccCcC--CcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEG--GFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G--~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
..++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999976 58999999997542 344567889999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999996542 345899999999999999999999998 999999999999999999999999998754
Q ss_pred CCCC-----ccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch-hHHHHHHH-
Q 003832 626 GGDE-----IQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL-LGHAWILW- 696 (792)
Q Consensus 626 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l-~~~~~~~~- 696 (792)
.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... ........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 3211 1111223478999999999987 6799999999999999999999999975433221100 00000000
Q ss_pred hh-----h-------------hhhhhc---------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hc
Q 003832 697 KE-----K-------------RAMELA---------GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LS 747 (792)
Q Consensus 697 ~~-----~-------------~~~~~~---------~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~ 747 (792)
.. . ...... ........+......+.+|+.+||+.||++|||++|+++. ++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~ 338 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK 338 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence 00 0 000000 0000001222334568899999999999999999999975 54
Q ss_pred CC
Q 003832 748 SD 749 (792)
Q Consensus 748 ~~ 749 (792)
+.
T Consensus 339 ~~ 340 (389)
T 3gni_B 339 QI 340 (389)
T ss_dssp GC
T ss_pred HH
Confidence 43
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=336.23 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=204.4
Q ss_pred hhcccccccccCcCCcccEEeeeccC----CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
..++|...+.||+|+||.||+|+..+ +..||+|++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 35789999999999999999998543 346999999765 33456789999999999999999999999764 4678
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999999653 345889999999999999999999988 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~------ 229 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEK------ 229 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHH------
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhc------
Confidence 543221 1233567889999999998899999999999999999998 999986433221 110 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+......+.+++.+||+.+|++||++.|+++.|+..
T Consensus 230 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 230 ---GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 111122333456688999999999999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=349.26 Aligned_cols=269 Identities=26% Similarity=0.402 Sum_probs=211.4
Q ss_pred hcccccccccCcCCcccEEeeec-----cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-----VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-----~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~ 544 (792)
.++|+..++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35788899999999999999983 358899999998877777788999999999999999999999987654 68
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++++|.+++... ...+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999999653 245899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH----HHHhhh
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW----ILWKEK 699 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~----~~~~~~ 699 (792)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... +..... ......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGNDKQGQMIVF 270 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH----HHHHHCTTCCTHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH----HHHhhccccchhhhHH
Confidence 7543321 1223346778899999999888999999999999999999999887532100 000000 000000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+.+........+...+..+.+++.+||+.+|++||++.||++.|++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122222222233445567788999999999999999999999999764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.55 Aligned_cols=265 Identities=22% Similarity=0.338 Sum_probs=189.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..++||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467889999999999999999875 48899999997553 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcc---cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQA---RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58988886532 1235889999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh---h--
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---R-- 700 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~-- 700 (792)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........... .
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence 3221 1233578999999999876 4689999999999999999999999975432111 10000000000 0
Q ss_pred -hhhh--ccccc------------cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 -AMEL--AGDTL------------ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 -~~~~--~~~~~------------~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+ ..+.. ....+......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000 00000 000011233568899999999999999999998863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.85 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=197.3
Q ss_pred ccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCCC
Q 003832 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNK 554 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~g 554 (792)
...+.||+|+||.||+|+.. +++.||+|+++.......+.+.+|+.++++++||||+++++++.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 33568999999999999864 58899999998776667788999999999999999999999999999999999999999
Q ss_pred ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe--cCCCCceEeeeccccccCCCCccc
Q 003832 555 SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--DNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 555 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999988653 345899999999999999999999988 9999999999999 5678899999999987654322
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ........ .....
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~----~~i~~~~~------~~~~~ 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETL----NNILACRW------DLEDE 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHHTCC------CSCSG
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhccC------CCChh
Confidence 22356999999999999999999999999999999999999999643221 000 00000000 00000
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
........+.+++.+||+.+|++||++.|+++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11123456889999999999999999999998
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.00 Aligned_cols=246 Identities=22% Similarity=0.252 Sum_probs=205.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..+.||+|+||.||+++.. +++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 58899999986532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999653 34899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..... .
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~----~~i~~--------~ 253 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIY----EKIVS--------G 253 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHH--------C
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHH----HHHHc--------C
Confidence 2 23467999999999999999999999999999999999999999643211 000 01111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
. ...+......+.+++.+||+.+|++||+ ++||+++
T Consensus 254 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 254 K--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp C--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred C--CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1 1223344567889999999999999998 8888864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.01 Aligned_cols=250 Identities=22% Similarity=0.255 Sum_probs=179.5
Q ss_pred cccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 479 NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
++||+|+||.||+++.. +++.||||++.+ .....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999875 488999999964 34567889999999997 99999999999999999999999999999
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC---CceEeeeccccccCCCCcccc
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---NPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DFgla~~~~~~~~~~~ 633 (792)
.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 94 FERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 9999653 45899999999999999999999988 99999999999998765 799999999987543321 2
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH 713 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 713 (792)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.....................+.. ......
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCccc
Confidence 23357899999999999999999999999999999999999999754432211111111111111100 000000
Q ss_pred CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 714 PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 714 ~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+.+++..||+.+|++|||++|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11235678899999999999999999998854
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=339.50 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=200.9
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc--ccccceeeeeeEEeC----Cc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL--QHRNLVKLLGCCIQA----DE 543 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l--~H~niv~l~g~~~~~----~~ 543 (792)
...++|++.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 44578999999999999999999885 899999998543 234455566665554 899999999999887 67
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC-----CCCEEecCCCCCcEEecCCCCceEee
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS-----RMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
.++||||+++|+|.+++... .+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred eEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 89999999999999999543 5899999999999999999999871 11399999999999999999999999
Q ss_pred eccccccCCCCccc--cccccccccCccccccccCCCCCcc------CcchhHHHHHHHHHhC----------CCCCCCC
Q 003832 619 FGMARIFGGDEIQT--NTHKVVGTYGYMSPEYAAEGLFSVK------SDVFSFGVLVLEIVSG----------KKNWRFS 680 (792)
Q Consensus 619 Fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k------~DVwS~Gvil~elltG----------~~p~~~~ 680 (792)
||++..+....... ......||+.|+|||++.+.....+ +|||||||++|||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99998764332211 1224579999999999987776665 9999999999999999 5555433
Q ss_pred CCCCccchhHHHHHHHhhhhhhhhccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 681 HPDHDHNLLGHAWILWKEKRAMELAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 681 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+..... ..... ...........+ ...+..+.+++.+||+.+|++|||+.||++.|+..
T Consensus 266 ~~~~~~~--~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 266 VPSDPSY--EDMRE--------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp SCSSCCH--HHHHH--------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCch--hhhHH--------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 3222211 00000 011111122222 26678899999999999999999999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=358.28 Aligned_cols=263 Identities=20% Similarity=0.232 Sum_probs=208.0
Q ss_pred CHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEE
Q 003832 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539 (792)
Q Consensus 464 ~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~ 539 (792)
.++++....++|+..++||+|+||.||+++.+ +++.||||++++.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 44455566789999999999999999999875 58999999996531 223345889999999999999999999999
Q ss_pred eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeee
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDF 619 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DF 619 (792)
+.+..++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 9999999999999999999996532 35899999999999999999999988 999999999999999999999999
Q ss_pred ccccccCCCCccccccccccccCcccccccc-------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~ 692 (792)
|+++.+..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||......+ ..
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~--- 279 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE---TY--- 279 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH---HH---
Confidence 99987654332 1223468999999999987 4678999999999999999999999996432211 00
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR---PNMSSVVLM 745 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~R---Ps~~evl~~ 745 (792)
....... .....+ ..+...+.++.+++.+||+ +|++| |+++||+++
T Consensus 280 ~~i~~~~--~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 280 GKIVHYK--EHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHTHH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHHhcc--cCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000000 001011 1122345578899999999 99998 699999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=344.84 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred hcccccccccCcCCcccEEeeec----cCCcEEEEEEccCCC----chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
.++|+..+.||+|+||.||+++. .+++.||+|++++.. ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999986 468999999997642 2344568899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998653 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... . .
T Consensus 170 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~----~--------~ 232 (327)
T 3a62_A 170 ESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTI----D--------K 232 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----H--------H
T ss_pred ccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHH----H--------H
Confidence 643222 1223467999999999999999999999999999999999999999643211 000 0 0
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
+.... ...+......+.+++.+||+.+|++|| ++.|++++
T Consensus 233 i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 233 ILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01111 123334456788999999999999999 77888763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=350.94 Aligned_cols=214 Identities=27% Similarity=0.351 Sum_probs=185.0
Q ss_pred ccccccccCHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-----cc
Q 003832 456 EDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----HR 529 (792)
Q Consensus 456 ~~~~~~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----H~ 529 (792)
.+.+...+.+.+.....++|.+.++||+|+||.||+|+.. +++.||||++... ....+.+..|+.++.+++ ||
T Consensus 18 ~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 18 GDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp --CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCC
Confidence 4445556777777777899999999999999999999874 5889999999643 344567888999999997 99
Q ss_pred cceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 530 niv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
||+++++++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~ 171 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLD 171 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEES
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEc
Confidence 9999999999999999999999 999999996543 335889999999999999999999988 99999999999997
Q ss_pred C-------------------------CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHH
Q 003832 610 N-------------------------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFG 664 (792)
Q Consensus 610 ~-------------------------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~G 664 (792)
. ++.+||+|||++...... .....||+.|+|||++.+..++.++||||||
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 246 (360)
T 3llt_A 172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246 (360)
T ss_dssp CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHH
Confidence 5 789999999999864332 2346789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 003832 665 VLVLEIVSGKKNWRFS 680 (792)
Q Consensus 665 vil~elltG~~p~~~~ 680 (792)
|++|||++|+.||...
T Consensus 247 ~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 247 CVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHCCCCCCCC
Confidence 9999999999999753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=351.36 Aligned_cols=256 Identities=27% Similarity=0.383 Sum_probs=195.2
Q ss_pred cccccccccCcCCcccEEeeeccC----CcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~l 546 (792)
..|...+.||+|+||.||+|+..+ ...||+|.++.. .....++|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 346777899999999999998643 236899998754 33556789999999999999999999999765 457899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++... ...+++.+++.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 99999999999999543 345789999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccc--cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 627 GDEIQT--NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 627 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. .. .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~----~~~~~---- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLLQG---- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH----HHHTT----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH----HHHcC----
Confidence 332211 1223467889999999999999999999999999999999 6777764433211 10 00111
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.....+...+..+.+++.+||+.+|++||+++||++.|+..
T Consensus 313 -----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 313 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11122333456788999999999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.75 Aligned_cols=265 Identities=23% Similarity=0.340 Sum_probs=199.2
Q ss_pred cccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+..++||+|+||.||+|+... ++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 679999999999999999998754 88999999865432 335678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999998887543 35899999999999999999999998 9999999999999999999999999998765322
Q ss_pred ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH--------HHHHhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA--------WILWKEKR 700 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~ 700 (792)
. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+... ...+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 1233578999999999875 67899999999999999999999999754322111100000 00000000
Q ss_pred hhh-hccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AME-LAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~-~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ...+......+ +.....+.+++.+||+.+|++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000000000 1234568899999999999999999999975
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=337.52 Aligned_cols=256 Identities=27% Similarity=0.336 Sum_probs=204.1
Q ss_pred ccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc-eEE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES-MLI 547 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~-~lV 547 (792)
.|...++||+|+||.||+|++.+ +..+|+|++.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45666899999999999998543 2379999997643 34567899999999999999999999999877665 999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+.+++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999999652 346889999999999999999999998 99999999999999999999999999986643
Q ss_pred CCc--cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DEI--QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
... ........+++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..+. ..+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~-------------~~~ 241 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLT-------------HFL 241 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHH-------------HHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHH-------------HHh
Confidence 321 11223456789999999999999999999999999999999966664322111 1111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
........+......+.+++.+||+.+|++|||++|+++.|++.
T Consensus 242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111222334456788999999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.85 Aligned_cols=252 Identities=23% Similarity=0.311 Sum_probs=190.3
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|++.+.||+|+||.||+|+... ++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 45789999999999999999998764 7889999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgla~~~~ 626 (792)
|+++++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 99999999998543 45899999999999999999999988 999999999999975 8899999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .......
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~----~~i~~~~------ 267 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMF----RRILNCE------ 267 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHH----HHHHTTC------
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHH----HHHHhCC------
Confidence 322 1234578999999999999999999999999999999999999986433211 000 0000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..............+.+++.+||+.||++||++.|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111123345678899999999999999999999884
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=347.28 Aligned_cols=258 Identities=23% Similarity=0.274 Sum_probs=191.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEe--------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ-------- 540 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~-------- 540 (792)
...+|++.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 4468999999999999999999864 58899999997776667788999999999996 9999999999953
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
....++|+||+. |+|.+++........+++.+++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 234789999996 789888876555567999999999999999999999875 349999999999999999999999999
Q ss_pred cccccCCCCccc----------cccccccccCccccccc---cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc
Q 003832 621 MARIFGGDEIQT----------NTHKVVGTYGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (792)
Q Consensus 621 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~ 687 (792)
++.......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765332111 11134689999999998 56778999999999999999999999986432211
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..........+......+.+++..||+.+|++||++.|+++.|+..
T Consensus 261 ----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~ 306 (337)
T 3ll6_A 261 ----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306 (337)
T ss_dssp ---------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0011111111122233477899999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=337.10 Aligned_cols=257 Identities=28% Similarity=0.381 Sum_probs=202.4
Q ss_pred hcccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEe-CCcce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-ADESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-~~~~~ 545 (792)
...|+..++||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3568888999999999999998643 2368999987643 3456789999999999999999999999654 56789
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 104 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999999643 345789999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc--ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 626 GGDEIQ--TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 626 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||........ .. ....
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~----~~~~---- 247 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----YLLQ---- 247 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HH----HHHT----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HH----HHhc----
Confidence 543221 12233567889999999999999999999999999999999 4555543322211 10 0000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+...+..+.+++.+||+.+|++||+++|+++.|++.
T Consensus 248 -----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 248 -----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111122233445688999999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=333.44 Aligned_cols=250 Identities=27% Similarity=0.434 Sum_probs=185.6
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346799999999999999999986 468999999986432 2234678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EEECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 99999999999998643 346899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---------------~~~~ 226 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN---------------KVVL 226 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCS
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH---------------HHhh
Confidence 3221 1223578999999999999899999999999999999999999997543321100 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.. ...+......+.+++.+||+.+|++||+++||++
T Consensus 227 ~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 AD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00 1123334557889999999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.89 Aligned_cols=263 Identities=22% Similarity=0.358 Sum_probs=200.4
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 346799999999999999999986 46899999999753 33456788999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999986532 3456899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ..... ......
T Consensus 187 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~------ 253 (310)
T 2wqm_A 187 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQC------ 253 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHTT------
T ss_pred cCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhcc------
Confidence 43321 122357899999999999999999999999999999999999998643221 11100 001110
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.............+.+++.+||+.+|++||++.+|+++|+...+
T Consensus 254 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 254 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp --CSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11111112344568899999999999999999999999987644
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.14 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=199.9
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.+.|+..+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35688899999999999999986 468899999997543 23446789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+. |+|.+++... ...+++.++..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 6777777543 346899999999999999999999998 99999999999999999999999999986542
Q ss_pred CCccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..... ....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~-~~~~----- 268 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQN----- 268 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHH-HHHS-----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHH-HHhc-----
Confidence 2 2357899999999984 567899999999999999999999998643211 00000 0000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..+. ..+......+.+++..||+.+|++|||++|+++.
T Consensus 269 ~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0111 1122334567889999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=332.48 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=204.4
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|++.++||+|+||.||+|+... ++.+|+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 35679999999999999999998755 67899999977656667889999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~~ 626 (792)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++..+.
T Consensus 87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 99999999988653 34899999999999999999999998 9999999999999 788999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.||....... . .....+.
T Consensus 161 ~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~----~~~~~~~------- 222 (277)
T 3f3z_A 161 PGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---V----MLKIREG------- 222 (277)
T ss_dssp TTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHC-------
T ss_pred Ccc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHhC-------
Confidence 432 22335789999999998654 8999999999999999999999996432210 0 0001110
Q ss_pred ccccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 707 DTLADSHPP----TEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~----~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
. ...+. .....+.+++.+||+.+|++||++.|+++
T Consensus 223 -~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 -T--FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -C--CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -C--CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01111 22456889999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.84 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=204.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe---------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------- 540 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 540 (792)
..++|+..+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4467999999999999999999876 68999999997643 356789999999999999999999864
Q ss_pred -------CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC
Q 003832 541 -------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN 613 (792)
Q Consensus 541 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~ 613 (792)
....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 345799999999999999996542 346899999999999999999999988 999999999999999999
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... ...
T Consensus 161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---------~~~- 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---------SKF- 227 (284)
T ss_dssp EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---------HHH-
T ss_pred EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---------HHH-
Confidence 99999999987654321 22356899999999999999999999999999999999998875310 000
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCCCCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPE 754 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~~~~ 754 (792)
...+.... .+......+.+++.+||+.+|++||++.|+++.|+....-++
T Consensus 228 -------~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 228 -------FTDLRDGI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -------HHHHHTTC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -------HHHhhccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00111111 122233457789999999999999999999999987654443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.06 Aligned_cols=248 Identities=26% Similarity=0.383 Sum_probs=201.9
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+.++|++.+.||+|+||.||+|+... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 35789999999999999999998654 6789999986432 2235678999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 99999999999998654 34889999999999999999999987 9999999999999999999999999986543
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..... ..
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~-----~~--- 221 (279)
T 3fdn_A 161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRI-----SR--- 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHH-----HH---
T ss_pred ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH-------HHHHH-----Hh---
Confidence 222 233578999999999999999999999999999999999999986432110 00000 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.....+......+.+++..||+.+|++||+++||++.
T Consensus 222 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 --VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112233345567899999999999999999999985
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.90 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=204.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|++.++||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999875 4889999998654 334557789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeeccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFGMARI 624 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFgla~~ 624 (792)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 9999999998888654 35899999999999999999999998 999999999999987655 99999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ........
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~---~~~----~~~~~~~~--- 224 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----AQIKAGAY--- 224 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC---
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh---HHH----HHHHhccc---
Confidence 643321 23357899999999999999999999999999999999999998643211 000 00000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.............+.+++..||+.+|++|||+.|+++.
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 225 ---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00111112334568899999999999999999999884
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=347.37 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=204.8
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (792)
..++|+..+.||+|+||.||+++... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 35789999999999999999998865 788999999754 223456788999999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999999653 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. . .+.
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~----~--------~i~ 234 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF----Q--------SIM 234 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----H--------HHH
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHH----H--------HHH
Confidence 3222 1233468999999999999999999999999999999999999999643211 111 0 011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
... ...+.....++.+++.+||+.+|++||+ ++||+++
T Consensus 235 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 235 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred hCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111 1233345567889999999999999995 5777754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=350.57 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=213.4
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC--cceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD--ESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~--~~~lV 547 (792)
.++|.+.++||+|+||.||+|+... ++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3678999999999999999998765 8999999997543 334577889999999999999999999998765 67999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe----cCCCCceEeeecccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKISDFGMAR 623 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DFgla~ 623 (792)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976555555999999999999999999999998 9999999999999 778889999999998
Q ss_pred ccCCCCccccccccccccCccccccccC--------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAE--------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............ ....
T Consensus 165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~--~~~~ 239 (396)
T 4eut_A 165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MYKI 239 (396)
T ss_dssp ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH--HHHH
T ss_pred EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH--HHHH
Confidence 764432 2233579999999999865 56788999999999999999999999754332221111 1111
Q ss_pred Hhhhhhhhhc---------------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 696 WKEKRAMELA---------------GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 696 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. +.-.... +.......+......+.+++..||+.||++||++.|+++.|+..
T Consensus 240 ~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 IT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 11 1000000 00112234567788899999999999999999999999988664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=334.45 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=201.5
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
+|.....||+|+||.||+|+.. +++.||||++........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555568999999999999864 578999999987766667889999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeeccccccCCCCcc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgla~~~~~~~~~ 631 (792)
+++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+||+++. ++.+||+|||++.......
T Consensus 103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-- 177 (295)
T 2clq_A 103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-- 177 (295)
T ss_dssp EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--
Confidence 9999999976544456778899999999999999999988 999999999999987 8999999999998764322
Q ss_pred ccccccccccCccccccccCCC--CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
.......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... . . ..... ....
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~--~--~~~~~------~~~~ 243 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----A--A--MFKVG------MFKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----H--H--HHHHH------HHCC
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----H--H--HHhhc------cccc
Confidence 1123457899999999997653 8899999999999999999999986322110 0 0 00000 0011
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
....+......+.+++.+||+.+|++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12233445567889999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.18 Aligned_cols=264 Identities=19% Similarity=0.241 Sum_probs=199.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|++.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999875 58899999997542 2334778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|+||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999653 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .. ...... ....
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~---~~~~~~----~~~~ 253 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VM---GAHINQ----AIPR 253 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HH---HHHHHS----CCCC
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HH---HHHhcc----CCCC
Confidence 33211 222357899999999999999999999999999999999999998642211 00 000000 0000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcCCCCCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-NMSSVVLMLSSDSLLPEP 755 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-s~~evl~~L~~~~~~~~p 755 (792)
....+...+..+.+++.+||+.+|++|| +++++++.|+....-..+
T Consensus 254 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 254 ---PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ---GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ---ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0112223345688899999999999999 999999999876544433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.99 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=198.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|...++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 367999999999999999999875 48899999986643 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeecccccc
Q 003832 550 YMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (792)
Q Consensus 550 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~ 625 (792)
|+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++..+
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988653 23456899999999999999999999988 9999999999999 45688999999999876
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||....... ... . ....
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~--------~--~~~~ 240 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQ--------K--ATYK 240 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH--------H--HHHC
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHh--------h--hccC
Confidence 4332 123457899999999885 568999999999999999999999996432110 000 0 0000
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...... ........+.+++.+||+.+|++||++.||++
T Consensus 241 ~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 EPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred Cccccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111100 00112356778999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.00 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=192.3
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCC--c
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQAD--E 543 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~--~ 543 (792)
...++|+..++||+|+||.||+|... +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999864 5889999998654 3345567889999999997 999999999998654 6
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++|||||+ ++|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999998 588888854 35889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCC-------------------ccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 624 IFGGDE-------------------IQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 624 ~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 753211 0111233579999999999876 67899999999999999999999999754321
Q ss_pred CccchhHHHHHHHhhhhh------------------hhhc---cccccC------------CCCHHHHHHHHHHHHHhcc
Q 003832 684 HDHNLLGHAWILWKEKRA------------------MELA---GDTLAD------------SHPPTEVLRCIHVGLLCVQ 730 (792)
Q Consensus 684 ~~~~l~~~~~~~~~~~~~------------------~~~~---~~~~~~------------~~~~~~~~~l~~li~~Cl~ 730 (792)
.....+ ......... .... ...... .........+.+|+.+||+
T Consensus 238 ~~~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQLERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HHHHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HHHHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 110000 000000000 0000 000000 0001224568899999999
Q ss_pred CCCCCCCCHHHHHHH
Q 003832 731 HRPEDRPNMSSVVLM 745 (792)
Q Consensus 731 ~~P~~RPs~~evl~~ 745 (792)
.||++|||++|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999886
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.91 Aligned_cols=262 Identities=19% Similarity=0.274 Sum_probs=203.2
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeE-EeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 548 (792)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++.+++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999986 4688999998754322 23578899999999988877776666 5667789999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~ 625 (792)
||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 99999998643 335899999999999999999999998 9999999999999 78999999999999876
Q ss_pred CCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 626 GGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 626 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc----c
Confidence 543221 1223467999999999999999999999999999999999999999865544333322211110 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ....+..... .+..+.+++..||+.+|++||++++|++.|++.
T Consensus 235 ~-~~~~~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 235 M-STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-HSCHHHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred c-cchhhhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 0000111111 235688999999999999999999999999764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=337.27 Aligned_cols=264 Identities=24% Similarity=0.361 Sum_probs=198.4
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-----chhHHHHHHHHHHHHhcc---cccceeeeeeEEeC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-----GQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQA 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-----~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~ 541 (792)
..++|++.++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4678999999999999999999864 58899999986432 122346677887777775 99999999999876
Q ss_pred C-----cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 542 D-----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 542 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
. ..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999997 59999886543 334899999999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 617 SDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 617 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
+|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||....... .........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 9999998764332 2234678999999999999999999999999999999999999996433211 111100000
Q ss_pred hhhhhhhh------cccccc--CC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 KEKRAMEL------AGDTLA--DS-----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ~~~~~~~~------~~~~~~--~~-----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ ...... .. ..++....+.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 000000 00 011234568899999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=333.16 Aligned_cols=247 Identities=23% Similarity=0.333 Sum_probs=201.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~l 546 (792)
..++|+..++||+|+||.||+|+.. +++.||+|++... ......++.+|+..+.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999876 6899999998764 334566788999999999 99999999999999999999
Q ss_pred EEeecCCCChhHHHhhccc-CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC--------------
Q 003832 547 IYEYMPNKSLDFFIFDQAR-ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-------------- 611 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------- 611 (792)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975432 356899999999999999999999998 9999999999999844
Q ss_pred -----CCceEeeeccccccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003832 612 -----MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (792)
Q Consensus 612 -----~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~ 685 (792)
..+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|+.++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence 479999999998764322 24589999999999765 66789999999999999999987653210
Q ss_pred cchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 686 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ .....+......+.+++.+||+.+|++||++.|+++.
T Consensus 236 ------~~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ------QWHEIRQG---------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ------HHHHHHTT---------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ------HHHHHHcC---------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01111111 1112233345678899999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=340.82 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=204.0
Q ss_pred cccccccccCcCCcccEEeeeccC-CcE--EEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQE--IAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~~--vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
++|+..+.||+|+||.||+|+... +.. +|+|++... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 678899999999999999998754 554 599998754 334456789999999999 899999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 548 YEYMPNKSLDFFIFDQA-------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
|||+++++|.+++.... ....+++.+++.++.||+.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999996542 2346899999999999999999999988 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~- 250 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------L- 250 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------H-
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------H-
Confidence 9999999874321 111223456889999999988889999999999999999998 999986432210 0
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+........+......+.+++.+||+.+|++||+++|+++.|+..
T Consensus 251 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 251 --------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111112223334456788999999999999999999999998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=333.16 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=199.5
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC-CcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~ 550 (792)
.++|+..+.||+|+||.||+++. .++.||||+++... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46799999999999999999987 48899999997543 457899999999999999999999997655 478999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 99999999996542 234789999999999999999999988 9999999999999999999999999988653321
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... .. ..+....
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~-------------~~~~~~~ 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV-------------PRVEKGY 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH-------------HHHTTTC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHhcCC
Confidence 22457889999999998999999999999999999998 999986433211 11 1111111
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+...+..+.+++..||+.+|++||++.|+++.|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 2233344556788999999999999999999999999764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=360.85 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=195.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|+..++||+|+||.||+++.. +++.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999865 5889999999653 334456778899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998653 358999999999999999999998 76 9999999999999999999999999998643
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .. ..
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~----~i--------~~ 363 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFE----LI--------LM 363 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HH--------HH
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH----HH--------Hh
Confidence 322 1223468999999999999999999999999999999999999999643221 1110 00 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
.. ...+......+.+++..||+.||++|| +++|++++
T Consensus 364 ~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 364 EE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11 112333456788999999999999999 99999873
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.30 Aligned_cols=259 Identities=24% Similarity=0.335 Sum_probs=205.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEe--CCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 546 (792)
.++|+..+.||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999875 5889999999754 33455679999999999999999999998864 567899
Q ss_pred EEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 547 IYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997543 2445899999999999999999999976 2349999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+. ......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~i~~~---- 231 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREG---- 231 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHT----
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHH----HHHhhc----
Confidence 7643321 122356899999999999989999999999999999999999998643211 110 111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.....+......+.+++.+||+.+|++||++.||++.+..
T Consensus 232 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 -----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1112333445678899999999999999999999987743
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.35 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=206.9
Q ss_pred HHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHh--cccccceeeeeeEEeCC----
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIAR--LQHRNLVKLLGCCIQAD---- 542 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~g~~~~~~---- 542 (792)
....++|...+.||+|+||.||+|+. +++.||||++.. ...+.+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999998 589999999964 334677889988888 78999999999998876
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh--------hcCCCCEEecCCCCCcEEecCCCCc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--------QDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
..++||||+++|+|.+++.. ..+++.+++.++.|++.||.||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 78999999999999999954 24899999999999999999999 555 9999999999999999999
Q ss_pred eEeeeccccccCCCCccc--cccccccccCccccccccCC------CCCccCcchhHHHHHHHHHhC----------CCC
Q 003832 615 KISDFGMARIFGGDEIQT--NTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSG----------KKN 676 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gvil~elltG----------~~p 676 (792)
||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433211 23345799999999999765 334789999999999999999 667
Q ss_pred CCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 677 WRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 677 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
|....+.... ... ... .+......... .......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 267 ~~~~~~~~~~-~~~-~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 267 YYDLVPSDPS-VEE-MRK--------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTTSCSSCC-HHH-HHH--------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCcCccc-HHH-HHH--------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7544332211 110 000 11111222222 235677899999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=361.38 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=209.0
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|+..+.||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.+|++++|||||++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999875 5899999999653 22345678899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999986543 345899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+. .. +..
T Consensus 338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~---~~-----i~~--- 403 (576)
T 2acx_A 338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RL-----VKE--- 403 (576)
T ss_dssp TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH---HH-----HHH---
T ss_pred cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH---HH-----hhc---
Confidence 4321 223579999999999999999999999999999999999999997544322111110 00 000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
.....+......+.+|+.+||+.||++|| +++||+++
T Consensus 404 --~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 404 --VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 01123344456788999999999999999 78888864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.18 Aligned_cols=243 Identities=22% Similarity=0.321 Sum_probs=202.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--------hhHHHHHHHHHHHHhcccccceeeeeeEEeC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
..++|+..+.||+|+||.||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 4578999999999999999999854 588999999976531 1334677899999999999999999999999
Q ss_pred CcceEEEeecCCC-ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 542 DESMLIYEYMPNK-SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 542 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
+..++||||+.+| +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 999888543 35899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9987654322 223578999999999988776 8899999999999999999999863111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...... ..+......+.+++..||+.+|++||+++|+++.
T Consensus 236 ----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000110 1122234568899999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.57 Aligned_cols=262 Identities=19% Similarity=0.272 Sum_probs=206.8
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeE-EeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC-IQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 548 (792)
..++|+..+.||+|+||.||+|+. .+++.||||++..... .+++.+|+.++.+++|++++..+.++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999986 5689999999865432 34688999999999998877766665 5566779999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~ 625 (792)
||+ +++|.+++... ...+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 99999999643 345899999999999999999999998 9999999999999 58899999999999876
Q ss_pred CCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 626 GGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 626 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----~ 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH----H
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc----c
Confidence 543221 1123467999999999999999999999999999999999999999865443332222111110 0
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
. ....+.... ..+..+.+++.+||+.+|++||++++|++.|+..
T Consensus 235 ~-~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 235 M-STPIEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-HSCHHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred c-CCchHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 0 000011111 2235688999999999999999999999999765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=334.09 Aligned_cols=249 Identities=26% Similarity=0.419 Sum_probs=206.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.+.|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356889999999999999999864 58899999987553 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999999843 45899999999999999999999998 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ... .. ..
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~-----~~----~~ 235 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---KVL----FLI-----PK----NN 235 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHH-----HH----SC
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---HHH----HHh-----hc----CC
Confidence 2 223457899999999999999999999999999999999999998643211 000 000 01 11
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++..||+.+|++||++.||++.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 112222334568899999999999999999999874
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=339.90 Aligned_cols=253 Identities=21% Similarity=0.281 Sum_probs=204.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
..++|++.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3467999999999999999999875 488999999875432 136789999999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC----CceEeee
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDF 619 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DF 619 (792)
.++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999643 45889999999999999999999988 99999999999999888 7999999
Q ss_pred ccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 620 GMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 620 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
|++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ......
T Consensus 164 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETL----ANITSV 233 (321)
T ss_dssp TTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHH----HHHHTT
T ss_pred ccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhc
Confidence 9998765432 123457899999999999999999999999999999999999999643211 000 000000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ....+.. .......+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ~--~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 234 S--YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 0000000 01223567899999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=355.08 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=205.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|.+.+.||+|+||.||+|++. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999875 58999999996532 23356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999854 345899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .+. .. +.+
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~----~~--------i~~ 230 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLF----KK--------ICD 230 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHH----HH--------HHT
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHH----HH--------Hhc
Confidence 321 234579999999999988765 78999999999999999999999743221 111 00 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ...+......+.+++.+||+.||++|||++||++.
T Consensus 231 ~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 231 GI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp TC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11 11223334568899999999999999999999973
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=344.36 Aligned_cols=253 Identities=18% Similarity=0.128 Sum_probs=204.4
Q ss_pred HhhcccccccccCcCCcccEEeee------ccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc---cccceeeeeeEEe
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQ 540 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~------~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~ 540 (792)
...++|.+.++||+|+||.||+|+ ...++.||||++.... ..++..|++++.+++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 446789999999999999999994 3458899999997643 456778888888886 9999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhcc--cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC--------
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQA--RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-------- 610 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------- 610 (792)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccc
Confidence 999999999999999999997532 3456999999999999999999999987 999999999999998
Q ss_pred ---CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc
Q 003832 611 ---DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (792)
Q Consensus 611 ---~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~ 687 (792)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 899999999999765432222333456799999999999999999999999999999999999999853222110
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCC-CCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDR-PNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~R-Ps~~evl~~L~~~ 749 (792)
.+....... + ....+.+++..|++.+|.+| |+++++.+.|++.
T Consensus 294 ----------------~~~~~~~~~-~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 ----------------KPEGLFRRL-P--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ----------------EECSCCTTC-S--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ----------------eechhcccc-C--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 011111111 1 24456778889999999999 6888888887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=335.51 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=199.3
Q ss_pred hcccccccccCcCCcccEEeeeccC--Cc--EEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE--GQ--EIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~--~~--~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|+..++||+|+||.||+|++.. ++ .||||+++.. .....+.+.+|+.++++++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3678999999999999999998532 33 6899998754 3345678999999999999999999999998754 8
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999999653 245889999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 625 FGGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 625 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
....... .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~------------~ 235 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QIL------------H 235 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH------------H
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHH------------H
Confidence 6543321 12233567889999999988889999999999999999999 99998643221 000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.+.........+...+..+.+++.+||+.+|++||++.++++.|++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 236 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111122233455678899999999999999999999999987543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=369.94 Aligned_cols=247 Identities=29% Similarity=0.416 Sum_probs=198.7
Q ss_pred cccCcCCcccEEeeecc---CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
++||+|+||.||+|.+. .++.||||+++... ....+++.+|+++|++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 36789999997642 344678999999999999999999999996 4568899999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc-cc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI-QT 632 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~-~~ 632 (792)
|+|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 9999999543 45899999999999999999999998 99999999999999999999999999987754332 12
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... +...+......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence 2233456889999999999999999999999999999998 999996433211 11111112222
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+..+.+++..||+.+|++||++.+|+++|+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 3444556778999999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.58 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=207.2
Q ss_pred cCHHhHHHhhcccccc-cccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcc-cccceeeeee
Q 003832 463 FDFASIAKATDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ-HRNLVKLLGC 537 (792)
Q Consensus 463 ~~~~~i~~~~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~ 537 (792)
..+...+...+.|.+. ++||+|+||.||+++.. +++.||+|++... .......+.+|+.++.+++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3344555666778877 88999999999999875 4899999998754 2344678999999999995 6999999999
Q ss_pred EEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCc
Q 003832 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNP 614 (792)
Q Consensus 538 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~ 614 (792)
+.+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~ 173 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDI 173 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcE
Confidence 99999999999999999999988543 2356899999999999999999999998 999999999999998 7899
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. .
T Consensus 174 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~----~ 243 (327)
T 3lm5_A 174 KIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE---TY----L 243 (327)
T ss_dssp EECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----H
T ss_pred EEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HH----H
Confidence 999999998764332 1233578999999999999999999999999999999999999996432210 00 0
Q ss_pred HHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. .. ................+.+++.+||+.+|++|||++|+++.
T Consensus 244 ~i-----~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 NI-----SQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH-----HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HH-----Hh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 00 00 01111112223345668899999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=357.10 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=208.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|...+.||+|+||.||+++.. +++.||+|++.+.. ....+.+..|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999875 48999999996532 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 548 YEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
|||+++|+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987543 2446899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ . . .+..
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~--~-~--------~i~~ 407 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--K-Q--------RVLE 407 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH--H-H--------HHHH
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH--H-H--------HHhh
Confidence 4322 123358999999999999999999999999999999999999999764332111100 0 0 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~ 744 (792)
. ....+......+.+++.+||+.+|++||++ +||++
T Consensus 408 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1 112334455678899999999999999975 66664
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=341.04 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=201.4
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++|+..+.||+|+||.||+++.. +++.||||++.+... ...+|++++.++ +||||+++++++.+....++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4578999999999999999999875 488999999976543 235688888888 7999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC----CCceEeeeccccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgla~~ 624 (792)
||+++|+|.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 999999999998653 45899999999999999999999998 9999999999998543 3499999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+. .....+.
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~---- 239 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGK---- 239 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCC----
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCC----
Confidence 654322 223457899999999998888999999999999999999999999753322211111 1111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..............+.+++.+||+.||++||++.|+++.
T Consensus 240 --~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 --FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp --CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred --cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011111223345678899999999999999999999873
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=353.21 Aligned_cols=262 Identities=23% Similarity=0.269 Sum_probs=194.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|+..++||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999865 4889999999764 3345677899999999999999999999997654
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
+.++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999875 555552 23889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH-----HHHh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW-----ILWK 697 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~ 697 (792)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ..+.
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764322 2234689999999999999999999999999999999999999997543211100000000 0000
Q ss_pred --hhhhhhhcccc---------------ccCCC---CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 --EKRAMELAGDT---------------LADSH---PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 --~~~~~~~~~~~---------------~~~~~---~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+... ..... .......+.+|+.+||+.||++|||++|++++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000011100 00000 01125678899999999999999999999985
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=338.64 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=206.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|...+.||+|+||.||+++..+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 34689999999999999999998765 788999998654 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 119 v~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 99999999999988543 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . ........ .
T Consensus 193 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~~~~~------~ 257 (335)
T 2owb_A 193 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIKKN------E 257 (335)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHHHT------C
T ss_pred cCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------H-HHHHHhcC------C
Confidence 3221 223467899999999999999999999999999999999999999643211 0 00000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+......+.+++.+||+.||++||+++|+++.
T Consensus 258 ----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11222334567889999999999999999999973
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=344.96 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=192.6
Q ss_pred hcccccc-cccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHh-cccccceeeeeeEEe----CCcc
Q 003832 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIAR-LQHRNLVKLLGCCIQ----ADES 544 (792)
Q Consensus 472 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~g~~~~----~~~~ 544 (792)
.++|... +.||+|+||+||+++.. +++.||||++.. ...+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 68999999999999875 488999999963 2457788888755 489999999999876 5678
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeecc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl 621 (792)
+|||||+++|+|.+++.... ...+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 99999999999999996532 345899999999999999999999988 999999999999997 78999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............. . ....+.
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~--~i~~~~- 283 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-T--RIRMGQ- 283 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH-H--HHHHTC-
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH-H--HHHcCc-
Confidence 98754322 1234678999999999999999999999999999999999999997654332211110 0 000000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. .............+.+|+..||+.||++|||+.||++.
T Consensus 284 --~---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 284 --Y---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp --C---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --c---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00001112344568899999999999999999999985
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=352.73 Aligned_cols=243 Identities=15% Similarity=0.148 Sum_probs=190.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHH---HHHHhcccccceeee-------e
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEV---TLIARLQHRNLVKLL-------G 536 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------g 536 (792)
..++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3578999999999999999999974 5899999999743 344567899999 555566899999998 6
Q ss_pred eEEeCC-----------------cceEEEeecCCCChhHHHhhccc----CccCChhhHHHHHHHHHHHHHHHhhcCCCC
Q 003832 537 CCIQAD-----------------ESMLIYEYMPNKSLDFFIFDQAR----ATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (792)
Q Consensus 537 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 595 (792)
++...+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 655443 278999999 6899999975421 123446888899999999999999998
Q ss_pred EEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCC-----------CCCccCcchhHH
Q 003832 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-----------LFSVKSDVFSFG 664 (792)
Q Consensus 596 ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~k~DVwS~G 664 (792)
|+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG 300 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence 99999999999999999999999999986432 2233567 999999999877 899999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 665 VLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 665 vil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
|++|||++|+.||........... ... . ....+..+.+++.+||+.+|++||++.|+++
T Consensus 301 ~il~elltg~~Pf~~~~~~~~~~~---------------~~~-~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 301 LVIYWIWCADLPITKDAALGGSEW---------------IFR-S-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHSSCCC------CCSGG---------------GGS-S-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHCCCCCcccccccchhh---------------hhh-h-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999965433221110 000 0 1122356889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=344.72 Aligned_cols=255 Identities=23% Similarity=0.316 Sum_probs=204.4
Q ss_pred hcccccccccCcCCcccEEeeec----cCCcEEEEEEccCCC----chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL----VEGQEIAVKRLSKGS----GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~----~~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~ 542 (792)
.++|++.++||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46899999999999999999987 368999999987532 23345678899999999 6999999999999999
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 999999999999999999654 35889999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
+.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ ...
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~------ 277 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRR------ 277 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHH------
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHH------
Confidence 87643222 12234679999999999975 45789999999999999999999999754433221111 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHh
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLML 746 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~L 746 (792)
... .....+......+.+++.+||+.+|++|| +++|+++..
T Consensus 278 ---~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 278 ---ILK--SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ---HHH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ---Hhc--cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 000 01123344556788999999999999999 999998864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.89 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=204.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999876 5889999999765 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|+++++|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999654 3588999999999999999999986 6 999999999999999999999999998765321
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH-----------------
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH----------------- 691 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~----------------- 691 (792)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 186 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 12335789999999999999999999999999999999999999975332111000000
Q ss_pred ------HHHHHhh----hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 ------AWILWKE----KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 ------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....... ......................+.+++.+||+.+|++|||++|+++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 00000111111111112234568899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=333.57 Aligned_cols=260 Identities=20% Similarity=0.318 Sum_probs=206.9
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|...+.||+|+||.||+++.. +++.||+|++........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3467999999999999999999875 588999999987655555678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~~ 626 (792)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 99999999988653 35889999999999999999999988 9999999999999 788999999999987643
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .+. ....+..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~----~~i~~~~------ 223 (304)
T 2jam_A 161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLF----EKIKEGY------ 223 (304)
T ss_dssp CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHCC------
T ss_pred CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCC------
Confidence 22 122356899999999999999999999999999999999999998643211 111 1111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCCCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL--MLSSDSLLP 753 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~--~L~~~~~~~ 753 (792)
..............+.+++.+||+.+|++||+++|+++ .+.+...+.
T Consensus 224 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (304)
T 2jam_A 224 YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272 (304)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCC
T ss_pred CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCccc
Confidence 00111122334567889999999999999999999997 355544433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.59 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=206.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|...+.||+|+||.||+++..+ ++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 34679999999999999999998764 788999998654 23456778999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 99999999999988543 35899999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ...... .
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~--------~ 229 (294)
T 2rku_A 167 YDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------E-TYLRIK--------K 229 (294)
T ss_dssp STTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------H-HHHHHH--------T
T ss_pred cCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHh--------h
Confidence 3221 223357899999999999989999999999999999999999999643211 0 000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ...+......+.+++.+||+.+|++||+++|+++.
T Consensus 230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 230 NE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cc--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 10 11223344568899999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.20 Aligned_cols=245 Identities=21% Similarity=0.281 Sum_probs=191.9
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHH-HHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTL-IARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|+..+.||+|+||.||+++.+. ++.||||++++.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4679999999999999999998764 7889999997642 2334456667766 567899999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998653 35788999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. . .++.
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~----~--------~i~~ 253 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMY----D--------NILN 253 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHH----H--------HHHH
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHH----H--------HHHh
Confidence 222 1233468999999999999999999999999999999999999999643211 000 0 0111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSS 741 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~e 741 (792)
.. ...+......+.+++.+||+.+|++||++.+
T Consensus 254 ~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 254 KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11 1123334566889999999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=330.74 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=201.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|+..+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 367899999999999999999876 588999999865421 2367899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC----CceEeeec
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg 620 (792)
++||||+++++|.+++... ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999999653 35899999999999999999999988 99999999999998877 89999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ......
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~- 226 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ---ETL----TNISAV- 226 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHTT-
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH---HHH----HHhHhc-
Confidence 998764322 122356899999999999999999999999999999999999998643211 000 000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...............+.+++.+||+.+|++||++.|+++.
T Consensus 227 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 227 -----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp -----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred -----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000000011224567899999999999999999999973
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=339.23 Aligned_cols=271 Identities=24% Similarity=0.347 Sum_probs=196.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHH--HHhcccccceeeeeeEEeC-----Ccc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTL--IARLQHRNLVKLLGCCIQA-----DES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~--l~~l~H~niv~l~g~~~~~-----~~~ 544 (792)
.++|+..++||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46899999999999999999987 68999999996432 3344444444 4558999999999866432 246
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC------CCCEEecCCCCCcEEecCCCCceEee
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------RMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
++||||+++|+|.+++... ..++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 8999999999999999543 3588999999999999999999981 11299999999999999999999999
Q ss_pred eccccccCCCCc------cccccccccccCccccccccC-------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003832 619 FGMARIFGGDEI------QTNTHKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (792)
Q Consensus 619 Fgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~ 685 (792)
||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 999987653221 111223579999999999976 4567899999999999999999877644322211
Q ss_pred -cchhHHHHHH-Hhhhhhhh-hccccccCC------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 686 -HNLLGHAWIL-WKEKRAME-LAGDTLADS------HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 686 -~~l~~~~~~~-~~~~~~~~-~~~~~~~~~------~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
.......... ........ ......... .....+..+.+++.+||+.+|++|||++||++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 1111000000 00000000 011111111 12346678999999999999999999999999998763
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=346.89 Aligned_cols=254 Identities=11% Similarity=0.080 Sum_probs=185.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc---hhHHHHHHHHHHHHhc--ccccceeee-------eeE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARL--QHRNLVKLL-------GCC 538 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------g~~ 538 (792)
..+|...++||+|+||.||+|+.. +++.||||++..... ...+.+++|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456889999999999999999865 688999999987542 3456778886555555 599988755 444
Q ss_pred EeC-----------------CcceEEEeecCCCChhHHHhhcccCccCChhhH------HHHHHHHHHHHHHHhhcCCCC
Q 003832 539 IQA-----------------DESMLIYEYMPNKSLDFFIFDQARATFLDWQKR------IHIVGGIARGILYLHQDSRMR 595 (792)
Q Consensus 539 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~~ 595 (792)
... ...++||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 23799999999 89999997642 23466666 788899999999999988
Q ss_pred EEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhC
Q 003832 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSG 673 (792)
Q Consensus 596 ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG 673 (792)
|+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998754221 13456799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 674 KKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 674 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+.||....+....... .......................+.+++.+||+.+|++|||+.|+++
T Consensus 290 ~~Pf~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGSWK--------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTCCC--------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccchh--------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9999865443221100 00000011111111112244567889999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=345.32 Aligned_cols=262 Identities=15% Similarity=0.186 Sum_probs=203.5
Q ss_pred hcccccccccCcCCcccEEeeeccC---------CcEEEEEEccCCCchhHHHHHHHHHHHHhccccccee---------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVK--------- 533 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~--------- 533 (792)
.++|.+.+.||+|+||.||+|+... ++.||||++... +.+.+|+.++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998764 788999998654 46789999999999999998
Q ss_pred ------eeeeEEe-CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcE
Q 003832 534 ------LLGCCIQ-ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNV 606 (792)
Q Consensus 534 ------l~g~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI 606 (792)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+.+ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6677776 67789999999 999999997542 356999999999999999999999998 99999999999
Q ss_pred EecCCC--CceEeeeccccccCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCC
Q 003832 607 LLDNDM--NPKISDFGMARIFGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRF 679 (792)
Q Consensus 607 ll~~~~--~~kl~DFgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~ 679 (792)
|++.++ .+||+|||+++.+...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876432211 112335799999999999999999999999999999999999999975
Q ss_pred CCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 680 SHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 680 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...... .+.. ..... ......+..... .....+..+.+++.+||+.+|++||+++||+++|++.
T Consensus 271 ~~~~~~-~~~~-~~~~~-~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 271 CLPNTE-DIMK-QKQKF-VDKPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GTTCHH-HHHH-HHHHH-HHSCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred CCcCHH-HHHH-HHHhc-cCChhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 432211 1110 00000 000011111100 0112245688999999999999999999999999765
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.31 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=197.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|+..+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 468999999999999999999874 5899999999654 3334567899999999999999999999998763
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999854 35889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HH
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AW 693 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~ 693 (792)
+..... .....+|+.|+|||++.+ ..++.++||||+||+++||++|+.||......+....+.. ..
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 875432 233578999999999877 6899999999999999999999999975432111000000 00
Q ss_pred HHHhhhhhhhhcc---c---cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 694 ILWKEKRAMELAG---D---TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
..+........+. . .............+.+|+.+||+.||++|||++|++++ +++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 0000000000000 0 00011122335568899999999999999999999984 5544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=347.97 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=205.6
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhccc-ccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.++||+|+||.||+|+. .+++.||||++..... .+++..|++++..++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999986 4589999998865432 2357889999999987 556666677777888899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~~~~ 626 (792)
|+ +++|.+++... ...+++..++.|+.||+.||.|||+.+ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 99999999643 345899999999999999999999998 9999999999999 688999999999998765
Q ss_pred CCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 627 GDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 627 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
..... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+.. ..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----ISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH----HHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH----Hhhccc
Confidence 43221 122356899999999999999999999999999999999999999986544332222111 111111
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+. .+... .+.++.+++..||+.+|++||++.+|+++|+..
T Consensus 234 ~~~~~-~l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 234 ATSIE-ALCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HSCHH-HHHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cccHH-HHhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11111 11112 234688999999999999999999999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=342.31 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=200.4
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.++|+..+.||+|+||.||+++... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 4679999999999999999998764 8899999986543 233556889999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+...
T Consensus 104 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 999999998886433 35899999999999999999999998 999999999999999999999999999876432
Q ss_pred CccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh--------HHHHHHHhhh
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------GHAWILWKEK 699 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~ 699 (792)
.. ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+ ......+...
T Consensus 178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 21 12335789999999999765 7899999999999999999999999754322110000 0000000000
Q ss_pred h-hhhhccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 R-AMELAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~-~~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ......+......+ +.....+.+++.+||+.+|++|||++|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 00111111111111 1235678899999999999999999998863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.66 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=199.5
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC----chhHHHHHHHHHHHHhcccccceeeeeeEE--eCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS----GQGMEEFKNEVTLIARLQHRNLVKLLGCCI--QADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~--~~~~ 543 (792)
..++|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3478999999999999999999875 47899999996532 244578999999999999999999999984 4557
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||++++ |.+++... ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999987 66666543 3456899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCC--CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
...............|++.|+|||.+.+.. ++.++||||||+++|||++|+.||...... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~-- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------K-LFENIGKG-- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------H-HHHHHhcC--
Confidence 765433233333467899999999987643 478999999999999999999999743211 0 00111110
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++.+||+.+|++||+++|+++.
T Consensus 229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 012233345568899999999999999999999974
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.15 Aligned_cols=250 Identities=22% Similarity=0.337 Sum_probs=197.8
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC----Ccce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----DESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~ 545 (792)
+.|...++||+|+||.||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++... ...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 44778889999999999999875 4778999998654 344567899999999999999999999998763 4579
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~ 624 (792)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ +++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999999653 45889999999999999999999875 3599999999999998 789999999999976
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
..... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||...... .. ..........
T Consensus 182 ~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~--- 247 (290)
T 1t4h_A 182 KRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVK--- 247 (290)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCC---
T ss_pred ccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HH-HHHHHhccCC---
Confidence 54332 22357899999999886 45899999999999999999999999643221 00 0011111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ..+......+.+++..||+.+|++|||++||++.
T Consensus 248 -~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 248 -PA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 00 1111223468899999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.42 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=204.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 367999999999999999999875 47789999986431 22356789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998654 35889999999999999999999987 99999999999999999999999999876543
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. . .+...
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~--------~~~~~ 227 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH-R--------RIVNV 227 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-H--------HHHTT
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH-H--------HHhcc
Confidence 21 233578999999999999999999999999999999999999986432110 00 0 00111
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
....+......+.+++.+||+.+|++||+++|+++
T Consensus 228 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 228 --DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11223344567889999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=333.31 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=200.4
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
..++|++.+.||+|+||.||+|+... ++.||+|++........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 34679999999999999999998764 88999999987766677899999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999998653 345899999999999999999999988 9999999999999999999999999976432111
Q ss_pred ccccccccccccCccccccc-----cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 630 IQTNTHKVVGTYGYMSPEYA-----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~-----~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
.......|++.|+|||++ ....++.++||||||+++|||++|+.||...... ... ......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~----- 237 (302)
T 2j7t_A 172 --QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVL----LKIAKS----- 237 (302)
T ss_dssp --HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHS-----
T ss_pred --cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHH----HHHhcc-----
Confidence 112235789999999998 4677899999999999999999999998643221 000 000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+......+.+++.+||+.+|++|||+.|+++.
T Consensus 238 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 238 --DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111233445678899999999999999999998763
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=347.56 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=191.6
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC--------chhHHHHHHHHHHHHhcccccceeeeeeEEe
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 540 (792)
...++|...++||+|+||.||+|.... ++.||||++.+.. ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 346789999999999999999998654 7899999986531 112235789999999999999999999975
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEe
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKIS 617 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 617 (792)
.+..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 4568999999999999888754 346899999999999999999999988 9999999999999754 459999
Q ss_pred eeccccccCCCCccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +..
T Consensus 285 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~---- 355 (419)
T 3i6u_A 285 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---- 355 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----
T ss_pred ecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----
Confidence 999998764322 223467999999999985 36788999999999999999999999975432211 110
Q ss_pred HHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ . .+.. .......+.+++.+||+.+|++||+++|+++.
T Consensus 356 ~i~~~~~~-~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYN-F-IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCC-C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCC-C-Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 0 0000 01234568899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.37 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=192.5
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
...++|++.++||+|+||.||+++.. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 45678999999999999999999854 588999999975532 234567899999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-----CCCCceEeeecc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-----NDMNPKISDFGM 621 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DFgl 621 (792)
||||+++ +|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999985 898888653 34899999999999999999999998 99999999999994 455699999999
Q ss_pred ccccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
+..+..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ............
T Consensus 184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~ 258 (329)
T 3gbz_A 184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ---LFKIFEVLGLPD 258 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCC
T ss_pred ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH---HHHHHHHhCCCc
Confidence 987643221 22335689999999999774 589999999999999999999999964322110 000000000000
Q ss_pred ---hhhh---c-----cccccCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 ---AMEL---A-----GDTLADS-----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ---~~~~---~-----~~~~~~~-----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.... . .+..... .+.....++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000 0 0000000 00113356789999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=335.30 Aligned_cols=266 Identities=23% Similarity=0.374 Sum_probs=188.0
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
...++|++.+.||+|+||.||+|+.. +++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 34578999999999999999999865 58899999986543 34456788999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-----ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 548 YEYMPNKSLDFFIFDQ-----ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998642 12456899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCc---cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 623 RIFGGDEI---QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 623 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
........ ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||........ . .... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~-~ 241 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTL-Q 241 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHH-T
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHh-c
Confidence 87643221 111234578999999999865 5689999999999999999999999975432211 1 0000 0
Q ss_pred hhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 KRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......................+.+++.+||+.+|++||++.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000000000111112234567899999999999999999999873
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.26 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=194.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch-hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|...++||+|+||.||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999875 5889999999754322 122456799999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
++ ++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 5888888653 346899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh----------
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---------- 699 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------- 699 (792)
.......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ...........
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGG
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhhhc
Confidence 12223578999999999876 5789999999999999999999999975432211 10000000000
Q ss_pred --hhhhhccccccC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 --RAMELAGDTLAD----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 --~~~~~~~~~~~~----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+.... ...+.....+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 0011234567899999999999999999999883
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.85 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=199.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC-------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------- 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------- 541 (792)
.++|+..++||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 468999999999999999999874 58999999986543 23356788999999999999999999999874
Q ss_pred -CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 542 -DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 542 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
+..++||||+++ +|...+... ...+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457999999986 666666443 235899999999999999999999998 9999999999999999999999999
Q ss_pred cccccCCCCc--cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 621 MARIFGGDEI--QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 621 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhC
Confidence 9987643221 122234678999999998875 5689999999999999999999999975432211 100000000
Q ss_pred hh-----------hhhhhccccccCCCCH-HH------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EK-----------RAMELAGDTLADSHPP-TE------VLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~-----------~~~~~~~~~~~~~~~~-~~------~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ................ .. ...+.+|+.+||+.||++|||++|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000000000000000 11 2457899999999999999999999884
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.11 Aligned_cols=259 Identities=22% Similarity=0.346 Sum_probs=201.9
Q ss_pred HHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcc--cccceeeeeeEEe
Q 003832 465 FASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQ 540 (792)
Q Consensus 465 ~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~ 540 (792)
+..+....++|++.+.||+|+||.||+++..+++.||||++... .....+.+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 33444556789999999999999999999888999999998654 3445678999999999997 5999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
....++||| +.+++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 6788999999653 35889999999999999999999998 999999999999965 899999999
Q ss_pred cccccCCCCccccccccccccCccccccccC-----------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-----------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 689 (792)
++..+.............|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~ 246 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----I 246 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----H
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----H
Confidence 9987654433223334578999999999865 47889999999999999999999998643211 0
Q ss_pred HHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 690 GHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ......+.......+......+.+++.+||+.+|++||++.|+++.
T Consensus 247 ~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 247 S---------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H---------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0 0111222222222333334578899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=331.09 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=188.2
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|+..++||+|+||.||+++.. +++.||+|+++.... ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3578999999999999999999874 588999999976532 2233455566668888999999999999999999999
Q ss_pred EeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 548 YEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
|||+++ +|.+++... .....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999984 887777542 2345799999999999999999999997 7 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccc----cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYA----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
..... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... .. . .
T Consensus 161 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~-~---------~ 223 (290)
T 3fme_A 161 VDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP----FQ-Q---------L 223 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH----HH-H---------H
T ss_pred ccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch----HH-H---------H
Confidence 43321 2234689999999996 5667899999999999999999999999643221 00 0 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
............+......+.+++.+||+.+|++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 224 KQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0111111111112234556889999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=338.40 Aligned_cols=265 Identities=23% Similarity=0.312 Sum_probs=196.7
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCch-----hHHHHHHHHHHHHhcccccceeeeeeEEeCCc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADE 543 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~ 543 (792)
...++|+..+.||+|+||.||+|+... ++.||||++...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 345789999999999999999998754 889999999754221 13468899999999999999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+++ +|..++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 788887543 346889999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.+..... ......||+.|+|||.+.+ ..++.++||||||+++|||++|..||...... ................
T Consensus 161 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~~~i~~~~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEE 235 (346)
T ss_dssp TTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTT
T ss_pred eccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHHHcCCCChh
Confidence 7643321 2234578999999999865 45899999999999999999999998643221 1111000000000000
Q ss_pred ------hhccc---cccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ------ELAGD---TLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ------~~~~~---~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+.+. ......+ ......+.+++.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0000111 2234678899999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=337.48 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=204.4
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc--------hhHHHHHHHHHHHHhc-ccccceeeeee
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARL-QHRNLVKLLGC 537 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~g~ 537 (792)
.....++|.+.+.||+|+||.||+|++. +|+.||||+++.... ...+.+.+|+.++.++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999985 689999999875431 1245678999999999 79999999999
Q ss_pred EEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 538 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 99999999999999999999999643 35899999999999999999999988 9999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccC------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~ 691 (792)
|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...
T Consensus 243 DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~-- 314 (365)
T 2y7j_A 243 DFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LML-- 314 (365)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH--
T ss_pred ecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHH--
Confidence 999998765432 1234679999999999853 36889999999999999999999999642211 000
Q ss_pred HHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 692 AWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ ....+. .......+.+++.+||+.+|++||++.|+++.
T Consensus 315 --~~i~~~~~-~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 315 --RMIMEGQY-QFSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp --HHHHHTCC-CCCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHhCCC-CCCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000000 000000 01123468899999999999999999999873
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=349.67 Aligned_cols=195 Identities=25% Similarity=0.403 Sum_probs=154.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 468999999999999999999865 5889999999654 334557889999999999999999999999544 46
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+. ++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeccc-cchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 899999985 688888854 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc-------------------------ccccccccccCccccccc-cCCCCCccCcchhHHHHHHHHHhC
Q 003832 624 IFGGDEIQ-------------------------TNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSG 673 (792)
Q Consensus 624 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gvil~elltG 673 (792)
........ ......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76422110 112345789999999976 566799999999999999999994
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=329.58 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=200.8
Q ss_pred HhhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
...++|+..+.||+|+||.||+|+... ++.||+|++.... ..+.+.+|+.++.+++||||+++++++......++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 345789999999999999999998754 8899999997643 3567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 999999999998532 346899999999999999999999988 999999999999999999999999999876433
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .. ... ..
T Consensus 179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~-~~-----~~~--~~ 242 (314)
T 3com_A 179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIF-MI-----PTN--PP 242 (314)
T ss_dssp BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HH-----HHS--CC
T ss_pred cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHH-HH-----hcC--CC
Confidence 21 223457899999999999999999999999999999999999998643211 0000 00 000 01
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.....+......+.+++.+||+.+|++||++.|+++
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111123334567889999999999999999999987
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.87 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=201.3
Q ss_pred cccCHHhHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeE
Q 003832 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC 538 (792)
Q Consensus 461 ~~~~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~ 538 (792)
..+++.++....++|++.+.||+|+||.||+|+.. +++.||||++.... ...+.+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 44555666677889999999999999999999874 58899999986543 3457889999999999 799999999999
Q ss_pred Ee------CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 539 IQ------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 539 ~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
.. ....++||||+++++|.+++.... ...+++..+..++.||+.||.|||+.+ |+|+||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENA 166 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTC
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCC
Confidence 87 457899999999999999996542 346889999999999999999999998 99999999999999999
Q ss_pred CceEeeeccccccCCCCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccc
Q 003832 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687 (792)
Q Consensus 613 ~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~ 687 (792)
.+||+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||......
T Consensus 167 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---- 240 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---- 240 (326)
T ss_dssp CEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH----
T ss_pred CEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH----
Confidence 99999999998764321 1123357899999999986 567899999999999999999999998643211
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ... .....+. ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 241 --~~~-~~~-----~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 241 --RAL-FLI-----PRNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --HHH-HHH-----HHSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HHH-HHh-----hcCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 000 0101111 1122234568899999999999999999999873
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=330.18 Aligned_cols=257 Identities=17% Similarity=0.286 Sum_probs=200.5
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEe--CCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ--ADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~--~~~~~lV 547 (792)
.++|++.++||+|+||.||+|+. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46899999999999999999976 45889999999743 3467899999999997 9999999999988 5678999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~ 626 (792)
|||+++++|.+++. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998873 3788999999999999999999998 99999999999999776 89999999998765
Q ss_pred CCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||........ .+. ............+.+
T Consensus 183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~-~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLV-RIAKVLGTEDLYDYI 257 (330)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHH-HHHHHHCHHHHHHHH
T ss_pred CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHH-HHHHhcCCchhhhHH
Confidence 4322 233578999999999877 6789999999999999999999999954332111 111 000111111111100
Q ss_pred cc-----------------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 706 GD-----------------------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 706 ~~-----------------------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
+. ......+......+.+++.+||+.||++|||++|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 00111122245678899999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=363.73 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=206.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC---CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcce
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~ 545 (792)
..++|+..++||+|+||.||+|+... ++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 45789999999999999999998764 788999999753 233456788899999988 7999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
|||||+++|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999654 35899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+. ..++
T Consensus 493 ~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~------------~~i~ 555 (674)
T 3pfq_A 493 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF------------QSIM 555 (674)
T ss_dssp CCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH------------HHHH
T ss_pred ccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHH------------HHHH
Confidence 33221 234468999999999999999999999999999999999999999753221 111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNM-----SSVVL 744 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~-----~evl~ 744 (792)
... ...+.....++.+|+..||+.+|++||++ +||++
T Consensus 556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111 12344556678899999999999999998 77765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=347.77 Aligned_cols=200 Identities=25% Similarity=0.405 Sum_probs=167.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
.++|.+.+.||+|+||.||+|+... ++.||||++... .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999998654 788999999764 334456889999999999999999999999876 56
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||++ ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 599888854 345899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCcc--------------------ccccccccccCccccccc-cCCCCCccCcchhHHHHHHHHHhCCCCCC
Q 003832 624 IFGGDEIQ--------------------TNTHKVVGTYGYMSPEYA-AEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (792)
Q Consensus 624 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~s~k~DVwS~Gvil~elltG~~p~~ 678 (792)
........ .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 76533211 112456899999999986 56679999999999999999998655553
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=337.87 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=199.8
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
...++|+..+.||+|+||.||+|+... .+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 345789999999999999999998753 49999986542 33345678899999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
+||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999543 346899999999999999999999998 99999999999998 67999999999876532
Q ss_pred CC---ccccccccccccCccccccccC---------CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 628 DE---IQTNTHKVVGTYGYMSPEYAAE---------GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 628 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
.. .........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...... ... ..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~----~~ 254 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AII----WQ 254 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH---HHH----HH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HH
Confidence 11 1112233568999999999864 45789999999999999999999998643221 000 00
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
.... ..+.. .+......+.+++..||+.+|++||++.||+++|+...
T Consensus 255 ~~~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 255 MGTG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp HHTT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred hccC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111 11111 11123345789999999999999999999999998874
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.66 Aligned_cols=215 Identities=14% Similarity=0.173 Sum_probs=168.8
Q ss_pred cccCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-
Q 003832 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (792)
Q Consensus 16 ~~~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l- 94 (792)
++.|+|++||+|++|++| ++|.|+|||+.+++ +. +|.. +|+||+|||+.| ..+.|.++.||+|+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~-ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LV-LFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EE-EEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EE-EEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 678999999999999999 59999999987654 23 3442 799999999998 468899999999999
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCcc-CCCCccccee-ccCC-----ceeEEeec
Q 003832 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTL-LPGMKLGRNF-KTGM-----DRHLSSWK 167 (792)
Q Consensus 95 ~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtl-Lpg~~l~~~~-~~g~-----~~~l~Sw~ 167 (792)
|++|.+||+|++.......+|+|+|+|||||++ .++||||||||||+ ||+| |.|. .+|+ +++|+|
T Consensus 72 d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~----~~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~s-- 143 (236)
T 1dlp_A 72 TAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLHA-- 143 (236)
T ss_dssp CTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC----SEEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEECS--
T ss_pred cCCCcEEEeCCccccCCcEEEEEeCCCCEEEec----CCEEECCCCCCcccccCCc--cceEEecCCcCCCccceEEc--
Confidence 889999999998644445689999999999984 28999999999888 7775 6665 6665 567874
Q ss_pred cCCCCCCcceEEeecCCCCceEEEecCceeeeecCCCCCccccCCCCCCCCcccceeeeeecCceEEEEEcCCCCceeEE
Q 003832 168 SINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGLGFTGTPPLKENVPLCDYKFVINENEVYYECDAKGPAVSRL 247 (792)
Q Consensus 168 s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~w~g~~~~~~p~~~~~~~~~~~~~v~n~~~~~~~~~~~~~~~~r~ 247 (792)
..||++|.|+|+++++| +++++++...||++++|++. +...+.+.....+ +.+..++++.++++........|+
T Consensus 144 -~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl--~ly~~~~~~vw~s~~~~~~~~~rl 217 (236)
T 1dlp_A 144 -TQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRM--DVLTNQNIAVWTSGNSRSAGRYVF 217 (236)
T ss_dssp -SCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEE--EEEETTTEEEEECCCCCSSSCCEE
T ss_pred -CcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcE--EEEeCCCcEEEEeCCCCCCCCEEE
Confidence 78999999999999999 67888888899999999754 5555665432211 222234445555555433457899
Q ss_pred EEecCCcEEEE
Q 003832 248 WVNQSGLVLRS 258 (792)
Q Consensus 248 ~l~~~G~l~~~ 258 (792)
+|+++|++++|
T Consensus 218 ~Ld~dG~l~ly 228 (236)
T 1dlp_A 218 VLQPDRNLAIY 228 (236)
T ss_dssp EECSSSCEEEE
T ss_pred EEcCCCcEEEe
Confidence 99999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.52 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=196.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467899999999999999999876 58999999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999999654 34889999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... .....|++.|+|||.+.+..+ +.++||||||++++||++|+.||...... .+. ......
T Consensus 164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~------- 226 (276)
T 2h6d_A 164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF----KKIRGG------- 226 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHC-------
T ss_pred Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH----HHhhcC-------
Confidence 321 223568999999999987765 68999999999999999999998642211 000 000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+......+.+++.+||+.+|++||+++||++.
T Consensus 227 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 ---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011223334568899999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=350.96 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=202.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|++.++||+|+||.||+++.. +++.||||++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3568999999999999999999875 5889999998643 233467889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec---CCCCceEeeeccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARI 624 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgla~~ 624 (792)
|||+++++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 9999999999888654 35899999999999999999999998 99999999999995 456799999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+. ........
T Consensus 174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~--- 239 (486)
T 3mwu_A 174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKY--- 239 (486)
T ss_dssp BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC---
T ss_pred CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC---
Confidence 64432 1234579999999999875 5999999999999999999999999643221 111 00111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.....+..+.+++.+||+.+|++|||+.|+++.
T Consensus 240 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 240 ---AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001112334568899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=351.31 Aligned_cols=252 Identities=23% Similarity=0.321 Sum_probs=198.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
..++|+..++||+|+||.||+++.. .++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3457999999999999999999875 58899999997652 33457889999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeeeccccc
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMARI 624 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgla~~ 624 (792)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999888654 35889999999999999999999988 9999999999999764 4599999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 704 (792)
+.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... .+. ........ ..
T Consensus 189 ~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~-~~ 256 (494)
T 3lij_A 189 FENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EIL----RKVEKGKY-TF 256 (494)
T ss_dssp CBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHTCC-CC
T ss_pred CCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCCC-CC
Confidence 65432 223467999999999886 56999999999999999999999999743321 111 01111100 00
Q ss_pred ccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... .....+..+.+++.+||+.+|++|||+.|+++.
T Consensus 257 -~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 -DSP----EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp -CSG----GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -Cch----hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 000 011234568899999999999999999999863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=338.22 Aligned_cols=263 Identities=20% Similarity=0.235 Sum_probs=203.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc--------cccceeeeeeEE---
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ--------HRNLVKLLGCCI--- 539 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~g~~~--- 539 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999864 5889999999653 344577899999999996 788999999998
Q ss_pred -eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCC-----
Q 003832 540 -QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDM----- 612 (792)
Q Consensus 540 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~----- 612 (792)
.....++||||+ +++|.+++... ....+++..+..++.||+.||.|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 456789999999 55555555443 234589999999999999999999998 7 99999999999999775
Q ss_pred --------------------------------------------CceEeeeccccccCCCCccccccccccccCcccccc
Q 003832 613 --------------------------------------------NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648 (792)
Q Consensus 613 --------------------------------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 648 (792)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 8999999999876432 233578999999999
Q ss_pred ccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH---HHHhh--------hhh-hhhcccc--------
Q 003832 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW---ILWKE--------KRA-MELAGDT-------- 708 (792)
Q Consensus 649 ~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~---~~~~~--------~~~-~~~~~~~-------- 708 (792)
+.+..++.++|||||||+||||++|+.||................ ..... ... .......
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999998655433221111100 00000 000 0000000
Q ss_pred -----------ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 -----------LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 -----------~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.....+......+.+|+.+||+.||++|||++||++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0112456777889999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.17 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=203.9
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCch-----------------hHHHHHHHHHHHHhcccccceee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQ-----------------GMEEFKNEVTLIARLQHRNLVKL 534 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~-----------------~~~~~~~Ei~~l~~l~H~niv~l 534 (792)
.++|.+.+.||+|+||.||+|+. +++.||||++...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 8999999998643211 12789999999999999999999
Q ss_pred eeeEEeCCcceEEEeecCCCChhHH------HhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEE
Q 003832 535 LGCCIQADESMLIYEYMPNKSLDFF------IFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVL 607 (792)
Q Consensus 535 ~g~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIl 607 (792)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999988 432 124679999999999999999999998 77 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccCC-CCCc-cCcchhHHHHHHHHHhCCCCCCCCCCCCc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSV-KSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-k~DVwS~Gvil~elltG~~p~~~~~~~~~ 685 (792)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 999999999999999876433 23346789999999999877 6766 9999999999999999999997543311
Q ss_pred cchhHHHHHHHhhhhhhhhccc----------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 686 HNLLGHAWILWKEKRAMELAGD----------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 686 ~~l~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+ ......... ..... .............+.+++.+||+.+|++||++.|+++.
T Consensus 260 -~~----~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 260 -EL----FNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -HH----HHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HH----HHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 011111100 00000 00000113345678899999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=324.96 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=203.7
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---------chhHHHHHHHHHHHHhcc-cccceeeeeeE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---------GQGMEEFKNEVTLIARLQ-HRNLVKLLGCC 538 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~ 538 (792)
...++|+..+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++ ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 34578999999999999999999875 48899999986543 123456889999999996 99999999999
Q ss_pred EeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEee
Q 003832 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 539 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
......++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 9999999999999999999999653 35899999999999999999999988 99999999999999999999999
Q ss_pred eccccccCCCCccccccccccccCcccccccc------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~ 692 (792)
||++..+.... ......|++.|+|||.+. ...++.++||||||++++||++|+.||...... ...
T Consensus 168 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~--- 238 (298)
T 1phk_A 168 FGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM---LML--- 238 (298)
T ss_dssp CTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---
T ss_pred ccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH---HHH---
Confidence 99998765432 123357899999999885 456899999999999999999999998643211 000
Q ss_pred HHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
....... ...........+..+.+++.+||+.+|++||++.|+++
T Consensus 239 -~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 -RMIMSGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp -HHHHHTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHhcCC------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0000000 00111112234567889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=343.15 Aligned_cols=265 Identities=20% Similarity=0.275 Sum_probs=199.0
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc------ce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE------SM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~------~~ 545 (792)
..+|...++||+|+||.||+|+...+..+|+|++...... ..+|++++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 3578999999999999999999888788999998654322 2369999999999999999999976543 78
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARI 624 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~ 624 (792)
+||||++++.+............+++..+..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999998665555443334567899999999999999999999998 99999999999999 799999999999987
Q ss_pred cCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh---h
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---R 700 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 700 (792)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.. ........ .
T Consensus 192 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~-i~~~~g~p~~~~ 265 (394)
T 4e7w_A 192 LIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVE-IIKVLGTPSREQ 265 (394)
T ss_dssp CCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCHHH
T ss_pred ccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCHHH
Confidence 643322 2235789999999998664 589999999999999999999999975432111 100 00000000 0
Q ss_pred h----hhhccccc---c-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 701 A----MELAGDTL---A-----DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 701 ~----~~~~~~~~---~-----~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
. ........ . ...+.....++.+|+.+||+.+|++|||+.|++++ +++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 0 00000000 0 00112234578899999999999999999999985 5443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.07 Aligned_cols=270 Identities=22% Similarity=0.290 Sum_probs=199.8
Q ss_pred CHHhHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCc-----------hhHHHHHHHHHHHHhcccccce
Q 003832 464 DFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG-----------QGMEEFKNEVTLIARLQHRNLV 532 (792)
Q Consensus 464 ~~~~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~-----------~~~~~~~~Ei~~l~~l~H~niv 532 (792)
...++....++|...+.||+|+||.||+|+..+++.||||++..... ...+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 34567788899999999999999999999988899999999864321 1237899999999999999999
Q ss_pred eeeeeEEeCC-----cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEE
Q 003832 533 KLLGCCIQAD-----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVL 607 (792)
Q Consensus 533 ~l~g~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl 607 (792)
++++++.... ..++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+.+ |+||||||+|||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999996533 4699999998 578777754 3346899999999999999999999998 999999999999
Q ss_pred ecCCCCceEeeeccccccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc
Q 003832 608 LDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686 (792)
Q Consensus 608 l~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~ 686 (792)
++.++.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~- 242 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ- 242 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-
T ss_pred EcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH-
Confidence 9999999999999998643322 2233578999999999876 6789999999999999999999999975332111
Q ss_pred chhHHHHHHHh-----------hhhhhhhccccccCC-------CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 687 NLLGHAWILWK-----------EKRAMELAGDTLADS-------HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 687 ~l~~~~~~~~~-----------~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......... ............... ..+.....+.+++.+||+.+|++|||+.|+++.
T Consensus 243 --~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 --LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp --HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 100000000 000111111111000 111224568899999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.55 Aligned_cols=252 Identities=26% Similarity=0.332 Sum_probs=204.7
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
..++|+..++||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3467999999999999999999876 58999999986542 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---cCCCCceEeeecccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL---DNDMNPKISDFGMAR 623 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DFgla~ 623 (792)
||||+.+++|.+++... ..+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999988653 35899999999999999999999998 9999999999999 567899999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.+..... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+. ........
T Consensus 178 ~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~----~~i~~~~~-- 244 (484)
T 3nyv_A 178 HFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY---DIL----KKVEKGKY-- 244 (484)
T ss_dssp HBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCC--
T ss_pred Ecccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHcCCC--
Confidence 7654321 223579999999999865 6999999999999999999999999743221 111 01111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+.....+..+.+++.+||+.+|++|||+.|++++
T Consensus 245 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 245 ----TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ----CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00001112345678899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=344.80 Aligned_cols=259 Identities=21% Similarity=0.281 Sum_probs=192.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------cce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~ 545 (792)
.+|+..+.||+|+||.||+|++. +++.||||++..... .+.+|+++|++++|||||++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888899999999999999985 489999999865432 2346999999999999999999986532 257
Q ss_pred EEEeecCCCChhHHHhh-cccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-CCceEeeecccc
Q 003832 546 LIYEYMPNKSLDFFIFD-QARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMAR 623 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DFgla~ 623 (792)
+||||+++ +|...+.. ......+++..+..++.||++||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999986 55555433 223456899999999999999999999987 9999999999999965 568999999998
Q ss_pred ccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---h
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---K 699 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~ 699 (792)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||......+ .+... ...... .
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i-~~~lg~p~~~ 279 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEI-IKVLGTPTRE 279 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-HHHHCSCCHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH-HHHhCCCCHH
Confidence 7643321 2235789999999998764 79999999999999999999999997533211 11110 000000 0
Q ss_pred hhhhh-------ccccccC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 RAMEL-------AGDTLAD-----SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ~~~~~-------~~~~~~~-----~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+... ..+.... ..+.....++.+|+.+||+.||++||++.|++++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000 0000000 0122334678899999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.30 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=194.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEE-----------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI----------- 539 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~----------- 539 (792)
.++|...+.||+|+||.||+|+... ++.||+|++........+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999998765 8899999998777677788999999999999999999999874
Q ss_pred ---eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCce
Q 003832 540 ---QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPK 615 (792)
Q Consensus 540 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k 615 (792)
+....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456799999998 699998843 45889999999999999999999988 99999999999997 567999
Q ss_pred EeeeccccccCCCCc-cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 616 ISDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 616 l~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
|+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|||++|+.||........ .....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHH
Confidence 999999987643211 112233567899999998865 6789999999999999999999999975432111 00000
Q ss_pred HHH---hhhhhhh-------hcccccc-CCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILW---KEKRAME-------LAGDTLA-DSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~---~~~~~~~-------~~~~~~~-~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ......+ .+..... ... .......+.+++.+||+.+|++||+++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 0000000 0000000 000 11234568899999999999999999999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=336.63 Aligned_cols=269 Identities=21% Similarity=0.241 Sum_probs=191.0
Q ss_pred hHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc--
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE-- 543 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~-- 543 (792)
......++|++.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34566789999999999999999999875 58899999986543 233466788889999999999999999976544
Q ss_pred -----ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh--hcCCCCEEecCCCCCcEEecC-CCCce
Q 003832 544 -----SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH--QDSRMRIIHRDLKASNVLLDN-DMNPK 615 (792)
Q Consensus 544 -----~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~~~k 615 (792)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543333322334556889999999999999999999 776 999999999999997 89999
Q ss_pred EeeeccccccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 616 ISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 616 l~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
|+|||+++.+..... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ......
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~ 246 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVR 246 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHH
Confidence 999999987654332 2235789999999998654 489999999999999999999999975432111 100000
Q ss_pred HHhhh--hhhhhccc----------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKEK--RAMELAGD----------------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~--~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
..... .......+ ......+......+.+|+.+||+.||++|||+.||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000000 00111222346678999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=360.10 Aligned_cols=257 Identities=24% Similarity=0.337 Sum_probs=205.1
Q ss_pred HhhcccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
...++|+..+.||+|+||.||+|++.. +..||||++.... ....+.+.+|+.++++++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999998643 4679999987643 344578999999999999999999999984 5678
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999643 345899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
....... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ....
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---~~~----~~i~------ 606 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI----GRIE------ 606 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH----HHHH------
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH---HHH----HHHH------
Confidence 6543221 2223467789999999998899999999999999999997 99998643221 111 0011
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.......+...+..+.+++.+||+.+|++||++.||++.|+..
T Consensus 607 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 607 ---NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---cCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111223444556788999999999999999999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=348.87 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=200.2
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCc-------------hhHHHHHHHHHHHHhcccccceeeee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG-------------QGMEEFKNEVTLIARLQHRNLVKLLG 536 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~g 536 (792)
..++|.+.++||+|+||.||+++... ++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 45789999999999999999998754 78999999865421 33567899999999999999999999
Q ss_pred eEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC---C
Q 003832 537 CCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM---N 613 (792)
Q Consensus 537 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~ 613 (792)
++.+....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988654 35899999999999999999999998 99999999999998776 6
Q ss_pred ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 614 PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 614 ~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
+||+|||++..+.... ......||+.|+|||++. +.++.++||||+||++|||++|+.||...... .+.
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~---- 256 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DII---- 256 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHH----
Confidence 9999999998765432 223457999999999986 56899999999999999999999999743221 111
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......... ...... ...+..+.+++.+||+.+|++|||++|+++.
T Consensus 257 ~~i~~~~~~--~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYY--FDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCC--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCC--CCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 001111000 000000 1224568899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.66 Aligned_cols=259 Identities=22% Similarity=0.282 Sum_probs=191.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|+..+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999864 5889999999754 3344567889999999999999999999997665
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++||||+++ +|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999985 6777773 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH--------
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-------- 694 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~-------- 694 (792)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......
T Consensus 175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCPE 248 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CCCCCHH
T ss_pred ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHH
Confidence 8754322 12335789999999999999999999999999999999999999975432110 000000
Q ss_pred HHh--hhhhh---------------hhccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWK--EKRAM---------------ELAGDTLADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~--~~~~~---------------~~~~~~~~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+. ..... .......... .+......+.+|+.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00000 0000000000 011235678999999999999999999999984
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=335.26 Aligned_cols=258 Identities=22% Similarity=0.311 Sum_probs=183.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------C
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 542 (792)
.++|+..+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999999854 5889999999754 334556788999999999999999999998754 5
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
..++|+|++ +++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 6899888843 45899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh----
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK---- 697 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~---- 697 (792)
+..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||........ +........
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~ 251 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 865422 233578999999999876 6889999999999999999999999975432111 000000000
Q ss_pred -------hhhhhhhccccc-cCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 -------EKRAMELAGDTL-ADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 -------~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......++.... ....+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000100000 00001 1123567899999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=336.77 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=201.4
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
..++|+..++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3468999999999999999999865 57889999997543 33457889999999999999999999999765 35
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++|+||++ ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999998 488888844 34899999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCccc-cccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh--
Q 003832 624 IFGGDEIQT-NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK-- 699 (792)
Q Consensus 624 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-- 699 (792)
......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+.... ........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCCCCH
Confidence 764332111 1234689999999998754 5589999999999999999999999975443221110 00000000
Q ss_pred ---------hhhhhccccc-cCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 700 ---------RAMELAGDTL-ADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 700 ---------~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......... ....+ +.....+.+|+.+||+.||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00111 1224568899999999999999999999974
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.97 Aligned_cols=252 Identities=21% Similarity=0.281 Sum_probs=195.8
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--------chhHHHHHHHHHHHHhcccccceeeeeeEEeC
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~ 541 (792)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3468999999999999999999875 47899999986532 12234588999999999999999999998765
Q ss_pred CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEee
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISD 618 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 618 (792)
. .++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 4 8999999999999998854 345899999999999999999999988 999999999999987664 99999
Q ss_pred eccccccCCCCccccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHH
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~ 695 (792)
||++....... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +.. .
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence 99998764332 122356899999999973 56789999999999999999999999975433211 111 0
Q ss_pred HhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 696 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
....... ..+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 0111000 00000 0122456889999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=339.38 Aligned_cols=200 Identities=20% Similarity=0.277 Sum_probs=172.7
Q ss_pred hhcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhc------ccccceeeeeeEEeCCc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL------QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~g~~~~~~~ 543 (792)
...+|++.++||+|+||.||+|+... ++.||||+++.. ....+++.+|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 34679999999999999999997654 889999999753 33456778899888887 46799999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC--ceEeeecc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN--PKISDFGM 621 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DFgl 621 (792)
.++||||+. ++|.+++.... ...+++..+..++.||+.||.|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999996 58888886543 335899999999999999999999998 999999999999999987 99999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCC
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSH 681 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~ 681 (792)
+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9764322 223578999999999999999999999999999999999999997543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.70 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=204.0
Q ss_pred hcccccccccCcCCcccEEeeec--cCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc------ceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL--VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~--~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 543 (792)
.++|++.++||+|+||.||++.. .+++.||||+++.. ....+.+.+|+.++++++|++ ++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999975 35889999999653 344577899999999998765 9999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN------------- 610 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------------- 610 (792)
.++||||+ +++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 889999886543 345889999999999999999999998 999999999999987
Q ss_pred ------CCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 003832 611 ------DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (792)
Q Consensus 611 ------~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~ 684 (792)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 678999999999864322 233578999999999999999999999999999999999999997543221
Q ss_pred ccchhHHHHH-----HHhhhh---------------------hhhhccc-cccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 685 DHNLLGHAWI-----LWKEKR---------------------AMELAGD-TLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 685 ~~~l~~~~~~-----~~~~~~---------------------~~~~~~~-~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
....+..... .+.... ......+ ......+......+.+++.+||+.||++||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 1000000000 000000 0000000 000122345577899999999999999999
Q ss_pred CHHHHHHH
Q 003832 738 NMSSVVLM 745 (792)
Q Consensus 738 s~~evl~~ 745 (792)
|+.||++.
T Consensus 322 t~~ell~h 329 (339)
T 1z57_A 322 TLREALKH 329 (339)
T ss_dssp CHHHHTTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=321.60 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=194.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe---------
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--------- 540 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--------- 540 (792)
..++|+..+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 3568999999999999999999864 688999999964 33456788999999999999999999999865
Q ss_pred ----CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceE
Q 003832 541 ----ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKI 616 (792)
Q Consensus 541 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl 616 (792)
....++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 34578999999999999999653 345788899999999999999999998 999999999999999999999
Q ss_pred eeeccccccCCCCc------------cccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCC
Q 003832 617 SDFGMARIFGGDEI------------QTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683 (792)
Q Consensus 617 ~DFgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~ 683 (792)
+|||++........ ........|++.|+|||.+.+. .++.++||||||+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 99999987643210 1112335689999999999754 78999999999999999998 443110
Q ss_pred CccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 684 HDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 684 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... ..... ............+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 233 ---~~~----~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 233 ---ERV----NILKK---LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHH----HHHHH---HHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hHH----HHHHh---ccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 000 00000 00011112223344455678899999999999999999999874
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=337.38 Aligned_cols=263 Identities=20% Similarity=0.250 Sum_probs=195.2
Q ss_pred HHhhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC-----
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----- 542 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----- 542 (792)
+...++|+..++||+|+||.||+|+. .+++.||||++...... ..+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999986 45899999998654322 346999999999999999999985432
Q ss_pred ---------------------------------cceEEEeecCCCChhHHHhhc-ccCccCChhhHHHHHHHHHHHHHHH
Q 003832 543 ---------------------------------ESMLIYEYMPNKSLDFFIFDQ-ARATFLDWQKRIHIVGGIARGILYL 588 (792)
Q Consensus 543 ---------------------------------~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~L~yL 588 (792)
..++||||++ ++|.+.+... .....+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3789999998 5887777542 2345689999999999999999999
Q ss_pred hhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHH
Q 003832 589 HQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVL 666 (792)
Q Consensus 589 H~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvi 666 (792)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||.+.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999998 688999999999987644332 2235789999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh----------hhhhcccc-----ccCCCCHHHHHHHHHHHHHhccC
Q 003832 667 VLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR----------AMELAGDT-----LADSHPPTEVLRCIHVGLLCVQH 731 (792)
Q Consensus 667 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~----------~~~~~~~~-----~~~~~~~~~~~~l~~li~~Cl~~ 731 (792)
+|||++|+.||......+. +........... ..+..-+. .....+...+..+.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999975432211 100000000000 00000000 00012223455688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 003832 732 RPEDRPNMSSVVLM 745 (792)
Q Consensus 732 ~P~~RPs~~evl~~ 745 (792)
+|++|||+.|+++.
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=340.31 Aligned_cols=267 Identities=21% Similarity=0.308 Sum_probs=182.1
Q ss_pred ccccc-ccccCcCCcccEEeeecc---CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe--CCcceE
Q 003832 473 DNFAS-YNKLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (792)
Q Consensus 473 ~~~~~-~~~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 546 (792)
+.|++ .++||+|+||.||+|++. +++.||||++.... ..+.+.+|+.+|++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 458999999999999865 47889999997543 23578899999999999999999999965 567899
Q ss_pred EEeecCCCChhHHHhhcc------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe----cCCCCceE
Q 003832 547 IYEYMPNKSLDFFIFDQA------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL----DNDMNPKI 616 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kl 616 (792)
||||+++ +|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6766664321 2234899999999999999999999998 9999999999999 77899999
Q ss_pred eeeccccccCCCCc-cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCcc------ch
Q 003832 617 SDFGMARIFGGDEI-QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH------NL 688 (792)
Q Consensus 617 ~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~------~l 688 (792)
+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987653221 122334678999999999977 45899999999999999999999999754432110 00
Q ss_pred hHHHHHHHhhh---------------hhhhhccccccCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 689 LGHAWILWKEK---------------RAMELAGDTLADSHP---------PTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 689 ~~~~~~~~~~~---------------~~~~~~~~~~~~~~~---------~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
+.......... ............... ......+.+|+.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000000000000000 011345788999999999999999999998
Q ss_pred H
Q 003832 745 M 745 (792)
Q Consensus 745 ~ 745 (792)
.
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.29 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=200.6
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-----------cccceeeeeeEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCI 539 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~ 539 (792)
.++|.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999986 45889999999753 334567889999999886 899999999998
Q ss_pred eCC----cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEec-----
Q 003832 540 QAD----ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLD----- 609 (792)
Q Consensus 540 ~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~----- 609 (792)
... ..++|||++ +++|.+++.... ...+++..+..++.||+.||.|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 689999999 889999986543 34588999999999999999999997 7 99999999999994
Q ss_pred -CCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccch
Q 003832 610 -NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNL 688 (792)
Q Consensus 610 -~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l 688 (792)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 4457999999999876432 2235789999999999999999999999999999999999999975443221111
Q ss_pred hHHHHHHH---hh--------hh-hhhhccc-------------------cccCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 003832 689 LGHAWILW---KE--------KR-AMELAGD-------------------TLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737 (792)
Q Consensus 689 ~~~~~~~~---~~--------~~-~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP 737 (792)
........ .. .. ....... ......+......+.+|+.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 11000000 00 00 0000000 001234567788899999999999999999
Q ss_pred CHHHHHHH
Q 003832 738 NMSSVVLM 745 (792)
Q Consensus 738 s~~evl~~ 745 (792)
|++||++.
T Consensus 327 t~~ell~h 334 (373)
T 1q8y_A 327 DAGGLVNH 334 (373)
T ss_dssp CHHHHHTC
T ss_pred CHHHHhhC
Confidence 99999984
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=327.88 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=200.2
Q ss_pred HhhcccccccccCcCCcccEEeeec--cCCcEEEEEEccCCC--chhHHHHHHHHHHHHhc---ccccceeeeeeEE---
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTL--VEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCI--- 539 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~--~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~--- 539 (792)
.+.++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+.+++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3557899999999999999999987 357899999986432 12233566777777766 8999999999997
Q ss_pred --eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 540 --QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 540 --~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
.....++||||++ |+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999986543 335899999999999999999999998 9999999999999999999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
|||++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 163 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~ 236 (326)
T 1blx_A 163 DFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIG 236 (326)
T ss_dssp SCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHC
T ss_pred cCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcC
Confidence 999998654221 2234678999999999999999999999999999999999999997433211 1110000000
Q ss_pred hhhhhhh----------cc---ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EKRAMEL----------AG---DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~~~~~~----------~~---~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....... .. ..............+.+++.+||+.+|++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 00 000001122345567899999999999999999999963
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.02 Aligned_cols=264 Identities=23% Similarity=0.295 Sum_probs=199.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
..++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999875 58899999996543 34456788999999999999999999998764 67
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 899999997 589888854 35899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCccc--------cccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 624 IFGGDEIQT--------NTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 624 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
.+....... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||........ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 765322111 1223578999999998754 7789999999999999999999999975432110 000000
Q ss_pred HHhh------------hhhhhhccccc-cCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKE------------KRAMELAGDTL-ADS-----HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~------------~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.... ....+...... ... ..+.....+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00000000000 000 011234567899999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=327.13 Aligned_cols=255 Identities=22% Similarity=0.353 Sum_probs=179.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHH-HHHhcccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVT-LIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.++|+..+.||+|+||.||+|... +++.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467899999999999999999875 58899999997653 333445566665 677789999999999999999999999
Q ss_pred eecCCCChhHHHhhc--ccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 549 EYMPNKSLDFFIFDQ--ARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 549 e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||+++ +|.+++... .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 777776531 2245689999999999999999999998 7 999999999999999999999999999876
Q ss_pred CCCCccccccccccccCccccccc----cCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYA----AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
..... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... . ...
T Consensus 177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~--~~~ 242 (327)
T 3aln_A 177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L--TQV 242 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCC
T ss_pred ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H--HHH
Confidence 43221 2234689999999998 4667899999999999999999999999743221100 0 000
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.....+.+...........+.+++.+||+.+|++||++.||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0000011111112234557889999999999999999999976
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=318.28 Aligned_cols=252 Identities=24% Similarity=0.330 Sum_probs=201.6
Q ss_pred HhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
...++|++.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34578999999999999999999875 5889999998654 23456789999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC---CCceEeeecccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND---MNPKISDFGMAR 623 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DFgla~ 623 (792)
|+||+++++|.+++... ..+++.+++.++.|++.||.|||+.+ ++||||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999888654 35899999999999999999999988 9999999999999754 469999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
....... .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||...... ... .........
T Consensus 173 ~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~----~~~~~~~~~- 240 (287)
T 2wei_A 173 CFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY---DIL----KRVETGKYA- 240 (287)
T ss_dssp TBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHCCCC-
T ss_pred eecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH---HHH----HHHHcCCCC-
Confidence 7643321 223468899999998865 4899999999999999999999998643211 110 111111000
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.........+..+.+++.+||+.+|++|||+.|+++
T Consensus 241 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000001123456889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=328.36 Aligned_cols=257 Identities=23% Similarity=0.323 Sum_probs=195.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES---- 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~---- 544 (792)
.++|...+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999865 5889999999764 333457889999999999999999999999887665
Q ss_pred --eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 545 --MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 545 --~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 57877762 24899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH-----
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW----- 696 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~----- 696 (792)
+..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. ........
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 263 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT 263 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcH
Confidence 865322 233578999999999877 7899999999999999999999999975332111 00000000
Q ss_pred ------hhhhhhhh---ccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 ------KEKRAMEL---AGDTLADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ------~~~~~~~~---~~~~~~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ +....... ..+.....+.+|+.+||+.+|++|||++|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000 00000000 011234578899999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.87 Aligned_cols=258 Identities=19% Similarity=0.235 Sum_probs=176.1
Q ss_pred hhccccccc-ccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEe----CCcc
Q 003832 471 ATDNFASYN-KLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ----ADES 544 (792)
Q Consensus 471 ~~~~~~~~~-~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~----~~~~ 544 (792)
..++|.+.+ .||+|+||.||+|+.. +++.||||++.... ....+....+..++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 356788855 5999999999999876 58999999996531 222233344667799999999999976 4457
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeecc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl 621 (792)
++||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999997543 346899999999999999999999998 999999999999986 45599999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............. . .
T Consensus 178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~---~ 244 (336)
T 3fhr_A 178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK------R---R 244 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH------H---h
Confidence 98654322 223578999999999988899999999999999999999999996543321100000 0 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH--HhcCC
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL--MLSSD 749 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~--~L~~~ 749 (792)
...................+.+++..||+.+|++|||++|+++ .+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 245 IRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0000000111111234556889999999999999999999998 34443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=329.11 Aligned_cols=257 Identities=22% Similarity=0.309 Sum_probs=196.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467899999999999999999875 58899999997642 3345678999999999999999999999987654
Q ss_pred -ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 544 -SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 544 -~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
.++||||++ ++|.+++. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58877662 24889999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH-----
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW----- 696 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~----- 696 (792)
...... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .........
T Consensus 174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~ 245 (353)
T 3coi_A 174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGT 245 (353)
T ss_dssp TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCH
T ss_pred cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 865322 223578999999999876 678999999999999999999999997543211 000000000
Q ss_pred ------hhhhhhhh---ccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 ------KEKRAMEL---AGDTL---ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ------~~~~~~~~---~~~~~---~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
........ +.... ...........+.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 246 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00000 011223445678899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.96 Aligned_cols=205 Identities=22% Similarity=0.314 Sum_probs=173.2
Q ss_pred hHHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cc-----cceeeeeeEE
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HR-----NLVKLLGCCI 539 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~g~~~ 539 (792)
......++|++.++||+|+||.||+|+.. +++.||||+++.. ....+++..|+.++..++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33456789999999999999999999865 4788999999743 344567888999998885 44 4999999999
Q ss_pred eCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec--CCCCceEe
Q 003832 540 QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKIS 617 (792)
Q Consensus 540 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~ 617 (792)
..+..++||||++ ++|.+++.... ...+++..+..++.|++.||.|||.+. .+|+||||||+||||+ .++.+||+
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred cCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEE
Confidence 9999999999996 49999886543 245899999999999999999999531 2499999999999995 57889999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCC
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFS 680 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~ 680 (792)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 204 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 204 DFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999876432 22367899999999999999999999999999999999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=335.12 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=188.4
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+....++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345556789999999998766667999999998643 345678999999987 8999999999999999999999999
Q ss_pred CCCChhHHHhhcccCc----cCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC-------------CCc
Q 003832 552 PNKSLDFFIFDQARAT----FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-------------MNP 614 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~ 614 (792)
+ |+|.+++....... ...+..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999996543211 1244466789999999999999988 9999999999999754 479
Q ss_pred eEeeeccccccCCCCcc--ccccccccccCccccccccC-------CCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCC
Q 003832 615 KISDFGMARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAE-------GLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDH 684 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~ 684 (792)
||+|||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987543221 12234679999999999965 678999999999999999999 999986432210
Q ss_pred ccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 685 DHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 685 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
. ... ... ...+......+.....++.+++.+||+.+|++||++.||++
T Consensus 248 -------~-~i~-~~~---~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -------S-NII-RGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -------H-HHH-HTC---CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------H-HHh-cCC---CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 000 000 00111122234566788999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.26 Aligned_cols=245 Identities=22% Similarity=0.402 Sum_probs=192.1
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch------hHHHHHHHHHHHHhc----ccccceeeee
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ------GMEEFKNEVTLIARL----QHRNLVKLLG 536 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~g 536 (792)
.+...++|++.+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3455678999999999999999999864 5889999999765321 223456799999999 8999999999
Q ss_pred eEEeCCcceEEEee-cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCc
Q 003832 537 CCIQADESMLIYEY-MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNP 614 (792)
Q Consensus 537 ~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~ 614 (792)
++...+..++|+|+ +.+++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 99999999999999 7899999999653 35899999999999999999999998 99999999999999 88999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||++....... .....|+..|+|||++.+..+ +.++||||||+++|||++|+.||.... .
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~------ 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----E------ 244 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H------
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----H------
Confidence 999999998765432 233568999999999877666 458999999999999999999985210 0
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ... ....+......+.+++.+||+.+|++||+++|+++.
T Consensus 245 -------~---~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -------I---LEA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------H---HHT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------H---hhh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000 011223345568899999999999999999999984
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.94 Aligned_cols=259 Identities=19% Similarity=0.276 Sum_probs=199.7
Q ss_pred hcccccccccCcCCcccEEeeeccC-C-cEEEEEEccCCCchhHHHHHHHHHHHHhccccc------ceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-G-QEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN------LVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~-~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~g~~~~~~~ 543 (792)
.++|++.++||+|+||.||+++... + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++.....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 4789999999999999999998643 4 68999999653 345577889999999998776 9999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe---------------
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL--------------- 608 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--------------- 608 (792)
.++||||+ +++|.+++... ....+++.++..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 55666666543 2345899999999999999999999987 9999999999999
Q ss_pred ----cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 003832 609 ----DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH 684 (792)
Q Consensus 609 ----~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~ 684 (792)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 67889999999999864322 233578999999999999999999999999999999999999997533211
Q ss_pred ccchhHHHHHHHhh--------hhhh---------------------hhccc-cccCCCCHHHHHHHHHHHHHhccCCCC
Q 003832 685 DHNLLGHAWILWKE--------KRAM---------------------ELAGD-TLADSHPPTEVLRCIHVGLLCVQHRPE 734 (792)
Q Consensus 685 ~~~l~~~~~~~~~~--------~~~~---------------------~~~~~-~~~~~~~~~~~~~l~~li~~Cl~~~P~ 734 (792)
. .......... .... +...+ .............+.+|+.+||+.||+
T Consensus 247 ~---~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 247 H---LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp H---HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred H---HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1 0000000000 0000 00000 000112334466889999999999999
Q ss_pred CCCCHHHHHH
Q 003832 735 DRPNMSSVVL 744 (792)
Q Consensus 735 ~RPs~~evl~ 744 (792)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=320.06 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=179.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCch--hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ--GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
.++|+..+.||+|+||.||+|+.. +++.||||++...... ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467899999999999999999875 5889999999765322 2334555666788889999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+ ++.+..+... ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..+..
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4455544432 234689999999999999999999985 7 99999999999999999999999999976543
Q ss_pred CCccccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... .......
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~----~~~~~~~-- 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL----TKVLQEE-- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH----HHHHHSC--
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH----HHHhccC--
Confidence 22 122356899999999984 567899999999999999999999998643221 0000 0000000
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.+. ..........+.+++.+||+.+|++||+++||++.
T Consensus 247 ---~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 ---PPL--LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---CCC--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---CCC--CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 000 01111234568899999999999999999999873
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=324.42 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=199.0
Q ss_pred HHhhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCCc------hhHHHHHHHHHHHHhcc--cccceeeeeeEE
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQ--HRNLVKLLGCCI 539 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~ 539 (792)
....++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++++++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 34567899999999999999999985 4588999999865422 12345678999999996 599999999999
Q ss_pred eCCcceEEEeecCC-CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEe
Q 003832 540 QADESMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKIS 617 (792)
Q Consensus 540 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 617 (792)
..+..++|+|++.+ ++|.+++... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999986 8999998653 35889999999999999999999988 99999999999999 78999999
Q ss_pred eeccccccCCCCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILW 696 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~ 696 (792)
|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~- 255 (320)
T 3a99_A 193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------I- 255 (320)
T ss_dssp CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------H-
T ss_pred eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------h-
Confidence 999998765322 223578999999999977665 7889999999999999999999853110 0
Q ss_pred hhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 KEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... . ...+......+.+++.+||+.+|++||+++||++.
T Consensus 256 ~~~--------~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 IRG--------Q--VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp HHC--------C--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hcc--------c--ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0 01122234568899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.21 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=187.4
Q ss_pred hhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEEEe
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV~e 549 (792)
...+|...+.||+|+||+|+.....+++.||||++..... ..+.+|+.+++++ +|||||++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3457888999999999996655555799999999965432 2356799999999 79999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-----CCCceEeeeccccc
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgla~~ 624 (792)
|+. |+|.+++.... ..+.+..++.++.||+.||.|||+.+ |+||||||+||||+. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 997 59999986543 23455667899999999999999998 999999999999953 33578999999987
Q ss_pred cCCCCc-cccccccccccCcccccccc---CCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 625 FGGDEI-QTNTHKVVGTYGYMSPEYAA---EGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 625 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
+..... ........||+.|+|||++. ...++.++|||||||++|||++ |+.||....... .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~- 244 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGA- 244 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTC-
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhcc-
Confidence 653321 12233467999999999997 4567889999999999999999 898985322110 0000000
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
. .......+......+.+|+.+||+.+|++||+++||++
T Consensus 245 ----~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 ----C--SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ----C--CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----C--CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 00001112344556789999999999999999999994
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=340.26 Aligned_cols=262 Identities=22% Similarity=0.314 Sum_probs=199.8
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEe------CCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ------ADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~------~~~ 543 (792)
.++|++.++||+|+||.||+|... +++.||||+++.. .....+.+.+|++++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999875 4889999999765 34456789999999999999999999999765 667
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCC---ceEeeec
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMN---PKISDFG 620 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DFg 620 (792)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999977655557899999999999999999999988 999999999999997765 8999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCc-cchhHHHHHHHhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD-HNLLGHAWILWKEK 699 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~ 699 (792)
++........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... .....
T Consensus 170 ~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~--~~~~~ 244 (676)
T 3qa8_A 170 YAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREK--SNEHI 244 (676)
T ss_dssp CCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC--------C
T ss_pred cccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcc--cchhh
Confidence 9987654322 2346789999999999999999999999999999999999999964211000 0000000 00000
Q ss_pred hhhhhcc------c--cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 003832 700 RAMELAG------D--TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSS 741 (792)
Q Consensus 700 ~~~~~~~------~--~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~e 741 (792)
....... . .............+.+++..||+.||++|||+.|
T Consensus 245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0000000 0 1112344557788999999999999999999966
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=306.28 Aligned_cols=230 Identities=10% Similarity=0.036 Sum_probs=184.1
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|++.+.||+|+||.||+|+... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 3679999999999999999998754 8999999997653 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++.. . ....+..+++.|++.||.|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999999843 1 345678899999999999999998 9999999999999999999997443
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
|++| ++.++||||||+++|||++|+.||............ ...+..
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------~~~~~~ 220 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ERDTAG 220 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------CBCTTS
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------HHHhcc
Confidence 3333 688999999999999999999999865443211000 000000
Q ss_pred ccc--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 708 TLA--DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 708 ~~~--~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
... .......+..+.+++.+||+.||++| |+.|+++.|+....
T Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 000 00112234568899999999999999 99999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=342.50 Aligned_cols=237 Identities=19% Similarity=0.259 Sum_probs=191.7
Q ss_pred hcccccccccCcCCcccEEeeecc--CCcEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCc-----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV--EGQEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE----- 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~--~~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~----- 543 (792)
.++|++.++||+|+||.||+|+.. +++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999875 5889999998654 33455678999999999999999999999988776
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+|||||+++++|.+++.. .+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999887632 5899999999999999999999998 9999999999999986 99999999998
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
..... ....||+.|+|||++.+.. +.++|||||||+|+||++|..|+.........
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-----------------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-----------------
Confidence 76432 3357999999999987654 89999999999999999998887532111100
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHhc
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-MSSVVLMLS 747 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-~~evl~~L~ 747 (792)
...........+.+++.+||+.+|++||+ ++++...|.
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00001122356789999999999999995 555555554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=297.84 Aligned_cols=228 Identities=20% Similarity=0.240 Sum_probs=178.5
Q ss_pred hcccccc-cccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHH-HhcccccceeeeeeEEe----CCcc
Q 003832 472 TDNFASY-NKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLI-ARLQHRNLVKLLGCCIQ----ADES 544 (792)
Q Consensus 472 ~~~~~~~-~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~g~~~~----~~~~ 544 (792)
.++|... +.||+|+||.||++... +++.||+|++.. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 67999999999999874 588999999954 24677888888 55589999999999987 6678
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeecc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl 621 (792)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 99999999999999997643 346899999999999999999999988 999999999999998 78999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
+.... +..++.++||||||+++|||++|+.||.......... ...
T Consensus 167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~ 211 (299)
T 3m2w_A 167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMK 211 (299)
T ss_dssp CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSC
T ss_pred ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHH
Confidence 87532 2346789999999999999999999996543221100 000
Q ss_pred hhhccccccCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 MELAGDTLADSHP----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~~~~~~~~~~~~----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....... ...+ ......+.+++.+||+.+|++|||+.|+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 212 TRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 0111 1234568899999999999999999999984
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-34 Score=317.00 Aligned_cols=243 Identities=14% Similarity=0.124 Sum_probs=180.5
Q ss_pred hhcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC---chhHHHHHHHHHHHHhccc-ccceee---------ee
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQH-RNLVKL---------LG 536 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H-~niv~l---------~g 536 (792)
.+.+|...+.||+|+||.||+|++ .+++.||||++.... ....+.+++|+.+++.++| +|...+ ..
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345678888999999999999995 458999999987432 2336789999999999977 321111 11
Q ss_pred e------------EEe-----CCcceEEEeecCCCChhHHHhh----cccCccCChhhHHHHHHHHHHHHHHHhhcCCCC
Q 003832 537 C------------CIQ-----ADESMLIYEYMPNKSLDFFIFD----QARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595 (792)
Q Consensus 537 ~------------~~~-----~~~~~lV~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 595 (792)
. +.. ....+++|++ .+++|.+++.. ......+++..++.++.||++||.|||+.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1 111 1234566665 46899888842 223456888999999999999999999988
Q ss_pred EEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccc----------cCCCCCccCcchhHHH
Q 003832 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA----------AEGLFSVKSDVFSFGV 665 (792)
Q Consensus 596 ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~k~DVwS~Gv 665 (792)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998865322 234567 999999999 5667889999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 666 LVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 666 il~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
++|||++|+.||.......... ..... .... +..+.+|+..||+.+|++||++.|+++
T Consensus 306 il~elltg~~Pf~~~~~~~~~~---------------~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSE---------------WIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSG---------------GGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhhHH---------------HHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999997543221110 01110 0122 356889999999999999999766643
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=309.54 Aligned_cols=240 Identities=14% Similarity=0.159 Sum_probs=183.0
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--------chhHHHHHHHHHHHHhcc---------cccceee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--------GQGMEEFKNEVTLIARLQ---------HRNLVKL 534 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv~l 534 (792)
.++|+..++||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999998 78999999997542 233478899999999986 6666666
Q ss_pred eeeE-----------------Ee-------------CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHH
Q 003832 535 LGCC-----------------IQ-------------ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARG 584 (792)
Q Consensus 535 ~g~~-----------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~ 584 (792)
.+++ .+ ....+|||||+++|++.+.+.+ ..+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 5553 33 6788999999999976666532 458999999999999999
Q ss_pred HHHHh-hcCCCCEEecCCCCCcEEecCCC--------------------CceEeeeccccccCCCCccccccccccccCc
Q 003832 585 ILYLH-QDSRMRIIHRDLKASNVLLDNDM--------------------NPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643 (792)
Q Consensus 585 L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y 643 (792)
|.||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 888 99999999999999887 8999999999876432 24799999
Q ss_pred cccccccCCCCCccCcchhHHHH-HHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhh--ccccccCCCCHHHHHH
Q 003832 644 MSPEYAAEGLFSVKSDVFSFGVL-VLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL--AGDTLADSHPPTEVLR 720 (792)
Q Consensus 644 ~aPE~~~~~~~s~k~DVwS~Gvi-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 720 (792)
+|||++.+.. +.++||||++++ .+++++|..||.. ..+........... .........+.....+
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK 311 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHH
Confidence 9999998766 899999998776 7788889888631 00000000011100 0111111123356778
Q ss_pred HHHHHHHhccCCCCCCCCHHHHH
Q 003832 721 CIHVGLLCVQHRPEDRPNMSSVV 743 (792)
Q Consensus 721 l~~li~~Cl~~~P~~RPs~~evl 743 (792)
+.+|+.+||+.+ |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999965 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-28 Score=279.30 Aligned_cols=184 Identities=18% Similarity=0.164 Sum_probs=130.0
Q ss_pred ccCcCCcccEEeeec-cCCcEEEEEEccCCC----------chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 480 KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 480 ~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~----------~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
..+.|++|.+..++. --|+.+++|++.+.. ....++|.+|+++|+++ +|+||+++++++++....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456777776666543 238889999997642 22346799999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||++|++|.++|.+. .+++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....
T Consensus 321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 9999999999999654 345543 58899999999999998 99999999999999999999999999987654
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCC
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK 675 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~ 675 (792)
... .....+||+.|||||++.+ .+..++|+||+|++++++.++..
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 322 2334689999999999965 46778999999999988877643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.4e-25 Score=253.47 Aligned_cols=186 Identities=18% Similarity=0.203 Sum_probs=148.0
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCc--------hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
...++||+|+||.||++.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...++.+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4457899999999999955 578889988643211 1134589999999999999999877777788889999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||+++ ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999843 5689999999999999988 999999999999999 999999999998754
Q ss_pred CCccc-----cccccccccCccccccccC--CCCCccCcchhHHHHHHHHHhCCCCCC
Q 003832 628 DEIQT-----NTHKVVGTYGYMSPEYAAE--GLFSVKSDVFSFGVLVLEIVSGKKNWR 678 (792)
Q Consensus 628 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~s~k~DVwS~Gvil~elltG~~p~~ 678 (792)
..... ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 1234689999999999976 668889999999999999888887763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=206.76 Aligned_cols=149 Identities=19% Similarity=0.141 Sum_probs=120.5
Q ss_pred HHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCc------------------hhHHHHHHHHHHHHhccccc
Q 003832 469 AKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHRN 530 (792)
Q Consensus 469 ~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~n 530 (792)
......|...+.||+|+||.||+|+..+|+.||||+++.... .....+.+|+.++++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334455667799999999999999997799999999965321 13467899999999999 5
Q ss_pred ceeeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC
Q 003832 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN 610 (792)
Q Consensus 531 iv~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~ 610 (792)
+++.+++. .+..++||||+++++|.+ +. ......++.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp -SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred -CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 66666543 466799999999999987 41 1334579999999999999988 99999999999999
Q ss_pred CCCceEeeeccccccCCCCccccccccccccCcccccccc
Q 003832 611 DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650 (792)
Q Consensus 611 ~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 650 (792)
++.+||+|||+++. +..++|||++.
T Consensus 228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99999999999863 34578999874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=3.3e-20 Score=167.08 Aligned_cols=107 Identities=14% Similarity=0.243 Sum_probs=93.4
Q ss_pred cccCcCCCCCCcCCCCEEE--eCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEE
Q 003832 16 AANDNITPSQSIRDGETLV--SVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVL 93 (792)
Q Consensus 16 ~~~~~i~~g~~l~~~~~l~--S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~ 93 (792)
++.|+|++||+|.+|++|+ |++|.|+|+|+.+++ -+||++ +++||+||++.| +..+.+.+.+||+|+
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccC--CCceEEEEccCCEEE
Confidence 6789999999999999999 999999999998765 258875 799999999876 335789999999999
Q ss_pred e-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 94 L-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 94 l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
| |.++.++|+|++....+..+++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC----ccEeCC
Confidence 9 888999999997655556789999999999986 289998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.6e-20 Score=160.47 Aligned_cols=104 Identities=19% Similarity=0.362 Sum_probs=89.6
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
.|+|.+||.|.+|+.|+| |.|.|.|...++ |.++. ..++||+||++.|..+ .+.|.++.||+|+| |+
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~----~~~~vW~ant~~~~~~-~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD----HSTSTWASNTEIGGKS-GCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-SCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE----CCEEEEEecCCCCCCc-cEEEEEeCCccEEEECC
Confidence 478999999999999988 889999987665 56653 4689999999999765 56899999999998 99
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
++.+||+|+++......+|+|+|+|||||++ ..||||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~----~~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYG----SDIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEEC----CcEecC
Confidence 9999999998766566789999999999995 369998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=161.31 Aligned_cols=109 Identities=18% Similarity=0.379 Sum_probs=93.4
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
.|+|.+||+|.+|++|+ ++|.|+|+|+..++ | +||+ ..++||.||++.|. ..+.+.+.+||+|+| |.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 47899999999999999 99999999987765 2 6787 37999999998763 357899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPC 142 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PT 142 (792)
++.++|+|++....+..+++|+|+|||||++. ++||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP----VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence 89999999987555566899999999999863 7999999983
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=3.3e-19 Score=160.09 Aligned_cols=109 Identities=17% Similarity=0.323 Sum_probs=92.3
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
.|||.+||+|.+|++|+ +|.|+|+|+..++ . ++|+ ..++||+||++.|. ..+.|.+.++|+|+| |.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn---l---vly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN---L---VKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC---E---EEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc---E---EEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 58999999999999998 8999999987664 2 2465 48999999999883 357899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTD 143 (792)
++.++|+|++..+....+++|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence 89999999976544567899999999999852 89999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.77 E-value=7.8e-19 Score=156.92 Aligned_cols=109 Identities=18% Similarity=0.402 Sum_probs=92.1
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
+|||.|||+|.+|++| ++|.|+|+|+.+++ -+||++ .++||+||++.+ +..+.+.+.++|+|+| |
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 58999999998775 246764 689999999763 3457899999999999 8
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHP 141 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~P 141 (792)
++.++|+|++....+..+++|+++|||||++.+ +.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTT-SCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCC-CceEEECCCcc
Confidence 888999999765445678999999999999855 67999999984
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8.8e-18 Score=174.40 Aligned_cols=136 Identities=16% Similarity=0.180 Sum_probs=106.8
Q ss_pred cccccccCcCCcccEEeeec-cCCcE--EEEEEccCCCch------------------------hHHHHHHHHHHHHhcc
Q 003832 475 FASYNKLGEGGFGPVYKGTL-VEGQE--IAVKRLSKGSGQ------------------------GMEEFKNEVTLIARLQ 527 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~Ei~~l~~l~ 527 (792)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999987543111 1136789999999999
Q ss_pred cccc--eeeeeeEEeCCcceEEEeecCC-C----ChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHh-hcCCCCEEec
Q 003832 528 HRNL--VKLLGCCIQADESMLIYEYMPN-K----SLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH-QDSRMRIIHR 599 (792)
Q Consensus 528 H~ni--v~l~g~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~ 599 (792)
|+++ ..++.+ ...+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8864 334432 467999999942 4 56655422 235567889999999999999 877 9999
Q ss_pred CCCCCcEEecCCCCceEeeecccccc
Q 003832 600 DLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 600 Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
||||+|||+++ .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=1.4e-17 Score=147.85 Aligned_cols=104 Identities=23% Similarity=0.343 Sum_probs=86.1
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
++||.|||+|.+|++|+ +|.|+|+|+..++ |- .|.. .++||++|++.+ +..+.|.+.+||+|+| |.
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lv-ly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~ 67 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LV-LYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSP 67 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EE-EEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EE-EEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECC
Confidence 46899999999999996 7999999987765 22 2654 689999999876 3457899999999999 88
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeecc
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSF 138 (792)
++.++|+|++.......+|+|+|+|||||++. ++|||=
T Consensus 68 ~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~----~~W~s~ 105 (109)
T 3dzw_A 68 RNNPIWASNTGGENGNYVCVLQKDRNVVIYGT----ARWATG 105 (109)
T ss_dssp TSCEEEECCCCCSSSCEEEEECTTSCEEEEES----CCCCCC
T ss_pred CCCEEEECCCCCCCCCEEEEEeCCCEEEEECC----CEEeCC
Confidence 88999999986544456899999999999963 799983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.64 E-value=4.3e-16 Score=138.17 Aligned_cols=104 Identities=20% Similarity=0.317 Sum_probs=83.8
Q ss_pred cccCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-
Q 003832 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (792)
Q Consensus 16 ~~~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l- 94 (792)
.++|||.|||+|..|+.|+|. .|.|-|...++ |.+ |.. ++||.+|++.. +..+.+.+.++|+|++
T Consensus 4 ~~~dtL~~gq~L~~g~~L~sg--~~~L~~q~dGn-----Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGDGRLTAK--NHQLVMQGDCN-----LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETTEEEECS--SCEEEECTTSC-----EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCCCEEEeC--CEEEEEcCCCe-----EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 578999999999999999984 58886654443 444 654 48999999863 3346899999999999
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 95 ~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
|.++.++|+|++.......+|+|+|+|||||++ ..+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec----CCEecC
Confidence 888999999998644445789999999999996 379997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.2e-15 Score=136.22 Aligned_cols=96 Identities=20% Similarity=0.351 Sum_probs=78.0
Q ss_pred CCCCCCCceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccc
Q 003832 75 TPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGR 153 (792)
Q Consensus 75 ~p~~~~~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~ 153 (792)
.|+.+....|.+..||+|++ +. ++++|++++.....+.+|+|+|+|||||+| + +.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~-~~~~W~S~~-------------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-G-SRAIWASNT-------------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-T-TEEEEECCC--------------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-C-CEEEEECCc--------------
Confidence 44445567899999999988 55 789999997643345789999999999998 5 789999993
Q ss_pred eeccCCceeEEeeccCCCCCCcceEEeecCCCCceEEEec-CceeeeecCCCCC
Q 003832 154 NFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRK-GSVLQYRAGSWNG 206 (792)
Q Consensus 154 ~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~-~~~~~~~~g~w~g 206 (792)
+|++|.|++.++++|.. +++. +...||++++|+|
T Consensus 77 -----------------~~~~g~~~l~l~~dGnl--vl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------NRQNGNYYLILQRDRNV--VIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------CCSCCCCEEEECTTSCE--EEECTTSCEEEECCCCCC
T ss_pred -----------------cCCCCCEEEEEeCCCcE--EEECCCCceEEECCCccC
Confidence 46678999999999984 4444 5679999999986
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.62 E-value=2.1e-15 Score=134.53 Aligned_cols=107 Identities=19% Similarity=0.248 Sum_probs=87.2
Q ss_pred cccCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-
Q 003832 16 AANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL- 94 (792)
Q Consensus 16 ~~~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l- 94 (792)
.+.|+|.+||.|.+|+.|.+ |.|.|-|...++ |.++.. ...++||.+|+..+ +..+.+.+.++|+|++
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~~~--~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~ 72 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLTKG--SKTNIVWESGTSGR--GQHCFMRLGHSGELDIT 72 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEET--TTTEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEEEC--CCCEEEEECCcccC--CcCEEEEEeCCCcEEEE
Confidence 47899999999999999974 889999876554 555432 13789999999875 2357899999999999
Q ss_pred CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 95 DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 95 ~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
|.++.++|+|++.......+|+|+|+|||||++ ..+|+|
T Consensus 73 d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 73 DDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp CTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCCEEEECCCcCCCCCEEEEEcCCceEEEec----CCEecC
Confidence 888899999998654445789999999999996 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=3e-15 Score=132.92 Aligned_cols=89 Identities=24% Similarity=0.334 Sum_probs=73.4
Q ss_pred CCCceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceecc
Q 003832 79 DQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKT 157 (792)
Q Consensus 79 ~~~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~ 157 (792)
+....|.+..||+|+| + .+++||++|+.......+++|+|+|||||++.+ +.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-~~~~W~S~------------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-NRVIWQTK------------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECC-------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-CcEEEecC-------------------
Confidence 3357799999999999 6 589999999864444578999999999999976 78999999
Q ss_pred CCceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCCC
Q 003832 158 GMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (792)
Q Consensus 158 g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~w 204 (792)
++|++|.|++.++++|. ++++++ .||+++++
T Consensus 78 ------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35677999999999997 455654 79998865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=165.37 Aligned_cols=137 Identities=13% Similarity=0.182 Sum_probs=98.4
Q ss_pred cccccccCcCCcccEEeeeccCCcEEEEEEccCCCc--------------hhHHHH--------HHHHHHHHhcccccce
Q 003832 475 FASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG--------------QGMEEF--------KNEVTLIARLQHRNLV 532 (792)
Q Consensus 475 ~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~Ei~~l~~l~H~niv 532 (792)
|++.++||+|+||.||+|...+|+.||||+++.... ...... ..|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 888999999999999999998999999998754210 011112 2345555555443322
Q ss_pred eeeeeEEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC
Q 003832 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612 (792)
Q Consensus 533 ~l~g~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~ 612 (792)
...-+ .....+|||||+++++|..+. .......++.|++.+|.|||+.+ ||||||||.||||++++
T Consensus 177 vp~p~--~~~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPI--AQSRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEE--EEETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCeee--eccCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 11111 112347999999998885442 12344578899999999999988 99999999999998877
Q ss_pred C----------ceEeeecccccc
Q 003832 613 N----------PKISDFGMARIF 625 (792)
Q Consensus 613 ~----------~kl~DFgla~~~ 625 (792)
. +.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3 789999987653
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.57 E-value=7.2e-15 Score=130.01 Aligned_cols=107 Identities=21% Similarity=0.383 Sum_probs=85.9
Q ss_pred ccCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-C
Q 003832 17 ANDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-D 95 (792)
Q Consensus 17 ~~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~ 95 (792)
|.|||.|||.|..|+.| .+|.|.|.|...++ |-+ |.. +|.+|+..+ +....|.+.+||+|++ |
T Consensus 2 ~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 68999999999999999 57999999976554 222 432 599998765 3357899999999999 8
Q ss_pred CCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCC
Q 003832 96 GRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPG 148 (792)
Q Consensus 96 ~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg 148 (792)
.++.++|++++.......+|+|+|+|||||++ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 88999999998654445689999999999996 579998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-14 Score=127.73 Aligned_cols=85 Identities=19% Similarity=0.246 Sum_probs=70.4
Q ss_pred ceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCc
Q 003832 82 GLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (792)
Q Consensus 82 ~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~ 160 (792)
..|.+..||+|++ +. +++||++|+.....+.+|+|+|+|||||+|.+ +.++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-~~~lW~S~---------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-NVTVWQSP---------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECS----------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-CcEEEcCC----------------------
Confidence 4588889999988 65 89999999764444578999999999999976 78999999
Q ss_pred eeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 161 ~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
+||++|.|++.++++|. +++++ ..||++|+
T Consensus 88 ---------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 ---------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp ---------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred ---------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 46778999999999998 45555 38999875
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.50 E-value=8e-14 Score=124.85 Aligned_cols=90 Identities=24% Similarity=0.358 Sum_probs=73.6
Q ss_pred CceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCC
Q 003832 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (792)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~ 159 (792)
...|.+..||+|+| + .++++|++|+.....+..++|+++|||||+|.+ +.++||||++
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-~~~vW~S~~~------------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-NNDVWGSACW------------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-CCEEEECCCC-------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-ceEEEEcCCC-------------------
Confidence 45688889999988 6 588999999764434578999999999999976 7899999997
Q ss_pred ceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCCCCCc
Q 003832 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSWNGL 207 (792)
Q Consensus 160 ~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~w~g~ 207 (792)
|++|.|++.++++|. +++++. .+|++++|...
T Consensus 80 ------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 456789999999997 455654 89999999643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.1e-12 Score=116.45 Aligned_cols=102 Identities=13% Similarity=0.233 Sum_probs=80.3
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
+|+|.|||.|.+|+.| .+|.|.|-|...++ |.+ |.. .. ||.+|+..+ .....+.+.++|+|++ |.
T Consensus 2 ~~~l~~gq~L~~g~~L--~~g~~~L~~q~dGn-----Lvl-~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQL--SYESAAFVMQGDCN-----LVL-YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEE--ecCCEEEEEccCCe-----EEE-ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 6899999999999999 47899999976554 333 543 23 999999876 2357899999999999 77
Q ss_pred CCc-eEEeeccCC--CCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 97 RDR-IFWSSNTSI--TMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 97 ~~~-~~Wss~~~~--~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
++. ++|+|++.. .....+++|+|+|||||++ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 765 599999632 2245689999999999996 579997
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.20 E-value=4.7e-11 Score=123.71 Aligned_cols=145 Identities=17% Similarity=0.107 Sum_probs=114.2
Q ss_pred HhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEE
Q 003832 470 KATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 470 ~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 548 (792)
...+.|+....++.|+.+.||+... +++.+++|+...........+..|+.+++.+. |..+.++++++......++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3456788878889999999999976 46899999986532222346889999999985 677888999998888899999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------ 592 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 592 (792)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 12334578889999999999821
Q ss_pred --------------------CCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 593 --------------------RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 593 --------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876667799999865
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.15 E-value=6.5e-11 Score=122.58 Aligned_cols=112 Identities=16% Similarity=0.300 Sum_probs=86.2
Q ss_pred cccCcCCCCCC----cCCCCEEEeCCCEEEEEeeCCC--CCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecC
Q 003832 16 AANDNITPSQS----IRDGETLVSVNGTFELGFFSPG--TSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSK 89 (792)
Q Consensus 16 ~~~~~i~~g~~----l~~~~~l~S~~g~F~lgF~~~~--~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~ 89 (792)
--.||+.||+. |..|+.|+| ..+++.|+|... .....+ + |.+ ..+++|.+++..+- ...+.+..+
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S-~~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~---~~~l~l~~d 204 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQ-GVVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG---AVRAVFQGD 204 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECT-TCEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT---CCEEEECTT
T ss_pred ccccccccccccccccccCccccc-CCCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc---cEEEEEcCC
Confidence 34699999999 889999865 467777776542 222333 3 332 36899999998762 267999999
Q ss_pred ceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCC
Q 003832 90 GIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (792)
Q Consensus 90 g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~ 140 (792)
|+|++ |.++.++|++++... ...+|+|+++|||||++. .++||||||
T Consensus 205 GnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 205 GNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp SCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred CeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 99988 887889999997643 457899999999999974 589999997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.3e-10 Score=103.41 Aligned_cols=95 Identities=21% Similarity=0.312 Sum_probs=72.4
Q ss_pred CCCCCCCCCceeEEecCceEEe-CC-CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCc
Q 003832 73 RETPLTDQSGLLNVTSKGIVLL-DG-RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMK 150 (792)
Q Consensus 73 r~~p~~~~~~~l~~~~~g~l~l-~~-~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~ 150 (792)
.+.|+.+....|.+..||+|+| +. .+.++|++++.....+..++|+|+|||||++.+ +.++|||=.+ +
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~-~~~iW~S~t~-------~-- 86 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDR-LNTVFVSNTV-------G-- 86 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-SCEEEECSCC-------C--
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCC-CCEEEECCCc-------C--
Confidence 3556666677899999999999 66 589999999864334568999999999999876 6789998321 0
Q ss_pred ccceeccCCceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 151 LGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 151 l~~~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
..|.|.+.++.+|...++ + ...|.+|+
T Consensus 87 ----------------------~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 87 ----------------------QEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ----------------------SSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ----------------------CCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 014588999999987655 3 57788764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=102.11 Aligned_cols=95 Identities=14% Similarity=0.187 Sum_probs=69.9
Q ss_pred CCCCCCCCceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCccc
Q 003832 74 ETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLG 152 (792)
Q Consensus 74 ~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~ 152 (792)
+.++......|.+..||+|+| +.++ +|++++........++|+|+|||||++.+.+.++|||.-+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~------------ 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS------------ 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS------------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc------------
Confidence 344444567899999999999 6655 9999986443457899999999999987733469999721
Q ss_pred ceeccCCceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 153 RNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 153 ~~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
.....|.|.+.++.+|...++ . ..+|.++.
T Consensus 80 -----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~t 109 (111)
T 3mez_A 80 -----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTPA 109 (111)
T ss_dssp -----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECCC
T ss_pred -----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccCC
Confidence 011236799999999987665 3 67887763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.2e-10 Score=116.99 Aligned_cols=139 Identities=17% Similarity=0.175 Sum_probs=102.0
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~~~~~~~~~lV~e 549 (792)
..++......+.|..+.||+....+|+.+++|+.... ....+..|+.+++.+++.+ +.+++++....+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445543333466679999998777888999997653 2346788999999996544 4558888887778899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------- 592 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 592 (792)
|+++.+|. ... . ....++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 210 1 12356777788888888643
Q ss_pred ------------------CCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 593 ------------------RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 593 ------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998876678999998753
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.92 E-value=2.7e-09 Score=94.05 Aligned_cols=92 Identities=23% Similarity=0.411 Sum_probs=69.1
Q ss_pred CCCCCCCCCceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcc
Q 003832 73 RETPLTDQSGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKL 151 (792)
Q Consensus 73 r~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l 151 (792)
.+.|+.+....|.+..||+|+| ++ +|+|++........++|+++|||||+|.+ +.++|+|-..
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~-~~~vWss~t~----------- 77 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGD-GSTVWKSGAQ----------- 77 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTT-SCEEEECCCC-----------
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCC-CCEEEcCCCc-----------
Confidence 3445555567899999999999 64 79999875434578999999999999876 6789976210
Q ss_pred cceeccCCceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCCC
Q 003832 152 GRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGSW 204 (792)
Q Consensus 152 ~~~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~w 204 (792)
...+.|.+.++.+|...++ . ...|.+++|
T Consensus 78 --------------------~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 --------------------SVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp --------------------CSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred --------------------CCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 0125688999999976655 3 578999877
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.90 E-value=4.4e-09 Score=92.86 Aligned_cols=84 Identities=21% Similarity=0.392 Sum_probs=64.0
Q ss_pred CceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCC
Q 003832 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (792)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~ 159 (792)
.-.|.+..||+|+| +. .++|++++........++|+|+|||||+|.+ +.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~-~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDD-FKTIWSSRSSS------------------ 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTT-CCEEEECCCCC------------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCC-CCEEEEcCCcC------------------
Confidence 46788999999999 54 5899999864434468999999999999876 78999986410
Q ss_pred ceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecC
Q 003832 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (792)
Q Consensus 160 ~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 202 (792)
..|.|.+.++.+|...++ + ...|.+|
T Consensus 84 -------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 014488899999987655 3 3678765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.88 E-value=6.4e-09 Score=91.78 Aligned_cols=85 Identities=18% Similarity=0.286 Sum_probs=64.6
Q ss_pred CceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCC
Q 003832 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (792)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~ 159 (792)
...|.+..||+|+| +. +.++|++++........++|+|+|||||+|.+ +.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~-~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPR-NNPIWASNTGG------------------ 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTT-SCEEEECCCCC------------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCC-CCEEEECCCCC------------------
Confidence 45788999999999 55 78999999864434578999999999999876 68999986421
Q ss_pred ceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecC
Q 003832 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (792)
Q Consensus 160 ~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 202 (792)
..+.|.+.++.+|...++ +. ..|.++
T Consensus 80 -------------~~~~~~~~L~ddGNlvly--~~--~~W~s~ 105 (109)
T 3dzw_A 80 -------------ENGNYVCVLQKDRNVVIY--GT--ARWATG 105 (109)
T ss_dssp -------------SSSCEEEEECTTSCEEEE--ES--CCCCCC
T ss_pred -------------CCCCEEEEEeCCCEEEEE--CC--CEEeCC
Confidence 114578899999987654 32 567665
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.82 E-value=1.2e-08 Score=110.80 Aligned_cols=142 Identities=17% Similarity=0.248 Sum_probs=106.7
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEcc--CCC-chhHHHHHHHHHHHHhcc--cccceeeeeeEEeC---CcceEEE
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLS--KGS-GQGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQA---DESMLIY 548 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~---~~~~lV~ 548 (792)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.++ +..+.+++.++.+. ...++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3568999999999999875 4678888876 322 123456788999999997 45678888888776 3479999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC------------------------------------
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS------------------------------------ 592 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 592 (792)
||+++..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774321 123667788889999999999999731
Q ss_pred -------------------CCCEEecCCCCCcEEecCCCC--ceEeeeccccc
Q 003832 593 -------------------RMRIIHRDLKASNVLLDNDMN--PKISDFGMARI 624 (792)
Q Consensus 593 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DFgla~~ 624 (792)
...++|+|+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.72 E-value=7.6e-09 Score=109.54 Aligned_cols=183 Identities=20% Similarity=0.262 Sum_probs=120.0
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-ccc--ceeeeeeEEeCC---cceEEEeec
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRN--LVKLLGCCIQAD---ESMLIYEYM 551 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~g~~~~~~---~~~lV~e~~ 551 (792)
.+.++.|....||+.. ..+++|+.... .....+..|+++|+.+. +.. +.+++....... ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999874 46888886432 34567899999999884 333 334444433332 348899999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc----------------------------------------
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---------------------------------------- 591 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------- 591 (792)
++.+|..... ..++..++..++.++++.|+.||+.
T Consensus 99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9998865432 1356667777888888888888851
Q ss_pred ---------------CCCCEEecCCCCCcEEecC--CCCceEeeeccccccCCCCccccccccccccCc---cccccccC
Q 003832 592 ---------------SRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY---MSPEYAAE 651 (792)
Q Consensus 592 ---------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 651 (792)
..+.++|+|++|.||++++ ...+.|+||+.+..-.... . ....... ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D-----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D-----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H-----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H-----HHHHHhhccccCHHHHHH
Confidence 1245899999999999998 5568899999887532210 0 0000011 12221110
Q ss_pred -----CCC---------CccCcchhHHHHHHHHHhCCCCC
Q 003832 652 -----GLF---------SVKSDVFSFGVLVLEIVSGKKNW 677 (792)
Q Consensus 652 -----~~~---------s~k~DVwS~Gvil~elltG~~p~ 677 (792)
+.. ....+.|+++.++|++.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 000 12258899999999999998654
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.57 E-value=2.5e-07 Score=80.78 Aligned_cols=77 Identities=22% Similarity=0.332 Sum_probs=58.8
Q ss_pred ceeEEecCceEEeCCCCceEEeeccCCC-CCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCc
Q 003832 82 GLLNVTSKGIVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (792)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~Wss~~~~~-~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~ 160 (792)
-.|.+..||+|+|-..+.+||++|+... ..+..+.|.++|||||.|.+ +.++|+|=.
T Consensus 21 y~l~~q~DgNLvly~~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~-~~~vWss~t--------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDHSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSS-GRSLWASHS--------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCSCEEEECTTSCEEEECTT-CCEEEECCC---------------------
T ss_pred EEEEECCCCeEEEEECCEEEEEecCCCCCCccEEEEEeCCccEEEECCC-cEEEEEecC---------------------
Confidence 4588899999999445689999997532 24567999999999999987 789998621
Q ss_pred eeEEeeccCCCCCCcceEEeecCCCCceEE
Q 003832 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (792)
Q Consensus 161 ~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~ 190 (792)
....+.+.+.++.+|...++
T Consensus 79 ----------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 ----------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp ----------CCCSSCEEEEECTTSCEEEE
T ss_pred ----------CCCCCCEEEEEeCCCeEEEE
Confidence 11235688999999987654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-06 Score=89.15 Aligned_cols=85 Identities=16% Similarity=0.231 Sum_probs=64.3
Q ss_pred CceeEEecCceEEe-CCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCC
Q 003832 81 SGLLNVTSKGIVLL-DGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGM 159 (792)
Q Consensus 81 ~~~l~~~~~g~l~l-~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~ 159 (792)
.-.|.++.+|+|+| +++ .++|++++.......+++|+++||||+.+.+ +.++||||.+
T Consensus 151 ~~~l~l~~dG~LvL~~~~-~~~W~s~~~~~~~~~~~~L~~~Gnl~ly~~~-~~~vw~s~~~------------------- 209 (236)
T 1dlp_A 151 PYRLSMETDCNLVLFDRD-DRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-NIAVWTSGNS------------------- 209 (236)
T ss_dssp SCEEEEETTTEEEEEBTT-BCCSCCCCCSSCSSCEEEEETTTEEEEEETT-TEEEEECCCC-------------------
T ss_pred cEEEEECCCCcEEEEcCC-EeEEeCCCcCCCCceEEEECCCCcEEEEeCC-CcEEEEeCCC-------------------
Confidence 45688999999988 554 6899998754333467899999999999865 6799999943
Q ss_pred ceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecC
Q 003832 160 DRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (792)
Q Consensus 160 ~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 202 (792)
| ++|.|++.+|++|..+++ . ..||.+|
T Consensus 210 ------~------~~~~~rl~Ld~dG~l~ly--~--~~~W~sg 236 (236)
T 1dlp_A 210 ------R------SAGRYVFVLQPDRNLAIY--G--GALWTTG 236 (236)
T ss_dssp ------C------SSSCCEEEECSSSCEEEE--C--CCCCBC-
T ss_pred ------C------CCCCEEEEEcCCCcEEEe--C--CCCccCC
Confidence 1 236789999999987766 2 2677654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=8.9e-06 Score=85.86 Aligned_cols=136 Identities=21% Similarity=0.172 Sum_probs=91.3
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccc---cceeeeeeEE-eCCcceEEEeecCC
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCI-QADESMLIYEYMPN 553 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~-~~~~~~lV~e~~~~ 553 (792)
.+.++.|....||+. ++.+++|+-. .......+..|+++|..+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356788888899987 5678888853 223456789999999999752 3555666664 34457899999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc------------------------------------------
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD------------------------------------------ 591 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------ 591 (792)
..+...... .++..++..++.++++.|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888653211 122333334444444444444432
Q ss_pred ---------------CCCCEEecCCCCCcEEecC---CCC-ceEeeeccccc
Q 003832 592 ---------------SRMRIIHRDLKASNVLLDN---DMN-PKISDFGMARI 624 (792)
Q Consensus 592 ---------------~~~~ivH~Dlkp~NIll~~---~~~-~kl~DFgla~~ 624 (792)
..+.++|+|+++.||++++ ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2345799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1e-05 Score=83.50 Aligned_cols=135 Identities=18% Similarity=0.167 Sum_probs=97.3
Q ss_pred ccCcCCcc-cEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 480 KLGEGGFG-PVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 480 ~lg~G~fg-~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
.+..|..+ .||+..... +..+++|+-.. .....+..|...|+.+. +--+.+++.++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556655 589876543 56789998643 34567888999998885 33467788899888999999999999888
Q ss_pred hHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc---------------------------------------------
Q 003832 557 DFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD--------------------------------------------- 591 (792)
Q Consensus 557 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------------- 591 (792)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654221 223345566666666666642
Q ss_pred ----------CCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 592 ----------SRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 592 ----------~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112379999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=7.8e-06 Score=88.28 Aligned_cols=80 Identities=6% Similarity=-0.014 Sum_probs=56.1
Q ss_pred cccc-CcCCcccEEeeecc-------CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcc-c--ccceeeeeeEEeC--
Q 003832 478 YNKL-GEGGFGPVYKGTLV-------EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQ-H--RNLVKLLGCCIQA-- 541 (792)
Q Consensus 478 ~~~l-g~G~fg~Vy~g~~~-------~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~-H--~niv~l~g~~~~~-- 541 (792)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998764 26788898864322 001245778999998885 3 2466778777655
Q ss_pred -CcceEEEeecCCCChh
Q 003832 542 -DESMLIYEYMPNKSLD 557 (792)
Q Consensus 542 -~~~~lV~e~~~~gsL~ 557 (792)
...++|||++++..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=9.9e-05 Score=80.81 Aligned_cols=75 Identities=12% Similarity=0.223 Sum_probs=50.5
Q ss_pred ccccCcCCcccEEeeecc-CCcEEEEEEccCCCc-------hhHHHHHHHHHHHHhccc--ccce-eeeeeEEeCCcceE
Q 003832 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG-------QGMEEFKNEVTLIARLQH--RNLV-KLLGCCIQADESML 546 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~-------~~~~~~~~Ei~~l~~l~H--~niv-~l~g~~~~~~~~~l 546 (792)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.+++..+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999764 467899998643211 123456789999888742 4444 45443 4556789
Q ss_pred EEeecCCC
Q 003832 547 IYEYMPNK 554 (792)
Q Consensus 547 V~e~~~~g 554 (792)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.74 E-value=8.2e-05 Score=79.41 Aligned_cols=140 Identities=14% Similarity=0.191 Sum_probs=80.4
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccc--cceeeee------eEEeCCcceEEEee
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLG------CCIQADESMLIYEY 550 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g------~~~~~~~~~lV~e~ 550 (792)
+.|+.|..+.||+....++ .+++|+.... .+.+..|+.++..+... .+.+++. +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566678899999887544 5899998652 23344556666655321 2333332 12345667899999
Q ss_pred cCCCChh--------------HHHhhccc-C----------ccCChhhHH------------------------------
Q 003832 551 MPNKSLD--------------FFIFDQAR-A----------TFLDWQKRI------------------------------ 575 (792)
Q Consensus 551 ~~~gsL~--------------~~l~~~~~-~----------~~l~~~~~~------------------------------ 575 (792)
+++..+. ..++.... . ....|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987542 11111110 0 011232210
Q ss_pred -HHHHHHHHHHHHHhh----------cCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 576 -HIVGGIARGILYLHQ----------DSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 576 -~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+...+..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111123445666663 123569999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00019 Score=74.80 Aligned_cols=79 Identities=19% Similarity=0.254 Sum_probs=59.3
Q ss_pred ccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccc---cceeeeeeEEeCCcceEEEee
Q 003832 474 NFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR---NLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~g~~~~~~~~~lV~e~ 550 (792)
....++.+|.|..+.||+.++.+|+.+++|+-..........|..|+..|+.+.-. -+.+++++ +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 45566789999999999999999999999987655444445688899999988421 23444443 345899999
Q ss_pred cCCCCh
Q 003832 551 MPNKSL 556 (792)
Q Consensus 551 ~~~gsL 556 (792)
++.+..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00041 Score=72.98 Aligned_cols=139 Identities=19% Similarity=0.136 Sum_probs=92.6
Q ss_pred cccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc---cccceeeeeeEEeCCcceEEEeecCC
Q 003832 477 SYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ---HRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 477 ~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
..+.|+.|....+|+... +++.+++|+... .....+..|.+.|+.+. ...+.+++.++...+..++|||++++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 456799999999999886 567888998753 23567889999998884 25678888888877889999999998
Q ss_pred CChhH-----------HHhhccc-C------------------ccCChhhHH---HHHH----------------HHHHH
Q 003832 554 KSLDF-----------FIFDQAR-A------------------TFLDWQKRI---HIVG----------------GIARG 584 (792)
Q Consensus 554 gsL~~-----------~l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~~ 584 (792)
..+.. -|+.... . -.-+|.... ++.. .+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 86521 1222111 0 011343221 1111 11111
Q ss_pred -HHHHhh-cCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 585 -ILYLHQ-DSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 585 -L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223422 2356799999999999999887 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00096 Score=73.52 Aligned_cols=80 Identities=11% Similarity=0.027 Sum_probs=47.0
Q ss_pred CCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCC---CCccCcchhHHHHHHH
Q 003832 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL---FSVKSDVFSFGVLVLE 669 (792)
Q Consensus 593 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~k~DVwS~Gvil~e 669 (792)
...++|+|+++.||++++++ ++|+||+.+..-.... ....-...-...|.+|+...... -....++......+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 34699999999999999876 9999999887532100 00000000013466666553111 1122445577777888
Q ss_pred HHhCC
Q 003832 670 IVSGK 674 (792)
Q Consensus 670 lltG~ 674 (792)
.++++
T Consensus 309 ~y~~~ 313 (420)
T 2pyw_A 309 LFNKR 313 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0021 Score=70.87 Aligned_cols=72 Identities=19% Similarity=0.285 Sum_probs=50.0
Q ss_pred cccCcCCcccEEeeeccC--------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEEe
Q 003832 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 549 (792)
+.|+.|....+|+....+ ++.+++|+..... ..+.+..|..++..+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 578889899999998653 4789999874321 12556689999998864444 556665532 38999
Q ss_pred ecCCCCh
Q 003832 550 YMPNKSL 556 (792)
Q Consensus 550 ~~~~gsL 556 (792)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986444
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0015 Score=68.28 Aligned_cols=71 Identities=11% Similarity=0.192 Sum_probs=45.6
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEEeec-CCCC
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYM-PNKS 555 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~-~~gs 555 (792)
.+.|+.|....+|+. +.+++|+....... ......|+.+++.+....+ .+++++ ..+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 568999999999998 56888887643211 1123568888877753333 345543 344568999999 6655
Q ss_pred h
Q 003832 556 L 556 (792)
Q Consensus 556 L 556 (792)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0033 Score=66.31 Aligned_cols=143 Identities=16% Similarity=0.148 Sum_probs=80.2
Q ss_pred ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeee------EEeCCcceEEEe
Q 003832 478 YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGC------CIQADESMLIYE 549 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~------~~~~~~~~lV~e 549 (792)
.+.|+.|....+|+....++ .+++|+..... ..+.+..|+.++..+.... +.+++.. ....+..+++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 35677888899999887555 68899886521 2234566777777774222 2233321 122345689999
Q ss_pred ecCCCChhH--------------HHhhccc----C-----ccCChhhHHH------------HHHHHHHHHHHHhhc---
Q 003832 550 YMPNKSLDF--------------FIFDQAR----A-----TFLDWQKRIH------------IVGGIARGILYLHQD--- 591 (792)
Q Consensus 550 ~~~~gsL~~--------------~l~~~~~----~-----~~l~~~~~~~------------i~~~ia~~L~yLH~~--- 591 (792)
++++..+.. .++.... . ....|..... +...+...+..++..
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 999865421 0111100 0 0011322110 111244455555532
Q ss_pred -CCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 592 -~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23459999999999999987666899999765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0037 Score=67.54 Aligned_cols=141 Identities=18% Similarity=0.218 Sum_probs=82.3
Q ss_pred cccCcCCcccEEeeecc--------CCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc-ceeeeeeEEeCCcceEEEe
Q 003832 479 NKLGEGGFGPVYKGTLV--------EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-LVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~--------~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~g~~~~~~~~~lV~e 549 (792)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.+.-.. ..++++++.+ .+|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46777888899998764 2478999986332 234566778999998885323 3556666543 29999
Q ss_pred ecCCCChhHH-----------------Hhhcc--cCccCC--hhhHHHHHHHHHH-------------------HHHHH-
Q 003832 550 YMPNKSLDFF-----------------IFDQA--RATFLD--WQKRIHIVGGIAR-------------------GILYL- 588 (792)
Q Consensus 550 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~L~yL- 588 (792)
|+++..|..- |+... -.+... |.++.++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665311 01100 011122 3344444433321 22333
Q ss_pred ---hhc-CCCCEEecCCCCCcEEecCC----CCceEeeeccccc
Q 003832 589 ---HQD-SRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (792)
Q Consensus 589 ---H~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgla~~ 624 (792)
... ....++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 221 23459999999999999876 7899999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.01 Score=62.94 Aligned_cols=141 Identities=16% Similarity=0.139 Sum_probs=72.3
Q ss_pred cccCcCCccc-EEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccc--cceeeeeeEEeCCcceEEEeecCCCC
Q 003832 479 NKLGEGGFGP-VYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHR--NLVKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 479 ~~lg~G~fg~-Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+... .+.+++.+.. ..-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 4566665544 6677654467787876543221 2345567777766422 2445665532 33478999998766
Q ss_pred hhHHHhhcc---------------------c--CccCChhhHH-------H-------------HHHHHHHHHHHHh---
Q 003832 556 LDFFIFDQA---------------------R--ATFLDWQKRI-------H-------------IVGGIARGILYLH--- 589 (792)
Q Consensus 556 L~~~l~~~~---------------------~--~~~l~~~~~~-------~-------------i~~~ia~~L~yLH--- 589 (792)
+.+++.... . ....+..... . ....+...+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654332110 0 0001110000 0 0011112222221
Q ss_pred hcCCCCEEecCCCCCcEEecCC----CCceEeeeccccc
Q 003832 590 QDSRMRIIHRDLKASNVLLDND----MNPKISDFGMARI 624 (792)
Q Consensus 590 ~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DFgla~~ 624 (792)
......++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1123469999999999999875 6789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.69 E-value=0.013 Score=61.92 Aligned_cols=142 Identities=13% Similarity=0.129 Sum_probs=81.5
Q ss_pred cccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc--ceeeeee-----EEeCCcceEEEeec
Q 003832 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN--LVKLLGC-----CIQADESMLIYEYM 551 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~g~-----~~~~~~~~lV~e~~ 551 (792)
..|+ |....||+....+|+.+++|+..... ...+.+..|..++..+.... +.+++.. ....+..++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999887777789999986331 23456777888888875322 3444433 12234557899999
Q ss_pred CCCChh----HH----------Hhhcc------cCccCChhhH----HH---------------HHHHHHHHHHHHhh--
Q 003832 552 PNKSLD----FF----------IFDQA------RATFLDWQKR----IH---------------IVGGIARGILYLHQ-- 590 (792)
Q Consensus 552 ~~gsL~----~~----------l~~~~------~~~~l~~~~~----~~---------------i~~~ia~~L~yLH~-- 590 (792)
++..+. +. ++... .....++... .. +...+...+..+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 886542 11 11100 0111222111 00 01111122223322
Q ss_pred --cCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 591 --DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 591 --~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
.....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0079 Score=66.69 Aligned_cols=74 Identities=14% Similarity=0.136 Sum_probs=48.0
Q ss_pred ccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEEeecCCCC
Q 003832 478 YNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYEYMPNKS 555 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e~~~~gs 555 (792)
++.|+.|-...+|+....+ +..+++|+......... .-..|..++..+...++ .++++.+. + .+|+||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578889999999998755 47888888754322111 12578889998865444 45666662 2 35999998755
Q ss_pred h
Q 003832 556 L 556 (792)
Q Consensus 556 L 556 (792)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.0056 Score=65.97 Aligned_cols=73 Identities=14% Similarity=0.180 Sum_probs=44.8
Q ss_pred cccCcCCcccEEeeeccC---------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEE
Q 003832 479 NKLGEGGFGPVYKGTLVE---------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIY 548 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~---------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 548 (792)
+.|+.|....+|+....+ ++.+++|+....... ......|..++..+...++ .++++.. .-.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 567888888999987654 268888887543221 1234678888888854343 3566543 247899
Q ss_pred eecCCCCh
Q 003832 549 EYMPNKSL 556 (792)
Q Consensus 549 e~~~~gsL 556 (792)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.02 Score=55.84 Aligned_cols=99 Identities=9% Similarity=0.034 Sum_probs=64.5
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcccc
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTN 633 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~ 633 (792)
-+|.++|.. ...++++.++|.++.|.+.+|.-+-.... + ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 478888854 45689999999999999999877622110 1 1233457899999999988764 1110
Q ss_pred ccccccccCccccccccCCCCCccCcchhHHHHHHHHHh
Q 003832 634 THKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672 (792)
Q Consensus 634 ~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt 672 (792)
.....+.|||... ...+.+.-|||+|+++|.-+-
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123566888763 345678899999999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.95 E-value=0.024 Score=60.29 Aligned_cols=32 Identities=28% Similarity=0.446 Sum_probs=28.0
Q ss_pred CCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 593 ~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
...++|+|+.+.||++++++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34699999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.24 E-value=0.28 Score=53.56 Aligned_cols=74 Identities=16% Similarity=0.211 Sum_probs=48.5
Q ss_pred ccccCcCCcccEEeeeccC--------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEE
Q 003832 478 YNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIY 548 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~ 548 (792)
++.|..|-...+|+....+ ++.+++|+...... ..-.-.+|..+++.+.-.++ .++++.+ .-++|+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567788889999988753 57899998654322 11223578888888853333 4455433 247899
Q ss_pred eecCCCCh
Q 003832 549 EYMPNKSL 556 (792)
Q Consensus 549 e~~~~gsL 556 (792)
||+++..|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998764
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.35 E-value=0.78 Score=49.62 Aligned_cols=30 Identities=23% Similarity=0.380 Sum_probs=25.3
Q ss_pred CEEecCCCCCcEEe------cCCCCceEeeeccccc
Q 003832 595 RIIHRDLKASNVLL------DNDMNPKISDFGMARI 624 (792)
Q Consensus 595 ~ivH~Dlkp~NIll------~~~~~~kl~DFgla~~ 624 (792)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 792 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-66 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-62 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-60 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-48 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 9e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-23 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-18 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 4e-15 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-11 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 4e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 1e-71
Identities = 66/289 (22%), Positives = 130/289 (44%), Gaps = 27/289 (9%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++G G FG VYKG + + ++ + Q ++ FKNEV
Sbjct: 3 WEIPD-------GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 55
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ + +H N++ +G + ++ ++ SL + T + K I I
Sbjct: 56 GVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQ 112
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
A+G+ YLH IIHRDLK++N+ L D+ KI DFG+A + ++ G+
Sbjct: 113 TAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 641 YGYMSPEYA---AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697
+M+PE + +S +SDV++FG+++ E+++G+ + + I++
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFM 221
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
R + S+ P + R + C++ + ++RP ++ +
Sbjct: 222 VGRGYLSPDLSKVRSNCPKAMKRLM---AECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 5e-68
Identities = 80/294 (27%), Positives = 133/294 (45%), Gaps = 32/294 (10%)
Query: 453 HMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQG 512
+++ WE + +LG G FG V+ G ++AVK L +GS
Sbjct: 3 WWEDE---WEVPR-------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MS 51
Query: 513 MEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQ 572
+ F E L+ +LQH+ LV+L Q + +I EYM N SL F+ L
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTIN 109
Query: 573 KRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632
K + + IA G+ ++ + IHRDL+A+N+L+ + ++ KI+DFG+AR+ +E
Sbjct: 110 KLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
Query: 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA 692
+ +PE G F++KSDV+SFG+L+ EIV+ + + +
Sbjct: 167 REG-AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------- 218
Query: 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
++ +R + P + LC + RPEDRP + +L
Sbjct: 219 -VIQNLERGYRM-------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-66
Identities = 69/275 (25%), Positives = 120/275 (43%), Gaps = 22/275 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
++G G FG V+ G + ++A+K + +G+ E+F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C++ L++E+M + L ++ Q + + + + G +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEG---MAYLE 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+IHRDL A N L+ + K+SDFGM R D+ T++ + SPE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
+S KSDV+SFGVL+ E+ S K + + + ++ L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFRL-------Y 222
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
P + C + RPEDRP S ++ L+
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 215 bits (548), Expect = 1e-64
Identities = 76/297 (25%), Positives = 134/297 (45%), Gaps = 31/297 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNE 519
WE + + +KLG G +G VY+G + +AVK L + + + +EEF E
Sbjct: 12 WEMER-------TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 63
Query: 520 VTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
++ ++H NLV+LLG C + +I E+M +L ++ + R + +++
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMAT 122
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
I+ + YL + IHRDL A N L+ + K++DFG++R+ GD +
Sbjct: 123 QISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG-AKF 178
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699
+ +PE A FS+KSDV++FGVL+ EI + + L + L ++
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEKD 232
Query: 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN 756
ME P + + C Q P DRP+ + + +++ E +
Sbjct: 233 YRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF--ETMFQESS 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 1e-64
Identities = 77/300 (25%), Positives = 135/300 (45%), Gaps = 30/300 (10%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
WE ++ KLG+G FG V+ GT +A+K L G+ E F E
Sbjct: 12 WEIPR-------ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEA 63
Query: 521 TLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGG 580
++ +L+H LV+L + + ++ EYM SL F+ + +L + + +
Sbjct: 64 QVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQ 121
Query: 581 IARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGT 640
IA G+ Y+ + M +HRDL+A+N+L+ ++ K++DFG+AR+ +E
Sbjct: 122 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG-AKFP 177
Query: 641 YGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700
+ +PE A G F++KSDV+SFG+L+ E+ + + + + +L + +R
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVER 229
Query: 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN-RPG 759
+ PP + C + PE+RP + L EP +PG
Sbjct: 230 GYRM-------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 282
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 1e-63
Identities = 59/291 (20%), Positives = 115/291 (39%), Gaps = 28/291 (9%)
Query: 480 KLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCI 539
+G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 540 QADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD---- 591
+ + + L+ +Y + SL ++ + + I + A G+ +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 592 -SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF--GGDEIQTNTHKVVGTYGYMSPEY 648
+ I HRDLK+ N+L+ + I+D G+A D I + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 649 AAEGL------FSVKSDVFSFGVLVLEIVSGKKNWR----FSHPDHDHNLLGHAWILWKE 698
+ + ++D+++ G++ EI + P +D + ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 699 KRAMELAGDTLADSHPPTEVLRCIH-VGLLCVQHRPEDRPNMSSVVLMLSS 748
+ + + E LR + + C R + LS
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 1e-63
Identities = 77/311 (24%), Positives = 130/311 (41%), Gaps = 39/311 (12%)
Query: 463 FDFASIAKATDNFASY---------NKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG- 508
F F +A FA +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 509 SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF 568
+ + +F +E +++ + H N++ L G ++ M+I E+M N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 569 LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628
+ + ++ GIA G+ YL M +HRDL A N+L+++++ K+SDFG++R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 629 EIQTNTHKVVG---TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+G + +PE F+ SDV+S+G+++ E++S + P D
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWD 236
Query: 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745
+ ++ R P + L C Q RP +V
Sbjct: 237 MTNQDVINAIEQDYRLPP----------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 746 LSSDSLLPEPN 756
L D ++ PN
Sbjct: 287 L--DKMIRNPN 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 8e-63
Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 22/274 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLV 532
+ +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
+L G C + +I EYM N L ++ + Q+ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEG 652
+ +HRDL A N L+++ K+SDFG++R DE ++ + PE
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPVRWSPPEVLMYS 176
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
FS KSD+++FGVL+ EI S K + + E L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLY 221
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
P + + C + ++RP ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-62
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 35/287 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEV 520
W + +G+G FG V G G ++AVK + + + F E
Sbjct: 2 WALNM-------KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEA 51
Query: 521 TLIARLQHRNLVKLLGCCIQADESM-LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVG 579
+++ +L+H NLV+LLG ++ + ++ EYM SL ++ + R + L +
Sbjct: 52 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSL 110
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ + YL +HRDL A NVL+ D K+SDFG+ + E +
Sbjct: 111 DVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 162
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699
+ +PE E FS KSDV+SFG+L+ EI S + P D ++ + +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVE 214
Query: 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
+ ++ D PP V C RP+ + L
Sbjct: 215 KGYKM---DAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 209 bits (533), Expect = 2e-62
Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 53/314 (16%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQGME 514
E+ +N +GEG FG V++ +AVK L + + M+
Sbjct: 8 LEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 515 -EFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
+F+ E L+A + N+VKLLG C L++EYM L+ F+ + T
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 569 ----------------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L +++ I +A G+ YL + + +HRDL N L+ +M
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENM 177
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
KI+DFG++R + +M PE ++ +SDV+++GV++ EI S
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237
Query: 673 GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHR 732
P + H +++ + L + P L ++ LC
Sbjct: 238 YGL-----QPYYGMA---HEEVIYYVRDGNIL-------ACPENCPLELYNLMRLCWSKL 282
Query: 733 PEDRPNMSSVVLML 746
P DRP+ S+ +L
Sbjct: 283 PADRPSFCSIHRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 3e-62
Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 28/278 (10%)
Query: 479 NKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGSGQG-MEEFKNEVTLIARLQHRNLVK 533
+G G FG VY GTL++ AVK L++ + G + +F E ++ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 534 LLGCCIQADES-MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LLG C++++ S +++ YM + L FI ++ + + + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK--VVGTYGYMSPEYAA 650
+ +HRDL A N +LD K++DFG+AR E + +K +M+ E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
F+ KSDV+SFGVL+ E+++ P D N L + +R ++
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLLQ------- 255
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
P V L C + E RP+ S +V +S+
Sbjct: 256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 5e-62
Identities = 63/301 (20%), Positives = 117/301 (38%), Gaps = 38/301 (12%)
Query: 471 ATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQH 528
D+F ++LG G G V+K + G +A K + + + E+ ++
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
+V G E + E+M SLD + R + Q + + +G+ YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+ +I+HRD+K SN+L+++ K+ DFG++ I + + VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG------HAWILWKEKRAM 702
+SV+SD++S G+ ++E+ G+ + G A + +
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 703 ELAGDTLADSHPPTEVLRCIHVGLL---------------------CVQHRPEDRPNMSS 741
DS PP + + + C+ P +R ++
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 742 V 742
+
Sbjct: 295 L 295
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 4e-61
Identities = 73/316 (23%), Positives = 120/316 (37%), Gaps = 52/316 (16%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSGQG-M 513
WEF +N LG G FG V T ++AVK L + +
Sbjct: 32 WEFPR-------ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSER 84
Query: 514 EEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ--------- 563
E +E+ ++ +L H N+V LLG C + LI+EY L ++ +
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 564 -----------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM 612
L ++ + +A+G+ +L +HRDL A NVL+ +
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGK 201
Query: 613 NPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS 672
KI DFG+AR D +M+PE EG++++KSDV+S+G+L+ EI S
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 673 GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHR 732
+P + + + L + M+ P + C
Sbjct: 262 LGV-----NPYPGIPVDANFYKLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFD 307
Query: 733 PEDRPNMSSVVLMLSS 748
RP+ ++ L
Sbjct: 308 SRKRPSFPNLTSFLGC 323
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-60
Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 29/291 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKGSGQGM-EEFKNEVTLIARL 526
+G G FG VYKG L +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 527 QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGIL 586
H N+++L G + M+I EYM N +LD F+ ++ + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMK 124
Query: 587 YLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK-VVGTYGYMS 645
YL M +HRDL A N+L+++++ K+SDFG++R+ D T T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
PE + F+ SDV+SFG+++ E+++ + + +H+ M+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKAI 226
Query: 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN 756
D P + + C Q RP + +V +L D L+ P+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL--DKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-60
Identities = 72/321 (22%), Positives = 118/321 (36%), Gaps = 48/321 (14%)
Query: 452 SHMKEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRL 505
+ + D + WEF + + LG G FG V + T +AVK L
Sbjct: 10 TQLPYDHK-WEFPR-------NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML 61
Query: 506 SKGSGQG-MEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQ 563
+ E +E+ +++ L H N+V LLG C +++I EY L F+ +
Sbjct: 62 KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121
Query: 564 ---------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608
LD + + +A+G+ +L IHRDL A N+LL
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL 178
Query: 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVL 668
+ KI DFG+AR D +M+PE +++ +SDV+S+G+ +
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 669 EIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLC 728
E+ S + P + + KE M P + C
Sbjct: 239 ELFSLGSSPYPGMPVDS-----KFYKMIKEGFRMLS---------PEHAPAEMYDIMKTC 284
Query: 729 VQHRPEDRPNMSSVVLMLSSD 749
P RP +V ++
Sbjct: 285 WDADPLKRPTFKQIVQLIEKQ 305
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-60
Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 27/284 (9%)
Query: 471 ATDNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGSGQG-MEEFKNEVTLIAR 525
DN + +LG G FG V +G + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L + +V+L+G C QA+ ML+ E L F+ + + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGM 122
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYM 644
YL + +HRDL A NVLL N KISDFG+++ G D+ T +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
+PE FS +SDV+S+GV + E +S + P + + KR ME
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGKR-MEC 233
Query: 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
PP + C ++ EDRP+ +V + +
Sbjct: 234 ---------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-60
Identities = 78/322 (24%), Positives = 141/322 (43%), Gaps = 28/322 (8%)
Query: 468 IAKATDNFASYNKLGEGGFGPVYKGTLVEGQE-----IAVKRLSKG-SGQGMEEFKNEVT 521
I K T+ F LG G FG VYKG + E +A+K L + S + +E +E
Sbjct: 5 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 522 LIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
++A + + ++ +LLG C+ LI + MP L ++ + + Q ++ I
Sbjct: 64 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQI 120
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
A+G+ YL R++HRDL A NVL+ + KI+DFG+A++ G +E + +
Sbjct: 121 AKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
+M+ E +++ +SDV+S+GV V E+++ P + IL K +R
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKGER- 231
Query: 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGFF 761
PP + + + C + RP +++ S + P+
Sbjct: 232 ---------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 282
Query: 762 TERSLPEAEFSPSYPQSSTTNE 783
ER + ++ ++ E
Sbjct: 283 DERMHLPSPTDSNFYRALMDEE 304
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (517), Expect = 7e-60
Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 34/279 (12%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
F+ ++G G FG VY V + +A+K++S Q ++ EV + +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H N ++ GC ++ + L+ EY + D + L + + G +G+ Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH +IHRD+KA N+LL K+ DFG A I + VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 648 YAA---EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
EG + K DV+S G+ +E+ K P + N + + + + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNES---- 231
Query: 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
L H + C+Q P+DRP ++
Sbjct: 232 --PALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 8e-60
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 28/276 (10%)
Query: 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHRNLVK 533
+LG G FG V KG + +AVK L + +E E ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 534 LLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSR 593
++G C +A+ ML+ E L+ ++ + + I +V ++ G+ YL +
Sbjct: 73 MIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEE--- 125
Query: 594 MRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-TNTHKVVGTYGYMSPEYAAEG 652
+HRDL A NVLL KISDFG+++ DE + +PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 653 LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712
FS KSDV+SFGVL+ E S + P +L K +R
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER----------MG 230
Query: 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
P + LC + E+RP ++V L L +
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-58
Identities = 62/277 (22%), Positives = 115/277 (41%), Gaps = 27/277 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN 530
D + +LG+G FG VYK E A K + S + +E++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKLL + ++ E+ ++D + + R L + + + YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+IIHRDLKA N+L D + K++DFG++ + ++ +GT +M+PE
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 651 -----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
+ + K+DV+S G+ ++E+ + P H+ N +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPM--------RVLLKIAK 229
Query: 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ + P C++ + R S +
Sbjct: 230 SEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 4e-58
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 23/273 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHRN 530
+++ LGEG +G V + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VK G + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ I HRD+K N+LLD N KISDFG+A +F + + +K+ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 651 EGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
F + DV+S G+++ +++G+ W + WKEK+ +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKI 232
Query: 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ L +H + P R + +
Sbjct: 233 -----DSAPLALLH---KILVENPSARITIPDI 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-57
Identities = 73/293 (24%), Positives = 126/293 (43%), Gaps = 39/293 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEG---QEIAVKRLSK-GSGQGMEEFKNEVTLIARL-Q 527
++ + +GEG FG V K + + + A+KR+ + S +F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFI-------------FDQARATFLDWQKR 574
H N++ LLG C L EY P+ +L F+ + A+ L Q+
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 575 IHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNT 634
+H +ARG+ YL Q + IHRDL A N+L+ + KI+DFG++R E+
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 635 HKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694
+M+ E +++ SDV+S+GVL+ EIVS P
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747
L + R P + C + +P +RP+ + +++ L+
Sbjct: 239 LPQGYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 64/279 (22%), Positives = 112/279 (40%), Gaps = 26/279 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHR 529
+++ +G G +G K G+ + K L GS + +EV L+ L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 530 NLVKLLGCCIQADESML--IYEYMPNKSLDFFIFDQARAT-FLDWQKRIHIVGGIARGIL 586
N+V+ I + L + EY L I + +LD + + ++ + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 587 YLHQ--DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
H+ D ++HRDLK +NV LD N K+ DFG+ARI D VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
SPE ++ KSD++S G L+ E+ + P + A + + K
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIREGKF---- 231
Query: 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
+ + + + + RP++ ++
Sbjct: 232 --RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-57
Identities = 74/282 (26%), Positives = 110/282 (39%), Gaps = 28/282 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSK---GSGQGMEEFKNEVTLIAR 525
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L HRNL++L G + ++ E P SL + L R + +A G+
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGM 124
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-GDEIQTNTHKVVGTYGYM 644
YL R IHRDL A N+LL KI DFG+ R D+ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL 704
+PE FS SD + FGV + E+ + + P N + KE +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPR 236
Query: 705 AGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
P +V + C H+PEDRP ++ L
Sbjct: 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-57
Identities = 60/273 (21%), Positives = 110/273 (40%), Gaps = 31/273 (11%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLL 535
++G G F VYKG E E+A L + + FK E ++ LQH N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 536 GCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ +L+ E M + +L ++ + + I +G+ +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLHTR 131
Query: 592 SRMRIIHRDLKASNVLL-DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
+ IIHRDLK N+ + + KI D G+A + + V+GT +M+PE
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEM-Y 185
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
E + DV++FG+ +LE+ + + + N + +
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPY-----SECQNAAQIYRRVTSGVKPASF------ 234
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
D EV I C++ ++R ++ ++
Sbjct: 235 DKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-56
Identities = 74/315 (23%), Positives = 127/315 (40%), Gaps = 40/315 (12%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKG-SGQGM 513
WE + +LG+G FG VY+G +A+K +++ S +
Sbjct: 15 WEVAR-------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67
Query: 514 EEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF----- 568
EF NE +++ ++V+LLG Q +++I E M L ++ A
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 569 --LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626
K I + G IA G+ YL+ + +HRDL A N ++ D KI DFGM R
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 184
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDH 686
+ K + +MSPE +G+F+ SDV+SFGV++ EI + + +
Sbjct: 185 ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 243
Query: 687 NLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLML 746
E ++ P + +C Q+ P+ RP+ ++ +
Sbjct: 244 -----VLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 747 SSDSLLPEPNRPGFF 761
+ + P F+
Sbjct: 290 KEE-MEPGFREVSFY 303
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-55
Identities = 78/314 (24%), Positives = 116/314 (36%), Gaps = 46/314 (14%)
Query: 457 DMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGT------LVEGQEIAVKRLSKGSG 510
D WEF D LG G FG V + + +AVK L +G+
Sbjct: 4 DASKWEFPR-------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 56
Query: 511 QG-MEEFKNEVTLIAR-LQHRNLVKLLGCCIQADES-MLIYEYMPNKSLDFFIFDQ---- 563
+E+ ++ H N+V LLG C + M+I E+ +L ++ +
Sbjct: 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEF 116
Query: 564 ---------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614
FL + I +A+G+ +L + IHRDL A N+LL
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVV 173
Query: 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK 674
KI DFG+AR D +M+PE + +++++SDV+SFGVL+ EI S
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 233
Query: 675 KNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPE 734
P + KE M P L C P
Sbjct: 234 A-----SPYPGVKIDEEFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPS 279
Query: 735 DRPNMSSVVLMLSS 748
RP S +V L +
Sbjct: 280 QRPTFSELVEHLGN 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-55
Identities = 59/277 (21%), Positives = 118/277 (42%), Gaps = 24/277 (8%)
Query: 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIAR 525
S+ + + K+G+G G VY V GQE+A+++++ E NE+ ++
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
++ N+V L + DE ++ EY+ SL + + D + + + +
Sbjct: 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQAL 129
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
+LH ++IHRD+K+ N+LL D + K++DFG + Q+ +VGT +M+
Sbjct: 130 EFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMA 184
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705
PE + K D++S G++ +E++ G+ P + N L +++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIATNGTP---- 234
Query: 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ + C+ E R + +
Sbjct: 235 -ELQNPEKLSAIFRDFL---NRCLDMDVEKRGSAKEL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 9e-55
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 31/275 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
N+++L G A LI EY P ++ + ++ D Q+ + +A + Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEM 175
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708
+ K D++S GVL E + GK + + + + +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--------------SRVEF 221
Query: 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743
I ++H P RP + V+
Sbjct: 222 TFPDFVTEGARDLI---SRLLKHNPSQRPMLREVL 253
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 4e-53
Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 34/293 (11%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKGSGQGM-EE 515
+E + +GEG FG V++G + +A+K + + E+
Sbjct: 2 YEIQR-------ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 54
Query: 516 FKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRI 575
F E + + H ++VKL+G + + +I E L F+ + + LD I
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLI 111
Query: 576 HIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTH 635
++ + YL R +HRD+ A NVL+ ++ K+ DFG++R D
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM-EDSTYYKAS 167
Query: 636 KVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695
K +M+PE F+ SDV+ FGV + EI+ P + ++
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVK---NNDVI 219
Query: 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
+ + L PP + C + P RP + + LS+
Sbjct: 220 GRIENGERL-------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-52
Identities = 75/310 (24%), Positives = 121/310 (39%), Gaps = 48/310 (15%)
Query: 461 WEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKG-SGQ 511
WE D LGEG FG V + ++AVK L + +
Sbjct: 8 WELPR-------DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK 60
Query: 512 GMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATF-- 568
+ + +E+ ++ + +H+N++ LLG C Q +I EY +L ++ +
Sbjct: 61 DLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY 120
Query: 569 -----------LDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617
L + + +ARG+ YL + IHRDL A NVL+ D KI+
Sbjct: 121 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIA 177
Query: 618 DFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNW 677
DFG+AR + T +M+PE + +++ +SDV+SFGVL+ EI + +
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 678 RFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737
P + + L KE M+ P + C P RP
Sbjct: 238 YPGVPVEE------LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRP 282
Query: 738 NMSSVVLMLS 747
+V L
Sbjct: 283 TFKQLVEDLD 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 1e-50
Identities = 62/322 (19%), Positives = 118/322 (36%), Gaps = 33/322 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D++ + +LG G FG V++ T G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
V L +E ++IYE+M L + D+ + + + + + +G+ ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMH-- 141
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+H DLK N++ + K+ DFG+ + + GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVKVTTGTAEFAAPEVA 197
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
+D++S GVL ++SG + + D + ++ + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE----------TLRNVKSCDWNMDDS 247
Query: 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV--------VLMLSSDSLLPEPNRPGFF 761
A S + I + P R + DS +P
Sbjct: 248 AFSGISEDGKDFI---RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 762 TE-RSLPEAEFSPSYPQSSTTN 782
++ +A P P +N
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISN 326
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 7e-50
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 10/213 (4%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKG---SGQGMEEFKNEVTLIAR 525
K ++F LGEG F V L +E A+K L K + E +++R
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
L H VKL ++ Y N L +I D I +
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
YLH IIHRDLK N+LL+ DM+ +I+DFG A++ + Q + VGT Y+S
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 646 PEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR 678
PE E SD+++ G ++ ++V+G +R
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 1e-48
Identities = 57/273 (20%), Positives = 100/273 (36%), Gaps = 24/273 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
D + +LG G FG V++ G+ K ++ KNE++++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L E +LI E++ L I A + + I+ + G+ ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
I+H D+K N++ + KI DFG+A DEI T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
+D+++ GVL ++SG + + + + D
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE----------TLQNVKRCDWEFDED 250
Query: 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
A S E I +Q P R +
Sbjct: 251 AFSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 2e-46
Identities = 61/339 (17%), Positives = 121/339 (35%), Gaps = 36/339 (10%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGM-EEFKNEVTLIARLQHR 529
+ + + +GEG +G V V +A+K++S Q + E+ ++ R +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N++ + + Y+ + ++ + L + + I RG+ Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHK-VVGTYGYMSPEY 648
++HRDLK SN+LL+ + KI DFG+AR+ D T V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 649 AAEGLFSVKS-DVFSFGVLVLEIVSGKKNWRFSH--------------PDHDHNLLGHAW 693
KS D++S G ++ E++S + + H P +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLP 753
++ + P + + + + P R + L
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI---------EVEQALA 294
Query: 754 EPNRPGFFTERSLPEAE--FSPSYPQSSTTNEITITELQ 790
P + + P E + +++ +L+
Sbjct: 295 HP----YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLK 329
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 51/273 (18%), Positives = 103/273 (37%), Gaps = 25/273 (9%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
+ + LG G FG V++ + K + G K E++++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 532 VKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD 591
+ L +E ++I+E++ + I A L+ ++ + V + + +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 592 SRMRIIHRDLKASNVLLDNDMNP--KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
I H D++ N++ + KI +FG AR + N + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVH 175
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
+ S +D++S G LV ++SG + + +A + E+ E+
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI----- 230
Query: 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
E + + + + R S
Sbjct: 231 -----SIEAMDFVD---RLLVKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (409), Expect = 2e-45
Identities = 59/282 (20%), Positives = 113/282 (40%), Gaps = 28/282 (9%)
Query: 472 TDNFASYNKLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQG---MEEFKNEVTLIARLQ 527
+D + LG GG V+ L +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 528 HRNLVKLLGCCIQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
H +V + + ++ EY+ +L + + + ++ I ++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG-GDEIQTNTHKVVGTYG 642
+ + H + IIHRD+K +N+++ K+ DFG+AR T T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 643 YMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702
Y+SPE A +SDV+S G ++ E+++G+ + P + ++ R
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---------VAYQHVRED 230
Query: 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744
+ + V L + PE+R ++ +
Sbjct: 231 PIPPSARHEGLSA----DLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 163 bits (414), Expect = 4e-45
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQ- 527
++F+ + +G GGFG VY + G+ A+K L K QG NE +++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 528 --HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+V + D+ I + M L + + I G+
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGL 120
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMS 645
++H +++RDLK +N+LLD + +ISD G+A F + H VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 646 PEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL 689
PE +G+ + +D FS G ++ +++ G +R H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (407), Expect = 1e-44
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 15/214 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
+F LG G FG V+ G+ A+K L K + +E +E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
++++ G A + +I +Y+ L + R + V L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
II+RDLK N+LLD + + KI+DFG A+ + T+ + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP 682
+ ++ D +SFG+L+ E+++G + S+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (404), Expect = 2e-44
Identities = 52/278 (18%), Positives = 99/278 (35%), Gaps = 25/278 (8%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
K+G G FG +Y GT + G+E+A+K + + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
+ ++ + SL+ +R + + + + I Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 599 RDLKASNVL---LDNDMNPKISDFGMARIFGGDEIQTN-----THKVVGTYGYMSPEYAA 650
RD+K N L I DFG+A+ + + + GT Y S
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710
S + D+ S G +++ G W+ ++ M + L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISEKKMSTPIEVLC 241
Query: 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
+P E ++ C R +D+P+ S + + +
Sbjct: 242 KGYPS-EFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (404), Expect = 3e-44
Identities = 52/273 (19%), Positives = 101/273 (36%), Gaps = 21/273 (7%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-FKNEVTLIARLQHR 529
D + + LG G F V + +A+K ++K + +G E +NE+ ++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V L LI + + L I ++ + ++ + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
+ + LD D ISDFG++++ + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
A+ +S D +S GV+ ++ G + + L+++ E D+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK----------LFEQILKAEYEFDSP 231
Query: 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
I ++ PE R
Sbjct: 232 YWDDISDSAKDFI---RHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 155 bits (394), Expect = 3e-43
Identities = 56/287 (19%), Positives = 109/287 (37%), Gaps = 39/287 (13%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGM---------EEFKNEVTL 522
+N+ LG G V + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 523 IARLQ-HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
+ ++ H N+++L L+++ M L ++ ++ L ++ I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRAL 119
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTY 641
I LH ++ I+HRDLK N+LLD+DMN K++DFG + E +V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 642 GYMSPEYAAEGL------FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL 695
Y++PE + + + D++S GV++ +++G + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 696 WKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ + V + + +P+ R
Sbjct: 234 FGSPEWDDY----------SDTVKDLV---SRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 64/277 (23%), Positives = 108/277 (38%), Gaps = 30/277 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG---QGMEEFKNEVTLIAR-LQ 527
++F + LG+G FG V+ + Q A+K L K +E E +++ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 528 HRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
H L + + + EY+ L + I + D + I G+ +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
LH I++RDLK N+LLD D + KI+DFGM + + +TNT GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707
++ D +SFGVL+ E++ G+ P H + +E +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDE--------EELFHSIRMDN 219
Query: 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744
E + PE R + +
Sbjct: 220 PFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIR 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 4e-42
Identities = 43/280 (15%), Positives = 97/280 (34%), Gaps = 27/280 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
++GEG FG +++GT L+ Q++A+K + S + ++E L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 539 IQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIH 598
Q ++ + SL+ + R + + + +H+ +++
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 599 RDLKASNVLLDNDMNP-----KISDFGMARIFGGDEIQTNTHK-----VVGTYGYMSPEY 648
RD+K N L+ + + DFGM + + + + + GT YMS
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708
S + D+ + G + + + G W+ + + +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT------NKQKYERIGEKKQSTPLR 238
Query: 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748
+ P E + +H + P+ + + S
Sbjct: 239 ELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 4e-42
Identities = 64/293 (21%), Positives = 120/293 (40%), Gaps = 26/293 (8%)
Query: 470 KATDNFASYNKLGEGGFGPVYKGTLVE--GQEIAVKRLSKGSGQGM--EEFKNEVTLIAR 525
+A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 526 L---QHRNLVKLLGCCIQADESMLIYEYMPNKSLD---FFIFDQARATFLDWQKRIHIVG 579
L +H N+V+L C + + + +D D+ + + ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 580 GIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVG 639
+ RG+ +LH R++HRDLK N+L+ + K++DFG+ARI+ Q VV
Sbjct: 124 QLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVV 177
Query: 640 TYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWIL---- 695
T Y +PE + ++ D++S G + E+ K +R S + L
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 696 -WKEKRAMELAGDTLADSHPPTEVLRCIHVGLL-----CVQHRPEDRPNMSSV 742
W A+ + P + + I C+ P R + S
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (380), Expect = 2e-41
Identities = 61/285 (21%), Positives = 109/285 (38%), Gaps = 23/285 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVK--RLSKGSGQGMEEFKNEVTLIARLQHRN 530
+ + K+GEG +G VYK G+ A+K RL K E++++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+VKL +L++E++ + L+ + + GI Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD 118
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE-YA 649
R++HRDLK N+L++ + KI+DFG+AR FG + T Y +P+
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLM 173
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMEL----- 704
+S D++S G + E+V+G + + K +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 705 --AGDTLADSHPPTEVLRCIHVGLL-----CVQHRPEDRPNMSSV 742
T+ + P L+ + + ++ P R
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 8e-41
Identities = 71/315 (22%), Positives = 114/315 (36%), Gaps = 37/315 (11%)
Query: 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE-----FKNEVTLIARLQHRNLV 532
+ LGEG F VYK Q +A+K++ G ++ E+ L+ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 533 KLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS 592
LL L++++M + L + +G+ YLHQ
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQ-- 118
Query: 593 RMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE- 651
I+HRDLK +N+LLD + K++DFG+A+ FG V T Y +PE
Sbjct: 119 -HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGA 175
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
++ V D+++ G ++ E++ F D D + L R E G +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV---PFLPGDSDLDQL---------TRIFETLGTPTEE 223
Query: 712 SHPPTEVLRC-IHVGLLCVQHRPEDRPNMSSVVLMLSSDSLLPEPN-RPG--------FF 761
P L + +L L L P R +F
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
Query: 762 TERSLPEAEFSPSYP 776
+ R P P
Sbjct: 284 SNRPGPTPGCQLPRP 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-41
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 21/285 (7%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+NF K+GEG +G VYK G+ +A+K++ + E++L+ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+VKLL ++ L++E++ F D + T + + + +G+ + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
R++HRDLK N+L++ + K++DFG+AR F G ++T TH+VV +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILL 175
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHP------------DHDHNLLGHAWILWK 697
+S D++S G + E+V+ + + D + +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
K + P + + + P R + +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 55/271 (20%), Positives = 101/271 (37%), Gaps = 30/271 (11%)
Query: 481 LGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCC 538
LG G G V + ++ A+K L + + EV L R Q ++V+++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 74
Query: 539 IQADES----MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRM 594
+++ E + L I D+ F ++ I+ I I YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 595 RIIHRDLKASNVLLDNDMNP---KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAE 651
I HRD+K N+L + K++DFG A+ + T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGP 187
Query: 652 GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711
+ D++S GV++ ++ G P + ++ L + + R +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
S EV I ++ P R ++
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 55/281 (19%), Positives = 107/281 (38%), Gaps = 33/281 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGS------GQGMEEFKNEVTLIAR 525
D + + +LG G F V K G + A K + K G E+ + EV+++
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 526 LQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+QH N++ L + +LI E + L F+ ++ L ++ + I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNG- 125
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDNDMNP----KISDFGMARIFGGDEIQTNTHKVVGTY 641
++ ++I H DLK N++L + P KI DFG+A + GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTP 180
Query: 642 GYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
+++PE +++D++S GV+ ++SG + + ++++
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY- 239
Query: 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
S+ I + P+ R +
Sbjct: 240 ---------FSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 1e-39
Identities = 63/274 (22%), Positives = 100/274 (36%), Gaps = 43/274 (15%)
Query: 480 KLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEE------FKNEVTLIARLQ--HRN 530
LG GGFG VY G V +A+K + K E EV L+ ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 531 LVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+++LL + D +LI E F + A L + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCHN 128
Query: 591 DSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++HRD+K N+L+D N K+ DFG + T GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEWI 181
Query: 650 A-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708
+ V+S G+L+ ++V G +HD + + G
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD-----IPFEHDEEI---------------IRGQV 221
Query: 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+E C H+ C+ RP DRP +
Sbjct: 222 FFRQRVSSE---CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 52/290 (17%), Positives = 101/290 (34%), Gaps = 29/290 (10%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL 531
++ +G G FG VY+ L + G+ +A+K++ + E+ ++ +L H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 532 VKLLGCCIQADESM------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
V+L + E L+ +Y+P L + + R +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 586 LYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
Y+H I HRD+K N+LLD D K+ DFG A+ E + + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY--ICSRYYRA 190
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDH------------DHNLLGHA 692
++ DV+S G ++ E++ G+ + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 693 WILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSV 742
+ E + ++ P I + +++ P R
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-38
Identities = 55/299 (18%), Positives = 110/299 (36%), Gaps = 35/299 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQG--MEEFKNEVTLIARLQHR 529
+ K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 530 NLVKLLGCCIQADESM--------LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGI 581
N+V L+ C L++++ + + T + ++ + ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 582 ARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG--GDEIQTNTHKVVG 639
+ L+ R +I+HRD+KA+NVL+ D K++DFG+AR F + V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 640 TYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL--------G 690
T Y PE E + D++ G ++ E+ + + + H L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 691 HAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLL-------CVQHRPEDRPNMSSV 742
W E + L+ + P R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 47/215 (21%), Positives = 84/215 (39%), Gaps = 12/215 (5%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQH 528
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
L L D + EY L F + +R ++ I L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSA---L 118
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEY 648
+++RD+K N++LD D + KI+DFG+ + D GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 649 AAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
+ + D + GV++ E++ G+ + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 5e-37
Identities = 54/287 (18%), Positives = 106/287 (36%), Gaps = 25/287 (8%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHR 529
+ K+GEG +G V+K E + +A+KR+ E+ L+ L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 530 NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLH 589
N+V+L + L++E+ +F + + + + L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLG 115
Query: 590 QDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYA 649
++HRDLK N+L++ + K+++FG+AR F G ++ + +VV +
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 650 AEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709
L+S D++S G + E+ + + F D D L +L + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 710 ADSHPPTEVLRCIHVGLL--------------CVQHRPEDRPNMSSV 742
D P + + ++ P R +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 7e-36
Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 16/233 (6%)
Query: 455 KEDMELWEFDFASIAKATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG---SG 510
++ ++ WE + A+ D F LG G FG V E G A+K L K
Sbjct: 24 EDFLKKWETPSQNTAQ-LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 511 QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLD 570
+ +E NE ++ + LVKL ++ EY+ + + R
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FS 139
Query: 571 WQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630
I YLH + +I+RDLK N+L+D +++DFG A+
Sbjct: 140 EPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----- 191
Query: 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPD 683
+ T + GT ++PE ++ D ++ GVL+ E+ +G + P
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 5e-34
Identities = 63/331 (19%), Positives = 122/331 (36%), Gaps = 41/331 (12%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G +G V G ++A+K+L + S + E+ L+ ++H N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 537 CCIQADESMLIYE-YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMR 595
+ + Y+ + + + L + +V + +G+ Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 596 IIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGL-F 654
IIHRDLK N+ ++ D KI DFG+AR + + V T Y +PE + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWYRAPEVILNWMRY 196
Query: 655 SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAW---------ILWKEKRAMELA 705
+ D++S G ++ E+++GK ++ S + L ++ +
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256
Query: 706 GDTLADSHPPTEVLRCIHVGLL-----CVQHRPEDRPNMSSVVLMLSSDSLLPEPNRPGF 760
G + +L + + E R ++ L P +
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV---------TAGEALAHP----Y 303
Query: 761 FTERSLPEAEFS-PSYPQSSTTNEITITELQ 790
F E E Y S + T+ E +
Sbjct: 304 FESLHDTEDEPQVQKYDDSFDDVDRTLDEWK 334
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 127 bits (319), Expect = 9e-33
Identities = 53/312 (16%), Positives = 119/312 (38%), Gaps = 23/312 (7%)
Query: 453 HMKEDMELWEFDFASIA-KATDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSG 510
+ E W+++ + D++ KLG G + V++ + +++ VK L
Sbjct: 14 NTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK- 72
Query: 511 QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM--LIYEYMPNKSLDFFIFDQARAT 567
++ K E+ ++ L+ N++ L L++E++ N
Sbjct: 73 --KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------Q 124
Query: 568 FLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND-MNPKISDFGMARIFG 626
L + I + + Y H M I+HRD+K NV++D++ ++ D+G+A +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 627 GDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHD 685
+ V + + PE + ++ D++S G ++ ++ K+ + H ++D
Sbjct: 182 PGQEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 686 HNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745
L+ A +L E + + ++L E++ +S L
Sbjct: 239 Q-LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297
Query: 746 LSSDSLLPEPNR 757
L +
Sbjct: 298 FLDKLLRYDHQS 309
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-32
Identities = 66/338 (19%), Positives = 128/338 (37%), Gaps = 39/338 (11%)
Query: 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQH 528
+ + + + +G G +G V + G +AVK+LS+ S + E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 529 RNLVKLLGCCIQADESMLI-YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILY 587
N++ LL A Y+ + + + + L ++ I RG+ Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 588 LHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPE 647
+H IIHRDLK SN+ ++ D KI DFG+AR T V +
Sbjct: 137 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEI 189
Query: 648 YAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-----LWKEKRAM 702
++ D++S G ++ E+++G+ + + L+ L K+ +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 703 ELAGDTLADSHPPTEVLRCIHVG-------LL--CVQHRPEDRPNMSSVVLMLSSDSLLP 753
+ + P + +G LL + + R ++ L
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI---------TAAQALA 300
Query: 754 EPNRPGFFTERSLPEAE-FSPSYPQSSTTNEITITELQ 790
+F + P+ E + Y QS + ++ I E +
Sbjct: 301 HA----YFAQYHDPDDEPVADPYDQSFESRDLLIDEWK 334
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 58/276 (21%), Positives = 112/276 (40%), Gaps = 31/276 (11%)
Query: 473 DNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS----GQGMEEFKNEVTLIA 524
+NF LG G +G V+ + G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 525 RLQHR-NLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIAR 583
++ LV L + LI +Y+ L + + R T + Q +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137
Query: 584 GILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGY 643
+L L ++ II+RD+K N+LLD++ + ++DFG+++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEY 196
Query: 644 MSPEYAAEGL--FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701
M+P+ G D +S GVL+ E+++G + + + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP 737
E+ S ++++ + P+ R
Sbjct: 257 QEM-------SALAKDLIQR------LLMKDPKKRL 279
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 3e-31
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLG 536
+G G G V V + +A+K+LS+ + + E+ L+ + H+N++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 537 CCI------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ 590
+ + L+ E M + D ++ +++ + GI +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHS 137
Query: 591 DSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAA 650
IIHRDLK SN+++ +D KI DFG+AR G + T V T Y +PE
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP---YVVTRYYRAPEVIL 191
Query: 651 EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHN 687
+ D++S G ++ E+V K + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (289), Expect = 1e-28
Identities = 53/338 (15%), Positives = 111/338 (32%), Gaps = 36/338 (10%)
Query: 480 KLGEGGFGPVYKGT-LVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCC 538
KLG G F V+ +V +A+K + E ++E+ L+ R+ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 539 I-------------QADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGI 585
+ ++ + + + + I + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 586 LYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYM 644
Y+H+ R IIH D+K NVL++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 645 SPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWR----FSHPDHDHNLLGHAWILWKEKR 700
SPE + +D++S L+ E+++G + S+ D ++ +L +
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
Query: 701 AMELAGDTLADSHPPTEVLRCIHVGLL-----CVQHRPEDRPNMSSVVLMLSSDSLLPEP 755
+ G +LR I + + + + + + S L +P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316
Query: 756 N-RPG--------FFTERSLPEAEFSPSYPQSSTTNEI 784
R + + E P + ++I
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 96.4 bits (239), Expect = 2e-23
Identities = 32/155 (20%), Positives = 48/155 (30%), Gaps = 20/155 (12%)
Query: 479 NKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS----------GQGMEEFKNEVTLIARLQH 528
+GEG V+ + E VK G G F AR +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 529 RNLVKLLGCCIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYL 588
R L KL G + +Y + N L I + ++ I +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 589 HQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623
+ I+H DL NVL+ + I DF +
Sbjct: 120 YH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 79.6 bits (196), Expect = 1e-18
Identities = 23/115 (20%), Positives = 44/115 (38%), Gaps = 11/115 (9%)
Query: 27 IRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNV 86
+ +GE L + ++ + L ++ T W +N +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYD----HSTSVWASNTGILGKKGCKA-VL 57
Query: 87 TSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140
S G V+ D R W+S++ N V+ L + GN+V+ Y S +W + +
Sbjct: 58 QSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVI----YGSDIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 69.7 bits (170), Expect = 4e-15
Identities = 23/123 (18%), Positives = 42/123 (34%), Gaps = 16/123 (13%)
Query: 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPL 77
++ + +++ GE L G+F L ++ W N
Sbjct: 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS 49
Query: 78 TDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137
L T +V+ + ++ W+SNT N V L N+V+ Y + W +
Sbjct: 50 RS-CFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVI----YGTDRWAT 104
Query: 138 FDH 140
H
Sbjct: 105 GTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 68.4 bits (167), Expect = 2e-14
Identities = 16/92 (17%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I Y + L L++ + ++L RD WS+NT+
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAV 71
Query: 117 LMDSGNLVLTDGNYNSLLWQSFD--HPCDTLL 146
L +G + + N +W S + +
Sbjct: 72 LQPNGRMDVLTNQ-NIAVWTSGNSRSAGRYVF 102
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 67.9 bits (165), Expect = 2e-14
Identities = 20/125 (16%), Positives = 44/125 (35%), Gaps = 14/125 (11%)
Query: 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLT 78
D + + G +L G + + + Y W + +
Sbjct: 2 DRLNSGHQLDTGGSLA--EGGYLFIIQNDCNL------VLY---DNNRAVWASGTNGKAS 50
Query: 79 DQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSF 138
L + + G +++ R W+SNT+ N + L N+V+ D + N+ +W +
Sbjct: 51 GCV--LKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATH 107
Query: 139 DHPCD 143
+ +
Sbjct: 108 TNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 58.9 bits (142), Expect = 3e-11
Identities = 20/130 (15%), Positives = 41/130 (31%), Gaps = 20/130 (15%)
Query: 11 ILGASAANDNITPSQSIRDGETL--VSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVA 68
I+ + +DN Q + E+L + + + L ++
Sbjct: 3 IIFSKQPDDN--HPQILHATESLEILFGTHVYRFIMQTDCN-----LVLY----DNNNPI 51
Query: 69 WVANRETPLTDQSGLLNVTSKG-IVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTD 127
W N + G +V++ + W S + + V+ L N+V+
Sbjct: 52 WATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI-- 107
Query: 128 GNYNSLLWQS 137
Y LW +
Sbjct: 108 --YGDALWAT 115
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.0 bits (127), Expect = 4e-09
Identities = 17/84 (20%), Positives = 28/84 (33%), Gaps = 2/84 (2%)
Query: 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQ 116
I + + + L S + S ++L D W+SNT+
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGA-TGCRAV 61
Query: 117 LMDSGNLVLTDGNYNSLLWQSFDH 140
L G LV+ N++ W S
Sbjct: 62 LQSDGLLVILTAQ-NTIRWSSGTK 84
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 792 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.81 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.78 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.78 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.68 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.51 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.49 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.22 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.92 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.8 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.78 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.42 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.32 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.34 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.18 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.29 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 90.19 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.02 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.99 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=413.41 Aligned_cols=255 Identities=27% Similarity=0.444 Sum_probs=201.0
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|+..++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788889999999999999999888999999997643 445789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence 99999998653 356899999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+. .. +.......
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~----~~---------i~~~~~~~ 222 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVV----ED---------ISTGFRLY 222 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHH----HH---------HHHTCCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHH----HH---------HHhcCCCC
Confidence 223357899999999999999999999999999999999965544321111 1111 11 11111222
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.|...+.++.+++.+||+.+|++||||+||+++|+++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 3344456788999999999999999999999999764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=414.05 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=203.7
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|+..++||+|+||+||+|+++ ..||||+++.. .....+.|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367888999999999999999874 36999998654 44567889999999999999999999998754 56899999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++... ...+++.+++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999643 345899999999999999999999987 9999999999999999999999999998775444
Q ss_pred ccccccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.........||+.|||||++.+ ..|+.++|||||||+||||+||+.||....+... .......+ ...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~------~~~~~~~~----~~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRG----YLS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHHT----SCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC----CCC
Confidence 3334455789999999999864 4589999999999999999999999975432211 11111111 111
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+. ....+...+..+.+|+.+||+.+|++||||+||+++|+.+
T Consensus 229 p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Cc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 1122334456788999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.2e-49 Score=415.51 Aligned_cols=257 Identities=27% Similarity=0.415 Sum_probs=214.5
Q ss_pred hcccccccccCcCCcccEEeeeccC-CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE-GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|+..++||+|+||+||+|++.. ++.||||+++... ...++|.+|+.+|++++|||||+++++|.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4678889999999999999998764 8899999997654 4467899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 9999999998654 3456899999999999999999999987 99999999999999999999999999997654432
Q ss_pred cccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 631 QTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
. ......|++.|+|||++.+..++.++|||||||++|||++|+.|+...... . .+.+.+.....
T Consensus 171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~-------------~~~~~i~~~~~ 234 (287)
T d1opja_ 171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--S-------------QVYELLEKDYR 234 (287)
T ss_dssp E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--H-------------HHHHHHHTTCC
T ss_pred e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--H-------------HHHHHHhcCCC
Confidence 2 223356889999999999999999999999999999999987776422211 0 01112222223
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
...+...+.++.+|+..||+.||++||||+||++.|+..
T Consensus 235 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 235 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 344455667789999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=410.25 Aligned_cols=255 Identities=30% Similarity=0.481 Sum_probs=208.9
Q ss_pred hcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
.++|++.++||+|+||.||+|++++++.||||+++... ...++|.+|+.++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 35788899999999999999999888999999997643 445789999999999999999999998754 5679999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.... ...+++.++++|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999875432 335899999999999999999999987 999999999999999999999999999987644322
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......||+.|+|||++.++.++.++|||||||++|||+||+.|+...... ..+. ..+......
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~-------------~~i~~~~~~ 229 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVI-------------QNLERGYRM 229 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH-------------HHHHTTCCC
T ss_pred -cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHH-------------HHHHhcCCC
Confidence 233467899999999999999999999999999999999976654322111 0010 111111222
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..+...+.++.+|+.+||+.+|++||||+||+++|+.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 3344455678899999999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=409.05 Aligned_cols=253 Identities=24% Similarity=0.308 Sum_probs=205.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.++||+|+||+||+|++. +++.||||++.... .+..+.+.+|+++|++++|||||++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 468999999999999999999875 58999999997653 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+++|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 84 y~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999999843 346899999999999999999999988 9999999999999999999999999999875444
Q ss_pred ccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.........||+.|||||++.+..+ +.++|||||||+||||++|+.||........ .. .. .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~----~~--------~~~~~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY----SD--------WKEKK 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH----HH--------HHTTC
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH----HH--------HhcCC
Confidence 3334455789999999999988776 6789999999999999999999975432211 00 00 01111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...........++.+|+.+||+.||++|||++||++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111112233466788999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-49 Score=414.39 Aligned_cols=256 Identities=26% Similarity=0.424 Sum_probs=200.3
Q ss_pred cccccccccCcCCcccEEeeeccC-C---cEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-G---QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~---~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|+..++||+|+||+||+|+++. + ..||||++... .....++|.+|+++|++++|||||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999998753 2 35899998765 444567899999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||||++|+|.+++... ...++|.+++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 9999999999988643 346899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCccc---cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 628 DEIQT---NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 628 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |+.||...... .+ ..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~-------------~~ 244 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DV-------------IN 244 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH-------------HH
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HH-------------HH
Confidence 33221 1222457899999999999999999999999999999998 89998643221 11 11
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+........+...+..+.+|+.+||+.+|++||||.||++.|+..
T Consensus 245 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 245 AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111222334555667789999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-48 Score=401.14 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=213.8
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|+..++||+|+||+||+|++++++.||||++++.. ...++|.+|+.++++++|||||+++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788899999999999999999888899999997653 345789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|+|..++... ...+++..+.+++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+......
T Consensus 83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 99999997554 346889999999999999999999987 999999999999999999999999999876544322
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +. ..+......
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~-------------~~i~~~~~~ 220 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA-------------EHIAQGLRL 220 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH-------------HHHHTTCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH-------------HHHHhCCCC
Confidence 2334678999999999999999999999999999999998 898986443211 11 111111222
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..|...+..+.+|+.+||+.+|++|||++||++.|.+
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 3344555678899999999999999999999999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=405.77 Aligned_cols=249 Identities=23% Similarity=0.417 Sum_probs=208.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
++|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 57999999999999999999864 58999999997665556678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.+ ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 99999988754 35899999999999999999999988 99999999999999999999999999998754332
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... ......
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~~~~--------~~~~~~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---A---LYLIAT--------NGTPEL 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHH--------HCSCCC
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---H---HHHHHh--------CCCCCC
Confidence 2334679999999999999999999999999999999999999996432210 0 000000 011111
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..+......+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233445667889999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=415.16 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=210.0
Q ss_pred hcccccccccCcCCcccEEeeeccC------CcEEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE------GQEIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~------~~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 543 (792)
.++|++.++||+|+||+||+|++.. ...||+|++... .......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3678999999999999999998643 236999998654 334556899999999998 89999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhccc--------------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCC
Q 003832 544 SMLIYEYMPNKSLDFFIFDQAR--------------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKA 603 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp 603 (792)
.++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975432 245899999999999999999999987 99999999
Q ss_pred CcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCC
Q 003832 604 SNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHP 682 (792)
Q Consensus 604 ~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~ 682 (792)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333345678999999999999999999999999999999998 8999975433
Q ss_pred CCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhc
Q 003832 683 DHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLS 747 (792)
Q Consensus 683 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~ 747 (792)
... + ..++........|...+.++.+|+.+||+.+|++||||+||+++|.
T Consensus 273 ~~~--~-------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--H-------------HHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 1 1111122223344455677899999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-48 Score=403.93 Aligned_cols=254 Identities=28% Similarity=0.438 Sum_probs=208.1
Q ss_pred ccccccc-ccCcCCcccEEeeecc---CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYN-KLGEGGFGPVYKGTLV---EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~-~lg~G~fg~Vy~g~~~---~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|...+ +||+|+||+||+|.++ ++..||||+++... ....++|.+|+++|++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 4999999999999764 35579999997653 3456789999999999999999999999864 568999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++... ...+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 9999999999998543 346899999999999999999999987 99999999999999999999999999998764
Q ss_pred CCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 628 DEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 628 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... .+. ...
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~----~~i--------- 225 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVM----AFI--------- 225 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHH----HHH---------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHH----HHH---------
Confidence 4322 22334578999999999999999999999999999999998 89999754321 111 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
........|...+.++.+|+.+||+.+|++||||.+|++.|+.
T Consensus 226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1112223455566778999999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=403.91 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=206.4
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecC
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMP 552 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~ 552 (792)
++|++.++||+|+||.||+|++++++.||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 5799999999999999999999888899999997543 44578999999999999999999999985 456899999999
Q ss_pred CCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCccc
Q 003832 553 NKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQT 632 (792)
Q Consensus 553 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~ 632 (792)
+|+|..++.... ...++|.+++.++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 999998886543 345899999999999999999999988 999999999999999999999999999876543322
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccCC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLADS 712 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 712 (792)
......||+.|+|||++..+.++.++|||||||++|||++|+.|+...... ..+. ..+......+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~-------------~~i~~~~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVL-------------DQVERGYRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHH-------------HHHHTTCCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHH-------------HHHHhcCCCC
Confidence 223367899999999999999999999999999999999977766432221 1111 1111112223
Q ss_pred CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 713 HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 713 ~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
.+...++++.+++.+||+.+|++||+|++|+++|+..-.
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 445556778999999999999999999999999988643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=406.99 Aligned_cols=259 Identities=27% Similarity=0.437 Sum_probs=205.0
Q ss_pred cccccccccCcCCcccEEeeeccCC-----cEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEG-----QEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~-----~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
+.|+..++||+|+||.||+|+++.. ..||||+++... ....++|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999987542 369999997653 3445679999999999999999999999999999999
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+.++++.+++... ...+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999887553 346899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
..... .......||+.|||||++.+..++.++|||||||++|||++|+.|+...... .. +...+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~-------------~~~~i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE-------------VMKAI 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH-------------HHHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH-------------HHHHH
Confidence 43222 2223456899999999999999999999999999999999977665432211 00 11122
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDSL 751 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~~ 751 (792)
........+...+..+.+|+.+||+.+|++||||.||+++|+....
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2223334455566789999999999999999999999999986543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=404.26 Aligned_cols=255 Identities=25% Similarity=0.352 Sum_probs=196.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEe--CCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ--ADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~--~~~~~l 546 (792)
.++|++.+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 368999999999999999999865 58899999987653 3445678999999999999999999999975 355789
Q ss_pred EEeecCCCChhHHHhhcc-cCccCChhhHHHHHHHHHHHHHHHhhcC--CCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 547 IYEYMPNKSLDFFIFDQA-RATFLDWQKRIHIVGGIARGILYLHQDS--RMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
||||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986532 3457999999999999999999999865 2359999999999999999999999999999
Q ss_pred ccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
.+..... ......||+.|||||++.+..++.++|||||||++|||+||+.||...... .+. ......
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~----~~i~~~---- 229 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELA----GKIREG---- 229 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHHT----
T ss_pred ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHH----HHHHcC----
Confidence 8754322 223468999999999999999999999999999999999999999643221 111 111111
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 230 -----~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 -----KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111233344567889999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=401.33 Aligned_cols=245 Identities=26% Similarity=0.374 Sum_probs=206.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.+.||+|+||+||+|+.+ +++.||+|++.+. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 57999999999999999999875 4889999998643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... ..+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999653 35899999999999999999999988 999999999999999999999999999876433
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. ..... .
T Consensus 160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~--------~- 219 (263)
T d2j4za1 160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETY----KRISR--------V- 219 (263)
T ss_dssp C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HHHHT--------T-
T ss_pred c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHH----HHHHc--------C-
Confidence 2 23467999999999999999999999999999999999999999643221 110 00000 0
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
....|...+.++.+|+.+||+.||++|||++||++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11233344567889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=402.75 Aligned_cols=247 Identities=29% Similarity=0.415 Sum_probs=200.2
Q ss_pred cccCcCCcccEEeeeccC---CcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeecCC
Q 003832 479 NKLGEGGFGPVYKGTLVE---GQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYMPN 553 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~---~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~~~ 553 (792)
++||+|+||+||+|.+.+ ++.||||+++.. .....++|.+|+.+|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 468999999654 33445789999999999999999999999864 567899999999
Q ss_pred CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc-c
Q 003832 554 KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ-T 632 (792)
Q Consensus 554 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~-~ 632 (792)
|+|.+++... ..+++..++.++.||++||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 9999998653 45899999999999999999999987 999999999999999999999999999877543322 2
Q ss_pred cccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccccC
Q 003832 633 NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLAD 711 (792)
Q Consensus 633 ~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 711 (792)
......||+.|||||.+.+..++.++|||||||++|||+| |+.||...... .+ ...+......
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~-------------~~~i~~~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EV-------------TAMLEKGERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HH-------------HHHHHTTCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HH-------------HHHHHcCCCC
Confidence 2334678999999999999999999999999999999998 89999743221 11 1111112223
Q ss_pred CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 712 SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 712 ~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
..|...+.++.+|+.+||+.+|++||||+||+++|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 3445556778899999999999999999999998863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=403.37 Aligned_cols=251 Identities=24% Similarity=0.357 Sum_probs=208.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+.|++.++||+|+||+||+|+.. +++.||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46888999999999999999875 58899999998777777788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.+. ...+++.++..++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 999999988653 346899999999999999999999998 9999999999999999999999999997653211
Q ss_pred ccccccccccCcccccccc-----CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 632 TNTHKVVGTYGYMSPEYAA-----EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~-----~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
.......||+.|+|||++. ...|+.++|||||||++|||++|+.||....+.+ ... .....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~~----~i~~~------- 230 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VLL----KIAKS------- 230 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHH----HHHHS-------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HHH----HHHcC-------
Confidence 1223468999999999983 5568999999999999999999999997543321 110 00000
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 231 EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111223445667889999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=405.23 Aligned_cols=264 Identities=26% Similarity=0.424 Sum_probs=214.3
Q ss_pred HHHhhcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCCc-hhHHHHHHHHHHHHhcccccceeeeeeEEe
Q 003832 468 IAKATDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGSG-QGMEEFKNEVTLIARLQHRNLVKLLGCCIQ 540 (792)
Q Consensus 468 i~~~~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~ 540 (792)
++...++|++.++||+|+||+||+|+.+ +++.||||+++.... +..++|.+|+++|++++||||++++++|..
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 3345678999999999999999999853 357899999976543 345679999999999999999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhcc---------------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQA---------------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHR 599 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 599 (792)
....++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ |+||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr 164 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 164 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence 999999999999999999996432 1234899999999999999999999988 9999
Q ss_pred CCCCCcEEecCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCC-CCCC
Q 003832 600 DLKASNVLLDNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWR 678 (792)
Q Consensus 600 Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~-~p~~ 678 (792)
||||+||||+.++.+||+|||+++.+.............|++.|+|||.+.+..++.++|||||||++|||++|. +||.
T Consensus 165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence 999999999999999999999998775444333444567899999999999999999999999999999999996 4565
Q ss_pred CCCCCCccchhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 679 FSHPDHDHNLLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 679 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
..... .+. ..+.+ ......+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 245 ~~~~~---e~~----~~v~~---------~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 245 GMAHE---EVI----YYVRD---------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TSCHH---HHH----HHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCHH---HHH----HHHHc---------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 33221 111 11111 1122334455667899999999999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=408.86 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=206.1
Q ss_pred hhcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
..++|++.++||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+|++++|||||+++++|.+.++.++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3578999999999999999999875 58899999997653 344578999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+. + |+||||||+||||++++++||+|||+|+.+..
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 999999999999654 3589999999999999999999974 6 99999999999999999999999999987632
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHH-----HHH----H--
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHA-----WIL----W-- 696 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~-----~~~----~-- 696 (792)
. ......||+.|+|||++.+..|+.++||||+||++|||++|+.||............... ... .
T Consensus 158 ~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp H----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred C----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 2 223468999999999999999999999999999999999999999754432110000000 000 0
Q ss_pred ------------hhhhhhhhccccc---cCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 697 ------------KEKRAMELAGDTL---ADSHP-PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 697 ------------~~~~~~~~~~~~~---~~~~~-~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......+..+... ....+ .....++.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000 00011 1123568889999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=401.26 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=203.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999874 5889999998643 2334567999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988653 35899999999999999999999998 999999999999999999999999999987654
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||...... .+. ... ....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i--------~~~~ 226 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIF----QKI--------IKLE 226 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHH--------HTTC
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHH----HHH--------HcCC
Confidence 4333444568999999999999999999999999999999999999999743211 110 000 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVV 743 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl 743 (792)
...+.....++.+|+.+||+.||++|||++|++
T Consensus 227 --~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 --YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp --CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 123334456788999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=390.83 Aligned_cols=246 Identities=22% Similarity=0.360 Sum_probs=195.3
Q ss_pred ccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC----CcceEEE
Q 003832 476 ASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA----DESMLIY 548 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~----~~~~lV~ 548 (792)
+..++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++... ...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 45568999999999999875 4789999998654 334566899999999999999999999998753 3478999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec-CCCCceEeeeccccccCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD-NDMNPKISDFGMARIFGG 627 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DFgla~~~~~ 627 (792)
||+++|+|.+++.+. ..+++..+..++.||++||.|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999653 35899999999999999999999875 4599999999999997 578999999999986543
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .....||+.|||||++.+ .++.++|||||||++|||++|+.||....... .+ ......+. .+
T Consensus 168 ~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~----~~~i~~~~-----~~ 231 (270)
T d1t4ha_ 168 SF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QI----YRRVTSGV-----KP 231 (270)
T ss_dssp TS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HH----HHHHTTTC-----CC
T ss_pred Cc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HH----HHHHHcCC-----CC
Confidence 22 234689999999999865 59999999999999999999999996332210 00 01111110 00
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
...+.....++.+|+.+||+.||++|||++|+++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 ---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0111223345789999999999999999999986
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-46 Score=398.02 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=194.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
.+.|++.++||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 466999999999999999999875 48899999997653 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec---CCCCceEeeeccccccC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFG 626 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgla~~~~ 626 (792)
|+++|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999964 346999999999999999999999988 99999999999995 57899999999998764
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAG 706 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 706 (792)
... ......||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. ...... .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~----~~i~~~------~ 225 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLF----EQILKA------E 225 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH----HHHHTT------C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHhcc------C
Confidence 332 123467999999999999999999999999999999999999999643211 110 000000 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCC
Q 003832 707 DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSL 751 (792)
Q Consensus 707 ~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~ 751 (792)
.......+...+.++.+|+.+||+.||++|||++|+++. +.+...
T Consensus 226 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 272 (307)
T d1a06a_ 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTA 272 (307)
T ss_dssp CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCC
T ss_pred CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCc
Confidence 111112233455678899999999999999999999984 555433
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-46 Score=397.92 Aligned_cols=245 Identities=26% Similarity=0.427 Sum_probs=201.0
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc---hhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---QGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
+.|+.+++||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45899999999999999999864 588999999976532 34467899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
|||++|+|..++.. ...+++.++..++.||+.||.|||+++ |+||||||+||||++++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 99999999776643 346899999999999999999999998 99999999999999999999999999986532
Q ss_pred CccccccccccccCccccccccC---CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAE---GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ... ...... .
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~----~~i~~~-----~ 230 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL----YHIAQN-----E 230 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHH----HHHHHS-----C
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHH----HHHHhC-----C
Confidence 233679999999999853 46899999999999999999999998643211 000 000000 0
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.+. ..+...++.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111 112233457889999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=399.73 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=205.2
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc----EEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ----EIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~----~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
++|+..++||+|+||+||+|++.. |+ +||+|+++.. ..+..++|.+|+.++++++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 468999999999999999998653 43 6899998654 445677899999999999999999999999864 5678
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
++||+.+|+|.+++... ...+++..+++++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 89999999999888653 456899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
............||+.|+|||.+.++.++.++|||||||+||||+| |+.||....... +. ..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~-------------~~i 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS-------------SIL 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH-------------HHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH-------------HHH
Confidence 5544444445678999999999999999999999999999999999 788886443221 11 111
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....+...+...+..+.+|+.+||+.+|++|||+.||++.|+..
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11222334555667789999999999999999999999988654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-46 Score=395.80 Aligned_cols=260 Identities=28% Similarity=0.405 Sum_probs=201.4
Q ss_pred hcccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhc-ccccceeeeeeEEeCC-
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQAD- 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~- 542 (792)
.++|++.++||+|+||.||+|+.. +++.||||+++... ....+.+..|...+.++ +|+|||.+++++.+.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999753 24689999997653 34456788888888887 6899999999987654
Q ss_pred cceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD 609 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~ 609 (792)
..++|||||++|+|.+++..... ...+++.+++.++.||++||.|||+++ |+||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 57999999999999999975432 345899999999999999999999988 99999999999999
Q ss_pred CCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCC-CCCCCCCCCCccch
Q 003832 610 NDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWRFSHPDHDHNL 688 (792)
Q Consensus 610 ~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~-~p~~~~~~~~~~~l 688 (792)
+++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. .||........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--- 245 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--- 245 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH---
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence 99999999999998776544444445578999999999999999999999999999999999975 56654332211
Q ss_pred hHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 689 LGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 689 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
......+ ......+...+.++.+++.+||+.+|++|||++||+++|+.+
T Consensus 246 ---~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 246 ---FCRRLKE---------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHhc---------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111 112233444556788999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-46 Score=400.84 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=209.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999874 5899999999877666678899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC--CCCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN--DMNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DFgla~~~~~~ 628 (792)
|++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999998543 345999999999999999999999998 999999999999964 678999999999887543
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...... ... ...... ...
T Consensus 180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~----~~i~~~------~~~ 243 (350)
T d1koaa2 180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETL----RNVKSC------DWN 243 (350)
T ss_dssp SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHHT------CCC
T ss_pred cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHHhC------CCC
Confidence 32 23367999999999999999999999999999999999999999643221 111 000000 001
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.........+.++.+|+.+||+.||++|||++|++++
T Consensus 244 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111122344578899999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=389.85 Aligned_cols=255 Identities=27% Similarity=0.420 Sum_probs=199.1
Q ss_pred cccccccccCcCCcccEEeeeccC--C--cEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE--G--QEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~--~--~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
++|+..++||+|+||.||+|++.. + ..||||++.+. ..+..++|.+|+.+|++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 578999999999999999998643 2 37899998754 33456789999999999999999999999965 4678
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
+||||+++|++.+++... .+.+++..++.++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999888653 346999999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcc-ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 626 GGDEIQ-TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 626 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
...... .......|+..|+|||.+.+..++.++|||||||++|||+| |+.||......+ .. ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~------------~~ 226 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL------------HK 226 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH------------HH
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HH------------HH
Confidence 544322 22334578899999999999999999999999999999998 899986432211 11 11
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+.......+.+...+..+.+|+.+||+.||++||||+||+++|++
T Consensus 227 i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 227 IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111222223344455678899999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-46 Score=385.47 Aligned_cols=249 Identities=26% Similarity=0.393 Sum_probs=200.0
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeC-CcceEEEeec
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYM 551 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 551 (792)
++|+..++||+|+||.||+|++ .|+.||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 5678889999999999999998 5789999999754 3457899999999999999999999999764 5689999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++.... ...++|..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999996542 335899999999999999999999987 999999999999999999999999999865432
Q ss_pred ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccccc
Q 003832 632 TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTLA 710 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 710 (792)
.....+|..|+|||++.++.++.++||||||+++|||+| |+.||...... .+. ..+....+
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~-------------~~i~~~~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVV-------------PRVEKGYK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHH-------------HHHTTTCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHH-------------HHHHcCCC
Confidence 223567899999999999999999999999999999998 67776543222 111 11112223
Q ss_pred CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 711 DSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 711 ~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.+.+...+.++.+|+.+||+.||++||||.||+++|+..
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 344555567788999999999999999999999999754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-46 Score=387.83 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=198.1
Q ss_pred hcccccccccCcCCcccEEeeeccC----CcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE----GQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESML 546 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~----~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~l 546 (792)
.++|++.+.||+|+||.||+|++.. +..||||+++... ....+.|.+|+.++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3678999999999999999998643 3568999987543 344578999999999999999999999985 567899
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccC
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFG 626 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~ 626 (792)
||||+++|+|.+++... ...+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999987543 346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccchhHHHHHHHhhhhhhhhc
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHNLLGHAWILWKEKRAMELA 705 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 705 (792)
.... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......+ +.. ...
T Consensus 160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~----~i~-------- 223 (273)
T d1mp8a_ 160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIE-------- 223 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHH--------
T ss_pred CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHH----HHH--------
Confidence 4332 22334678999999999999999999999999999999998 888887543321 111 011
Q ss_pred cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 706 GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 706 ~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
.....+.+...+..+.+|+.+||+.||++|||++||++.|+.
T Consensus 224 -~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 224 -NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 111223444556778999999999999999999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-45 Score=397.97 Aligned_cols=257 Identities=22% Similarity=0.284 Sum_probs=211.9
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 357999999999999999999864 5899999999877666667889999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec--CCCCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD--NDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DFgla~~~~~~ 628 (792)
+++|+|.+++... ...+++.++..++.||+.||.|||+.+ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 108 ~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 9999998877432 345899999999999999999999988 99999999999998 6789999999999987644
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. ..... ....
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~----~~i~~------~~~~ 246 (352)
T d1koba_ 183 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL----QNVKR------CDWE 246 (352)
T ss_dssp SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH----HHHHH------CCCC
T ss_pred Cc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HH----HHHHh------CCCC
Confidence 32 233578999999999999999999999999999999999999996432210 10 00000 1111
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
.........+.++.+|+.+||+.||++|||+.|++++ +.+.
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1122233445678899999999999999999999885 6543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=393.14 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=212.9
Q ss_pred hcccccccccCcCCcccEEeeec------cCCcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL------VEGQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~------~~~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~ 543 (792)
.++|+..++||+|+||.||+|++ ..++.||||+++.... ....+|.+|+.+++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 36788889999999999999975 2356899999976543 4456799999999999 69999999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcc---------------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 544 SMLIYEYMPNKSLDFFIFDQA---------------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
.++||||+++|+|.+++.... ....+++..+..++.||++||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997543 2335899999999999999999999998 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCC-CCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKN-WRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p-~~~~~~~~~~~ 687 (792)
+.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||+|++.| +........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~-- 256 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence 99999999999999987655444444557899999999999999999999999999999999995544 433222111
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
+..++........+...+..+.+|+.+||+.+|++||||+||+++|++
T Consensus 257 -------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp -------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111122222333444456778999999999999999999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=390.00 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=210.4
Q ss_pred hcccccccccCcCCcccEEeeeccC--------CcEEEEEEccCCCc-hhHHHHHHHHHHHHhc-ccccceeeeeeEEeC
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSG-QGMEEFKNEVTLIARL-QHRNLVKLLGCCIQA 541 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~ 541 (792)
.++|++.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578889999999999999997532 34799999987643 4457889999999888 799999999999999
Q ss_pred CcceEEEeecCCCChhHHHhhccc-------------CccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEe
Q 003832 542 DESMLIYEYMPNKSLDFFIFDQAR-------------ATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLL 608 (792)
Q Consensus 542 ~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll 608 (792)
...++||||+++|+|.+++..... ...+++.++++++.||+.||.|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975432 346899999999999999999999998 9999999999999
Q ss_pred cCCCCceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHh-CCCCCCCCCCCCccc
Q 003832 609 DNDMNPKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVS-GKKNWRFSHPDHDHN 687 (792)
Q Consensus 609 ~~~~~~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~ellt-G~~p~~~~~~~~~~~ 687 (792)
+.++.+||+|||+++...............|++.|+|||.+.++.|+.++|||||||++|||++ |+.||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 9999999999999998765554444555789999999999999999999999999999999998 68787633221
Q ss_pred hhHHHHHHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 688 LLGHAWILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 688 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.... .+........+...+.++.+|+.+||+.+|++|||+.||+++|+++
T Consensus 245 ---~~~~---------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 ---ELFK---------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHH---------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHH---------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 0111 1112222233444566789999999999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=390.39 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=213.1
Q ss_pred cccccccccCcCCcccEEeeecc------CCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcce
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV------EGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESM 545 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~------~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~ 545 (792)
++|+..++||+|+||+||+|.+. +++.||||+++... .+....|.+|+.++++++|||||+++++|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 67888899999999999999863 25789999997653 344567899999999999999999999999999999
Q ss_pred EEEeecCCCChhHHHhhcc-------cCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEee
Q 003832 546 LIYEYMPNKSLDFFIFDQA-------RATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
+||||+++|+|.+++.... ....+++..+.+++.|+++||.|||+++ |+||||||+||||++++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 9999999999999986532 2235789999999999999999999987 99999999999999999999999
Q ss_pred eccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCC-CCCCCCCCCCccchhHHHHHHHh
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGK-KNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
||+++.+.............||+.|+|||.+.+..++.++||||||+++|||+||+ .||...... ... ...
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~~~----~~i- 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---QVL----RFV- 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---HHH----HHH-
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---HHH----HHH-
Confidence 99998775544444445567899999999999999999999999999999999985 566432211 000 111
Q ss_pred hhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCCC
Q 003832 698 EKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSDS 750 (792)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~~ 750 (792)
. .......+...+..+.+++.+||+.+|++||||+||+++|++..
T Consensus 249 -------~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 -------M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp -------H-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -------H-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 11122334445567999999999999999999999999998763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=387.76 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=205.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC------chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS------GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.+.|++.++||+|+||+||+|+.. +|+.||||++.+.. ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 367999999999999999999874 58999999986532 22467899999999999999999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC----CceEeeec
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM----NPKISDFG 620 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DFg 620 (792)
+||||||++|+|.+++... +.+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999999654 35899999999999999999999998 99999999999998776 59999999
Q ss_pred cccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .. .......
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~----~~i~~~~ 232 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TL----ANVSAVN 232 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHTTC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH---HH----HHHHhcC
Confidence 998765432 2234578999999999999999999999999999999999999997432211 00 0000000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.......+...+..+.+|+.+||+.||++|||++||++.
T Consensus 233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000111234567899999999999999999999873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=388.27 Aligned_cols=255 Identities=28% Similarity=0.426 Sum_probs=205.3
Q ss_pred cccccccccCcCCcccEEeeeccC-Cc--EEEEEEccCC-CchhHHHHHHHHHHHHhc-ccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVE-GQ--EIAVKRLSKG-SGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~-~~--~vavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~~~~~~lV 547 (792)
++|+..++||+|+||.||+|++++ +. .||||+++.. .....++|.+|+++|.++ +|||||+++++|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999998865 33 5788888654 344566899999999999 799999999999999999999
Q ss_pred EeecCCCChhHHHhhc-------------ccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCc
Q 003832 548 YEYMPNKSLDFFIFDQ-------------ARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNP 614 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~ 614 (792)
|||+++|+|.+++... .....+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999653 23457999999999999999999999987 9999999999999999999
Q ss_pred eEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCC-CCCCCCCCCccchhHHHH
Q 003832 615 KISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKK-NWRFSHPDHDHNLLGHAW 693 (792)
Q Consensus 615 kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~-p~~~~~~~~~~~l~~~~~ 693 (792)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|.. ||...... .
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~------ 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E------ 234 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---H------
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---H------
Confidence 99999999865322 12234578999999999999999999999999999999999765 55432211 0
Q ss_pred HHHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 694 ILWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
+...+........+...+.++.+|+.+||+.+|++||||+||++.|+..
T Consensus 235 -------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 235 -------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp -------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1111111222344455667899999999999999999999999998775
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-45 Score=386.33 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=202.8
Q ss_pred ccccCcCCcccEEeeeccCC----cEEEEEEccCC-CchhHHHHHHHHHHHHhcccccceeeeeeEEeC-CcceEEEeec
Q 003832 478 YNKLGEGGFGPVYKGTLVEG----QEIAVKRLSKG-SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-DESMLIYEYM 551 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~~~----~~vavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-~~~~lV~e~~ 551 (792)
.++||+|+||+||+|++.++ ..||||++++. .....++|.+|+++|++++|||||+++|++.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 36899999999999987542 25899999754 445667899999999999999999999998765 5789999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
++|+|.+++... ...+++..+++++.|++.||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 999999998643 345778899999999999999999987 999999999999999999999999999987543322
Q ss_pred c--cccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccccc
Q 003832 632 T--NTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDTL 709 (792)
Q Consensus 632 ~--~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 709 (792)
. ......||+.|+|||.+....++.++||||||+++|||+||+.||....... .+... ...+ .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g---------~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQG---------R 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTT---------C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcC---------C
Confidence 2 2234578999999999999999999999999999999999888876432211 11110 1111 1
Q ss_pred cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 710 ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 710 ~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
....|...+..+.+|+.+||+.+|++||+|.||+++|+++
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1223334456788999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-45 Score=389.42 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=207.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV 547 (792)
.++|++++.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.+|++++|||||++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367999999999999999999874 5899999999754 233467789999999999999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 9999999999998654 35888999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...... .+. ..... .
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~----~~i~~--------~ 220 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLF----ELILM--------E 220 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHH--------C
T ss_pred CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHH----HHHhc--------C
Confidence 322 233478999999999999999999999999999999999999999754321 111 00000 0
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVLM 745 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~~ 745 (792)
....|...+.++.+|+.+||+.||++||+ ++||+++
T Consensus 221 --~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11233445567889999999999999995 8888763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-44 Score=385.99 Aligned_cols=245 Identities=23% Similarity=0.320 Sum_probs=205.3
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|++.++||+|+||+||+|+.+ +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 67999999999999999999874 5899999999653 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999888653 34788888999999999999999988 999999999999999999999999999876432
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. .. +...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~----~~--------i~~~- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTY----EK--------ILNA- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHH----HH--------HHHC-
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHH----HH--------HHcC-
Confidence 23468999999999999999999999999999999999999999743221 000 00 0001
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDRP-----NMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-----s~~evl~~ 745 (792)
....+...+.++.+++.+||+.+|++|| |++|++++
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1123344456788999999999999996 89999874
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-45 Score=386.05 Aligned_cols=267 Identities=20% Similarity=0.233 Sum_probs=199.5
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC----cceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~lV~ 548 (792)
++|...++||+|+||.||+|++ +|+.||||+++... ........|+..+.+++|||||+++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 5677788999999999999997 68999999996432 11122334555666789999999999998765 468999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhc-----CCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQD-----SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
|||++|+|.+++.+. .++|..+++++.|++.||+|||+. ...+|+||||||+||||++++.+||+|||+++
T Consensus 81 Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999643 489999999999999999999974 12459999999999999999999999999998
Q ss_pred ccCCCCc--cccccccccccCccccccccCC------CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchh----HH
Q 003832 624 IFGGDEI--QTNTHKVVGTYGYMSPEYAAEG------LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLL----GH 691 (792)
Q Consensus 624 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~------~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~----~~ 691 (792)
....... ........||+.|+|||++.+. .++.++|||||||+||||+||..|+............ ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 8754322 2233457899999999998654 3678999999999999999999887543322110000 00
Q ss_pred HHHHHhhhhhhhhccccccCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 692 AWILWKEKRAMELAGDTLADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
..... .....+...+... +.+.+..+.+|+.+||+.||++||||.||+++|+++
T Consensus 237 ~~~~~----~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 237 SVEEM----RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHH----HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHH----HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000 1112222222222 224566789999999999999999999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-44 Score=385.98 Aligned_cols=244 Identities=22% Similarity=0.262 Sum_probs=205.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIY 548 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~ 548 (792)
++|+++++||+|+||.||+|+++ +|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 67999999999999999999875 5899999998643 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCC
Q 003832 549 EYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGD 628 (792)
Q Consensus 549 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~ 628 (792)
||+.+|+|..++... +.+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998654 35899999999999999999999998 999999999999999999999999999876532
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... .+. .... ...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~----~~i~--------~~~ 254 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIY----EKIV--------SGK 254 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHH--------HCC
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHH----HHHh--------cCC
Confidence 23467999999999999999999999999999999999999999643211 111 0000 011
Q ss_pred ccCCCCHHHHHHHHHHHHHhccCCCCCC-----CCHHHHHH
Q 003832 709 LADSHPPTEVLRCIHVGLLCVQHRPEDR-----PNMSSVVL 744 (792)
Q Consensus 709 ~~~~~~~~~~~~l~~li~~Cl~~~P~~R-----Ps~~evl~ 744 (792)
...+.....++.+++.+||+.||++| |+++|+++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12233445678899999999999999 48999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-44 Score=374.07 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=205.4
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc---------hhHHHHHHHHHHHHhcc-cccceeeeeeEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG---------QGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQ 540 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~ 540 (792)
.++|+..+.||+|+||+||+++.. +++.||||++.+... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999874 588999999876421 12346889999999997 9999999999999
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
.+..+|||||+++|+|.+++..+ ..+++.++..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999653 35899999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCccccccccccccCcccccccc------CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH
Q 003832 621 MARIFGGDEIQTNTHKVVGTYGYMSPEYAA------EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI 694 (792)
Q Consensus 621 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 694 (792)
+++.+.... ......||+.|+|||++. ...++.++||||+||+||||++|+.||....... ...
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~ 225 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLR 225 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHH
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHH
Confidence 999875432 223467999999999985 3457889999999999999999999997543211 001
Q ss_pred HHhhhhhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 695 LWKEKRAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 695 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
....+. ...........++++.+++.+||+.+|++|||++||++.
T Consensus 226 ~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 226 MIMSGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111110 011122233455678899999999999999999998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-44 Score=376.80 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=200.2
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHHHHHHHHhcccccceeeeeeEEeCCc----
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADE---- 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~---- 543 (792)
.++|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.|.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999864 58999999997653 3345679999999999999999999999987654
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+|||||+++++|..++... +.+++.+++.++.||+.||.|||+.+ |+||||||+||||+.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999888554 35899999999999999999999988 9999999999999999999999999987
Q ss_pred ccCCCC-ccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 624 IFGGDE-IQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 624 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||....+. ...........
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~-- 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP-- 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC--
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCC--
Confidence 654322 222334468999999999999999999999999999999999999999643221 11111111110
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHhcC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRP-NMSSVVLMLSS 748 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RP-s~~evl~~L~~ 748 (792)
..........+..+.+++.+||+.||++|| |++++++.|..
T Consensus 232 -----~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 -----IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -----CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -----CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 000111223445688999999999999999 89999887753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-43 Score=385.25 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=200.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC---chhHHHHHH---HHHHHHhcccccceeeeeeEEeCCcc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS---GQGMEEFKN---EVTLIARLQHRNLVKLLGCCIQADES 544 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~---~~~~~~~~~---Ei~~l~~l~H~niv~l~g~~~~~~~~ 544 (792)
.++|++.++||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999875 58999999986431 122233444 46677777899999999999999999
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 9999999999999999654 35789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh
Q 003832 625 FGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME 703 (792)
Q Consensus 625 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 703 (792)
+.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..........+ ..
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------------~~ 219 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DR 219 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-------------HH
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HH
Confidence 65432 234679999999999865 5689999999999999999999999975443321110 00
Q ss_pred hccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003832 704 LAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVL 744 (792)
Q Consensus 704 ~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~ 744 (792)
.. .......+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 220 ~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MT-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HS-SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hc-ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 01111223344567889999999999999999 688876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-44 Score=377.32 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=194.1
Q ss_pred ccccCcCCcccEEeeecc-CCcEEEEEEccCCCch-----hHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEeec
Q 003832 478 YNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQ-----GMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEYM 551 (792)
Q Consensus 478 ~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~~ 551 (792)
+++||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+.++.+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999875 4899999999654321 2346889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCcc
Q 003832 552 PNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEIQ 631 (792)
Q Consensus 552 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~~ 631 (792)
.++++..+.. ....+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 9987765552 3456889999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhh------h
Q 003832 632 TNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAME------L 704 (792)
Q Consensus 632 ~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------~ 704 (792)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. +.............. .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhcc
Confidence 2233579999999998865 4689999999999999999999999975432111 100000000000000 0
Q ss_pred cc---ccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 705 AG---DTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 705 ~~---~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. .......+ .....++.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 00 00000111 1224568899999999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-43 Score=380.06 Aligned_cols=259 Identities=19% Similarity=0.224 Sum_probs=202.3
Q ss_pred hccccccc-ccCcCCcccEEeeec-cCCcEEEEEEccCCCchhHHHHHHHHHHHHhc-ccccceeeeeeEEe----CCcc
Q 003832 472 TDNFASYN-KLGEGGFGPVYKGTL-VEGQEIAVKRLSKGSGQGMEEFKNEVTLIARL-QHRNLVKLLGCCIQ----ADES 544 (792)
Q Consensus 472 ~~~~~~~~-~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~g~~~~----~~~~ 544 (792)
.++|.+.+ .||+|+||+||+|+. .+++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788875 599999999999986 4589999999964 34677899987665 89999999999876 3568
Q ss_pred eEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC---CCCceEeeecc
Q 003832 545 MLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN---DMNPKISDFGM 621 (792)
Q Consensus 545 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DFgl 621 (792)
++|||||++|+|.+++.... ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++ .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 99999999999999996532 346899999999999999999999998 999999999999985 56799999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
++....... .....||+.|||||++.+..|+.++|||||||+||||+||+.||...........+ .
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~-----------~ 226 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-----------K 226 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH-----------H
Confidence 987654332 23467999999999999999999999999999999999999999754332211000 0
Q ss_pred hhhccccccC--CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCCCCC
Q 003832 702 MELAGDTLAD--SHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDSLLP 753 (792)
Q Consensus 702 ~~~~~~~~~~--~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~~~~ 753 (792)
.......... ......+.++.+|+.+||+.||++|||+.|++++ +.+....+
T Consensus 227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 0000011101 1112345678899999999999999999999984 44443333
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-44 Score=381.86 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=202.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCC---CchhHHHHHHHHHHHH-hcccccceeeeeeEEeCCcceEE
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG---SGQGMEEFKNEVTLIA-RLQHRNLVKLLGCCIQADESMLI 547 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~g~~~~~~~~~lV 547 (792)
++|++.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+.+..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999875 4889999999753 2234456677777665 68999999999999999999999
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGG 627 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~ 627 (792)
|||+++|+|.+++.... .+++.++..++.||+.||.|||+++ |+||||||+|||+++++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999996543 4788999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhccc
Q 003832 628 DEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGD 707 (792)
Q Consensus 628 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 707 (792)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..... ..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~----~~i~~------~~- 219 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELF----HSIRM------DN- 219 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH----HHHHH------CC-
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHH----HHHHc------CC-
Confidence 32 2233468999999999999999999999999999999999999999743321 111 00000 01
Q ss_pred cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 003832 708 TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMS-SVVL 744 (792)
Q Consensus 708 ~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~-evl~ 744 (792)
...|...+.++.+|+.+||+.||++||++. |+++
T Consensus 220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 122334456788999999999999999996 7764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=376.56 Aligned_cols=248 Identities=18% Similarity=0.271 Sum_probs=204.3
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
.++|++.++||+|+||+||+|+.. +++.||||+++... .....+.+|+++|++++|||||++++++.+.+..+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 468999999999999999999875 58899999997654 3345688999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCC--CCceEeeeccccccCCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDND--MNPKISDFGMARIFGGD 628 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DFgla~~~~~~ 628 (792)
|++|+|.+++... ...+++.++..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 9999999998543 335899999999999999999999988 9999999999999854 57999999999876543
Q ss_pred CccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhhhhcccc
Q 003832 629 EIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAMELAGDT 708 (792)
Q Consensus 629 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 708 (792)
.. .....+|+.|+|||.+.+..++.++||||+||++|||++|+.||....... +. .. +....
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~----~~--------i~~~~ 219 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II----EN--------IMNAE 219 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HH--------HHHTC
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH----HH--------HHhCC
Confidence 22 233578999999999999999999999999999999999999997543211 10 00 00000
Q ss_pred ccCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 709 LADSHPP----TEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 709 ~~~~~~~----~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ..+. ..+.++.+|+..||+.||++|||+.|++++
T Consensus 220 ~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 220 Y--TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp C--CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1111 224567899999999999999999999983
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=372.93 Aligned_cols=266 Identities=22% Similarity=0.319 Sum_probs=200.7
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+++++||+|+||+||+|+.. +++.||||+++... ....+++.+|+++|++++|||||++++++.+..+.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68999999999999999999864 58999999996543 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
|+.++.+.... .. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~-~~-~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD-AS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH-HT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh-hh-cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99865554333 22 3456999999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---hh---hh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---KR---AM 702 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~~ 702 (792)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||......+. .......... .. ..
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ---LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH---HHHHHHhcCCCchhhccccc
Confidence 2 233457999999999876655 58899999999999999999999975332110 0000000000 00 00
Q ss_pred hhccc--cc--cCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcC
Q 003832 703 ELAGD--TL--ADSH-----PPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSS 748 (792)
Q Consensus 703 ~~~~~--~~--~~~~-----~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~ 748 (792)
...+. .. .... ......++.+|+.+||+.||++|||++|+++. +++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 00000 00 0000 01223567889999999999999999999986 644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-43 Score=368.76 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=200.9
Q ss_pred cccccccccCcCCcccEEeeeccCCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e~ 550 (792)
++|+.+++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.+|++++|||||++++++...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999997653 33457899999999999999999999999999999999999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCCc
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDEI 630 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~~ 630 (792)
+.++.+..+... .+.+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhh---cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 998877766532 356999999999999999999999987 99999999999999999999999999988654322
Q ss_pred cccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh---------h
Q 003832 631 QTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK---------R 700 (792)
Q Consensus 631 ~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------~ 700 (792)
......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+ ............ .
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGG
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCChhhccchhh
Confidence 2233568999999999865 457999999999999999999999997433211 110000000000 0
Q ss_pred hhhhc------cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 701 AMELA------GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 701 ~~~~~------~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
..... ...............+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 000000112223456889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-43 Score=364.36 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=195.1
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCc------hhHHHHHHHHHHHHhcc--cccceeeeeeEEeCCc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSG------QGMEEFKNEVTLIARLQ--HRNLVKLLGCCIQADE 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~g~~~~~~~ 543 (792)
++|++.++||+|+||+||+|+.. +++.||||++.+... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999864 589999999865321 12234678999999997 8999999999999999
Q ss_pred ceEEEeecCC-CChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-CCCceEeeecc
Q 003832 544 SMLIYEYMPN-KSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-DMNPKISDFGM 621 (792)
Q Consensus 544 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DFgl 621 (792)
.++||||+.+ +++.+++... ..+++.++..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5777777543 35899999999999999999999988 999999999999985 57999999999
Q ss_pred ccccCCCCccccccccccccCccccccccCCCC-CccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh
Q 003832 622 ARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLF-SVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR 700 (792)
Q Consensus 622 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 700 (792)
++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .. ...
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i--------~~~- 219 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI--------IRG- 219 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH--------HHC-
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH--------hhc-
Confidence 98754322 234679999999999987665 677999999999999999999996311 00 000
Q ss_pred hhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 701 AMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 701 ~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
. ...+...+.++.+++.+||+.||++|||++|++++
T Consensus 220 -----~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 -----Q----VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----C----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----c----cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 01222334568899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=368.94 Aligned_cols=264 Identities=23% Similarity=0.326 Sum_probs=197.3
Q ss_pred hhcccccccccCcCCcccEEeeecc-C-CcEEEEEEccCCC--chhHHHHHHHHHHHHhc---ccccceeeeeeEEeC--
Q 003832 471 ATDNFASYNKLGEGGFGPVYKGTLV-E-GQEIAVKRLSKGS--GQGMEEFKNEVTLIARL---QHRNLVKLLGCCIQA-- 541 (792)
Q Consensus 471 ~~~~~~~~~~lg~G~fg~Vy~g~~~-~-~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~g~~~~~-- 541 (792)
..++|+++++||+|+||+||+|++. + ++.||||+++... ......+.+|+.+|+.+ +||||++++++|...
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 3478999999999999999999863 3 5679999986532 22233566777777666 799999999998642
Q ss_pred ---CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEee
Q 003832 542 ---DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISD 618 (792)
Q Consensus 542 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 618 (792)
...++++||++++.+...... ....+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 457899999999877655432 3456889999999999999999999998 99999999999999999999999
Q ss_pred eccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh
Q 003832 619 FGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE 698 (792)
Q Consensus 619 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 698 (792)
||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. +.........
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~ 233 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGL 233 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCC
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCC
Confidence 9998865322 233457899999999999999999999999999999999999999975432111 1100000000
Q ss_pred hh---h------hhhc----cccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 699 KR---A------MELA----GDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 699 ~~---~------~~~~----~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. . .... .............+.+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0 0000 0000001122334567889999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-41 Score=365.14 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=194.4
Q ss_pred ccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------cceE
Q 003832 474 NFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ESML 546 (792)
Q Consensus 474 ~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------~~~l 546 (792)
+|+..++||+|+||+||+|+.. +++.||||++..... .+.+|+++|++++|||||++++++.... +.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999975 489999999976532 2347999999999999999999986532 3689
Q ss_pred EEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeecccccc
Q 003832 547 IYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIF 625 (792)
Q Consensus 547 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~ 625 (792)
||||++++.+..+.........+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987765555443444567999999999999999999999988 99999999999999775 8999999999876
Q ss_pred CCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhh---hhh
Q 003832 626 GGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKE---KRA 701 (792)
Q Consensus 626 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~ 701 (792)
..... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.... ..... ...
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~-~~~g~~~~~~~ 247 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTREQI 247 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHH-HHHCCCCHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHH-HHhCCChHHhh
Confidence 54332 223579999999998764 5789999999999999999999999975432111 10000 00000 000
Q ss_pred hh----hcccc--------ccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 702 ME----LAGDT--------LADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 702 ~~----~~~~~--------~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
.. ..+.. ...........++.+|+.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000 0001122345568899999999999999999999974
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=360.06 Aligned_cols=268 Identities=19% Similarity=0.281 Sum_probs=195.5
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEe--------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQ-------- 540 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~-------- 540 (792)
.++|+++++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999864 6899999998654 33445778999999999999999999999865
Q ss_pred CCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeec
Q 003832 541 ADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFG 620 (792)
Q Consensus 541 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFg 620 (792)
..+.++||||++++.+..+.. ....++...+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 345789999999887765442 3345788999999999999999999988 9999999999999999999999999
Q ss_pred cccccCCCCcc--ccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh
Q 003832 621 MARIFGGDEIQ--TNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK 697 (792)
Q Consensus 621 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 697 (792)
+++.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99876533221 122335799999999998754 689999999999999999999999974332111000000000000
Q ss_pred hhh--------hhhhccccccCCCCHH-------HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 698 EKR--------AMELAGDTLADSHPPT-------EVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 698 ~~~--------~~~~~~~~~~~~~~~~-------~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
... .............+.. ....+.+|+.+||+.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000 0000000000011111 12356789999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=361.32 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=196.1
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeCC------
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD------ 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~------ 542 (792)
.++|+++++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 468999999999999999999864 5899999999764 3344567899999999999999999999998665
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
+.++||||+ +.+|..++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 5567666632 35899999999999999999999998 999999999999999999999999999
Q ss_pred cccCCCCccccccccccccCccccccccC-CCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH--------HH
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAE-GLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH--------AW 693 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~--------~~ 693 (792)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.............. ..
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 876432 234678999999999876 4579999999999999999999999975432111000000 00
Q ss_pred HHHhhhh---hhhhccccc---cCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCCC
Q 003832 694 ILWKEKR---AMELAGDTL---ADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSDS 750 (792)
Q Consensus 694 ~~~~~~~---~~~~~~~~~---~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~~ 750 (792)
....... ......... ...........+.+|+.+||+.||++|||+.||+++ |++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000000 000000000 001112234567899999999999999999999986 76654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-41 Score=362.11 Aligned_cols=270 Identities=21% Similarity=0.291 Sum_probs=199.4
Q ss_pred hcccccccccCcCCcccEEeeec-cCCcEEEEEEccCCC-chhHHHHHHHHHHHHhcccccceeeeeeEEeCC----cce
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTL-VEGQEIAVKRLSKGS-GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQAD----ESM 545 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~-~~~~~vavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~----~~~ 545 (792)
.++|+++++||+|+||+||+|+. .+|+.||||++++.. ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999986 468999999997653 344568899999999999999999999997654 235
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccccc
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIF 625 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~ 625 (792)
++++++.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+||||+.++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666778899999998542 5899999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCcc-ccccccccccCcccccccc-CCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh------
Q 003832 626 GGDEIQ-TNTHKVVGTYGYMSPEYAA-EGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK------ 697 (792)
Q Consensus 626 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~------ 697 (792)
...... .......||+.|+|||.+. ...++.++||||+||+++||++|+.||......+.............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433221 2234467999999999984 45678999999999999999999999975432211100000000000
Q ss_pred ----hhhhhhhccccccCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 698 ----EKRAMELAGDTLADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 698 ----~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
.........+. ....+ +....++.+|+.+||+.||++|||++|++++ |+..
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 240 IINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000000000 00111 1123467899999999999999999999985 5443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-40 Score=347.81 Aligned_cols=259 Identities=20% Similarity=0.294 Sum_probs=195.4
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccceee-eeeEEeCCcceEEEee
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNLVKL-LGCCIQADESMLIYEY 550 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~g~~~~~~~~~lV~e~ 550 (792)
++|++.++||+|+||.||+|++. +++.||||++..... .+++..|++++++++|+|++.. .++..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999864 588999999865432 2457889999999987765554 5555677788899999
Q ss_pred cCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEec---CCCCceEeeeccccccCC
Q 003832 551 MPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLD---NDMNPKISDFGMARIFGG 627 (792)
Q Consensus 551 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DFgla~~~~~ 627 (792)
+. ++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+..
T Consensus 85 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 95 455555533 2346899999999999999999999998 99999999999985 456799999999998754
Q ss_pred CCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhhh
Q 003832 628 DEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRAM 702 (792)
Q Consensus 628 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 702 (792)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||................ ... .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~----~~~-~ 233 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----EKK-M 233 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH----HHH-H
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh----ccc-C
Confidence 3221 12334689999999999999999999999999999999999999997654433222111110 000 0
Q ss_pred hhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcC
Q 003832 703 ELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSS 748 (792)
Q Consensus 703 ~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~ 748 (792)
....+..... .+.++.+++..|++.+|++||+++++.+.|+.
T Consensus 234 ~~~~~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 234 STPIEVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp HSCHHHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred CCChhHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0001111122 23567889999999999999999999888864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.6e-40 Score=345.20 Aligned_cols=261 Identities=16% Similarity=0.221 Sum_probs=204.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhccc-ccceeeeeeEEeCCcceEEEe
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~~~lV~e 549 (792)
.++|++.++||+|+||+||+|++. +|+.||||++.... ..+.+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 367999999999999999999865 58899999986543 22457789999999975 899999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecC-----CCCceEeeeccccc
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDN-----DMNPKISDFGMARI 624 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DFgla~~ 624 (792)
|+ +++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 68998887543 346899999999999999999999998 999999999999974 57899999999998
Q ss_pred cCCCCcc-----ccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhh
Q 003832 625 FGGDEIQ-----TNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEK 699 (792)
Q Consensus 625 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 699 (792)
+...... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............. ...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~----~i~~~ 231 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE----RIGEK 231 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHH----HHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHH----HHHhc
Confidence 6532211 12334689999999999999999999999999999999999999997654433221111 11111
Q ss_pred hhhhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHhcCC
Q 003832 700 RAMELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLMLSSD 749 (792)
Q Consensus 700 ~~~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~L~~~ 749 (792)
.. ....+.+.... ++++.+++..|++.+|++||+++.+.+.|++.
T Consensus 232 ~~-~~~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 232 KQ-STPLRELCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HH-HSCHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred cC-CCChHHhcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 10 00011111223 34578889999999999999999998887653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=354.55 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=202.7
Q ss_pred cccccccccCcCCcccEEeeecc----CCcEEEEEEccCC----CchhHHHHHHHHHHHHhccc-ccceeeeeeEEeCCc
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV----EGQEIAVKRLSKG----SGQGMEEFKNEVTLIARLQH-RNLVKLLGCCIQADE 543 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~----~~~~vavK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~g~~~~~~~ 543 (792)
++|+..++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999752 3789999998653 22345678899999999976 899999999999999
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+++|||+.+|+|.+++.... .+.......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999986543 4677888999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCCccccccccccccCccccccccCC--CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhhh
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG--LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKRA 701 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 701 (792)
.+...... ......|++.|+|||.+... .++.++|||||||+||||++|+.||...........+.. .
T Consensus 178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~-------~-- 247 (322)
T d1vzoa_ 178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-------R-- 247 (322)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH-------H--
T ss_pred hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-------h--
Confidence 76433322 23346799999999998654 478899999999999999999999976554432111110 0
Q ss_pred hhhccccccCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 003832 702 MELAGDTLADSHPPTEVLRCIHVGLLCVQHRPEDRPN-----MSSVVL 744 (792)
Q Consensus 702 ~~~~~~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs-----~~evl~ 744 (792)
.... ....+.....++.+++.+||+.||++||| ++|+++
T Consensus 248 --~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 248 --ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0000 11234455677889999999999999994 788886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-40 Score=348.71 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=203.6
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeCCcceEEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQADESMLIYE 549 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~~~~~lV~e 549 (792)
++|+++++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999864 58899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccccccCCCC
Q 003832 550 YMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMARIFGGDE 629 (792)
Q Consensus 550 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~~~~~~ 629 (792)
++.+++|..++.. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 9999998887743 345789999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccccccccCCC-CCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHhhhh------hh
Q 003832 630 IQTNTHKVVGTYGYMSPEYAAEGL-FSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWKEKR------AM 702 (792)
Q Consensus 630 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------~~ 702 (792)
. ......++..|+|||.+.... ++.++|||||||++|||++|+.||........ ............. ..
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGG
T ss_pred c--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhh
Confidence 2 222346788999999887654 69999999999999999999999753222111 1111100000000 00
Q ss_pred hhcc---------ccccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 703 ELAG---------DTLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 703 ~~~~---------~~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
...+ ..............+.+|+.+||+.||++|||++||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 001111223344567889999999999999999999873
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=349.77 Aligned_cols=256 Identities=17% Similarity=0.282 Sum_probs=196.7
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeC--CcceEE
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQA--DESMLI 547 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~--~~~~lV 547 (792)
.++|+++++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 368999999999999999999874 5889999999653 3467889999999995 99999999999854 458899
Q ss_pred EeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCC-CceEeeeccccccC
Q 003832 548 YEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDM-NPKISDFGMARIFG 626 (792)
Q Consensus 548 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DFgla~~~~ 626 (792)
|||+++++|..+. +.+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 111 FEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp EECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999997653 34889999999999999999999998 99999999999998665 58999999998765
Q ss_pred CCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHHHHh--------
Q 003832 627 GDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWILWK-------- 697 (792)
Q Consensus 627 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~~~~-------- 697 (792)
.... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... ........
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 182 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYI 256 (328)
T ss_dssp TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHH
T ss_pred CCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHHHHCCchhhhhh
Confidence 4322 2346789999999998765 57999999999999999999999997544321110 00000000
Q ss_pred -hh--h----hhhhccc--------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 003832 698 -EK--R----AMELAGD--------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVL 744 (792)
Q Consensus 698 -~~--~----~~~~~~~--------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~ 744 (792)
.. . ....... ............++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 0000000 0011111223456889999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=351.65 Aligned_cols=262 Identities=23% Similarity=0.270 Sum_probs=190.6
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCC--CchhHHHHHHHHHHHHhcccccceeeeeeEEeC------C
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKG--SGQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA------D 542 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~------~ 542 (792)
.++|+++++||+|+||+||+|++. +|+.||||++.+. .....+.+.+|+.++++++|||||++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999875 5899999999754 234456789999999999999999999999643 5
Q ss_pred cceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeeccc
Q 003832 543 ESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMA 622 (792)
Q Consensus 543 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla 622 (792)
+.++||||+.++.+..+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 779999999776554332 34789999999999999999999998 999999999999999999999999998
Q ss_pred cccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhH------------
Q 003832 623 RIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLG------------ 690 (792)
Q Consensus 623 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~------------ 690 (792)
+...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||...+.......+.
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 8754322 2334678999999999999999999999999999999999999997543211100000
Q ss_pred ----HHHHHHhhh------hhhhhccccccCC---CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 003832 691 ----HAWILWKEK------RAMELAGDTLADS---HPPTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM 745 (792)
Q Consensus 691 ----~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~ 745 (792)
......... ............. ........+.+|+.+||+.||++|||++||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 0000111111111 122346678899999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-39 Score=349.99 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=197.0
Q ss_pred hcccccccccCcCCcccEEeeecc-CCcEEEEEEccCCC--chhHHHHHHHHHHHHhcccccceeeeeeEEeC-----Cc
Q 003832 472 TDNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGS--GQGMEEFKNEVTLIARLQHRNLVKLLGCCIQA-----DE 543 (792)
Q Consensus 472 ~~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~g~~~~~-----~~ 543 (792)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ....+.+.+|+.+|++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 568999999999999999999864 68999999997653 34456788999999999999999999998643 34
Q ss_pred ceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 544 SMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 544 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.+++++|+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 5778888999999999843 35899999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCccccccccccccCccccccccCC-CCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHHHHH-----HH-
Q 003832 624 IFGGDEIQTNTHKVVGTYGYMSPEYAAEG-LFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGHAWI-----LW- 696 (792)
Q Consensus 624 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~-----~~- 696 (792)
.... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.......+..... ..
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 6432 22346789999999987665 568999999999999999999999975432111000000000 00
Q ss_pred --hhhhhhhhccccc-cCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--hcCC
Q 003832 697 --KEKRAMELAGDTL-ADSHP-----PTEVLRCIHVGLLCVQHRPEDRPNMSSVVLM--LSSD 749 (792)
Q Consensus 697 --~~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~Cl~~~P~~RPs~~evl~~--L~~~ 749 (792)
............. ....+ .....++.+|+.+||+.||++|||++|++++ +.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000000000000 00000 1123567899999999999999999999983 6544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-35 Score=322.20 Aligned_cols=284 Identities=19% Similarity=0.215 Sum_probs=205.5
Q ss_pred cccccccccCcCCcccEEeeecc-CCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-----------cccceeeeeeEEe
Q 003832 473 DNFASYNKLGEGGFGPVYKGTLV-EGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-----------HRNLVKLLGCCIQ 540 (792)
Q Consensus 473 ~~~~~~~~lg~G~fg~Vy~g~~~-~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~g~~~~ 540 (792)
++|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999864 58999999997643 33467788999988875 5789999998865
Q ss_pred C--CcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhh-cCCCCEEecCCCCCcEEecCCCC----
Q 003832 541 A--DESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQ-DSRMRIIHRDLKASNVLLDNDMN---- 613 (792)
Q Consensus 541 ~--~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~---- 613 (792)
. ...+++++++..+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 4566777777666554444444456678899999999999999999998 55 999999999999986654
Q ss_pred --ceEeeeccccccCCCCccccccccccccCccccccccCCCCCccCcchhHHHHHHHHHhCCCCCCCCCCCCccchhHH
Q 003832 614 --PKISDFGMARIFGGDEIQTNTHKVVGTYGYMSPEYAAEGLFSVKSDVFSFGVLVLEIVSGKKNWRFSHPDHDHNLLGH 691 (792)
Q Consensus 614 --~kl~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~k~DVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~ 691 (792)
+|++|||.+..... ......||+.|+|||.+....++.++||||+||+++||++|+.||..............
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 89999999886532 22346799999999999999999999999999999999999999975432211111000
Q ss_pred HH---HHHh--------hh-hhhhhccc-------------------cccCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 003832 692 AW---ILWK--------EK-RAMELAGD-------------------TLADSHPPTEVLRCIHVGLLCVQHRPEDRPNMS 740 (792)
Q Consensus 692 ~~---~~~~--------~~-~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~Cl~~~P~~RPs~~ 740 (792)
.. .... .. ......+. ............++.+|+.+||+.||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 0000 00 00000000 001223456778899999999999999999999
Q ss_pred HHHHH--hcC---CCCCCCCCCCCccccCC
Q 003832 741 SVVLM--LSS---DSLLPEPNRPGFFTERS 765 (792)
Q Consensus 741 evl~~--L~~---~~~~~~p~~p~~~~~~~ 765 (792)
|++++ +.+ ..++..|++|.+...++
T Consensus 324 e~L~Hp~f~~~~~~~~~~~p~~~~~~~~~~ 353 (362)
T d1q8ya_ 324 GLVNHPWLKDTLGMEEIRVPDRELYGSGSD 353 (362)
T ss_dssp HHHTCGGGTTCTTCTTCCCTTSCTTCBSTT
T ss_pred HHhcCcccCCCCCcccCCCCCcccCCCCCC
Confidence 99985 543 35666677776654443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=2.6e-21 Score=189.18 Aligned_cols=163 Identities=20% Similarity=0.192 Sum_probs=121.4
Q ss_pred ccccccCcCCcccEEeeeccCCcEEEEEEccCCCc------------------hhHHHHHHHHHHHHhcccccceeeeee
Q 003832 476 ASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSG------------------QGMEEFKNEVTLIARLQHRNLVKLLGC 537 (792)
Q Consensus 476 ~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~g~ 537 (792)
.+.++||+|+||+||+|+..+|+.||||+++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34679999999999999988899999998753210 012234568889999999999988765
Q ss_pred EEeCCcceEEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcCCCCEEecCCCCCcEEecCCCCceEe
Q 003832 538 CIQADESMLIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDSRMRIIHRDLKASNVLLDNDMNPKIS 617 (792)
Q Consensus 538 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 617 (792)
. ..+++|||+++..+. .++......++.|++++|.|||+.+ |+||||||+|||+++++ ++|+
T Consensus 83 ~----~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEEC
T ss_pred c----CCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEE
Confidence 3 347999999886542 2445566789999999999999988 99999999999999765 8999
Q ss_pred eeccccccCCCCccccccccccccCccc------cccccCCCCCccCcchhHHHHH
Q 003832 618 DFGMARIFGGDEIQTNTHKVVGTYGYMS------PEYAAEGLFSVKSDVFSFGVLV 667 (792)
Q Consensus 618 DFgla~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~s~k~DVwS~Gvil 667 (792)
|||++......... .|.. .|.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 99999765432211 1111 1112 35678899999976443
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.81 E-value=5.4e-20 Score=162.15 Aligned_cols=111 Identities=19% Similarity=0.409 Sum_probs=93.6
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
+|||.|||.|.+|+.|+| |.|+|.|...|+ |.++. ..++||.||++.|.. .+.+.++.||+|+| ++
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 489999999999999974 999999998775 55654 468999999998754 46799999999999 65
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCD 143 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTD 143 (792)
+..+|++++.......+|+|+|+|||||++.+ +.++|||+.+|+|
T Consensus 68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~-~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-NNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-SCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCceEEEEcCCCCEEEECCC-CcEEecCCCccCC
Confidence 56788887665556678999999999999977 7899999999986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.78 E-value=2.4e-19 Score=156.37 Aligned_cols=106 Identities=21% Similarity=0.334 Sum_probs=90.6
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
+|+|.+||.|.+|+.|. +|.|.|.|+..|+ |.||. ..++||.||++.|- +.+.+.+..+|+|+| ++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 47899999999999995 6999999998876 66764 46889999999874 346799999999988 99
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~ 140 (792)
+|.++|+|++.......+|+|+|+|||||++ ..+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~----~~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYG----TDRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEE----CCCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeC----CCcccCCCC
Confidence 9999999998755566678999999999995 359999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.78 E-value=6e-19 Score=153.83 Aligned_cols=107 Identities=20% Similarity=0.302 Sum_probs=90.2
Q ss_pred cCcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CC
Q 003832 18 NDNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DG 96 (792)
Q Consensus 18 ~~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~ 96 (792)
.|+|.|||.|.+|+.|. +|.|.|+|...++ |.++. ..++||+||++.|... .+.|.+++||+|+| |+
T Consensus 1 ~~~L~~g~~L~~g~~l~--~g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~~dGnLvl~~~ 68 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLD--VEPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQSDGNFVVYDA 68 (109)
T ss_dssp CCEEETTCEEETTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEECTTSCEEEECS
T ss_pred CCCccCCCEEeCCCEEE--eCCEEEEecCCCe-----EEEEe----CCEEEEEeCCCCCCce-eEEEEEcCCceEEEEeC
Confidence 47899999999999996 5889999987655 44543 4689999999999865 56799999999988 99
Q ss_pred CCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCC
Q 003832 97 RDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDH 140 (792)
Q Consensus 97 ~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~ 140 (792)
+|.++|+|+++......+|+|+|+|||||++ ..+|||+-|
T Consensus 69 ~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~----~~~W~S~t~ 108 (109)
T d1kj1a_ 69 EGRSLWASHSVRGNGNYVLVLQEDGNVVIYG----SDIWSTGTY 108 (109)
T ss_dssp SSCEEEECCCCCCSSCCEEEECTTSCEEEEC----CEEEECCCC
T ss_pred CCcEEEEEeeECCCCCEEEEEeCCCcEEEEC----CCEecCCCc
Confidence 9999999998765566789999999999995 359999865
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.68 E-value=2.9e-17 Score=145.38 Aligned_cols=103 Identities=17% Similarity=0.205 Sum_probs=87.7
Q ss_pred EEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceee
Q 003832 56 GIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLW 135 (792)
Q Consensus 56 giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lW 135 (792)
.|||.++++++.+|++|++.|+....-.|.+..||+|+|...+.++|++++.......+|+|+|+|||||++.+ +.+||
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~-~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ-NIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBTTBCCSCCCCCSSCSSCEEEEETTTEEEEEETT-TEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecCCcEEEEEccccCCCcEEEEEeCCeeEEEEcCC-CCEEE
Confidence 68999999999999999999998877889999999999944578899999876556678999999999999987 88999
Q ss_pred eccCCCCCccCCCCcccceeccCCceeEEeeccCCCCCCcceEEeecCCCCceEE
Q 003832 136 QSFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLV 190 (792)
Q Consensus 136 qSFd~PTDtlLpg~~l~~~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~ 190 (792)
|||. +.++|.|.+.+|++|...+|
T Consensus 90 ~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9983 34568899999999987654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.51 E-value=3.4e-15 Score=130.42 Aligned_cols=110 Identities=18% Similarity=0.199 Sum_probs=91.9
Q ss_pred EEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeee
Q 003832 57 IWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQ 136 (792)
Q Consensus 57 iw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWq 136 (792)
|||.-.++.+..|+.+.+.++....-.|.+..||+|+|...+.++|++++.. ..+..|.|+|+|||||++.+ +.+|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~-~~~vWs 80 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ-NTIRWS 80 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEESSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT-TCCSCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcCCeeEEEcccCC-CCceEEEEeccCCEEEEccC-CCEEEE
Confidence 6787777888889999999998878889999999999944678999999764 45678999999999999987 789999
Q ss_pred ccCCCCCccCCCCcccceeccCCceeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 137 SFDHPCDTLLPGMKLGRNFKTGMDRHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 137 SFd~PTDtlLpg~~l~~~~~~g~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
|+. +.++|.|.+.++++|...++ ...+|.+|.
T Consensus 81 S~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 81 SGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred cCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 873 34579999999999987554 346888774
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.49 E-value=5.7e-14 Score=123.48 Aligned_cols=102 Identities=14% Similarity=0.260 Sum_probs=80.4
Q ss_pred CcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CCC
Q 003832 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGR 97 (792)
Q Consensus 19 ~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~~ 97 (792)
++|.++|+| .+.+..|.|.|.|...|+ |.+ |. ..++||.||+..|.. ...|.+..||+|+| |++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc-----EEE-EE---CCeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence 445555554 246789999999998776 444 43 468999999987643 46799999999999 999
Q ss_pred CceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccC
Q 003832 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (792)
Q Consensus 98 ~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd 139 (792)
|.+||++++.......+++|+|+|||||.+ .++|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC----CCEeccCC
Confidence 999999998755556679999999999984 47999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.22 E-value=1.2e-11 Score=107.57 Aligned_cols=97 Identities=21% Similarity=0.341 Sum_probs=75.0
Q ss_pred CCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CCCCceEEe
Q 003832 25 QSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGRDRIFWS 103 (792)
Q Consensus 25 ~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~~~~~~Ws 103 (792)
|.|.+++.| .+|.|.|.|...|+ |.++. ..++||.+|... ...+.+.+.++|+|+| |..+.+||+
T Consensus 15 ~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 15 QTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp SCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred ceecCCCcE--EcCCEEEEECCCCe-----EEEEc----CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEE
Confidence 445555555 46779999988776 66653 357889998653 2356799999999999 899999999
Q ss_pred eccCCCCCCcEEEEeeccceEEecCCCCceeeeccC
Q 003832 104 SNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFD 139 (792)
Q Consensus 104 s~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd 139 (792)
+++.......+++|+++|||||++ ..+|+|-.
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~----~~~Wssgt 112 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYG----PGLWDSGT 112 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred cCCCCCCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence 998766667789999999999984 47999854
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.92 E-value=1.3e-09 Score=95.36 Aligned_cols=96 Identities=17% Similarity=0.281 Sum_probs=68.6
Q ss_pred CcCCCCCCcCCCCEEEeCCCEEEEEeeCCCCCCceEEEEEEeecCCCeeEEeecCCCCCCCCCceeEEecCceEEe-CCC
Q 003832 19 DNITPSQSIRDGETLVSVNGTFELGFFSPGTSAKRYLGIWYKRVSPRTVAWVANRETPLTDQSGLLNVTSKGIVLL-DGR 97 (792)
Q Consensus 19 ~~i~~g~~l~~~~~l~S~~g~F~lgF~~~~~~~~~~~giw~~~~~~~tvvW~ANr~~p~~~~~~~l~~~~~g~l~l-~~~ 97 (792)
+++.++|+|.. |.|.|.|-..|+ |.|+. ...+||.+|- +.......+.+.++|+|+| |.+
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t--~~~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVLFD----RDDRVWSTNT--AGKGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEEEB----TTBCCSCCCC--CSSCSSCEEEEETTTEEEEEETT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEEec----CCcEEEEEcc--ccCCCcEEEEEeCCeeEEEEcCC
Confidence 35555666554 446666654433 44432 3467898874 3334456799999999999 889
Q ss_pred CceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeec
Q 003832 98 DRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQS 137 (792)
Q Consensus 98 ~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqS 137 (792)
+.++|+|++.......++.|+++|||||++ ..+|.|
T Consensus 85 ~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~----~~~W~t 120 (120)
T d1dlpa2 85 NIAVWTSGNSRSAGRYVFVLQPDRNLAIYG----GALWTT 120 (120)
T ss_dssp TEEEEECCCCCSSSCCEEEECSSSCEEEEC----CCCCBC
T ss_pred CCEEEEeCCCCCCCcEEEEECCCCcEEEeC----CCcccC
Confidence 999999998765566789999999999984 468976
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.80 E-value=9.8e-09 Score=89.45 Aligned_cols=85 Identities=16% Similarity=0.205 Sum_probs=65.7
Q ss_pred eeEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCcee
Q 003832 83 LLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDRH 162 (792)
Q Consensus 83 ~l~~~~~g~l~l~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~~~ 162 (792)
.|.+..||+|+|-..+.++|++++........+.|.++|||||.+.+ +.++|+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~-g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDNNNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-NVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEECCeEEEEecCCCCCcceEEEEEeCCCEEEECCC-CcEEEECCC-----------------------
Confidence 47788999999955577899999875545678999999999999987 788998631
Q ss_pred EEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 163 LSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 163 l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
.-+.|.|.+.++.+|...++ ....|.++.
T Consensus 89 --------~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~T 117 (119)
T d1b2pa_ 89 --------AGKAGHYVLVLQPDRNVVIY----GDALWATQT 117 (119)
T ss_dssp --------CCCSSCEEEEECTTSCEEEE----ESEEEECCC
T ss_pred --------cCCCCceEEEEcCCCCEEEE----CCCEeccCC
Confidence 11236789999999987654 235787763
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.78 E-value=9.7e-09 Score=88.16 Aligned_cols=85 Identities=16% Similarity=0.284 Sum_probs=64.3
Q ss_pred ceeEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCce
Q 003832 82 GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (792)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~~ 161 (792)
-.|.+..||+|+|-..+.+||++++........+.|.++|||||.+.+ +.++|+|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~-g~~vWsS------------------------ 75 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDVDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS-NKPIWAS------------------------ 75 (108)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-CCEEEEC------------------------
T ss_pred EEEEECCCCeEEEEeCCceeeEeCCCCCCCccEEEEeccceEEEECCC-ccceEEc------------------------
Confidence 357888999999955678999999875545668999999999999988 8899986
Q ss_pred eEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecC
Q 003832 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAG 202 (792)
Q Consensus 162 ~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 202 (792)
.+...++.|.+.++.+|...++ . ...|.++
T Consensus 76 -------~t~~~~~~~~l~L~ddGNlVly--~--~~~W~S~ 105 (108)
T d1jpca_ 76 -------NTGGQNGNYVCILQKDRNVVIY--G--TDRWATG 105 (108)
T ss_dssp -------CCCCSCSCEEEEECTTSCEEEE--E--CCCCCCC
T ss_pred -------cccCCCCcEEEEEcCCCCEEEe--C--CCcccCC
Confidence 1112346788999999987655 2 2356554
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.70 E-value=3.3e-08 Score=84.83 Aligned_cols=86 Identities=22% Similarity=0.322 Sum_probs=64.3
Q ss_pred ceeEEecCceEEeCCCCceEEeeccCCC-CCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCc
Q 003832 82 GLLNVTSKGIVLLDGRDRIFWSSNTSIT-MKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMD 160 (792)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~Wss~~~~~-~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~ 160 (792)
-.|.+..||+|++-..+.+||++|+... .....+.|.++|||||.+++ +.++|+|= |
T Consensus 21 ~~l~~q~dgnLvl~~~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~-g~~vW~s~-----t---------------- 78 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE-GRSLWASH-----S---------------- 78 (109)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS-SCEEEECC-----C----------------
T ss_pred EEEEecCCCeEEEEeCCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCC-CcEEEEEe-----e----------------
Confidence 4577889999999667789999997532 24567999999999999987 88999871 1
Q ss_pred eeEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 161 RHLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 161 ~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
....|.|.+.++++|...++ + ...|.++.
T Consensus 79 ----------~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 79 ----------VRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp ----------CCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred ----------ECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 11236788999999987654 3 34777654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.42 E-value=4.7e-07 Score=90.81 Aligned_cols=149 Identities=17% Similarity=0.105 Sum_probs=103.4
Q ss_pred hHHHhhcccccccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcc-cccceeeeeeEEeCCcce
Q 003832 467 SIAKATDNFASYNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQ-HRNLVKLLGCCIQADESM 545 (792)
Q Consensus 467 ~i~~~~~~~~~~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~g~~~~~~~~~ 545 (792)
++....+.|...+..+.++...||+... +++.+++|+...........+.+|...+..+. +--+.+++.+....+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555567777766665556678998865 56678889876554444456778888888774 434667788888888899
Q ss_pred EEEeecCCCChhHHHhhcccCccCChhhHHHHHHHHHHHHHHHhhcC---------------------------------
Q 003832 546 LIYEYMPNKSLDFFIFDQARATFLDWQKRIHIVGGIARGILYLHQDS--------------------------------- 592 (792)
Q Consensus 546 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------- 592 (792)
+||+++++.++...... ......++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999999887554321 1122334555555566665421
Q ss_pred -----------------------CCCEEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 593 -----------------------RMRIIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 593 -----------------------~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
...++|+|+.|.||++++++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877777999998753
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.32 E-value=1.4e-06 Score=74.87 Aligned_cols=88 Identities=18% Similarity=0.339 Sum_probs=64.8
Q ss_pred ceeEEecCceEEeCCCCceEEeeccCCCCCCcEEEEeeccceEEecCCCCceeeeccCCCCCccCCCCcccceeccCCce
Q 003832 82 GLLNVTSKGIVLLDGRDRIFWSSNTSITMKNPVVQLMDSGNLVLTDGNYNSLLWQSFDHPCDTLLPGMKLGRNFKTGMDR 161 (792)
Q Consensus 82 ~~l~~~~~g~l~l~~~~~~~Wss~~~~~~~~~~a~Lld~GNlVl~~~~~~~~lWqSFd~PTDtlLpg~~l~~~~~~g~~~ 161 (792)
-.|.+..||+|+|-..+.+||++++.....++.++|..+|||||++.+ ..+|.|
T Consensus 21 ~~l~~q~DGNLvly~~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~--~~~w~s------------------------ 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS--RAIWAS------------------------ 74 (112)
T ss_dssp EEEEECTTSCEEEEETTEEEEECCCTTSCSSEEEEECTTSCEEEEETT--EEEEEC------------------------
T ss_pred EEEEEcCCCCEEEEcCCcEEEEccCccCCCCcEEEEeccccEEEEecC--CeEEEE------------------------
Confidence 468888999999966778999999765455678999999999999843 456654
Q ss_pred eEEeeccCCCCCCcceEEeecCCCCceEEEecCceeeeecCC
Q 003832 162 HLSSWKSINDPAPGEFSLWIDTHGFPQLVLRKGSVLQYRAGS 203 (792)
Q Consensus 162 ~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 203 (792)
.+.-..|.|.+.++.+|...++ .......|.++.
T Consensus 75 -------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 -------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHT 108 (112)
T ss_dssp -------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCC
T ss_pred -------eeccCCCceEEEEcCCCCEEEE-CCCCcEEecCCC
Confidence 1111236789999999987655 233456788764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=7.8e-05 Score=73.53 Aligned_cols=74 Identities=18% Similarity=0.243 Sum_probs=53.4
Q ss_pred ccCcCCc-ccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccc--ccceeeeeeEEeCCcceEEEeecCCCCh
Q 003832 480 KLGEGGF-GPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQH--RNLVKLLGCCIQADESMLIYEYMPNKSL 556 (792)
Q Consensus 480 ~lg~G~f-g~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~g~~~~~~~~~lV~e~~~~gsL 556 (792)
.+..|.. ..||+....++..+++|.-.... ...+..|+..++.+.. -.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455553 67899988778888999865443 2346678888877743 3356678888888888999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.32 E-value=0.00064 Score=71.57 Aligned_cols=75 Identities=12% Similarity=0.192 Sum_probs=48.4
Q ss_pred cccCcCCcccEEeeeccC-CcEEEEEEccCC-------CchhHHHHHHHHHHHHhcc-c-c-cceeeeeeEEeCCcceEE
Q 003832 479 NKLGEGGFGPVYKGTLVE-GQEIAVKRLSKG-------SGQGMEEFKNEVTLIARLQ-H-R-NLVKLLGCCIQADESMLI 547 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~-~~~vavK~l~~~-------~~~~~~~~~~Ei~~l~~l~-H-~-niv~l~g~~~~~~~~~lV 547 (792)
+.||.|....||+....+ ++.++||.-... .....+....|.+.|..+. + | .+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 578999999999998755 678999964321 1122344566888887663 2 3 34445443 56677899
Q ss_pred EeecCCCC
Q 003832 548 YEYMPNKS 555 (792)
Q Consensus 548 ~e~~~~gs 555 (792)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.34 E-value=0.0083 Score=60.89 Aligned_cols=136 Identities=13% Similarity=0.134 Sum_probs=77.9
Q ss_pred cccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc--eeee-----eeEEeCCcceEEEeecCCCChh-
Q 003832 486 FGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL--VKLL-----GCCIQADESMLIYEYMPNKSLD- 557 (792)
Q Consensus 486 fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~e~~~~gsL~- 557 (792)
--.||+.+..+|+.+++|+.+.. ....+++..|...+..|....+ +..+ .........+.++++++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35799999999999999998653 2345678889988888853222 1111 1123445577889998765431
Q ss_pred ----HH---------Hhhc------ccCccCCh-------------------hhHHHHHHHHHHHHHHHh----hcCCCC
Q 003832 558 ----FF---------IFDQ------ARATFLDW-------------------QKRIHIVGGIARGILYLH----QDSRMR 595 (792)
Q Consensus 558 ----~~---------l~~~------~~~~~l~~-------------------~~~~~i~~~ia~~L~yLH----~~~~~~ 595 (792)
.+ ++.. .....+++ ..+..+...+.+.+..+. +.....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 0110 00111111 111112222223333332 222346
Q ss_pred EEecCCCCCcEEecCCCCceEeeeccccc
Q 003832 596 IIHRDLKASNVLLDNDMNPKISDFGMARI 624 (792)
Q Consensus 596 ivH~Dlkp~NIll~~~~~~kl~DFgla~~ 624 (792)
++|+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45889998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.18 E-value=0.0082 Score=62.75 Aligned_cols=72 Identities=19% Similarity=0.308 Sum_probs=49.0
Q ss_pred cccCcCCcccEEeeeccC--------CcEEEEEEccCCCchhHHHHHHHHHHHHhcccccc-eeeeeeEEeCCcceEEEe
Q 003832 479 NKLGEGGFGPVYKGTLVE--------GQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRNL-VKLLGCCIQADESMLIYE 549 (792)
Q Consensus 479 ~~lg~G~fg~Vy~g~~~~--------~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~g~~~~~~~~~lV~e 549 (792)
+.|+.|-.-.+|+....+ .+.|++++... . .......+|..+++.+.-.++ .++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 578889999999987644 34567766642 2 233455678889888853344 46777764 268999
Q ss_pred ecCCCCh
Q 003832 550 YMPNKSL 556 (792)
Q Consensus 550 ~~~~gsL 556 (792)
|+++..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.29 E-value=0.034 Score=55.74 Aligned_cols=157 Identities=11% Similarity=0.042 Sum_probs=79.9
Q ss_pred CHHhHHHhhccccc-----ccccCcCCcccEEeeeccCCcEEEEEEccCCCchhHHHHHHHHHHHHhccccc-----cee
Q 003832 464 DFASIAKATDNFAS-----YNKLGEGGFGPVYKGTLVEGQEIAVKRLSKGSGQGMEEFKNEVTLIARLQHRN-----LVK 533 (792)
Q Consensus 464 ~~~~i~~~~~~~~~-----~~~lg~G~fg~Vy~g~~~~~~~vavK~l~~~~~~~~~~~~~Ei~~l~~l~H~n-----iv~ 533 (792)
+.++++....+|.. .+.|..|.--+.|+.+..+| .+++|+..... ..+++..|+.++..+.+.+ .+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 44556666666644 33456677788899887655 58999886532 2234555677777774322 211
Q ss_pred ee-e--eEEeCCcceEEEeecCCCChhH--------------HHhhccc------------------------CccCChh
Q 003832 534 LL-G--CCIQADESMLIYEYMPNKSLDF--------------FIFDQAR------------------------ATFLDWQ 572 (792)
Q Consensus 534 l~-g--~~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~~------------------------~~~l~~~ 572 (792)
.. | +.........++.+..+..... .++.... .......
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0 1122334555666665543210 0000000 0001111
Q ss_pred hHHHHHHHHHHHHHHHhhc-CCCCEEecCCCCCcEEecCCCCceEeeecccc
Q 003832 573 KRIHIVGGIARGILYLHQD-SRMRIIHRDLKASNVLLDNDMNPKISDFGMAR 623 (792)
Q Consensus 573 ~~~~i~~~ia~~L~yLH~~-~~~~ivH~Dlkp~NIll~~~~~~kl~DFgla~ 623 (792)
.....+..+...+.-.+.. -+..+||+|+.++||+++.+...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1122222223333332221 23459999999999999988877899999875
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.19 E-value=0.072 Score=33.11 Aligned_cols=31 Identities=39% Similarity=0.925 Sum_probs=25.0
Q ss_pred ccCcCCCCCCCCccccCC-CCCccCCCCCcccC
Q 003832 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFVPK 307 (792)
Q Consensus 276 d~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~ 307 (792)
|.|.+-..|| ||-|+.- ..-.|.|-.||+|.
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCC
Confidence 7899999999 6889743 34469999999985
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.02 E-value=0.18 Score=33.52 Aligned_cols=31 Identities=32% Similarity=0.920 Sum_probs=24.3
Q ss_pred CccCcC-CCCCCCCccccCC-CCCccCCCCCcc
Q 003832 275 LDRCDL-YSVCGANARCTTN-SSRRCDCLEGFV 305 (792)
Q Consensus 275 ~d~C~~-~~~CG~~g~C~~~-~~~~C~C~~Gf~ 305 (792)
.|.|.. ...|..+|.|... .+-.|.|++||+
T Consensus 3 ideC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 3 VDECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CCTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 367875 5789999999743 445899999996
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.99 E-value=0.3 Score=31.75 Aligned_cols=29 Identities=38% Similarity=0.987 Sum_probs=22.1
Q ss_pred ccCcCCCCCCCCccccCC-CCCccCCCCCcc
Q 003832 276 DRCDLYSVCGANARCTTN-SSRRCDCLEGFV 305 (792)
Q Consensus 276 d~C~~~~~CG~~g~C~~~-~~~~C~C~~Gf~ 305 (792)
|.|. ...|...|.|... ..-.|.|++||.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCC
Confidence 4565 4778889999743 456899999996
|